<SEC-DOCUMENT>0001188112-11-002207.txt : 20110810
<SEC-HEADER>0001188112-11-002207.hdr.sgml : 20110810
<ACCEPTANCE-DATETIME>20110810172359
ACCESSION NUMBER:		0001188112-11-002207
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20110630
FILED AS OF DATE:		20110810
DATE AS OF CHANGE:		20110810

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			APPLIED DNA SCIENCES INC
		CENTRAL INDEX KEY:			0000744452
		STANDARD INDUSTRIAL CLASSIFICATION:	INDUSTRIAL ORGANIC CHEMICALS [2860]
		IRS NUMBER:				592262718
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	002-90539
		FILM NUMBER:		111025228

	BUSINESS ADDRESS:	
		STREET 1:		25 HEALTH SCIENCES DRIVE
		STREET 2:		SUITE 113
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790
		BUSINESS PHONE:		631 444 6861

	MAIL ADDRESS:	
		STREET 1:		25 HEALTH SCIENCES DRIVE
		STREET 2:		SUITE 113
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PROHEALTH MEDICAL TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20010504

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DCC ACQUISITION CORP
		DATE OF NAME CHANGE:	19990211

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DATALINK CAPITAL CORP/TX/
		DATE OF NAME CHANGE:	19980306
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>t71271_10q.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<html>
<head>
    <title>t71271_10q.htm</title>
    <!-- Licensed to: TriState Financial -->
    <!-- Document Created using EDGARizerAgent 5.2.3.0 -->
    <!-- Copyright 1995 - 2009 Thomson Reuters. All rights reserved. -->
</head>



<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">UNITED STATES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SECURITIES AND EXCHANGE COMMISSION</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Washington, D.C. 20549</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">FORM&#160;10-Q</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font></font></div>
</td>
<td align="left" valign="top" width="84%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">QUARTERLY REPORT PURSUANT TO SECTION&#160;13 OR&#160;15(d)&#160;OF&#160;THE SECURITIES EXCHANGE ACT OF 1934</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the quarterly period ended June 30, 2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">OR</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font></font></div>
</td>
<td align="left" valign="top" width="84%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR&#160;15(d)&#160;OF&#160;THE SECURITIES EXCHANGE ACT OF 1934</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the transition period from &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Commission File Number: 33-17387</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Applied DNA Sciences, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Exact name of registrant as specified in its charter)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="44%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Delaware</font></div>
</td>
<td align="left" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="44%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">59-2262718</font></div>
</td>
</tr><tr>
<td valign="top" width="44%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(State or other jurisdiction of</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">incorporation or organization)</font></div>
</td>
<td align="left" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="44%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(I.R.S.&#160;&#160;Employer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Identification No.)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="44%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">25 Health Sciences Drive, Suite 215</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Stony Brook, New York</font></div>
</td>
<td align="left" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="44%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">11790</font></div>
</td>
</tr><tr>
<td valign="top" width="44%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Address of principal executive offices)</font></div>
</td>
<td align="left" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="44%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Zip Code)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">631-444-8090</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Registrant&#8217;s telephone number, including area code)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.</font></div>

<div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">x</font></font>&#160;&#160;Yes <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">o</font></font>&#160;&#160;No</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule&#160;405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).</font></div>

<div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">o</font></font>&#160;&#160;Yes <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">o</font></font>&#160;&#160;No</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company.&#160;&#160;See the definitions of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221;, and &#8220;smaller reporting company&#8221; in Rule&#160;12b-2 of the Exchange Act.&#160;&#160;(Check one):</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="44%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Large accelerated filer <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font></font></font></font></div>
</td>
<td align="left" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="44%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accelerated filer <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font></font></font></font></div>
</td>
</tr><tr>
<td valign="top" width="44%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Non-accelerated filer&#160;&#160;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font></font></font></font></div>
</td>
<td align="left" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="44%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Smaller reporting company&#160;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font></font></font></font></div>
</td>
</tr><tr>
<td valign="top" width="44%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Do not check if a smaller reporting company)</font></div>
</td>
<td align="left" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="44%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).</font></div>

<div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">o</font></font>&#160;&#160;Yes <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">x</font></font>&#160;&#160;No</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of August 10, 2011, the registrant had 472,786,160 shares of common stock outstanding.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Applied DNA Sciences, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Form 10-Q for the Quarter Ended June 30, 2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Table of Contents</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="95%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Page</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Part I - Financial Information</font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 1 - Financial Statements</font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 2 - Management&#8217;s Discussion and Analysis or Plan of Operation</font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 3 - Quantitative and Qualitative Disclosures About Market Risk</font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 4 - Controls and Procedures</font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Part II - Other Information</font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 1 &#8211; Legal Proceedings</font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 5 - Other Information&#160;</font></td>
<td align="right" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;35</font></td>
</tr><tr>
<td align="left" valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 6 - Exhibits</font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Signatures</font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">36</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Part I</font></font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 1. - Financial Statements</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">APPLIED DNA SCIENCES, INC.<br>
</font>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONDENSED CONSOLIDATED BALANCE SHEETS</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
</div>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">June 30,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(unaudited)</font></font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td colspan="8" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">ASSETS</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Current assets:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,464</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,618</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts receivable</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">177,833</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">63,029</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prepaid expenses</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">102,675</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">161,456</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total current assets</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">292,972</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">242,103</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Property, plant and equipment-net of accumulated depreciation of $210,862 and $207,097 respectively</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,765</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other assets:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deposits</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23,458</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,322</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Capitalized finance costs-net of accumulated amortization of $1,678,872 and $947,276, respectively</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">213,365</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">522,489</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intangible assets:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Patents, net of accumulated amortization of $34,257 (Note B)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intellectual property, net of accumulated amortization and write off of $9,067,109 and $8,794,265, respectively&#160;&#160;(Note B)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">363,791</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">636,635</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total Assets</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">893,586</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,413,314</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td colspan="8" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">LIABILITIES AND DEFICIENCY IN STOCKHOLDERS&#8217; EQUITY</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Current liabilities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts payable and accrued liabilities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,316,371</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">967,550</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Advances from officers</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">600,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">50,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Convertible notes payable, net of unamortized discount of $1,088,317 and $545,920, (Note D)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,951,683</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,774,080</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total current liabilities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,868,054</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,791,630</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Long term debt:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Convertible note payable-related party, net of unamortized discount of $5,286</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">219,714</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Commitments and contingencies (Note H)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deficiency in Stockholders&#8217; Equity (Note F)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- issued and outstanding as of June 30, 2011 and September 30, 2010</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Common stock, par value $0.001 per share; 800,000,000 shares authorized; 352,523,001 and 346,366,244 issued and outstanding as of June 30, 2011 and September 30, 2010, respectively</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">352,523</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">346,366</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional paid in capital</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">153,112,072</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">149,396,907</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated deficit</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(157,439,063</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(151,341,303</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total deficiency in stockholders&#8217; equity</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,974,468</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,598,030</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total Liabilities and Deficiency in Stockholders&#8217; Equity</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">893,586</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,413,314</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">See the accompanying notes to the unaudited condensed consolidated financial statements</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">APPLIED DNA SCIENCES, INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONDENSED&#160;CONSOLIDATED STATEMENTS OF OPERATIONS<br>
</font></font>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</font></font></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="6" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Three Months Ended June 30,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="6" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nine Months Ended June 30,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenue</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">229,710</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">170,195</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">687,970</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">430,185</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Operating expenses:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Selling, general and administrative</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,580,788</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,529,777</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,529,352</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,363,215</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research and development</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">47,988</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,142</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">161,645</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">44,944</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Depreciation and amortization</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">91,892</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">92,823</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">276,608</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">278,619</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total operating expenses</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,720,668</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,640,742</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,967,605</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,686,778</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NET LOSS FROM OPERATIONS</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,490,958</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,470,547</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,279,635</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,256,593</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other income (Note C)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Interest expense, net</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(664,037</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(126,388</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,818,125</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(537,252</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss before provision for income taxes</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,154,995</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,596,935</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(6,097,760</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,793,845</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income taxes (benefit)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NET LOSS</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,154,995</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,596,935</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(6,097,760</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,793,845</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss per share-basic and fully diluted</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.01</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.01</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.02</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.02</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted average shares outstanding-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Basic and fully diluted</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">351,962,281</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">301,362,329</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">350,828,973</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">287,448,792</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">See the accompanying notes to the unaudited condensed consolidated financial statements</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">APPLIED DNA SCIENCES, INC</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS<br>
</font></font></font>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</font></font></font></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="6" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nine months ended June 30,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash flows from operating activities:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(6,097,760</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,793,845</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjustments to reconcile net loss&#160;&#160;to net cash used in operating activities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Depreciation and amortization</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">276,608</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">278,619</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair value of vested options issued to officers, directors and employees</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">459,967</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,969,483</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amortization of capitalized financing costs</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">731,595</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">158,167</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amortization of debt discount attributable to convertible debentures</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,549,230</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">335,342</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Equity based compensation</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">567,083</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">956,438</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Common stock issued in settlement of interest</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34,960</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">102,794</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Change in assets and liabilities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Decrease in accounts receivable</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(114,804</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(9,766</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Decrease (increase) in prepaid expenses and deposits</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,645</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(23,221</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Increase in accounts payable and accrued liabilities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">348,822</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">497,248</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net cash used in operating activities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,200,654</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,528,741</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash flows from investing activities:</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash flows from financing activities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net proceeds from&#160;&#160;related party advances</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">550,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net proceeds from issuance of convertible notes</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,645,500</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,337,000</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net cash provided by financing activities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,195,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,337,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net increase in cash and cash equivalents</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,154</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(191,741</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents at beginning of period</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,618</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">213,307</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents at end of period</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,464</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21,566</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Supplemental Disclosures of Cash Flow Information:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash paid during the period for interest</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash paid during the period for taxes</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Non-cash transactions:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair value of warrants issued for financing costs</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">217,971</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Common stock issued in exchange for previously incurred debt</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">389,960</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,800,000</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">See the accompanying notes to the unaudited condensed consolidated financial statements</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">5</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">APPLIED DNA SCIENCES, INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">JUNE 30, 2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE A &#8212; SUMMARY OF ACCOUNTING POLICIES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">General</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The accompanying unaudited&#160;condensed consolidated financial statements as of June 30, 2011 and for the three and nine months ended June 30, 2011 and 2010 are unaudited. These financial statements have been prepared in accordance with Rule S-X of the Securities and Exchange Commission (the &#8220;SEC&#8221;) and with&#160;the instructions to Form 10-Q.&#160; Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the nine month period ended June 30, 2011 are not necessarily indicative of the results that may be expected for the fiscal year ending September 30, 2011. The unaudited condensed consolidated financial statements should be read in conjunction with the consolidated September 30, 2010 financial statements and footnotes thereto included in the Company&#8217;s Annual Report on Form 10-K, as amended, filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Business and Basis of Presentation</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On September 16, 2002, Applied DNA Sciences, Inc. (the &#8220;Company&#8221;) was incorporated under the laws of the State of Nevada.&#160;Effective December 17, 2008, the Company reincorporated from the State of Nevada to the State of Delaware. The Company is principally devoted to developing DNA embedded biotechnology security solutions in the United States and Europe.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Applied DNA Operations Management, Inc., APDN (B.V.I.) Inc. and Applied DNA Sciences Europe Limited. Significant inter-company transactions have been eliminated in consolidation.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Estimates</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures.&#160;&#160;Accordingly, actual results could differ from those estimates.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Revenue Recognition</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Revenues are derived from research, development, qualification and production testing for certain commercial products. Revenue from fixed price testing contracts is generally recorded upon completion of the contracts, which are generally short-term, or upon completion of identifiable contractual tasks. At the time the Company enters into a contract that includes multiple tasks, the Company estimates the amount of actual labor and other costs that will be required to complete each task based on historical experience. Revenues are recognized which provide for a profit margin relative to the testing performed. Revenue relative to each task and from contracts which are time and materials based is recorded as effort is expended. Billings in excess of amounts earned are deferred. Any anticipated losses on contracts are charged to income when identified. To the extent management does not accurately forecast the level of effort required to complete a contract, or individual tasks within a contract, and the Company is unable to negotiate additional billings with a customer for cost over-runs, the Company may incur losses on individual contracts. All selling, general and administrative costs are treated as period costs and expensed as incurred.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">6</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">APPLIED DNA SCIENCES, INC.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">JUNE 30, 2011</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">NOTE A &#8212; SUMMARY OF ACCOUNTING POLICIES (continued)</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For revenue from product sales, the Company recognizes revenue in accordance with Accounting Standards Codification subtopic 605-10, Revenue Recognition (&#8220;ASC 605-10&#8221;). ASC 605-10 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management&#8217;s judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for allowances and other adjustments are provided for in the same period the related sales are recorded. The Company defers any revenue for which the product has not been delivered or is subject to refund until such time that the Company and the customer jointly determine that the product has been delivered or no refund will be required. At June 30, 2011 and September 30, 2010, the Company did not record any&#160;deferred revenue for the respective periods.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Cash Equivalents</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For the purpose of the accompanying unaudited condensed&#160;consolidated financial statements, all highly liquid investments with a maturity of three months or less are considered to be cash equivalents.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Accounts Receivable</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company provides an allowance for doubtful accounts equal to the estimated uncollectible amounts. The Company&#8217;s estimate is based on historical collection experience and a review of the current status of trade accounts receivable. It is reasonably possible that the Company&#8217;s estimate of the allowance for doubtful accounts will change. At June 30, 2011 and September 30, 2010, the Company has deemed that no allowance for doubtful accounts was necessary.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Income Taxes</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company has adopted Accounting Standards Codification subtopic 740-10, Income Taxes (&#8220;ASC 740-10&#8221;) which requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Property and Equipment</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Property and equipment are stated at cost and depreciated over their estimated useful lives of 3 to 5 years using the straight line method.&#160;&#160;At June 30, 2011 and September 30, 2010,&#160;property and equipment consist of:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="70%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="46%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Unaudited)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">June 30,<br>
</font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30,<br>
</font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Computer equipment</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,404</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,404</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Lab equipment</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">77,473</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">77,473</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Furniture</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">105,985</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">105,985</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">210,862</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">210,862</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated depreciation</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">210,862</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">207,097</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,765</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">7</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">APPLIED DNA SCIENCES, INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">JUNE 30, 2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold">NOTE A &#8212; SUMMARY OF ACCOUNTING POLICIES (continued)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Impairment of Long-Lived Assets</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company has adopted Accounting Standards Codification subtopic 360-10, Property, Plant and Equipment (&#8220;ASC 360-10&#8221;). ASC 360-10 requires that long-lived assets and certain identifiable intangibles held and used by the Company be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.&#160;The Company evaluates its long lived assets for impairment annually or </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">more often if events and circumstances&#160;warrant.&#160;Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve break-even operating results over an extended period. The Company evaluates the recoverability of long-lived assets based upon forecasted undiscounted cash flows. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted, based on estimates of future discounted cash flows resulting from the use and ultimate disposition of the asset.&#160;&#160;ASC 360-10 also requires assets to be disposed of be reported at the lower of the carrying amount or the fair value less costs to sell.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Net Loss Per Share</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company has adopted Accounting Standards Codification subtopic 260-10, Earnings Per Share (&#8220;ASC 260-10&#8221;) which specifies the&#160;computation,&#160;presentation and disclosure requirements&#160;of earnings per share information.&#160;&#160;Basic earnings per share have been calculated based upon the weighted average number of common shares outstanding. Dilutive common stock equivalents consist of shares issuable upon conversion of convertible notes and the exercise of the Company&#8217;s stock options and warrants. For the&#160;three and nine months ended&#160;June 30, 2011 and 2010, common stock equivalent shares are excluded from the computation of the diluted loss per share as their effect would be anti-dilutive.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Fully diluted shares outstanding were 496,504,218 and 495,370,910 for the three month and nine months ended June 30, 2011, respectively. Fully diluted shares outstanding were 371,785,665 and 362,372,128 for the three and nine months ended June 30, 2010, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Stock Based Compensation</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company&#160;follows Accounting Standards Codification subtopic 718-10, Compensation (&#8220;ASC 718-10&#8221;) which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the income statement based on their fair values. Stock-based compensation expense recognized under ASC 718-10 for the nine months ended June 30, 2011 and 2010 was $459,967 and $587,235, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of&#160; June 30, 2011, 70,400,000 employee stock options were outstanding with 42,550,000 shares vested and exercisable.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Concentrations</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and trade receivables.&#160;&#160;The Company places its cash and temporary cash investments with high credit quality institutions.&#160;&#160;At times, such investments may be in excess of the FDIC insurance limit.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company&#8217;s revenues earned from sale of products and services for the three and nine months ended June 30, 2011 included an aggregate of 65% and 56% from four and three customers of the Company&#8217;s total revenues, respectively.&#160;Five and three customers accounted for 90% and 65% of the Company&#8217;s revenues earned from sale of products and services for the three and nine months ended June 30, 2010, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Four customers accounted for 69% and 90% of the Company&#8217;s total accounts receivable at June 30, 2011 and September 30, 2010, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">8</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">APPLIED DNA SCIENCES, INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">JUNE 30, 2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE A &#8212; SUMMARY OF ACCOUNTING POLICIES (continued)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Research and Development</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company accounts for research and development costs in accordance with the Accounting Standards Codification subtopic 730-10, Research and Development (&#8220;ASC 730-10&#8221;).&#160;&#160;Under ASC 730-10, all research and development costs must be charged to expense as incurred. Accordingly, internal research and development costs are expensed as incurred.&#160;&#160;Third-party research and development costs are expensed when the contracted work has been performed or as milestone results have been achieved. Company-sponsored research and development costs related to both present and future products are expensed in the period incurred.&#160; The Company incurred research and development expenses of $47,988 and $18,142 for the three month periods ended June 30, 2011 and 2010, respectively, and $161,645 and $44,944 for the nine month periods ended June 30, 2011 and 2010, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Advertising</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company follows the policy of charging the costs of advertising to expense as incurred. The Company charged to operations $45,346 and $95,828 for the three and nine month periods ended June 30, 2011, respectively, and $12,225 and $37,680 as advertising costs for the three and nine month periods ended June 30, 2010, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Intangible Assets</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company amortizes its intangible assets using the straight-line method over their estimated period of benefit.&#160;&#160;The estimated useful life for patents is five years while other intellectual property uses a seven year useful life. We periodically evaluate the recoverability of intangible assets and take into account events or circumstances that warrant revised estimates of useful lives or that indicate that impairment exists.&#160;&#160;All of our intangible assets are subject to amortization.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Fair Value of Financial Instruments</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In the first quarter of fiscal year 2008, the Company adopted Accounting Standards Codification subtopic 820-10, Fair Value Measurements and Disclosures (&#8220;ASC 820-10&#8221;).&#160;&#160;ASC 820-10 defines fair value, establishes a framework for measuring fair value, and enhances fair value measurement disclosure. ASC 820-10 delayed, until the first quarter of fiscal year 2009, the effective date for ASC 820-10 for all non-financial assets and non-financial liabilities, except those that are recognized or disclosed at fair value in the financial statements on a recurring basis (at least annually). The adoption of ASC 820-10 did not have a material impact on the Company&#8217;s financial position or operations. Refer to Note I for further discussion regarding fair valuation.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Effective October 1, 2008, the Company adopted Accounting Standards Codification subtopic 820-10, Fair Value Measurements and Disclosures (&#8220;ASC 820-10&#8221;) and Accounting Standards Codification subtopic 825-10, Financial Instruments (&#8220;ASC 825-10&#8221;), which permits entities to choose to measure many financial instruments and certain other items at fair value. Neither of these statements had an impact on the Company&#8217;s consolidated financial position, results of operations or cash flows. The carrying value of cash and cash equivalents, accounts payable and short-term borrowings, as reflected in the balance sheets, approximate fair value because of the short-term maturity of these instruments.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Recent Accounting Pronouncements</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There were various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to have a material impact on the Company&#8217;s consolidated financial position, results of operations or cash flows.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">9</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">APPLIED DNA SCIENCES, INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">JUNE 30, 2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE B - INTANGIBLE ASSETS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Intangible assets acquired and their carrying values at June 30, 2011 and September 30, 2010&#160;are as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="70%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="46%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Unaudited)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">June 30,</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30,</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Trade secrets and developed technologies (Weighted average life of 7 years)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,430,900</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,430,900</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Patents (Weighted average life of 5 years)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34,257</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34,257</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Total Amortized identifiable intangible assets-Gross carrying value:</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,465,157</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,465,157</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Less:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated amortization</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,446,355</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,173,511</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="46%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Impairment (See below)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,655,011</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,655,011</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="46%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net:</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">363,791</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">636,635</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Residual value:</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the year ended September 30,&#160;2006, the Company&#8217;s management performed an evaluation of its intangible assets (intellectual property) for purposes of determining the implied fair value of the assets at September 30, 2006. The test indicated that the recorded remaining book value of its intellectual property exceeded its fair value for the year ended September 30, 2006, as determined by discounted future cash flows.&#160;&#160;As a result, upon completion of the assessment, management recorded a non-cash impairment charge of $5,655,011, net of tax, or $0.05 per share during the year ended September 30, 2006 to reduce the carrying value of the patents to $2,091,800. Considerable management judgment is necessary to estimate the fair value.&#160;&#160;Accordingly, actual results could vary significantly from management&#8217;s estimates.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Total amortization expense charged to operations for the three and nine months ended June 30, 2011 was $90,948 and $272,844, respectively.&#160;&#160;Total amortization expense charged to operations for the three and nine months ended June 30, 2010 was $90,948 and $272,988, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE C &#8211; ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Accounts payable and accrued liabilities at June 30, 2011 and September 30, 2010 are as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="70%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="46%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Unaudited)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">June 30,</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30,</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts payable</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">669,874</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">721,340</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accrued consulting fees</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">102,500</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">102,500</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accrued interest payable</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">323,089</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">88,937</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accrued salaries payable</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">220,908</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">54,773</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,316,371</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">967,550</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">APPLIED DNA SCIENCES, INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">JUNE 30, 2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE D &#8211;&#160;CONVERTIBLE NOTES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Convertible notes payable as of June 30, 2011 and September 30, 2010 are as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Unaudited)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">June 30,</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30,</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Secured Convertible Notes Payable dated October 14, 2009, net of unamortized debt discount of $819 (see below)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$&#160;</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$&#160;</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">269,181</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Secured Convertible Note Payable dated January 7, 2010, net of unamortized debt discount of $673 and&#160;&#160;$9,521, respectively (see below)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">40,479</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Secured Convertible Note Payable dated June 4, 2010, net of unamortized debt discount of $2,329 and&#160;&#160;$5,286, respectively (see below)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">222,671</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">219,714</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Secured Convertible Notes Payable dated July 15, 2010, net of unamortized debt discount of $50,337 and $535,580, respectively (see below)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">399,663</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,464,420</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Secured Convertible Notes Payable dated November 19, 2010, net of unamortized debt discount of $29,759 (see below)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">320,241</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Secured Convertible Note Payable dated November 30, 2010, net of unamortized debt discount of $113,211 (see below)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">636,789</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Secured Convertible Note Payable dated January 7, 2011, net of unamortized debt discount of $125,711 (see below)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">624,289</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Secured Convertible Notes Payable, dated July 15, 2010, modified January 7, 2011, net of unamortized debt discount of $766,970 (see below)</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">748,030</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,951,683</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,993,794</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: current portion</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,951,683</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,774,080</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Long-term debt- net</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">219,714</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">10% Secured Convertible Promissory Notes dated October 14, 2009</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On October 14, 2009, the Company issued an aggregate of $270,000 convertible promissory notes due October 14, 2010 with interest at 10% per annum due upon maturity. The notes are convertible at any time prior to maturity, at the holders&#8217; option, into shares of our common stock at a price equal to the greater of (i) 50% of the average price of our common stock for the ten trading days prior to the date of the notice of conversion or (ii) at $0.092674218 per share, which is equal to a 20% discount to the average volume, weighted average price of our common stock for the ten trading days prior to issuance. At maturity, the notes, including any accrued and unpaid interest, are automatically convertible at $0.092674218 per share. The Company has granted the noteholders a security interest in all the Company&#8217;s assets.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In accordance with ASC 470-20, the Company recognized an embedded beneficial conversion feature present in the notes. The Company allocated a portion of the proceeds equal to the intrinsic value of that feature to additional paid-in capital. The Company recognized and measured an aggregate of $21,343 of the proceeds, which is equal to the intrinsic value of the embedded beneficial conversion feature, to additional paid-in capital and a discount against the notes. The debt discount attributed to the beneficial conversion feature is amortized over the notes&#8217; maturity period (one year) as interest expense.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company recorded the intrinsic value of the embedded beneficial conversion feature ($21,343) to debt discount which will be amortized to interest expense over the term of the notes. The Company recorded the intrinsic value of the embedded beneficial conversion feature ($21,343) to debt discount which will be amortized to interest expense over the term of the notes. Amortization of $819 was recorded for the three and nine months ended June 30, 2011, and $5,321 and $15,145 was recorded for the three and nine month periods ended June 30, 2010, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">11</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">APPLIED DNA SCIENCES, INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">JUNE 30, 2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE D &#8211;&#160;CONVERTIBLE NOTES (continued)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On October 14, 2010, the Company issued 3,204,776 shares of common stock in settlement of the convertible notes and related interest.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">10% Secured Convertible Promissory Note dated January 7, 2010</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On January 7, 2010, the Company issued a $50,000 convertible promissory note due January 7, 2011 with interest at 10% per annum due upon maturity. The note is convertible at any time prior to maturity, at the holder&#8217;s option, into shares of our common stock at a price equal to the greater of (i) 50% of the average price of our common stock for the ten trading days prior to the date of the notice of conversion or (ii) at $0.052877384 per share, which is equal to a 20% discount to the average volume, weighted average price of our common stock for the ten trading days prior to issuance. At maturity, the note, including any accrued and unpaid interest, is automatically convertible at $0.052877384 per share. The Company has granted the noteholder a security interest in all the Company&#8217;s assets.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In accordance with ASC 470-20, the Company recognized an embedded beneficial conversion feature present in the note. The Company allocated a portion of the proceeds equal to the intrinsic value of that feature to additional paid-in capital.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company recognized and measured an aggregate of $35,103 of the proceeds, which is equal to the intrinsic value of the embedded beneficial conversion feature, to additional paid-in capital and a discount against the note. The debt discount attributed to the beneficial conversion feature is amortized over the note&#8217;s maturity period (one year) as interest expense.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company recorded the intrinsic value of the embedded beneficial conversion feature ($35,103) to debt discount which will be amortized to interest expense over the term of the note. Amortization of $-0- and $9,521 was recorded for the three and nine months ended June 30, 2011, respectively, and $8,752 and $16,734 was recorded for the three and nine month periods ended June 30, 2010, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On January 7, 2011, the Company issued 1,040,142 shares of common stock in settlement of the convertible note and related interest.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">10% Secured Convertible Promissory Note dated&#160;&#160;June 4, 2010</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On June 4, 2010, the Company issued a $675,000 related party convertible promissory note due January 31, 2012 with interest at 10% per annum due upon maturity. The note is convertible at any time prior to maturity, at the holder&#8217;s option, into shares of our common stock at a price equal to the greater of (i) 50% of the average price of our common stock for the ten trading days prior to the date of the notice of conversion or (ii) at $0.038866151 per share, which is equal to a 20% discount to the average volume, weighted average price of our common stock for the ten trading days prior to issuance. At maturity, the note, including any accrued and unpaid interest, is automatically convertible at $0.038866151 per share. The Company has granted the noteholder a security interest in all the Company&#8217;s assets.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In accordance with ASC 470-20, the Company recognized an embedded beneficial conversion feature present in the note. The Company allocated a portion of the proceeds equal to the intrinsic value of that feature to additional paid-in capital. The Company recognized and measured an aggregate of $19,692 of the proceeds, which is equal to the intrinsic value of the embedded beneficial conversion feature, to additional paid-in capital and a discount against the note. The debt discount attributed to the beneficial conversion feature is amortized over the note&#8217;s maturity period as interest expense.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">12</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">APPLIED DNA SCIENCES, INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">JUNE 30, 2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE D &#8211;&#160;CONVERTIBLE NOTES (continued)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company recorded the intrinsic value of the embedded beneficial conversion feature ($19,692) to debt discount which will be amortized to interest expense over the term of the note. Amortization of $986 and $2,957 was recorded for the three and nine months ended June 30, 2011, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On July 15, 2010, $450,000 of the $675,000 related party convertible promissory note was converted to the same terms and conditions as described in the 10% Secured Convertible Promissory Notes dated July 15, 2010 below.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">10% Senior Secured Convertible Promissory Notes dated July 15, 2010</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On July 15, 2010, the Company issued an aggregate of $2,000,000 senior secured convertible promissory notes due July 15, 2011 with interest at 10% per annum due upon maturity to &#8220;accredited investors,&#8221; as defined in regulations promulgated under the Securities Act of 1933, as amended (&#8220;Securities Act&#8221;). The notes are convertible at any time prior to maturity, at the holders&#8217; option, into shares of our common stock (i) prior to the occurrence of Subsequent Financing at a rate&#160;of $0.04405, or (ii) after Subsequent Financing in the event the holder elects to receive conversion shares that are not Subsequent Financing securities, at a rate of $0.04405, or as of any conversion date that occurs after the closing of a Subsequent Financing at a rate of 80% of the purchase price paid by investors in the Subsequent Financing. The notes automatically convert at the earlier occurrence of (i) maturity or (ii) Qualified Financing including any accrued and unpaid interest, at a rate as described above. The Company has granted the noteholders a security interest in all the Company&#8217;s assets and the assets of APDN (B.V.I.) Inc., the Company&#8217;s wholly-owned subsidiary.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Subsequent Financing is defined as the issuance and sale by the Company securities&#160;that does not qualify as Qualified Financing.&#160;&#160;Qualified Financing is defined as the issuance and sale by the Company or an affiliate thereof of&#160;equity or debt securities in a single transaction that results in gross proceeds of&#160;(before transaction fees and expenses) equal to or in excess of&#160;$10,000,000.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In accordance with ASC 470-20, the Company recognized an embedded beneficial conversion feature present in the notes. The Company allocated a portion of the proceeds equal to the intrinsic value of that feature to additional paid-in capital. The Company recognized and measured an aggregate of $678,774 of the proceeds, which is equal to the intrinsic value of the embedded beneficial conversion feature, to additional paid-in capital and a discount against the notes. The debt discount attributed to the beneficial conversion feature is amortized over the notes&#8217; maturity period (one year) as interest expense.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company recorded the intrinsic value of the embedded beneficial conversion feature ($678,774) to debt discount which will be amortized to interest expense over the term of the notes.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On January 7, 2011, upon the completion of a Subsequent Financing, the above described conversion rate changed&#160;&#160;from $0.04405 to $0.37104 with an extended due date from July 15, 2011 to January 7, 2012 on $1,550,000 of the $2,000,000 issued senior convertible promissory notes.&#160;&#160;All other terms are remaining the same.&#160;&#160;Although the conversion rate of the remaining $450,000 senior secured convertible promissory notes remained the same, the due date was extended also to January 7, 2012.&#160;&#160;In conjunction with the conversion rate and term modifications of the $1,550,000 senior secured convertible promissory notes, the Company wrote off the remaining unamortized debt discount of $331,332 to operations.&#160;&#160;See below discussion of the restructured senior secured convertible promissory notes.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">13</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">APPLIED DNA SCIENCES, INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">JUNE 30, 2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold">NOTE D &#8211;&#160;CONVERTIBLE NOTES (continued)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">10% Senior Secured Convertible Promissory Notes dated November 19, 2010</font></font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On November 19, 2010, the Company issued an aggregate of $350,000 in principal amount of senior secured convertible notes bearing interest at a rate of 10% per annum to &#8220;accredited investors,&#8221; as defined in regulations promulgated under the Securities Act.&#160;&#160;The notes are convertible, in whole or in part, at any time, at the option of the noteholders, into either (A) such number of shares of the Company&#8217;s common stock, $0.001 par value per share, </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">determined by dividing (i) the principal amount of each note, together with any and all accrued and unpaid interest and penalties, by (ii) a conversion price of $ 0.032825817, which is equal to a 20% discount to the average volume, weighted average price of our common stock for the ten trading days prior to issuance (the &#8220;Common Conversion Price&#8221;) or (B) securities issued in any Subsequent Financing (&#8220;Subsequent Securities&#8221;) at a conversion price equal to 80% of the price per Subsequent Security paid by investors for Subsequent Securities in a Subsequent Financing (the &#8220;Subsequent Financing Price&#8221;).&#160;&#160;A &#8220;Subsequent Financing&#8221; is the sale by the Company or an affiliate thereof of securities at any time after November 19, 2010 and prior to the earlier of (i) a Qualified Financing or (ii) November 19, 2011.&#160;&#160;A noteholder may convert its notes in whole in connection with any one Subsequent Financing or in part in connection with one or more Subsequent Financings. The notes shall be automatically converted upon the earlier of (I) November 19, 2011 and (II) the completion of a Qualified Financing at the election of each noteholder into either (A) shares of common stock at the Common Conversion Price, (B) Subsequent Securities at a conversion price equal to 80% of the Subsequent Financing Price, or (C) securities issued in a Qualified Financing (the &#8220;Qualified Financing Securities&#8221;) at a conversion price equal to 80% of the price per Qualified Financing Security paid by investors for the Qualified Financing Securities in the Qualified Financing.&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;A &#8220;Qualified Financing&#8221; is the sale by the Company or an affiliate thereof of securities resulting in gross proceeds (before transaction fees and expenses) in a single transaction equal to or in excess of $10 million. The notes bear interest at the rate of 10% per annum and are due and payable in full on November 19, 2011.&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Until the principal and accrued but unpaid interest under the notes are paid in full, or converted into Conversion Shares pursuant to their terms, the Company&#8217;s obligations under the notes will be secured by a lien on all assets of the Company and the assets of APDN (B.V.I.) Inc., the Company&#8217;s wholly-owned subsidiary.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In accordance with ASC 470-20, the Company recognized an embedded beneficial conversion feature present in the notes. The Company allocated a portion of the proceeds equal to the intrinsic value of that feature to additional paid-in capital. The Company recognized and measured an aggregate of $76,494 of the proceeds, which is equal to the intrinsic value of the embedded beneficial conversion feature, to additional paid-in capital and a discount against the notes. The debt discount attributed to the beneficial conversion feature is amortized over the notes&#8217; maturity period (one year) as interest expense.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company recorded the intrinsic value of the embedded beneficial conversion feature ($76,494) to debt discount which will be amortized to interest expense over the term of the notes. Amortization of $19,071 and $46,734 was recorded for the three and nine month periods ended June 30, 2011, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">10% Senior Secured Convertible Promissory Note dated November 30, 2010</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On November 30, 2010, the Company issued&#160;a $750,000 principal amount senior secured convertible note bearing interest at a rate of 10% per annum to an &#8220;accredited investor,&#8221; as defined in regulations promulgated under the Securities Act.&#160;&#160;The note is convertible, in whole or in part, at any time, at the option of the noteholder, into either (A) such number of shares of the Company&#8217;s common stock, $0.001 par value per share, determined by dividing (i) the principal amount of each note, together with any and all accrued and unpaid interest and penalties, by (ii) a conversion price of $ 0.03088, which is equal to a 20% discount to the average volume, weighted average price of our common stock for the ten trading days prior to issuance (the &#8220;Common Conversion Price&#8221;) or (B) securities issued in any Subsequent Financing (&#8220;Subsequent Securities&#8221;) at a conversion price equal to 80% of the price per Subsequent Security paid by investors for Subsequent Securities in a Subsequent Financing (the &#8220;Subsequent Financing Price&#8221;).&#160;&#160;A &#8220;Subsequent Financing&#8221; is the sale by the Company or an affiliate thereof of securities at any time after November 30, 2010 and prior to the earlier of (i) a Qualified Financing or (ii) November 30, 2011.&#160;&#160;The noteholder may convert its note in whole in connection with any one Subsequent Financing or in part in connection with one or more Subsequent Financings. The note shall be automatically converted upon the earlier of (I) November 30, 2011 and (II) the completion of a Qualified Financing at the election of the noteholder into either (A) shares of common stock at the Common Conversion Price, (B) Subsequent Securities at a conversion price equal to 80% of the Subsequent Financing Price, or (C) securities issued in a Qualified Financing (the &#8220;Qualified Financing Securities&#8221;) at a conversion price equal to 80% of the price per Qualified Financing Security paid by investors for the Qualified Financing Securities in the Qualified Financing.&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">14</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">APPLIED DNA SCIENCES, INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">JUNE 30, 2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE D &#8211;&#160;CONVERTIBLE NOTES (continued)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A &#8220;Qualified Financing&#8221; is the sale by the Company or an affiliate thereof of securities resulting in gross proceeds (before transaction fees and expenses) in a single transaction equal to or in excess of $10 million. The note bears interest at the rate of 10% per annum and is due and payable in full on November 30, 2011.&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Until the principal and accrued but unpaid interest under the note is paid in full, or converted into Conversion Shares pursuant to its terms, the Company&#8217;s obligations under the note will be secured by a lien on all assets of the Company and the assets of APDN (B.V.I.) Inc., the Company&#8217;s wholly-owned subsidiary.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In accordance with ASC 470-20, the Company recognized an embedded beneficial conversion feature present in the note. The Company allocated a portion of the proceeds equal to the intrinsic value of that feature to additional paid-in capital. The Company recognized and measured an aggregate of $270,078 of the proceeds, which is equal to the intrinsic value of the embedded beneficial conversion feature, to additional paid-in capital and a discount against the note. The debt discount attributed to the beneficial conversion feature is amortized over the note&#8217;s maturity period (one year) as interest expense.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company recorded the intrinsic value of the embedded beneficial conversion feature ($270,078) to debt discount which will be amortized to interest expense over the term of the note. Amortization of $67,334 and $156,867 was recorded for the three and nine month periods ended June 30, 2011, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">10% Senior Secured Convertible Promissory Note dated January 7, 2011</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On January 7, 2011, the Company issued&#160;&#160;a $750,000 principal amount senior secured convertible note bearing interest at a rate of 10% per annum to an &#8220;accredited investor,&#8221; as defined in regulations promulgated under the Securities Act.&#160;&#160;The note is convertible, in whole or in part, at any time, at the option of the noteholder, into either (A) such number of shares of the Company&#8217;s common stock, $0.001 par value per share, determined by dividing (i) the principal amount of each note, together with any and all accrued and unpaid interest and penalties, by (ii) a conversion price of $ 0.05529, which is equal to a 20% discount to the average volume, weighted average price of our common stock for the ten trading days prior to issuance (the &#8220;Common Conversion Price&#8221;) or (B) securities issued in any Subsequent Financing (&#8220;Subsequent Securities&#8221;) at a conversion price equal to 80% of the price per Subsequent Security paid by investors for Subsequent Securities in a Subsequent Financing (the &#8220;Subsequent Financing Price&#8221;).&#160;&#160;A &#8220;Subsequent Financing&#8221; is the sale by the Company or an affiliate thereof of securities at any time after January 7, 2011 and prior to the earlier of (i) a Qualified Financing or (ii) January 7, 2012.&#160;&#160;The noteholder may convert its note in whole in connection with any one Subsequent Financing or in part in connection with one or more Subsequent Financings. The note shall be automatically converted upon the earlier of (I) January 7, 2012 and (II) the completion of a Qualified Financing at the election of the noteholder into either (A) shares of common stock at the Common Conversion Price, (B) Subsequent Securities at a conversion price equal to 80% of the Subsequent Financing Price, or (C) securities issued in a Qualified Financing (the &#8220;Qualified Financing Securities&#8221;) at a conversion price equal to 80% of the price per Qualified Financing Security paid by investors for the Qualified Financing Securities in the Qualified Financing.&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A &#8220;Qualified Financing&#8221; is the sale by the Company or an affiliate thereof of securities resulting in gross proceeds (before transaction fees and expenses) in a single transaction equal to or in excess of $10 million. The note bears interest at the rate of 10% per annum and is due and payable in full on January 7, 2012.&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Until the principal and accrued but unpaid interest under the note is paid in full, or converted into Conversion Shares pursuant to its terms, the Company&#8217;s obligations under the note will be secured by a lien on all assets of the Company and the assets of APDN (B.V.I.) Inc., the Company&#8217;s wholly-owned subsidiary.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">15</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">APPLIED DNA SCIENCES, INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">JUNE 30, 2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE D &#8211;&#160;CONVERTIBLE NOTES (continued)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In accordance with ASC 470-20, the Company recognized an embedded beneficial conversion feature present in the note. The Company allocated a portion of the proceeds equal to the intrinsic value of that feature to additional paid-in capital. The Company recognized and measured an aggregate of $240,233 of the proceeds, which is equal to the intrinsic value of the embedded beneficial conversion feature, to additional paid-in capital and a discount against the note. The debt discount attributed to the beneficial conversion feature is amortized over the note&#8217;s maturity period (one year) as interest expense.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company recorded the intrinsic value of the embedded beneficial conversion feature ($240,233) to debt discount which will be amortized to interest expense over the term of the note. Amortization of $59,894 and $114,522 was recorded for the three and nine month periods ended June 30, 2011.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">10% Senior Secured Convertible Promissory Notes issued on July 15, 2010, modified on January 7, 2011</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On January 7, 2011, the Company modified previously issued senior secured promissory notes initially dated July 15, 2010 totaling &#160;$1,550,000 in&#160;&#160;principal amount bearing interest at a rate of 10% per annum to &#8220;accredited investors,&#8221; as defined in regulations promulgated under the Securities Act.&#160;&#160;The notes are convertible, in whole or in part, at any time, at the option of the noteholders, into either (A) such number of shares of the Company&#8217;s common stock, $0.001 par value per share, determined by dividing (i) the principal amount of each note, together with any and all accrued and unpaid interest and penalties, by (ii) a conversion price of $ 0.037104 or (B) securities issued in any Subsequent Financing (&#8220;Subsequent Securities&#8221;) at a conversion price equal to 80% of the price per Subsequent Security paid by investors for Subsequent Securities in a Subsequent Financing (the &#8220;Subsequent Financing Price&#8221;).&#160;&#160;A &#8220;Subsequent Financing&#8221; is the sale by the Company or an affiliate thereof of securities at any time after January 7, 2011 and prior to the earlier of (i) a Qualified Financing or (ii) January 7, 2012.&#160;&#160;A noteholder may convert its note in whole in connection with any one Subsequent Financing or in part in connection with one or more Subsequent Financings. The notes shall be automatically converted upon the earlier of (I) January 7, 2012 and (II) the completion of a Qualified Financing at the election of the noteholder into either (A) shares of common stock at the Common Conversion Price, (B) Subsequent Securities at a conversion price equal to 80% of the Subsequent Financing Price, or (C) securities issued in a Qualified Financing (the &#8220;Qualified Financing Securities&#8221;) at a conversion price equal to 80% of the price per Qualified Financing Security paid by investors for the Qualified Financing Securities in the Qualified Financing. The effect of this refinancing was recognized as <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#8220;debt modification</font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#8221; in the financial statements.</font>&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A &#8220;Qualified Financing&#8221; is the sale by the Company or an affiliate thereof of securities resulting in gross proceeds (before transaction fees and expenses) in a single transaction equal to or in excess of $10 million. The notes bear interest at the rate of 10% per annum and is due and payable in full on January 7, 2012.&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Until the principal and accrued but unpaid interest under the notes are paid in full, or converted into Conversion Shares pursuant to their terms, the Company&#8217;s obligations under the notes will be secured by a lien on all assets of the Company and the assets of APDN (B.V.I.) Inc., the Company&#8217;s wholly-owned subsidiary.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In accordance with ASC 470-20, the Company recognized an embedded beneficial conversion feature present in the notes. The Company allocated a portion of the proceeds equal to the intrinsic value of that feature to additional paid-in capital. The Company recognized and measured an aggregate of $1,499,536 of the proceeds, which is equal to the intrinsic value of the embedded beneficial conversion feature, to additional paid-in capital and a discount against the notes. The debt discount attributed to the beneficial conversion feature is amortized over the notes&#8217; maturity period (one year) as interest expense.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company recorded the intrinsic value of the embedded beneficial conversion feature ($1,499,536) to debt discount which will be amortized to interest expense over the term of the note. Amortization of $391,576 and $732,566 was recorded for the three and nine month periods ended June 30, 2011, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">16</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">APPLIED DNA SCIENCES, INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">JUNE 30, 2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE D &#8211;&#160;CONVERTIBLE NOTES (continued)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the quarter ended June 30, 2011, the Company issued an aggregate of 1,023,026 shares of common stock in settlement of the $35,000 of convertible notes and related interest.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE E - RELATED PARTY TRANSACTIONS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company&#8217;s current and former officers and stockholders have advanced funds on a&#160;non-interest bearing basis&#160;to the Company for travel related and working capital purposes.&#160;&#160;The Company has not entered into any agreement on the repayment terms for these advances. As of June 30, 2011 and September 30, 2010, there were&#160;$600,000 and $50,000 advances outstanding, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company has consulting agreements with outside contractors, certain of whom are also company stockholders. The agreements are generally month to month.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE F - CAPITAL STOCK</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company is authorized to issue 800,000,000 shares of common stock, with a $0.001 par value per share, as the result of a vote of stockholders conducted on June 29, 2010 which effected an increase in the authorized shares of common stock from 410,000,000 to 800,000,000. In addition, the Company is authorized to issue 10,000,000 shares of preferred stock with a $0.001 par value per share. As of June 30, 2011 and September 30, 2010, there were 352,523,001 and 346,366,244 shares of common stock issued and outstanding, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the nine months ended June 30, 2011, the Company issued an aggregate of 888,813 shares valued at $65,000 for future consulting services.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the nine month periods ended June 30, 2011 and 2010, the Company has expensed $502,083 and $956,438 related to stock based compensation, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE G - STOCK OPTIONS AND WARRANTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Warrants</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table summarizes the changes in warrants outstanding and the related prices for the shares of the Company&#8217;s common stock issued to non-employees of the Company. These warrants were granted in lieu of cash compensation for services performed or financing expenses in connection with the sale of the Company&#8217;s common stock.&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrants</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercisable</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Remaining</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td colspan="2" valign="bottom" width="4%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Contractual</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td colspan="2" valign="bottom" width="4%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prices</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Life (Years)</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Price</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercisable</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise Price</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.03088</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,428,756</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.42</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.3088</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,428,756</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.3088</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.03283</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">533,116</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.39</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.3283</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">533,116</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.3283</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.04</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,000,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.17</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.04</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,000,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.04</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.04405</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,007,946</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.05</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.04405</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,007,946</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.04405</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.05529</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,356,484</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.53</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.05529</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,356,484</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.05529</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.06</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,000,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.63</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.06</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,000,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.06</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.07</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">200,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.71</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.07</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">200,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.07</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.09</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,400,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.17</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.09</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,400,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.09</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.10</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,500,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.74</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.10</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,500,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.10</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="4%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.50</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,700,000</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.49</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.50</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,700,000</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.50</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="4%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="5%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">57,126,302</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">46,126,302</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">17</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">APPLIED DNA SCIENCES, INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">JUNE 30, 2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE G - STOCK OPTIONS AND WARRANTS (continued)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Transactions involving warrants are summarized as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="70%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="46%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Number of</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Shares</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Weighted</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Average</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Price Per</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Share</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance, September 30, 2009</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">64,820,500</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.43</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,007,946</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.05</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercised</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Canceled or expired</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(17,620,500</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.73</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="46%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at September 30, 2010</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">69,207,946</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.24</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,318,356</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.04</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercised</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8212;</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Canceled or expired</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(16,400,000</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.50</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="46%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance, June 30, 2011</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">57,126,302</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.15</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On April 29, 2010, warrants totaling 10,000,000 were issued in connection with services.&#160;&#160;The warrants are exercisable for five years from the date of issuance at an exercise price of $0.06 per share with 25% vesting immediately, 25% on October 29, 2010, 25% on April 29, 2011 and 25% on October 29, 2011.&#160;&#160;The fair value of the&#160;&#160;warrants vesting during the nine month period ended June 30, 2011 was determined using the Black-Scholes Option Pricing Model with the following assumptions: dividend yield $-0-, volatility of 170.72% and risk free rate from 1.17%.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The determined fair value of $93,580 is charged ratably to current period operations.&#160;&#160;During the three and nine month periods&#160;ended June 30, 2011, $14,911 and $93,580 was charged to operations, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On July 15, 2010, warrants totaling 3,007,946 were issued in connection with services provided in connection with the issuance of convertible notes.&#160;&#160;The warrants are exercisable for seven years from the date of issuance at an exercise price of $0.04405 per share.&#160;&#160;The fair values of the warrants were determined using the Black-Scholes Option Pricing Model with the following assumptions: dividend yield $-0-, volatility of 173.55% and risk free rate from 2.43%.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The determined fair value of $174,429 is charged ratably to current period operations over one year.&#160;&#160;During the three and nine month periods ended June 30, 2011,&#160;$43,607 and $130,821 was charged to operations, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On August 30, 2010, warrants totaling 10,000,000 were issued in connection with services.&#160;&#160;The warrants are exercisable for five years from the date of issuance at an exercise price of $0.04 per share with 33% vesting immediately and 67% upon achieving defined milestones.&#160;&#160;The fair value of the vested warrants was determined using the Black-Scholes Option Pricing Model with the following assumptions: dividend yield $-0-, volatility of 173.24% and risk free rate from 1.39%.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The determined fair value of $113,885 is charged ratably to current period operations.&#160;&#160;During the three and nine month periods ended June 30, 2011, $28,393 and $84,867 was charged to operations, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In the month of November&#160;&#160;2010, warrants totaling 2,961,872 were issued in connection with services provided in connection with the issuance of convertible notes.&#160;&#160;The warrants are exercisable for seven years from the date of issuance at exercise prices from $0.03088 to $0.03283 per share.&#160;&#160;The fair value of the warrants were determined using the Black-Scholes Option Pricing Model with the following assumptions: dividend yield $-0-, volatility of 169.06% to 169.21% and risk free rate from 2.16 to 2.20%.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">18</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">APPLIED DNA SCIENCES, INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">JUNE 30, 2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE G - STOCK OPTIONS AND WARRANTS (continued)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The determined fair value of $120,840 is charged ratably to current period operations over one year.&#160;&#160;During the three and nine month periods ended June 30, 2011, $30,210 and $71,779 was charged to operations, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In the month of January 2011, warrants totaling 1,356,484 were issued in connection with services provided in connection with the issuance of convertible notes.&#160;&#160;The warrants are exercisable for seven years from the date of issuance at exercise price of $0.05529 per share.&#160;&#160;The fair values of the warrants were determined using the Black-Scholes Option Pricing Model with the following assumptions: dividend yield $-0-, volatility of 170.33% and risk free rate of 2.69%.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The determined fair value of $97,131 is charged ratably to current period operations over one year.&#160;&#160;During the three and nine month periods ended June 30, 2011, $24,283 and $46,370 was charged to operations, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Employee Stock Options</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On January 26, 2005, the Board of Directors, and on February 15, 2005, the holders of a majority of the outstanding shares of&#160;common stock of the Company approved the 2005 Incentive Stock Plan and authorized the issuance of 16,000,000 shares of common stock as stock awards and stock options thereunder. On May 16, 2007, at the annual meeting of stockholders, the holders of a majority of the outstanding shares of&#160;common stock of the Company approved an increase in the number of shares subject to the 2005 Incentive Stock Plan to 20,000,000 shares of common stock. On June 17, 2008, the Board of Directors unanimously adopted an amendment to the 2005 Incentive Stock Plan that increased the total number of shares of common stock issuable pursuant to the 2005 Incentive Stock Plan from a total of 20,000,000 shares to a total of 100,000,000 shares, which was approved by our stockholders at the 2008 annual meeting of stockholders held on December 16, 2008.&#160;&#160;In connection with the share increase amendment, the Board of Directors granted and we issued options to purchase a total of 37,670,000 shares at an exercise price of $0.11 to certain key employees and non-employee directors under the 2005 Incentive Stock Plan, including 17,000,000, 5,000,000 and 7,000,000 to James A. Hayward, Kurt H. Jensen and Ming-Hwa Liang, respectively. The options granted to our key employees and non-employee directors vested with respect to 25% of the underlying shares on the date of grant and the remaining vest ratably each anniversary thereafter until fully vested on the third anniversary of the date of grant.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On May 27, 2010, the our named executive officers elected to forfeit certain stock options to purchase up to 29 million shares of our Common Stock at an exercise price of $0.11 that were previously granted to them under the&#160;&#160;2005 Incentive Stock Plan.&#160;&#160;In lieu of the forfeited options, our Board of Directors granted new stock options to such named executive officers to purchase up to 29 million shares of our common stock at an exercise price of $0.05 under the 2005 Stock Incentive Plan which are fully vested and became exercisable on June 29, 2010 following approval by our stockholders to amend our certificate of incorporation to increase our authorized shares of common stock.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On July 1, 2010, our Board of Directors granted nonstatutory stock options under the 2005 Incentive Stock Plan to our named executive officers. The options granted to the named executive officers vested with respect to 25% of the underlying shares on the date of grant, and the remaining will vest ratably each anniversary thereafter until fully vested on the third anniversary of the date of grant.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The 2005 Incentive Stock Plan is designed to retain directors, executives, and selected employees and consultants by rewarding them for making contributions to our success with an award of options to purchase shares of our common stock.&#160;&#160;As of June 30, 2011, a total of 9,675,000 shares have been issued and options to purchase 70,400,000 shares have been granted under the 2005 Incentive Stock Plan.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table summarizes the changes in options outstanding and the related prices for the shares of the Company&#8217;s common stock issued to employees of the Company under&#160; the 2005 Incentive Stock Plan:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">19</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">APPLIED DNA SCIENCES, INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">JUNE 30, 2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE G - STOCK OPTIONS AND WARRANTS (continued)</font></font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="4%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>
</td>
<td colspan="8" valign="bottom" width="28%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Options Outstanding</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="10" valign="bottom" width="34%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Options Exercisable</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td colspan="2" valign="bottom" width="4%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise<br>
</font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prices</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Remaining</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Contractual</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Life</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Years)</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Price</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercisable</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Price</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.05</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">29,000,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.97</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.05</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">29,000,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.05</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.06</font></div>
</td>
<td align="right" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30,000,000</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.01</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.06</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,500,000</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.06</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.07</font></div>
</td>
<td align="right" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,500,000</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.46</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.07</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">500,000</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.07</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.08</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,000,000</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.52</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="left" valign="top" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td valign="top" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.09</font></div>
</td>
<td align="right" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,500,000</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.17</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.09</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,500,000</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.09</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="4%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.11</font></div>
</td>
<td align="right" valign="top" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,400,000</font></div>
</td>
<td align="left" valign="top" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.97</font></div>
</td>
<td align="left" valign="top" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.11</font></div>
</td>
<td align="left" valign="top" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,050,000</font></div>
</td>
<td align="left" valign="top" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.11</font></div>
</td>
<td align="left" valign="top" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="4%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="5%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">70,400,000</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.06</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">42,550,000</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.06</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Transactions involving stock options issued to employees are summarized as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="70%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="46%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number of</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Shares</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Price Per</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Share</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding at October 1, 2009</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">38,920,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.11</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">59,000,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.06</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercised</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cancelled or expired</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(31,020,000</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.11</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="46%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding at September 30, 2010</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">66,900,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.06</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,500,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.08</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercised</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Canceled or expired</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="46%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding at June 30, 2011</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">70,400,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.06</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On January 4, 2011, the Company granted 2,000,000 options to purchase the Company&#8217;s common stock at an exercise price of $0.08 per share for five years to an employee with vesting at 25% each anniversary for the&#160;next four years.&#160;&#160;The fair value of options was determined using the Black-Scholes Option Pricing Model with the following assumptions: dividend yield $-0-, volatility of 170.62% and risk free rate from 2.01%.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company recorded $154,499 and $459,968 as stock compensation expense for the three and nine month periods ended June 30, 2011,&#160;&#160;respectively, and $1,382,248 and $1,969,483 for the three and nine month periods ended June 30, 2010, respectively, for the vesting portion of all employee options outstanding.&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE H - COMMITMENTS AND CONTINGENCIES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company leases office space under an&#160;operating lease in Stony Brook, New York for its corporate use from an entity controlled by a significant former shareholder.&#160; Total lease rental expenses for the three and nine month periods ended June 30, 2011 were $36,056 and $108,054, respectively. Total lease rental expenses for the three and nine month periods ended on June 30, 2010&#160;were $21,858 and $62,408, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">20</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">APPLIED DNA SCIENCES, INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">JUNE 30, 2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</font><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE H - COMMITMENTS AND CONTINGENCIES (continued)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Litigation</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. Except as described below, we are currently not aware of any such legal proceedings that we believe will have, individually or in the aggregate, a material adverse affect on our business, financial condition or operating results.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Demodulation, Inc. v. Applied DNA Sciences, Inc., et al. (Civil Action No. - 2:11-cv-00296-WJM-MF):</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On May 18, 2011, the Company was served with a complaint in a lawsuit brought by Demodulation, Inc. against the Company, Corning Incorporated, Alfred University, and Alfred Technology Resources, Inc.&#160;&#160;On July 8, 2011, the Company filed a motion to dismiss the complaint.&#160;&#160;In response, on August 3, 2011, Demodulation, Inc. filed an amended complaint.&#160;&#160;Demodulation, Inc. alleges that it was unable to bring its microwire technology to market due to the wrongful acts of defendants, who allegedly conspired to steal Demodulation, Inc.&#8217;s trade secrets and other intellectual property and to interfere in its business opportunities.&#160;&#160;Of the 17 claims alleged in the amended complaint, five are asserted against the Company, including alleged misappropriation of trade secrets, antitrust violations, civil RICO, and patent infringement.&#160;&#160;The Company believes these claims are without merit.&#160;&#160;The Company intends to file a motion to dismiss the amended complaint for failure to state a claim and on other grounds.&#160;&#160;The Company intends to vigorously defend the action.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE I - FAIR VALUE MEASUREMENT</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company adopted the provisions of ASC 825-10 on October 1, 2008. ASC 825-10 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825-10 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 establishes three levels of inputs that may be used to measure fair value:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Level 1 - Quoted prices in active markets for identical assets or liabilities.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Upon adoption of ASC 825-10, there was no cumulative effect adjustment to the beginning retained earnings and no impact on the unaudited condensed&#160;consolidated financial statements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">21</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">APPLIED DNA SCIENCES, INC.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">JUNE 30, 2011</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE I - FAIR VALUE MEASUREMENT (continued)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The carrying value of the Company&#8217;s cash and cash equivalents, accounts receivable, accounts payable, short-term borrowings (including convertible notes payable), and other current assets and liabilities approximate fair value because of their short-term maturity.&#160;&#160;All other significant financial assets, financial liabilities and equity instruments of the Company are either recognized or disclosed in the consolidated financial statements together with other information relevant for making a reasonable assessment of future cash flows, interest rate risk and credit risk. Where practicable, the fair values of financial assets and financial liabilities have been determined and disclosed; otherwise, only available information pertinent to fair value has been disclosed.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At June 30, 2011, there were no identified assets or liabilities measured at fair value on a recurring basis.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE J - GOING CONCERN</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying unaudited condensed consolidated financial statements, at June 30, 2011, the Company has a negative working capital of $4.6 million, incurred a net loss for the nine month period ended June 30, 2011 of $6.1 million&#160;and has an accumulated deficit of $157.4 million. These factors, among others, may indicate that the Company will be unable to continue as a going concern for a reasonable period of time.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company&#8217;s existence is dependent upon management&#8217;s ability to develop profitable operations. Management is devoting substantially all of its efforts to developing DNA embedded biotechnology security solutions in the United States and Europe and there can be no assurance that the Company&#8217;s efforts will be successful and no assurance can be given that management&#8217;s actions will result in profitable operations or the resolution of its liquidity problems. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might result should the Company be unable to continue as a going concern.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE K &#8211; SUBSEQUENT EVENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Sale of common stock</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On July 15, 2011, the Company closed a private placement of its common stock.&#160;&#160;The Company issued and sold 105,263,158 shares of Common Stock at a purchase price of $0.0475 per share to accredited investors for gross proceeds of $5,000,000.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A registered broker dealer firm acted as our placement agent with respect to the private placement. In connection with the private placement, the Company paid placement agent commissions and discounts aggregating $265,000.&#160;&#160;In addition, the placement agent or its designees were issued warrants with a seven-year term to purchase an aggregate&#160;of 7,578,948 shares of Common Stock with an exercise price of $0.0475 per share.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Employment agreements</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On July 11, 2011, the Company&#8217;s Board of Directors approved the terms of employment for each of James A. Hayward, the Company&#8217;s Chief Executive Officer, and Kurt H. Jensen, the Company&#8217;s Chief Financial Officer.&#160;&#160;It is </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">anticipated that new employment agreements will be entered into as soon as practicable reflecting these terms.&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In connection with his employment agreement, Dr. Hayward was granted options to purchase 40 million shares of the Company&#8217;s Common Stock at an exercise price per share equal to the average of the bid and asked prices of the Company&#8217;s Common Stock on the Over The Counter (OTC) Bulletin Board on the date of grant..&#160;&#160;The option will vest as follows: 25% on the grant date, and 37.5% on each of the next two anniversaries of the grant date, subject to Dr. Hayward&#8217;s continuous employment.&#160;&#160;If Company revenues for any fiscal quarter increase by more than $1 </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">million over the prior fiscal quarter, then the vesting date for the next 37.5% tranche will be accelerated.&#160;&#160;Exercisability of options for the 40 million shares will be conditioned upon stockholder approval of an amendment of the Company&#8217;s 2005 Incentive Stock Plan made by the Board of Directors increasing the&#160;&#160;aggregate and individual limits on the shares of Company Common Stock issuable under the Plan.&#160;&#160;The Company also granted 15 million shares of the Company&#8217;s Common Stock to Dr. Hayward.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">22</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">APPLIED DNA SCIENCES, INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">JUNE 30, 2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE K &#8211; SUBSEQUENT EVENTS (continued)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition, Dr. Hayward agreed to participate in the private placement described above and purchased 10,526,316 shares of the Company&#8217;s Common Stock using $500,000 recently advanced to the Company.&#160;&#160;The Company has </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">also agreed to issue a one-year senior secured convertible note bearing interest at a rate of 4% per annum in the principal amount of $250,000.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In connection with his employment agreement, Mr. Jensen was granted options to purchase 10 million shares of the Company&#8217;s Common Stock at an exercise price per share equal to the average of the bid and asked prices of the Company&#8217;s Common Stock on the Over The Counter (OTC) Bulletin Board on the date of grant.&#160;&#160;The option will vest as follows: 25% on the grant date, and 37.5% on each of the next two anniversaries of the grant date, subject to Mr. Jensen&#8217;s continuous employment.&#160;&#160;If Company revenues for any fiscal quarter increase by more than $1 million over the prior fiscal quarter, then the vesting date for the next 37.5% tranche will be accelerated.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">C.F. Martin &amp; Co. Agreement</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On July 18, 2011, the Company entered into a Joint Development Agreement, dated as of June 30, 2011 with C.F. Martin &amp; Co., Inc., a designer and manufacturer of acoustic guitars, strings for acoustic guitars, and related guitar components and accessories (&#8220;Martin&#8221;). Under the terms of the agreement, Martin and the Company will jointly develop, create and apply new techniques and know-how for labeling and authenticating guitars, guitar strings and related guitar components and accessories using DNA security markers created by the Company.&#160;&#160;Under the agreement, each party shall bear and be responsible for its own expenses and costs of the development and creation of the techniques and know-how.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Subject to certain exceptions for the Company, the agreement provides for a period of exclusivity (&#8220;Period of Exclusivity&#8221;) of six (6) months beginning on June 30, 2011 whereby Martin and the Company agree not to sell, offer for sale, enter into any agreement with any third party for the future sale of, advertise, or market, anywhere in the world, any jointly developed technique for labeling guitars, guitar strings, and related guitar components and accessories with DNA security markers.&#160;&#160;The agreement also provides that Martin shall purchase DNA security markers exclusively from the Company during the longer of the term of the Agreement or the Period of Exclusivity.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The term of the agreement will continue until the parties agree that the development and creation of techniques or know-how for labeling guitars or guitar strings with DNA security markers is complete, unless either party terminates the agreement by giving at least sixty (60) days written notice to the other party.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">23</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">APPLIED DNA SCIENCES, INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">JUNE 30, 2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(unaudited)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">NOTE K &#8211; SUBSEQUENT EVENTS (continued)</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Disc Graphics Agreement</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On July 8, 2011, the Company entered into an agreement, dated as of July 7, 2011 with Disc Graphics Inc., a provider of specialty packaging (&#8220;DG&#8221;).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Under the terms of the agreement, DG will purchase DNA security markers from the Company to be incorporated into coatings for DG&#8217;s products.&#160;&#160;Additionally, DG will be the Company&#8217;s exclusive distributor in North America of Markers for the folding carton offset print sector and non-exclusive distributor of DNA security markers for pressure sensitive labels. Under the Agreement, the Company is obligated to provide DNA security markers for up to a fixed amount of coatings. The Company received an initial fee upon entering the agreement, and is entitled to an annual fee for the DNA security markers, as well as fees for any authentication services provided by the Company.&#160;&#160;The initial term of the agreement is three years and will automatically renew for successive one year periods, unless </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">either party terminates the agreement by giving written notice to the other party at least ninety (90) days prior to the end of the third year.&#160;&#160;After the initial term, the Company has the right to terminate if DG does not pay the annual fee.</font></div>

<div>&#160;</div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">3SI Agreement</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On August 9, 2011, the Company entered into a Supplier Agreement, dated as of August 3, 2011 (the &#8220;Supplier Agreement&#8221;), with 3SI Security Systems, Inc., a manufacturer and seller of asset protection security systems based on ink and smoke staining as well as GPS technology (&#8220;3SI&#8221;).&#160;&#160;&#160;On the same date, the parties also entered into a License Agreement, dated as of August 3, 2011 (the &#8220;License Agreement&#8221;).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Under the terms of the Supplier Agreement, 3SI will purchase DNA markers and related products (&#8220;Markers&#8221;) from the Company to be incorporated into products subject to certain patents (&#8220;Licensed Patents&#8221;) owned by 3SI (the &#8220;Products&#8221;).&#160;&#160;Pursuant to the License Agreement, 3SI granted a nonexclusive irrevocable license to the Company to make, have made, use, import, offer to sell and sell the Products.&#160;&#160;Under the terms of the Supplier Agreement, 3SI is permitted to purchase the Products from the Company from time to time pursuant to purchase orders.&#160;&#160;The purchase price for the Products will be as set forth in an applicable product schedule for the purchase orders and may be adjusted from time to time pursuant to the terms of the Supplier Agreement.&#160;&#160;Under the terms of the License Agreement, the Company agreed to pay an initial payment and royalties to 3SI based on the number of Products sold, with such royalties being subject to adjustment pursuant to the terms of the License Agreement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The terms of the Supplier Agreement and the License Agreement will continue until the expiration of the Licensed Patents, unless earlier terminated under the terms of the respective agreements.&#160;&#160;Under the terms of the Supplier Agreement, 3SI has the right to immediately terminate upon written notice to the Company in the event that the Company fails to continuously maintain a minimum number of Markers to be incorporated into the Products, or upon 30 days written notice to the Company.&#160;&#160;Under the terms of the License Agreement, 3SI has the right to immediately terminate upon written notice to the Company in the event that the Company fails to continuously maintain a minimum number of Markers, or fails to sell Markers to 3SI for incorporation into the Products for a certain time after being ordered.</font></div>
</div>

<div><br>
&#160;</div>

<div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">24</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 2. - Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following discussion should be read in conjunction with our Unaudited Condensed&#160;Consolidated Financial Statements and Notes thereto, included elsewhere within this report.&#160;&#160;The Quarterly Report contains forward-looking statements including statements using terminology such as &#8220;can&#8221;, &#8220;may&#8221;, &#8220;believe&#8221;, &#8220;designated to&#8221;, &#8220;will&#8221;, &#8220;expect&#8221;, &#8220;plan&#8221;, &#8220;anticipate&#8221;, &#8220;estimate&#8221;, &#8220;potential&#8221; or &#8220;continue&#8221;, or the negative thereof or other comparable terminology regarding beliefs, plans, expectations or intentions regarding the future. You should read statements that contain these words carefully because they:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td align="left" valign="top" width="75%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">discuss our future expectations;</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td align="left" valign="top" width="75%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">contain projections of our future results of operations or of our financial condition; and</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td align="left" valign="top" width="75%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">state other &#8220;forward-looking&#8221; information.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We believe it is important to communicate our expectations. However, forward-looking statements involve risks and uncertainties and our actual results and the timing of certain events could differ materially from those discussed in forward-looking statements as a result of certain factors, including those set forth under &#8220;Risk Factors,&#8221; &#8220;Business&#8221; and elsewhere in our Annual Report on Form 10-K for the year-ended September 30, 2010, as amended. All forward-looking statements and risk factors included in this document are made as of the date hereof, based on information available to us as of the date thereof, and we assume no obligations to update any forward-looking statement or risk factor, unless we are required to do so by law.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Introduction</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are a provider of botanical-DNA based security and authentication solutions that can help protect products, brands and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion.&#160;&#160;SigNature&#174; DNA, Cashield, DNANet and BioMaterial&#8482; Genotyping, our principal anti-counterfeiting and product authentication solutions, can be used in numerous industries, including cash-in-transit (transport and storage of banknotes), textiles and apparel, identity cards and other secure documents, pharmaceuticals, wine, and luxury consumer goods.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are currently selling our SigNature DNA, DNANet and BioMaterial GenoTyping products and services and intend to sell our Cashield product in the future.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SigNature DNA</font>. We use the DNA of plants to manufacture highly customized and encrypted botanical DNA markers, or SigNature DNA Markers, which we believe are virtually impossible to replicate. We have embedded SigNature DNA Markers into a range of our customers&#8217; products, including various inks, dyes, textile treatments, thermal ribbon, thread, varnishes and adhesives. These items can then be tested for the presence of SigNature DNA Markers through an instant field detection or a forensic level authentication. Our SigNature DNA solution provides a secure, accurate and cost-effective means for users to incorporate our SigNature DNA Markers in, and then quickly and reliably authenticate and identify, a broad range of items, such as recovered banknotes, branded textiles and apparel products, pharmaceuticals and cosmetic products, identity cards and other secure documents, digital media, artwork and collectibles and fine wine. Having the ability to reliably authenticate and identify counterfeit versions of such items enables companies and governments to detect, deter, interdict and prosecute counterfeiting enterprises and individuals.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Cashield</font>. Cashield is a family of cash degradation inks that permanently stain banknotes stolen from cash-handling or ATM systems. Cashield extends our offering beyond our prior singular product, AzSure&#174;, to a family of security inks that include Red, Violet, Green, Teal, Indigo, and the original AzSure&#174; Blue. Current degradation dyes suffer from a critical technical weakness, as the dyes may be removed by the use of solvents. We initiated the development of Cashield in response to demand for a more effective carrier for our SigNature DNA markers. Cashield has been certified for use in the EU by the Laboratoire National de M&#233;trologie et d&#8217;Essais (LNE) and passed all 47 individual dye penetration and wash-out-resistance tests. Additionally, a CViT study presented by the University of Leeds cited Cashield AzSure Blue ink as having improved performance versus staining inks from other suppliers. In this study, the AzSure blue ink was tested across a range of currencies, including British pounds, Euros, and U.S. dollars. The evaluation involved exposure to numerous industrial solvents. Final analysis of the results concluded that the AzSure blue ink was bound strongly in five seconds or less to a variety of banknotes, and could not be removed with any solvent.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">25</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">DNANet</font>. In 2010, we developed DNANet tactical DNA products for law enforcement, in the form of DNA-marked fixative sprays and liquids as well as transferable grease. These products, being marketed to global police forces, were created to help link criminals to crimes. DNANet is a tactical forensic system providing unique DNA codes for covert operations that require absolute proof of authentication.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">BioMaterial GenoTyping</font>. Our BioMaterial GenoTyping solution refers to the development of genetic assays to distinguish between varieties or strains of biomaterials, such as cotton, wool, tobacco, fermented beverages, natural drugs and foods, that contain their own source DNA. We have developed two proprietary genetic tests (FiberTyping&#8482; and PimaTyping&#8482;) to track American Pima cotton from the field to finished garments. These genetic assays provide the cotton industry with what we believe to be the first authentication tools that can be applied throughout the U.S. and worldwide cotton industry from cotton growers, mills, wholesalers, distributors, manufacturers and retailers through trade groups and government agencies.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In 2009 we discontinued our BioActive Ingredients program, which we began in 2007.&#160;&#160;We developed BioActive Ingredients for personal care products, such as skin care products, based on the biofermentation expertise developed during the manufacturing of DNA for our SigNature DNA and BioMaterial Genotyping solutions, and we have decided to focus our business on these security and authentication solutions.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Recent Developments</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On July 15, 2011, the Company closed a private placement of its common stock.&#160;&#160;The Company issued and sold 105,263,158 shares of Common Stock at a purchase price of $0.0475 per share to accredited investors for gross proceeds of $5,000,000. The company intends to use the proceeds to try to take advantage of available market opportunities to grow the company.&#160;&#160;In connection with the private placement and within 30 days of the closing thereof, the Company agreed to use its best efforts to expand the size of the Company&#8217;s board of directors and to elect Gerald Catenacci of Neustrada Capital and John Bitzer III of Abarta, Inc., both of which were investors in the private placement, as directors to serve on the board.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition, the Company entered into a Joint Development Agreement, dated as of June 30, 2011 with C.F. Martin &amp; Co., Inc., a designer and manufacturer of acoustic guitars, strings for acoustic guitars, and related guitar components and accessories; on July 8, 2011, the Company entered into an agreement, dated as of July 7, 2011 with Disc Graphics Inc., a provider of specialty packaging; and on August 9, 2011, the Company entered into a long-term supply agreement, dated as of August 3, 2011, with 3SI Security Systems, Inc., a manufacturer and seller of asset protection security systems.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Plan of Operations</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">General</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To date, our operations have produced revenues from SigNature&#174; DNA and BioMaterial&#8482; Genotyping, our principal anti-counterfeiting and product authentication solutions (&#8220;authentication services&#8221;).&#160;&#160;We have continued to incur expenses and have limited sources of liquidity.&#160;&#160;We expect to generate revenues principally from sales of our SigNature Program, Cashield&#8482;, DNANet&#8482; and BioMaterial Genotyping.&#160;&#160;We have developed or are currently attempting to develop business in the following target markets: cash-in-transit, textile and apparel authentication, secure documents, pharmaceuticals, consumer products, fine wine, art and collectibles, and digital and recording media (&#8220;target markets&#8221;).&#160;&#160;Our developments in the cash-in-transit and textile and apparel authentication markets have contributed to the increase in our revenues. We intend to pursue both domestic and international sales opportunities in each of these vertical markets.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Critical Accounting Policies</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Financial Reporting Release No. 60, published by the SEC, recommends that all companies include a discussion of critical accounting policies used in the preparation of their financial statements. While all these significant accounting policies impact our financial condition and results of operations, we view certain of these policies as critical. Policies determined to be critical are those policies that have the most significant impact on our consolidated financial statements and require management to use a greater degree of judgment and estimates. Actual results may differ from those estimates.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">26</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We believe that given current facts and circumstances, it is unlikely that applying any other reasonable judgments or estimate methodologies would cause a material effect on our consolidated results of operations, financial position or liquidity for the periods presented in this report.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The accounting policies identified as critical are as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td align="left" valign="top" width="75%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenue recognition;</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td align="left" valign="top" width="75%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Allowance for uncollectible receivables;</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td align="left" valign="top" width="75%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair value of intangible assets.</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td align="left" valign="top" width="75%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Use of estimates</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Revenue Recognition</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Revenues are derived from research, development, qualification and production testing for certain commercial products. Revenue from fixed price testing contracts is generally recorded upon completion of the contracts, which are generally short-term, or upon completion of identifiable contractual tasks. At the time we enter into a contract that includes multiple tasks, we estimate the amount of actual labor and other costs that will be required to complete each task based on historical experience. Revenues are recognized which provide for a profit margin relative to the testing performed. Revenue relative to each task and from contracts which are time and materials based is recorded as effort is expended. Billings in excess of amounts earned are deferred. Any anticipated losses on contracts are charged to income when identified. To the extent management does not accurately forecast the level of effort required to complete a contract, or individual tasks within a contract, and we are unable to negotiate additional billings with a customer for cost over-runs, we may incur losses on individual contracts. All selling, general and administrative costs are treated as period costs and expensed as incurred.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For revenue from product sales, we recognize revenue in accordance with Accounting Standards Codification subtopic 605-10, Revenue Recognition (&#8220;ASC 605-10&#8221;). ASC 605-10 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management&#8217;s judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. We defer any revenue for which the product has not been delivered or is subject to refund until such time that we and the customer jointly determine that the product has been delivered or no refund will be required.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Allowance for Uncollectible Receivables</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We maintain an allowance for doubtful accounts for estimated losses resulting from the inability of customers to make required payments. We use a combination of write-off history, aging analysis and any specific known troubled accounts in determining the allowance. If the financial condition of customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances could be required.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Fair Value of Intangible Assets</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have adopted Accounting Standards Codification subtopic 360-10, Property, Plant and Equipment (&#8220;ASC 360-10&#8221;).&#160;&#160;The Statement requires that long-lived assets and certain identifiable intangibles held and used by us be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.&#160;&#160;Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve break-even operating results over an extended period.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We evaluate the recoverability of long-lived assets based upon forecasted undiscounted cash flows. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted, based on estimates of future discounted cash flows resulting from the use and ultimate disposition of the asset.&#160;&#160;ASC 360-10 also requires assets to be disposed of be reported at the lower of the carrying amount or the fair value less costs to sell.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">27</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Use of Estimates</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenue and expenses during the reporting period. Actual results could differ from those estimates.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Comparison of Results of Operations for the Three Months Ended June 30, 2011 and 2010</font></font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Revenues</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For the three months ended June 30, 2011 and 2010, we generated $229,710 and $170,195, respectively,&#160;in revenues from operations, principally from the sales of our authentication services and sales of our Signature DNA, respectively. The increase in revenues of $59,515 or 35% for the three months ended June 30, 2011 as compared to the same period last year was primarily caused by higher volume activity for 2011.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Costs and Expenses</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Selling, General and Administrative</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Selling, general and administrative expenses decreased from $2,529,777&#160;for the three months ended June 30, 2010 to $1,580,788&#160;for the three months ended June 30, 2011.&#160;&#160;The decrease of $948,989, or 38%, is primarily attributable to reduced amortization of costs associated with financing.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Research and Development</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Research and development expenses increased from $18,142 for the three months ended June 30, 2010 to $47,988&#160;for the three months ended June 30, 2011.&#160;&#160;The increase of $29,846&#160;is attributed to additional research and development activity needed with current operations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Depreciation and Amortization</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In the three months ended June 30, 2011, depreciation and amortization decreased by $931 from $92,823 for the three months ended June 30, 2010 to $91,892&#160;for the three months ended June 30, 2011.&#160;&#160;The decrease is attributable to the aging of our property and equipment.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total Operating Expenses</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Total operating expenses decreased to $1,720,668 for the three months ended June 30, 2011 from $2,640,742&#160;for the three months ended June 30, 2010, or a decrease of $920,074, primarily attributable to reduced amortization of costs associated with financing .</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Interest Expenses</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Interest expense for the three months ended June 30, 2011 increased by $537,649 to $664,037&#160;from $126,388&#160;for the three months ended June 30, 2010.&#160;&#160;The increase in interest expense was due to larger amortization of debt discounts associated with recently issued or modified convertible promissory notes.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Net (Loss)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net loss for the three months ended June 30, 2011 was $2,154,995 as compared to net loss of $2,596,935 for the three months ended June 30, 2010, primarily attributable to our increase in our debt discount amortization reflected in our interest expense line and offset by a decrease in our&#160;&#160;selling, general and administrative costs.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">28</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Comparison of Results of Operations for the Nine Months Ended June 30, 2011 and 2010</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Revenues</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For the nine months ended June 30, 2011 and 2010, we generated $687,970 and $430,185, respectively,&#160;in revenues from operations, principally from the sales of our authentication services and sales of our Signature DNA, respectively. The increase in revenues of $257,785 or 60% for the nine months ended June 30, 2011 as compared to the same period last year was primarily caused by higher volume activity for 2011.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Costs and Expenses</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Selling, General and Administrative</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Selling, general and administrative expenses decreased from $5,363,215&#160;for the nine months ended June 30, 2010 to $4,529,352&#160;for the nine months ended June 30, 2011.&#160;&#160;The decrease of $833,863, or 16%, is primarily attributable to reduced amortization of costs associated with financing.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Research and Development</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Research and development expenses increased from $44,944 for the nine months ended June 30, 2010 to $161,645&#160;for the nine months ended June 30, 2011.&#160;&#160;The increase of $116,701&#160;is attributed to additional research and development activity related to the recent development and feasibility study agreements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Depreciation and Amortization</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In the nine months ended June 30, 2011, depreciation and amortization decreased by $2,011 from $278,619&#160;for the nine months ended June 30, 2010 to $276,608&#160;for the nine months ended June 30, 2011.&#160;&#160;The decrease is attributable to the reduced depreciation/additions to our property and equipment.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total Operating Expenses</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Total operating expenses decreased to $4,967,605 for the nine months ended June 30, 2011 from $5,686,778 for the nine months ended June 30, 2010, or a decrease of $719,173, primarily attributable to the reduction in amortization of capitalized financing costs in 2011.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Interest Expenses</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Interest expense for the nine months ended June 30, 2011 increased by $1,280,873&#160;to $1,818,125&#160;from $537,252&#160;for the nine months ended June 30, 2010.&#160;&#160;The increase in interest expense was due to larger amortization of debt discounts associated with recently issued or modified convertible promissory notes.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Net (Loss)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net loss for the nine months ended June 30, 2011 was $6,097,760 as compared to net loss of $5,793,845&#160;in the prior period primarily attributable to increase in interest expense and a decrease in our&#160;&#160;selling, general and administrative costs as described above.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Liquidity and Capital Resources</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our liquidity needs consist of our working capital requirements, indebtedness payments and research and development expenditure funding.&#160;&#160;Historically, we have financed our operations through the sale of equity and convertible debt as well as borrowings from various credit sources. In fiscal 2011, and in prior fiscal years, we have been relying in part on cash infusions from our President, Chairman and Chief Executive Officer, James A. Hayward, in order to fund our operations.&#160;&#160;During fiscal 2011 and 2010, Dr. Hayward provided $600,000 and $725,000 in new loans, respectively.&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">29</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of June 30, 2011, we had a working capital deficit of $4,575,082.&#160;&#160;For the nine months ended June 30, 2011, we generated a net cash flow deficit from operating activities of $2,200,654 consisting primarily of year to date loss of $6,097,760.&#160;&#160;Non cash adjustments included $2,557,433 in depreciation and amortization charges and, $1,027,050 for equity based compensation and $34,960 for settlement of accrued interest. Additionally, we had a net increase in assets of $71,159 and a net increase in current liabilities of $348,822.&#160;&#160;Cash provided by financing activities for the nine months ended June 30, 2011 totaled $2,195,500 consisting of proceeds from the issuance of convertible debt, net of the capitalized financing costs and related party advance repayments of $1,645,500 and $600,000 advances for officers.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We expect capital expenditures to be less than $200,000 in fiscal 2011.&#160;&#160;Our primary investments will be in laboratory equipment to support prototyping and our authentication services.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Exploitation of potential revenue sources&#160;is expected to&#160;be financed primarily through the sale of equity&#160;securities and convertible debt, exercise of outstanding warrants, issuance of notes payable and other debt or a combination thereof, depending upon the transaction size, market conditions and other factors. Any issuances of preferred stock will be on such terms and conditions as are approved by our board of directors, may have rights, preferences and privileges senior&#160;to those of common stock, and may dilute the rights of holders of our common stock.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To the extent our revenues continue to increase over comparable year periods, our liquidity will be enhanced. However, we expect to require additional financing to sustain our growth and operations, including an increase in the number of employees.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">By adjusting our operations and development to the level of capitalization, we believe we have sufficient capital resources to meet projected cash flow deficits. However, if during any period we are not successful in generating sufficient liquidity from operations or in raising sufficient capital resources, on terms acceptable to us, this could have a material adverse effect on our business, results of operations, liquidity and financial condition.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our registered independent certified public accountants have stated in their report dated December 15, 2010, that we have incurred operating losses in the last two years, and that we are dependent upon management&#8217;s ability to develop profitable operations and raise additional capital. These factors among others may raise substantial doubt about our ability to continue as a going concern.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Recent Debt and Equity Financing Transactions</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Fiscal 2010</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the year ended September 30, 2010, we issued and sold an aggregate principal amount of $270,000 in secured convertible promissory notes bearing interest at 10% per annum to &#8220;accredited investors,&#8221; as defined in regulations promulgated under the Securities Act.&#160;&#160;The promissory notes and accrued but unpaid interest thereon automatically convert one year after issuance at a conversion price equal to a discount to the average volume, weighted average price of our common stock for the ten trading days prior to issuance, and are convertible into shares of our common stock at the option of the holder at any time prior to such automatic conversion at a price equal to the greater of (i) 50% of the average price of our common stock for the ten trading days prior to the date of the notice of conversion and (ii) the automatic conversion price.&#160;&#160;In addition, any time prior to conversion, we have the irrevocable right to repay the unpaid principal and accrued but unpaid interest under the notes on three days notice.&#160;&#160;The promissory notes bear interest at the rate of 10% per annum and are due and payable in full on the one year anniversary of their issuance.&#160;&#160;The warrants are exercisable for cash or on a cashless basis for a period of four years commencing one year after issuance at a price of $0.50 per share.&#160;&#160;Each warrant may be redeemed at our option at a redemption price of $0.01 upon the earlier of (i) three years after the issuance, and (ii) the date our common stock has traded on The Over the Counter Bulletin Board at or above $1.00 per share for 20 consecutive trading days.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">30</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition, on July 15, 2010, we issued and sold an aggregate of $1,100,000 in principal amount of senior secured convertible notes (the &#8220;July 15 Notes&#8221;)&#160;bearing interest at a rate of 10% per annum to &#8220;accredited investors,&#8221; as defined in regulations promulgated under the Securities Act (the &#8220;Private Placement&#8221;).&#160;&#160;The July 15 Notes&#160;are convertible, in whole or in part, at any time, at the option of the holders, into either (A) such number of shares of the Company&#8217;s common stock, $0.001 par value per share, determined by dividing (i) the principal amount of each July 15&#160;Note, together with any and all accrued and unpaid interest and penalties, by (ii) a conversion price of $0.04405, which is equal to a 20% discount to the average volume, weighted average price of our common stock for the ten trading days prior to issuance (the &#8220;Common Conversion Price&#8221;) or (B) securities issued in any Subsequent Financing (&#8220;Subsequent Financing Securities&#8221;) at a conversion price equal to 80% of the price per Subsequent Security paid by investors for Subsequent Securities in a Subsequent Financing (the &#8220;Subsequent Financing Price&#8221;).&#160;&#160;A &#8220;Subsequent Financing&#8221; is the sale by the Company or an affiliate thereof of securities at any time after July 15, 2010 and prior to the earlier of (i) a Qualified Financing or (ii) July 15, 2011.&#160;&#160;A holder may convert its July 15&#160;Notes in whole in connection with any one Subsequent Financing or in part in connection with one or more Subsequent Financings. The July 15 Notes shall be automatically converted upon the earlier of (I) July 15, 2011 and (II) the completion of a Qualified Financing at the election of each holder into either (A) shares of common stock at the Common Conversion Price, (B) Subsequent Securities at a conversion price equal to 80% of the Subsequent Financing Price, or (C) securities issued in a Qualified Financing (the &#8220;Qualified Financing Securities&#8221;) at a conversion price equal to 80% of the price per Qualified Security paid by investors for the Qualified Securities in the Qualified Financing.&#160;&#160;A &#8220;Qualified Financing&#8221; is the sale by the Company or an affiliate thereof of securities resulting in gross proceeds (before transaction fees and expenses) in a single transaction equal to or in excess of $10 million. The July 15 Notes bear interest at the rate of 10% per annum and are due and payable in full on July 15, 2011. Until the principal and accrued but unpaid interest under the July 15 Notes are paid in full, or converted into shares of Common Stock, Subsequent Financing Securities or Qualified Financing Securities, as the case may be (the &#8220;Conversion Shares&#8221;) pursuant to their terms, the Company&#8217;s obligations under the July 15 Notes will be secured by a lien on all assets of the Company and the assets of APDN (B.V.I.) Inc., the Company&#8217;s wholly-owned subsidiary.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The July 15 Notes were issued pursuant to a Securities Purchase Agreement (the &#8220;Purchase Agreement&#8221;), dated as of July 15, 2010, by and among the Company and the purchasers named therein (the &#8220;Purchasers&#8221;).&#160;&#160;We have made customary representations and warranties and certain covenants in the Purchase Agreement and the July 15 Notes including, among others, covenants (i) not to offer, sell, grant any option or otherwise dispose of, with certain exceptions, any of our, or our subsidiaries&#8217;, equity or equity equivalent securities (a &#8220;Subsequent Placement&#8221;), unless we offer the Purchasers the option to participate pro rata in any proposed or intended issuance, sale or exchange of securities being offered in a Subsequent Placement, (ii) to use commercially reasonable efforts to adopt and comply with Nasdaq or New York Stock Exchange corporate governance standards, (iii) to hire additional senior officers and adopt compensation plans and arrangements that are competitive with comparably situated companies and (iv) not to incur or guarantee any indebtedness, with certain exceptions.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Additionally, the July 15 Notes contain certain events of default that are customarily included in financings of this nature.&#160;&#160;If an event of default occurs, the Purchasers may require the Company to redeem the July 15 Notes, in whole or in part, at a redemption price equal to the Event of Default Redemption Price (as defined in the July 15 Notes).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We also entered into a registration rights agreement, dated as of the date of the Purchase Agreement (the &#8220;Registration Rights Agreement&#8221;), with the Purchasers, pursuant to which we have agreed to prepare and file a registration statement with the SEC to register under the Securities Act of 1933 resales from time to time of the Conversion Shares issued or issuable upon conversion or redemption of the July 15 Notes.&#160;&#160;Pursuant to the Registration Rights Agreement, we are required to file a registration statement within 45 days of receiving a Demand Registration Request (as defined in the Registration Rights Agreement), and to cause the registration statement to be declared effective within 45 days (or 90 days if the registration statement is reviewed by the SEC).&#160;&#160;We will be required to pay penalties to Purchasers in the event that these deadlines are not met.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On July 15, 2010, we cancelled a $450,000 principal amount promissory note previously issued to an accredited investor (&#8220;Prior Investor&#8221;) on June 4, 2010 and, in lieu thereof, issued to the Prior Investor a $450,000 principal amount senior secured convertible note containing the same terms as the form of note issued to the holders in the Private Placement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">31</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On July 15, 2010, we cancelled a $675,000 principal amount promissory note (&#8220;Prior Hayward Note&#8221;) previously issued to James A. Hayward, the Company&#8217;s Chairman, President and Chief Executive Officer on June 4, 2010, and, in lieu thereof, issued to Dr. Hayward a $450,000 principal amount senior secured convertible note containing the same terms as the form of Note issued to the holders in the Private Placement and a $225,000 principal amount promissory note containing the same terms as the Prior Hayward Note.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In February 2011, the Company adjusted the conversion price of $1,550,000 of the $2,000,000 in principal amount of senior secured convertible promissory notes issued on July 15, 2010 (the &#8220;July 15 Notes&#8221;), from $0.04405 to $0.037104.&#160;&#160;The remaining $450,000 aggregate principal amount of the July 15 Notes, held by James A. Hayward, the Company&#8217;s Chairman, President and Chief Executive Officer, will continue to have a conversion price of $0.04405.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Fiscal 2011 (through July 31, 2011)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Since October 1, 2010, we issued and sold an aggregate of $1,850,000 in principal amount of senior secured convertible notes bearing interest at a rate of 10% per annum to &#8220;accredited investors,&#8221; as defined in regulations promulgated under the Securities Act.&#160;&#160;The notes are convertible, in whole or in part, at any time, at the option of the noteholders, into either (A) such number of shares of the Company&#8217;s common stock, $0.001 par value per share, determined by dividing (i) the principal amount of each note, together with any and all accrued and unpaid interest and penalties, by (ii) a conversion price which is equal to a 20% discount to the average volume, weighted average price of our common stock for the ten trading days prior to issuance (the &#8220;Common Conversion Price&#8221;) or (B) securities issued in any Subsequent Financing (&#8220;Subsequent Securities&#8221;) at a conversion price equal to 80% of the price per Subsequent Security paid by investors for Subsequent Securities in a Subsequent Financing (the &#8220;Subsequent Financing Price&#8221;).&#160; The conversion prices of the notes range between $0.03088 and $0.05529.&#160;A &#8220;Subsequent Financing&#8221; is the sale by the Company or an affiliate thereof of securities at any time after the date of issuance of the notes and prior to the earlier of (i) a Qualified Financing or (ii) the one year anniversary of the issuance of the notes.&#160;&#160;A noteholder may convert its notes in whole in connection with any one Subsequent Financing or in part in connection with one or more Subsequent Financings. The notes shall be automatically converted upon the earlier of (I) the one year anniversary of their issuance and (II) the completion of a Qualified Financing at the election of each noteholder into either (A) shares of common stock at the Common Conversion Price, (B) Subsequent Securities at a conversion price equal to 80% of the Subsequent Financing Price, or (C) securities issued in a Qualified Financing (the &#8220;Qualified Financing Securities&#8221;) at a conversion price equal to 80% of the price per Qualified Financing Security paid by investors for the Qualified Financing Securities in the Qualified Financing.&#160;&#160;A &#8220;Qualified Financing&#8221; is the sale by the Company or an affiliate thereof of securities resulting in gross proceeds (before transaction fees and expenses) in a single transaction equal to or in excess of $10 million. The notes bear interest at the rate of 10% per annum and are due and payable in full on the one year anniversary of issuance of the notes.&#160;&#160;Until the principal and accrued but unpaid interest under the notes are paid in full, or converted into Conversion Shares pursuant to their terms, the Company&#8217;s obligations under the notes will be secured by a lien on all assets of the Company and the assets of APDN (B.V.I.) Inc., the Company&#8217;s wholly-owned subsidiary.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We presently do not have any available credit, bank financing or other external sources of liquidity. Due to our brief history and historical operating losses, our operations have not been a material source of liquidity. We will need to obtain additional capital in order to expand operations and become profitable. We intend to pursue the building of a re-seller network outside the United States, and if successful, the re-seller agreements would constitute a source of liquidity and capital over time. In order to obtain capital, we may need to sell additional shares of our common stock or borrow funds from private lenders. There can be no assurance that we will be successful in obtaining additional funding and execution of re-seller agreements outside the Unites States.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;On July 15, 2011, the Company closed a private placement of its common stock.&#160;&#160;The Company issued and sold 105,263,158 shares of Common Stock at a purchase price of $0.0475 per share to accredited investors for gross proceeds of $5,000,000.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">32</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;A registered broker dealer firm acted as our placement agent with respect to the private placement. In connection with the private placement, the Company paid placement agent commissions and discounts aggregating $265,000.&#160;&#160;In addition, the placement agent or its designees were issued warrants with a seven-year term to purchase an aggregate&#160;of 7,578,948 shares of Common Stock with an exercise price of $0.0475 per share.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Additional investments are being sought, but we cannot guarantee that we will be able to obtain such investments. Financing transactions may include the issuance of equity or debt securities, obtaining credit facilities, or other financing mechanisms. Even if we are able to raise the funds required, it is possible that we could incur unexpected costs and expenses, fail to collect significant amounts owed to us, or experience unexpected cash requirements that would force us to seek alternative financing. Further, if we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock. </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Substantially all of the real property used in our business is leased under operating lease agreements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Product Research and Development</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We anticipate spending approximately $50,000 for product research and development activities during the next twelve months.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Acquisition of Plant and Equipment and Other Assets</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We do not anticipate the sale of any material property, plant or equipment during the next 12 months.&#160;&#160;We do anticipate spending approximately $20,000 on the acquisition of leasehold improvements during the next 12 months.&#160;&#160;We believe our current leased space as well as the facility from which we lease space has adequate capacity to manage our growth, if any, over the next 2 to 3 years.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Substantially all of the real property used in our business is leased under operating lease agreements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Number of Employees</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We currently have 16 full-time employees and three part-time employees, including two in management, nine in operations, seven in sales and marketing and one in investor relations.&#160;&#160;We expect to increase our staffing dedicated to sales, product prototyping, manufacturing of DNA markers and forensic authentication services.&#160;&#160;Expenses related to travel, marketing, salaries, and general overhead will be increased as necessary to support our growth in revenue.&#160;&#160;In order for us to attract and retain quality personnel, we anticipate we will have to offer competitive salaries to future employees.&#160;&#160;We anticipate that it may become desirable to add additional full and or part time employees to discharge certain critical functions during the next 12 months.&#160;&#160;This projected increase in personnel is dependent upon our ability to generate revenues and obtain sources of financing.&#160;&#160;There is no guarantee that we will be successful in raising the funds required or generating revenues sufficient to fund the projected increase in the number of employees.&#160;&#160;As we continue to expand, we will incur additional costs for personnel.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Off-Balance Sheet Arrangements</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We do not have any off-balance sheet arrangements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Inflation</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The effect of inflation on our revenue and operating results was not significant.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">33</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Going Concern</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The accompanying unaudited condensed consolidated financial statements included in this filing have been prepared in conformity with generally accepted accounting principles that contemplate our continuance as a going concern. Our auditors, in their report dated December 15, 2010, have expressed substantial doubt about our ability to continue as a going concern. Our cash position may be inadequate to pay all of the costs associated with the testing, production and marketing of our products. Management intends to use borrowings and the sale of equity or convertible debt to mitigate the effects of its cash position, however no assurance can be given that debt or equity financing, if and when required will be available. The accompanying unaudited condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets and classification of liabilities that might be necessary should we be unable to continue existence.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 3. - Quantitative and Qualitative Disclosures About Market Risk.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company is a smaller reporting company as defined by Rule 12b-2 under the Exchange Act and is not required to provide the information required under this item.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 4T. - Controls and Procedures</font>.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Material Weakness Previously Disclosed</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As discussed in our Annual Report on Form 10-K for the year ended September 30, 2010, as amended, we concluded that there were matters that constituted a material weakness in our internal control over financial reporting. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.&#160; Based on our assessment of the effectiveness of internal control over financial reporting as of June 30, 2011, we determined that control deficiencies existed that constituted material weaknesses, as described below:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">lack of documented policies and procedures;</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">we have no audit committee;</font></div>
</td>
</tr></table>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td align="left" valign="top" width="72%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">there is a risk of management override given that our officers have a high degree of involvement in our day to day operations.</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td align="left" valign="top" width="72%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">there is no policy on fraud, though we plan to implement such policies in fiscal 2011; and</font></div>
</td>
</tr></table>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td align="left" valign="top" width="72%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">there is no effective separation of duties, which includes monitoring controls, between the members of management.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Management is currently evaluating what steps can be taken in order to address these material weaknesses.&#160;&#160;We have undertaken the following steps to partially address the deficiencies stated above:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td align="left" valign="top" width="72%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">On July 11, 2011, our Board of Directors adopted a Code of Ethics and Business Conduct for the Company.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Evaluation of Disclosure Controls and Procedures</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of the end of the period covered by this Quarterly Report on Form 10-Q, we conducted an evaluation, under the supervision and with the participation of our management, including our principal executive and principal financial officers, of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act).&#160;&#160;Based on the evaluation of these disclosure controls and procedures, and in light of the material weaknesses previously found in our internal controls, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Changes in Internal Control over Financial Reporting</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the fiscal quarter ended June 30, 2011, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</font></div>

<div><br>
</div>

<div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">34</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Part II - Other Information</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 1. &#8211; Legal Proceedings</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. Except as described below, we are currently not aware of any such legal proceedings that we believe will have, individually or in the aggregate, a material adverse affect on our business, financial condition or operating results.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Demodulation, Inc. v. Applied DNA Sciences, Inc., et al. (Civil Action No. - 2:11-cv-00296-WJM-MF):</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On May 18, 2011, the Company was served with a complaint in a lawsuit brought by Demodulation, Inc. against the Company, Corning Incorporated, Alfred University, and Alfred Technology Resources, Inc.&#160;&#160;On July 8, 2011, the Company filed a motion to dismiss the complaint.&#160;&#160;In response, on August 3, 2011, Demodulation, Inc. filed an amended complaint.&#160;&#160;Demodulation, Inc. alleges that it was unable to bring its microwire technology to market due to the wrongful acts of defendants, who allegedly conspired to steal Demodulation, Inc.&#8217;s trade secrets and other intellectual property and to interfere in its business opportunities.&#160;&#160;Of the 17 claims alleged in the amended complaint, five are asserted against the Company, including alleged misappropriation of trade secrets, antitrust violations, civil RICO, and patent infringement.&#160;&#160;The Company believes these claims are without merit.&#160;&#160;The Company intends to file a motion to dismiss the amended complaint for failure to state a claim and on other grounds.&#160;&#160;The Company intends to vigorously defend the action.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="FONT-WEIGHT: bold">Item 5. &#8211;&#160;Other Information</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">3SI Agreement</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On August 9, 2011, the Company entered into a Supplier Agreement, dated as of August 3, 2011 (the &#8220;Supplier Agreement&#8221;), with 3SI Security Systems, Inc., a manufacturer and seller of asset protection security systems based on ink and smoke staining as well as GPS technology (&#8220;3SI&#8221;).&#160;&#160;&#160;On the same date, the parties also entered into a License Agreement, dated as of August 3, 2011 (the &#8220;License Agreement&#8221;).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Under the terms of the Supplier Agreement, 3SI will purchase DNA markers and related products (&#8220;Markers&#8221;) from the Company to be incorporated into products subject to certain patents (&#8220;Licensed Patents&#8221;) owned by 3SI (the &#8220;Products&#8221;).&#160;&#160;Pursuant to the License Agreement, 3SI granted a nonexclusive irrevocable license to the Company to make, have made, use, import, offer to sell and sell the Products.&#160;&#160;Under the terms of the Supplier Agreement, 3SI is permitted to purchase the Products from the Company from time to time pursuant to purchase orders.&#160;&#160;The purchase price for the Products will be as set forth in an applicable product schedule for the purchase orders and may be adjusted from time to time pursuant to the terms of the Supplier Agreement.&#160;&#160;Under the terms of the License Agreement, the Company agreed to pay an initial payment and royalties to 3SI based on the number of Products sold, with such royalties being subject to adjustment pursuant to the terms of the License Agreement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The terms of the Supplier Agreement and the License Agreement will continue until the expiration of the Licensed Patents, unless earlier terminated under the terms of the respective agreements.&#160;&#160;Under the terms of the Supplier Agreement, 3SI has the right to immediately terminate upon written notice to the Company in the event that the Company fails to continuously maintain a minimum number of Markers to be incorporated into the Products, or upon 30 days written notice to the Company.&#160;&#160;Under the terms of the License Agreement, 3SI has the right to immediately terminate upon written notice to the Company in the event that the Company fails to continuously maintain a minimum number of Markers, or fails to sell Markers to 3SI for incorporation into the Products for a certain time after being ordered.</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 6. &#8211; Exhibits</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.1<font style="FONT-SIZE: 10pt"><font style="FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">#</font></font></font></div>
</td>
<td align="left" valign="top" width="74%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subcontract, dated June 2, 2011, between Logistics Management Institute and Applied DNA Sciences, Inc.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31.1</font></div>
</td>
<td align="left" valign="top" width="74%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certification of Chief Executive Officer pursuant to Rule 13a-14 and Rule 15d-14(a), promulgated under the Securities and Exchange Act of 1934, as amended</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31.2</font></div>
</td>
<td align="left" valign="top" width="74%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certification of Chief Financial Officer pursuant to Rule 13a-14 and Rule 15d 14(a), promulgated under the Securities and Exchange Act of 1934, as amended</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">32.1</font></div>
</td>
<td align="left" valign="top" width="74%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Chief Executive Officer)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">32.2</font></div>
</td>
<td align="left" valign="top" width="74%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Chief Financial Officer)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101 INS</font></div>
</td>
<td align="left" valign="top" width="74%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">XBRL Instance Document</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" nowrap valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101 SCH</font></div>
</td>
<td align="left" valign="top" width="74%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">XBRL Taxonomy Extension Schema Document</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" nowrap valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101 CAL</font></div>
</td>
<td align="left" valign="top" width="74%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">XBRL Taxonomy Extension Calculation Linkbase Document</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" nowrap valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101 LAB</font></div>
</td>
<td align="left" valign="top" width="74%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">XBRL Extension Labels Linkbase Document</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101 PRE</font></div>
</td>
<td align="left" valign="top" width="74%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">XBRL Taxonomy Extension Presentation Linkbase Document</font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div><font style="FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">#</font> A request for confidentiality has been filed for certain portions of the indicated document. Confidential portions have been omitted and filed seperately with the Securities and Exchange Commission as required by Rule 24b-2 promulgated under the Securities Exchange Act of 1934.</div>

<div>&#160;</div>

<div>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">35</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Signatures</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="68%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" colspan="2" valign="top" width="32%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;Applied DNA Sciences, Inc.</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="68%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="25%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="68%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dated: August 10, 2011</font></div>
</td>
<td align="left" valign="top" width="7%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; By:</font></div>
</td>
<td align="right" valign="top" width="25%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ <font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">James A. Hayward, Ph. D.</font></font></font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="68%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="25%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">James A. Hayward, Ph. D.</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="68%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="25%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chief Executive Officer</font></div>
</td>
</tr><tr>
<td valign="top" width="68%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="25%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Principal Executive Officer)</font></div>
</td>
</tr><tr>
<td valign="top" width="68%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="25%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="68%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dated: August 10, 2011</font></div>
</td>
<td align="left" valign="top" width="7%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; By:</font></div>
</td>
<td align="right" valign="top" width="25%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ <font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Kurt H. Jensen.</font></font></font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="68%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="25%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Kurt H. Jensen</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="68%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="25%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chief Financial Officer</font></div>
</td>
</tr><tr>
<td valign="top" width="68%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td nowrap valign="top" width="25%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Principal Financial and Accounting Officer)</font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div style="TEXT-ALIGN: center">36</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html>
<head>
    <title>ex10-1.htm</title>
    <!-- Licensed to: TriState Financial -->
    <!-- Document Created using EDGARizerAgent 5.2.3.0 -->
    <!-- Copyright 1995 - 2009 Thomson Reuters. All rights reserved. -->
</head>



<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Arial; FONT-SIZE: 10pt">
<div>
<hr style="COLOR: black" align="left" noshade size="1" width="100%">
</div>

<div style="TEXT-ALIGN: right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exhibit 10.1</font></div>

<div style="TEXT-ALIGN: right"><font style="FONT-WEIGHT: bold">Confidential Treatment</font></div>

<div style="TEXT-ALIGN: justify">&#160;</div>

<div style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Certain portions of this exhibit, as indicated by XXX, have been omitted, pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of 1934. The omitted materials have been separately filed with the Securities and Exchange Commission.</font></div>

<div style="TEXT-ALIGN: left">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="90%" style="TEXT-ALIGN: left; PADDING-LEFT: 12px; MARGIN-LEFT: 9pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><img src="lmi.jpg" alt="graphic"></div>
</td>
</tr><tr>
<td valign="top" width="90%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td align="left" valign="top" width="45%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SUBCONTRACT</font></div>
</td>
<td align="left" valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Subcontract No.:</font></div>
</td>
<td align="left" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline">1124</font></div>
</td>
</tr><tr>
<td valign="top" width="45%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="45%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Between</font></div>
</td>
<td align="left" valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Subcontract Type:</font></div>
</td>
<td align="left" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline">T&amp;M</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="45%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Logistics Management Institute</font></div>
</td>
<td align="left" valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">STP No.:</font></div>
</td>
<td align="left" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline">STP 2-03</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="45%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2000 Corporate Ridge</font></div>
</td>
<td align="left" valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Delivery Order No.:</font></div>
</td>
<td align="left" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline">0019</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="45%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">McLean, VA 22102-7805</font></div>
</td>
<td align="left" valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">LMI Task No.:</font></div>
</td>
<td align="left" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline">DL118.10</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="45%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">And</font></div>
</td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="45%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="45%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Subcontract Ceiling:</font></div>
</td>
<td align="left" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">$913,400</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="45%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Applied DNA Sciences, Inc.</font></div>
</td>
<td align="left" valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total Funded Amt:</font></div>
</td>
<td align="left" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">XXX</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="45%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">25 Health Sciences Dr., Suite 213</font></div>
</td>
<td align="left" colspan="2" valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Subcontract Administrator:</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="45%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Stony Brook, NY 11790</font></div>
</td>
<td align="left" valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Julie A. Wagoner</font></font></div>
</td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="45%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Prime Contract:</font></div>
</td>
<td align="left" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">SP4701-09-D-0045</font></font></div>
</td>
</tr><tr>
<td valign="top" width="45%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Defense Logistics Agency Research &amp; Development</font></font></div>
</td>
</tr><tr>
<td valign="top" width="45%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Supply Support (RDSS) Program</font></font></div>
</td>
</tr><tr>
<td valign="top" width="45%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" colspan="2" valign="top" width="35%" style="BORDER-BOTTOM: black 1px solid">&#160;</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This Subcontract is entered into by the Logistics Management Institute (hereinafter called LMI), a non-profit corporation organized and existing under the laws of the State of Delaware, located at 2000 Corporate Ridge, McLean, Virginia, 22102-7805, and Applied DNA Sciences, Inc. (hereinafter called Subcontractor), located at 25 Health Sciences Dr., Suite 213, Stony Brook, NY 11790, organized and existing under the laws of the state of Delaware.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">WITNESSETH THAT:</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Whereas LMI has entered into a contract with the US Government and/or Government Agency under which various contract tasks are being performed; and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Whereas, the work and services hereinafter described to be performed by the Subcontractor are related to the work and services to be furnished by LMI to The US Government or Government Agency; and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Whereas, this Subcontract supersedes any and all written or oral agreements and constitutes the entire agreement between the parties for the work specified in <font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE I. WORK STATEMENT</font>; and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Whereas, the clause titles contained herein are only for convenience and shall not be construed to limit the scope or intent of the particular clause;</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; 2000 C<font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 7pt">ORPORATE</font> R<font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 7pt">IDGE</font> M<font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 7pt">C</font>L<font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 7pt">EAN</font>, V<font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 7pt">IRGINIA</font> 22102-7805&#160; P<font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 7pt">H</font>: (703) 917-9800&#160; F<font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 7pt">AX</font>: (703) 917-7100 www.lmi.org</font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Now, therefore, in consideration of the mutual promises, covenants, and agreements hereinafter set forth, the parties mutually agree as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">THE SCHEDULE</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE I.&#160;&#160; WORK STATEMENT</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The Subcontractor, as an independent contractor and not as an agent of LMI, shall provide all necessary personnel to accomplish the Statement of Work.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;STATEMENT OF WORK</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The Subcontractor shall perform work in accordance with the statement of work outlined in ATTACHMENT A to this Subcontract.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;REPORTS AND OTHER DELIVERABLES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The Subcontractor shall submit all reports and other deliverables in accordance with the requirements specified in ATTACHMENT A.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;PERIOD OF PERFORMANCE</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The period of performance for this Subcontract will be May 26, 2011 through November 26, 2012.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE II.&#160;&#160; TYPE OF CONTRACT</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;This is a Time and Material Subcontract.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE III.&#160;&#160; LIMITATIONS</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Any work performed in excess of the funded value of this Subcontract, shall be at the Subcontractor&#8217;s own risk. Further, LMI is not obligated to pay any amounts in excess of the funded value of this Subcontract.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE IV.&#160;&#160; OPTIONS</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;This Subcontract does not contemplate additional options. LMI has the right to exercise an option to purchase additional services from the Subcontractor under the terms and conditions of this Subcontract. The work to be performed under any option exercised and the price for said work will be in accordance with the Subcontractor&#8217;s proposal.</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE V.&#160;&#160; INSPECTION AND ACCEPTANCE</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Inspection and acceptance of the supplies or services to be furnished hereunder shall be made at</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 144pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Logistics Management Institute</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 144pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2000 Corporate Ridge</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 144pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">McLean, Virginia, 22102-7805</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Acceptance of supplies or services provided under this Agreement shall be made by the Project Leader specified in this Subcontract.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE VI.&#160;&#160; PLACE OF PERFORMANCE</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The Subcontractor shall perform the work at the customer&#8217;s on-site location, at LMI&#8217;s corporate headquarters, or at the Subcontractor&#8217;s site, depending on the schedule and deliverables.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE VII.&#160;&#160; ASSIGNMENT OF CLAIMS</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The Subcontractor shall not assign its rights to be paid amounts due or to become due as a result of performance under this Subcontract without the prior written consent of LMI. </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160; Copies of the Subcontract; any plans, specifications, or other similar documents relating to work under this Subcontract marked &#8220;Top Secret,&#8221; &#8220;Secret,&#8221; or &#8220;Confidential,&#8221; shall not be furnished or disclosed to any assignee of any claim arising under this Subcontract or any other person not entitled to receive the same without the prior written authorization of LMI.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE VIII.&#160;&#160; AUTHORIZED PERSONNEL</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">A. LMI</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The LMI Project Leader for this effort is Bruce Kaplan.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The Project Leader is authorized to act for LMI in matters pertaining to technical performance under this Subcontract, including approval of the Subcontractor&#8217;s deliverables and verification of monthly progress reports. All such issues must be coordinated through the LMI Project Leader. Bruce Kaplan can be reached by phone at (703) 917-7284 or by email at bkaplan@lmi.org).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160; The LMI Subcontracts Administrator for this effort is Julie Wagoner.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160; All contractual matters, including but not limited to: price, terms and conditions, types and quantities of services and/or products to be supplied, delivery schedule, financial adjustments and changes in the scope of work, must be coordinated through the LMI Subcontracts Administrator. Then, such action must be set forth in a formal modification to the Subcontract approved by LMI&#8217;s Director of Contracts, or his designee. The Subcontractor is advised that only the LMI&#8217;s Director of Contracts, or his designee, can change or modify the Subcontract terms or take any other action which obligates LMI. Julie Wagoner can be reached by phone at (571) 633-7792 or by email at jwagoner@lmi.org.</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;All may be reached at (703) 917-9800.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">B. SUBCONTRACTOR</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Dr. Jim Hayward is a Project Leader for the Subcontractor and may be reached at (631) 444-8445 (e-mail address: james.hayward@adnas.com).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Ms. Janice Meraglia is a Project Leader and Contract Coordinator for the Subcontractor and may be reached at (631) 444-6293 (e-mail address: janice.meraglia@adnas.com).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE IX.&#160;&#160; PRICE &amp; PAYMENT</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">A. PRICE</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The Subcontractor agrees to perform the work outlined in the statement of work and in accordance with the Subcontractor&#8217;s proposal dated April 27, 2011 for a not-to-exceed amount of&#160;$913,400. (See breakout of costs below).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="90%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid; BORDER-TOP: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Labor Category</font></div>
</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid; BORDER-TOP: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 1px solid; BORDER-TOP: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Rate/Hr</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left; BORDER-TOP: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid; BORDER-TOP: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 1px solid; BORDER-TOP: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Hours</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left; BORDER-TOP: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid; BORDER-TOP: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 1px solid; BORDER-TOP: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Subtotal</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left; BORDER-TOP: black 1px solid; BORDER-RIGHT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="azure">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Program Manager</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">XXX </td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">XXX&#160;&#160; </td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$913,400&#160;&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Senior Scientist</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">XXX</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">XXX&#160;&#160; </td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">$913,400&#160; &#160; </td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="azure">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Scientific Analyst</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">XXX </td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">XXX&#160;&#160; </td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">$913,400&#160; &#160; </td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Business Manager</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">XXX </td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">XXX&#160;&#160; </td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">$913,400 &#160;&#160; </td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="azure">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Travel Related Costs</font></div>
</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">$913,400&#160; &#160; </td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Misc. Lab Materials &amp; Fees (LAB)</font></div>
</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">$913,400 &#160;&#160; </td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="azure">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total</font></div>
</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">XXX&#160;&#160; </td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">$913,400&#160; &#160; </td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: left; BORDER-RIGHT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;This Subcontract provides for flexibility to move hours between labor categories, ODCs and Travel so long as the not-to-exceed ceiling is not exceeded and so long as the quality of the services is not adversely affected.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The total funding currently available for this Subcontract is XXX for Task 1. LMI Task No. <font style="FONT-STYLE: italic; DISPLAY: inline">DL118.10</font> has been funded in the amount of XXX for Labor and XXX for Travel. Additional funds may be allocated as they become available by issuing a modification to this Subcontract to increase funding up to the not-to-exceed amount of&#160;$913,400 to cover the entire period of performance through November 26, 2012. Additionally, both the funding and price under this Subcontract may also be increased should the Subcontractor be requested to perform additional support under this Subcontract.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;In accordance with FAR 52.232-22 (c), the Subcontractor shall notify the LMI Subcontracts Administrator in writing whenever it has reason to believe that the costs it expects to incur under this Subcontract, in the next 60 days, when added to all costs previously incurred, will exceed 75 percent of the total funded amount so far allotted to the Subcontract hereunder by LMI. This requirement looks at the Subcontract funded value as a whole and not the individual efforts contained within.</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The notice shall state the estimated amount of additional funds required to continue performance for the period specified in the Schedule and Statement of Work.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">B. REIMBURSEMENT OF OTHER DIRECT COSTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;If authorized as a part of its performance under this Subcontract, the Subcontractor may incur costs which are treated as direct charges in accordance with its disclosed accounting practices. Other direct costs may include expenses such as travel and travel related expenses required to be performed pursuant to this Agreement, and other charges necessary to support performance of the work called for the Statement of Work. All travel expenses (excluding local travel) will be reimbursed in accordance with the FAR Subpart 31.2., travel costs principles.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;LMI will reimburse the Subcontractor for those other direct costs which are necessary and reasonable expenses at actual cost incurred, burdened in accordance with the Subcontractor&#8217;s proposal and disclosed accounting practices, up to the not-to-exceed limit of XXX, and provided those costs are allowable in accordance with the Cost Principles of FAR Part 31. The reimbursement limitation established in this Agreement may not be exceeded by the Subcontractor without the prior written authorization of LMI&#8217;s Subcontracts Administrator. Expenses incurred by the Subcontractor in excess of the funded amount set forth in this Subcontract will not be reimbursed by LMI. Invoices requesting reimbursement for other direct costs <font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">must</font> be accompanied by adequate supporting documentation, <font style="DISPLAY: inline; FONT-WEIGHT: bold">including receipts for any expense greater than $75</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">C. INVOICE SUBMISSION AND PAYMENT</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;LMI will pay the Subcontractor monthly for satisfactory performance of the requirements of this Subcontract, including delivery of all reports and data required hereunder. All hours must be billed in &#189; hour increments. Any invoices including other than &#189; hour increments such as &#188; or &#190; of an hour may be reduced to the nearest hour or half hour accordingly. The invoice shall be certified and mailed to the following address:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 108pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Logistics Management Institute</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 108pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2000 Corporate Ridge</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 108pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">McLean, Virginia 22102-7805</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 108pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Attention: Accounts Payable</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A second copy shall be forwarded to LMI Subcontracts at the above address or via email to the designated Subcontracts Administrator at the email address provided under Article VIII, Section A or as so designated on any subsequent modifications.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The invoice shall include the following information:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 72pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Prime Contract Number</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 72pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subcontract Number</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 72pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;LMI Task Number</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">5</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 72pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Invoice Number and Date</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 72pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Period Covered by the Invoice</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 72pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Labor Hours, Rates Per Hours and Total Labor Cost by Category</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 72pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Travel and Other Direct Charges (if applicable)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 72pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Invoice Total and Cumulative Total</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The certification statement should read as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;I hereby certify that this invoice is accurate and complete and that it reflects only those charges for work performed by <font style="FONT-STYLE: italic; DISPLAY: inline">Applied DNA Sciences, Inc.</font> in accordance with the applicable Subcontract, and that payment therefore has not been previously received.&#8221;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Payment terms are Net 30.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">In order to expedite final payment to the Subcontractor upon completion of this Subcontract, the final invoice for this Subcontract shall be clearly marked &#8220;Final&#8221; and shall be submitted within 30 days following the completion of the period of performance of this effort. The Subcontractor shall identify any outstanding amounts due under this Subcontract as part of the Subcontractor&#8217;s final invoice submission. Final payment shall be made upon completion and acceptance of all deliverables. If the final invoice has not been received within the time period set forth herein (or as mutually agreed upon by extension thereof), the total amount &#8220;paid to date&#8221; to the Subcontractor shall constitute full and final settlement of all payments due under this Subcontract. The final invoice shall include the following certification:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;&#160;&#160;&#160;&#160;&#8220;Payment of this final invoice shall constitute complete satisfaction of all of LMI&#8217;s obligations under this Subcontract and the Subcontractor remises, releases, and discharges LMI and its officers, agents, and employees, of and from all liabilities, obligations, claims and demands whatsoever under or arising from the said Subcontract upon payment hereof.&#8221;</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">D. RECORDS AND AUDIT</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The Subcontractor shall maintain accurate records of all costs incurred in the performance of this Subcontract and agrees to allow representatives of LMI and the Government Client reasonable access to its records to verify the validity of expenses reimbursed under this Subcontract. The Subcontractor hereby warrants that it conducts audits as required by OMB Circulars (including OMB Circular A-133), federal cost principles, or cost accounting standards applicable to its performance as a recipient of U.S. Government funds. If the Subcontractor is required to conduct audits in accordance with OMB Circular A-133, the Subcontractor hereby warrants that it conducts such audits on time and submits the audit findings pursuant to the A-133 requirements. The Subcontractor shall maintain all financial records, supporting documents and other records pertaining to this Subcontract for a period of five years from the termination date of this Subcontract.</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">6</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE X.&#160;&#160; REPRESENTATIONS AND CERTIFICATIONS</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Attachment B of this Subcontract contains the necessary Representations and Certifications. The Subcontractor shall, as part of executing this Subcontract, complete all of the Representations and Certifications as they apply to this Subcontract. The Subcontractor further agrees that it will provide additional Representations and Certifications that may be requested by LMI in connection with this Subcontract, and also agrees to promptly notify LMI of any changes which modify the information contained in any Representations and Certifications.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XI.&#160;&#160; PACKAGING AND MARKING</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">A. GENERAL</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;All items to be delivered under this Subcontract shall be packaged, packed and marked to prevent deterioration and damage during shipping, handling and storage to ensure safe arrival at destination.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">B. CLASSIFIED ITEMS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Confidential or Secret material will be packed to conceal it properly and to avoid suspicion as to contents, and to reach destination in satisfactory condition. Internal markings or internal packaging will clearly indicate the classification. NO NOTATION TO INDICATE CLASSIFICATION WILL APPEAR IN EXTERNAL MARKINGS. (See Paragraph 17 of the <font style="FONT-STYLE: italic; DISPLAY: inline">Industrial Security Manual for Safeguarding Classified Information</font>, DoD 5220.22-M.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Confidential or Secret documents will be enclosed in two (2) opaque envelopes or covers. The inner envelope or cover containing the documents being transmitted will be addressed, return addressed, and sealed. The classification of the documents being transmitted will be clearly marked on the front and back of the inner container. The classified documents will be protected from direct contact with the inner cover by a cover sheet or by folding inward. For Secret documents, a receipt form identifying the addresser, addressee, and documents will be enclosed in the inner envelope. Confidential documents will be covered by a receipt only when the sender deems it necessary. The inner envelope or cover will be enclosed in an opaque outer envelope or cover. The classification markings of the inner envelope should not be detectable. The outer envelope will be addressed, return addressed, and sealed. NO CLASSIFICATION MARKINGS WILL APPEAR ON THE OUTER ENVELOPE OR COVER.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XII.&#160;&#160; NOTICE REGARDING LATE DELIVERY</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In the event the Subcontractor anticipates difficulty in complying with the Subcontract delivery schedule, the Subcontractor shall immediately notify the Project Leader in writing with a copy to the LMI Subcontracts Administrator, giving pertinent details, including the date by which it expects to make delivery; provided, however, that this data shall be informational only in character and that receipt thereof shall not be construed as a waiver by LMI of any Subcontract delivery schedule, or any rights or remedies provided by law or under this Subcontract.</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">7</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XIII. CHANGES</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Within the general scope of this Subcontract, the work to be performed may be changed unilaterally by LMI at any time by written notice to the Subcontractor. Within ten (10) working days after said notice, the Subcontractor will provide LMI with a price estimate, if applicable, for performing the changed work. Promptly thereafter, LMI and the Subcontractor shall negotiate an equitable adjustment of price and schedule resulting from the changes as may be required.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Failure to agree to any adjustment under this Article shall be resolved under <font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XVII. DISPUTES</font> of this Subcontract. However, nothing in this Article shall excuse the Subcontractor from proceeding diligently with the performance of the work as changed.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XIV.&#160;&#160; SUBCONTRACTS</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The Subcontractor agrees that none of the tasks or deliverables to be furnished hereunder shall be assigned or subcontracted without the written permission of LMI.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XV.&#160;&#160; INDEMNIFICATION AND INSURANCE</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">A. INDEMNIFICATION</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The Subcontractor will hold LMI and its Trustees, Officers, Directors, Agents, and employees harmless and will defend it from any claims or liabilities growing out of any suits or patent infringements, and will also hold harmless and defend LMI against any claims, liabilities, loss, damage, or injury to or death of persons arising or in any manner growing out of the performance of its work or services under this Subcontract, except when such injuries or damages are caused by gross negligence of LMI.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">B. INSURANCE</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The Subcontractor shall insure its employees under the Worker&#8217;s Compensation Act, and carry Bodily Injury, Property Damage, and Automobile Liability Insurance in amounts specified below. In addition, if the Subcontractor is providing design, design review, or other work deemed to be professional engineering services, the Subcontractor is also required to carry professional liability insurance in the amount specified below.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="80%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr bgcolor="azure">
<td valign="top" width="44%" style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; BORDER-LEFT: black 1px solid; BORDER-TOP: black 1px solid">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">TYPE OF INSURANCE</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>
</td>
<td valign="top" width="46%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid; PADDING-BOTTOM: 2px; BORDER-TOP: black 1px solid; BORDER-RIGHT: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">MINIMUM AMOUNT</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="44%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Worker&#8217;s Compensation and all occupational disease</font></div>
</td>
<td align="left" valign="top" width="46%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid; PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; BORDER-RIGHT: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As required by State Law</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="44%" style="BORDER-LEFT: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Employer&#8217;s Liability including all occupational disease</font></div>
</td>
<td valign="top" width="46%" style="BORDER-LEFT: black 1px solid; PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; BORDER-RIGHT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="44%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">when not so covered in Worker&#8217;s Compensation above</font></div>
</td>
<td align="left" valign="top" width="46%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid; PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; BORDER-RIGHT: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$100,000 per accident</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="44%" style="BORDER-LEFT: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">General Liability (Comprehensive)</font></div>
</td>
<td valign="top" width="46%" style="BORDER-LEFT: black 1px solid; PADDING-BOTTOM: 2px; BORDER-RIGHT: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="44%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Bodily Injury per occurrence</font></div>
</td>
<td align="left" valign="top" width="46%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid; PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; BORDER-RIGHT: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$500,000</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="44%" style="BORDER-LEFT: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Automobile Liability (Comprehensive)</font></div>
</td>
<td align="left" valign="top" width="46%" style="BORDER-LEFT: black 1px solid; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; BORDER-RIGHT: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$200,000</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="44%" style="BORDER-LEFT: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Bodily Injury per person</font></div>
</td>
<td align="left" valign="top" width="46%" style="BORDER-LEFT: black 1px solid; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; BORDER-RIGHT: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$500,000</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="44%" style="BORDER-LEFT: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Bodily Injury per occurrence</font></div>
</td>
<td align="left" valign="top" width="46%" style="BORDER-LEFT: black 1px solid; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; BORDER-RIGHT: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$ 20,000</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="44%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Property Damage per accident</font></div>
</td>
<td align="left" valign="top" width="46%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid; PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; BORDER-RIGHT: black 1px solid">&#160;</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="44%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Professional Liability</font></div>
</td>
<td align="left" valign="top" width="46%" style="BORDER-BOTTOM: black 1px solid; BORDER-LEFT: black 1px solid; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; BORDER-RIGHT: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$1,000,000 / claim &#8211;</font></font></div>

<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$2,000,000 aggregate</font></div>
</td>
</tr></table>
</div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">8</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XVI.&#160;&#160; INTELLECTUAL PROPERTY RIGHTS</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">A. PATENTS AND PROPRIETARY TECHNOLOGY</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The Subcontractor shall identify the use of any of the Subcontractor&#8217;s proprietary processes or patents in the performance of this Subcontract prior to commencing performance.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;In the event that the Subcontractor develops intellectual property rights (IPR) (to any patent or patents developed) as a result of performance of the Work, then the Subcontractor agrees that royalty-free license for use of the IPR will be provided to the Government through LMI for the life of the IPR. In the event that such IPR provides for the filing of or issuance of patents, the Subcontractor agrees to provide a royalty-free license for use of the patent(s) to the Government through LMI for the life of the patent(s).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">B. DATA RIGHTS</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;1. Intellectual Property Deliverable Restrictions. The Subcontractor shall identify, to the best of its ability, noncommercial and commercial technical data and computer software that it intends to deliver with restrictions on the Government&#8217;s right to use, release or disclose such identified technical data and/or computer software. The Government and LMI further require that the Subcontractor identify, prior to award, background inventions that will be embodied in items, components, processes, technical data, computer software or computer software documentation developed or delivered under the Subcontract. To identify such technical data, computer software and background inventions, the Subcontractor shall submit the following three lists:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="86%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Noncommercial Computer Software and Technical Data. The Government desires appropriate rights in all noncommercial technical data and noncommercial computer software developed or delivered under this Subcontract. The Subcontractor shall identify all asserted restrictions on the Government&#8217;s license rights in such data and software, pursuant to FAR 52.227-14, FAR 52.227-15, DFARS 252.227-7013 and DFARS 252.227-7014. The applicable FAR or DFAR clauses shall govern the format and content of the Contractor&#8217;s assertions of software and data restrictions. The Subcontractor shall submit the post-award assertions to LMI as soon as practicable before the scheduled delivery of the relevant data and/or software. The Subcontractor shall update the post-award assertions as necessary during performance to ensure that the list is accurate before making final delivery of data or software.</font></div>
</td>
</tr></table>
</div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">9</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="86%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Commercial Computer Software and Technical Data. The Subcontractor shall identify all asserted restrictions on the Government&#8217;s license rights in commercial computer software and commercial technical data pursuant to FAR 52.227-19 and DFARS 252.227-7017. To identify such restrictions, the Subcontractor shall submit a Commercial Restrictions List, dated and signed by an official contractually authorized to obligate the Subcontractor. The format of the Commercial Restrictions List shall be substantially same as the format set forth in DFARS 252.227-7017(d). The Commercial Restrictions List shall include the assertions of the Subcontractor&#8217;s Subcontractors or suppliers or potential Subcontractors or suppliers if permitted to do so under <font style="TEXT-DECORATION: underline">ARTICLE XIV. SUBCONTRACTS</font>. For each entry in the Commercial Restrictions List which indicates that the asserted rights category is a special license or the license customarily provided to the public, the Subcontractor shall attach to the Commercial Restrictions List a copy of such license, except that if any particular license is identified as applying to more than one such entry, only one copy of that license need be provided. The Subcontractor shall update the Commercial Restrictions List as necessary during performance of the Subcontract to ensure that the list is accurate before making final delivery of data or software.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="86%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td align="left" valign="top" width="86%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Background Inventions. The Subcontractor shall provide an identification and licensing list to LMI that identifies all inventions (background inventions), other than subject inventions, disclosed in any patents or pending patent applications in which it has:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></div>
</td>
<td align="left" valign="top" width="83%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">any title, right or interest; and</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="83%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></div>
</td>
<td align="left" valign="top" width="83%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">intends to include in any Items, Components or Processes developed or delivered under the Subcontract, or that are described or disclosed in any Technical Data, Computer Software or Computer Software Documentation developed or delivered under the Subcontract.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The list shall be an attachment to the Subcontract, and the Subcontractor shall update the list, as necessary, during performance of the Subcontract to promptly identify all background inventions.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;2. Delivery of Noncommercial Computer Software and Technical Data. Unless expressly otherwise stated in the Subcontract, the Subcontractor&#8217;s deliveries of noncommercial technical data shall include physical delivery of the digital version of that technical data. The Subcontractor&#8217;s deliveries of noncommercial computer software shall include physical delivery of a digital version of both the executable code and the annotated source code. This includes noncommercial data/software that was developed exclusively at private expense. As used in this paragraph, &#8220;physical delivery&#8221; means submission to the Government of the data/software in a predetermined format on appropriate digital storage media (e.g., CD-ROM), and, if specified in the delivery requirement, may also include submission of paper copies of that data/software. The Subcontractor may, before delivery of the affected computer software or technical data, notify LMI in writing that it intends to modify the physical delivery requirement. If LMI accepts the proposed modified physical delivery, the modified physical delivery shall be incorporated into the affected Subcontract by modification.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">C. ASSIGNMENT OF RIGHTS AND INTERESTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;1. Pre-Existing Intellectual Property. Each party acknowledges that the other party will own all rights to all data, information, techniques, methodologies and Materials, including without limitation any patents, patent rights, copyrights, trade secret rights and other intellectual property rights embodied therein, that such party owned prior to the commencement of the Services.</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;2. If Federal Acquisition Regulations (&#8220;FAR&#8221;) 52.227-11 or FAR 52.227-13 is applicable to the Prime Contract, LMI shall flow such clause down to the Subcontractor, and the treatment of any resultant subject invention will be governed by that clause.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;If FAR 52.227-14 is applicable to the Prime Contract, LMI shall flow such clause down to the Subcontractor and the Subcontractor shall convey rights in data through LMI to the Government as defined in such clause and shall be bound by all reporting and other obligations therein.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;If Defense Federal Acquisition Regulations Supplement (&#8220;DFARS&#8221;) clause 252.227-7013 is applicable to the Prime Contract, LMI shall flow such clause down to the Subcontractor, and any noncommercial technical data (as defined in that clause) provided by the Subcontractor under this Agreement will be governed by that clause. If DFARS clause 252.227-7014 is applicable to the Prime Contract, LMI shall flow such clause down to the Subcontractor and any noncommercial computer software and noncommercial computer software documentation (as each term is defined in such clause) will be governed by that clause. If DFARS clause 252.227-7038 is applicable to the Prime Contract, LMI shall flow such clause down to the Subcontractor, and the treatment of any resultant subject invention will be governed by that clause.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;No clause in this Subcontract will be interpreted as enlarging or diminishing the Government Client&#8217;s or LMI&#8217;s rights in the Subcontractor&#8217;s noncommercial technical data and/or noncommercial computer software and noncommercial computer software documentation, as the case may be.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XVII.&#160;&#160; DISPUTES</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">A.</font> The Parties shall make a good faith attempt to resolve all disputes relating to the performance of this Subcontract or any Purchase/Delivery Order issued hereunder by negotiation between the Parties.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">B.</font> Any dispute under this Subcontract which is not settled by agreement between the parties may be settled by appropriate legal or equitable proceedings. It is understood and agreed that if any such dispute is litigated, it shall be for the purpose of obtaining a judicial determination of the question of law and/or fact which is fair and reasonable, provided further that, pending such judicial determination, the Subcontractor shall proceed in accordance with LMI&#8217;s written directions.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">C.</font> Except as otherwise provided in this Subcontract, any claim or dispute arising out of or in connection with this Subcontract, which is not disposed of by agreement of the parties, shall be governed by the laws of the Commonwealth of Virginia. The substantive law applicable to any such proceeding shall be that of the Commonwealth of Virginia, excluding it choice of law principles.</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">11</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">D.</font> The Subcontractor hereby agrees to immediately give notice to the LMI Supervisor, Subcontracts &amp; Purchasing, of any anticipated or current litigation involving or in any way relating to the Subcontract, pertinent lower tier Subcontracts or the Customer&#8217;s relationship with the Subcontractor. Said notice shall include all relevant information with respect thereto.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td align="left" valign="top" width="83%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Subcontractor agrees to insert this requirement in any lower tier Subcontract under this Subcontract if permitted to do so under ARTICLE XIV. SUBCONTRACTS. In the event of litigation, the Subcontractor shall immediately notify his next tier Subcontractor or the Prime Contractor, as the case may be, of all relevant information with respect to such litigation.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="83%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td align="left" valign="top" width="83%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Government Contracting Officer shall have access to and the right to examine any pertinent books, documents, papers and records of the Prime Contractor or Subcontractor(s) involving customer transactions related to any contract litigation.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">E.</font> The Subcontractor acknowledges that the Prime Contract includes a disputes clause (&#8220;the Disputes Clause&#8221;), pursuant to which LMI may pursue certain procedures in the event of a dispute between the Government&#8217;s Contracting Officer and LMI with respect to questions of law or fact relating to the prime contract. Any Final Decision of the Contracting Officer under the prime contract relating to this Subcontract or the Subcontractor&#8217;s performance hereunder shall be conclusive and binding upon the Subcontractor, and LMI shall notify the Subcontractor of any such Final Decision within ten (10) days of LMI&#8217;s receipt thereof.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td align="left" valign="top" width="83%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In the event LMI elects to appeal any such decision, pursuant to the Disputes Clause of the prime contract, the Subcontractor shall provide LMI with reasonable assistance in the prosecution of such appeal including, but not limited to, access to all of the Subcontractor&#8217;s personnel and non-privileged documents.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="83%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td align="left" valign="top" width="83%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In the event LMI elects not to appeal any such decision pursuant to the Disputes Clause of the prime contract, LMI shall so notify the Subcontractor, in writing, within twenty (20) days of LMI&#8217;s receipt of any such Final Decision. </font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold">F.</font> Pending any decision, appeal or judgment on the settlement of any dispute arising under this Subcontract, the Subcontractor shall proceed diligently with the performance of this Subcontract.</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XVIII.&#160;&#160; CHOICE OF LAW</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;In the event it should become necessary to interpret or construe the meaning of any phrase, sentence clause or other provision or requirement of the Subcontract, such interpretation and construction shall be in accordance with the laws and statutes of the Commonwealth of Virginia. Should a question of validity or enforcement of the Subcontract arise, the laws and statutes of the Commonwealth of Virginia shall be applicable to such question.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Federal Government clauses incorporated by reference, however, shall be interpreted according to the federal common law of Government contracts as enunciated and applied by federal judicial bodies, Boards of Contract Appeals and quasi-judicial agencies of the Federal Government.</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">12</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XIX.&#160;&#160; JURISDICTION</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Each party irrevocably submits to the exclusive jurisdiction of (a) the United States District Court for the Eastern District of Virginia (Alexandria, Virginia), and (b) the Fairfax Circuit Court of the Commonwealth of Virginia, for the purposes of any suit, action or other proceeding arising out of this Agreement. The parties agree to commence any action, suit or proceeding either in the United States District Court for the Eastern District of Virginia (Alexandria, Virginia) or if such suit, action or other proceeding may not be brought for jurisdictional reasons, in the Fairfax Circuit Court of the Commonwealth of Virginia. The parties further agree that service of any process, summons, notice or document by U.S. registered mail to such party&#8217;s respective address set forth shall be effective service of process. The parties waive any objection to the laying of venue of any action, suit or proceeding arising out of this Agreement or the transactions contemplated in these forums. Further, the parties waive and agree not to plead or claim in either forum that any such action, suit or proceeding brought has been brought in an inconvenient forum.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XX.&#160;&#160; OMISSIONS AND ERRORS</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The Subcontractor shall, without due delay; rectify all omissions and errors found in deliverables in accordance with FAR 52.246-3, Inspection of Supplies &#8211; Cost-Reimbursement, or FAR 52.246-5, Inspection of Service &#8211; Cost-Reimbursement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XXI.&#160;&#160; DISSEMINATION OF INFORMATION</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;There shall be no dissemination or publication, except within and between LMI and the Subcontractor, of information developed under this Subcontract or contained in the reports to be furnished pursuant to this Subcontract without prior written approval of LMI&#8217;s Director of Contracts, or his designee.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">&#160;&#160;&#160;&#160;&#160;</font><font style="FONT-STYLE: italic; DISPLAY: inline; TEXT-DECORATION: underline">News Releases, Public Announcement, Advertisement or Publicity</font>. Any news releases, public announcement, advertisement or publicity released by the Subcontractor concerning this Subcontract, will be subject to prior approval of LMI, except that this Agreement and its terms may be made known to the Client. Any such publicity shall give due credit to the contribution of each party.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XXII.&#160;&#160; CONFIDENTIAL INFORMATION</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;During the course of performing this Agreement, the Subcontractor may be given access to information which relates to LMI&#8217;s business activities, products, services, technical knowledge, and sponsors all of which are collectively considered Confidential Information. The Subcontractor may use this Confidential Information only for the purpose of providing services to LMI in accordance with this Agreement. The Subcontractor shall not, at any time, use the Confidential Information in any other fashion, form, or manner; provided that &#8220;Confidential Information&#8221; does not include any information that the Subcontractor can demonstrate:</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">13</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(a)</font></div>
</td>
<td align="left" valign="top" width="83%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">is or becomes publicly known through no fault of the Subcontractor;</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="83%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(b)</font></div>
</td>
<td align="left" valign="top" width="83%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">is known by the Subcontractor when disclosed by LMI if the Subcontractor does not then have a duty to maintain its confidentiality; or</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="83%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(c)</font></div>
</td>
<td align="left" valign="top" width="83%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">is rightfully obtained by the Subcontractor from a third party not obligated to preserve its confidentiality who did not receive the material or information directly or indirectly from LMI.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The Subcontractor shall protect the confidentiality of the Confidential Information in at least the same manner that it protects the confidentiality of its own proprietary and confidential information, and in any event shall take all reasonable measures to prevent improper disclosure of the Confidential Information or any portion thereof. At LMI&#8217;s discretion, the Subcontractor may be required to enter into a separate Non-Disclosure Agreement for the protection of LMI&#8217;s Confidential Information.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XXIII.&#160;&#160; SECURITY CLASSIFICATION</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Any security requirements in the performance of this Subcontract shall be maintained in accordance with FAR 52.204-02, Security Requirements. The Contract Security Classification (DD254), if applicable, will be provided by attachment and become a part of the terms of the whole agreement. Please refer to the National Industrial Security Program Operating Manual (NISPOM) at <font style="TEXT-DECORATION: underline">http://www.dss.mil/isec/nispom.htm</font> for more information. The security classification for the work to be performed hereunder has been identified as &#8220;Unclassified&#8221;.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XXIV.&#160;&#160; PRIVITY OF CONTRACT</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;In order to properly perform and/or execute this agreement, the Subcontractor may require occasional interface with LMI&#8217;s Client. However, no privity of contract exists between the Subcontractor and the Client. The Subcontractor may neither take direction from, nor discuss any terms and conditions of this Subcontract, with the Client. The Subcontractor shall promptly notify LMI if at any time the Subcontractor believes the Client is effecting a change to this Subcontract.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XXV.&#160;&#160; COMPLIANCE WITH LAWS</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The Subcontractor shall in the performance of the Subcontract, comply with all applicable federal, state and local laws and ordinances, including, but not limited to all rules and orders in effect on the date of this Subcontract. Insofar as relevant, the parties shall likewise comply with all laws and rules of foreign countries that may be applicable.</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">14</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ARTICLE XXVI.&#160;&#160; EXPORT CONTROLS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Technical data provided, activities undertaken, and articles produced in support of this Subcontract may come under the purview of U.S. export control regulations. Each party must ensure its compliance with all applicable U.S. export regulations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Information furnished to the Subcontractor under this Agreement may be controlled for export purposes under the International Traffic in Arms Regulations (ITAR) controlled by the U.S. Department of State or the Export Administration Regulations (EAR) controlled by the U.S. Department of Commerce. ITAR controlled technology may not be exported without prior written authorization and certain EAR technology requires a prior license depending upon its categorization, destination, end-user and end-use.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Each party is bound by U.S. export statutes and regulations and shall comply with all U.S. export laws.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;By executing this Agreement, each party confirms that: &#61472;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="96%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font>&#160;&#160;&#160; &#160;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">It is a US firm incorporated under US law.</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="96%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;&#160;&#160;&#160;&#160;&#160;</font>Agrees to comply with all applicable U.S. export control laws and regulations, specifically including, but not limited to, the requirements of the Arms Export Control Act, 22 U.S.C. &#167; 2751-2794, the ITAR 22 C.F.R. &#167; 120 et seq.; and the Export Administration Act, 50 U.S.C. app. 2401-2420, including the EAR, 15 C.F.R. &#167; 730-774; including the requirement for obtaining any export license or agreement, if applicable. Without limiting the foregoing, each party agrees that it will not transfer any export controlled item, data, or services, to include transfer to foreign persons (as defined by the ITAR) employed by or associated with, or under contract to the Prime Contractor or Subcontractor or the lower-tier suppliers, without the other party&#8217;s prior approval and the authority of an export license, agreement, or applicable exemption or exception.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="92%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="96%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font>&#160;&#160;&#160;&#160;&#160;Both parties will immediately notify the other if it is, or becomes, listed in any Denied Parties List or export privileges are otherwise denied, suspended or revoked in whole or in part by any U.S. Government entity or agency.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XXVII.&#160;&#160; KEY PERSONNEL</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Key personnel may be specified in the Statement of Work provided under ATTACHMENT A to this Subcontract. Key personnel are individuals whose participation is considered essential to successful performance of the work required under this Subcontract. The Subcontractor agrees to make such key personnel available for the performance of this Subcontract if they are so named.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Proposed substitutions for the designated key personnel must be submitted at least two (2) weeks in advance of the substitution and must be accompanied by a detailed explanation of the circumstances necessitating the substitution, a resume for the proposed substitute and any other information requested by the LMI Program Manager needed to approve the proposed substitution. All substitutes must have, in the judgment of the LMI Program Manager, the</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">15</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">requisite qualifications to perform at an equivalent level to the person being replaced. The LMI Program Manager will notify the LMI Subcontracts Administrator of the decision and the Subcontract will be modified as appropriate.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XXVIII.&#160;&#160; GOVERNMENT FURNISHED EQUIPMENT</font></font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;LMI will furnish the property identified below to be used in performing the Subcontract. The property is provided on a rent-free and noninterference basis or an equitable adjustment shall be made in the terms of this Subcontract.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NONE</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Prior to receiving GFE, LMI reserves the right to require the Subcontractor to demonstrate to the satisfaction of LMI&#8217;s Property Administrator, that it has a satisfactory property control system for tracking and maintaining GFE. All GFE received by the Subcontractor shall be managed in accordance with the requirements of FAR Subpart 45.5, &#8220;Management of Government Property in the Possession of Contractors.&#8221; </font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;The Subcontractor agrees to report all GFE in its custody as of September 30 to LMI&#8217;s Subcontract Administrator by October 6 of each year. The Subcontractor is also required to report zero end of period balances when no GFE property remains accountable to the Subcontract.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XXIX.&#160;&#160; CONTRACTOR FURNISHED EQUIPMENT</font></font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;If any Contractor Furnished Equipment (CFE) or information (the title to which is with LMI), is furnished to the Subcontractor at any time during the term of this Subcontract, the Subcontractor assumes the risk of and shall be responsible for any loss thereof or damage thereto. The Subcontractor, in accordance with the provisions of this Subcontract, but in any event upon completion thereof, shall return such equipment/information to LMI in the condition in which it was received except for reasonable wear and tear and except to the extent that such equipment/information has been incorporated into items delivered under this Subcontract, or has been consumed in normal performance of work under this Subcontract. </font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">If Contractor Furnished Equipment (CFE) is not provided, state &#8220;none.&#8221;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td align="left" valign="top" width="45%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">DESCRIPTION</font></font></div>
</td>
<td valign="top" width="10%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="45%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">QUANTITY</font></font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="45%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="10%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="45%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="45%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NONE</font></div>
</td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="45%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">0</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Prior to receiving CFE, LMI reserves the right to require the Subcontractor to demonstrate to the satisfaction of LMI Property Administrator, that it has a satisfactory property control system for tracking and maintaining CFE.</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">16</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XXX.&#160;&#160; TITLE TO EQUIPMENT</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The Subcontractor shall not fabricate or acquire under this Subcontract, either directly or indirectly, any item of nonexpendable property without the prior approval of LMI. </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;Title to all other direct cost items purchased by the Subcontractor under this Subcontract and charged to LMI, shall vest with LMI.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XXXI.&#160;&#160; TECHNICAL DIRECTION</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Performance of the work under this Subcontract shall be subject to the technical direction of LMI&#8217;s Project Leader. Such technical direction includes those instructions to the Subcontractor necessary to perform the tasks and deliverables in the Scope of Work issued under this Subcontract. Technical direction shall not include any directions that:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Constitutes an assignment of additional work outside the scope of the Work Statement;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="90%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Constitutes a change as defined in ARTICLE XIII. CHANGES, herein;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="90%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.</font></div>
</td>
<td valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In any manner causes an increase or decrease in the total price or time required for Subcontract performance;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="90%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.</font></div>
</td>
<td valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Changes any of the expressed terms and conditions of this Subcontract.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XXXII.&#160;&#160; CONFLICT OF INTEREST</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">A. GENERAL</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;The Subcontractor warrants that there is no conflict of interest with the activities to be performed hereunder and the Subcontractor&#8217;s other activities and the Subcontractor shall advise LMI if a conflict of interest arises in the future. In the event a conflict of interest is possible or the appearance of a conflict, the Subcontractor shall notify LMI immediately, but not later than within one (1) business day of such knowledge, and LMI shall make a determination as to whether a conflict of interest exists.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">B. ORGANIZATIONAL</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;FAR Subpart 9.5 (48 CFR Section 9.5) governs Organizational and Consultant Conflict of Interest. If the Subcontractor is or becomes aware of any conflicts of interest or potential conflicts of interest, the Subcontractor will within one (1) business day inform LMI of those conflicts. When informing LMI of a conflict or potential conflict of interest, the Subcontractor may propose methods of avoiding, neutralizing or mitigating the conflict or potential conflict of interest. Any failure to comply with this section is a material breach.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">17</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XXXIII.&#160;&#160; COST ACCOUNTING STANDARDS</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;This Subcontract is (<font style="DISPLAY: inline;" face="Wingdings">o</font>), is not (<font style="DISPLAY: inline;" face="Wingdings">x</font>) subject to the Cost Accounting Clause referenced in the General Provisions hereof. If this Subcontract is subject to such clause, the Subcontractor shall comply with all Standards in effect on the date of award or of final agreement on the Subcontract price, as shown on the Subcontractor&#8217;s signed Certificate of Current Cost or Pricing Data, whichever is earlier.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;LMI retains the right to adjust the Subcontract price under the CAS clauses and other applicable provisions of this Subcontract if a subsequent final determination of noncompliance is made by the Contracting Officer or DCAA under the Prime Contract.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The Subcontractor agrees to indemnify and hold LMI harmless to the full extent of any cost or price reduction effected by LMI&#8217;s customer, which may result from (i) any certified cost or pricing data submitted by the Subcontractor or its lower tier Subcontractors which is not accurate, current or complete as certified by the Subcontractor; (ii) the failure by the Subcontractor or its lower tier Subcontractors to disclose and consistently follow applicable cost accounting practices and standards or otherwise comply with pertinent parts of the FAR, applicable agency supplements thereto, and regulations promulgated by the Cost Accounting Standards Board.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XXXIV. BANKRUPTCY AND INSOLVENCY</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;LMI may terminate this Subcontract for default, in whole or in part, by written or telegraphic notice to the Subcontractor in the event of the occurrence of any of the following:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Insolvent. The Subcontractor shall be deemed insolvent if it has ceased to pay its debts in the ordinary course of business or cannot pay its debts as they become due, whether it has committed an act of bankruptcy or not, and whether insolvent within the meaning of the Federal Bankruptcy Law or not.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="90%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Filing of a voluntary petition to have the Subcontractor declared bankrupt.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="90%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.</font></div>
</td>
<td valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The execution by the Subcontractor of an assignment for the benefit of creditors.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XXXV.&#160;&#160; PROVISIONS</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Under the Provisions of LMI&#8217;s Prime Contracts with the U.S. Government, LMI is obligated to pass down to its Subcontractors certain General and/or Special/Supplemental terms and conditions.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">A. GENERAL</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The General Provisions applicable to this agreement have been set forth by Attachment to this Subcontract and are comprised of a basic set of Terms &amp; Conditions. Except in those clauses where a right is intended to be reserved to the Government (as in FAR 52.215-2, Audit and Records &#8211; Negotiation (Jun 1999)), to provide logical application of said clauses, the word &#8220;Government&#8221; and &#8220;Contracting Officer&#8221; shall mean &#8220;LMI&#8221; and &#8220;Subcontracts Administrator&#8221; respectively. The word &#8220;Contractor&#8221; shall mean &#8220;Subcontractor&#8221;.</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">18</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">B. SPECIAL/SUPPLEMENTAL</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;This Subcontract may also be subject to Special/Supplemental Contract Requirements which are flowed down from LMI&#8217;s Prime Contracts with various Federal Agencies and the U. S. Postal Service. If such a flow down of Provisions is required, they shall be set forth by Attachment to this Subcontract and incorporated into and become a part of this agreement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XXXVI.&#160;&#160; ORDER OF PRECEDENCE</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;This Subcontract shall consist of the Schedule set forth in the body of this document; Attachment A - Statement of Work; Attachment B - Representations and Certifications; Attachment C - General Provisions; and Attachment D - Special/Supplemental Provisions.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;In the event of a conflict of any of the terms of this order, the order of precedence shall be as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Schedule;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="90%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Attachment D - Special/Supplemental Provisions;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="90%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Attachment C - General Provisions;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="90%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Attachment B - Representations and Certifications;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="90%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">e.</font></div>
</td>
<td valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Attachment A - Statement of Work.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XXXVII.&#160;&#160; WHOLE AGREEMENT</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;This agreement together with Attachments A, B, C, D, and the DD254, if attached, comprise the entire agreement between LMI and the Subcontractor. No change to the terms and conditions of this Subcontract shall be effective unless approved in writing and signed by LMI and the Subcontractor.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XXXVIII.&#160;&#160; SUBCONTRACT CLOSEOUT</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Upon completion of all work and services required by this Subcontract, or upon notification of termination by LMI, the Subcontractor agrees to provide as a condition precedent to final payment under this Subcontract, a release discharging LMI, its officers, agents and employees of and from all liabilities, obligations and claims arising out of or under this Subcontract.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The Subcontractor shall complete, as a minimum, the following release documents:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subcontractor&#8217;s Release,</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="90%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Property Closeout Report &amp; Certificate,</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="90%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Data Closeout Report &amp; Certificate,</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="90%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">DD882 &#8220;Report of Inventions and Subcontracts,</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="90%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">e.</font></div>
</td>
<td valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Return of Classified Information or Material (if applicable).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">19</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;These documents shall be completed and returned to LMI within thirty (30) working days after receipt.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XXXIX.&#160;&#160; SUBCONTRACT TERMINATION</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;1. The Buyer may terminate this Subcontract for convenience upon thirty (30) days written notice to the Seller. Termination for default may be exercised by the Buyer immediately without notice.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;2. TERMINATION FOR CONVENIENCE. The Buyer shall have the right to terminate this Subcontract in whole or in part for convenience regardless of dollar value in accordance with the provisions of FAR 52.249-6 (Cost Reimbursement) or 52.249-6, Alternate IV (Time and Material or Labor Hour) specifically incorporated herein by reference, modified, however, by deleting paragraph (c) or (d) respectively and further modified by deleting all references to one (1) year as specified in paragraph (d) or (e), substituting therefore the period of six (6) months.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Title to all complete work and work in process under this Subcontract shall pass to the Buyer immediately upon receipt by the Seller of Buyers Notice of Termination, or as otherwise directed by the Buyer.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;3. TERMINATION FOR DEFAULT. LMI may, by written notice of default to the Subcontractor, terminate the whole or any part of this Agreement in any one of the following circumstances: (a) if the Subcontractor fails to make progress in the work so as to endanger performance or (b) if the Subcontractor fails to perform any of the other provisions of this Agreement in accordance with its terms, and in either of these two circumstances does not cure such failure within a period of 10 days (or such longer period as LMI may authorize in writing) after receipt of notice from LMI specifying such failure; or (c) the Subcontractor becomes insolvent or the subject of proceedings under any law relating to bankruptcy or the relief of debtors or admits in writing its inability to pay its debts as they become due.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;If this Agreement is so terminated, the Subcontractor shall submit a final termination settlement proposal to LMI. The Subcontractor shall submit the proposal promptly but no later than six (6) months from the effective date of the termination. If the Subcontractor fails to submit the proposal within the time allowed, LMI may determine the amount, if any, due the Subcontractor because of the termination. The amount will be determined as follows; (a) An amount for direct labor hours determined by multiplying the number of direct labor hours expended before the effective date of termination by the fixed hourly rates, less profit, in <font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE IX. PRICE &amp; PAYMENT</font> hereto, less any fixed hourly rate payments already made to the Subcontractor; (b) An amount for material expenses incurred before the effective date of termination, not previously paid to the Subcontractor.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The Subcontractor shall transfer title and deliver to LMI, in the manner and to the extent requested in writing by LMI at or after termination such complete articles, partially completed articles and materials, parts, tools, dies, patterns, jigs, fixtures, plans, drawings, information and contract rights as the Subcontractor has produced or acquired for the performance of the terminated part of this Agreement, and LMI will pay the Subcontractor the contract price for complete articles delivered to and accepted by LMI and the fair value of the other property of the Subcontractor so requested and delivered.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">20</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The Subcontractor shall continue performance of this Agreement to the extent not terminated. LMI shall have no obligations to the Subcontractor with respect to the terminated part of this Agreement except as herein provided. In case of the Subcontractor&#8217;s default, LMI&#8217;s rights as set forth herein shall be in addition to LMI&#8217;s other rights although not set forth in this Agreement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The Subcontractor shall not be liable for damages resulting from default due to causes beyond the Subcontractor&#8217;s control and without the Subcontractor&#8217;s fault or negligence, provided, however, that if the Subcontractor&#8217;s default is caused by the default of its Subcontractor or supplier, such default must arise out of causes beyond the control of both the Subcontractor and its Subcontractor or supplier, and without the fault or negligence of either of them and, provided further, the supplies or services to be furnished by its Subcontractor or supplier were not obtainable from other sources.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XL.&#160;&#160; AMERICAN RECOVERY &amp; REINVESTMENT ACT OF 2009</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The following shall apply to all Agreements funded by the American Recovery and Reinvestment Act of 2009 (Act). Notwithstanding any provisions herein to the contrary, failure to comply with the subject requirements shall be considered a material breach of this Agreement and constitute immediate grounds for a termination for default.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;This Subcontract is (<font style="DISPLAY: inline;" face="Wingdings">o</font>), is not (<font style="DISPLAY: inline;" face="Wingdings">x</font>) subject to the Act.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;If subject to the Act, pursuant to FAR 52.204-11(c) and 52.204-11(d)(10), the Subcontractor is hereby required to report appropriate information, as specified in 52.204-11(d)(10), to LMI&#8217;s Subcontracts Administrator no later than the fifth (5) day after the end of each calendar quarter. This information will be made available to the public as required by Section 1512 of the Act.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">52.203-15 Whistleblower Protections Under the American Recovery and Reinvestment Act of 2009.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">WHISTLEBLOWER PROTECTIONS UNDER THE AMERICAN RECOVERY AND REINVESTMENT ACT OF 2009 (JUN 2010)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(a) The Contractor and Subcontractor shall post notice of employees rights and remedies for whistleblower protections provided under section 1553 of the American Recovery and Reinvestment Act of 2009 (Pub. L. 111-5)(Recovery Act).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(b) The Contractor shall include the substance of this clause including this paragraph (b) in all Subcontracts that are funded in whole or in part with Recovery Act funds.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">52.204-11 American Recovery and Reinvestment Act-Reporting Requirements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">AMERICAN RECOVERY AND REINVESTMENT ACT-REPORTING REQUIREMENTS (JUL 2010)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For updated definitions as they are revised and related to this clause (e.g., Contract, First-tier Subcontract, total compensation etc...) please see the Frequently Asked Questions (FAQs) available at http://www.whitehouse.gov/omb/recovery_faqs_contractors. These FAQs are also linked under http://www.FederalReporting.gov.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">21</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(a) <font style="FONT-STYLE: italic; DISPLAY: inline">Definitions. </font>As used in this c1ause-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;Contract&#8221; as defined in FAR 2.101, means a mutually binding legal relationship obligating the seller to furnish the supplies or services (including construction) and the buyer to pay for them. It includes all types of commitments that obligate the Government to an expenditure of appropriated funds and that, except as otherwise authorized, are in writing. In addition to bilateral instruments, contracts include (but are not limited to) awards and notices of awards; job orders or task letters issued under basic ordering agreements; letter contracts; orders, such as purchase orders, under which the contract becomes effective by written acceptance or performance; and bilateral contract modifications. Contracts do not include grants and cooperative agreements covered by 31 U.S.C. 6301, <font style="FONT-STYLE: italic; DISPLAY: inline">et seq</font>. For discussion of various types of contracts, see FAR Part 16.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#8220;Executive&#8221; means officers, managing partners, or any other employees in management positions. &#8220;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">First-tier Subcontract&#8221; means a Subcontract awarded directly by a Federal Government Prime Contractor whose Contract is funded by the Recovery Act, to furnish supplies or services (including construction) for performance of a Prime Contract, but excludes supplier agreements with vendors, such as long-term arrangements for materials or supplies that would normally be applied to a Contractor&#8217;s general and administrative expenses or indirect cost.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;Job Created&#8221; means those new positions created and filled, or previously existing unfilled positions that are filled, as a result of funding by the American Recovery and Reinvestment Act of 2009 (Recovery Act). This definition covers only positions established in the United States and outlying areas (see definition in FAR 2.101). The term does not include indirect jobs or induced jobs. The definition applies to Prime Contractor positions and First-tier Subcontractor positions where the Subcontract is $25,000 or more. The number shall be expressed as &#8220;full-time equivalent&#8221; (FTE), calculated quarterly as all hours worked and funded by the Recovery Act divided by the total number of hours in a full-time schedule, as defined by the Contractor (or First-tier Subcontractor). For instance, two full-time employees and one part-time employee working half days would be reported as 2.5 FTE in each calendar quarter.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;Job Retained&#8221; means those existing filled positions that are funded by the American Recovery and Reinvestment Act of 2009 (Recovery Act). This definition covers only positions established in the United States and outlying areas (see definition in FAR 2.101). The term does not include indirect jobs or induced jobs. The definition applies to Prime Contractor positions and First-tier Subcontractor positions where the Subcontract is $25,000 or more. The number shall be expressed as &#8220;full-time equivalent&#8221; (FTE), calculated quarterly as all hours worked and funded by the Recovery Act divided by the total number of hours in a full-time schedule, as defined by the Contractor (or First-tier Subcontractor). For instance, two full-time employees and one part-time employee working half days would be reported as 2.5 FTE in each calendar quarter.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;Total compensation&#8221; means the cash and noncash dollar value earned by the executive during the Contractor&#8217;s preceding completed fiscal year and includes the following (for more information see 17 CFR 229.402(c)(2)):</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1) <font style="FONT-STYLE: italic; DISPLAY: inline">Salary and bonus.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">22</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2) <font style="FONT-STYLE: italic; DISPLAY: inline">Awards of stock, stock options, and stock appreciation rights</font>. Use the dollar amount recognized for financial statement reporting purposes with respect to the fiscal year in accordance with the Statement of Financial Accounting Standards No. 123 (Revised 2004) (FAS l23R), Shared Based Payments.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(3) <font style="FONT-STYLE: italic; DISPLAY: inline">Earnings for services under non-equity incentive plans</font>. Does not include group life, health, hospitalization or medical reimbursement plans that do not discriminate in favor of executives, and are available generally to all salaried employees.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(4) <font style="FONT-STYLE: italic; DISPLAY: inline">Change i</font>n <font style="FONT-STYLE: italic; DISPLAY: inline">pension value</font>. This is the change in present value of defined benefit and actuarial pension plans.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(5) <font style="FONT-STYLE: italic; DISPLAY: inline">Above-market earnings on deferred compensation which is not tax-qualified.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(6) <font style="FONT-STYLE: italic; DISPLAY: inline">Other compensation</font>. For example, if the aggregate value of all such other compensation (e.g., severance, termination payments, value of life insurance paid on behalf of the employee, perquisites or property) for the executive exceeds $10,000.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(b) This Contract requires the Contractor to provide products and/or services that are funded under the American Recovery and Reinvestment Act of 2009 (Recovery Act). Section 1512(c) of the Recovery Act requires each Contractor to report on its use of Recovery Act funds under this Contract. These reports will be made available to the public.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(c) Reports from the Contractor for all work funded, in whole or in part, by the Recovery Act, are due no later than the 10th day following the end of each calendar quarter. The Contractor shall review the Frequently Asked Questions (FAQs) for Federal Contractors before each reporting cycle and prior to submitting each quarterly report as the FAQs may be updated from time-to-time. The first report is due no later than the 10th day after the end of the calendar quarter in which the Contractor received the award. Thereafter, reports shall be submitted no later than the 10th day after the end of each calendar quarter. For information on when the Contractor shall submit its final report, see</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">http://www.whitehouse.gov/omb/recovery_faqs_contractors.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(d) The Contractor shall report the following information, using the online reporting tool available at www.FederalReporting.gov.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1) The Government Contract and order number, as applicable.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2) The amount of Recovery Act funds invoiced by the Contractor for the reporting period. A cumulative amount from all the reports submitted for this action will be maintained by the Government&#8217;s on-line reporting tool.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(3) A list of all significant services performed or supplies delivered, including construction, for which the Contractor invoiced in this calendar quarter.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(4) Program or project title, if any.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(5) A description of the overall purpose and expected outcomes or results of the Contract, including significant deliverables and, if appropriate, associated units of measure.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(6) An assessment of the Contractor&#8217;s progress towards the completion of the overall purpose and expected outcomes or results of the Contract (<font style="FONT-STYLE: italic; DISPLAY: inline">i.e., </font>not started, less than 50 percent completed, completed 50 percent or more, or fully completed). This covers the Contract (or portion thereof) funded by the Recovery Act.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">23</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(7) A narrative description of the employment impact of work funded by the Recovery Act. This narrative should be cumulative for each calendar quarter and address the impact on the Contractor&#8217;s and First-tier Subcontractors&#8217; workforce for all First-tier Subcontracts valued at $25,000 or more. At a minimum, the Contractor shall provide-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(i) A brief description of the types of jobs created and jobs retained in the United States and outlying areas (see definition in FAR 2.101). This description may rely on job titles, broader labor categories, or the Contractor&#8217;s existing practice for describing jobs as long as the terms used are widely understood and describe the general nature of the work; and </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(ii) An estimate of the number of jobs created and jobs retained by the Prime Contractor and all First-tier Subcontracts valued at $25,000 or more, in the United States and outlying areas. A job cannot be reported as both created and retained. See an example of how to calculate the number of jobs at http://www.whitehouse.gov/omb/recovery_faqs_contractors.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(8) Names and total compensation of each of the five most highly compensated officers of the Contractor for the calendar year in which the Contract is awarded if-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(i) In the Contractor&#8217;s preceding fiscal year, the Contractor received-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(A) 80 percent or more of its annual gross revenues from Federal Contracts (and Subcontracts), loans, grants (and subgrants) and cooperative agreements; and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(B) $25,000,000 or more of annual gross revenues from Federal Contracts (and Subcontracts), loans, grants (and subgrants) and cooperative agreements; and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(ii) The public does not have access to information about the compensation of the senior executives through periodic reports filed under section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a), 78o(d)) or section 6104 of the Internal Revenue Code of 1986.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(9) For Subcontracts valued at less than $25,000 or any Subcontracts awarded to an individual, or Subcontracts awarded to a Subcontractor that in the previous tax year had gross income under $300,000, the Contractor shall only report the aggregate number of such First-tier Subcontracts awarded in the quarter and their aggregate total dollar amount.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(10) For any First-tier Subcontract funded in whole or in part under the Recovery Act, that is valued at $25,000 or more and not subject to reporting under paragraph 9, the Contractor shall require the Subcontractor to provide the information described in paragraphs (d)(10)(i), (ix), (x), (xi), and (xii) of this section to the Contractor for the purposes of the quarterly report. The Contractor shall advise the Subcontractor that the information will be made available to the public as required by section 1512 of the Recovery Act. The Contractor shall provide detailed information on these First-tier Subcontracts as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(i) Unique identifier (DUNS Number) for the Subcontractor receiving the award and for the Subcontractors parent company, if the Subcontractor has a parent company.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(ii) Name of the Subcontractor.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(iii) Amount of the Subcontract award.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(iv) Date of the Subcontract award.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(v) The applicable North American Industry Classification System (NAICS) code.</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">24</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(vi) Funding agency.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(vii) A description of the products or services (including construction) being provided under the Subcontract, including the overall purpose and expected outcomes or results of the Subcontract.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(viii) Subcontract number (the Contract number assigned by the Prime Contractor).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(ix) Subcontractor&#8217;s physical address including street address, city, State, and country. Also include the nine-digit zip code and congressional district if applicable.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(x) Subcontract primary performance location including street address, city, state, and country. Also include the nine digit zip code and congressional district if applicable.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(xi) Names and total compensation of each of the Subcontractor&#8217;s five most highly compensated officers, for the calendar year in which the Subcontract is awarded if-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(A) In the Subcontractor&#8217;s preceding fiscal year, the Subcontractor received-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1) 80 percent or more of its annual gross revenues in Federal Contracts (and Subcontracts), loans, grants (and subgrants), and cooperative agreements; and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2) $25,000,000 or more in annual gross revenues from Federal Contracts (and Subcontracts), loans, grants (and subgrants), and cooperative agreements; and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(B) The public does not have access to information about the compensation of the senior executives through periodic reports filed under section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a), 78o(d)) or section 6104 of the Internal Revenue Code of 1986.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(xii) A narrative description of the employment impact of work funded by the Recovery Act. This narrative should be cumulative for each calendar quarter and address the impact on the Subcontractor&#8217;s workforce. At a minimum, the Subcontractor shall provide-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(A) A brief description of the types of jobs created and jobs retained in the United States and outlying areas (see definition in FAR 2.101). This description may rely on job titles, broader labor categories, or the Subcontractor&#8217;s existing practice for describing jobs as long as the terms used are widely understood and describe the general nature of the work; and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(B) An estimate of the number of jobs created and jobs retained by the Subcontractor in the United States and outlying areas. A job cannot be reported as both created and retained. See an example of how to calculate the number of jobs at http://www.whitehouse.gov/omb/recovery_faqs_contractors.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(End of clause)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">52.215-2 Audit and Records-Negotiation.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">AUDITS AND RECORDS-NEGOTIATION (MAR 2009)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(a) As used in this clause, &#8220;records&#8221; includes books, documents, accounting procedures and practices, and other data, regardless of type and regardless of whether such items are in written form, in the form of computer data, or in any other form.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(b) <font style="FONT-STYLE: italic; DISPLAY: inline">Examination of costs</font>. If this is a cost-reimbursement, incentive, time-and-materials, labor-hour, or price redeterminable Contract, or any combination of these, the Contractor shall maintain and the Contracting Officer, or an authorized representative of the Contracting Officer, shall have the right to examine and audit all records and other evidence sufficient to reflect properly all costs claimed to have been incurred or anticipated to be incurred directly or <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">indirectly in performance of this Contract. This right of examination shall include inspection at all reasonable times of the Contractor&#8217;s plants, or parts of them, engaged in performing the Contract.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">25</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(c) <font style="FONT-STYLE: italic; DISPLAY: inline">Cost or pricing data</font>. If the Contractor has been required to submit cost or pricing data in connection with any pricing action relating to this Contract, the Contracting Officer, or an authorized representative of the Contracting Officer, in order to evaluate the accuracy, completeness, and currency of the cost or pricing data, shall have the right to examine and audit all of the Contractor&#8217;s records, including computations and projections, related to-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1) The proposal for the Contract, Subcontract, or modification;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2) The discussions conducted on the proposal(s), including those related to negotiating;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(3) Pricing of the Contract, Subcontract, or modification; or</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(4) Performance of the Contract, Subcontract, or modification.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(d) <font style="FONT-STYLE: italic; DISPLAY: inline">Comptroller General or Inspector General</font>. (1) The Comptroller General of the United States, an appropriate Inspector General appointed under section 3 or 8G of the Inspector General Act of 1978 (5 U.S.C. App.), or an authorized representative of either of the foregoing officials, shall have access to and the right to-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(i) Examine any of the Contractor&#8217;s or any Subcontractor&#8217;s records that pertain to and involve transactions relating to this Contract or a Subcontract hereunder; and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(ii) Interview any officer or employee regarding such transactions.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2) This paragraph may not be construed to require the Contractor or Subcontractor to create or maintain any record that the Contractor or Subcontractor does not maintain in the ordinary course of business or pursuant to a provision of law.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(e) <font style="FONT-STYLE: italic; DISPLAY: inline">Reports</font>. If the Contractor is required to furnish cost, funding, or performance reports, the Contracting Officer or an authorized representative of the Contracting Officer shall have the right to examine and audit the supporting records and materials, for the purpose of evaluating-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1) The effectiveness of the Contractor&#8217;s policies and procedures to produce data compatible with the objectives of these reports; and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2) The data reported.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(f) <font style="FONT-STYLE: italic; DISPLAY: inline">Availability</font>. The Contractor shall make available to its office at all reasonable times the records, materials, and other evidence described in paragraphs (a), (b), (c), (d), and (e) of this clause, for examination, audit or reproduction, until 3 years after final payment under this Contract or for any shorter period specified in Subpart 4.7, Contractor Records Retention, of the Federal Acquisition Regulation (FAR), or for any longer period required by statute or by other clauses of this Contract. In addition-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1) If this Contract is completely or partially terminated, the Contractor shall make available the records relating to the work terminated until 3 years after any resulting final termination settlement; and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2) The Contractor shall make available records relating to appeals under the Disputes c1ause or to litigation or the settlement of claims arising under or relating to this Contract until such appeals, litigation, or claims are finally resolved.</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">26</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(g)(1) Except as provided in paragraph (g)(2) or this clause, the Contractor shall insert a clause containing all the terms of this clause, including this paragraph (g), in all Subcontracts under this Contract. The clause may be altered only as necessary to identify properly the contracting parties and the Contracting Officer under the Government Prime Contract.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2) The authority of the Inspector General under paragraph (d)(1)(ii) of this clause does not flow down to Subcontracts.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XLI.&#160;&#160; CODE OF BUSINESS ETHICS: MANDATORY DISCLOSURE</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;If this Agreement exceeds $5 million in value and 120 days in duration, this Agreement hereby incorporates FAR 52.203-13. Accordingly, the Subcontractor hereby understands and warrants that it shall timely disclose, in writing, to the agency&#8217;s Office of Inspector General, with a copy to the Contracting Officer, whenever, in connection with the award, performance or closeout of this Subcontract, the Subcontractor has credible evidence that a principal, employee, agent, or the subcontractor has committed: (a) violation of Federal criminal law involving fraud, conflict of interest, bribery, or gratuity violations found in Title 18 of the U.S. Code; or (b) violation of the civil False Claims Act (31 U.S.C. 3729-3733). Additionally, the Subcontractor hereby warrants that it is, or will be within the timeframes established in FAR 52.203-13, in compliance with the business code of ethics, internal control system and business ethics awareness and compliance program requirements of FAR 2.203-13.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Notwithstanding any provisions herein to the contrary, failure to satisfy any of the aforementioned conditions shall be considered a material breach of this Agreement and constitute immediate grounds for a termination for default.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XLII.&#160;&#160; SUSPENSION AND DEBARMENT</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;This Agreement incorporates FAR 9.406-2(b)(1)(vi) and 9.407-2(a)(8). Accordingly, the Subcontractor hereby understands and warrants that it can be suspended and/or debarred for a knowing failure by a principal of the Subcontractor, until 3 years after final payment on this Subcontract, to timely disclose to the Government, in connection with the award, performance or closeout of this Subcontract, credible evidence of: (a) violation of Federal criminal law involving fraud, conflict of interest, bribery, or gratuity violations found in Title 18 of the U.S. Code; (b) violation of the civil False Claims Act (31 U.S.C. 3729-3733); or (c) significant overpayment(s) on the Subcontract, other than overpayments resulting from contract financing payments as defined in 32.001.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Notwithstanding any provisions herein to the contrary, failure to satisfy any of the aforementioned conditions shall be considered a material breach of this Agreement and constitute immediate grounds for a termination for default.</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">27</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XLIII.&#160;&#160; FORCE MAJEURE</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Neither party shall be responsible for any failure to comply with, or for any delay in performance of the terms of this Agreement, where such failure or delay arises from: acts of God, acts of the Government in its sovereign (and not contractual) capacity, fires, floods, epidemics, quarantine restrictions, strikes, freight embargoes, delays by the government in processing required U.S. export control authorizations, unusually severe weather, shortages of supplies or materials where such supplies or materials were unobtainable from an alternate source, acts of war or terrorism, or domestic unrest.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;In all such events where performance is delayed or prevented, the affected party shall nonetheless exert reasonable and diligent efforts to remove said causes and resume performance hereunder.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XLIV.&#160;&#160; EMPLOYMENT ELIGIBILITY VERIFICATION</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Under the terms of this Agreement, the Subcontractor must comply with the provisions of FAR 52.222-54, Employment Eligibility Verification (Jan 2009) in the performance of this effort. Unless specified otherwise, for the purposes of Sections (b) and (d), the term &#8220;Contractor&#8221; shall mean Subcontractor and the term &#8220;Contract&#8221; shall mean &#8220;Subcontract Agreement&#8221;.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(a) <font style="FONT-STYLE: italic; DISPLAY: inline">Definitions</font>. As used in this clause-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;Commercially available off-the-shelf (COTS) item&#8221;-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1) Means any item of supply that is-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(i) A commercial item (as defined in paragraph (1) of the definition at 2.101);</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(ii) Sold in substantial quantities in the commercial marketplace; and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(iii) Offered to the Government, without modification, in the same form in which it is sold in the commercial marketplace; and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2) Does not include bulk cargo, as defined in section 3 of the Shipping Act of 1984 (46 U.S.C. App. 1702), such as agricultural products and petroleum products. Per 46 CFR 525.1 (c)(2), &#8220;bulk cargo&#8221; means cargo that is loaded and carried in bulk onboard ship without mark or count, in a loose unpackaged form, having homogenous characteristics. Bulk cargo loaded into intermodal equipment, except LASH or Seabee barges, is subject to mark and count and, therefore, ceases to be bulk cargo.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;Employee assigned to the Contract&#8221; means an employee who was hired after November 6, 1986, who is directly performing work, in the United States, under a Contract that is required to include the clause prescribed at 22.1803. An employee is not considered to be directly performing work under a Contract if the employee-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1) Normally performs support work, such as indirect or overhead functions; and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2) Does not perform any substantial duties applicable to the Contract.</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">28</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;Subcontract&#8221; means any contract, as defined in 2.101, entered into by a Subcontractor to furnish supplies or services for performance of a Prime Contract or a Subcontract. It includes but is not limited to purchase orders, and changes and modifications to purchase orders.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;Subcontractor&#8221; means any supplier, distributor, vendor, or firm that furnishes supplies or services to or for a Prime Contractor or another Subcontractor.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;United States&#8221;, as defined in 8 U.S.C. 1101(a)(38), means the 50 States, the District of Columbia, Puerto Rico, Guam, and the U.S. Virgin Islands.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(b) <font style="FONT-STYLE: italic; DISPLAY: inline">Enrollment and verification requirements</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1) If the Contractor is not enrolled as a Federal Contractor in E-Verify at time of Contract award, the Contractor shall-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(i) <font style="FONT-STYLE: italic; DISPLAY: inline">Enroll</font>. Enroll as a Federal Contractor in the E-Verify program within 30 calendar days of Contract award;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(ii) <font style="FONT-STYLE: italic; DISPLAY: inline">Verify all new employees</font>. Within 90 calendar days of enrollment in the E-Verify program, begin to use E-Verify to initiate verification of employment eligibility of all new hires of the Contractor, who are working in the United States, whether or not assigned to the Contract, within 3 business days after the date of hire (but see paragraph (b)(3) of this section); and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(iii) <font style="FONT-STYLE: italic; DISPLAY: inline">Verify employees assigned to the Contract</font>. For each employee assigned to the Contract, initiate verification within 90 calendar days after date of enrollment or within 30 calendar days of the employee&#8217;s assignment to the Contract, whichever date is later (but see paragraph (b)(4) of this section).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2) If the Contractor is enrolled as a Federal Contractor in E-Verify at time of contract award, the Contractor shall use E-Verify to initiate verification of employment eligibility of-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(i) <font style="FONT-STYLE: italic; DISPLAY: inline">All new employees</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(A) <font style="FONT-STYLE: italic; DISPLAY: inline">Enrolled 90 calendar days or more</font>. The Contractor shall initiate verification of all new hires of the Contractor, who are working in the United States, whether or not assigned to the Contract, within 3 business days after the date of hire (but see paragraph (b)(3) of this section); or</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(B) <font style="FONT-STYLE: italic; DISPLAY: inline">Enrolled less than 90 calendar days</font>. Within 90 calendar days after enrollment as a Federal Contractor in E-Verify, the Contractor shall initiate verification of all new hires of the Contractor, who are working in the United States, whether or not assigned to the Contract, within 3 business days after the date of hire (but see paragraph (b)(3) of this section); or</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(ii) <font style="FONT-STYLE: italic; DISPLAY: inline">Employees assigned to the Contract</font>. For each employee assigned to the Contract, the Contractor shall initiate verification within 90 calendar days after date of Contract award or within 30 days after assignment to the Contract, whichever date is later (but see paragraph (b)(4) of this section).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(3) If the Contractor is an institution of higher education (as defined at 20 U.S.C. 1001(a)); a State or local Government or the Government of a Federally recognized Indian tribe; or a surety performing under a takeover agreement entered into with a Federal agency pursuant to a performance bond, the Contractor may choose to verify only employees assigned to the Contract, whether existing employees or new hires. The Contractor shall follow the applicable verification <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">requirements at (b)(1) or (b)(2) respectively, except that any requirement for verification of new employees applies only to new employees assigned to the Contract.</font></font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">29</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(4) <font style="FONT-STYLE: italic; DISPLAY: inline">Option to verify employment eligibility of all employees</font>. The Contractor may elect to verify all existing employees hired after November 6, 1986, rather than just those employees assigned to the Contract. The Contractor shall initiate verification for each existing employee working in the United States who was hired after November 6, 1986, within 180 calendar days of-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(i) Enrollment in the E-Verify program; or</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(ii) Notification to E-Verify Operations of the Contractor&#8217;s decision to exercise this option, using the contact information provided in the E-Verify program Memorandum of Understanding (MOU).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(5) The Contractor shall comply, for the period of performance of this Contract, with the requirements of the E-Verify program MOU.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(i) The Department of Homeland Security (DHS) or the Social Security Administration (SSA) may terminate the Contractor&#8217;s MOU and deny access to the E-Verify system in accordance with the terms of the MOU. In such case, the Contractor will be referred to a suspension or debarment official.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(ii) During the period between termination of the MOU and a decision by the suspension or debarment official whether to suspend or debar, the Contractor is excused from its obligations under paragraph (b) of this clause. If the suspension or debarment official determines not to suspend or debar the Contractor, then the Contractor must reenroll in E-Verify.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(c) <font style="FONT-STYLE: italic; DISPLAY: inline">Web site</font>. Information on registration for and use of the E-Verify program can be obtained via the Internet at the Department of Homeland Security Web site: <font color="blue" style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">http://www.dhs.gov/E-Verify</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(d) <font style="FONT-STYLE: italic; DISPLAY: inline">Individuals previously verified</font>. The Contractor is not required by this clause to perform additional employment verification using E-Verify for any employee-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1) Whose employment eligibility was previously verified by the Contractor through the E-Verify program;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2) Who has been granted and holds an active U.S. Government security clearance for access to confidential, secret, or top secret information in accordance with the National Industrial Security Program Operating Manual; or</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(3) Who has undergone a completed background investigation and been issued credentials pursuant to Homeland Security Presidential Directive (HSPD)-12, Policy for a Common Identification Standard for Federal Employees and Contractors.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(e) <font style="FONT-STYLE: italic; DISPLAY: inline">Subcontracts</font>. The Contractor shall include the requirements of this clause, including this paragraph (e) (appropriately modified for identification of the parties), in each Subcontract that-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1) Is for-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(i) Commercial or noncommercial services (except for commercial services that are part of the purchase of a COTS item (or an item that would be a COTS item, but for minor modifications), performed by the COTS provider, and are normally provided for that COTS item); or</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(ii) Construction;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2) Has a value of more than $3,000; and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">30</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(3) Includes work performed in the United States.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XLV.&#160;&#160; USE OF MANDATORY ARBITRATION AGREEMENTS</font></font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Additional Requirements and Responsibilities Restriction the Use of Mandatory Arbitration Agreements (Deviation) (Feb 2010).</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(a) <font style="FONT-STYLE: italic; DISPLAY: inline">Definitions</font>. As used in this clause-</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;Covered Subcontract,&#8221; as used in this clause, means any Subcontract, except a Subcontract for the acquisition of commercial items or commercially available off-the-shelf items, that is in excess of $1 million and uses Fiscal Year 2010 funds.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(b) The Contractor-</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1) Agrees not to-</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(i) Enter into any agreement with any of its employees or independent contractors that requires, as a condition of employment, that the employee or independent contractor agree to resolve through arbitration any claim under title VII of the Civil Rights Act of 1964 or any tort related to or arising out of sexual assault or harassment, including assault and battery, intentional infliction of emotional distress, false imprisonment, or negligent hiring, supervision, or retention; or</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(ii) Take any action to enforce any provision of an existing agreement with an employee or independent contractor that mandates that the employee or independent contractor resolve through arbitration any claim under title VII of the Civil Rights Act of 1964 or any tort related to or arising out of sexual assault or harassment, including assault and battery, intentional infliction of emotional distress, false imprisonment, or negligent hiring, supervision, or retention; and</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2) Certifies, by signature of the contract, for contracts awarded after June 17, 2010 that it requires each covered Subcontractor to agree not to enter into, and not to take any action to enforce any provision of any agreements, as described in paragraph (b)(1) of this clause, with respect to any employee or independent contractor performing work related to such Subcontract.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(c) The prohibitions of this clause do not apply with respect to a Contractor&#8217;s or Subcontractor&#8217;s agreements with employees or independent contractors that may not be enforced in a court of the United States.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(d) The Secretary of Defense may waive the applicability of the restrictions of paragraph (b) to the Contractor or a particular Subcontractor for the purposes of the Contract or a particular Subcontract if the Secretary or the Deputy Secretary personally determines that the waiver is necessary to avoid harm to national security interests of the United States, and that the term of the Contract or Subcontract is not longer that necessary to avoid such harm. This determination will be made public not less that 15 business days before the Contract or Subcontract addressed in the determination may be awarded.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XLVI.&#160;&#160; COMPLIANCE WITH 29 CFR PART 471, APPENDIX A, SUBPART A</font></font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Effective June 19, 2010, Federal Contractors and their Subcontractors are required to post notices informing their employees of their rights under the National Labor Relations Act (NLRA). The notice to employees, required by the new regulation, informs employees about their rights under the NLRA to form, join and assist a union, and to bargain collectively with their employer. The notice provides examples of unlawful employer and union conduct that interferes with those rights and indicates how employees can contact the National Labor Relations Board, the Federal agency that enforces those rights, with questions or to file complaints. Contractors and Subcontractors must post the employee notice conspicuously in and around their plants and offices so that it is prominent and readily seen by employees who are covered by the NLRA and who engage in Contract related activity.</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">31</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The poster can be found at <font style="DISPLAY: inline; TEXT-DECORATION: underline"><font color="blue" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">http://www.dol.gov/olms/regs/compliance/EO13496.htm</font></font><font style="DISPLAY: inline">.</font></font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Contractors and Subcontractors that violate the Labor Department&#8217;s regulations requiring employee notification of these rights may be subject to sanctions, including suspension or cancellation of the Contract.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">ARTICLE XLVII.&#160;&#160; FEDERAL FUNDING ACCOUNTABILITY &amp; TRANSPARENCY ACT</font></font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;The intent of the Federal Funding Accountability and Transparency Act (FFATA) of 2006 (Pub. L. 109-282) as amended by Section 6202 of the Government Funding Transparency Act of 2008 (Pub. L. 110-252) is to empower every American with the ability to hold the Government accountable for each spending decision. The end result is to reduce wasteful spending in the Government. The FFATA legislation requires information on federal awards (federal financial assistance and expenditures) be made available to the public via a single, searchable website, which is www.USASpending.gov.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;If subject to the Act, pursuant to FAR 52.204-10(c)(1) and 52.204-10(d)(2), and the phased-in reporting schedule outlined under FAR 52.204-10(e)(1), (2), and (3); the Subcontractor is hereby required to report appropriate information, as specified in 52.204-10(c)(1) and (c)(3), to LMI&#8217;s Subcontracts Administrator no later than the due date specified in the LMI provided FFATA reporting form.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Notwithstanding any provisions herein to the contrary, failure to comply with the subject requirements shall be considered a material breach of this Agreement and constitute immediate grounds for a termination for default.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;52.204-10 Reporting Executive Compensation and First-Tier Subcontract Awards.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">REPORTING EXECUTIVE COMPENSATION AND FIRST-TIER SUBCONTRACT AWARDS (JUL 2010)</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(a) <font style="FONT-STYLE: italic; DISPLAY: inline">Definitions. </font>As used in this c1ause-</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;Executive&#8221; means officers, managing partners, or any other employees in management positions.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;First-tier Subcontract&#8221; means a Subcontract awarded directly by a Contractor to furnish supplies or services (including construction) for performance of a Prime Contract, but excludes supplier agreements with vendors, such as long-term arrangements for materials or supplies that would normally be applied to a Contractor&#8217;s general and administrative expenses or indirect cost.</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">32</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;Contract&#8221; as defined in FAR 2.101, means a mutually binding legal relationship obligating the seller to furnish the supplies or services (including construction) and the buyer to pay for them. It includes all types of commitments that obligate the Government to an expenditure of appropriated funds and that, except as otherwise authorized, are in writing. In addition to bilateral instruments, contracts include (but are not limited to) awards and notices of awards; job orders or task letters issued under basic ordering agreements; letter contracts; orders, such as purchase orders, under which the contract becomes effective by written acceptance or performance; and bilateral contract modifications. Contracts do not include grants and cooperative agreements covered by 31 U.S.C. 6301, <font style="FONT-STYLE: italic; DISPLAY: inline">et seq</font>. For discussion of various types of contracts, see FAR Part 16.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;Total compensation&#8221; means the cash and noncash dollar value earned by the executive during the Contractor&#8217;s preceding completed fiscal year and includes the following (for more information see 17 CFR 229.402(c)(2)):</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1) <font style="FONT-STYLE: italic; DISPLAY: inline">Salary and bonus.</font></font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2) <font style="FONT-STYLE: italic; DISPLAY: inline">Awards of stock, stock options, and stock appreciation rights</font>. Use the dollar amount recognized for financial statement reporting purposes with respect to the fiscal year in accordance with the Statement of Financial Accounting Standards No. 123 (Revised 2004) (FAS l23R), Shared Based Payments.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(3) <font style="FONT-STYLE: italic; DISPLAY: inline">Earnings for services under non-equity incentive plans</font>. This does not include group life, health, hospitalization or medical reimbursement plans that do not discriminate in favor of executives, and are available generally to all salaried employees.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(4) <font style="FONT-STYLE: italic; DISPLAY: inline">Change i</font>n <font style="FONT-STYLE: italic; DISPLAY: inline">pension value</font>. This is the change in present value of defined benefit and actuarial pension plans.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(5) <font style="FONT-STYLE: italic; DISPLAY: inline">Above-market earnings on deferred compensation which is not tax-qualified.</font></font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(6) <font style="FONT-STYLE: italic; DISPLAY: inline">Other compensation</font>, if the aggregate value of all such other compensation (e.g., severance, termination payments, value of life insurance paid on behalf of the employee, perquisites or property) for the executive exceeds $10,000.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(b) Section 2(d)(2) of the Federal Funding Accountability and Transparency Act of 2006 (Pub. L. 109-282), as amended by section 6202 of the Government Funding Transparency Act of 2008 (Pub. L. 110-252), requires the Contractor to report information on Subcontract awards. The law requires all reported information be made public; therefore, the Contractor is responsible for notifying its Subcontractors that the required information will be made public.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(c)(1) Unless otherwise directed by the Contracting Officer, by the end of the month following the month of award of a First-tier Subcontract with a value of $25,000 or more, (and any modifications to these Subcontracts that change previously reported data), the Contractor shall report the following information at http://www.fsrs.gov for each First-tier Subcontract. (The Contractor shall follow the instructions at http://www.fsrs.gov to report the data.)</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(i) Unique identifier (DUNS Number) for the Subcontractor receiving the award and for the Subcontractors parent company, if the Subcontractor has a parent company.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(ii) Name of the Subcontractor.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(iii) Amount of the Subcontract award.</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">33</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(iv) Date of the Subcontract award.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(v) A description of the products or services (including construction) being provided under the subcontract, including the overall purpose and expected outcomes or results of the Subcontract.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(vi) Subcontract number (the Subcontract number assigned by the Contractor).</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(vii) Subcontractor&#8217;s physical address including street address, city, state, and country. Also include the nine-digit zip code and congressional district.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(viii) Subcontractor&#8217;s primary performance location including street address, city, state, and country. Also include the nine-digit zip code and congressional district.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(ix) The Prime Contract number and order number (if applicable).</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(x) Awarding agency name and code.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(xi) Funding agency name and code.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(xii) Government contracting office code.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(xiii) Treasury account symbol (TAS) as reported in FPDS.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(xiv) The applicable North American Industry Classification System code (NAICS).</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2) By the end of the month following the month of a Contract award, and annually thereafter, the Contractor shall report the names and total compensation of each of the five most highly compensated executives for the Contractor&#8217;s preceding completed fiscal year at http://www.ccr.gov, if-</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(i) In the Contractor&#8217;s preceding fiscal year, the Contractor received-</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(A) 80 percent or more of its annual gross revenues from Federal Contracts (and Subcontracts), loans, grants (and subgrants) and cooperative agreements; and</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(B) $25,000,000 or more in annual gross revenues from Federal Contracts (and Subcontracts), loans, grants (and subgrants) and cooperative agreements; and</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(ii) The public does not have access to information about the compensation of the executives through periodic reports filed under section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a), 78o(d)) or section 6104 of the Internal Revenue Code of 1986. (To determine if the public has access to the compensation information, see the U.S. Security and Exchange Commission total compensation filings at http://www.sec.gov/answers/execomp.htm.)</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(3) Unless otherwise directed by the Contracting Officer, by the end of the month following the month of a First-tier Subcontract with a value of $25,000 or more, and annually thereafter, the Contractor shall report the names and total compensation of each of the five most highly compensated executives for each First-tier Subcontractor for the Subcontractor&#8217;s preceding completed fiscal year at http://www.fsrs.gov, if-</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(i) In the Subcontractor&#8217;s preceding fiscal year, the Subcontractor received&#8212;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(A) 80 percent or more of its annual gross revenues from Federal Contracts (and Subcontracts), loans, grants (and subgrants) and cooperative agreements; and</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(B) $25,000,000 or more in annual gross revenues from Federal Contracts (and Subcontracts), loans, grants (and subgrants) and cooperative agreements; and</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(ii) The public does not have access to information about the compensation of the executives through periodic reports filed under section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a), 78o(d)) or section 6104 of the Internal Revenue Code of 1986. (To determine if the public has access to the compensation information, see the U.S. Security and Exchange Commission total compensation filings at http://www.sec.gov/answers/execomp.htm.)</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">34</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(d)(1) If the Contractor in the previous tax year had gross income, from all sources, under $300,000, the Contractor is exempt from the requirement to report Subcontractor awards.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2) If a Subcontractor in the previous tax year had gross income from all sources under $300,000, the Contractor does not need to report awards to that Subcontractor.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(e) Phase-in of reporting of Subcontracts of $25,000 or more.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1) Until September 30, 2010, any newly awarded Subcontract must be reported if the Prime Contract award amount was $20,000,000 or more.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2) From October 1, 2010, until February 28, 2011, any newly awarded Subcontract must be reported if the Prime Contract award amount was $550,000 or more.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(3) Starting March 1, 2011, any newly awarded Subcontract must be reported if the Prime Contract award amount was $25,000 or more.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">IN WITNESS WHEREOF</font>, the parties hereto have executed this contract as indicated below:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td align="left" valign="top" width="43%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Logistics Management Institute</font></div>
</td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="43%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Applied DNA Sciences, Inc.</font></div>
</td>
</tr><tr>
<td valign="top" width="43%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="43%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="43%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Julie A. Wagoner</font></td>
<td valign="top" width="4%" style="PADDING-BOTTOM: 1px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="43%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Kurt Jensen</font></td>
</tr><tr>
<td align="left" valign="top" width="43%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">By: Julie A. Wagoner</font></div>
</td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="43%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">By: Kurt Jensen</font></div>
</td>
</tr><tr>
<td valign="top" width="43%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="43%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="43%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Supervisor, Subcontracts &amp; Purchasing</font></div>
</td>
<td valign="top" width="4%" style="PADDING-BOTTOM: 1px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="43%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chief Financial Officer</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="43%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Title</font></div>
</td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="43%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Title</font></div>
</td>
</tr><tr>
<td valign="top" width="43%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="43%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="43%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">May 26, 2011</font></div>
</td>
<td valign="top" width="4%" style="PADDING-BOTTOM: 1px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="43%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">June 2, 2011&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="43%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Date</font></div>
</td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="43%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Date</font></div>
</td>
</tr></table>
</div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">35</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ATTACHMENT A</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">STATEMENT OF WORK</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">FROM</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PRIME CONTRACT</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal">xxx</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="1">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ATTACHMENT B</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">REPRESENTATIONS &amp; CERTIFICATIONS</font></div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td align="left" valign="top" width="90%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><img src="lmi1.jpg" alt="graphic"></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">REPRESENTATIONS AND CERTIFICATIONS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Under the Government&#8217;s procurement acquisition regulations, it is necessary that vendors certify that they comply with certain Government policies prior to award of an order funded under a Government prime contract. In this regard, since your company is being considered as a potential supplier to the Logistics Management Institute under a Government funded prime contract, it is necessary that you complete, date, sign (by an authorized representative), and return the Representations and Certifications as part of your proposal.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Government requires that these Representations and Certifications be completed prior to award. In accordance with this policy, no Purchase Orders/Subcontracts may be issued to your company for products or services which will be used in the performance of our Government prime contracts prior to the return of these Representations and Certifications.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Instructions</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The representations and certifications are arranged in four (4) parts. Based on the amount of your offer, complete the following and sign the signature page:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td align="left" valign="top" width="21%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$10,000 to $99,999</font></div>
</td>
<td align="left" valign="top" width="79%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Complete Section I</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="21%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$100,000 to $499,999</font></div>
</td>
<td align="left" valign="top" width="79%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Complete Section I and II.</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="21%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$500,000 or above</font></div>
</td>
<td align="left" valign="top" width="79%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Complete the entire document</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Offeror represents and certifies as part of its offer that:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SECTION I</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Taxpayer Identification (FAR 52.204-3) (Oct 1998)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">All offerors must submit the information required in paragraphs (a) though (c) of this provision to comply with debt collection requirements of 31 U.S.C. 7701(c) and 3325 (d), reporting requirements of 26 U.S.C. 6041, 6041 A, and 6050M, and implementing regulations issued by the IRS. If the resulting contract is subject to the payment reporting requirements described in Federal Acquisition Regulation (FAR) 4.904, the failure or refusal by the offeror to furnish the information may result in a 31 percent reduction of payments otherwise due under the contract.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The TIN may be used by the Government to collect and report on any delinquent amounts arising out of the offerors relationship with the Government (31 U.S.C. 7701(c)(3)). If the resulting contract is subject to the payment reporting requirements as described in FAR 4.904, the TIN provided hereunder may be matched with IRS records to verify the accuracy of the offeror&#8217;s TIN.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The offeror by checking the appropriate box below, represents the following:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(a) Taxpayer Identification Number (TIN)</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<br>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font></font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TIN: <font style="TEXT-DECORATION: underline">59-2262718</font></font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt">o</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TIN has been applied for.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt">o</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TIN is not required because:,________________________________________</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt">o</font></div>
</td>
<td valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Offeror is a nonresident alien, foreign corporation, or foreign partnership that does not have income effectively connected with the conduct of a trade or business in the United States and does not have an office of place of business or a fiscal paying agent in the United States; </font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt">o</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Offeror is an agency or instrumentality of a foreign government;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt">o</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Offeror is an agency or instrumentality of a state or local government;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt">o</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other. State basis __________________________</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="top" width="90%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(b)</font></div>
</td>
<td colspan="2" valign="top" width="90%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Type of organization</font></td>
</tr></table>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt">o</font></div>
</td>
<td align="left" valign="top" width="45%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sole Proprietorship</font></div>
</td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt">o</font></div>
</td>
<td align="left" valign="top" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Partnership</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font></font></div>
</td>
<td align="left" valign="top" width="45%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Corporate Entity (non tax exempt)</font></div>
</td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt">o</font></div>
</td>
<td align="left" valign="top" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Corporate Entity (tax exempt)</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt">o</font></div>
</td>
<td align="left" valign="top" width="45%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Government entity (Federal, State, Local)</font></div>
</td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt">o</font></div>
</td>
<td align="left" valign="top" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign Government</font></div>
</td>
</tr></table>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt">o</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">International organization per 26 CFR 1.6049-4</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt">o</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other _________________________________________</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="top" width="90%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(c)</font></div>
</td>
<td colspan="2" valign="top" width="90%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Common Parent ___________________________________________</font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font></font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Offeror is not owned or controlled by a common parent;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt">o</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Name and TIN of Common Parent:</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Name: __________________________________________________</font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TIN ____________________________________________________</font></td>
</tr><tr>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(d)</font></div>
</td>
<td colspan="2" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Definitions:</font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt">&#160;</font></div>
</td>
<td valign="top" width="85%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8220;Common Parent&#8221; as used in this provision, means that corporate entity that owns or controls an affiliated group of corporations that files its federal income tax returns on a consolidated basis, and of which the offeror is a member.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="85%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt">&#160;</font></div>
</td>
<td valign="top" width="85%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8220;Taxpayer Identification Number&#8221;, as used in this provision, means the number required by the Internal revenue Service (IRS) to be used by the offeror in reporting income tax and other returns. The TIN may be a Social Security Number or an Employer Identification Number.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2.</font></div>
</td>
<td valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Small Business Program Representations (FAR 52.219-1) (Mar 2001)</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(a)</font></div>
</td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td valign="top" width="85%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The North American Industry Classification System (NAICS) code for this acquisition is</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Administrator for this solicitation.) </font>(2) The small business size standard is________. <font style="FONT-STYLE: italic; DISPLAY: inline">(To be completed by LMI. If no NAICS code is included, contact the LMI Subcontracts Administrator for this solicitation.)</font></font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The small business size standard is ________. <font style="FONT-STYLE: italic; DISPLAY: inline">(To be completed by LMI)</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3)</font></div>
</td>
<td valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The small business size standard for a concern which submits an offer in its own name, other than on a construction or service contract, but which proposes to furnish a product which it does not itself manufacture is 500 employees.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(b)</font></div>
</td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The offeror represents as a part of its offer that it <font style="DISPLAY: inline; FONT-FAMILY: wingdings"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font></font> is, <font style="DISPLAY: inline; FONT-FAMILY: wingdings"><font style="DISPLAY: inline; FONT-FAMILY: wingdings"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font></font></font> is not a small business concern.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Complete this (b)(2) only if the offeror represents itself as a small business concern in paragraph (b)(1), above.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The offeror represents, for general statistical purposes, that it <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> is, <font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font> is not, a small disadvantaged business concern as defined in 13 CFR 124.1002.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3)</font></div>
</td>
<td valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Complete this (b)(3) only if the offeror represents itself as a small business concern in paragraph (b)(1), above.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The offeror represents, for general statistical purposes, that it <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> is, <font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font> is not, a women-owned small business concern.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4)</font></div>
</td>
<td valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Complete this (b)(4) only if the offeror represents itself as a small business concern in paragraph (b)(1), above.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The offeror represents, for general statistical purposes, that it <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> is, <font style="DISPLAY: inline; FONT-FAMILY: wingdings"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font></font> is not, a veteran-owned small business concern.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5)</font></div>
</td>
<td valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Complete this (b)(5) only if the offeror represents itself as a veteran-owned small business concern in paragraph (b)(4), above.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The offeror represents, for general statistical purposes, that it <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> is, <font style="DISPLAY: inline; FONT-FAMILY: wingdings"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font></font><font style="FONT-STYLE: italic; DISPLAY: inline">&#160;</font>is not, a service-disabled veteran-owned small business concern.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(6)</font></div>
</td>
<td valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Complete this (b)(6) only if the offeror represents itself as a small business concern in paragraph (b)(1), above.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The offeror represents, as a part of its offer, that-</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(i)</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">It <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> is, <font style="DISPLAY: inline; FONT-FAMILY: wingdings"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font></font> is not, a HUBZone small business concern listed, on the date of this representation, on the List of Qualified HUBZone Small Business Concerns maintained by the Small Business Administration, and no material change in ownership and control, principal office, or HUBZone employee percentage has occurred since it was certified by the Small Business Administration in accordance with 13 CFR Part 126; and</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="80%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(ii)</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">It <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> is, <font style="DISPLAY: inline; FONT-FAMILY: wingdings"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font></font> is not, a joint venture that complies with requirements of 13 CFR Part 126, and trre representative in paragraph (b)(6)(i) of this provision is accurate for the HUBZone small business concern or concerns that are participating in the joint venture. ____________ ] Each HUBZone small business concern participating in the joint venture shall submit a separate signed copy of the HUBZone representation.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="80%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(7)</font></div>
</td>
<td colspan="2" valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Complete this (b)(7) only if the offeror represents itself as disadvantaged in paragraph (b)(2), above.</font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="80%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The offeror shall check the category in which its ownership falls:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="77%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Black American</font></div>
</td>
</tr><tr>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="77%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Hispanic American</font></div>
</td>
</tr><tr>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="77%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Native American (American Indians, Eskimos, Aleuts, or Native Hawaiians)</font></div>
</td>
</tr></table>
</div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<br>
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="80%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">__________ Asian-Pacific Americans (persons with origins from Burma, Thailand, Malaysia, Indonesia, Singapore, Brunei, Japan, China, Taiwan, Laos, Cambodia (Kampuchea), Vietnam, Korea, The Philippines, U.S Trust Territory of the Pacific Islands (Republic of Palau), Republic of the Marshall Islands, Federated States of Micronesia, the Commonwealth of the Northern Mariana Islands, Guam, Samoa, Macao, Hong Kong, Fiji, Tonga, Kiribati, Tuvalu, or Nauru).</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="80%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">____________ Subcontinent Asian (Asian Indian) American (persons with origins from India, Pakistan, Bangladesh, Sri Lanka, Bhutan, the Maldives Islands, or Nepal).</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="3" valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(c)</font></font></div>
</td>
<td colspan="3" valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Definitions. As used in this provision:</font></font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="80%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>
</td>
<td colspan="3" valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Service-disabled veteran-owned small business concern-</font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td colspan="2" valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Means a small business concern-</font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(i)</font></div>
</td>
<td valign="top" width="80%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Not less than 51 percent of which is owned by one or more service- disabled veterans or, in the case of any publicly owned business, not less than 51 percent of the stock of which s owned by one or more service-disabled veterans, and;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(ii)</font></div>
</td>
<td valign="top" width="80%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The management and daily business operations of which are controlled by one or more service-disabled veterans or, in the case of a veteran with permanent and severe disability, the spouse or permanent caregiver of such veteran.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td colspan="2" valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Service-disabled veteran means a veteran, as defined in 38 U.S.C. 101(2), with disability that is service-connected, as defined in 38 U.S.C. 101(16).</font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="3" valign="top" width="90%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8220;Small business concern,&#8221; means a concern, including its affiliates, that is independently owned and operated, not dominant in the field of operation in which it is bidding on Government contracts, as qualified as small business under the criteria in 13 CFR Part 11 and the size standard in paragraph (a) of this provision.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="3" valign="top" width="90%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="3" valign="top" width="90%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Veteran-owned small business concern means a small business concern-</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="80%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td colspan="2" valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Not less than 51 percent of which is owned by one or more veterans (as defined at 38 U.S.C. 101(2)) or, in the case of any publicly owned business, not less than 51 percent of the stock of which is owned by one or more veterans; and</font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td colspan="2" valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The management and daily business operations of which are controlled by one or more veterans.</font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="3" valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="3" valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8220;Women-owed small business concern,&#8221; means a small business concern-</font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td colspan="2" valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">That is at least 51 percent owned by one or more women; or in the case of a publicly owned business, at least 51 percent of the stock of which is owned by one or more women; and</font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="80%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td colspan="2" valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Whose management and daily business operations are controlled by one or more women.</font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="80%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(d)</font></div>
</td>
<td colspan="3" valign="top" width="90%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Notice</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="80%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td colspan="2" valign="top" width="85%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">If this solicitation is for supplies and has been set aside, in whole or in part, for small business concerns, then the clause in this solicitation providing notice of the set-aside contains restrictions on the source of the end items to be furnished.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td colspan="2" valign="top" width="85%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Under 15 U.S.C 645(d), any person who misrepresents a firm&#8217;s status as a small, HUBZone small, small disadvantaged, or women-owned small business concern in order to obtain a contract to be awarded under the preference programs established pursuant to</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(i)</font></div>
</td>
<td valign="top" width="80%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Be punished by imposition of fine, imprisonment, or both;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(ii)</font></div>
</td>
<td valign="top" width="80%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Be subject to administrative remedies, including suspension and debarment; and</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(iii)</font></div>
</td>
<td valign="top" width="80%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Be ineligible for participation in programs conducted under the authority of the Act.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="80%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">3.</font></div>
</td>
<td colspan="4" valign="top" width="95%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Prohibition of Segregated Facilities (FAR 52-222-21) (Mar 2001)</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="80%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(a)</font></div>
</td>
<td colspan="3" valign="top" width="90%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8220;Segregated facilities&#8221; as used in this provision, means any waiting rooms, work areas, rest rooms and wash rooms, restaurants and other eating areas, time clocks, locker rooms and other storage or dressing areas, parking lots, drinking fountains, recreation or entertainment areas, transportation, and housing facilities provided for employees, that are segregated by explicit directive or are in fact segregated on the basis of race, color, religion, or national origin because of written or oral policies or employee custom. The term does not include separate or single-user restrooms or necessary dressing or sleeping areas provided to assure privacy between sexes.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="80%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(b)</font></div>
</td>
<td colspan="3" valign="top" width="90%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Subcontractor agrees that it does not and will not maintain or provide for its employees any segregated facilities at any of its establishments and that it does not and will not permit its employees to perform their services at any location under its control where segregated facilities are maintained. The Subcontractor agrees that a breach of this clause is a violation of the Equal Opportunity clause in this contract.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="80%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(c)</font></div>
</td>
<td colspan="3" valign="top" width="90%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Subcontractor shall include this clause in every subcontract and purchase order that is subject to the Equal Opportunity clause of this contract.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="80%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">4.</font></div>
</td>
<td colspan="4" valign="top" width="95%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Previous Contracts and Compliance Reports (FAR 52-222-22) (Feb 1999)</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="4" valign="top" width="95%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The offeror represents that:</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="80%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(a)</font></div>
</td>
<td colspan="3" valign="top" width="90%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">It <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> has, <font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font> has not, participated in a previous contract or subcontract subject to the Equal Opportunity clause of this solicitation;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(b)</font></div>
</td>
<td colspan="3" valign="top" width="90%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">It <font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font> has, <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> has not, filed all required compliance reports <font style="FONT-STYLE: italic; DISPLAY: inline">{note that if no reports were required, mark &#8220;has&#8221; filed all reports); </font>and</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(c)</font></div>
</td>
<td colspan="3" valign="top" width="90%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Representations indicating submission of required compliance reports, signed by proposed Subcontractors, will be obtained before subcontract awards.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="80%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">5.</font></div>
</td>
<td colspan="4" valign="top" width="95%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Affirmative Action Compliance (FAR 52.222-25) (Apr 1984)</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="4" valign="top" width="95%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The offeror represents that:</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="80%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(a)</font></div>
</td>
<td colspan="3" valign="top" width="90%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">It <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> has developed and has on file, or, <font style="FONT-STYLE: italic; DISPLAY: inline"><font style="FONT-STYLE: normal; DISPLAY: inline; FONT-FAMILY: wingdings">x</font> </font>has not developed and does not have on file, at each establishment, affirmative action programs required by the rules and regulations of the Secretary of Labor (41 CFR 60-1 and 60-2),</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="80%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(b)</font></div>
</td>
<td colspan="3" valign="top" width="90%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">It <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> has not previously had contracts subject to the written affirmative action programs requirement of the rules and regulations of the Secretary of Labor.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SECTION II</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">1.</font></div>
</td>
<td align="left" colspan="4" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Women-Owned Business (Other than Small Business) (FAR 52.204-5) (May 1999)</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="80%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(a)</font></div>
</td>
<td align="left" colspan="3" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Definition. </font>Women-owned business concern, as used in this provision, means a concern which is at least 51 percent owned by one or more women; or in the case of any publicly owned business, at least 51 percent of the stock of which is owned by one or more women; and whose management and daily business operations are controlled by one or more women.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="80%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(b)</font></div>
</td>
<td align="left" colspan="3" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Representation. </font>Complete the following only if the offeror is a women-owned business concern and has not represented itself as a small business concern in paragraph 2.(b)(1) above.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="80%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="3" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Offeror represents that it <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> is, or <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> is not a women-owned business concern.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="80%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2.</font></div>
</td>
<td align="left" colspan="4" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Certification Regarding Debarment, Suspension, Proposed Debarment, and Other Responsibility Matters (FAR 52.209-5) (Apr 2001)</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="80%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(a)</font></div>
</td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td align="left" colspan="2" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The offeror certifies, to the best of its knowledge and belief, that-</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="80%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(i)</font></div>
</td>
<td align="left" valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The offeror and/or any of its Principals -</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(A)</font></div>
</td>
<td align="left" valign="top" width="75%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> are <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> are not presently debarred, suspended, proposed for debarment, or declared ineligible for the award of contracts by any Federal agency:</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="75%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(B)</font></div>
</td>
<td align="left" valign="top" width="75%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> have <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> have not within the three-year period prior preceding this offer, been convicted of or had a civil judgment rendered against them for: commission of fraud or a criminal offense in connection with obtaining , attempting to obtain, or performing a public (Federal, state, or local) contract or subcontract; violation of Federal or state antitrust statutes relating to the submission of offers; or commission of embezzlement, theft, forgery, bribery, falsification or destruction of records, making false statements, tax evasion, or receiving stolen property; and</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="75%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(C)</font></div>
</td>
<td align="left" valign="top" width="75%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> are <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> are not presently indicted for, or otherwise criminally or civilly charged by a governmental entity with, commission of any of the offenses enumerated in subdivision (a)(l)(i)(B) of this provision.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="75%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(ii)</font></div>
</td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="75%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The offeror <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> has <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> has not, within a three-year period preceding this offer, had one or more contracts terminated for default by any Federal agency.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="75%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td align="left" colspan="3" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8220;Principals&#8221;, for the purpose of this certification, means officers; directors; owners; partners; and, persons having primary management or supervisory responsibilities within a business entity (e.g. general manager; plant manager; head of a subsidiary, division, or business segment, and similar positions).</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="3" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">This certification concerns a matter within the jurisdiction of an agency of the United States and the making of false, fictitious, or fraudulent certification may render the maker subject to prosecution under section 1001, title 18, United States Code.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="75%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(b)</font></div>
</td>
<td align="left" colspan="4" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The offeror shall provide immediate written notice to the LMI Subcontracts Administrator if, at any time prior to contract award, the offeror learns that its certification was erroneous when submitted or has become erroneous by reason of changed circumstances.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="75%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(c)</font></div>
</td>
<td align="left" colspan="4" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">A certification that any of the items in paragraph (a) of this provision exists will not necessarily result in withholding of an award under this solicitation. However, the certification will be considered in connection with a determination of the offeror&#8217;s</font></div>
</td>
</tr></table>
</div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div><br>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="68%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">responsibility. Failure of the offeror to furnish a certification or provide such additional information as requested by the LM1 Subcontracts Administrator may render the offeror nonresponsible.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="68%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(d)</font></div>
</td>
<td valign="top" width="68%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nothing contained in the forgoing shall be construed to require establishment of a system of records in order to render, in good faith, the certification required by paragraph (a) of this provision. The knowledge and information of an offeror is not required to exceed that which is normally possessed by a prudent person in the ordinary course of business dealings.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="68%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(c)</font></div>
</td>
<td valign="top" width="68%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The certification in paragraph (a) of this provision is a material representation of fact upon which reliance was placed when making award. If it is later determined that the offeror knowingly rendered an erroneous certification, in addition to the other remedies available to the Government, the LMI Subcontracts Administrator may terminate the contract resulting from this solicitation for default.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">3.</font></div>
</td>
<td align="left" valign="top" width="71%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Certification and Disclosure Regarding Payments to Influence Certain Federal Transactions (FAR 52.203-11) (Apr 1991)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(a)</font></div>
</td>
<td valign="top" width="67%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The definitions and prohibitions contained in the clause at FAR 52.203-12, Limitation on Payments to Influence Certain Federal Transactions, included in this solicitation, are hereby incorporated by reference in paragraph (b) of this certification.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="67%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(b)</font></div>
</td>
<td valign="top" width="67%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The offeror, by signing its offer, hereby certifies to the best of his or her knowledge and belief that on or after December 23, 1989:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td valign="top" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">No Federal or appropriated funds have been paid or will be paid to any person for influencing or attempting to influence an officer of any agency, a Member of Congress, an officer or employee of Congress or an employee of a Member of Congress on his or her behalf in the connection with the awarding of any Federal contract, the making of any Federal grant, the making of any Federal loan, the entering into of any cooperative agreement, and the extension, continuation, renewal, amendment or modification of any Federal contract, grant, loan, or cooperative agreement;</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td valign="top" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">If any funds other than Federal appropriated funds (including profit or fee received under a covered Federal transaction) have been paid to any person for influencing or attempting to influence an officer to employee of any agency, a Member of Congress, an officer or employee of Congress, or an employee of a Member of Congress on his or her behalf in connection with this solicitation, the offeror shall complete and submit, with its offer, OMB standard form LLL, Disclosure of Lobbying Activities to the Contracting Officer; and</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3)</font></div>
</td>
<td valign="top" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">He or she will include the language of this certification in all subcontract awards at any tier and require that all recipients of subcontract awards in excess of $10,000 shall certify and disclose accordingly.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(a)</font></div>
</td>
<td valign="top" width="67%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Submission of this certification and disclosure is a prerequisite for making or entering into this contract imposed by section 1352, title 31, United States Code. Any person who makes an expenditure prohibited under this provision or who fails to file or amend the disclosure form to be filed or amended by this provision, shall be subject to a civil penalty of not less than $10,000, and not more than $100,000, for each failure.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="67%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SECTION III</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">1.</font></div>
</td>
<td align="left" valign="top" width="71%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Cost Accounting Standards Notices and Certifications (FAR 52.230-1) (Jun 2000)</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="71%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="71%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Note: This notice does not apply to small businesses or foreign governments. Check here to indicate that the offeror is a <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> small business or <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> foreign government and therefore is not required to complete the following certification.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="71%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="71%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">This notice is in three parts; identified by Roman numerals I through III.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="71%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="71%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Offerors shall examine each part and provide the requested information in order to determine Cost Accounting Standards (CAS) requirements applicable to any resultant contract.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="71%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="71%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">If the offeror is an educational institution. Part II does not apply unless the contemplated contract will be subject to full or modified CAS coverage pursuant to 48 CFR 9903.201-2(c)(5) or 9903.201-2(c)(6), respectively.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">I.</font></div>
</td>
<td align="left" valign="top" width="71%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">DISCLOSURE STATEMENT - COST ACCOUNTING PRACTICES AND CERTIFICATION</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(a)</font></div>
</td>
<td valign="top" width="68%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Any contract in excess of $650,000 resulting from this solicitation will be subject to the requirements of the Cost Accounting Standards Board (48 CFR Chapter 99), except for those contracts which are exempt as specified in 48 CFR 9903.201-1.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="68%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(b)</font></div>
</td>
<td valign="top" width="68%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Any offeror submitting a proposal which, if accepted, will result in a contract subject to the requirements of 48 CFR Chapter 99 must, as a condition of contracting, submit a Disclosure Statement as required by 48 CFR 9903.202. When required, the Disclosure Statement must be submitted as a part of the offeror&#8217;s proposal under this solicitation unless the offeror has already submitted a Disclosure Statement disclosing the practices used in connection with the pricing of this proposal. If an applicable Disclosure statement has already been submitted, the offeror may satisfy the requirement for submission by providing the information requested in paragraph (c) of Pert I of this provision.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="68%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="68%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">CAUTION: In the absence of specific regulations or agreements, a practice disclosed in a Disclosure Statement shall not, by virtue of such disclosure, be deemed to be a proper, approved, or agreed-to practice for pricing proposals or accumulating and report contract performance cost data.</font></div>
</td>
</tr></table>
</div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<br>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(c)</font></div>
</td>
<td align="left" valign="top" width="62%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Check to appropriate box below:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt">o</font></div>
</td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td align="left" valign="top" width="59%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certificate of Concurrent Submission of Disclosure Statement.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="62%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The offeror hereby certifies that, as a part of the offer, copies of the Disclosure Statement have been submitted as follows: (i) original and one copy to the cognizant Administrative Contacting Officer (ACO) or cognizant federal agency official authorized to act in that capacity (Federal official), as applicable, and (ii) one copy to the cognizant Federal auditor.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="62%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="62%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Disclosure must be on Form No. CASB DS-1 or CASB DS-2, as applicable. Forms may be obtained from the cognizant ACO or Federal official and/or from the loose-leaf version of the Federal Acquisition Regulation.)</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="62%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%" style="PADDING-BOTTOM: 1px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="13%" style="PADDING-BOTTOM: 1px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Date of Disclosure Statement:</font></div>
</td>
<td valign="top" width="82%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="62%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="top" width="62%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Name and Address of cognizant ACO or Federal Officer where filed:</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="PADDING-BOTTOM: 1px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="62%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%" style="PADDING-BOTTOM: 1px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="62%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="62%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="62%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The offeror further certifies that the practices used in estimating costs in pricing this proposal are consistent with the cost accounting practices disclosed in the Disclosure Statement.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt">o</font></div>
</td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td align="left" valign="top" width="59%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certificate of Previously Submitted Disclosure Statement.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="3" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The offeror hereby certifies that the required Disclosure Statement was filed as follows:</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="3" valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%" style="PADDING-BOTTOM: 1px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="top" width="14%" style="PADDING-BOTTOM: 1px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Date of Disclosure Statement:</font></div>
</td>
<td valign="top" width="81%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="3" valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="3" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Name and Address of cognizant ACO or Federal Officer where filed:</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="PADDING-BOTTOM: 1px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="3" valign="top" width="95%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%" style="PADDING-BOTTOM: 1px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="3" valign="top" width="95%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="3" valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="3" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The offeror further certifies that the practices used in estimating costs in pricing this proposal are consistent with the cost accounting practices disclosed in the Disclosure Statement.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="3" valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt">o</font></div>
</td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3)</font></div>
</td>
<td align="left" colspan="2" valign="top" width="59%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certificate of Monetary Exemption.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="59%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="3" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The offeror hereby certifies that the offeror together with all divisions, subsidiaries, and affiliates under common control, did not receive net awards of negotiated prime contracts and subcontracts subject to CAS totaling $50 million or more in the cost accounting period immediately preceding the period in which this proposal was submitted. The offeror further certifies that if such status changes before an award resulting from this proposal, the offeror will advise the LMI Subcontracts Administrator immediately.</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="3" valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt">o</font></div>
</td>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4)</font></div>
</td>
<td align="left" colspan="2" valign="top" width="59%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certification of Interim Exemption</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="59%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="3" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The offeror hereby certifies that (i) the offeror first exceeded the monetary exemption for disclosure, as defined in (3) of this subsection, in the cost accounting period</font></div>
</td>
</tr></table>
</div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<br>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="66%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">immediately preceding the period in which this offer was submitted and (ii) in accordance with 48 CFR 9903.202-1, the offeror is not yet required to submit a Disclosure Statement. The offeror further certifies that if an award resulting from this proposal as not been made within 90 days after the end of that period, the offeror will immediately submit a revised certificate to the LMI Subcontracts Administrator, in the form specified under subparagraph (c)(1) or (c)(2) of Part I of this provision, as appropriate, to verify submission of a completed Disclosure Statement.</font></div>
</td>
</tr><tr>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="66%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="66%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">CAUTION: Offerors currently required to disclose because they were awarded a CAS covered prime contract or subcontract of $50 million or more in the current cost account period may not claim this exemption (4). Further, the exemption applies only in connection with proposals submitted before the expiration of the 90-day period following the cost accounting period in which the monetary exemption was exceeded.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">II.</font></div>
</td>
<td align="left" valign="top" width="70%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">COST ACCOUNTING STANDARDS - ELIGIBILITY FOR MODIFICATION</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="70%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="70%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">If the offeror is eligible to use the modified provisions of 48 CFR 9903.201-2(b) and elects to do so, the offeror shall indicate by checking the box below. Checking the box below shall mean that the resultant contract is subject to the Disclosure and Consistency of Cost Accounting Practices clause in lieu of the Cost Accounting Standards clause.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt">o</font></div>
</td>
<td valign="top" width="66%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The offeror hereby claims an exemption from the Cost Accounting Standards clause under the provisions of 48 CFR 9903.201-2(b) and certifies that the offeror is eligible for use of the Disclosure and Consistency of Cost Accounting Practices clause because during the cost accounting period immediately preceding the period in which this proposal was submitted, the offeror received less that $50 million in awards of CAS-covered prime contracts and subcontracts. The offeror further certifies that if such status changes before an award resulting from this proposal, the offeror will advise the LMI Subcontracts Administrator immediately.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="66%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="66%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">CAUTION: An offeror may not claim the above eligibility for modified contract coverage if this proposal is expected to result in the award of a CAS-covered contract of $50 million or more or if, during its current cost accounting period, the offeror has been awarded a single CAS-covered prime contract or subcontract of $50 million or more.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">III</font></div>
</td>
<td align="left" valign="top" width="70%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">ADDITIONAL COST ACCOUNTING STANDARDS APPLICABLE TO EXISTING CONTRACTS</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="70%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="70%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The offeror shall indicate below whether award of the contemplated contract should, in accordance with subparagraph (a)(3) of the Cost Accounting Standards clause, require a change in established cost accounting practices affecting existing contracts and subcontracts.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="70%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;o<font style="DISPLAY: inline; FONT-FAMILY: times new roman"> YES </font>o<font style="DISPLAY: inline; FONT-FAMILY: times new roman"> NO</font></font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="70%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="70%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Note: If the offeror is an educational institution under the transition provisions of 48 CFR 9903.202-1(f), contact the LMI Subcontracts Administrator for the appropriate alternate certification.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SIGNATURE / CERTIFICATION</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">By signing below, the bidder / offeror certifies, under penalty of law, that the representations and certifications are accurate, current and complete. The bidder / offeror further certifies that it will notify the LMI Subcontracts Administrator of any changes to these representations and certifications. The representations and certifications made by the bidder / offeror, as contained herein, concern matters within the jurisdiction of an agency of the United States and the making of false, fictitious, or fraudulent representation or certification may render the maker subject to prosecution under Title 18, United States Code, Section 1001.</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td colspan="3" valign="top" width="75%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="51%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;/s/ KURT JENSEN</font></div>
</td>
<td valign="top" width="7%" style="PADDING-BOTTOM: 1px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="17%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10/15/2010</font></div>
</td>
</tr><tr>
<td align="left" colspan="3" valign="top" width="75%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Signature of Bidder / Offeror Responsible for Bid / Offer Date</font></div>
</td>
</tr><tr>
<td align="left" colspan="3" valign="top" width="75%" style="BORDER-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" colspan="3" valign="top" width="75%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;KURT JENSEN</font></div>
</td>
</tr><tr>
<td align="left" colspan="3" valign="top" width="75%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Typed Name of Person Responsible for the Bid / Offer</font></div>
</td>
</tr><tr>
<td align="left" colspan="3" valign="top" width="75%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" colspan="3" valign="top" width="75%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;CHIEF FINANCIAL OFFICER</font></div>
</td>
</tr><tr>
<td align="left" colspan="3" valign="top" width="75%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Title of Person Responsible for Bid / Offer</font></div>
</td>
</tr><tr>
<td align="left" colspan="3" valign="top" width="75%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" colspan="3" valign="top" width="75%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;APPLIED DNA SCIENCES, INC.</font></div>
</td>
</tr><tr>
<td align="left" colspan="3" valign="top" width="75%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Name of Organization</font></div>
</td>
</tr><tr>
<td align="left" colspan="3" valign="top" width="75%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" colspan="3" valign="top" width="75%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;25 HEALTH SCIENCES DR, STE 213</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td align="left" valign="top" width="30%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Street</font></div>
</td>
<td valign="top" width="22%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="22%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="30%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">STONY BROOK</font></div>
</td>
<td align="left" valign="top" width="22%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NY</font></div>
</td>
<td align="left" valign="top" width="22%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11746</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="30%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">City</font></div>
</td>
<td align="left" valign="top" width="22%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">State</font></div>
</td>
<td align="left" valign="top" width="22%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Zip</font></div>
</td>
</tr></table>
</div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">ATTACHMENT C</font><br>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">GENERAL PROVISIONS</font></div>
</div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<br>
&#160;<br>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td align="right" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Attachment C</font></div>
</td>
</tr><tr>
<td align="right" valign="top" width="90%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subcontract 1124</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">GENERAL PROVISIONS</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In addition to the clauses referenced in the LMI Subcontract, the following terms and conditions shall apply.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">I.1 FAR 52.252-2 Clauses Incorporated by Reference (Feb 1998)</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The contract clauses set forth below from the Federal Acquisition Regulation (FAR), as applicable, and as in effect on the date of this Subcontract, are incorporated into this Subcontract by reference with the same force and effect as though they were given in full text.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;All such clauses shall, with respect to the rights, duties and obligations of the subcontractor and LMI thereunder, be interpreted and construed in such manner as to recognize and give effect to the contractual relationship between the subcontractor and LMI under this Subcontract and the rights of the U.S. Government with respect thereto under the Prime Contract from which such clauses are derived.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;As used throughout these General Provisions, the following terms shall have the meanings set forth below, unless otherwise specified herein:</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Prime Contract </font>- means the Government Prime contract between LMI and the United States of America (hereinafter called the &#8220;Government&#8221;).</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Government </font>- means the United States of America or any department or agency thereof.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Subcontract, Contract, Purchase Order, Order or Agreement </font>- are interchangeable and include any amendments or change orders. Wherever appearing herein, these terms shall be deemed to mean the contractual instrument of which these General Provisions are a part.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Provision </font>- any part of this Subcontract or attachment thereto including, but not limited to any referenced or incorporated agreement, specification, documentation, data, or any clauses or parts or combinations thereof.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Contracting Officer </font>- the individual having cognizance on behalf of the Government of the Prime Contract and any other officer or civilian employee of the Government who is properly designated as the Contracting Officer of the procuring agency. The term includes, except as otherwise provided in the</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Subcontract, any authorized representative of such Contracting Officer acting within the limits of his authority.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">I.2 Federal Acquisition Regulation Clauses (48 CFR Chapter 1)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="1%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Clause</font></div>
</td>
<td valign="top" width="3%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Title</font></div>
</td>
<td valign="top" width="1%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="10%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Date</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.202-01</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Definitions</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jul 2004</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.203-03</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gratuities</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr 1984</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.203-05</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Covenant Against Contingent Fees</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr 1984</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.203-06</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Restrictions on Subcontractor Sales to the Government</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sep 2006</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.203-07</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Anti-Kickback Procedures</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jul 1995</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.203-10</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Price or Fee Adjustment for Illegal or Improper Activity</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jan 1997</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.203-12</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Limitations on Payments to Influence Certain Federal Transactions</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Oct 2010</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.204-02</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Security Requirements</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aug 1996</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.209-06</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Protecting the Government&#8217;s Interest when Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dec 2010</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.215-02</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Audit and Records - Negotiations</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Oct 2010</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.219-08</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Utilization of Small Business Concerns</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">May 2004</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.219-09</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Small Business Subcontracting Plan</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jul 2010</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.222-01</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Notice to the Government of Labor Disputes</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Feb 1997</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.222-03</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Convict Labor</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jun 2003</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.222-04</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Contract Work Hours and Safety Standards Act - Overtime Compensation</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jul 2005</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.222-21</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prohibition of Segregated Facilities</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Feb 1999</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.222-26</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Equal Opportunity</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Mar 2007</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.222-35</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Equal Opportunity for Veterans</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sep 2010</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.222-36</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Affirmative Action for Workers with Disabilities</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Oct 2010</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.222-37</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Employment Reports Veterans</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sep 2010</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.222-41</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Service Contract Act of 1965, As Amended</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nov 2007</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Revised 03/02/2011</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td align="right" valign="top">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Attachment C</font></div>
</td>
</tr><tr>
<td align="right" valign="top" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subcontract 1124</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="1%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Clause</font></div>
</td>
<td valign="top" width="3%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Title</font></div>
</td>
<td valign="top" width="1%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="10%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Date</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.222-50</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Combating Trafficking in Persons</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Feb 2009</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.223-06</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Drug-Free Workplace</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">May 2001</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.223-18</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Contractor Policy to Ban Text Messaging While Driving</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sep 2010</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.224-01</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Privacy Act Notification</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr 1984</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.224-02</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Privacy Act</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr 1984</font> </font></td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.225-13</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Restrictions on Certain Foreign Purchases</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jun 2008</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.227-02</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Notice and Assistance Regarding Patent and Copyright Infringement</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dec 2007</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.227-03</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Patent Indemnity</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr 1984</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.227-06</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Royalty Information</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr 1984</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.227-09</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Refund of Royalties</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr 1984</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.227-10</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Filing of Patent Applications - Classified Subject Matter</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dec 2007</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.227-11</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Patent Rights - Ownership by the Contractor</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dec 2007</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.227-14</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Rights in Data - General</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dec 2007</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.228-07</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Insurance - Liability to Third Persons</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Mar 1996</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.229-03</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Federal, State, and Local Taxes</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr 2003</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.232-07</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Payment under Time-and- Material and Labor-Hour Contracts</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Feb 2007</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.232-11</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Extras</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr 1984</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.232-17</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Interest</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Oct 2010</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.233-01</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Disputes</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jul 2002</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.237-02</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Protection of Government Buildings, Equipment, and Vegetation</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr 1984</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.237-03</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Continuity of Services</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jan 1991</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.242-01</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Notice of Intent to Disallow Costs</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr 1984</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.242-13</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Bankruptcy</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jul 1995</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.242-15</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stop-Work Order [paragraph (b)(2) modified to read 15 days]</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aug 1989</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.244-02</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subcontracts</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Oct 2010</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.245-01</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Government Property (Cost-Reimbursement, Time-And-Materials, or Labor-Hour Contracts)</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aug 2010</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.246-04</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inspection of Services-- Fixed-Price</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aug 1996</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.246-05</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inspection of Services -- Cost-Reimbursement</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr 1984</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.246-06</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inspection--Time-and- Material and Labor Hour</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">May 2001</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.246-09</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inspection of Research &amp; Development (Short Form)</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr 1984</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.246-16</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Responsibility for Supplies</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr 1984</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.246-20</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warranty of Services</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">May 2001</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.246-23</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Limitation of Liability</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Feb 1997</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.246-25</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Limitation of Liability -- Services</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Feb 1997</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.247-34</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F.O.B. Destination</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nov 1991</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.247-63</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Preference for U.S. Flag Air Carriers</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jun 2003</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.247-64</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Preference for Privately Owned U.S. Flag Commercial Vessels</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Feb 2006</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.249-04</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Termination for Convenience of the Government (Services) (Short Form)</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr 1984</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.249-06</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Termination (Cost- Reimbursement)</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">May 2004</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.249-08</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Default (Fixed-Price Supply and Service)</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr 1984</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.249-14</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Excusable Delays</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr 1984</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.251-01</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Government Supply Sources</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aug 2010</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.253-01</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Computer Generated Forms</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jan 1991</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">I.3 DoD FAR Supplement (DFARS) Clauses (48 CFR Chapter 2)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="1%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Clause</font></div>
</td>
<td valign="top" width="3%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Title</font></div>
</td>
<td valign="top" width="1%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="10%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Date</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252.204-7008</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Export-Controlled Items</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr 2010</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Revised 03/02/2011</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ATTACHMENT D</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SUPPLEMENTAL PROVISIONS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the DLA Research &amp; Development Supply Support (RDSS)</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td align="right" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Attachment D</font></div>
</td>
</tr><tr>
<td align="right" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subcontract 1124</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SUPPLEMENTAL PROVISIONS</font></div>
</td>
</tr><tr>
<td valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the DLA Research &amp; Development Supply Support Program</font></div>
</td>
</tr><tr>
<td valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Under LMI Prime Contract SP4701-09-D-0045</font></div>
</td>
</tr><tr>
<td valign="top" width="90%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In addition to the clauses referenced in the LMI Subcontract, the following terms and conditions shall apply. In the event of a conflict of any of these clauses, these clauses listed below shall prevail.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">I.1.1 FAR 52.252-2 Clauses Incorporated by Reference (Feb 1998)</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The contract clauses set forth below from the Federal Acquisition Regulation (FAR) or the DoD Federal Acquisition Regulation (DFARs), as applicable, and as in effect on the date of this Subcontract, are incorporated into this Subcontract by reference with the same force and effect as though they were given in full text. The full text of each clause may be accessed electronically at: <font style="DISPLAY: inline; TEXT-DECORATION: underline">http://www.arnet.gov/far/</font> and at <font style="DISPLAY: inline; TEXT-DECORATION: underline">http://www.acq.osd.miVdp/dars/dfars.html</font>.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;All such clauses shall, with respect to the rights, duties and obligations of the Subcontractor and LMI thereunder, be interpreted and construed in such manner as to recognize and give effect to the contractual relationship between the Subcontractor and LMI under this Subcontract and the rights of the U.S. Government with respect thereto under the Prime Contract from which such clauses are derived.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;As used throughout these Supplemental Provisions, the following terms shall have the meanings set forth below, unless otherwise specified herein:</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Prime Contract </font>- means the Government Prime Contract between LMI and the United States of America (hereinafter called the &#8220;Government&#8221;).</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Government </font>- means the United States of America or any department or agency thereof.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Subcontract, Contract, Purchase Order, Order or Agreement </font>- are interchangeable and include any amendments or change orders. Wherever appearing herein, these terms shall be deemed to mean the contractual instrument of which these Supplemental Provisions are a part.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Provision </font>- any part of this Subcontract or attachment thereto including, but not limited to any referenced or incorporated agreement, specification, documentation, data, or any clauses or parts or combinations thereof.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Contracting Officer </font>- the individual having cognizance on behalf of the Government of the Prime Contract and any other officer or civilian employee of the Government who is properly designated as the Contracting Officer of the procuring agency. The term includes, except as otherwise provided in the Subcontract, any authorized representative of such Contracting Officer acting within the limits of his authority.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">I.2.1 FAR Supplement Clauses (48 CFR Chapter 1)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="1%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Clause</font></div>
</td>
<td valign="top" width="3%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Title</font></div>
</td>
<td valign="top" width="1%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="10%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Date</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.203-08</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cancellation, Rescission, and Recovery of Funds for Illegal or Improper Activity</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jan 1997</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.204-04</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Printing/Copying Double Sided on Recycled Paper</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aug 2000</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.204-07</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Central Contractor Registration (CCR)</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr 2008</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.215-10</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Price Reduction for Defective Cost or Pricing Data</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Oct 1997</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.215-12</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subcontractor Cost or Pricing Data</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Oct 1997</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.216-07</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Allowable Cost and Payment</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dec 2002</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.216-15</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Predetermined Indirect Cost Rates</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr 1998</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.223-14</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Toxic Chemical Release Reporting</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aug 2003</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.227-01</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Authorization and Consent</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dec 2007</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.230-03</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Disclosure and Consistency of Cost Accounting Practices</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Oct 2008</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.230-06</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Administration of Cost Accounting Standards</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Mar 2008</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.232-22</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Limitation of Funds</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr 1984</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.232-23</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Assignment of Claims</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jan 1986</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.232-25</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prompt Payment</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Oct 2008</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.232-33</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Payment by Electronic Funds Transfer - CCR</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Oct 2003</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.233-03</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Protest Against Award</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jun 1985</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="23%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="60%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Alternate I</font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aug 1996</font></font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.233-04</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Applicable Law for Breach of Contract</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Oct 2004</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.243-02</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Changes - Cost Reimbursement </font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr 1984</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="23%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="60%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Alternate V</font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aug&#160;1987</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Revised 10/1/09</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td align="right" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Attachment D</font></div>
</td>
</tr><tr>
<td align="right" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subcontract 1124</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="1%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Clause</font></div>
</td>
<td valign="top" width="3%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Title</font></div>
</td>
<td valign="top" width="1%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="10%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Date</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.243-07</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Notification of Changes</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr 1984</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.244-05</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Competition In Subcontracting</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dec 1996</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.244-06</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subcontracts for Commercial Items</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aug 2009</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.247-01</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Commercial Bill of Lading Notations</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Feb 2006</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52.249-05</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Termination For Convenience of the Government (Educational &amp; Other Non Profit Institutions)</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sept 1996</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">I.2.2 DoD FAR Supplement (DFARS) Clauses (48 CFR Chapter 2)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="1%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Clause</font></div>
</td>
<td valign="top" width="3%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Title</font></div>
</td>
<td valign="top" width="1%" style="BORDER-BOTTOM: black 1px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="10%" style="BORDER-BOTTOM: black 1px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Date</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252.203-7001</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prohibition On Persons Convicted of Fraud or Other Defense Contract Related Felonies</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dec 2008</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252.203-7002</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Requirement to Inform Employees for Whistleblower Rights</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jan 2009</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252.204-7003</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Control Of Government Personnel Work Product</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr 1992</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252.205-7000</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Provisions Of Information To Cooperative Agreement Holders</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dec 1991</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252.209-7004</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subcontracting with Firms that are Owned or Controlled by the Government of a Terrorist Country</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dec 2006</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252.209-7005</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Reserve Officer Training Corps and Military Recruiting on Campus</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jan 2000</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252.215-7000</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Pricing Adjustments</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dec 1991</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252.215-7002</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cost Estimating System Requirements</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dec 2006</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252.219-7003</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Small, Small Disadvantaged &amp; Woman-Owned</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr 2007</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Small Business Subcontracting Plan</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(DoD Contracts)</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252.226-7001</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Utilization of Indian Organizations, Indian- Owned Economic Enterprises, &amp; Native Hawaiian Small Business Concerns [Appl. &gt;$500K]</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sept 2004</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252.227-7000</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Non-Estoppel</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Oct 1966</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252.227-7013</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Rights in Technical Data-Noncommercial Items</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nov 1995</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252.227-7014</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Rights in Noncommercial Computer Software and Noncommercial Computer Software Documentation</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jun 1995</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252.227-7016</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Rights in Bid or Proposal Information</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jun 1995</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252.227-7017</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Identification and Assertion of Use, Release, or Disclosure Restrictions</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jun 1995</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252.227-7025</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Limitations on the Use or Disclosure of Government Furnished Information Marked w/ Restrictive Legends</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jun 1995</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252.227-7030</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Technical Data - Withholding Of Payment</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Mar 2000</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252.227-7037</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Validation of Restrictive Markings on Technical Data</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sept 1999</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252.227-7039</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Patents - Reporting Of Subject Inventions</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Apr 1990</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252.231-7000</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Supplemental Cost Principles</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dec 1991</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252.235-7010</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Acknowledgment of Support and Disclaimer</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">May 1995</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252.235-7011</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Final Scientific or Technical Report</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nov 2004</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252.243-7002</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Requests for Equitable Adjustment</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Mar 1998</font></div>
</td>
</tr><tr bgcolor="azure">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252.246-7001</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warranty of Data</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dec 1991</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252.251-7000</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Ordering From Government Supply Sources</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nov 2004</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<br>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="68%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="21%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Attachment D</font></div>
</td>
</tr><tr>
<td valign="top" width="68%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="21%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subcontract 1124</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">SPECIAL PRIME CONTRACT REQUIREMENTS</font></font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">I.3</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ACKNOWLEGDMENT OF SPONSORSHIP</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">I.3.1 </font>The Subcontractor agrees that in the release of information relating to this Subcontract such release shall include a statement to the effect that the project depicted is or was sponsored by the Defense Supply Center Philadelphia, Philadelphia, PA and the Defense Logistics Agency, Ft. Belvoir, VA.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">I.3.2 </font>For the purpose of this Subcontract, the term &#8220;information&#8221; includes, but is not limited to, news releases/articles, manuscripts, brochures, advertisements, still and motion pictures, speeches, industry/trade association meetings, symposiums, etc.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">I.3.3 </font>The Subcontractor agrees to include the statement in I.3.1 above, in any third tier Subcontract awarded as a result of this Subcontract.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">I.4</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">KEY PERSONNEL</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">I.4.1 </font>The Subcontractor is required to identify their key personnel. Certain skilled, experienced, professional and/or technical personnel are essential for successful accomplishment of the work to be performed under this Subcontract. These are identified as &#8220;Key Personnel&#8221; and are those persons whose resumes were submitted as part of the technical/business proposal for evaluation. The Subcontractor agrees to use said key personnel during the performance of this Subcontract and that they shall not be removed from the Subcontract work, replaced, or supplemented with additional personnel, unless authorized in accordance with this clause.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">I.4.2 </font>If one or more of the key personnel, for whatever reason, becomes, or is expected to become, unavailable for work under this Subcontract for a continuous period exceeding 30 work days, or is expected to devote substantially less effort to the work than indicated in the proposal or initially anticipated, the Subcontractor shall immediately notify the LMI Subcontracts Administrator and shall, subject to the concurrence of the Contracting Officer or his authorized representative, promptly replace such personnel with the personnel of at least substantially equal ability and qualifications.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">I.4.3 </font>The Subcontractor agrees that during the first 120 days of the Subcontract performance period, no key personnel substitutions or additions shall be permitted unless such substitutions or additions are necessitated by an individual&#8217;s sudden illness, death, or termination of employment. If any of these occur, the Subcontractor shall promptly notify the LMI Subcontracts Administrator and provide the information required in paragraph I.4.5 below. After the initial 120 day period, proposed substitutions/additions of key personnel must be submitted in writing to the LMI Subcontracts Administrator 30 days in advance of the proposed substitution or addition. Such requests must provide the information required by paragraph I.4.5 below.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">I.4.4 </font>All additional and substitute key personnel assigned to this Subcontract must be approved prior to being assigned to work under this Subcontract. Any proposed key personnel assigned to a task prior to approval shall work at the sole risk of the Subcontractor and may not be reimbursed by the Government.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">I.4.5 </font>Requests for approval of substitutions shall be in writing and shall provide a detailed explanation of the circumstances necessitating the proposed substitutions. The request must contain a complete resume for the proposed substitute, and any other information requested by the Contracting Officer to approve or disapprove the request. Proposed substitutes must have qualifications that are equal to or higher than the key personnel being augmented. The Contracting Officer or his/her authorized representative shall evaluate such requests and promptly notify the Subcontractor in writing through the LMI Subcontracts Administrator whether the proposed substitution is acceptable.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<br>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="90%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="right" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Attachment D</font></div>
</td>
</tr><tr>
<td align="right" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subcontract 1124</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">I.4.6 </font>If the Contracting Officer determines that (1) suitable and timely replacement of key personnel who have been reassigned, terminated or have otherwise become unavailable for the Subcontract work is not reasonably forthcoming, or (2) the resultant substitution would be so substantial as to impair the successful completion of the Subcontract or delivery order in accordance with the proposal accepted by the Government at the time of Contract award, the Contracting Officer may (1) terminate the contract for default or for the convenience of the Government, as appropriate, or (2) at his/her discretion, if he/she finds the Subcontractor at fault for the condition, equitably adjust the contract price downward to compensate the Government for any resultant delay, loss or damage.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">I.4.7</font> The provisions of this clause shall be fully applicable to any third tier Subcontract which may be entered into.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">I.5</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ORGANIZATIONAL CONFLICT OF INTEREST</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">I.5.1</font> By virtue of the performance of this Subcontract or delivery orders, the Subcontractor and their employees may encounter and/or have access to proprietary data that could result in a conflict of interest. As a result, certain requirements or restrictions shall be imposed.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">I.5.2</font> An &#8220;organizational conflict of interest&#8221; (OCI) occurs where, because of other activities or relationships with other persons, a person is unable or potentially unable to render impartial assistance or advice to the government, or the person&#8217;s objectivity in performing the contract work is or might be otherwise impaired, or a person has an unfair competitive advantage, FAR 9.501. An organizational conflict of interest may result when factors create an actual or potential conflict of interest on an instant contract, or when the nature of the work to be performed on the instant contract creates an actual or potential conflict of interest on a future acquisition. In the latter case, some restrictions on future activities of the contractor may be required, FAR 9.502.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Contracting officials are required to avoid, neutralize, or mitigate potential significant conflicts of interest before contract award, so as to prevent an unfair competitive advantage or the existence of conflicting roles that might impair one&#8217;s objectivity, FAR 9.504(a), FAR 9.505. This duty may result in the Contracting Officer requesting that Contractors provide reasonable assurance that restrictions on procurement sensitive or proprietary data have been, or will be, honored. To avoid an OCI and to avoid prejudicing the best interests of the Government, the Contracting Officer may place restrictions on Contractors, its affiliates, subsidiaries and Subcontractors at any tier. Such restrictions shall be consistent with FAR 9.505 and shall be designed to avoid, neutralize or mitigate an OCI that might otherwise exist. Examples of situations which may require restrictions are provided in FAR 9.508.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In order to assist the Contracting Officer in fulfilling his or her responsibilities concerning an OCI, the Subcontractor represents that it will promptly disclose to the LMI Subcontracts Administrator all relevant facts that may evidence a potential or actual OCl. This disclosure will include a description of the action that the Subcontractor has taken or will take in order to avoid, neutralize, or mitigate such OCl.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">I.5.3</font> The obligation above continues after award for the successful Subcontractor. The Subcontractor must promptly disclose all relevant facts that may evidence a potential or actual OCI during the performance of this Subcontract.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">I.5.4</font> Addition, the performance of this Subcontract may require the Subcontractor to access data and information proprietary to the Government agency or of such a nature that its dissemination or use, other than in performance of this Subcontract would be adverse to the interest of the Government or others. The Subcontractor shall not divulge or release data or information developed or obtained in performance of the Subcontract except to authorize Government personnel or upon written approval of the Contracting Officer. Agency information marked &#8220;For Official Use Only&#8221; or bearing other sensitivity markings shall be handled in accordance with Agency information security program regulations and shall not be divulged or disclosed without DLA&#8217;s permission. Requests for disclosure shall be addressed to the Contracting Officer and submitted through the LMI Subcontracts Administrator.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<br>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="68%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="21%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Attachment D</font></div>
</td>
</tr><tr>
<td valign="top" width="68%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="21%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subcontract 1124</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Subcontractor shall not use, disclose, or reproduce proprietary data, other than as required in the performance of this Subcontract. The limitations above do not apply to data or information that has been made public by the Government. Further, this provision does not preclude the use of any data independently acquired by the Subcontractor without such limitations or prohibit an agreement at no cost to the Government between the Subcontractor and the data owner, which provides for greater rights to the Subcontractor.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">I.6</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">GOVERNMENT&#8217;S RIGHT TO AUDIT</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In addition to any other audits required by this Subcontract, the Government reserves the right to audit the Government&#8217;s accounting and procurement records related to the payments made under this Subcontract. The audit may be conducted by either the Government or a private contractor at the Government&#8217;s expense. Any Government claims of overpayment will be pursued in accordance with FAR Part 32, as well as, any and all applicable supplemental regulations. The Government may demand collection of overpayments within six years from final disbursement.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">INSTRUCTIONS, CONDITIONS AND NOTICES TO OFFERORS</font></font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The contents of this section, which originates from the Broad Agency Announcement BAA-0001-09 for LMI&#8217;s Prime Contract SP4701-09-D-0045, concern the proposal and selection criteria for Short Term Projects (STPs). LMI shall require the support of the Subcontractor when necessary in order to comply with these provisions.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">I.7</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SHORT TERM PROJECTS</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The R&amp;D Solutions to be achieved from this program will be accomplished through Short Term Projects (STPs). STPs have an expected duration of 4-24 months. STPs are intended to mature an R&amp;D solution idea to the point where it can be transferred to a DLA customer for implementation and deployment as far as possible across the enterprise. With this clear implementation focus, STPs generally will not be funded unless there is a DLA customer who supports the work and will play a key role in driving implementation of successful project results. The scope of the STP(s) awarded through this Subcontract will address DLA&#8217;s four key process areas: Order Fulfillment, Planning, Procurement, and Technical/Quality.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">THE FOLLOWING OUTLINES THE OFFEROR&#8217;S POSSIBLE RESPONSIBILITIES WHEN SUBMITTING RESEARCH IDEAS (STPs) IF PARTICIPATING AS A PARTNER THROUGH AN ID/IQ CONTRACT:</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">When supporting an STP, the Subcontractor must be able to address the following considerations and issues when managing projects:</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">I.7.1</font> Task 1: Problem Identification. The Contractor shall participate as required with the RDSS PM and his PM support team in identifying DLA problems that would be appropriate for R&amp;D investment. The RDSS PM will identify candidate problems and relevant customers to the Contractor. The Contractor&#8217;s participation is to provide sufficient additional information for the PM to make an informed decision whether to proceed to formal project structuring. Contractor activities may include (but not be limited to) the following: validating and quantifying the magnitude of the problem and potential benefits, analyzing related commercial problems and their solutions, and identifying related initiatives within DLA. The contractor also may suggest candidate problems to the RDSS PM.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">I.7.2</font> Task 2: Project Structuring. The Contractor shall define the technical approaches for STPs that will solve DLA problems as assigned by the RDSS PM, including the preparation of technical and cost proposals. At a minimum, project structuring shall include details of the following:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">5</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<br>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="68%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="21%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="68%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="21%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Attachment D</font></div>
</td>
</tr><tr>
<td valign="top" width="68%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="21%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subcontract 1124</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></div>
</td>
<td align="left" colspan="2" valign="top" width="81%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Objective: Describe what the STP is to achieve.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="81%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></div>
</td>
<td align="left" colspan="2" valign="top" width="81%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Problem Description: Clearly state the problem to be solved.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="81%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></div>
</td>
<td align="left" colspan="2" valign="top" width="81%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">DLA Needs and Benefits: Address how solving the problem will satisfy an existing DLA need and what the benefits to DLA will be from the new problem solution and/or capability.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="81%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></div>
</td>
<td align="left" colspan="2" valign="top" width="81%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">R&amp;D Content: Provide rationale for the development and demonstration of the new solution and/or capability.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="81%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></div>
</td>
<td align="left" colspan="2" valign="top" width="81%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Customer: Clearly identify the DLA functional organization responsible for supporting solution development and implementation and the name of the individual in that organization who endorses the project.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="81%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></div>
</td>
<td align="left" colspan="2" valign="top" width="81%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Implementation Considerations: Describe how successful results will be implemented or transferred, including solution maturity considerations.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="81%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></div>
</td>
<td align="left" colspan="2" valign="top" width="81%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Operating Environment: Describe any constraints or considerations related to the operating environment the solution is targeted for and that will impact solution development and/or implementation.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="81%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></div>
</td>
<td align="left" colspan="2" valign="top" width="81%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Metrics: Describe metrics to be employed to assess progress and achievement of the objective.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="81%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></div>
</td>
<td align="left" colspan="2" valign="top" width="81%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Technical Concept and Approach: Clearly define the proposed tasks and describe how each will be executed to accomplish the objective.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="81%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></div>
</td>
<td align="left" colspan="2" valign="top" width="81%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Management Approach and Resource Assignments: Identify the task participants, their roles, their qualifications to perform those roles, and how they will be directed to accomplish the objective within cost and schedule.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="81%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></div>
</td>
<td align="left" colspan="2" valign="top" width="81%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Period of Performance and Schedule: Submit a schedule with detail to the task level.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="81%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></div>
</td>
<td align="left" colspan="2" valign="top" width="81%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Technology Transfer and Data Rights: The presumption is that all data and/or products developed under this contract will become the property of DLA. Address any exceptions to this requirement here.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="81%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></div>
</td>
<td align="left" colspan="2" valign="top" width="81%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Detailed Cost Estimate and Rationale: Provide the estimated levels of effort associated with proposed tasks and the supporting rationale for those estimates at the sub task level.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="81%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></div>
</td>
<td align="left" colspan="2" valign="top" width="81%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deliverables: Submit deliverables as identified by the PM. Types of deliverables may include:</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="top" width="81%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td align="left" valign="top" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Monthly technical progress and financial reports</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td align="left" valign="top" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Interim progress briefings or reports as directed</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.</font></div>
</td>
<td align="left" valign="top" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Minutes of meetings as directed</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.</font></div>
</td>
<td align="left" valign="top" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Final summary briefing or report including BCA and transition plan</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="3" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">I.7.3</font> Task 3: Project Execution. The Contractor shall conduct approved projects as directed by the RDSS PM, including (but not limited to): appropriate resource application, awarding any necessary subcontracts, and ensuring technical excellence, cost control, and schedule performance. Interim Progress Reviews (IPRs) and a final review shall be provided for each STP at times and locations as directed by the PM. The Contractor shall notify the PM support team of problems and issues as they arise, and be prepared to alter the R&amp;D approach if required.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="3" valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">I.8</font></div>
</td>
<td align="left" colspan="3" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">STP OVERSIGHT MANAGEMENT</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="3" valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="3" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">THE FOLLOWING OUTLINES THE OFFEROR&#8217;S POSSIBLE RESPONSIBILITIES WHEN PARTICIPATING AS A PARTNER THROUGH AN ID/IQ CONTRACT AND PROVIDING COLLABORATION SUPPORT:</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="3" valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="3" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Implementation STP presents significant management challenges because the implementation decision process itself within DLA can be very complex. In planning an STP where the next step after completion of the project is implementation, it is frequently necessary to complete a number of the implementation decision process steps in order to structure the project to address the needs and concerns of those who will be responsible for implementation. Accomplishing this can require considerable effort and calendar time.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">6</font></div>

<br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<br>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="68%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="21%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="68%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="21%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Attachment D</font></div>
</td>
</tr><tr>
<td valign="top" width="68%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="21%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subcontract 1124</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: arial; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: arial">
<tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Because of the broad scope of the RDSS program, STPs require many different kinds of detailed expertise, and managing them can be a challenge when many are active at one time. The RDSS program has had up to 20 simultaneously active STPs. The oversight management task of ensuring technical excellence of activities involving so many different disciplines is not easy, but it is critical to the success of the STPs and therefore to the success of the RDSS program itself.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The operating environments in which R&amp;D results will be implemented can include the HQ, all three hardware ICPs, Strategic Distribution Points and forward operating locations such as Service maintenance depots, and they are all different. One significant aspect and challenge of oversight management is to understand enough about the similarities and differences among these environments to ensure STPs are structured to maximize the possibilities for successful downstream implementation and deployment. At the same time, as R&amp;D, STPs can be expected to run into difficulties which require changes in technical approach. As a result, another oversight management challenge is to create an environment wherein the need for such changes can be recognized as early as possible and alternate approaches defined and recommended to the RDSS PM.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Contractor must support the PM in establishing a STP Oversight Management structure and processes capable of structuring and executing high-payoff R&amp;D projects against problems in all four key DLA processes. While identifying candidate problems to address is principally the role of DLA, assistance is needed to accurately determine the benefits of solving them and in creating solution approaches that not only produce successful and beneficial results, but also foster subsequent implementation.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">7</font></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>ex31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<html>
<head>
    <title>ex31-1.htm</title>
    <!-- Licensed to: TriState Financial -->
    <!-- Document Created using EDGARizerAgent 5.2.3.0 -->
    <!-- Copyright 1995 - 2009 Thomson Reuters. All rights reserved. -->
</head>




<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right">
<hr style="COLOR: black" align="left" noshade size="1" width="100%">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">EXHIBIT 31.1</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">APPLIED DNA SCIENCES, INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">OFFICER&#8217;S CERTIFICATE PURSUANT TO SECTION 302</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">I, James A. Hayward, certify that:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">I have reviewed this quarterly report on Form&#160;10-Q of Applied DNA Sciences, Inc.;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">5.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Date:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;August 10, 2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td nowrap width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/&#160;&#160;JAMES A. HAYWARD&#160;</font></td>
<td width="88%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">James A. Hayward</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Chief Executive Officer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>ex31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<html>
<head>
    <title>ex31-2.htm</title>
    <!-- Licensed to: TriState Financial -->
    <!-- Document Created using EDGARizerAgent 5.2.3.0 -->
    <!-- Copyright 1995 - 2009 Thomson Reuters. All rights reserved. -->
</head>




<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right">
<hr style="COLOR: black" align="left" noshade size="1" width="100%">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">EXHIBIT 31.2</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">APPLIED DNA SCIENCES, INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">OFFICER&#8217;S CERTIFICATE PURSUANT TO SECTION 302</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">I, Kurt H. Jensen, certify that:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">I have reviewed this quarterly report on Form&#160;10-Q of Applied DNA Sciences, Inc.;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">5.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Date:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;August 10, 2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td nowrap width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/&#160;&#160;KURT H. JENSEN</font></td>
<td nowrap width="88%">&#160;</td>
</tr></table>
</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Kurt H. Jensen</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Chief Financial Officer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>ex32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<html>
<head>
    <title>ex32-1.htm</title>
    <!-- Licensed to: TriState Financial -->
    <!-- Document Created using EDGARizerAgent 5.2.3.0 -->
    <!-- Copyright 1995 - 2009 Thomson Reuters. All rights reserved. -->
</head>




<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="COLOR: black" align="left" noshade size="1" width="100%">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">EXHIBIT 32.1</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CERTIFICATION PURSUANT TO</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">18 U.S.C. SECTION 1350,</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AS ADOPTED PURSUANT TO</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The undersigned, James A. Hayward, Chief Executive Officer of Applied DNA Sciences, Inc. (the &#8220;Company&#8221;), in connection with the Company&#8217;s Quarterly Report on Form&#160;10-Q for the period ended June 30, 2011 (the &#8220;Report&#8221;), as filed with the Securities and Exchange Commission on the date hereof, hereby certifies pursuant to the requirements of 18 U.S.C. 1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#9679;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the Report fully complies with the requirements of Section&#160;13(a)&#160;or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended, and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#9679;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 2.5pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This certification is being provided pursuant to 18 U.S.C. 1350 and is not to be deemed a part of the Report, nor is it to be deemed to be &#8220;filed&#8221; for any purpose whatsoever.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap width="12%" style="BORDER-BOTTOM: black 2px solid"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/&#160;&#160;JAMES A. HAYWARD</font></td>
<td width="38%">&#160;</td>
</tr><tr>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap width="12%">
<div><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">James A. Hayward</font></font></div>

<div><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chief Executive Officer</font></font></div>

<div><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">August 10, 2011</font></font></div>
</td>
<td width="38%">&#160;</td>
</tr></table>
</div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>ex32-2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<html>
<head>
    <title>ex32-2.htm</title>
    <!-- Licensed to: TriState Financial -->
    <!-- Document Created using EDGARizerAgent 5.2.3.0 -->
    <!-- Copyright 1995 - 2009 Thomson Reuters. All rights reserved. -->
</head>




<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="COLOR: black" align="left" noshade size="1" width="100%">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">EXHIBIT 32.2</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CERTIFICATION PURSUANT TO</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">18 U.S.C. SECTION 1350,</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AS ADOPTED PURSUANT TO</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The undersigned, Kurt H. Jensen, Chief Financial Officer of Applied DNA Sciences, Inc. (the &#8220;Company&#8221;), in connection with the Company&#8217;s Quarterly Report on Form&#160;10-Q for the period ended June 30, 2011 (the &#8220;Report&#8221;), as filed with the Securities and Exchange Commission on the date hereof, hereby certifies pursuant to the requirements of 18 U.S.C. 1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#9679;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the Report fully complies with the requirements of Section&#160;13(a)&#160;or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended, and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#9679;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 2.5pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This certification is being provided pursuant to 18 U.S.C. 1350 and is not to be deemed a part of the Report, nor is it to be deemed to be &#8220;filed&#8221; for any purpose whatsoever.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap width="12%" style="BORDER-BOTTOM: black 2px solid">/s/&#160;&#160;KURT H. JENSEN</td>
<td width="38%">&#160;</td>
</tr><tr>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap width="12%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Kurt H. Jensen</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chief Financial Officer</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">August 10, 2011</font></div>
</td>
<td width="38%">&#160;</td>
</tr></table>
</div>

<div>&#160;</div>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>7
<FILENAME>apdn-20110630.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!-- XBRL document created with Ez-XBRL version 3.0.1.4  -->
<!-- Based on XBRL 2.1  -->
<xbrli:xbrl xmlns:apdn="http://www.adnas.com/2011-06-30" xmlns:us-gaap="http://fasb.org/us-gaap/2011-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap-att="http://fasb.org/us-gaap/attributes" xmlns:country="http://xbrl.sec.gov/country/2011-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2011-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2011-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2011-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2011-01-31" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-types="http://fasb.org/us-types/2011-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:schemaRef xlink:type="simple" xlink:href="apdn-20110630.xsd" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
  <xbrli:context id="Context_3ME_30-Jun-2010">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-04-01</xbrli:startDate>
      <xbrli:endDate>2010-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_9ME_30-Jun-2010">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-10-01</xbrli:startDate>
      <xbrli:endDate>2010-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_As_Of_30-Sep-2010">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_3ME_30-Jun-2011">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-04-01</xbrli:startDate>
      <xbrli:endDate>2011-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_9ME_30-Jun-2011">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-10-01</xbrli:startDate>
      <xbrli:endDate>2011-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_As_Of_30-Jun-2011">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_As_Of_10-Aug-2011">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-08-10</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_As_Of_30-Sep-2009">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_As_Of_30-Jun-2010">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000744452</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:unit id="USD">
    <xbrli:measure>iso4217:USD</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="USDPerShare">
    <xbrli:divide>
      <xbrli:unitNumerator>
        <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unitNumerator>
      <xbrli:unitDenominator>
        <xbrli:measure>xbrli:shares</xbrli:measure>
      </xbrli:unitDenominator>
    </xbrli:divide>
  </xbrli:unit>
  <xbrli:unit id="Shares">
    <xbrli:measure>xbrli:shares</xbrli:measure>
  </xbrli:unit>
  <us-gaap:SalesRevenueNet decimals="0" contextRef="Context_3ME_30-Jun-2010" unitRef="USD">170195</us-gaap:SalesRevenueNet>
  <us-gaap:SalesRevenueNet decimals="0" contextRef="Context_9ME_30-Jun-2010" unitRef="USD">430185</us-gaap:SalesRevenueNet>
  <us-gaap:SalesRevenueNet decimals="0" contextRef="Context_3ME_30-Jun-2011" unitRef="USD">229710</us-gaap:SalesRevenueNet>
  <us-gaap:SalesRevenueNet decimals="0" contextRef="Context_9ME_30-Jun-2011" unitRef="USD">687970</us-gaap:SalesRevenueNet>
  <us-gaap:ResearchAndDevelopmentExpense decimals="0" contextRef="Context_3ME_30-Jun-2010" unitRef="USD">18142</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense decimals="0" contextRef="Context_9ME_30-Jun-2010" unitRef="USD">44944</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense decimals="0" contextRef="Context_3ME_30-Jun-2011" unitRef="USD">47988</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense decimals="0" contextRef="Context_9ME_30-Jun-2011" unitRef="USD">161645</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:AmortizationOfFinancingCosts decimals="0" contextRef="Context_9ME_30-Jun-2010" unitRef="USD">158167</us-gaap:AmortizationOfFinancingCosts>
  <us-gaap:AmortizationOfFinancingCosts decimals="0" contextRef="Context_9ME_30-Jun-2011" unitRef="USD">731595</us-gaap:AmortizationOfFinancingCosts>
  <us-gaap:DepreciationAndAmortization decimals="0" contextRef="Context_3ME_30-Jun-2010" unitRef="USD">92823</us-gaap:DepreciationAndAmortization>
  <us-gaap:DepreciationAndAmortization decimals="0" contextRef="Context_9ME_30-Jun-2010" unitRef="USD">278619</us-gaap:DepreciationAndAmortization>
  <us-gaap:DepreciationAndAmortization decimals="0" contextRef="Context_3ME_30-Jun-2011" unitRef="USD">91892</us-gaap:DepreciationAndAmortization>
  <us-gaap:DepreciationAndAmortization decimals="0" contextRef="Context_9ME_30-Jun-2011" unitRef="USD">276608</us-gaap:DepreciationAndAmortization>
  <us-gaap:OtherNonrecurringIncomeExpense xsi:nil="true" contextRef="Context_3ME_30-Jun-2010" unitRef="USD"/>
  <us-gaap:OtherNonrecurringIncomeExpense xsi:nil="true" contextRef="Context_9ME_30-Jun-2010" unitRef="USD"/>
  <us-gaap:OtherNonrecurringIncomeExpense xsi:nil="true" contextRef="Context_9ME_30-Jun-2011" unitRef="USD"/>
  <us-gaap:SellingGeneralAndAdministrativeExpense decimals="0" contextRef="Context_3ME_30-Jun-2010" unitRef="USD">2529777</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:SellingGeneralAndAdministrativeExpense decimals="0" contextRef="Context_9ME_30-Jun-2010" unitRef="USD">5363215</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:SellingGeneralAndAdministrativeExpense decimals="0" contextRef="Context_3ME_30-Jun-2011" unitRef="USD">1580788</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:SellingGeneralAndAdministrativeExpense decimals="0" contextRef="Context_9ME_30-Jun-2011" unitRef="USD">4529352</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:OperatingExpenses decimals="0" contextRef="Context_3ME_30-Jun-2010" unitRef="USD">2640742</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses decimals="0" contextRef="Context_9ME_30-Jun-2010" unitRef="USD">5686778</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses decimals="0" contextRef="Context_3ME_30-Jun-2011" unitRef="USD">1720668</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses decimals="0" contextRef="Context_9ME_30-Jun-2011" unitRef="USD">4967605</us-gaap:OperatingExpenses>
  <us-gaap:OperatingIncomeLoss decimals="0" contextRef="Context_3ME_30-Jun-2010" unitRef="USD">-2470547</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss decimals="0" contextRef="Context_9ME_30-Jun-2010" unitRef="USD">-5256593</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss decimals="0" contextRef="Context_3ME_30-Jun-2011" unitRef="USD">-1490958</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss decimals="0" contextRef="Context_9ME_30-Jun-2011" unitRef="USD">-4279635</us-gaap:OperatingIncomeLoss>
  <us-gaap:InterestExpense decimals="0" contextRef="Context_3ME_30-Jun-2010" unitRef="USD">126388</us-gaap:InterestExpense>
  <us-gaap:InterestExpense decimals="0" contextRef="Context_9ME_30-Jun-2010" unitRef="USD">537252</us-gaap:InterestExpense>
  <us-gaap:InterestExpense decimals="0" contextRef="Context_3ME_30-Jun-2011" unitRef="USD">664037</us-gaap:InterestExpense>
  <us-gaap:InterestExpense decimals="0" contextRef="Context_9ME_30-Jun-2011" unitRef="USD">1818125</us-gaap:InterestExpense>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest decimals="0" contextRef="Context_3ME_30-Jun-2010" unitRef="USD">-2596935</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest decimals="0" contextRef="Context_9ME_30-Jun-2010" unitRef="USD">-5793845</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest decimals="0" contextRef="Context_3ME_30-Jun-2011" unitRef="USD">-2154995</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest decimals="0" contextRef="Context_9ME_30-Jun-2011" unitRef="USD">-6097760</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeTaxExpenseBenefit xsi:nil="true" contextRef="Context_3ME_30-Jun-2010" unitRef="USD"/>
  <us-gaap:IncomeTaxExpenseBenefit xsi:nil="true" contextRef="Context_9ME_30-Jun-2010" unitRef="USD"/>
  <us-gaap:IncomeTaxExpenseBenefit xsi:nil="true" contextRef="Context_3ME_30-Jun-2011" unitRef="USD"/>
  <us-gaap:IncomeTaxExpenseBenefit xsi:nil="true" contextRef="Context_9ME_30-Jun-2011" unitRef="USD"/>
  <us-gaap:ProfitLoss decimals="0" contextRef="Context_3ME_30-Jun-2010" unitRef="USD">-2596935</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss decimals="0" contextRef="Context_9ME_30-Jun-2010" unitRef="USD">-5793845</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss decimals="0" contextRef="Context_3ME_30-Jun-2011" unitRef="USD">-2154995</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss decimals="0" contextRef="Context_9ME_30-Jun-2011" unitRef="USD">-6097760</us-gaap:ProfitLoss>
  <us-gaap:EarningsPerShareBasicAndDiluted decimals="2" contextRef="Context_3ME_30-Jun-2010" unitRef="USDPerShare">-0.01</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted decimals="2" contextRef="Context_9ME_30-Jun-2010" unitRef="USDPerShare">-0.02</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted decimals="2" contextRef="Context_3ME_30-Jun-2011" unitRef="USDPerShare">-0.01</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted decimals="2" contextRef="Context_9ME_30-Jun-2011" unitRef="USDPerShare">-0.02</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:Cash decimals="0" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD">17618</us-gaap:Cash>
  <us-gaap:Cash decimals="0" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD">12464</us-gaap:Cash>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue decimals="0" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD">17618</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue decimals="0" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD">12464</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue decimals="0" contextRef="Context_As_Of_30-Sep-2009" unitRef="USD">213307</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue decimals="0" contextRef="Context_As_Of_30-Jun-2010" unitRef="USD">21566</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:AccountsReceivableNetCurrent decimals="0" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD">63029</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:AccountsReceivableNetCurrent decimals="0" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD">177833</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:PrepaidExpenseCurrent decimals="0" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD">161456</us-gaap:PrepaidExpenseCurrent>
  <us-gaap:PrepaidExpenseCurrent decimals="0" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD">102675</us-gaap:PrepaidExpenseCurrent>
  <us-gaap:AssetsCurrent decimals="0" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD">242103</us-gaap:AssetsCurrent>
  <us-gaap:AssetsCurrent decimals="0" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD">292972</us-gaap:AssetsCurrent>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment decimals="0" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD">207097</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment decimals="0" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD">210862</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:PropertyPlantAndEquipmentNet decimals="0" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD">3765</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet xsi:nil="true" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD"/>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization decimals="0" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD">8794265</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization decimals="0" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD">9067109</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsNet decimals="0" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD">636635</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsNet decimals="0" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD">363791</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:DeferredFinanceCostsNoncurrentNet decimals="0" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD">522489</us-gaap:DeferredFinanceCostsNoncurrentNet>
  <us-gaap:DeferredFinanceCostsNoncurrentNet decimals="0" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD">213365</us-gaap:DeferredFinanceCostsNoncurrentNet>
  <us-gaap:Assets decimals="0" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD">1413314</us-gaap:Assets>
  <us-gaap:Assets decimals="0" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD">893586</us-gaap:Assets>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent decimals="0" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD">967550</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent decimals="0" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD">1316371</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
  <us-gaap:ConvertibleNotesPayableCurrent decimals="0" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD">1774080</us-gaap:ConvertibleNotesPayableCurrent>
  <us-gaap:ConvertibleNotesPayableCurrent decimals="0" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD">2951683</us-gaap:ConvertibleNotesPayableCurrent>
  <us-gaap:LiabilitiesCurrent decimals="0" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD">2791630</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent decimals="0" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD">4868054</us-gaap:LiabilitiesCurrent>
  <us-gaap:CommitmentsAndContingencies xsi:nil="true" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD"/>
  <us-gaap:CommitmentsAndContingencies xsi:nil="true" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD"/>
  <us-gaap:PreferredStockValue xsi:nil="true" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD"/>
  <us-gaap:PreferredStockValue xsi:nil="true" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD"/>
  <us-gaap:CommonStockValue decimals="0" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD">346366</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue decimals="0" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD">352523</us-gaap:CommonStockValue>
  <us-gaap:AdditionalPaidInCapitalCommonStock decimals="0" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD">149396907</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:AdditionalPaidInCapitalCommonStock decimals="0" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD">153112072</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:RetainedEarningsAccumulatedDeficit decimals="0" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD">-151341303</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RetainedEarningsAccumulatedDeficit decimals="0" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD">-157439063</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest decimals="0" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD">-1598030</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest decimals="0" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD">-3974468</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:PreferredStockParOrStatedValuePerShare decimals="3" contextRef="Context_As_Of_30-Sep-2010" unitRef="USDPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare decimals="3" contextRef="Context_As_Of_30-Jun-2011" unitRef="USDPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized decimals="INF" contextRef="Context_As_Of_30-Sep-2010" unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesAuthorized decimals="INF" contextRef="Context_As_Of_30-Jun-2011" unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued decimals="INF" contextRef="Context_As_Of_30-Sep-2010" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesIssued decimals="INF" contextRef="Context_As_Of_30-Jun-2011" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding decimals="INF" contextRef="Context_As_Of_30-Sep-2010" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockSharesOutstanding decimals="INF" contextRef="Context_As_Of_30-Jun-2011" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:CommonStockParOrStatedValuePerShare decimals="3" contextRef="Context_As_Of_30-Sep-2010" unitRef="USDPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare decimals="3" contextRef="Context_As_Of_30-Jun-2011" unitRef="USDPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized decimals="INF" contextRef="Context_As_Of_30-Sep-2010" unitRef="Shares">800000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized decimals="INF" contextRef="Context_As_Of_30-Jun-2011" unitRef="Shares">800000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued decimals="INF" contextRef="Context_As_Of_30-Sep-2010" unitRef="Shares">346366244</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued decimals="INF" contextRef="Context_As_Of_30-Jun-2011" unitRef="Shares">352523001</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding decimals="INF" contextRef="Context_As_Of_30-Sep-2010" unitRef="Shares">346366244</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding decimals="INF" contextRef="Context_As_Of_30-Jun-2011" unitRef="Shares">352523001</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:LiabilitiesAndStockholdersEquity decimals="0" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD">1413314</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity decimals="0" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD">893586</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:AmortizationOfDebtDiscountPremium decimals="0" contextRef="Context_9ME_30-Jun-2010" unitRef="USD">335342</us-gaap:AmortizationOfDebtDiscountPremium>
  <us-gaap:AmortizationOfDebtDiscountPremium decimals="0" contextRef="Context_9ME_30-Jun-2011" unitRef="USD">1549230</us-gaap:AmortizationOfDebtDiscountPremium>
  <us-gaap:DepreciationDepletionAndAmortization decimals="0" contextRef="Context_9ME_30-Jun-2010" unitRef="USD">278619</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization decimals="0" contextRef="Context_9ME_30-Jun-2011" unitRef="USD">276608</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:ShareBasedCompensation decimals="0" contextRef="Context_9ME_30-Jun-2010" unitRef="USD">956438</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation decimals="0" contextRef="Context_9ME_30-Jun-2011" unitRef="USD">567083</us-gaap:ShareBasedCompensation>
  <us-gaap:IncreaseDecreaseInAccountsReceivable decimals="0" contextRef="Context_9ME_30-Jun-2010" unitRef="USD">9766</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInAccountsReceivable decimals="0" contextRef="Context_9ME_30-Jun-2011" unitRef="USD">114804</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets decimals="0" contextRef="Context_9ME_30-Jun-2010" unitRef="USD">23221</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets decimals="0" contextRef="Context_9ME_30-Jun-2011" unitRef="USD">-43645</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities decimals="0" contextRef="Context_9ME_30-Jun-2010" unitRef="USD">497248</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities decimals="0" contextRef="Context_9ME_30-Jun-2011" unitRef="USD">348822</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities decimals="0" contextRef="Context_9ME_30-Jun-2010" unitRef="USD">-1528741</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities decimals="0" contextRef="Context_9ME_30-Jun-2011" unitRef="USD">-2200654</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities xsi:nil="true" contextRef="Context_9ME_30-Jun-2010" unitRef="USD"/>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities xsi:nil="true" contextRef="Context_9ME_30-Jun-2011" unitRef="USD"/>
  <us-gaap:ProceedsFromConvertibleDebt decimals="0" contextRef="Context_9ME_30-Jun-2010" unitRef="USD">1337000</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:ProceedsFromConvertibleDebt decimals="0" contextRef="Context_9ME_30-Jun-2011" unitRef="USD">1645500</us-gaap:ProceedsFromConvertibleDebt>
  <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt xsi:nil="true" contextRef="Context_9ME_30-Jun-2010" unitRef="USD"/>
  <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt decimals="0" contextRef="Context_9ME_30-Jun-2011" unitRef="USD">550000</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities decimals="0" contextRef="Context_9ME_30-Jun-2010" unitRef="USD">1337000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities decimals="0" contextRef="Context_9ME_30-Jun-2011" unitRef="USD">2195500</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease decimals="0" contextRef="Context_9ME_30-Jun-2010" unitRef="USD">-191741</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease decimals="0" contextRef="Context_9ME_30-Jun-2011" unitRef="USD">-5154</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <apdn:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne decimals="0" contextRef="Context_3ME_30-Jun-2010" unitRef="Shares">301362329</apdn:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne>
  <apdn:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne decimals="0" contextRef="Context_9ME_30-Jun-2010" unitRef="Shares">287448792</apdn:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne>
  <apdn:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne decimals="0" contextRef="Context_3ME_30-Jun-2011" unitRef="Shares">351962281</apdn:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne>
  <apdn:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne decimals="0" contextRef="Context_9ME_30-Jun-2011" unitRef="Shares">350828973</apdn:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne>
  <us-gaap:DepositAssets decimals="0" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD">8322</us-gaap:DepositAssets>
  <us-gaap:DepositAssets decimals="0" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD">23458</us-gaap:DepositAssets>
  <us-gaap:DueToOfficersOrStockholdersCurrent decimals="0" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD">50000</us-gaap:DueToOfficersOrStockholdersCurrent>
  <us-gaap:DueToOfficersOrStockholdersCurrent decimals="0" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD">600000</us-gaap:DueToOfficersOrStockholdersCurrent>
  <us-gaap:NotesPayableRelatedPartiesNoncurrent decimals="0" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD">219714</us-gaap:NotesPayableRelatedPartiesNoncurrent>
  <us-gaap:NotesPayableRelatedPartiesNoncurrent xsi:nil="true" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD"/>
  <apdn:VestedOptionsIssuedToOfficersDirectorsAndEmployees decimals="0" contextRef="Context_9ME_30-Jun-2010" unitRef="USD">1969483</apdn:VestedOptionsIssuedToOfficersDirectorsAndEmployees>
  <apdn:VestedOptionsIssuedToOfficersDirectorsAndEmployees decimals="0" contextRef="Context_9ME_30-Jun-2011" unitRef="USD">459967</apdn:VestedOptionsIssuedToOfficersDirectorsAndEmployees>
  <apdn:CommonStockIssuedInSettlementOfInterest decimals="0" contextRef="Context_9ME_30-Jun-2011" unitRef="USD">34960</apdn:CommonStockIssuedInSettlementOfInterest>
  <us-gaap:AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts decimals="0" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD">947276</us-gaap:AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts>
  <us-gaap:AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts decimals="0" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD">1678872</us-gaap:AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts>
  <apdn:UnamortizedDiscountOnConvertibleNotesPayableCurrent decimals="0" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD">545920</apdn:UnamortizedDiscountOnConvertibleNotesPayableCurrent>
  <apdn:UnamortizedDiscountOnConvertibleNotesPayableCurrent decimals="0" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD">1088317</apdn:UnamortizedDiscountOnConvertibleNotesPayableCurrent>
  <apdn:UnamortizedDiscountOnConvertibleNotePayableRelatedPartyNoncurrent decimals="0" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD">5286</apdn:UnamortizedDiscountOnConvertibleNotePayableRelatedPartyNoncurrent>
  <apdn:UnamortizedDiscountOnConvertibleNotePayableRelatedPartyNoncurrent decimals="0" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD">5286</apdn:UnamortizedDiscountOnConvertibleNotePayableRelatedPartyNoncurrent>
  <us-gaap:InterestPaid xsi:nil="true" contextRef="Context_9ME_30-Jun-2010" unitRef="USD"/>
  <us-gaap:InterestPaid xsi:nil="true" contextRef="Context_9ME_30-Jun-2011" unitRef="USD"/>
  <us-gaap:IncomeTaxesPaid xsi:nil="true" contextRef="Context_9ME_30-Jun-2010" unitRef="USD"/>
  <us-gaap:IncomeTaxesPaid xsi:nil="true" contextRef="Context_9ME_30-Jun-2011" unitRef="USD"/>
  <apdn:WarrantsIssuedForFinancingCosts xsi:nil="true" contextRef="Context_9ME_30-Jun-2010" unitRef="USD"/>
  <apdn:WarrantsIssuedForFinancingCosts decimals="0" contextRef="Context_9ME_30-Jun-2011" unitRef="USD">217971</apdn:WarrantsIssuedForFinancingCosts>
  <us-gaap:DebtConversionConvertedInstrumentAmount1 decimals="0" contextRef="Context_9ME_30-Jun-2010" unitRef="USD">1800000</us-gaap:DebtConversionConvertedInstrumentAmount1>
  <us-gaap:DebtConversionConvertedInstrumentAmount1 decimals="0" contextRef="Context_9ME_30-Jun-2011" unitRef="USD">389960</us-gaap:DebtConversionConvertedInstrumentAmount1>
  <dei:EntityVoluntaryFilers contextRef="Context_9ME_30-Jun-2011">No</dei:EntityVoluntaryFilers>
  <dei:EntityCurrentReportingStatus contextRef="Context_9ME_30-Jun-2011">Yes</dei:EntityCurrentReportingStatus>
  <dei:EntityRegistrantName contextRef="Context_9ME_30-Jun-2011">APPLIED DNA SCIENCES INC</dei:EntityRegistrantName>
  <dei:EntityCentralIndexKey contextRef="Context_9ME_30-Jun-2011">0000744452</dei:EntityCentralIndexKey>
  <dei:CurrentFiscalYearEndDate contextRef="Context_9ME_30-Jun-2011">--09-30</dei:CurrentFiscalYearEndDate>
  <dei:EntityFilerCategory contextRef="Context_9ME_30-Jun-2011">Smaller Reporting Company</dei:EntityFilerCategory>
  <dei:EntityCommonStockSharesOutstanding decimals="INF" contextRef="Context_As_Of_10-Aug-2011" unitRef="Shares">472786160</dei:EntityCommonStockSharesOutstanding>
  <dei:AmendmentFlag contextRef="Context_9ME_30-Jun-2011">false</dei:AmendmentFlag>
  <dei:DocumentPeriodEndDate contextRef="Context_9ME_30-Jun-2011">2011-06-30</dei:DocumentPeriodEndDate>
  <dei:DocumentFiscalYearFocus contextRef="Context_9ME_30-Jun-2011">2011</dei:DocumentFiscalYearFocus>
  <dei:DocumentFiscalPeriodFocus contextRef="Context_9ME_30-Jun-2011">Q3</dei:DocumentFiscalPeriodFocus>
  <dei:DocumentType contextRef="Context_9ME_30-Jun-2011">10-Q</dei:DocumentType>
  <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="Context_9ME_30-Jun-2011">&lt;div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" &gt;NOTE A &amp;#8212; SUMMARY OF ACCOUNTING POLICIES&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;General&lt;br/&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The accompanying unaudited condensed consolidated financial statements as of June 30, 2011 and for the three and nine months ended June 30, 2011 and 2010 are unaudited. These financial statements have been prepared in accordance with Rule S-X of the Securities and Exchange Commission (the &amp;#8220;SEC&amp;#8221;) and with the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the nine month period ended June 30, 2011 are not necessarily indicative of the results that may be expected for the fiscal year ending September 30, 2011. The unaudited condensed consolidated financial statements should be read in conjunction with the consolidated September 30, 2010 financial statements and footnotes thereto included in the Company&amp;#8217;s Annual Report on Form 10-K, as amended, filed with the Securities and Exchange Commission (the &amp;#8220;SEC&amp;#8221;).
&lt;/font&gt;&lt;br/&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;Business and Basis of Presentation&lt;br/&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;On September 16, 2002, Applied DNA Sciences, Inc. (the &amp;#8220;Company&amp;#8221;) was incorporated under the laws of the State of Nevada. Effective December 17, 2008, the Company reincorporated from the State of Nevada to the State of Delaware. The Company is principally devoted to developing DNA embedded biotechnology security solutions in the United States and Europe.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Applied DNA Operations Management, Inc., APDN (B.V.I.) Inc. and Applied DNA Sciences Europe Limited. Significant inter-company transactions have been eliminated in consolidation.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;Estimates
&lt;/font&gt;
&lt;/font&gt;&lt;br/&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;Revenue Recognition&lt;br/&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Revenues are derived from research, development, qualification and production testing for certain commercial products. Revenue from fixed price testing contracts is generally recorded upon completion of the contracts, which are generally short-term, or upon completion of identifiable contractual tasks. At the time the Company enters into a contract that includes multiple tasks, the Company estimates the amount of actual labor and other costs that will be required to complete each task based on historical experience. Revenues are recognized which provide for a profit margin relative to the testing performed. Revenue relative to each task and from contracts which are time and materials based is recorded as effort is expended. Billings in excess of amounts earned are deferred. Any anticipated losses on contracts are charged to income when identified. To the extent management does not accurately forecast the level of
 effort required to complete a contract, or individual tasks within a contract, and the Company is unable to negotiate additional billings with a customer for cost over-runs, the Company may incur losses on individual contracts. All selling, general and administrative costs are treated as period costs and expensed as incurred.
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" &gt;&lt;div&gt;&lt;div style="width:100%;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div&gt;&lt;p&gt;
&lt;/p&gt;
&lt;/div&gt;&lt;div&gt;&lt;div style="width:100%;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;For revenue from product sales, the Company recognizes revenue in accordance with Accounting Standards Codification subtopic 605-10, Revenue Recognition (&amp;#8220;ASC 605-10&amp;#8221;). ASC 605-10 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has
&lt;/font&gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management&amp;#8217;s judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for allowances and other adjustments are provided for in the same period the related sales are recorded. The Company defers any revenue for which the product has not been delivered or is subject to refund until such time that the Company and the customer jointly determine that the product has been delivered or no refund will be required. At June 30, 2011 and September 30, 2010, the Company did not record any deferred revenue for the respective periods.
&lt;/font&gt;&lt;br/&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;Cash Equivalents&lt;br/&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;For the purpose of the accompanying unaudited condensed consolidated financial statements, all highly liquid investments with a maturity of three months or less are considered to be cash equivalents.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;Accounts Receivable
&lt;/font&gt;
&lt;/font&gt;&lt;br/&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The Company provides an allowance for doubtful accounts equal to the estimated uncollectible amounts. The Company&amp;#8217;s estimate is based on historical collection experience and a review of the current status of trade accounts receivable. It is reasonably possible that the Company&amp;#8217;s estimate of the allowance for doubtful accounts will change. At June 30, 2011 and September 30, 2010, the Company has deemed that no allowance for doubtful accounts was necessary.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;Income Taxes&lt;br/&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The Company has adopted Accounting Standards Codification subtopic 740-10, Income Taxes (&amp;#8220;ASC 740-10&amp;#8221;) which requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between financial
 statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. &lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;Property and Equipment&lt;br/&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Property and equipment are stated at cost and depreciated over their estimated useful lives of 3 to 5 years using the straight line method. At June 30, 2011 and September 30, 2010, property and equipment consist of:
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;
&lt;/div&gt;&lt;div style="text-align:center;" &gt;&lt;table cellspacing="0" cellpadding="0" width="70%" style="font-family:times new roman;font-size:10pt;" &gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;(Unaudited)
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;June 30,&lt;br /&gt;
&lt;/font&gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;2011
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;September 30,&lt;br /&gt;
&lt;/font&gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;2010
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Computer equipment
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;27,404
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;27,404
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Lab equipment
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;77,473
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td
 valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;77,473
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Furniture
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;105,985
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;105,985
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;210,862
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;210,862
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Accumulated depreciation
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;210,862
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;207,097
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="padding-bottom:4px;text-align:left;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Net
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font
 style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;-
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="padding-bottom:4px;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;3,765
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" &gt;&lt;div&gt;&lt;div style="width:100%;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="page-break-after:always;width:100%;" &gt;&lt;div style="text-align:center;width:100%;" &gt;
&lt;/div&gt;&lt;div style="text-align:center;width:100%;" &gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div&gt;&lt;div style="width:100%;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;Impairment of Long-Lived Assets
&lt;/font&gt;
&lt;/font&gt;&lt;br/&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The Company has adopted Accounting Standards Codification subtopic 360-10, Property, Plant and Equipment (&amp;#8220;ASC 360-10&amp;#8221;). ASC 360-10 requires that long-lived assets and certain identifiable intangibles held and used by the Company be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company evaluates its long lived assets for impairment annually or
&lt;/font&gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;more often if events and circumstances warrant. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve break-even operating results over an extended period. The Company evaluates the recoverability of long-lived assets based upon forecasted undiscounted cash flows. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted, based on estimates of future discounted cash flows resulting from the use and ultimate disposition of the asset. ASC 360-10 also requires assets to be disposed of be reported at the lower of the carrying amount or the fair value less costs to sell.&lt;br /&gt;
&lt;br /&gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;Net Loss Per Share&lt;br/&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The Company has adopted Accounting Standards Codification subtopic 260-10, Earnings Per Share (&amp;#8220;ASC 260-10&amp;#8221;) which specifies the computation, presentation and disclosure requirements of earnings per share information. Basic earnings per share have been calculated based upon the weighted average number of common shares outstanding. Dilutive common stock equivalents consist of shares issuable upon conversion of convertible notes and the exercise of the Company&amp;#8217;s stock options and warrants. For the three and nine months ended June 30, 2011 and 2010, common stock equivalent shares are excluded from the computation of the diluted loss per share as their effect would be anti-dilutive.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Fully diluted shares outstanding were 496,504,218 and 495,370,910 for the three month and nine months ended June 30, 2011,  respectively. Fully diluted shares outstanding were 371,785,665 and 362,372,128 for the three and nine months ended June 30, 2010, respectively.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new
 roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;Stock Based Compensation
&lt;/font&gt;
&lt;/font&gt;&lt;br/&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The Company follows Accounting Standards Codification subtopic 718-10, Compensation (&amp;#8220;ASC 718-10&amp;#8221;) which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the income statement based on their fair values. Stock-based compensation expense recognized under ASC 718-10 for the nine months ended June 30, 2011 and 2010 was $459,967 and $587,235, respectively.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;As of June 30, 2011, 70,400,000 employee stock options were outstanding with 42,550,000 shares vested and exercisable.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;Concentrations&lt;br/&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and trade receivables. The Company places its cash and temporary cash investments with high credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The Company&amp;#8217;s revenues earned from sale of products and services for the three and nine months ended June 30, 2011 included an aggregate of 65% and 56% from four and three customers of the Company&amp;#8217;s total revenues, respectively. Five and three customers accounted for 90% and 65% of the Company&amp;#8217;s revenues earned from sale of products and services for the three and nine months ended June 30, 2010, respectively.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Four customers accounted for 69% and 90% of the Company&amp;#8217;s total accounts receivable at June 30, 2011 and September 30, 2010, respectively.
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" &gt;&lt;div&gt;&lt;div style="width:100%;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div&gt;&lt;p&gt;
&lt;/p&gt;
&lt;/div&gt;&lt;div&gt;&lt;div style="width:100%;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;Research and Development&lt;br/&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The Company accounts for research and development costs in accordance with the Accounting Standards Codification subtopic 730-10, Research and Development (&amp;#8220;ASC 730-10&amp;#8221;). Under ASC 730-10, all research and development costs must be charged to expense as incurred. Accordingly, internal research and development costs are expensed as incurred. Third-party research and development costs are expensed when the contracted work has been performed or as milestone results have been achieved. Company-sponsored research and development costs related to both present and future products are expensed in the period incurred. The Company incurred research and development expenses of $47,988 and $18,142 for the three month periods ended June 30, 2011 and 2010, respectively, and $161,645 and $44,944 for the nine month periods ended June 30, 2011 and 2010, respectively.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;Advertising&lt;br/&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div
 style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The Company follows the policy of charging the costs of advertising to expense as incurred. The Company charged to operations $45,346 and $95,828 for the three and nine month periods ended June 30, 2011, respectively, and $12,225 and $37,680 as advertising costs for the three and nine month periods ended June 30, 2010, respectively.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;Intangible Assets&lt;br/&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The Company amortizes its intangible assets using the straight-line method over their estimated period of benefit. The estimated useful life for patents is five years while other intellectual property uses a seven year useful life. We periodically evaluate the recoverability of intangible assets and take into account events or circumstances that warrant revised estimates of useful lives or that indicate that impairment exists. All of our intangible assets are subject to amortization.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;Fair Value of Financial Instruments&lt;br/&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;In the first quarter of fiscal year 2008, the Company adopted Accounting Standards Codification subtopic 820-10, Fair Value Measurements and Disclosures (&amp;#8220;ASC 820-10&amp;#8221;). ASC 820-10 defines fair value, establishes a framework for measuring fair value, and enhances fair value measurement disclosure. ASC 820-10 delayed, until the first quarter of fiscal year 2009, the effective date for ASC 820-10 for all non-financial assets and non-financial liabilities, except those that are recognized or disclosed at fair value in the financial statements on a recurring basis (at least annually). The adoption of ASC 820-10 did not have a material impact on the Company&amp;#8217;s financial position or operations. Refer to Note I for further discussion regarding fair valuation.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Effective October 1, 2008, the Company adopted Accounting Standards Codification subtopic 820-10, Fair Value Measurements and Disclosures (&amp;#8220;ASC 820-10&amp;#8221;) and Accounting Standards Codification subtopic 825-10, Financial Instruments (&amp;#8220;ASC 825-10&amp;#8221;), which permits entities to choose to measure many financial instruments and certain other items at fair value. Neither of these statements had an impact on the Company&amp;#8217;s consolidated financial position, results of operations or cash flows. The carrying value of cash and cash equivalents, accounts payable and short-term borrowings, as reflected in the balance sheets, approximate fair value because of the short-term maturity of these instruments.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;Recent Accounting Pronouncements
&lt;/font&gt;
&lt;/font&gt;&lt;br/&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;There were various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to have a material impact on the Company&amp;#8217;s consolidated financial position, results of operations or cash flows.
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="Context_9ME_30-Jun-2011">&lt;div&gt;&lt;div&gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" &gt;NOTE B - INTANGIBLE ASSETS&lt;br /&gt;
&lt;br /&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Intangible assets acquired and their carrying values at June 30, 2011 and September 30, 2010 are as follows:&lt;br /&gt;
&lt;br /&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-align:left;" &gt;&lt;table cellspacing="0" cellpadding="0" width="70%" style="font-family:times new roman;font-size:10pt;" &gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;(Unaudited)
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;June 30,
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;2011
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;September 30,
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;2010
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Trade secrets and developed technologies (Weighted average life of 7 years)
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;9,430,900
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;9,430,900
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Patents (Weighted average life of 5 years)
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;34,257
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td
 valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;34,257
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Total Amortized identifiable intangible assets-Gross carrying value:
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;9,465,157
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;9,465,157
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Less:
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Accumulated amortization
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;(3,446,355
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;)
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;(3,173,511
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;)
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Impairment (See below)
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;(5,655,011
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;)
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td
 valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;(5,655,011
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;)
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Net:
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;363,791
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;636,635
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Residual value:
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;During the year ended September 30, 2006, the Company&amp;#8217;s management performed an evaluation of its intangible assets (intellectual property) for purposes of determining the implied fair value of the assets at September 30, 2006. The test indicated that the recorded remaining book value of its intellectual property exceeded its fair value for the year ended September 30, 2006, as determined by discounted future cash flows. As a result, upon completion of the assessment, management recorded a non-cash impairment charge of $5,655,011, net of tax, or $0.05 per share during the year ended September 30, 2006 to reduce the carrying value of the patents to $2,091,800. Considerable management judgment is necessary to estimate the fair value. Accordingly, actual results could vary significantly from management&amp;#8217;s estimates.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Total amortization expense charged to operations for the three and nine months ended June 30, 2011 was $90,948 and $272,844, respectively. Total amortization expense charged to operations for the three and nine months ended June 30, 2010 was $90,948 and $272,988, respectively.
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="Context_9ME_30-Jun-2011">&lt;div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" &gt;NOTE C &amp;#8211; ACCOUNTS PAYABLE AND ACCRUED LIABILITIES&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Accounts payable and accrued liabilities at June 30, 2011 and September 30, 2010 are as follows:
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;
&lt;/div&gt;&lt;div style="text-align:center;" &gt;&lt;table cellspacing="0" cellpadding="0" width="70%" style="font-family:times new roman;font-size:10pt;" &gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;(Unaudited)
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;June 30,
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;September 30,
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;2011
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;2010
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="padding-bottom:2px;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Accounts payable
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;669,874
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;721,340
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Accrued consulting fees
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;102,500
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom"
 width="9%" style="text-align:right;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;102,500
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Accrued interest payable
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;323,089
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;88,937
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="border-bottom:black 4px double;text-align:left;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Accrued salaries payable
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;220,908
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;54,773
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="padding-bottom:4px;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="padding-bottom:4px;text-align:left;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Total
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;1,316,371
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="padding-bottom:4px;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;967,550
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="padding-bottom:4px;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
  <us-gaap:LongTermDebtTextBlock contextRef="Context_9ME_30-Jun-2011">&lt;div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" &gt;NOTE D &amp;#8211; CONVERTIBLE NOTES&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Convertible notes payable as of June 30, 2011 and September 30, 2010 are as follows:&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;
&lt;/div&gt;&lt;div style="text-align:left;" &gt;&lt;div&gt;&lt;table cellspacing="0" cellpadding="0" width="100%" style="font-family:times new roman;font-size:10pt;" &gt;&lt;tr&gt;&lt;td valign="bottom" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" colspan="2" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;(Unaudited)
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;June 30,
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" colspan="2" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;September 30,
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" colspan="2" style="border-bottom:black 2px solid;" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;2011
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" colspan="2" style="border-bottom:black 2px solid;" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;2010
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Secured Convertible Notes Payable dated October 14, 2009, net of unamortized debt discount of $819 (see below)
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;-
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;269,181
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Secured Convertible Note Payable dated January 7, 2010, net of unamortized debt discount of $673 and $9,521, respectively (see below)
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;-
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;"
 &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;40,479
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Secured Convertible Note Payable dated June 4, 2010, net of unamortized debt discount of $2,329 and $5,286, respectively (see below)
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;222,671
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;219,714
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Secured Convertible Notes Payable dated July 15, 2010, net of unamortized debt discount of $50,337 and $535,580, respectively (see below)
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;399,663
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;1,464,420
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Secured Convertible Notes Payable dated November 19, 2010, net of unamortized debt discount of $29,759 (see below)
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;320,241
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;-
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Secured Convertible Note Payable dated November 30, 2010, net of unamortized debt discount of $113,211 (see below)
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;636,789
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times
 new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;-
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Secured Convertible Note Payable dated January 7, 2011, net of unamortized debt discount of $125,711 (see below)
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;624,289
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;-
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Secured Convertible Notes Payable, dated July 15, 2010, modified January 7, 2011, net of unamortized debt discount of $766,970 (see below)
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;748,030
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Total
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;2,951,683
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;1,993,794
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;div style="text-align:left;text-indent:5pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Less: current portion
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;(2,951,683
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom"
 width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;)
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;(1,774,080
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;)
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Long-term debt- net
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;-
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;219,714
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br /&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;10% Secured Convertible Promissory Notes dated October 14, 2009&lt;br/&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;On October 14, 2009, the Company issued an aggregate of $270,000 convertible promissory notes due October 14, 2010 with interest at 10% per annum due upon maturity. The notes are convertible at any time prior to maturity, at the holders&amp;#8217; option, into shares of our common stock at a price equal to the greater of (i) 50% of the average price of our common stock for the ten trading days prior to the date of the notice of conversion or (ii) at $0.092674218 per share, which is equal to a 20% discount to the average volume, weighted average price of our common stock for the ten trading days prior to issuance. At maturity, the notes, including any accrued and unpaid interest, are automatically convertible at $0.092674218 per share. The Company has granted the noteholders a security interest in all the Company&amp;#8217;s assets.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;In accordance with ASC 470-20, the Company recognized an embedded beneficial conversion feature present in the notes. The Company allocated a portion of the proceeds equal to the intrinsic value of that feature to additional paid-in capital. The Company recognized and measured an aggregate of $21,343 of the proceeds, which is equal to the intrinsic value of the embedded beneficial conversion feature, to additional paid-in capital and a discount against the notes. The debt discount attributed to the beneficial conversion feature is amortized over the notes&amp;#8217; maturity period (one year) as interest expense.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The Company recorded the intrinsic value of the embedded beneficial conversion feature ($21,343) to debt discount which will be amortized to interest expense over the term of the notes. The Company recorded the intrinsic value of the embedded beneficial conversion feature ($21,343) to debt discount which will be amortized to interest expense over the term of the notes. Amortization of $819 was recorded for the three and nine months ended June 30, 2011, and $5,321 and $15,145 was recorded for the three and nine month periods ended June 30, 2010, respectively.
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" &gt;&lt;div&gt;&lt;div style="width:100%;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="page-break-after:always;width:100%;" &gt;&lt;div style="text-align:center;width:100%;" &gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div&gt;&lt;div style="width:100%;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new
 roman;font-size:8pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;On October 14, 2010, the Company issued 3,204,776 shares of common stock in settlement of the convertible notes and related interest.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;10% Secured Convertible Promissory Note dated January 7, 2010&lt;br/&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;On January 7, 2010, the Company issued a $50,000 convertible promissory note due January 7, 2011 with interest at 10% per annum due upon maturity. The note is convertible at any time prior to maturity, at the holder&amp;#8217;s option, into shares of our common stock at a price equal to the greater of (i) 50% of the average price of our common stock for the ten trading days prior to the date of the notice of conversion or (ii) at $0.052877384 per share, which is equal to a 20% discount to the average volume, weighted average price of our common stock for the ten trading days prior to issuance. At maturity, the note, including any accrued and unpaid interest, is automatically convertible at $0.052877384 per share. The Company has granted the noteholder a security interest in all the Company&amp;#8217;s assets.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;In accordance with ASC 470-20, the Company recognized an embedded beneficial conversion feature present in the note. The Company allocated a portion of the proceeds equal to the intrinsic value of that feature to additional paid-in capital.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The Company recognized and measured an aggregate of $35,103 of the proceeds, which is equal to the intrinsic value of the embedded beneficial conversion feature, to additional paid-in capital and a discount against the note. The debt discount attributed to the beneficial conversion feature is amortized over the note&amp;#8217;s maturity period (one year) as interest expense.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The Company recorded the intrinsic value of the embedded beneficial conversion feature ($35,103) to debt discount which will be amortized to interest expense over the term of the note. Amortization of $-0- and $9,521 was recorded for the three and nine months ended June 30, 2011, respectively, and $8,752 and $16,734 was recorded for the three and nine month periods ended June 30, 2010, respectively.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;On January 7, 2011, the Company issued 1,040,142 shares of common stock in settlement of the convertible note and related interest.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;10% Secured Convertible Promissory Note dated June 4, 2010&lt;br/&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;On June 4, 2010, the Company issued a $675,000 related party convertible promissory note due January 31, 2012 with interest at 10% per annum due upon maturity. The note is convertible at any time prior to maturity, at the holder&amp;#8217;s option, into shares of our common stock at a price equal to the greater of (i) 50% of the average price of our common stock for the ten trading days prior to the date of the notice of conversion or (ii) at $0.038866151 per share, which is equal to a 20% discount to the average volume, weighted average price of our common stock for the ten trading days prior to issuance. At maturity, the note, including any accrued and unpaid interest, is automatically convertible at $0.038866151 per share. The Company has granted the noteholder a security
 interest in all the Company&amp;#8217;s assets.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;In accordance with ASC 470-20, the Company recognized an embedded beneficial conversion feature present in the note. The Company allocated a portion of the proceeds equal to the intrinsic value of that feature to additional paid-in capital. The Company recognized and measured an aggregate of $19,692 of the proceeds, which is equal to the intrinsic value of the embedded beneficial conversion feature, to additional paid-in capital and a discount against the note. The debt discount attributed to the beneficial conversion feature is amortized over the note&amp;#8217;s maturity period as interest expense.
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" &gt;&lt;div&gt;&lt;div style="width:100%;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="page-break-after:always;width:100%;" &gt;&lt;div style="text-align:center;width:100%;" &gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div&gt;&lt;div style="width:100%;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;&lt;div style="text-indent:0pt;display:block;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The Company recorded the intrinsic value of the embedded beneficial conversion feature ($19,692) to debt discount which will be amortized to interest expense over the term of the note. Amortization of $986 and $2,957 was recorded for the three and nine months ended June 30, 2011, respectively.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;On July 15, 2010, $450,000 of the $675,000 related party convertible promissory note was converted to the same terms and conditions as described in the 10% Secured Convertible Promissory Notes dated July 15, 2010 below.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;10% Senior Secured Convertible Promissory Notes dated July 15, 2010&lt;br/&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;On July 15, 2010, the Company issued an aggregate of $2,000,000 senior secured convertible promissory notes due July 15, 2011 with interest at 10% per annum due upon maturity to &amp;#8220;accredited investors,&amp;#8221; as defined in regulations promulgated under the Securities Act of 1933, as amended (&amp;#8220;Securities Act&amp;#8221;). The notes are convertible at any time prior to maturity, at the holders&amp;#8217; option, into shares of our common stock (i) prior to the occurrence of Subsequent Financing at a rate of $0.04405, or (ii) after Subsequent Financing in the event the holder elects to receive conversion shares that are not Subsequent Financing securities, at a rate of $0.04405, or as of any conversion date that occurs after the closing of a Subsequent Financing at a rate of 80% of the purchase price paid by investors in the Subsequent Financing. The notes automatically convert at the earlier occurrence of (i) maturity or (ii) Qualified Financing including any accrued and unpaid interest, at a rate as described above. The Company has granted the noteholders a security interest in all the Company&amp;#8217;s assets and the assets of APDN (B.V.I.) Inc., the Company&amp;#8217;s wholly-owned subsidiary.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Subsequent Financing is defined as the issuance and sale by the Company securities that does not qualify as Qualified Financing. Qualified Financing is defined as the issuance and sale by the Company or an affiliate thereof of equity or debt securities in a single transaction that results in gross proceeds of (before transaction fees and expenses) equal to or in excess of $10,000,000.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;In accordance with ASC 470-20, the Company recognized an embedded beneficial conversion feature present in the notes. The Company allocated a portion of the proceeds equal to the intrinsic value of that feature to additional paid-in capital. The Company recognized and measured an aggregate of $678,774 of the proceeds, which is equal to the intrinsic value of the embedded beneficial conversion feature, to additional paid-in capital and a discount against the notes. The debt discount attributed to the beneficial conversion feature is amortized over the notes&amp;#8217; maturity period (one
 year) as interest expense.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The Company recorded the intrinsic value of the embedded beneficial conversion feature ($678,774) to debt discount which will be amortized to interest expense over the term of the notes.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;On January 7, 2011, upon the completion of a Subsequent Financing, the above described conversion rate changed from $0.04405 to $0.37104 with an extended due date from July 15, 2011 to January 7, 2012 on $1,550,000 of the $2,000,000 issued senior convertible promissory notes. All other terms are remaining the same. Although the conversion rate of the remaining $450,000 senior secured convertible promissory notes remained the same, the due date was extended also to January 7, 2012. In conjunction with the conversion rate and term modifications of the $1,550,000 senior secured convertible promissory notes, the Company wrote off the remaining unamortized debt discount of $331,332 to operations. See below discussion of the restructured senior secured convertible promissory notes.
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" &gt;&lt;div&gt;&lt;div style="width:100%;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="page-break-after:always;width:100%;" &gt;&lt;div style="text-align:center;width:100%;" &gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div&gt;&lt;div style="width:100%;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;div style="text-indent:0pt;display:block;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;10% Senior Secured Convertible Promissory Notes dated November 19, 2010&lt;br/&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;On November 19, 2010, the Company issued an aggregate of $350,000 in principal amount of senior secured convertible notes bearing interest at a rate of 10% per annum to &amp;#8220;accredited investors,&amp;#8221; as defined in regulations promulgated under the Securities Act. The notes are convertible, in whole or in part, at any time, at the option of the noteholders, into either (A) such number of shares of the Company&amp;#8217;s common stock, $0.001 par value per share,
&lt;/font&gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;determined by dividing (i) the principal amount of each note, together with any and all accrued and unpaid interest and penalties, by (ii) a conversion price of $ 0.032825817, which is equal to a 20% discount to the average volume, weighted average price of our common stock for the ten trading days prior to issuance (the &amp;#8220;Common Conversion Price&amp;#8221;) or (B) securities issued in any Subsequent Financing (&amp;#8220;Subsequent Securities&amp;#8221;) at a conversion price equal to 80% of the price per Subsequent Security paid by investors for Subsequent Securities in a Subsequent Financing (the &amp;#8220;Subsequent Financing Price&amp;#8221;). A &amp;#8220;Subsequent Financing&amp;#8221; is the sale by the Company or an affiliate thereof of securities at any time after November 19, 2010 and prior to the earlier of (i) a Qualified Financing or (ii) November 19, 2011. A noteholder may convert its notes in whole in connection with any one Subsequent Financing or in part in connection with one or more Subsequent Financings. The notes shall be automatically converted upon the earlier of (I) November 19, 2011 and (II) the completion of a Qualified Financing at the election of each noteholder into either (A) shares of common stock at the Common Conversion Price, (B) Subsequent Securities at a conversion price equal to 80% of the Subsequent Financing Price, or (C) securities issued in a Qualified Financing (the &amp;#8220;Qualified Financing Securities&amp;#8221;) at a conversion price equal to 80% of the price per Qualified Financing Security paid by investors for the Qualified Financing Securities in the Qualified Financing.
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font&gt;&lt;br /&gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;A &amp;#8220;Qualified Financing&amp;#8221; is the sale by the Company or an affiliate thereof of securities resulting in gross proceeds (before transaction fees and expenses) in a single transaction equal to or in excess of $10 million. The notes bear interest at the rate of 10% per annum and are due and payable in full on November 19, 2011. &lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div
 style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Until the principal and accrued but unpaid interest under the notes are paid in full, or converted into Conversion Shares pursuant to their terms, the Company&amp;#8217;s obligations under the notes will be secured by a lien on all assets of the Company and the assets of APDN (B.V.I.) Inc., the Company&amp;#8217;s wholly-owned subsidiary.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;In accordance with ASC 470-20, the Company recognized an embedded beneficial conversion feature present in the notes. The Company allocated a portion of the proceeds equal to the intrinsic value of that feature to additional paid-in capital. The Company recognized and measured an aggregate of $76,494 of the proceeds, which is equal to the intrinsic value of the embedded beneficial conversion feature, to additional paid-in capital and a discount against the notes. The debt discount attributed to the beneficial conversion feature is amortized over the notes&amp;#8217; maturity period (one year) as interest expense.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The Company recorded the intrinsic value of the embedded beneficial conversion feature ($76,494) to debt discount which will be amortized to interest expense over the term of the notes. Amortization of $19,071 and $46,734 was recorded for the three and nine month periods ended June 30, 2011, respectively.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;10% Senior Secured Convertible Promissory Note dated November 30, 2010&lt;br/&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;On November 30, 2010, the Company issued a $750,000 principal amount senior secured convertible note bearing interest at a rate of 10% per annum to an &amp;#8220;accredited investor,&amp;#8221; as defined in regulations promulgated under the Securities Act. The note is convertible, in whole or in part, at any time, at the option of the noteholder, into either (A) such number of shares of the Company&amp;#8217;s common stock, $0.001 par value per share, determined by dividing (i) the principal amount of each note, together with any and all accrued and unpaid interest and penalties, by (ii) a conversion price of $ 0.03088, which is equal to a 20% discount to the average volume, weighted average price of our common stock for the ten trading days prior to issuance (the &amp;#8220;Common Conversion Price&amp;#8221;) or (B) securities issued in any Subsequent Financing (&amp;#8220;Subsequent Securities&amp;#8221;) at a conversion price equal to 80% of the price per Subsequent Security paid by investors for Subsequent Securities in a Subsequent Financing (the &amp;#8220;Subsequent Financing Price&amp;#8221;). A &amp;#8220;Subsequent Financing&amp;#8221; is the sale by the Company or an affiliate thereof of securities at any time after November 30, 2010 and prior to the earlier of (i) a Qualified Financing or (ii) November 30, 2011. The noteholder may convert its note in whole in connection with any one Subsequent Financing or in part in connection with one or more Subsequent Financings. The note shall be automatically converted upon the earlier of (I) November 30, 2011 and (II) the completion of a Qualified Financing at the election of the noteholder into either (A) shares of common stock at the Common Conversion Price, (B) Subsequent Securities at a conversion price equal to 80% of the Subsequent Financing Price, or (C) securities issued in a Qualified Financing (the &amp;#8220;Qualified Financing Securities&amp;#8221;) at a conversion price equal to 80% of the price per Qualified Financing Security paid by investors for the Qualified Financing Securities in the Qualified Financing.
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" &gt;&lt;div&gt;&lt;div style="width:100%;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="page-break-after:always;width:100%;" &gt;&lt;div style="text-align:center;width:100%;" &gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div&gt;&lt;div style="width:100%;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;&lt;div style="text-indent:0pt;display:block;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;A &amp;#8220;Qualified Financing&amp;#8221; is the sale by the Company or an affiliate thereof of securities resulting in gross proceeds (before
 transaction fees and expenses) in a single transaction equal to or in excess of $10 million. The note bears interest at the rate of 10% per annum and is due and payable in full on November 30, 2011. &lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Until the principal and accrued but unpaid interest under the note is paid in full, or converted into Conversion Shares pursuant to its terms, the Company&amp;#8217;s obligations under the note will be secured by a lien on all assets of the Company and the assets of APDN (B.V.I.) Inc., the Company&amp;#8217;s wholly-owned subsidiary.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;In accordance with ASC 470-20, the Company recognized an embedded beneficial conversion feature present in the note. The Company allocated a portion of the proceeds equal to the intrinsic value of that feature to additional paid-in capital. The Company recognized and measured an aggregate of $270,078 of the proceeds, which is equal to the intrinsic value of the embedded beneficial conversion feature, to additional paid-in capital and a discount against the note. The debt discount attributed to the beneficial conversion feature is amortized over the note&amp;#8217;s maturity period (one year) as interest expense.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The Company recorded the intrinsic value of the embedded beneficial conversion feature ($270,078) to debt discount which will be amortized to interest expense over the term of the note. Amortization of $67,334 and $156,867 was recorded for the three and nine month periods ended June 30, 2011, respectively.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;10% Senior Secured Convertible Promissory Note dated January 7, 2011&lt;br/&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;On January 7, 2011, the Company issued a $750,000 principal amount senior secured convertible note bearing interest at a rate of 10% per annum to an &amp;#8220;accredited investor,&amp;#8221; as defined in regulations promulgated under the Securities Act. The note is convertible, in whole or in part, at any time, at the option of the noteholder, into either (A) such number of shares of the Company&amp;#8217;s common stock, $0.001 par value per share, determined by dividing (i) the principal amount of each note, together with any and all accrued and unpaid interest and penalties, by (ii) a conversion price of $ 0.05529, which is equal to a 20% discount to the average volume, weighted average price of our common stock for the ten trading days prior to issuance (the &amp;#8220;Common Conversion Price&amp;#8221;) or (B) securities issued in any Subsequent Financing (&amp;#8220;Subsequent Securities&amp;#8221;) at a conversion price equal to 80% of the price per Subsequent Security paid by investors for Subsequent Securities in a Subsequent Financing (the &amp;#8220;Subsequent Financing Price&amp;#8221;). A &amp;#8220;Subsequent Financing&amp;#8221; is the sale by the Company or an affiliate thereof of securities at any time after January 7, 2011 and prior to the earlier of (i) a Qualified Financing or (ii) January 7, 2012. The noteholder may convert its note in whole in connection with any one Subsequent Financing or in part in connection with one or more Subsequent Financings. The note shall be automatically converted upon the earlier of (I) January 7, 2012 and (II) the completion of a Qualified Financing at the election of the noteholder into either (A) shares of common stock at the Common Conversion Price, (B) Subsequent Securities at a conversion price equal to 80% of the Subsequent Financing Price, or (C) securities issued in a Qualified Financing (the &amp;#8220;Qualified Financing Securities&amp;#8221;) at a conversion price equal to 80% of the price per Qualified Financing Security paid by investors for the Qualified Financing Securities in the Qualified Financing. &lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;A &amp;#8220;Qualified Financing&amp;#8221; is the sale by the Company or an affiliate thereof of securities resulting in gross proceeds (before transaction fees and expenses) in a single transaction equal to or in excess of $10 million. The note bears interest at the rate of 10% per annum and is due and payable in full on January 7, 2012. &lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Until the principal and accrued but unpaid interest under the note is paid in full, or converted into Conversion Shares pursuant to its terms, the Company&amp;#8217;s obligations under the note will be secured by a lien on all assets of the Company and the assets of APDN (B.V.I.) Inc., the Company&amp;#8217;s wholly-owned subsidiary.
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" &gt;&lt;div&gt;&lt;div style="width:100%;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;"
 &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div&gt;&lt;p&gt;
&lt;/p&gt;
&lt;/div&gt;&lt;div&gt;&lt;div style="width:100%;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;In accordance with ASC 470-20, the Company recognized an embedded beneficial conversion feature present in the note. The Company allocated a portion of the proceeds equal to the intrinsic value of that feature to additional paid-in capital. The Company recognized and measured an aggregate of $240,233 of the proceeds, which is equal to the intrinsic value of the embedded beneficial conversion feature, to additional paid-in capital and a discount against the note. The debt discount attributed to the beneficial conversion feature is amortized over the note&amp;#8217;s maturity period (one year) as interest expense.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The Company recorded the intrinsic value of the embedded beneficial conversion feature ($240,233) to debt discount which will be amortized to interest expense over the term of the note. Amortization of $59,894 and $114,522 was recorded for the three and nine month periods ended June 30, 2011.
&lt;/font&gt;&lt;br/&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;10% Senior Secured Convertible Promissory Notes issued on July 15, 2010, modified on January 7, 2011&lt;br/&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;On January 7, 2011, the Company modified previously issued senior secured promissory notes initially dated July 15, 2010 totaling $1,550,000 in principal amount bearing interest at a rate of 10% per annum to &amp;#8220;accredited investors,&amp;#8221; as defined in regulations promulgated under the Securities Act. The notes are convertible, in whole or in part, at any time, at the option of the noteholders, into either (A) such number of shares of the Company&amp;#8217;s common stock, $0.001 par value per share, determined by dividing (i) the principal amount of each note, together with any and all accrued and unpaid interest and penalties, by (ii) a conversion price of $ 0.037104 or (B) securities issued in any Subsequent Financing (&amp;#8220;Subsequent Securities&amp;#8221;) at a conversion price equal to 80% of the price per Subsequent Security paid by investors for Subsequent Securities in a Subsequent Financing (the &amp;#8220;Subsequent Financing Price&amp;#8221;). A &amp;#8220;Subsequent Financing&amp;#8221; is the sale by the Company or an affiliate thereof of securities at any time after January 7, 2011 and prior to the earlier of (i) a Qualified Financing or (ii) January 7, 2012. A noteholder may convert its note in whole in connection with any one Subsequent Financing or in part in connection with one or more Subsequent Financings. The notes shall be automatically converted upon the earlier of (I) January 7, 2012 and (II) the completion of a Qualified Financing at the election of the noteholder into either (A) shares of common stock at the Common Conversion Price, (B) Subsequent Securities at a conversion price equal to 80% of the Subsequent Financing Price, or (C) securities issued in a Qualified Financing (the &amp;#8220;Qualified Financing Securities&amp;#8221;) at a conversion price equal to 80% of the price per Qualified Financing Security paid by investors for the Qualified Financing Securities in the Qualified Financing. The effect of this refinancing was recognized as &lt;font style="display:inline;font-family:times new roman;" &gt;&amp;#8220;debt modification
&lt;/font&gt;&lt;font style="display:inline;font-family:times new roman;" &gt;&amp;#8221; in the financial statements.
&lt;/font&gt;
&lt;/font&gt;&lt;br/&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;A &amp;#8220;Qualified Financing&amp;#8221; is the sale by the Company or an affiliate thereof of securities resulting in gross proceeds (before transaction fees and expenses) in a single transaction equal to or in excess of $10 million. The notes bear interest at the rate of 10% per annum and is due and payable in full on January 7, 2012. &lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Until the principal and accrued but unpaid interest under the notes are paid in full, or converted into Conversion Shares pursuant to their terms, the Company&amp;#8217;s obligations under the notes will be secured by a lien on all assets of the Company and the assets of APDN (B.V.I.) Inc., the Company&amp;#8217;s wholly-owned subsidiary.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;In accordance with ASC 470-20, the Company recognized an embedded beneficial conversion feature present in the notes. The Company allocated a portion of the proceeds
 equal to the intrinsic value of that feature to additional paid-in capital. The Company recognized and measured an aggregate of $1,499,536 of the proceeds, which is equal to the intrinsic value of the embedded beneficial conversion feature, to additional paid-in capital and a discount against the notes. The debt discount attributed to the beneficial conversion feature is amortized over the notes&amp;#8217; maturity period (one year) as interest expense.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The Company recorded the intrinsic value of the embedded beneficial conversion feature ($1,499,536) to debt discount which will be amortized to interest expense over the term of the note. Amortization of $391,576 and $732,566 was recorded for the three and nine month periods ended June 30, 2011, respectively.
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" &gt;&lt;div&gt;&lt;div style="width:100%;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="page-break-after:always;width:100%;" &gt;&lt;div style="text-align:center;width:100%;" &gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div&gt;&lt;div style="width:100%;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;During the quarter ended June 30, 2011, the Company issued an aggregate of 1,023,026 shares of common stock in settlement of the $35,000 of convertible notes and related interest.
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
  <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="Context_9ME_30-Jun-2011">&lt;div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" &gt;NOTE E - RELATED PARTY TRANSACTIONS&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The Company&amp;#8217;s current and former officers and stockholders have advanced funds on a non-interest bearing basis to the Company for travel related and working capital purposes. The Company has not entered into any agreement on the repayment terms for these advances. As of June 30, 2011 and September 30, 2010, there were $600,000 and $50,000 advances outstanding, respectively.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The Company has consulting agreements with outside contractors, certain of whom are also company stockholders. The agreements are generally month to month.
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
  <apdn:CapitalStockTextBlock contextRef="Context_9ME_30-Jun-2011">&lt;div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" &gt;NOTE F - CAPITAL STOCK&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The Company is authorized to issue 800,000,000 shares of common stock, with a $0.001 par value per share, as the result of a vote of stockholders conducted on June 29, 2010 which effected an increase in the authorized shares of common stock from 410,000,000 to 800,000,000. In addition, the Company is authorized to issue 10,000,000 shares of preferred stock with a $0.001 par value per share. As of June 30, 2011 and September 30, 2010, there were 352,523,001 and 346,366,244 shares of common stock issued and outstanding, respectively.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;During the nine months ended June 30, 2011, the Company issued an aggregate of 888,813 shares valued at $65,000 for future consulting services.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;During the nine month periods ended June 30, 2011 and 2010, the Company has expensed $502,083 and $956,438 related to stock based compensation, respectively.
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;</apdn:CapitalStockTextBlock>
  <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="Context_9ME_30-Jun-2011">&lt;div&gt;&lt;div&gt;&lt;div&gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" &gt;NOTE G - STOCK OPTIONS AND WARRANTS&lt;br /&gt;
&lt;br /&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;Warrants&lt;br /&gt;
&lt;br /&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The following table summarizes the changes in warrants outstanding and the related prices for the shares of the Company&amp;#8217;s common stock issued to non-employees of the Company. These warrants were granted in lieu of cash compensation for services performed or financing expenses in connection with the sale of the Company&amp;#8217;s common stock. &lt;br /&gt;
&lt;br /&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:left;" &gt;&lt;table cellspacing="0" cellpadding="0" width="100%" style="font-family:times new roman;font-size:10pt;" &gt;&lt;tr&gt;&lt;td valign="bottom" width="4%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="5%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Warrants
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="4%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="5%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Outstanding
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Weighted
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Exercisable
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;"
 &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="4%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="5%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Remaining
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Average
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Weighted
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Weighted
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="4%" colspan="2" style="text-align:center;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Exercise
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Number
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Contractual
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Exercise
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Average
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Average
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="4%" colspan="2" style="border-bottom:black 2px solid;text-align:center;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Prices
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;padding-bottom:4px;" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Outstanding
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%"
 colspan="2" style="border-bottom:black 2px solid;padding-bottom:4px;" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Life (Years)
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;padding-bottom:4px;" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Price
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;padding-bottom:4px;" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Exercisable
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;padding-bottom:4px;" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Exercise Price
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="4%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="5%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.03088
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;2,428,756
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;6.42
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.3088
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;2,428,756
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.3088
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="4%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font
 style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="5%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.03283
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;533,116
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;6.39
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.3283
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;533,116
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.3283
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="4%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="5%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.04
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;9,000,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;4.17
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.04
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%"
 style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;3,000,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.04
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="4%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="5%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.04405
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;3,007,946
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;6.05
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.04405
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;3,007,946
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.04405
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="4%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="5%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.05529
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;1,356,484
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%"
 style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;6.53
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.05529
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;1,356,484
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.05529
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="4%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="5%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.06
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;12,000,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;3.63
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.06
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;7,000,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.06
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font
 style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="4%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="5%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.07
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;200,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.71
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.07
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;200,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.07
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="4%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="5%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.09
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;16,400,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.17
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.09
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times
 new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;16,400,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.09
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="4%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="5%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.10
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;1,500,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;1.74
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.10
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;1,500,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.10
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="4%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="5%" style="border-bottom:black 2px solid;text-align:right;padding-bottom:4px;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.50
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;padding-bottom:4px;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font
 style="display:inline;font-family:times new roman;font-size:10pt;" &gt;10,700,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;padding-bottom:4px;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;1.49
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;padding-bottom:4px;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.50
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;padding-bottom:4px;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;10,700,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;padding-bottom:4px;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.50
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="4%" style="text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="5%" style="text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;57,126,302
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" &gt;&lt;div
 style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;46,126,302
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" &gt;&lt;div&gt;&lt;div style="text-align:left;width:100%;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="page-break-after:always;width:100%;" &gt;&lt;div style="text-align:center;width:100%;" &gt;
&lt;/div&gt;&lt;div style="text-align:center;width:100%;" &gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div&gt;&lt;div style="text-align:right;width:100%;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Transactions involving warrants are summarized as follows:
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:center;" &gt;&lt;table cellspacing="0" cellpadding="0" width="70%" style="font-family:times new roman;font-size:10pt;" &gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" &gt;Number of
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" &gt;Shares
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" &gt;Weighted
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" &gt;Average
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" &gt;Price Per
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" &gt;Share
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Balance, September 30, 2009
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;64,820,500
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div
 style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.43
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Granted
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;22,007,946
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.05
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Exercised
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&amp;#8212;
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Canceled or expired
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;padding-bottom:2px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;(17,620,500
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;)
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;padding-bottom:2px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;(0.73
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;)
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Balance at September 30, 2010
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;69,207,946
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td
 valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.24
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Granted
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;4,318,356
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.04
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Exercised
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&amp;#8212;
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&amp;#8212;
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Canceled or expired
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;padding-bottom:2px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;(16,400,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;)
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;padding-bottom:2px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;(0.50
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;)
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;padding-bottom:4px;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Balance, June 30, 2011
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 4px
 double;text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;57,126,302
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.15
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="text-align:center;" &gt;
&lt;/div&gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;On April 29, 2010, warrants totaling 10,000,000 were issued in connection with services. The warrants are exercisable for five years from the date of issuance at an exercise price of $0.06 per share with 25% vesting immediately, 25% on October 29, 2010, 25% on April 29, 2011 and 25% on October 29, 2011. The fair value of the warrants vesting during the nine month period ended June 30, 2011 was determined using the Black-Scholes Option Pricing Model with the following assumptions: dividend yield $-0-, volatility of 170.72% and risk free rate from 1.17%.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The determined fair value of $93,580 is charged ratably to current period operations. During the three and nine month periods ended June 30, 2011, $14,911 and $93,580 was charged to operations, respectively.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;On July 15, 2010, warrants totaling 3,007,946 were issued in connection with services provided in connection with the issuance of convertible notes. The warrants are exercisable for seven years from the date of issuance at an exercise price of $0.04405 per share. The fair values of the warrants were determined using the Black-Scholes Option Pricing Model with the following assumptions: dividend yield $-0-, volatility of 173.55% and risk free rate from 2.43%.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The determined fair value of $174,429 is charged ratably to current period operations over one year. During the three and nine month periods ended June 30, 2011, $43,607 and $130,821 was charged to operations, respectively.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;On August 30, 2010, warrants totaling 10,000,000 were issued in connection with services. The warrants are exercisable for five years from the date of issuance at an exercise price of $0.04 per share with 33% vesting immediately and 67% upon achieving defined milestones. The fair value of the vested warrants was determined using the Black-Scholes Option Pricing Model with the following assumptions: dividend yield $-0-, volatility of 173.24% and risk free rate from 1.39%.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The determined fair value of $113,885 is charged ratably to current period operations. During the three and nine month periods ended June 30, 2011, $28,393 and $84,867 was charged to operations, respectively.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;In the month of November 2010, warrants totaling 2,961,872 were issued in connection with services provided in connection with the issuance of convertible notes. The warrants are exercisable for seven years from the date of issuance at exercise prices from $0.03088 to $0.03283 per share. The fair value of the warrants were determined using the Black-Scholes Option Pricing Model with the following assumptions: dividend yield $-0-, volatility of 169.06% to 169.21% and risk free rate from 2.16 to 2.20%.
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" &gt;&lt;div&gt;&lt;div style="text-align:left;width:100%;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="page-break-after:always;width:100%;" &gt;&lt;div style="text-align:center;width:100%;" &gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div&gt;&lt;div style="text-align:right;width:100%;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div
 style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The determined fair value of $120,840 is charged ratably to current period operations over one year. During the three and nine month periods ended June 30, 2011, $30,210 and $71,779 was charged to operations, respectively.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;In the month of January 2011, warrants totaling 1,356,484 were issued in connection with services provided in connection with the issuance of convertible notes. The warrants are exercisable for seven years from the date of issuance at exercise price of $0.05529 per share. The fair values of the warrants were determined using the Black-Scholes Option Pricing Model with the following assumptions: dividend yield $-0-, volatility of 170.33% and risk free rate of 2.69%.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The determined fair value of $97,131 is charged ratably to current period operations over one year. During the three and nine month periods ended June 30, 2011, $24,283 and $46,370 was charged to operations, respectively.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;Employee Stock Options&lt;br/&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;On January 26, 2005, the Board of Directors, and on February 15, 2005, the holders of a majority of the outstanding shares of common stock of the Company approved the 2005 Incentive Stock Plan and authorized the issuance of 16,000,000 shares of common stock as stock awards and stock options thereunder. On May 16, 2007, at the annual meeting of stockholders, the holders of a majority of the outstanding shares of common stock of the Company approved an increase in the number of shares subject to the 2005 Incentive Stock Plan to 20,000,000 shares of common stock. On June 17, 2008, the Board of Directors unanimously adopted an amendment to the 2005 Incentive Stock Plan that increased the total number of shares of common stock issuable pursuant to the 2005 Incentive Stock Plan from a total of 20,000,000 shares to a total of 100,000,000 shares, which was approved by our stockholders at the 2008 annual meeting of stockholders held on December 16, 2008. In connection with the share increase amendment, the Board of Directors granted and we issued options to purchase a total of 37,670,000 shares at an exercise price of $0.11 to certain key employees and non-employee directors under the 2005 Incentive Stock Plan, including 17,000,000, 5,000,000 and 7,000,000 to James A. Hayward, Kurt H. Jensen and Ming-Hwa Liang, respectively. The options granted to our key employees and non-employee directors vested with respect to 25% of the underlying shares on the date of grant and the remaining vest ratably each anniversary thereafter until fully vested on the third anniversary of the date of grant.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;On May 27, 2010, the our named executive officers elected to forfeit certain stock options to purchase up to 29 million shares of our Common Stock at an exercise price of $0.11 that were previously granted to them under the 2005 Incentive Stock Plan. In lieu of the forfeited options, our Board of Directors granted new stock options to such named executive officers to purchase up to 29 million shares of our common stock at an exercise price of $0.05 under the 2005 Stock Incentive Plan which are fully vested and became exercisable on June 29, 2010 following approval by our stockholders to amend our certificate of incorporation to increase our authorized shares of common stock.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;On July 1, 2010, our Board of Directors granted nonstatutory stock options under the 2005 Incentive Stock Plan to our named executive officers. The options granted to the named executive officers vested with respect to 25% of the underlying shares on the date of grant, and the remaining will vest ratably each anniversary thereafter until fully vested on the third anniversary of the date of grant.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The 2005 Incentive Stock Plan is designed to retain directors, executives, and selected employees and consultants by rewarding them for making contributions to our success with an award of options to purchase shares of our common stock. As of June 30, 2011, a total of 9,675,000 shares have been issued and options to purchase 70,400,000 shares have been granted under the 2005 Incentive Stock Plan.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div
 style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The following table summarizes the changes in options outstanding and the related prices for the shares of the Company&amp;#8217;s common stock issued to employees of the Company under the 2005 Incentive Stock Plan:
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" &gt;&lt;div&gt;&lt;div style="text-align:left;width:100%;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="page-break-after:always;width:100%;" &gt;&lt;div style="text-align:center;width:100%;" &gt;
&lt;/div&gt;&lt;div style="text-align:center;width:100%;" &gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div&gt;&lt;div style="text-align:right;width:100%;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-align:left;" &gt;&lt;div&gt;&lt;table cellspacing="0" cellpadding="0" width="100%" style="font-family:times new roman;font-size:10pt;" &gt;&lt;tr&gt;&lt;td valign="bottom" width="4%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="28%" colspan="8" style="border-bottom:black 2px solid;" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Options Outstanding
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="34%" colspan="10" style="border-bottom:black 2px solid;" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Options Exercisable
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="4%" colspan="2" style="border-bottom:black 2px solid;text-align:center;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Exercise&lt;br /&gt;
&lt;/font&gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Prices
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;padding-bottom:2px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Number
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Outstanding
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;padding-bottom:2px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;padding-bottom:2px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Weighted
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Average
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Remaining
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Contractual
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Life
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;(Years)
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;padding-bottom:2px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;padding-bottom:2px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" &gt;&lt;div
 style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Weighted
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Average
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Exercise
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Price
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;padding-bottom:2px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;padding-bottom:2px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Number
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Exercisable
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;padding-bottom:2px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;padding-bottom:2px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Weighted
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Average
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Exercise
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Price
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;padding-bottom:2px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="4%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="5%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.05
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;29,000,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;1.97
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.05
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;29,000,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font
 style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.05
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="4%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="5%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.06
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;30,000,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;4.01
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.06
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;7,500,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.06
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="4%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="5%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.07
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;2,500,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;4.46
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.07
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%"
 style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;500,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.07
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="4%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="5%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.08
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;2,000,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;4.52
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="9%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;-
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;-
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="4%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="5%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.09
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;1,500,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;"
 &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.17
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.09
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;1,500,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.09
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="4%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="5%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.11
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="9%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;5,400,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="9%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;1.97
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="9%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.11
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="9%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;4,050,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="border-bottom:black
 2px solid;text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="9%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.11
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="top" width="1%" style="text-align:left;padding-bottom:2px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="4%" style="text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="5%" style="text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;70,400,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;padding-bottom:4px;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.06
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;42,550,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;padding-bottom:4px;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.06
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br /&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Transactions involving stock options issued to employees are summarized as follows:
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:center;" &gt;&lt;div&gt;&lt;table cellspacing="0" cellpadding="0" width="70%" style="font-family:times new roman;font-size:10pt;" &gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Number of
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Shares
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;"
 &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Weighted
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Average
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Exercise
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Price Per
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Share
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Outstanding at October 1, 2009
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;38,920,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.11
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Granted
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;59,000,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.06
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Exercised
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;-
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Cancelled or expired
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;padding-bottom:2px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new
 roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;(31,020,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;)
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;padding-bottom:2px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;(0.11
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;)
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Outstanding at September 30, 2010
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;66,900,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.06
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Granted
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;3,500,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.08
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Exercised
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;-
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Canceled or expired
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%"
 style="border-bottom:black 2px solid;text-align:right;padding-bottom:2px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;-
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;padding-bottom:2px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="46%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Outstanding at June 30, 2011
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;70,400,000
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;$
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="9%" style="text-align:right;" &gt;&lt;div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;0.06
&lt;/font&gt;
&lt;/div&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%" style="text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;br /&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;On January 4, 2011, the Company granted 2,000,000 options to purchase the Company&amp;#8217;s common stock at an exercise price of $0.08 per share for five years to an employee with vesting at 25% each anniversary for the next four years. The fair value of options was determined using the Black-Scholes Option Pricing Model with the following assumptions: dividend yield $-0-, volatility of 170.62% and risk free rate from 2.01%.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The Company recorded $154,499 and $459,968 as stock compensation expense for the three and nine month periods ended June 30, 2011, respectively, and $1,382,248 and $1,969,483 for the three and nine month periods ended June 30, 2010, respectively, for the vesting portion of all employee options outstanding.
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="Context_9ME_30-Jun-2011">&lt;div&gt;&lt;div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" &gt;NOTE H - COMMITMENTS AND CONTINGENCIES&lt;br /&gt;
&lt;br /&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The Company leases office space under an operating lease in Stony Brook, New York for its corporate use from an entity controlled by a significant former shareholder. Total lease rental expenses for the three and nine month periods ended June 30, 2011 were $36,056 and $108,054, respectively. Total lease rental expenses for the three and nine month periods ended on June 30, 2010 were $21,858 and $62,408, respectively.
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" &gt;&lt;div&gt;&lt;div style="text-align:left;width:100%;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div&gt;&lt;div style="text-align:right;width:100%;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div&gt;
&lt;/div&gt;&lt;div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;br /&gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;Litigation&lt;br /&gt;
&lt;br /&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. Except as described below, we are currently not aware of any such legal proceedings that we believe will have, individually or in the aggregate, a material adverse affect on our business, financial condition or operating results.&lt;br /&gt;
&lt;br /&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="font-style:italic;display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;Demodulation, Inc. v. Applied DNA Sciences, Inc., et al. (Civil Action No. - 2:11-cv-00296-WJM-MF):&lt;br /&gt;
&lt;br /&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;On May 18, 2011, the Company was served with a complaint in a lawsuit brought by Demodulation, Inc. against the Company, Corning Incorporated, Alfred University, and Alfred Technology Resources, Inc. On July 8, 2011, the Company filed a motion to dismiss the complaint. In response, on August 3, 2011, Demodulation, Inc. filed an amended complaint. Demodulation, Inc. alleges that it was unable to bring its microwire technology to market due to the wrongful acts of defendants, who allegedly conspired to steal Demodulation, Inc.&amp;#8217;s trade secrets and other intellectual property and to interfere in its business opportunities. Of the 17 claims alleged in the amended complaint, five are asserted against the Company, including alleged misappropriation of trade secrets, antitrust violations, civil RICO, and patent infringement. The Company believes these claims are without merit. The Company intends to file a motion to dismiss the amended complaint for failure to state a claim and on other grounds. The Company intends to vigorously defend the action.
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:FairValueDisclosuresTextBlock contextRef="Context_9ME_30-Jun-2011">&lt;div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" &gt;NOTE I - FAIR VALUE MEASUREMENT&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The Company adopted the provisions of ASC 825-10 on October 1, 2008. ASC 825-10 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825-10 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 establishes three levels of inputs that may be used to measure fair value:&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Level 1 - Quoted prices in active markets for identical assets or liabilities.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Upon adoption of ASC 825-10, there was no cumulative effect adjustment to the beginning retained earnings and no impact on the unaudited condensed consolidated financial statements.
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" &gt;&lt;div&gt;&lt;div style="width:100%;text-align:left;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="page-break-after:always;width:100%;" &gt;&lt;div style="text-align:center;width:100%;" &gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div&gt;&lt;div style="width:100%;text-align:right;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The carrying value of the Company&amp;#8217;s cash and cash equivalents, accounts receivable, accounts payable, short-term borrowings (including convertible notes payable), and other current assets and liabilities approximate fair value because of their short-term maturity. All other significant financial assets, financial liabilities and
 equity instruments of the Company are either recognized or disclosed in the consolidated financial statements together with other information relevant for making a reasonable assessment of future cash flows, interest rate risk and credit risk. Where practicable, the fair values of financial assets and financial liabilities have been determined and disclosed; otherwise, only available information pertinent to fair value has been disclosed.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;At June 30, 2011, there were no identified assets or liabilities measured at fair value on a recurring basis.
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:LiquidityDisclosureTextBlock contextRef="Context_9ME_30-Jun-2011">&lt;div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" &gt;NOTE J - GOING CONCERN&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying unaudited condensed consolidated financial statements, at June 30, 2011, the Company has a negative working capital of $4.6 million, incurred a net loss for the nine month period ended June 30, 2011 of $6.1 million and has an accumulated deficit of $157.4 million. These factors, among others, may indicate that the Company will be unable to continue as a going concern for a reasonable period of time.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The Company&amp;#8217;s existence is dependent upon management&amp;#8217;s ability to develop profitable operations. Management is devoting substantially all of its efforts to developing DNA embedded biotechnology security solutions in the United States and Europe and there can be no assurance that the Company&amp;#8217;s efforts will be successful and no assurance can be given that management&amp;#8217;s actions will result in profitable operations or the resolution of its liquidity problems. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might result should the Company be unable to continue as a going concern.
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:LiquidityDisclosureTextBlock>

  <us-gaap:SubsequentEventsTextBlock contextRef="Context_9ME_30-Jun-2011">&lt;div&gt;&lt;div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" &gt;NOTE K &amp;#8211; SUBSEQUENT EVENTS&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;Sale of common stock&lt;br/&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;On July 15, 2011, the Company closed a private placement of its common stock.&amp;#160;&amp;#160;The Company issued and sold 105,263,158 shares of Common Stock at a purchase price of $0.0475 per share to accredited investors for gross proceeds of $5,000,000.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;A registered broker dealer firm acted as our placement agent with respect to the private placement. In connection with the private placement, the Company paid placement agent commissions and discounts aggregating $265,000.&amp;#160;&amp;#160;In addition, the placement agent or its designees were issued warrants with a seven-year term to purchase an aggregate&amp;#160;of 7,578,948 shares of Common Stock with an exercise price of $0.0475 per share.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;Employment agreements&lt;br/&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;On July 11, 2011, the Company&amp;#8217;s Board of Directors approved the terms of employment for each of James A. Hayward, the Company&amp;#8217;s Chief Executive Officer, and Kurt H. Jensen, the Company&amp;#8217;s Chief Financial Officer.&amp;#160;&amp;#160;It is
&lt;/font&gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;anticipated that new employment agreements will be entered into as soon as practicable reflecting these terms.&amp;#160;&amp;#160;&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;In connection with his employment agreement, Dr. Hayward was granted options to purchase 40 million shares of the Company&amp;#8217;s Common Stock at an exercise price per share equal to the average of the bid and asked prices of the Company&amp;#8217;s Common Stock on the Over The Counter (OTC) Bulletin Board on the date of grant..&amp;#160;&amp;#160;The option will vest as follows: 25% on the grant date, and 37.5% on each of the next two anniversaries of the grant date, subject to Dr. Hayward&amp;#8217;s continuous employment.&amp;#160;&amp;#160;If Company revenues for any fiscal quarter increase by more than $1 million over the prior fiscal quarter, then the vesting date for the next 37.5% tranche will be accelerated.&amp;#160;&amp;#160;Exercisability of options for the 40 million shares will be conditioned upon stockholder approval of an amendment of the Company&amp;#8217;s 2005 Incentive Stock Plan made by the Board of Directors increasing the&amp;#160;&amp;#160;aggregate and individual limits on the shares of Company Common Stock issuable under the Plan.&amp;#160;&amp;#160;The Company also granted 15 million shares of the Company&amp;#8217;s Common Stock to Dr. Hayward.
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" &gt;&lt;div&gt;&lt;div style="text-align:left;width:100%;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;" &gt;&amp;#160;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="page-break-after:always;width:100%;" &gt;&lt;div&gt;&lt;p&gt;
&lt;/p&gt;
&lt;/div&gt;&lt;div style="text-align:center;width:100%;" &gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;In addition, Dr. Hayward agreed to participate in the private placement described above and purchased 10,526,316 shares of the Company&amp;#8217;s Common Stock using $500,000 recently advanced to the Company.&amp;#160;&amp;#160;The Company has
&lt;/font&gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;also agreed to issue a one-year senior secured convertible note bearing interest at a rate of 4% per annum in the principal amount of $250,000.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;In connection with his employment agreement, Mr. Jensen was granted options to purchase 10 million shares of the Company&amp;#8217;s Common Stock at an exercise price per share equal to the average of the bid and asked prices of the Company&amp;#8217;s Common Stock on the Over The Counter (OTC) Bulletin Board on the date of grant.&amp;#160;&amp;#160;The option will vest as follows: 25% on the grant date, and 37.5% on each of the next two anniversaries of the grant date, subject to Mr. Jensen&amp;#8217;s continuous employment.&amp;#160;&amp;#160;If Company revenues for any fiscal quarter increase by more than $1 million over the prior fiscal quarter, then the vesting date for the next 37.5% tranche will be accelerated.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;C.F. Martin &amp;amp; Co. Agreement&lt;br/&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;On July 18, 2011, the Company entered into a Joint Development Agreement, dated as of June 30, 2011 with C.F. Martin &amp;amp; Co., Inc., a designer and manufacturer of acoustic guitars, strings for acoustic guitars, and related guitar components and accessories (&amp;#8220;Martin&amp;#8221;). Under the terms of the agreement, Martin and the Company will jointly develop, create and apply new techniques and know-how for labeling and authenticating guitars, guitar strings and related guitar components and accessories using DNA security markers created by the Company.&amp;#160;&amp;#160;Under the agreement, each party shall bear and be responsible for its own expenses and costs of the development and creation of the techniques and know-how.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Subject to certain exceptions for the Company, the agreement provides for a period of exclusivity (&amp;#8220;Period of Exclusivity&amp;#8221;) of six (6) months beginning on June 30, 2011 whereby Martin and the Company agree not to sell, offer for sale, enter into any agreement with any third party for the future sale of, advertise, or market, anywhere in the world, any jointly developed technique for labeling guitars, guitar strings, and related guitar components and accessories with DNA security markers.&amp;#160;&amp;#160;The agreement also provides that Martin shall purchase DNA security markers exclusively from the Company during the longer of the term of the Agreement or the Period of Exclusivity.&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The term of the agreement will continue until the parties agree that the development and creation of techniques or know-how for labeling guitars or guitar strings with DNA security markers is complete, unless either party terminates the agreement by giving at least sixty (60) days written notice to the other party.
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" &gt;&lt;div&gt;&lt;div style="text-align:left;width:100%;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:8pt;" &gt;&amp;#160;
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="page-break-after:always;width:100%;" &gt;&lt;div&gt;&lt;p&gt;
&lt;/p&gt;
&lt;/div&gt;&lt;div style="text-align:center;width:100%;" &gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;&lt;div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;&lt;div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" &gt;Disc Graphics Agreement&lt;br/&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;On July 8, 2011, the Company entered into an agreement, dated as of July 7, 2011 with Disc Graphics Inc., a provider of specialty packaging (&amp;#8220;DG&amp;#8221;).&lt;br/&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="font-family:times new roman;font-size:10pt;" &gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Under the terms of the agreement, DG will purchase DNA security markers from the Company to be incorporated into coatings for DG&amp;#8217;s products.&amp;#160;&amp;#160;Additionally, DG will be the Company&amp;#8217;s exclusive distributor in North America of Markers for the folding carton offset print sector and non-exclusive distributor of DNA security markers for pressure sensitive labels. Under the Agreement, the Company is obligated to provide DNA security markers for up to a fixed amount of coatings. The Company received an initial fee upon entering the agreement, and is entitled to an annual fee for the DNA security markers, as well as fees for any authentication services provided by the Company.&amp;#160;&amp;#160;The initial term of the agreement is three years and will automatically renew for successive one year periods, unless &lt;br/&gt;
&lt;/font&gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;either party terminates the agreement by giving written notice to the other party at least ninety (90) days prior to the end of the third year.&amp;#160;&amp;#160;After the initial term, the Company has the right to terminate if DG does not pay the annual fee.
&lt;/font&gt;
&lt;/div&gt;&lt;div&gt;&amp;#160;
&lt;/div&gt;&lt;div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;&lt;font style="display:inline;text-decoration:underline;" &gt;3SI Agreement&lt;br/&gt;
&lt;/font&gt;
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;&lt;br /&gt;

&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;On August 9, 2011, the Company entered into a Supplier Agreement, dated as of August 3, 2011 (the &amp;#8220;Supplier Agreement&amp;#8221;), with 3SI Security Systems, Inc., a manufacturer and seller of asset protection security systems based on ink and smoke staining as well as GPS technology (&amp;#8220;3SI&amp;#8221;).&amp;#160;&amp;#160;&amp;#160;On the same date, the parties also entered into a License Agreement, dated as of August 3, 2011 (the &amp;#8220;License Agreement&amp;#8221;).
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;&lt;br /&gt;

&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;Under the terms of the Supplier Agreement, 3SI will purchase DNA markers and related products (&amp;#8220;Markers&amp;#8221;) from the Company to be incorporated into products subject to certain patents (&amp;#8220;Licensed Patents&amp;#8221;) owned by 3SI (the &amp;#8220;Products&amp;#8221;).&amp;#160;&amp;#160;Pursuant to the License Agreement, 3SI granted a nonexclusive irrevocable license to the Company to make, have made, use, import, offer to sell and sell the Products.&amp;#160;&amp;#160;Under the terms of the Supplier Agreement, 3SI is permitted to purchase the Products from the Company from time to time pursuant to purchase orders.&amp;#160;&amp;#160;The purchase price for the Products will be as set forth in an applicable product schedule for the purchase orders and may be adjusted from time to time pursuant to the terms of the Supplier Agreement.&amp;#160;&amp;#160;Under the terms of the License Agreement, the Company agreed to pay an initial payment and royalties to 3SI based on the number of Products sold, with such royalties being subject to adjustment pursuant to the terms of the License Agreement.
&lt;/font&gt;
&lt;/div&gt;&lt;div style="text-indent:0pt;display:block;" &gt;&lt;br /&gt;

&lt;/div&gt;&lt;div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" &gt;&lt;font style="display:inline;font-family:times new roman;font-size:10pt;" &gt;The terms of the Supplier Agreement and the License Agreement will continue until the expiration of the Licensed Patents, unless earlier terminated under the terms of the respective agreements.&amp;#160;&amp;#160;Under the terms of the Supplier Agreement, 3SI has the right to immediately terminate upon written notice to the Company in the event that the Company fails to continuously maintain a minimum number of Markers to be incorporated into the Products, or upon 30 days written notice to the Company.&amp;#160;&amp;#160;Under the terms of the License Agreement, 3SI has the right to immediately terminate upon written notice to the Company in the event that the Company fails to continuously maintain a minimum number of Markers, or fails to sell Markers to 3SI for incorporation into the Products for a certain time after being ordered.
&lt;/font&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>

  <apdn:FiniteLivedPatentsIntangibleAssetsNet xsi:nil="true" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD"/>
  <apdn:FiniteLivedPatentsIntangibleAssetsNet xsi:nil="true" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD"/>
  <dei:TradingSymbol contextRef="Context_9ME_30-Jun-2011">apdn</dei:TradingSymbol>
  <apdn:FiniteLivedPatentsIntangibleAssetsAccumulatedAmortizationAndWriteOff decimals="0" contextRef="Context_As_Of_30-Sep-2010" unitRef="USD">34257</apdn:FiniteLivedPatentsIntangibleAssetsAccumulatedAmortizationAndWriteOff>
  <apdn:FiniteLivedPatentsIntangibleAssetsAccumulatedAmortizationAndWriteOff decimals="0" contextRef="Context_As_Of_30-Jun-2011" unitRef="USD">34257</apdn:FiniteLivedPatentsIntangibleAssetsAccumulatedAmortizationAndWriteOff>
  <apdn:CommonStockIssuedInSettlementOfInterest decimals="0" contextRef="Context_9ME_30-Jun-2010" unitRef="USD">102794</apdn:CommonStockIssuedInSettlementOfInterest>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>apdn-20110630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<schema targetNamespace="http://www.adnas.com/2011-06-30" elementFormDefault="qualified" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:apdn="http://www.adnas.com/2011-06-30" xmlns:us-gaap="http://fasb.org/us-gaap/2011-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap-att="http://fasb.org/us-gaap/attributes" xmlns:country="http://xbrl.sec.gov/country/2011-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2011-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2011-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2011-01-31" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:invest="http://xbrl.sec.gov/invest/2011-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:us-types="http://fasb.org/us-types/2011-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <annotation>
    <appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="apdn-20110630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="apdn-20110630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="apdn-20110630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="apdn-20110630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:roleType roleURI="http://www.adnas.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>01 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adnas.com/role/StatementOfFinancialPositionClassified" id="StatementOfFinancialPositionClassified">
        <link:definition>02 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adnas.com/role/CondensedConsolidatedBalanceSheetsParentheticals" id="CondensedConsolidatedBalanceSheetsParentheticals">
        <link:definition>03 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adnas.com/role/StatementOfIncome" id="StatementOfIncome">
        <link:definition>04 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adnas.com/role/StatementOfCashFlowsIndirect" id="StatementOfCashFlowsIndirect">
        <link:definition>05 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adnas.com/role/SummaryOfAccountingPolicies" id="SummaryOfAccountingPolicies">
        <link:definition>06 - Disclosure - SUMMARY OF ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adnas.com/role/IntangibleAssets" id="IntangibleAssets">
        <link:definition>07 - Disclosure - INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adnas.com/role/AccountsPayableAndAccruedLiabilities" id="AccountsPayableAndAccruedLiabilities">
        <link:definition>08 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adnas.com/role/PrivatePlacementOfConvertibleNotes" id="PrivatePlacementOfConvertibleNotes">
        <link:definition>09 - Disclosure - CONVERTIBLE NOTES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adnas.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
        <link:definition>10 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adnas.com/role/CapitalStock" id="CapitalStock">
        <link:definition>11 - Disclosure - CAPITAL STOCK</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adnas.com/role/StockOptionsAndWarrants" id="StockOptionsAndWarrants">
        <link:definition>12 - Disclosure - STOCK OPTIONS AND WARRANTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adnas.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
        <link:definition>13 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adnas.com/role/FairValueMeasurement" id="FairValueMeasurement">
        <link:definition>14 - Disclosure - FAIR VALUE MEASUREMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adnas.com/role/GoingConcern" id="GoingConcern">
        <link:definition>15 - Disclosure - GOING CONCERN</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.adnas.com/role/SubsequentEvents" id="SubsequentEvents">
        <link:definition>16 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </appinfo>
  </annotation>
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <import namespace="http://fasb.org/us-gaap/2011-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/invest/2011-01-31" schemaLocation="http://xbrl.sec.gov/invest/2011/invest-2011-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/country/2011-01-31" schemaLocation="http://xbrl.sec.gov/country/2011/country-2011-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/currency/2011-01-31" schemaLocation="http://xbrl.sec.gov/currency/2011/currency-2011-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/exch/2011-01-31" schemaLocation="http://xbrl.sec.gov/exch/2011/exch-2011-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>
  <import namespace="http://xbrl.sec.gov/dei/2011-01-31" schemaLocation="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <element name="DocumentAndEntityInformationAbstract" id="apdn_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration"/>
  <element name="FiniteLivedPatentsIntangibleAssetsNet" id="apdn_FiniteLivedPatentsIntangibleAssetsNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant"/>
  <element name="FiniteLivedPatentsIntangibleAssetsAccumulatedAmortizationAndWriteOff" id="apdn_FiniteLivedPatentsIntangibleAssetsAccumulatedAmortizationAndWriteOff" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant"/>
  <element name="UnamortizedDiscountOnConvertibleNotesPayableCurrent" id="apdn_UnamortizedDiscountOnConvertibleNotesPayableCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant"/>
  <element name="UnamortizedDiscountOnConvertibleNotePayableRelatedPartyNoncurrent" id="apdn_UnamortizedDiscountOnConvertibleNotePayableRelatedPartyNoncurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant"/>
  <element name="WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne" id="apdn_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="VestedOptionsIssuedToOfficersDirectorsAndEmployees" id="apdn_VestedOptionsIssuedToOfficersDirectorsAndEmployees" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration"/>
  <element name="CommonStockIssuedInSettlementOfInterest" id="apdn_CommonStockIssuedInSettlementOfInterest" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration"/>
  <element name="WarrantsIssuedForFinancingCosts" id="apdn_WarrantsIssuedForFinancingCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="IntangibleAssetsDisclosureAbstract" id="apdn_IntangibleAssetsDisclosureAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration"/>
  <element name="CapitalStockAbstract" id="apdn_CapitalStockAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration"/>
  <element name="CapitalStockTextBlock" id="apdn_CapitalStockTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
  <element name="GoingConcernAbstract" id="apdn_GoingConcernAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>apdn-20110630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef roleURI="http://www.adnas.com/role/StatementOfFinancialPositionClassified" xlink:type="simple" xlink:href="apdn-20110630.xsd#StatementOfFinancialPositionClassified"/>
  <roleRef roleURI="http://www.adnas.com/role/StatementOfIncome" xlink:type="simple" xlink:href="apdn-20110630.xsd#StatementOfIncome"/>
  <roleRef roleURI="http://www.adnas.com/role/StatementOfCashFlowsIndirect" xlink:type="simple" xlink:href="apdn-20110630.xsd#StatementOfCashFlowsIndirect"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/StatementOfFinancialPositionClassified">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_Cash" use="optional" order="20.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent" use="optional" order="40.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_PrepaidExpenseCurrent" use="optional" order="60.0" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/StatementOfFinancialPositionClassified">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_AssetsCurrent" use="optional" order="20.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet" use="optional" order="40.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepositAssets" xlink:label="loc_us-gaap_DepositAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_DepositAssets" use="optional" order="60.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" use="optional" order="80.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_FiniteLivedPatentsIntangibleAssetsNet" xlink:label="loc_apdn_FiniteLivedPatentsIntangibleAssetsNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_apdn_FiniteLivedPatentsIntangibleAssetsNet" use="optional" order="100.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet" use="optional" order="120.0" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/StatementOfFinancialPositionClassified">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" use="optional" order="20.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DueToOfficersOrStockholdersCurrent" xlink:label="loc_us-gaap_DueToOfficersOrStockholdersCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_DueToOfficersOrStockholdersCurrent" use="optional" order="40.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_ConvertibleNotesPayableCurrent" use="optional" order="60.0" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/StatementOfFinancialPositionClassified">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaap_PreferredStockValue" use="optional" order="20.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaap_CommonStockValue" use="optional" order="40.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock" use="optional" order="60.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit" use="optional" order="80.0" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/StatementOfFinancialPositionClassified">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_LiabilitiesCurrent" use="optional" order="20.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent" use="optional" order="40.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_CommitmentsAndContingencies" use="optional" order="60.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" use="optional" order="80.0" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/StatementOfIncome">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense" use="optional" order="20.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense" use="optional" order="40.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_DepreciationAndAmortization" use="optional" order="60.0" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/StatementOfIncome">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaap_SalesRevenueNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="loc_us-gaap_SalesRevenueNet" use="optional" order="20.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="loc_us-gaap_OperatingExpenses" use="optional" order="40.0" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/StatementOfIncome">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaap_OperatingIncomeLoss" use="optional" order="20.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherNonrecurringIncomeExpense" xlink:label="loc_us-gaap_OtherNonrecurringIncomeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaap_OtherNonrecurringIncomeExpense" use="optional" order="40.0" weight="-1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaap_InterestExpense" use="optional" order="60.0" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/StatementOfIncome">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" use="optional" order="20.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit" use="optional" order="40.0" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/StatementOfCashFlowsIndirect">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_ProfitLoss" use="optional" order="20.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization" use="optional" order="40.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_VestedOptionsIssuedToOfficersDirectorsAndEmployees" xlink:label="loc_apdn_VestedOptionsIssuedToOfficersDirectorsAndEmployees"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_apdn_VestedOptionsIssuedToOfficersDirectorsAndEmployees" use="optional" order="60.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts" use="optional" order="80.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium" use="optional" order="100.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_ShareBasedCompensation" use="optional" order="120.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_CommonStockIssuedInSettlementOfInterest" xlink:label="loc_apdn_CommonStockIssuedInSettlementOfInterest"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_apdn_CommonStockIssuedInSettlementOfInterest" use="optional" order="140.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" use="optional" order="160.0" weight="-1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" use="optional" order="180.0" weight="-1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" use="optional" order="200.0" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/StatementOfCashFlowsIndirect">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" use="optional" order="20.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt" use="optional" order="40.0" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/StatementOfCashFlowsIndirect">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" use="optional" order="20.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" use="optional" order="40.0" weight="1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" use="optional" order="60.0" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>apdn-20110630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef roleURI="http://www.adnas.com/role/StatementOfFinancialPositionClassified" xlink:type="simple" xlink:href="apdn-20110630.xsd#StatementOfFinancialPositionClassified"/>
  <roleRef roleURI="http://www.adnas.com/role/StatementOfIncome" xlink:type="simple" xlink:href="apdn-20110630.xsd#StatementOfIncome"/>
  <roleRef roleURI="http://www.adnas.com/role/StatementOfCashFlowsIndirect" xlink:type="simple" xlink:href="apdn-20110630.xsd#StatementOfCashFlowsIndirect"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.adnas.com/role/StatementOfFinancialPositionClassified">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" use="optional" order="0.0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementScenarioAxis_2" use="optional" order="0.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_3"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementScenarioAxis_2" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_3" use="optional" order="0.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_3_Default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementScenarioAxis_2" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_3_Default" use="optional" order="0.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4" use="optional" order="10.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_5"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4" xlink:to="loc_us-gaap_ClassOfStockDomain_5" use="optional" order="0.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_5_Default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4" xlink:to="loc_us-gaap_ClassOfStockDomain_5_Default" use="optional" order="0.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_6"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_AssetsAbstract_6" use="optional" order="10.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_7"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_6" xlink:to="loc_us-gaap_AssetsCurrentAbstract_7" use="optional" order="0.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7" xlink:to="loc_us-gaap_Cash_8" use="optional" order="0.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_9"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_9" use="optional" order="10.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_10"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_10" use="optional" order="20.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_11"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7" xlink:to="loc_us-gaap_AssetsCurrent_11" use="optional" order="30.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_12"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_12" use="optional" order="10.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherAssetsAbstract" xlink:label="loc_us-gaap_OtherAssetsAbstract_13"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_6" xlink:to="loc_us-gaap_OtherAssetsAbstract_13" use="optional" order="20.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepositAssets" xlink:label="loc_us-gaap_DepositAssets_14"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherAssetsAbstract_13" xlink:to="loc_us-gaap_DepositAssets_14" use="optional" order="0.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_15"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherAssetsAbstract_13" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_15" use="optional" order="10.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_16"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_6" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_16" use="optional" order="30.0"/>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_FiniteLivedPatentsIntangibleAssetsNet" xlink:label="loc_apdn_FiniteLivedPatentsIntangibleAssetsNet_17"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_16" xlink:to="loc_apdn_FiniteLivedPatentsIntangibleAssetsNet_17" use="optional" order="0.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_18"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_16" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_18" use="optional" order="10.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_19"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_6" xlink:to="loc_us-gaap_Assets_19" use="optional" order="40.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_20"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_20" use="optional" order="20.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_21"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_20" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_21" use="optional" order="0.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_22"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_21" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_22" use="optional" order="0.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DueToOfficersOrStockholdersCurrent" xlink:label="loc_us-gaap_DueToOfficersOrStockholdersCurrent_23"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_21" xlink:to="loc_us-gaap_DueToOfficersOrStockholdersCurrent_23" use="optional" order="10.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent_24"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_21" xlink:to="loc_us-gaap_ConvertibleNotesPayableCurrent_24" use="optional" order="20.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_25"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_21" xlink:to="loc_us-gaap_LiabilitiesCurrent_25" use="optional" order="30.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongTermDebtNoncurrentAbstract" xlink:label="loc_us-gaap_LongTermDebtNoncurrentAbstract_26"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_20" xlink:to="loc_us-gaap_LongTermDebtNoncurrentAbstract_26" use="optional" order="10.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent_27"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_26" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent_27" use="optional" order="0.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_28"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_20" xlink:to="loc_us-gaap_CommitmentsAndContingencies_28" use="optional" order="20.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_29"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_20" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_29" use="optional" order="30.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_30"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_29" xlink:to="loc_us-gaap_PreferredStockValue_30" use="optional" order="0.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_31"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_29" xlink:to="loc_us-gaap_CommonStockValue_31" use="optional" order="10.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_32"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_29" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_32" use="optional" order="20.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_33"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_29" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_33" use="optional" order="30.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_34"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_29" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_34" use="optional" order="40.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_35"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_20" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_35" use="optional" order="40.0"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.adnas.com/role/StatementOfIncome">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" use="optional" order="0.0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementScenarioAxis_2" use="optional" order="0.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_3"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementScenarioAxis_2" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_3" use="optional" order="0.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_3_Default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementScenarioAxis_2" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_3_Default" use="optional" order="0.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaap_SalesRevenueNet_4"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_SalesRevenueNet_4" use="optional" order="10.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_5"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_OperatingExpensesAbstract_5" use="optional" order="20.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_6"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_6" use="optional" order="0.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_7"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_7" use="optional" order="10.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5" xlink:to="loc_us-gaap_DepreciationAndAmortization_8" use="optional" order="20.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_9"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5" xlink:to="loc_us-gaap_OperatingExpenses_9" use="optional" order="30.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_10"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5" xlink:to="loc_us-gaap_OperatingIncomeLoss_10" use="optional" order="40.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherNonrecurringIncomeExpense" xlink:label="loc_us-gaap_OtherNonrecurringIncomeExpense_11"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5" xlink:to="loc_us-gaap_OtherNonrecurringIncomeExpense_11" use="optional" order="50.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_12"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_InterestExpense_12" use="optional" order="30.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_13"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_13" use="optional" order="40.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_14"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_14" use="optional" order="50.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_15"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_ProfitLoss_15" use="optional" order="60.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_16"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_16" use="optional" order="70.0"/>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne" xlink:label="loc_apdn_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne_17"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_apdn_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne_17" use="optional" order="80.0"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.adnas.com/role/StatementOfCashFlowsIndirect">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" use="optional" order="0.0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementScenarioAxis_2" use="optional" order="0.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_3"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementScenarioAxis_2" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_3" use="optional" order="0.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_3_Default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementScenarioAxis_2" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_3_Default" use="optional" order="0.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4" use="optional" order="10.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_5"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4" xlink:to="loc_us-gaap_ProfitLoss_5" use="optional" order="0.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6" use="optional" order="10.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_7"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_7" use="optional" order="0.0"/>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_VestedOptionsIssuedToOfficersDirectorsAndEmployees" xlink:label="loc_apdn_VestedOptionsIssuedToOfficersDirectorsAndEmployees_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6" xlink:to="loc_apdn_VestedOptionsIssuedToOfficersDirectorsAndEmployees_8" use="optional" order="10.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_9"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_9" use="optional" order="20.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_10"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_10" use="optional" order="30.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_11"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6" xlink:to="loc_us-gaap_ShareBasedCompensation_11" use="optional" order="40.0"/>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_CommonStockIssuedInSettlementOfInterest" xlink:label="loc_apdn_CommonStockIssuedInSettlementOfInterest_12"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6" xlink:to="loc_apdn_CommonStockIssuedInSettlementOfInterest_12" use="optional" order="50.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_13"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_13" use="optional" order="60.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_14"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_13" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_14" use="optional" order="0.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_15"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_13" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_15" use="optional" order="10.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_16"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_13" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_16" use="optional" order="20.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_17"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_17" use="optional" order="20.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_18"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_18" use="optional" order="20.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19" use="optional" order="30.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_20"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_20" use="optional" order="0.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_21"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_21" use="optional" order="10.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_22"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_22" use="optional" order="20.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_23"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_23" use="optional" order="40.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_24"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_24" use="optional" order="50.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_25"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_25" use="optional" order="60.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaap_InterestPaid_26"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_25" xlink:to="loc_us-gaap_InterestPaid_26" use="optional" order="0.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaap_IncomeTaxesPaid_27"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_25" xlink:to="loc_us-gaap_IncomeTaxesPaid_27" use="optional" order="10.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_28"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_25" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_28" use="optional" order="20.0"/>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_WarrantsIssuedForFinancingCosts" xlink:label="loc_apdn_WarrantsIssuedForFinancingCosts_29"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_28" xlink:to="loc_apdn_WarrantsIssuedForFinancingCosts_29" use="optional" order="0.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_30"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_28" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_30" use="optional" order="10.0"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>apdn-20110630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef roleURI="http://xbrl.us/us-gaap/role/label/negated" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2008-03-31.xsd#negated"/>
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_DocumentAndEntityInformationAbstract" xlink:label="loc_apdn_DocumentAndEntityInformationAbstract"/>
    <label xlink:type="resource" xlink:label="lab_apdn_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Document and Entity Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_apdn_DocumentAndEntityInformationAbstract" xlink:to="lab_apdn_DocumentAndEntityInformationAbstract"/>
    <label xlink:type="resource" xlink:label="lab_apdn_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Document and Entity Information [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol"/>
    <label xlink:type="resource" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol"/>
    <label xlink:type="resource" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus"/>
    <label xlink:type="resource" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus"/>
    <label xlink:type="resource" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Entity Current Reporting Status</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers"/>
    <label xlink:type="resource" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers"/>
    <label xlink:type="resource" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Entity Voluntary Filers</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Current Fiscal Year End Date</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Entity Filer Category</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType"/>
    <label xlink:type="resource" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType"/>
    <label xlink:type="resource" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Document Type</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Amendment Flag</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Document Fiscal Year Focus</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Document Fiscal Period Focus</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Statement Of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Statement [Table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Statement [Line Items]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">ASSETS</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Assets, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Current assets:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Cash" xlink:to="lab_us-gaap_Cash"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US">Cash, Beginning Balance</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US">Cash, Ending Balance</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Accounts Receivable, Net, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Accounts receivable</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Accounts receivable</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Prepaid Expense, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Prepaid expenses</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Prepaid expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Total current assets</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Total current assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Property, Plant and Equipment, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Property, plant and equipment-net of accumulated depreciation of $210,862 and $207,097 respectively</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Property, plant and equipment-net of accumulated depreciation of $209,917 and $207,097, respectively</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US">Property, Plant and Equipment, Net, Beginning Balance</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US">Property, Plant and Equipment, Net, Ending Balance</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherAssetsAbstract" xlink:label="loc_us-gaap_OtherAssetsAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_OtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Other Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsAbstract" xlink:to="lab_us-gaap_OtherAssetsAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_OtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Other assets:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepositAssets" xlink:label="loc_us-gaap_DepositAssets"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_DepositAssets" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Deposit Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositAssets" xlink:to="lab_us-gaap_DepositAssets"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_DepositAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Deposits</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Deferred Finance Costs, Noncurrent, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Capitalized finance costs-net of accumulated amortization of $1,678,872 and $947,276, respectively</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Deferred Finance Costs, Noncurrent, Net, Total</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill) [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Intangible assets:</label>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_FiniteLivedPatentsIntangibleAssetsNet" xlink:label="loc_apdn_FiniteLivedPatentsIntangibleAssetsNet"/>
    <label xlink:type="resource" xlink:label="lab_apdn_FiniteLivedPatentsIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Finite-Lived Patents Intangible Assets, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_apdn_FiniteLivedPatentsIntangibleAssetsNet" xlink:to="lab_apdn_FiniteLivedPatentsIntangibleAssetsNet"/>
    <label xlink:type="resource" xlink:label="lab_apdn_FiniteLivedPatentsIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Patents, net of accumulated amortization of $34,257 (Note B)</label>
    <label xlink:type="resource" xlink:label="lab_apdn_FiniteLivedPatentsIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">The aggregate sum of gross carrying value of a major Finite-Lived Patents Intangible Assets class, less accumulated amortization and any impairment charges. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Finite-Lived Intangible Assets, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Intellectual property, net of accumulated amortization and write off of $9,067,109 and $8,794,265, respectively (Note B)</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Patents, net of accumulated amortization of $34,257 (Note B)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Total Assets</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Total Assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Liabilities and Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">LIABILITIES AND DEFICIENCY IN STOCKHOLDERS' EQUITY</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Liabilities, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Current liabilities:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Accounts payable and accrued liabilities</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Accounts payable and accrued liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DueToOfficersOrStockholdersCurrent" xlink:label="loc_us-gaap_DueToOfficersOrStockholdersCurrent"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_DueToOfficersOrStockholdersCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Due To Officers Or Stockholders, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToOfficersOrStockholdersCurrent" xlink:to="lab_us-gaap_DueToOfficersOrStockholdersCurrent"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_DueToOfficersOrStockholdersCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Advances from officers</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_ConvertibleNotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Convertible Notes Payable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayableCurrent" xlink:to="lab_us-gaap_ConvertibleNotesPayableCurrent"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_ConvertibleNotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Convertible notes payable, net of unamortized discount of $1,088,317 and $545,920, (Note D)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Total current liabilities</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Total current liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongTermDebtNoncurrentAbstract" xlink:label="loc_us-gaap_LongTermDebtNoncurrentAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_LongTermDebtNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract" xlink:to="lab_us-gaap_LongTermDebtNoncurrentAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_LongTermDebtNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Long term debt:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Notes Payable, Related Parties, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:to="lab_us-gaap_NotesPayableRelatedPartiesNoncurrent"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Convertible note payable-related party, net of unamortized discount of $5,286</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US">Convertible note payable-related party, net of unamortized discount of $5,286</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Commitments and Contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Commitments and contingencies (Note H)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Stockholders Equity, Including Portion Attributable To Noncontrolling Interest [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Deficiency in Stockholder' Equity (Note F)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Preferred Stock, Value, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- issued and outstanding as of June 30, 2011 and September 30, 2010</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Preferred Stock, Value, Issued, Total</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US">Preferred Stock, Value, Issued, Beginning Balance</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US">Preferred Stock, Value, Issued, Ending Balance</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Common Stock, Value, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Common stock, par value $0.001 per share; 800,000,000 shares authorized; 352,523,001 and 346,366,244 issued and outstanding as of June 30, 2011 and September 30, 2010, respectively</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Common Stock, Value, Issued, Total</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US">Common Stock, Value, Issued, Beginning Balance</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US">Common Stock, Value, Issued, Ending Balance</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Additional Paid In Capital, Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Additional paid in capital</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US">Additional Paid in Capital, Common Stock, Beginning Balance</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US">Additional Paid in Capital, Common Stock, Ending Balance</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US">Retained Earnings (Accumulated Deficit), Beginning Balance</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US">Retained Earnings (Accumulated Deficit), Ending Balance</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Stockholders Equity, Including Portion Attributable To Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Total deficiency in stockholders' equity</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Total deficiency in stockholders' equity</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Total Liabilities and Deficiency in Stockholders' Equity</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Total Liabilities and Deficiency in Stockholders' Equity</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Accumulated depreciation on Property, plant and equipment (in dollars)</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts" xlink:label="loc_us-gaap_AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Accumulated Amortization Of Noncurrent Deferred Finance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts" xlink:to="lab_us-gaap_AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Accumulated amortization on Capitalized finance costs (in dollars)</label>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_FiniteLivedPatentsIntangibleAssetsAccumulatedAmortizationAndWriteOff" xlink:label="loc_apdn_FiniteLivedPatentsIntangibleAssetsAccumulatedAmortizationAndWriteOff"/>
    <label xlink:type="resource" xlink:label="lab_apdn_FiniteLivedPatentsIntangibleAssetsAccumulatedAmortizationAndWriteOff" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Finite-Lived Patents Intangible Assets, Accumulated Amortization and Write Off</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_apdn_FiniteLivedPatentsIntangibleAssetsAccumulatedAmortizationAndWriteOff" xlink:to="lab_apdn_FiniteLivedPatentsIntangibleAssetsAccumulatedAmortizationAndWriteOff"/>
    <label xlink:type="resource" xlink:label="lab_apdn_FiniteLivedPatentsIntangibleAssetsAccumulatedAmortizationAndWriteOff" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Accumulated amortization on Patents (in dollars)</label>
    <label xlink:type="resource" xlink:label="lab_apdn_FiniteLivedPatentsIntangibleAssetsAccumulatedAmortizationAndWriteOff" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">The accumulated amount of amortization of a major finite-lived Patents intangible asset class. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Accumulated amortization and write off on Intellectual property (in dollars)</label>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_UnamortizedDiscountOnConvertibleNotesPayableCurrent" xlink:label="loc_apdn_UnamortizedDiscountOnConvertibleNotesPayableCurrent"/>
    <label xlink:type="resource" xlink:label="lab_apdn_UnamortizedDiscountOnConvertibleNotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Unamortized Discount On Convertible Notes Payable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_apdn_UnamortizedDiscountOnConvertibleNotesPayableCurrent" xlink:to="lab_apdn_UnamortizedDiscountOnConvertibleNotesPayableCurrent"/>
    <label xlink:type="resource" xlink:label="lab_apdn_UnamortizedDiscountOnConvertibleNotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Unamortized discount on Convertible notes payable, current (in dollars)</label>
    <label xlink:type="resource" xlink:label="lab_apdn_UnamortizedDiscountOnConvertibleNotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">The unamortized discount related to convertible notes payable.</label>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_UnamortizedDiscountOnConvertibleNotePayableRelatedPartyNoncurrent" xlink:label="loc_apdn_UnamortizedDiscountOnConvertibleNotePayableRelatedPartyNoncurrent"/>
    <label xlink:type="resource" xlink:label="lab_apdn_UnamortizedDiscountOnConvertibleNotePayableRelatedPartyNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Unamortized Discount On Convertible Note Payable-Related Party, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_apdn_UnamortizedDiscountOnConvertibleNotePayableRelatedPartyNoncurrent" xlink:to="lab_apdn_UnamortizedDiscountOnConvertibleNotePayableRelatedPartyNoncurrent"/>
    <label xlink:type="resource" xlink:label="lab_apdn_UnamortizedDiscountOnConvertibleNotePayableRelatedPartyNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Unamortized discount on Convertible note payable-related party, non-current (in dollars)</label>
    <label xlink:type="resource" xlink:label="lab_apdn_UnamortizedDiscountOnConvertibleNotePayableRelatedPartyNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">The unamortized discount related to convertible note payable-related party.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Preferred Stock, Par Or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Preferred stock, par value (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Preferred Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Preferred stock, shares authorized</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Preferred Stock, Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Preferred stock, shares issued</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Preferred Stock, Shares Issued, Total</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Preferred Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Preferred stock, shares outstanding</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US">Preferred Stock, Shares Outstanding, Beginning Balance</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US">Preferred Stock, Shares Outstanding, Ending Balance</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Common Stock, Par Or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Common stock, par value (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Common Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Common stock, shares authorized</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Common Stock, Shares, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Common stock, shares issued</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Common Stock, Shares, Issued, Total</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Common stock, shares outstanding</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US">Common Stock, Shares, Outstanding, Beginning Balance</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US">Common Stock, Shares, Outstanding, Ending Balance</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Income Statement [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaap_SalesRevenueNet"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_SalesRevenueNet" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Revenue, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNet" xlink:to="lab_us-gaap_SalesRevenueNet"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_SalesRevenueNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Revenue</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_SalesRevenueNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Sales</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Operating Expenses [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Operating expenses:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Selling, General and Administrative Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Selling, general and administrative</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Selling, general and administrative</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Research and Development Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Research and development</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Research and development</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Depreciation and amortization</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Depreciation and amortization</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Operating Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Total operating expenses</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Total operating expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Operating Income (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">NET LOSS FROM OPERATIONS</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">NET LOSS FROM OPERATIONS</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherNonrecurringIncomeExpense" xlink:label="loc_us-gaap_OtherNonrecurringIncomeExpense"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_OtherNonrecurringIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Other Nonrecurring (Income) Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonrecurringIncomeExpense" xlink:to="lab_us-gaap_OtherNonrecurringIncomeExpense"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_OtherNonrecurringIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Other income (Note C)</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_OtherNonrecurringIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Other income (Note C)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Interest Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Interest expense, net (Note C)</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Interest expense, net (Note C)</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US">Interest expense, net</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Income (Loss) From Continuing Operations Before Income Taxes, Extraordinary Items, Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Net loss before provision for income taxes</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Net loss before provision for income taxes</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Income taxes (benefit)</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Income taxes (benefit)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Net Income (Loss), Including Portion Attributable To Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Net loss</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">NET LOSS</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Earnings Per Share, Basic and Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDiluted"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Net loss per share-basic and fully diluted (in dollars per share)</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Net (loss) per share-basic and fully diluted</label>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne" xlink:label="loc_apdn_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne"/>
    <label xlink:type="resource" xlink:label="lab_apdn_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Weighted Average Number Of Shares Outstanding, Basic and Diluted, One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_apdn_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne" xlink:to="lab_apdn_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne"/>
    <label xlink:type="resource" xlink:label="lab_apdn_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Weighted average shares outstanding-Basic and fully diluted (in shares)</label>
    <label xlink:type="resource" xlink:label="lab_apdn_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">The average number of shares or units issued and outstanding that are used in calculating basic and diluted EPS.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Statement Of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Net Cash Provided By (Used In) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Cash flows from operating activities:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Adjustments To Reconcile Net Income (Loss) To Cash Provided By (Used In) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Depreciation, Depletion and Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Depreciation and amortization</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Depreciation and amortization</label>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_VestedOptionsIssuedToOfficersDirectorsAndEmployees" xlink:label="loc_apdn_VestedOptionsIssuedToOfficersDirectorsAndEmployees"/>
    <label xlink:type="resource" xlink:label="lab_apdn_VestedOptionsIssuedToOfficersDirectorsAndEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Vested Options Issued To Officers, Directors and Employees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_apdn_VestedOptionsIssuedToOfficersDirectorsAndEmployees" xlink:to="lab_apdn_VestedOptionsIssuedToOfficersDirectorsAndEmployees"/>
    <label xlink:type="resource" xlink:label="lab_apdn_VestedOptionsIssuedToOfficersDirectorsAndEmployees" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Fair value of vested options issued to officers, directors and employees</label>
    <label xlink:type="resource" xlink:label="lab_apdn_VestedOptionsIssuedToOfficersDirectorsAndEmployees" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">The fair value of vested options issued to officers, directors and employees.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Amortization Of Financing Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Amortization of capitalized financing costs</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Amortization Of Debt Discount (Premium)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Amortization of debt discount attributable to convertible debentures</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Share-Based Compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Equity based compensation</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Equity based compensation</label>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_CommonStockIssuedInSettlementOfInterest" xlink:label="loc_apdn_CommonStockIssuedInSettlementOfInterest"/>
    <label xlink:type="resource" xlink:label="lab_apdn_CommonStockIssuedInSettlementOfInterest" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Common Stock Issued In Settlement Of Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_apdn_CommonStockIssuedInSettlementOfInterest" xlink:to="lab_apdn_CommonStockIssuedInSettlementOfInterest"/>
    <label xlink:type="resource" xlink:label="lab_apdn_CommonStockIssuedInSettlementOfInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Common stock issued in settlement of interest</label>
    <label xlink:type="resource" xlink:label="lab_apdn_CommonStockIssuedInSettlementOfInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">The fair value of common stock issued in settlement of interest.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Increase (Decrease) In Operating Capital [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Change in assets and liabilities:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Increase (Decrease) In Accounts Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">(Increase) decrease in accounts receivable</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US">Decrease in accounts receivable</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Increase (Decrease) In Prepaid Expense and Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Decrease in prepaid expenses and deposits</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Decrease in prepaid expenses and deposits</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xml:lang="en-US">Decrease (increase) in prepaid expenses and deposits</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Increase (Decrease) In Accounts Payable and Accrued Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Increase in accounts payable and accrued liabilities</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">(Decrease) increase in accounts payable and accrued liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Net Cash Provided By (Used In) Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Net cash used in operating activities</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Net cash used in operating activities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Net Cash Provided By (Used In) Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Cash flows from investing activities:</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Cash flows from investing activities:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Net Cash Provided By (Used In) Financing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Cash flows from financing activities:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Proceeds From (Repayments Of) Related Party Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Net proceeds from related party advances</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Proceeds from (Repayments of) Related Party Debt, Total</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Proceeds From Convertible Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Net proceeds from issuance of convertible notes</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Net Cash Provided By (Used In) Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Net cash provided by financing activities</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Net cash provided by financing activities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Net increase in cash and cash equivalents</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Cash and Cash Equivalents, At Carrying Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Cash and cash equivalents at end of period</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value, Total</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xml:lang="en-US">Cash and cash equivalents at beginning of period</label>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xml:lang="en-US">Cash and cash equivalents at end of period</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Supplemental Disclosures of Cash Flow Information:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaap_InterestPaid"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Interest Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaid" xlink:to="lab_us-gaap_InterestPaid"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Cash paid during the period for interest</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaap_IncomeTaxesPaid"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Income Taxes Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Cash paid during the period for taxes</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Non-cash transactions:</label>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_WarrantsIssuedForFinancingCosts" xlink:label="loc_apdn_WarrantsIssuedForFinancingCosts"/>
    <label xlink:type="resource" xlink:label="lab_apdn_WarrantsIssuedForFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Warrants Issued For Financing Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_apdn_WarrantsIssuedForFinancingCosts" xlink:to="lab_apdn_WarrantsIssuedForFinancingCosts"/>
    <label xlink:type="resource" xlink:label="lab_apdn_WarrantsIssuedForFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Fair value of warrants issued for financing costs</label>
    <label xlink:type="resource" xlink:label="lab_apdn_WarrantsIssuedForFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">Fair value of warrants issued for financing costs in noncash investing and financing activities.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Debt Conversion, Converted Instrument, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Common stock issued in exchange for previously incurred debt</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">SUMMARY OF ACCOUNTING POLICIES</label>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_IntangibleAssetsDisclosureAbstract" xlink:label="loc_apdn_IntangibleAssetsDisclosureAbstract"/>
    <label xlink:type="resource" xlink:label="lab_apdn_IntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Intangible Assets Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_apdn_IntangibleAssetsDisclosureAbstract" xlink:to="lab_apdn_IntangibleAssetsDisclosureAbstract"/>
    <label xlink:type="resource" xlink:label="lab_apdn_IntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Intangible Assets Disclosure [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">INTANGIBLE ASSETS</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Payables and Accruals [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Payables and Accruals [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongTermDebtAbstract" xlink:label="loc_us-gaap_LongTermDebtAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_LongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Long-Term Debt, Unclassified [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAbstract" xlink:to="lab_us-gaap_LongTermDebtAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_LongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Long-term Debt, Unclassified [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="loc_us-gaap_LongTermDebtTextBlock"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Long-Term Debt [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">CONVERTIBLE NOTES</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Related Party Transactions [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Related Party Transactions [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">RELATED PARTY TRANSACTIONS</label>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_CapitalStockAbstract" xlink:label="loc_apdn_CapitalStockAbstract"/>
    <label xlink:type="resource" xlink:label="lab_apdn_CapitalStockAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Capital Stock [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_apdn_CapitalStockAbstract" xlink:to="lab_apdn_CapitalStockAbstract"/>
    <label xlink:type="resource" xlink:label="lab_apdn_CapitalStockAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Capital Stock [Abstract]</label>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_CapitalStockTextBlock" xlink:label="loc_apdn_CapitalStockTextBlock"/>
    <label xlink:type="resource" xlink:label="lab_apdn_CapitalStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Capital Stock [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_apdn_CapitalStockTextBlock" xlink:to="lab_apdn_CapitalStockTextBlock"/>
    <label xlink:type="resource" xlink:label="lab_apdn_CapitalStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">CAPITAL STOCK</label>
    <label xlink:type="resource" xlink:label="lab_apdn_CapitalStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US">The entire disclosure for Capital Stock.</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Disclosure Of Compensation Related Costs, Share-Based Payments [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">STOCK OPTIONS AND WARRANTS</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Fair Value Disclosures [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Fair Value Disclosures [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Fair Value Disclosures [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">FAIR VALUE MEASUREMENT</label>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_GoingConcernAbstract" xlink:label="loc_apdn_GoingConcernAbstract"/>
    <label xlink:type="resource" xlink:label="lab_apdn_GoingConcernAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Going Concern [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_apdn_GoingConcernAbstract" xlink:to="lab_apdn_GoingConcernAbstract"/>
    <label xlink:type="resource" xlink:label="lab_apdn_GoingConcernAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Going Concern [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiquidityDisclosureTextBlock" xlink:label="loc_us-gaap_LiquidityDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_LiquidityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Liquidity Disclosure [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiquidityDisclosureTextBlock" xlink:to="lab_us-gaap_LiquidityDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_LiquidityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">GOING CONCERN</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xml:lang="en-US">SUBSEQUENT EVENTS</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Statement, Scenario [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementScenarioAxis" xlink:to="lab_us-gaap_StatementScenarioAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Class of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Scenario, Unspecified [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScenarioUnspecifiedDomain" xlink:to="lab_us-gaap_ScenarioUnspecifiedDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Class of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Cash, Cash Equivalents, and Short-term Investments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ReceivablesNetCurrentAbstract" xlink:label="loc_us-gaap_ReceivablesNetCurrentAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_ReceivablesNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Receivables, Net, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrentAbstract" xlink:to="lab_us-gaap_ReceivablesNetCurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable, Net, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableNetCurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsReceivableNetCurrentAbstract" xlink:label="loc_us-gaap_AccountsReceivableNetCurrentAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AccountsReceivableNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Accounts Receivable, Net, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrentAbstract" xlink:to="lab_us-gaap_AccountsReceivableNetCurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Prepaid Expense and Other Assets, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PrepaidExpenseCurrentAbstract" xlink:label="loc_us-gaap_PrepaidExpenseCurrentAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PrepaidExpenseCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Prepaid Expense, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrentAbstract" xlink:to="lab_us-gaap_PrepaidExpenseCurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Assets, Noncurrent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Property, Plant and Equipment, Net [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Finite-Lived Intangible Assets, Net [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredCostsNoncurrentAbstract" xlink:label="loc_us-gaap_DeferredCostsNoncurrentAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_DeferredCostsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Deferred Costs, Noncurrent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsNoncurrentAbstract" xlink:to="lab_us-gaap_DeferredCostsNoncurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAbstract" xlink:label="loc_us-gaap_LiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DebtCurrentAbstract" xlink:label="loc_us-gaap_DebtCurrentAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_DebtCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Debt, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrentAbstract" xlink:to="lab_us-gaap_DebtCurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrentAbstract" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrentAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Long-term Debt and Capital Lease Obligations, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrentAbstract" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongTermDebtCurrentAbstract" xlink:label="loc_us-gaap_LongTermDebtCurrentAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_LongTermDebtCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Long-term Debt, Current Maturities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrentAbstract" xlink:to="lab_us-gaap_LongTermDebtCurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NotesAndLoansPayableCurrentAbstract" xlink:label="loc_us-gaap_NotesAndLoansPayableCurrentAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_NotesAndLoansPayableCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Notes and Loans Payable, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesAndLoansPayableCurrentAbstract" xlink:to="lab_us-gaap_NotesAndLoansPayableCurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NotesPayableCurrentAbstract" xlink:label="loc_us-gaap_NotesPayableCurrentAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_NotesPayableCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Notes Payable, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableCurrentAbstract" xlink:to="lab_us-gaap_NotesPayableCurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Long-term Debt and Capital Lease Obligations [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdditionalPaidInCapitalAbstract" xlink:label="loc_us-gaap_AdditionalPaidInCapitalAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AdditionalPaidInCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Additional Paid in Capital [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalAbstract" xlink:to="lab_us-gaap_AdditionalPaidInCapitalAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficitAbstract" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficitAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficitAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Retained Earnings (Accumulated Deficit) [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficitAbstract" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficitAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="loc_us-gaap_NetIncomeLossAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Net Income (Loss) Attributable to Parent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAbstract" xlink:to="lab_us-gaap_NetIncomeLossAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetIncomeLossAttributableToReportingEntityAbstract" xlink:label="loc_us-gaap_NetIncomeLossAttributableToReportingEntityAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_NetIncomeLossAttributableToReportingEntityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToReportingEntityAbstract" xlink:to="lab_us-gaap_NetIncomeLossAttributableToReportingEntityAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeLossBeforeExtraordinaryItemsAndCumulativeEffectOfChangeInAccountingPrincipleAbstract" xlink:label="loc_us-gaap_IncomeLossBeforeExtraordinaryItemsAndCumulativeEffectOfChangeInAccountingPrincipleAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncomeLossBeforeExtraordinaryItemsAndCumulativeEffectOfChangeInAccountingPrincipleAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Income (Loss) from Operations before Extraordinary Items [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossBeforeExtraordinaryItemsAndCumulativeEffectOfChangeInAccountingPrincipleAbstract" xlink:to="lab_us-gaap_IncomeLossBeforeExtraordinaryItemsAndCumulativeEffectOfChangeInAccountingPrincipleAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsAbstract" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Income (Loss) from Continuing Operations, Including Portion Attributable to Noncontrolling Interest [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsAbstract" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingIncomeLossAbstract" xlink:label="loc_us-gaap_OperatingIncomeLossAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_OperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Operating Income (Loss) [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract" xlink:to="lab_us-gaap_OperatingIncomeLossAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_GrossProfitAbstract" xlink:label="loc_us-gaap_GrossProfitAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_GrossProfitAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Gross Profit [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfitAbstract" xlink:to="lab_us-gaap_GrossProfitAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaap_RevenuesAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Revenues [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SalesRevenueNetAbstract" xlink:label="loc_us-gaap_SalesRevenueNetAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_SalesRevenueNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Revenue, Net [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetAbstract" xlink:to="lab_us-gaap_SalesRevenueNetAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Operating Costs and Expenses [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="lab_us-gaap_OperatingCostsAndExpensesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseAbstract" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Research and Development Expense [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseAbstract" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepreciationDepletionAndAmortizationNonproductionAbstract" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortizationNonproductionAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortizationNonproductionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortizationNonproductionAbstract" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortizationNonproductionAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisionsAbstract" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisionsAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_RestructuringSettlementAndImpairmentProvisionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Restructuring, Settlement and Impairment Provisions [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringSettlementAndImpairmentProvisionsAbstract" xlink:to="lab_us-gaap_RestructuringSettlementAndImpairmentProvisionsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherNonrecurringIncomeExpenseAbstract" xlink:label="loc_us-gaap_OtherNonrecurringIncomeExpenseAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_OtherNonrecurringIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Other Nonrecurring (Income) Expense [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonrecurringIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonrecurringIncomeExpenseAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpenseAbstract" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Selling, General and Administrative Expense [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestAndDebtExpenseAbstract" xlink:label="loc_us-gaap_InterestAndDebtExpenseAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_InterestAndDebtExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Interest and Debt Expense [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndDebtExpenseAbstract" xlink:to="lab_us-gaap_InterestAndDebtExpenseAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestExpenseAbstract" xlink:label="loc_us-gaap_InterestExpenseAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_InterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Interest Expense [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseAbstract" xlink:to="lab_us-gaap_InterestExpenseAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitAbstract" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Income Tax Expense (Benefit) [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitAbstract" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Earnings Per Share [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepreciationAndAmortizationAbstract" xlink:label="loc_us-gaap_DepreciationAndAmortizationAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_DepreciationAndAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Depreciation, Depletion and Amortization [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortizationAbstract" xlink:to="lab_us-gaap_DepreciationAndAmortizationAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdjustmentForAmortizationAbstract" xlink:label="loc_us-gaap_AdjustmentForAmortizationAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AdjustmentForAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Amortization [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortizationAbstract" xlink:to="lab_us-gaap_AdjustmentForAmortizationAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscountsAbstract" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscountsAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Amortization of Financing Costs and Discounts [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscountsAbstract" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscountsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensationAbstract" xlink:label="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensationAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Employee Benefits and Share-based Compensation [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensationAbstract" xlink:to="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensationAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Share-based Compensation [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Increase (Decrease) in Operating Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInReceivablesAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivablesAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Increase (Decrease) in Receivables [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivablesAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssetsAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssetsAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssetsAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssetsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Increase (Decrease) in Operating Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfDebtAbstract" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfDebtAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Proceeds from (Repayments of) Debt [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfDebtAbstract" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfDebtAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecuritiesAbstract" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecuritiesAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Proceeds from (Repayments of) Long-term Debt and Capital Securities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecuritiesAbstract" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecuritiesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNetAbstract" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNetAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Proceeds from Issuance of Long-term Debt and Capital Securities, Net [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNetAbstract" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNetAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebtAbstract" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebtAbstract"/>
    <label xlink:type="resource" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US">Proceeds from Issuance of Long-term Debt [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebtAbstract" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebtAbstract"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>apdn-20110630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef roleURI="http://www.adnas.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="apdn-20110630.xsd#DocumentAndEntityInformation"/>
  <roleRef roleURI="http://www.adnas.com/role/StatementOfFinancialPositionClassified" xlink:type="simple" xlink:href="apdn-20110630.xsd#StatementOfFinancialPositionClassified"/>
  <roleRef roleURI="http://www.adnas.com/role/CondensedConsolidatedBalanceSheetsParentheticals" xlink:type="simple" xlink:href="apdn-20110630.xsd#CondensedConsolidatedBalanceSheetsParentheticals"/>
  <roleRef roleURI="http://www.adnas.com/role/StatementOfIncome" xlink:type="simple" xlink:href="apdn-20110630.xsd#StatementOfIncome"/>
  <roleRef roleURI="http://www.adnas.com/role/StatementOfCashFlowsIndirect" xlink:type="simple" xlink:href="apdn-20110630.xsd#StatementOfCashFlowsIndirect"/>
  <roleRef roleURI="http://www.adnas.com/role/SummaryOfAccountingPolicies" xlink:type="simple" xlink:href="apdn-20110630.xsd#SummaryOfAccountingPolicies"/>
  <roleRef roleURI="http://www.adnas.com/role/IntangibleAssets" xlink:type="simple" xlink:href="apdn-20110630.xsd#IntangibleAssets"/>
  <roleRef roleURI="http://www.adnas.com/role/AccountsPayableAndAccruedLiabilities" xlink:type="simple" xlink:href="apdn-20110630.xsd#AccountsPayableAndAccruedLiabilities"/>
  <roleRef roleURI="http://www.adnas.com/role/PrivatePlacementOfConvertibleNotes" xlink:type="simple" xlink:href="apdn-20110630.xsd#PrivatePlacementOfConvertibleNotes"/>
  <roleRef roleURI="http://www.adnas.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="apdn-20110630.xsd#RelatedPartyTransactions"/>
  <roleRef roleURI="http://www.adnas.com/role/CapitalStock" xlink:type="simple" xlink:href="apdn-20110630.xsd#CapitalStock"/>
  <roleRef roleURI="http://www.adnas.com/role/StockOptionsAndWarrants" xlink:type="simple" xlink:href="apdn-20110630.xsd#StockOptionsAndWarrants"/>
  <roleRef roleURI="http://www.adnas.com/role/CommitmentsAndContingencies" xlink:type="simple" xlink:href="apdn-20110630.xsd#CommitmentsAndContingencies"/>
  <roleRef roleURI="http://www.adnas.com/role/FairValueMeasurement" xlink:type="simple" xlink:href="apdn-20110630.xsd#FairValueMeasurement"/>
  <roleRef roleURI="http://www.adnas.com/role/GoingConcern" xlink:type="simple" xlink:href="apdn-20110630.xsd#GoingConcern"/>
  <roleRef roleURI="http://www.adnas.com/role/SubsequentEvents" xlink:type="simple" xlink:href="apdn-20110630.xsd#SubsequentEvents"/>
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_DocumentAndEntityInformationAbstract" xlink:label="loc_apdn_DocumentAndEntityInformationAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityRegistrantName_1" use="optional" order="0.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityCentralIndexKey_2" use="optional" order="10.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_TradingSymbol_3" use="optional" order="20.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityCurrentReportingStatus_4" use="optional" order="30.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityVoluntaryFilers_5" use="optional" order="40.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_CurrentFiscalYearEndDate_6" use="optional" order="50.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityFilerCategory_7" use="optional" order="60.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_8" use="optional" order="70.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_DocumentType_9" use="optional" order="80.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_DocumentPeriodEndDate_10" use="optional" order="90.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_11"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_AmendmentFlag_11" use="optional" order="100.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_dei_AmendmentDescription_12"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_AmendmentDescription_12" use="optional" order="110.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_DocumentFiscalYearFocus_13" use="optional" order="120.0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_14"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_14" use="optional" order="130.0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/StatementOfFinancialPositionClassified">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementScenarioAxis_2" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementScenarioAxis_2" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_3" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4" use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4" xlink:to="loc_us-gaap_ClassOfStockDomain_5" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_6" use="optional" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_AssetsAbstract_7" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7" xlink:to="loc_us-gaap_AssetsCurrentAbstract_8" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8" xlink:to="loc_us-gaap_Cash_9" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_10" use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_11"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_11" use="optional" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_12"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8" xlink:to="loc_us-gaap_AssetsCurrent_12" use="optional" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_13" use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherAssetsAbstract" xlink:label="loc_us-gaap_OtherAssetsAbstract_14"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7" xlink:to="loc_us-gaap_OtherAssetsAbstract_14" use="optional" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepositAssets" xlink:label="loc_us-gaap_DepositAssets_15"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_14" xlink:to="loc_us-gaap_DepositAssets_15" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_16"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_14" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_16" use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_17"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_17" use="optional" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_FiniteLivedPatentsIntangibleAssetsNet" xlink:label="loc_apdn_FiniteLivedPatentsIntangibleAssetsNet_18"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_17" xlink:to="loc_apdn_FiniteLivedPatentsIntangibleAssetsNet_18" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_19"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_17" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_19" use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_20"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7" xlink:to="loc_us-gaap_Assets_20" use="optional" order="40.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_21"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_21" use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_22"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_21" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_22" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_23"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_22" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_23" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DueToOfficersOrStockholdersCurrent" xlink:label="loc_us-gaap_DueToOfficersOrStockholdersCurrent_24"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_22" xlink:to="loc_us-gaap_DueToOfficersOrStockholdersCurrent_24" use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent_25"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_22" xlink:to="loc_us-gaap_ConvertibleNotesPayableCurrent_25" use="optional" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_26"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_22" xlink:to="loc_us-gaap_LiabilitiesCurrent_26" use="optional" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongTermDebtNoncurrentAbstract" xlink:label="loc_us-gaap_LongTermDebtNoncurrentAbstract_27"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_21" xlink:to="loc_us-gaap_LongTermDebtNoncurrentAbstract_27" use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent_28"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_27" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent_28" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_29"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_21" xlink:to="loc_us-gaap_CommitmentsAndContingencies_29" use="optional" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_30"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_21" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_30" use="optional" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_31"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_30" xlink:to="loc_us-gaap_PreferredStockValue_31" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_32"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_30" xlink:to="loc_us-gaap_CommonStockValue_32" use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_33"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_30" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_33" use="optional" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_34"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_30" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_34" use="optional" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_35"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_30" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_35" use="optional" order="40.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_36"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_21" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_36" use="optional" order="40.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/CondensedConsolidatedBalanceSheetsParentheticals">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts" xlink:label="loc_us-gaap_AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts_2" use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_FiniteLivedPatentsIntangibleAssetsAccumulatedAmortizationAndWriteOff" xlink:label="loc_apdn_FiniteLivedPatentsIntangibleAssetsAccumulatedAmortizationAndWriteOff_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_apdn_FiniteLivedPatentsIntangibleAssetsAccumulatedAmortizationAndWriteOff_3" use="optional" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4" use="optional" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_UnamortizedDiscountOnConvertibleNotesPayableCurrent" xlink:label="loc_apdn_UnamortizedDiscountOnConvertibleNotesPayableCurrent_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_apdn_UnamortizedDiscountOnConvertibleNotesPayableCurrent_5" use="optional" order="40.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_UnamortizedDiscountOnConvertibleNotePayableRelatedPartyNoncurrent" xlink:label="loc_apdn_UnamortizedDiscountOnConvertibleNotePayableRelatedPartyNoncurrent_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_apdn_UnamortizedDiscountOnConvertibleNotePayableRelatedPartyNoncurrent_6" use="optional" order="50.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_7" use="optional" order="60.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_8" use="optional" order="70.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_PreferredStockSharesIssued_9" use="optional" order="80.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_10" use="optional" order="90.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_11"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_11" use="optional" order="100.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_12"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_12" use="optional" order="110.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesIssued_13" use="optional" order="120.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_14"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_14" use="optional" order="130.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/StatementOfIncome">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementScenarioAxis_2" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementScenarioAxis_2" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_3" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_4" use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaap_SalesRevenueNet_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_us-gaap_SalesRevenueNet_5" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_us-gaap_OperatingExpensesAbstract_6" use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_6" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_6" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_8" use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_6" xlink:to="loc_us-gaap_DepreciationAndAmortization_9" use="optional" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_6" xlink:to="loc_us-gaap_OperatingExpenses_10" use="optional" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_11"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_6" xlink:to="loc_us-gaap_OperatingIncomeLoss_11" use="optional" order="40.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_OtherNonrecurringIncomeExpense" xlink:label="loc_us-gaap_OtherNonrecurringIncomeExpense_12"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_6" xlink:to="loc_us-gaap_OtherNonrecurringIncomeExpense_12" use="optional" order="50.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_us-gaap_InterestExpense_13" use="optional" order="20.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_14"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_14" use="optional" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_15"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_15" use="optional" order="40.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_16"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_us-gaap_ProfitLoss_16" use="optional" order="50.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_17"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_17" use="optional" order="60.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne" xlink:label="loc_apdn_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne_18"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_apdn_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne_18" use="optional" order="70.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/StatementOfCashFlowsIndirect">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementScenarioAxis_2" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementScenarioAxis_2" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_3" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_4" use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5" xlink:to="loc_us-gaap_ProfitLoss_6" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7" use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_8" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_VestedOptionsIssuedToOfficersDirectorsAndEmployees" xlink:label="loc_apdn_VestedOptionsIssuedToOfficersDirectorsAndEmployees_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7" xlink:to="loc_apdn_VestedOptionsIssuedToOfficersDirectorsAndEmployees_9" use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_10" use="optional" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_11"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_11" use="optional" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_12"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7" xlink:to="loc_us-gaap_ShareBasedCompensation_12" use="optional" order="40.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_CommonStockIssuedInSettlementOfInterest" xlink:label="loc_apdn_CommonStockIssuedInSettlementOfInterest_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7" xlink:to="loc_apdn_CommonStockIssuedInSettlementOfInterest_13" use="optional" order="50.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_14"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_14" use="optional" order="60.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_15"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_14" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_15" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_16"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_14" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_16" use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_17"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_14" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_17" use="optional" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_18"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_18" use="optional" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_19"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_19" use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_20"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_20" use="optional" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_21"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_20" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_21" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_22"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_20" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_22" use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_23"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_20" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_23" use="optional" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_24"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_24" use="optional" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_25"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_25" use="optional" order="40.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_26"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_26" use="optional" order="50.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_27"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_27" use="optional" order="60.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaap_InterestPaid_28"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_27" xlink:to="loc_us-gaap_InterestPaid_28" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaap_IncomeTaxesPaid_29"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_27" xlink:to="loc_us-gaap_IncomeTaxesPaid_29" use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_30"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_27" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_30" use="optional" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_WarrantsIssuedForFinancingCosts" xlink:label="loc_apdn_WarrantsIssuedForFinancingCosts_31"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_30" xlink:to="loc_apdn_WarrantsIssuedForFinancingCosts_31" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_32"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_30" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_32" use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/SummaryOfAccountingPolicies">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/IntangibleAssets">
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_IntangibleAssetsDisclosureAbstract" xlink:label="loc_apdn_IntangibleAssetsDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_IntangibleAssetsDisclosureAbstract_0" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_1" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/AccountsPayableAndAccruedLiabilities">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_0" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_1" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/PrivatePlacementOfConvertibleNotes">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongTermDebtAbstract" xlink:label="loc_us-gaap_LongTermDebtAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="loc_us-gaap_LongTermDebtTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_0" xlink:to="loc_us-gaap_LongTermDebtTextBlock_1" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/RelatedPartyTransactions">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_0" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/CapitalStock">
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_CapitalStockAbstract" xlink:label="loc_apdn_CapitalStockAbstract_0"/>
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_CapitalStockTextBlock" xlink:label="loc_apdn_CapitalStockTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_CapitalStockAbstract_0" xlink:to="loc_apdn_CapitalStockTextBlock_1" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/StockOptionsAndWarrants">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/CommitmentsAndContingencies">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/FairValueMeasurement">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_1" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/GoingConcern">
    <loc xlink:type="locator" xlink:href="apdn-20110630.xsd#apdn_GoingConcernAbstract" xlink:label="loc_apdn_GoingConcernAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_LiquidityDisclosureTextBlock" xlink:label="loc_us-gaap_LiquidityDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_apdn_GoingConcernAbstract_0" xlink:to="loc_us-gaap_LiquidityDisclosureTextBlock_1" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.adnas.com/role/SubsequentEvents">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_0" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_1" use="optional" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>lmi.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lmi.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````/```_^X`#D%D
M;V)E`&3``````?_;`(0`!@0$!`4$!@4%!@D&!08)"P@&!@@+#`H*"PH*#!`,
M#`P,#`P0#`X/$`\.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-#`T8$!`8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\``$0@`,P""`P$1``(1`0,1`?_$`+,```,``P`#````````
M```````'"`0&"0$#!0$``P$!`0$```````````````0%`P(!!A````0$`08)
M!@H%#0```````0(#!``1!082(1,4%0<(,4%188$B,A8W<8)S-'0UL4)2LB,S
M0[.T%Y'!<D4FH>%BDJ+24Y-4566E5A$``0,!!@0#!@0'``````````$"`Q$A
M01(R!`4Q<8$S4:$B\&%"8J(3D<'14N&"TB-3%!7_V@`,`P$``A$#$0`_`*I@
M`(`"``@`(`"``@`(`"``@`(`"``@`PJTZJ+6E.7%-::>_3((MV@G!,%#\08S
M9`CB151JJU*J:P,8YZ(]<+;U%;6]FNU"OM1J%2N0B52*`G;TMN!TVZ8\($!0
M@AEXL0E'RQ*ET4\B55]OA<?1:?=-'"N%D=67N7BO0QZ/4]ORB.H3,4T52]0:
MT[*69"!DGC*82*#R#A$8\C?JU]%.JFD\6V(OW<2JG[4]JI^)LWY6U3_U=2]4
MS?U@^N?ZCA[/]#^6&O\`2=^]W#S\2?\`]9G^)F;Z?#^)KVUE?:]:-OU&YZ5=
MK=Q3F0E.=BXIR`*@510J92D5+D-+&'"4(NZ9(GN1JMMYD!]42M18[.-L.VV^
M;K;V\UK[-DHLFHL9PJQ2.4I$@F:12@$QY,L.3Z6&-N*B_B9L>Y5H4Y;E/K;"
MG`C6JL-9?"83&=YA-J``(``$*FG,)!+C$1B0]R*MB4-T/J1P>G@Y3&(8I38#
M"`@!PD(@/+ER0`3SMBNK;=LZ1:ORW0SJ-,>K"W0Q,$4G!3@03]<H`8@A(O"`
M]$4]+'#+9A5%YF+U<TU'9[O,7XM>=);7.^06H;I<K=V!6Z20D!;J$4QD`!D0
MX@(\T,3Z!B,56I:<ME6MI6L1!@(`%WMUVBN;&L=1]3CD)6GJQ&M-QE`X`<1Q
M*'$@Y#`5,H],H:TD'W'T7@<2.HA/%(WB=L]4J[&F)5=JFJ^<)-4U#LT<)3+'
M!,!-(LY`)HJ.T,2(JTX>\P21Q5%GT>]&"2A[GN$E:74*4"IHLTFB20APB7")
MCFGSCT1&D<Q<J4ZC*(MYF732:U5*29K1JRI0GV,IR/DD4G`R"<R&36`2B49\
M4AYXYC<B+54J@*A+6TC:9MPL6ZEK?=W85ZHFDFL5PDT;D*8BLQ+,IDQD.3+E
M&+$$$,C<2-\Q=SG(M*C!V-'VQ7Q1T+DJ%[BUI>D'3T)%DU,LIF#R.!CF(!2`
M:7$`C"VJ2*-<*-MYJ=LQ+;4?<338(`%SO$^#=Q^C0_%)0UHNZTXDRJ3INO>+
MS+V-W\P(J[AVNJ&$68M&(`T$`!`!/V]^8-16N'&-2./Z$OYXI[9F=R,9N`E-
MN5D!:.T.H,D$Q3IKZ3^FRR`"2PCB('HU`,7R2BAHY<<:+>EAE(VBE8;$+V[W
M[.:8_64QU!J70JCRY]``+B'TA,)^F(NKBP2*EPPQU4-\A8[)[NLOYD;PK&WP
M^EH%F(F</PX2&<9#F*/E4S:8_LFBG'_:@5WQ/,5]3J>!.EHXDKWHDQ#$G56H
M";BF5R7+%67(O(P;Q.A\?+CH0`1CO2^+;CV%K\!HO;=VNHK+F'CNL>$;7VUY
M]Z,3]Q[O1#:+*-V$30(`%SO$^#=Q^C0_%)0UHNZTXDRJ3INO>+S+V-W\P(J[
MAVNJ&$68M&(`T$`!`!/N]X4QZ9:2(2#.5%0`$>42%#]<4]MXNY&,UQ]7>HLC
M6]C(W`V3Q/K>/C5$`RF:*R*J'F&`I_(`QQM\N%^&YQ[*VJ"RW4KUU3>;FVW*
MF%G7D\3<!'(#MN`F+_73Q!Y0"&]QBJS%X&<+K:%/WO=#6UK3JEP.9"2GMSJD
M(/QU.RF3SSB!8D11J]R-2\8<M$J+3=EM9TULY[==3F>L76X.[45/VA1`QL'#
MEZYS'/Y!"&]?(BOPIP:9Q)97Q)1HY\Q=[$Y@GFJFB(@''A<A%ER58O+\A=.)
MT4CY<="`",=Z7Q;<>PM?@-%[;NUU%9<P\=UCPC:^VO/O1B?N/=Z(;191NPB:
M!``N=XGP;N/T:'XI*&M%W6G$F52=-U[Q>9>QN_F!%7<.UU0PBS%HQ`&@@`(`
M)[WMS!ALHD^L:H*B!>66:#]<4]N^+D8RW#]J#%K4&#E@[("K5VD=!=,>`R:A
M1*8.D!B:BT6J&Q`%P4JKV!?SEDF<25"@/049K<&($S`H@IY#DPC'TS')*RMS
MD$U3"H^MK]X%VD(6)9E!4$`NH4:E4<.44D`F&$TO\,2JF'G($3--']K&]WPV
M&SUQ41+RA*>P:T]@V8-"`DU:)$003#@*FF4"E#H`(F.556JFQSP;S)=*0CD$
MM1+,>23@(^H7+T$KSHO'RPZ$`$8[TOBVX]A:_`:+VW=KJ*RYAX[K'A&U]M>?
M>C$_<>[T0VBRC=A$T"`!;[Q1R%V.7$!C``F(@!0$93'24AD$-:+NM.),JDX[
MLSILUVLLUG*Q$$@9NP%10P$+,2!+*80"*NX)6+J81<2QN\5O_P"YM/\`/3_O
M1"P+X#-37=H6T>B6S9=7K:#YLN[:-S"T1(JF<3KGZB080$1$,9@GS1K#`KWH
ME#QSJ(?>M5X[>VO1WCP^<>.6399RI("XE%$BF.,BR`)F'BC.1$1RHGB>IP$5
MO9*D&IV(EB#&5XL82S"8`)VX`,NB*.W<'\OU,I;BB8EFQ,V]U9.!:EWFU3R'
ME3JD(!QA,[<X_P!HGZ(K;;+Q8O,PF;>>K=&LPR[ZIWBZ()DVA=74P390`YY'
M7,7]DHE+YPQ[N4MB,3FH0MO*>B0;G.50V"Y#F'XC\1&?,O./J?AZ"5YT9(<B
MA"G(8#$,`"4P#,!`>,!"/EAT\P`1?O1J$/M;=8#`;"R:E-(9R$`-D&+VW=KJ
M*RYAY;JYR#LE;E`P"8KUWB`!RA-683B?N/=Z(;191O0B:!`!'^V_47>0<]IN
M=QFQ]Y-;RG,?5LS]%@Y,/%%O28L-W\N$7D%JIW=P_N?SM=RASU?-])G9[5/5
M_#O_``G_`'<'J^;Z0L]JA_#LA]R\`\&NY\$'J^;Z0L+G3S7Y;M?6\UJQO[IS
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M/Y,LLXEZZM]/*OD;QC*VUZ'W+/I>L<UG0]V:5.>`WU^B?29GEXIRA32UQV4Z
MT_,[?P(X5[NYY3W5VA[>O,?G<\7DQ>_Z16PVS9?W>[SHX<[BQDP]W==Z3.8=
6K%U</EC#4XL/]6$[9Q+9B`,A`!__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>lmi1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lmi1.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"``@`$D#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W&XUK2K.<
MP7.IV4$P(!CEG56!/(X)S4MGJ-CJ"LUE>6]RJ_>,,JN!]<'V->??&P0KX1L9
M9!&'&H(JNPY'R/D`^^.:ZSP3%!%X(T/R$C4-8P,Q08#,4&3^>:`-XD`$DX`[
MU7CO[.5U2.[@=F^Z%D!)[\58(!&#R*^>_'FDO;Z_XAUW2K>..73=0MT!C7'D
M,T2.'51CYC(%Y'>3)'4T`?0E(6`."0,UF>&]93Q#X<T_5D`7[3"'=`<A'Z,N
M?9@1^%>1_%H/KLUU?^>HTW2)ETZ$Y3;)/("TYS@G*[8E'3YMP[&@#W"D;=M.
MW`;L3TK%\(VMK:^$M*^RV\4*R6D4C".,)N8H"20.YKR_X@:+I47Q/\/6Z:;9
MI!=/;">-8%"R;KD;MP`YST.>M`'K\#Z@&9;B.`_-\K1L<;<=\]\U<J&UL[:Q
MMUM[.WAMX$^['"@11]`.*FH`\U^-K*O@^Q)+C_B8KC8<$GRI>,^AZ=#UKM/"
MX*^$M&4C!%C""/0[!7._$+PKK/C&TMK"V_LZ&UM[C[0'GD<L["-E&5"8`!<G
MJ>@Z5<TZ#QGINE6MG]GT*X:")8RYNIH]V!C/^K;%`'65YSX?TR+Q!>?$/3[S
MS!%=WY@+_P`2CRE4,ONN`1Z8%=7I$&OQKJ-SJC6;7,[AK:WAF=HHE"`;=Q0'
ME@S$[?XO:LKPAH>NZ-J^MW&HPZ<(-3O&N\V]W)(T9(`VX:-01QGKWZ4`<#X`
M\3S>$](\2Z)?%6NM.9GACR=S3EMA4*>@9RC#'7>2,UI_$+1SH7PITW3S(7N/
MMD;7$H4%I9F5VD?C')8D]>.W2MV[^'$-U\3X/$[?9VLD`G:`@A_M*C"L,#!'
M"MR<AE[YXG^)/A_6?$^DVNG:5;6CA)Q.\MS/M`PK`*%VG.=QZXQ[]@#<\&MO
M\#>'VSG.FVQSC&?W2UYW\0S&OQ8\,E\;F:R1,D<'[6#_`.RXKT3PE::AIWA7
M3=.U*WCBN;*VCMSY4OF*^Q`NX'`QG'3'%<7XM\->*==\8Z9K-GIUK';V36S[
G)+P!W\N;S"#A2%XR.":`/3Z*BMY))8%>6!X'/6-B"1^()%2T`?_9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0EAPAE">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Jun. 30, 2011</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement Of Financial Position [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation on Property, plant and equipment (in dollars)</a></td>
        <td class="nump">$ 210,862<span></span></td>
        <td class="nump">$ 207,097<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts', window );">Accumulated amortization on Capitalized finance costs (in dollars)</a></td>
        <td class="nump">1,678,872<span></span></td>
        <td class="nump">947,276<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_FiniteLivedPatentsIntangibleAssetsAccumulatedAmortizationAndWriteOff', window );">Accumulated amortization on Patents (in dollars)</a></td>
        <td class="nump">34,257<span></span></td>
        <td class="nump">34,257<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization and write off on Intellectual property (in dollars)</a></td>
        <td class="nump">9,067,109<span></span></td>
        <td class="nump">8,794,265<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_UnamortizedDiscountOnConvertibleNotesPayableCurrent', window );">Unamortized discount on Convertible notes payable, current (in dollars)</a></td>
        <td class="nump">1,088,317<span></span></td>
        <td class="nump">545,920<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_UnamortizedDiscountOnConvertibleNotePayableRelatedPartyNoncurrent', window );">Unamortized discount on Convertible note payable-related party, non-current (in dollars)</a></td>
        <td class="nump">$ 5,286<span></span></td>
        <td class="nump">$ 5,286<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
        <td class="nump">$ 0.001<span></span></td>
        <td class="nump">$ 0.001<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
        <td class="nump">10,000,000<span></span></td>
        <td class="nump">10,000,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
        <td class="nump">$ 0.001<span></span></td>
        <td class="nump">$ 0.001<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
        <td class="nump">800,000,000<span></span></td>
        <td class="nump">800,000,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
        <td class="nump">352,523,001<span></span></td>
        <td class="nump">346,366,244<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
        <td class="nump">352,523,001<span></span></td>
        <td class="nump">346,366,244<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_FiniteLivedPatentsIntangibleAssetsAccumulatedAmortizationAndWriteOff">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The accumulated amount of amortization of a major finite-lived Patents intangible asset class. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>apdn_FiniteLivedPatentsIntangibleAssetsAccumulatedAmortizationAndWriteOff</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>apdn</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_UnamortizedDiscountOnConvertibleNotePayableRelatedPartyNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The unamortized discount related to convertible note payable-related party.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>apdn_UnamortizedDiscountOnConvertibleNotePayableRelatedPartyNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>apdn</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_UnamortizedDiscountOnConvertibleNotesPayableCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The unamortized discount related to convertible notes payable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>apdn_UnamortizedDiscountOnConvertibleNotesPayableCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>apdn</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount of accumulated amortization of long-term deferred finance costs capitalized at the end of the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 17<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cumulative amount of depreciation, depletion and amortization (related to property, plant and equipment, but not including land) that has been recognized in the income statement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Principles Board Opinion (APB)<br> -Number 12<br> -Paragraph 5<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 14<br> -Article 5<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Principles Board Opinion (APB)<br> -Number 12<br> -Paragraph 5<br> -Subparagraph c<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value of common stock per share; generally not indicative of the fair market value per share.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 129<br> -Paragraph 4<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of shares of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares represent the ownership interest of the common shareholders. Shares outstanding equals shares issued minus shares held in treasury and other adjustments, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Principles Board Opinion (APB)<br> -Number 12<br> -Paragraph 10<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Article 3<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The accumulated amount of amortization of a major finite-lived intangible asset class. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 142<br> -Paragraph 45<br> -Subparagraph a(1)<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6905858&amp;loc=d3e16323-109275<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.28)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Principles Board Opinion (APB)<br> -Number 12<br> -Paragraph 10<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 5<br> -Section 02<br> -Paragraph 29<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 129<br> -Paragraph 2, 3, 4, 5, 6, 7, 8<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 5<br> -Section 02<br> -Paragraph 29<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 129<br> -Paragraph 2, 3, 4, 5, 6, 7, 8<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.28)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 5<br> -Section 02<br> -Paragraph 29<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.28)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 5<br> -Section 02<br> -Paragraph 29<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.28)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StatementOfFinancialPositionAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0EBDAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2011</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2010</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2011</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Revenue</a></td>
        <td class="nump">$ 229,710<span></span></td>
        <td class="nump">$ 170,195<span></span></td>
        <td class="nump">$ 687,970<span></span></td>
        <td class="nump">$ 430,185<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
        <td class="nump">1,580,788<span></span></td>
        <td class="nump">2,529,777<span></span></td>
        <td class="nump">4,529,352<span></span></td>
        <td class="nump">5,363,215<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
        <td class="nump">47,988<span></span></td>
        <td class="nump">18,142<span></span></td>
        <td class="nump">161,645<span></span></td>
        <td class="nump">44,944<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
        <td class="nump">91,892<span></span></td>
        <td class="nump">92,823<span></span></td>
        <td class="nump">276,608<span></span></td>
        <td class="nump">278,619<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
        <td class="nump">1,720,668<span></span></td>
        <td class="nump">2,640,742<span></span></td>
        <td class="nump">4,967,605<span></span></td>
        <td class="nump">5,686,778<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">NET LOSS FROM OPERATIONS</a></td>
        <td class="num">(1,490,958)<span></span></td>
        <td class="num">(2,470,547)<span></span></td>
        <td class="num">(4,279,635)<span></span></td>
        <td class="num">(5,256,593)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonrecurringIncomeExpense', window );">Other income (Note C)</a></td>
        <td class="text"> <span></span></td>
        <td class="text">&nbsp;<span></span></td>
        <td class="text">&nbsp;<span></span></td>
        <td class="text">&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense, net</a></td>
        <td class="num">(664,037)<span></span></td>
        <td class="num">(126,388)<span></span></td>
        <td class="num">(1,818,125)<span></span></td>
        <td class="num">(537,252)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before provision for income taxes</a></td>
        <td class="num">(2,154,995)<span></span></td>
        <td class="num">(2,596,935)<span></span></td>
        <td class="num">(6,097,760)<span></span></td>
        <td class="num">(5,793,845)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes (benefit)</a></td>
        <td class="text">&nbsp;<span></span></td>
        <td class="text">&nbsp;<span></span></td>
        <td class="text">&nbsp;<span></span></td>
        <td class="text">&nbsp;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">NET LOSS</a></td>
        <td class="num">$ (2,154,995)<span></span></td>
        <td class="num">$ (2,596,935)<span></span></td>
        <td class="num">$ (6,097,760)<span></span></td>
        <td class="num">$ (5,793,845)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share-basic and fully diluted (in dollars per share)</a></td>
        <td class="num">$ (0.01)<span></span></td>
        <td class="num">$ (0.01)<span></span></td>
        <td class="num">$ (0.02)<span></span></td>
        <td class="num">$ (0.02)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne', window );">Weighted average shares outstanding-Basic and fully diluted (in shares)</a></td>
        <td class="nump">351,962,281<span></span></td>
        <td class="nump">301,362,329<span></span></td>
        <td class="nump">350,828,973<span></span></td>
        <td class="nump">287,448,792<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The average number of shares or units issued and outstanding that are used in calculating basic and diluted EPS.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>apdn_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>apdn</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 28<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Principles Board Opinion (APB)<br> -Number 12<br> -Paragraph 5<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DepreciationAndAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 5<br> -Section 03<br> -Paragraph 10<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Income Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 08<br> -Paragraph h<br> -Article 4<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 109<br> -Paragraph 45<br> -Subparagraph a, b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxExpenseBenefit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cost of borrowed funds accounted for as interest that was charged against earnings during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 34<br> -Paragraph 21<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Paragraph 9<br> -Article 9<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher OTS<br> -Name Federal Regulation (FR)<br> -Number Title 12<br> -Chapter V<br> -Section 563c.102<br> -Paragraph 9<br> -Subsection II<br> -LegacyDoc This is a non-GAAP reference that was included in the 2009 taxonomy.  It will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingExpenses</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingExpensesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net result for the period of deducting operating expenses from operating revenues.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonrecurringIncomeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of other nonrecurring expenses, not previously categorized, that are infrequent in occurrence or unusual in nature.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6365513&amp;loc=d3e15122-107781<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherNonrecurringIncomeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=6922042&amp;loc=SL4591551-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 38<br> -Subparagraph a<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph A1, A4, A5<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 38<br> -Subparagraph c(1)<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 29<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6921930&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=6922042&amp;loc=SL4591552-111686<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 5<br> -Subparagraph b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=6921628&amp;loc=SL4569616-111683<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProfitLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 141<br> -Paragraph 51<br> -Subparagraph g<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 2<br> -Paragraph 12, 13<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 86<br> -Paragraph 11, 12<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ResearchAndDevelopmentExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 5<br> -Section 03<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SalesRevenueNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 43<br> -Chapter 4<br> -Paragraph 5A<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 5<br> -Section 03<br> -Paragraph 4<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6386349&amp;loc=d3e3636-108311<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SellingGeneralAndAdministrativeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E4KAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Document and Entity Information<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2011</div>
        </th>
        <th class="th">
          <div>Aug. 10, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
        <td class="text">APPLIED DNA SCIENCES INC<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
        <td class="text">0000744452<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
        <td class="text">apdn<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
        <td class="text">Yes<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
        <td class="text">No<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
        <td class="text">--09-30<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
        <td class="text">Smaller Reporting Company<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
        <td class="text"> <span></span></td>
        <td class="nump">472,786,160<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
        <td class="text">10-Q<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
        <td class="text">Jun. 30,
         2011<span></span></td>
        <td class="text"><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
        <td class="text">false<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
        <td class="text">2011<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
        <td class="text">Q3<span></span></td>
        <td class="text"> <span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_DocumentAndEntityInformationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>apdn_DocumentAndEntityInformationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>apdn</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>If the value is true, then the document as an amendment to previously-filed/accepted document.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_AmendmentFlag</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:booleanItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>End date of current fiscal year in the format --MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_CurrentFiscalYearEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gMonthDayItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalPeriodFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:fiscalPeriodItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalYearFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gYearItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentPeriodEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The type of document being provided (such as 10-K, 10-Q, N-1A, etc). The document type is limited to the same value as the supporting SEC submission type, minus any "/A" suffix. The acceptable values are as follows: S-1, S-3, S-4, S-11, F-1, F-3, F-4, F-9, F-10, 6-K, 8-K, 10, 10-K, 10-Q, 20-F, 40-F, N-1A, 485BPOS, 497, NCSR, N-CSR, N-CSRS, N-Q, 10-KT, 10-QT, 20-FT, and Other.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentType</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:submissionTypeItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCentralIndexKey</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:centralIndexKeyItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate number of shares outstanding of each of registrant's classes of common stock, as of latest practicable date. Where multiple classes exist define each class by adding class of stock items such as Common Class A [Member], Common Class B [Member] onto the Instrument [Domain] of the Entity Listings, Instrument</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCurrentReportingStatus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, or (4) Smaller Reporting Company. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityFilerCategory</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:filerCategoryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityRegistrantName</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:normalizedStringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityVoluntaryFilers</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Trading symbol of an instrument as listed on an exchange.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_TradingSymbol</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:normalizedStringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.1.0.1
 *
 */

var moreDialog = null;
var Show = {
    Default:'raw',

    more:function( obj ){
        var bClosed = false;
        if( moreDialog != null )
        {
			try
			{
				bClosed = moreDialog.closed;
			}
			catch(e)
			{
				//Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control
				// that somtimes causes it to throw when checking the closed property on a child window that has been
				//closed.  So if the exception occurs we assume the window is closed and move on from there.
				bClosed = true;
			}

			if( !bClosed ){
				moreDialog.close();
			}
        }

        obj = obj.parentNode.getElementsByTagName( 'pre' )[0];
		var hasHtmlTag = false;
		var objHtml = '';
		var raw = '';

		//Check for raw HTML
		var nodes = obj.getElementsByTagName( '*' );
		if( nodes.length ){
			objHtml = obj.innerHTML;
		}else{
			if( obj.innerText ){
				raw = obj.innerText;
			}else{
				raw = obj.textContent;
			}

			var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g );
			if( matches && matches.length ){
				objHtml = raw;

				//If there is an html node it will be 1st or 2nd,
				//   but we can check a little further.
				var n = Math.min( 5, matches.length );
				for( var i = 0; i < n; i++ ){
					var el = matches[ i ].toString().toLowerCase();
					if( el.indexOf( '<html' ) >= 0 ){
						hasHtmlTag = true;
						break;
					}
				}
			}
		}

        if( objHtml.length ){
			var html = '';

			if( hasHtmlTag ){
				html = objHtml;
			}else{
				html = '<html>'+
					"\n"+'<head>'+
					"\n"+'    <title>Report Preview Details</title>'+
					"\n"+'    <style type="text/css">'+
					"\n"+'    body {'+
					"\n"+'    }'+
					"\n"+'    table {'+
					"\n"+'    }'+
					"\n"+'    </style>'+
					"\n"+'</head>'+
					"\n"+'<body>'+
						objHtml +
					"\n"+'</body>'+
					"\n"+'</html>';
			}

			moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes");
			moreDialog.document.write( html );
			moreDialog.document.close();

			if( !hasHtmlTag ){
				moreDialog.document.body.style.margin = '0.5em';
			}
        }
        else
        {
			//default view logic
			var lines = raw.split( "\n" );
			var longest = 0;

			if( lines.length > 0 ){
				for( var p = 0; p < lines.length; p++ ){
					longest = Math.max( longest, lines[p].length );
				}
			}

			//Decide on the default view
			this.Default = longest < 120 ? 'raw' : 'formatted';

			//Build formatted view
			var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ;
			var formatted = '';

			if( text.length > 0 ){
				if( text.length == 1 ){
					text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ;
					formatted = "<p>"+ text.join( "<br /><br />\n" ) +"</p>";
				}else{
					for( var p = 0; p < text.length; p++ ){
						formatted += "<p>" + text[p] + "</p>\n";
					}
				}
			}else{
				formatted = '<p>' + raw + '</p>';
			}

			html = '<html>'+
				"\n"+'<head>'+
				"\n"+'    <title>Report Preview Details</title>'+
				"\n"+'    <style type="text/css">'+
				"\n"+'    body {'+
				"\n"+'       background-color: #f0f9ee;'+
				"\n"+'       font-family: Arial, san-serif; font-size: 0.8em;'+
				"\n"+'    }'+
				"\n"+'    table {'+
				"\n"+'       font-size: 1em;'+
				"\n"+'    }'+
				"\n"+'    </style>'+
				"\n"+'</head>'+
				"\n"+'<body>'+
				"\n"+'    <table border="0" width="100%">'+
				"\n"+'    <tr>'+
				"\n"+'        <td>'+
				"\n"+'            formatted: <a href="javascript:void(0);" onclick="opener.Show.toggle( window, this );">'+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +'</a>'+
				"\n"+'        </td>'+
				"\n"+'    </tr>'+
				"\n"+'    <tr>'+
				"\n"+'        <td>'+
				"\n"+'            <div id="formatted" style="display: none;">'+formatted+'</div>'+
				"\n"+'        </td>'+
				"\n"+'    </tr>'+
				"\n"+'    <tr>'+
				"\n"+'        <td>'+
				"\n"+'            <pre id="raw" style="display: none; font-size: 1.2em;">'+raw+'</pre>'+
				"\n"+'        </td>'+
				"\n"+'    </tr>'+
				"\n"+'    </table>'+
				"\n"+'</body>'+
				"\n"+'</html>';

			moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes");
			moreDialog.document.write(html);
			moreDialog.document.close();

			this.toggle( moreDialog );
        }

		moreDialog.document.title = 'Report Preview Details';
    },

    toggle:function( win, domLink ){
        var domId = this.Default;

        var doc = win.document;
        var domEl = doc.getElementById( domId );
        domEl.style.display = 'block';

        this.Default = domId == 'raw' ? 'formatted' : 'raw';

        if( domLink ){
            domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed';
        }

        var domElOpposite = doc.getElementById( this.Default );
        domElOpposite.style.display = 'none';
    },

	LastAR : null,
	showAR : function ( link, id, win ){
		if( Show.LastAR ){
			Show.hideAR();
		}

		var ref = link;
		do {
			ref = ref.nextSibling;
		} while (ref && ref.nodeName != 'TABLE');

		if (!ref || ref.nodeName != 'TABLE') {
			var tmp = win ?
				win.document.getElementById(id) :
				document.getElementById(id);

			if( tmp ){
				ref = tmp.cloneNode(true);
				ref.id = '';
				link.parentNode.appendChild(ref);
			}
		}

		if( ref ){
			ref.style.display = 'block';
			Show.LastAR = ref;
		}
	},

	toggleNext : function( link ){
		var ref = link;

		do{
			ref = ref.nextSibling;
		}while( ref.nodeName != 'DIV' );

		if( ref.style &&
			ref.style.display &&
			ref.style.display == 'none' ){
			ref.style.display = 'block';

			if( link.textContent ){
				link.textContent = link.textContent.replace( '+', '-' );
			}else{
				link.innerText = link.innerText.replace( '+', '-' );
			}
		}else{
			ref.style.display = 'none';

			if( link.textContent ){
				link.textContent = link.textContent.replace( '-', '+' );
			}else{
				link.innerText = link.innerText.replace( '-', '+' );
			}
		}
	},

	hideAR : function(){
		Show.LastAR.style.display = 'none';
	}
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E2H">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCK OPTIONS AND WARRANTS<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK OPTIONS AND WARRANTS</a></td>
        <td class="text"><div><div><div><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" >NOTE G - STOCK OPTIONS AND WARRANTS<br />
<br />
</font>
</div><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >Warrants<br />
<br />
</font>
</font>
</div><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The following table summarizes the changes in warrants outstanding and the related prices for the shares of the Company&#8217;s common stock issued to non-employees of the Company. These warrants were granted in lieu of cash compensation for services performed or financing expenses in connection with the sale of the Company&#8217;s common stock. <br />
<br />
</font>
</div><div style="text-align:left;" ><table cellspacing="0" cellpadding="0" width="100%" style="font-family:times new roman;font-size:10pt;" ><tr><td valign="bottom" width="4%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="5%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Warrants
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="4%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="5%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Outstanding
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Weighted
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Exercisable
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;"
 >
</font>
</td>
</tr><tr><td valign="bottom" width="4%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="5%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Remaining
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Average
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Weighted
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Weighted
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="4%" colspan="2" style="text-align:center;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Exercise
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Number
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Contractual
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Exercise
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Average
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Average
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="4%" colspan="2" style="border-bottom:black 2px solid;text-align:center;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Prices
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;padding-bottom:4px;" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Outstanding
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%"
 colspan="2" style="border-bottom:black 2px solid;padding-bottom:4px;" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Life (Years)
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;padding-bottom:4px;" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Price
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;padding-bottom:4px;" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Exercisable
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;padding-bottom:4px;" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Exercise Price
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="4%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="5%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.03088
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >2,428,756
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >6.42
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.3088
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >2,428,756
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.3088
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="4%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font
 style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="5%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.03283
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >533,116
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >6.39
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.3283
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >533,116
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.3283
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="4%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="5%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.04
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >9,000,000
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >4.17
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.04
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%"
 style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >3,000,000
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.04
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="4%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="5%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.04405
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >3,007,946
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >6.05
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.04405
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >3,007,946
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.04405
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="4%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="5%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.05529
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >1,356,484
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%"
 style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >6.53
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.05529
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >1,356,484
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.05529
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="4%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="5%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.06
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >12,000,000
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >3.63
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.06
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >7,000,000
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.06
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font
 style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="4%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="5%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.07
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >200,000
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.71
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.07
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >200,000
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.07
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="4%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="5%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.09
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >16,400,000
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.17
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.09
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times
 new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >16,400,000
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.09
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="4%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="5%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.10
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >1,500,000
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >1.74
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.10
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >1,500,000
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.10
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="4%" style="border-bottom:black 2px solid;text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="5%" style="border-bottom:black 2px solid;text-align:right;padding-bottom:4px;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.50
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;padding-bottom:4px;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font
 style="display:inline;font-family:times new roman;font-size:10pt;" >10,700,000
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;padding-bottom:4px;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >1.49
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;padding-bottom:4px;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.50
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;padding-bottom:4px;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >10,700,000
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;padding-bottom:4px;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.50
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="4%" style="text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="5%" style="text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >57,126,302
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" ><div
 style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >46,126,302
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr>
</table>
</div><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" ><div><div style="text-align:left;width:100%;" ><font style="display:inline;font-family:times new roman;font-size:8pt;" >
</font>
</div>
</div><div style="page-break-after:always;width:100%;" ><div style="text-align:center;width:100%;" >
</div><div style="text-align:center;width:100%;" >
</div>
</div><div><div style="text-align:right;width:100%;" ><font style="display:inline;font-family:times new roman;font-size:8pt;" >
</font>
</div>
</div>
</div><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div>
</div><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Transactions involving warrants are summarized as follows:
</font>
</div><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-align:center;" ><table cellspacing="0" cellpadding="0" width="70%" style="font-family:times new roman;font-size:10pt;" ><tr><td valign="bottom" width="46%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" >Number of
</font>
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" >Shares
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" >Weighted
</font>
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" >Average
</font>
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" >Price Per
</font>
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" >Share
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Balance, September 30, 2009
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >64,820,500
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div
 style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.43
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Granted
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >22,007,946
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.05
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Exercised
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >&#8212;
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Canceled or expired
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;padding-bottom:2px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >(17,620,500
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >)
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;padding-bottom:2px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >(0.73
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >)
</font>
</div>
</td>
</tr><tr><td valign="bottom" width="46%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Balance at September 30, 2010
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >69,207,946
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td
 valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.24
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Granted
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >4,318,356
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.04
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Exercised
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >&#8212;
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >&#8212;
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Canceled or expired
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;padding-bottom:2px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >(16,400,000
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >)
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;padding-bottom:2px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >(0.50
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >)
</font>
</div>
</td>
</tr><tr><td valign="bottom" width="46%" style="text-align:left;padding-bottom:4px;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Balance, June 30, 2011
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:right;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 4px
 double;text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >57,126,302
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.15
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr>
</table><br />
</div><div style="text-align:center;" >
</div><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >On April 29, 2010, warrants totaling 10,000,000 were issued in connection with services. The warrants are exercisable for five years from the date of issuance at an exercise price of $0.06 per share with 25% vesting immediately, 25% on October 29, 2010, 25% on April 29, 2011 and 25% on October 29, 2011. The fair value of the warrants vesting during the nine month period ended June 30, 2011 was determined using the Black-Scholes Option Pricing Model with the following assumptions: dividend yield $-0-, volatility of 170.72% and risk free rate from 1.17%.<br/>
</font>
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The determined fair value of $93,580 is charged ratably to current period operations. During the three and nine month periods ended June 30, 2011, $14,911 and $93,580 was charged to operations, respectively.<br/>
</font>
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >On July 15, 2010, warrants totaling 3,007,946 were issued in connection with services provided in connection with the issuance of convertible notes. The warrants are exercisable for seven years from the date of issuance at an exercise price of $0.04405 per share. The fair values of the warrants were determined using the Black-Scholes Option Pricing Model with the following assumptions: dividend yield $-0-, volatility of 173.55% and risk free rate from 2.43%.<br/>
</font>
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The determined fair value of $174,429 is charged ratably to current period operations over one year. During the three and nine month periods ended June 30, 2011, $43,607 and $130,821 was charged to operations, respectively.<br/>
</font>
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >On August 30, 2010, warrants totaling 10,000,000 were issued in connection with services. The warrants are exercisable for five years from the date of issuance at an exercise price of $0.04 per share with 33% vesting immediately and 67% upon achieving defined milestones. The fair value of the vested warrants was determined using the Black-Scholes Option Pricing Model with the following assumptions: dividend yield $-0-, volatility of 173.24% and risk free rate from 1.39%.<br/>
</font>
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The determined fair value of $113,885 is charged ratably to current period operations. During the three and nine month periods ended June 30, 2011, $28,393 and $84,867 was charged to operations, respectively.<br/>
</font>
</div><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >In the month of November 2010, warrants totaling 2,961,872 were issued in connection with services provided in connection with the issuance of convertible notes. The warrants are exercisable for seven years from the date of issuance at exercise prices from $0.03088 to $0.03283 per share. The fair value of the warrants were determined using the Black-Scholes Option Pricing Model with the following assumptions: dividend yield $-0-, volatility of 169.06% to 169.21% and risk free rate from 2.16 to 2.20%.
</font>
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" ><div><div style="text-align:left;width:100%;" ><font style="display:inline;font-family:times new roman;font-size:8pt;" >
</font>
</div>
</div><div style="page-break-after:always;width:100%;" ><div style="text-align:center;width:100%;" >
</div>
</div><div><div style="text-align:right;width:100%;" ><font style="display:inline;font-family:times new roman;font-size:8pt;" >
</font>
</div>
</div>
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-indent:0pt;display:block;" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div
 style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The determined fair value of $120,840 is charged ratably to current period operations over one year. During the three and nine month periods ended June 30, 2011, $30,210 and $71,779 was charged to operations, respectively.<br/>
</font>
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >In the month of January 2011, warrants totaling 1,356,484 were issued in connection with services provided in connection with the issuance of convertible notes. The warrants are exercisable for seven years from the date of issuance at exercise price of $0.05529 per share. The fair values of the warrants were determined using the Black-Scholes Option Pricing Model with the following assumptions: dividend yield $-0-, volatility of 170.33% and risk free rate of 2.69%.<br/>
</font>
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The determined fair value of $97,131 is charged ratably to current period operations over one year. During the three and nine month periods ended June 30, 2011, $24,283 and $46,370 was charged to operations, respectively.<br/>
</font>
</div><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >Employee Stock Options<br/>
</font>
</font>
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >On January 26, 2005, the Board of Directors, and on February 15, 2005, the holders of a majority of the outstanding shares of common stock of the Company approved the 2005 Incentive Stock Plan and authorized the issuance of 16,000,000 shares of common stock as stock awards and stock options thereunder. On May 16, 2007, at the annual meeting of stockholders, the holders of a majority of the outstanding shares of common stock of the Company approved an increase in the number of shares subject to the 2005 Incentive Stock Plan to 20,000,000 shares of common stock. On June 17, 2008, the Board of Directors unanimously adopted an amendment to the 2005 Incentive Stock Plan that increased the total number of shares of common stock issuable pursuant to the 2005 Incentive Stock Plan from a total of 20,000,000 shares to a total of 100,000,000 shares, which was approved by our stockholders at the 2008 annual meeting of stockholders held on December 16, 2008. In connection with the share increase amendment, the Board of Directors granted and we issued options to purchase a total of 37,670,000 shares at an exercise price of $0.11 to certain key employees and non-employee directors under the 2005 Incentive Stock Plan, including 17,000,000, 5,000,000 and 7,000,000 to James A. Hayward, Kurt H. Jensen and Ming-Hwa Liang, respectively. The options granted to our key employees and non-employee directors vested with respect to 25% of the underlying shares on the date of grant and the remaining vest ratably each anniversary thereafter until fully vested on the third anniversary of the date of grant.<br/>
</font>
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >On May 27, 2010, the our named executive officers elected to forfeit certain stock options to purchase up to 29 million shares of our Common Stock at an exercise price of $0.11 that were previously granted to them under the 2005 Incentive Stock Plan. In lieu of the forfeited options, our Board of Directors granted new stock options to such named executive officers to purchase up to 29 million shares of our common stock at an exercise price of $0.05 under the 2005 Stock Incentive Plan which are fully vested and became exercisable on June 29, 2010 following approval by our stockholders to amend our certificate of incorporation to increase our authorized shares of common stock.<br/>
</font>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >On July 1, 2010, our Board of Directors granted nonstatutory stock options under the 2005 Incentive Stock Plan to our named executive officers. The options granted to the named executive officers vested with respect to 25% of the underlying shares on the date of grant, and the remaining will vest ratably each anniversary thereafter until fully vested on the third anniversary of the date of grant.<br/>
</font>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The 2005 Incentive Stock Plan is designed to retain directors, executives, and selected employees and consultants by rewarding them for making contributions to our success with an award of options to purchase shares of our common stock. As of June 30, 2011, a total of 9,675,000 shares have been issued and options to purchase 70,400,000 shares have been granted under the 2005 Incentive Stock Plan.<br/>
</font>
</div><div
 style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The following table summarizes the changes in options outstanding and the related prices for the shares of the Company&#8217;s common stock issued to employees of the Company under the 2005 Incentive Stock Plan:
</font>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" ><div><div style="text-align:left;width:100%;" ><font style="display:inline;font-family:times new roman;font-size:8pt;" >
</font>
</div>
</div><div style="page-break-after:always;width:100%;" ><div style="text-align:center;width:100%;" >
</div><div style="text-align:center;width:100%;" >
</div>
</div><div><div style="text-align:right;width:100%;" ><font style="display:inline;font-family:times new roman;font-size:8pt;" >
</font>
</div>
</div>
</div><div style="text-indent:0pt;display:block;" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" >
</font>
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="font-family:times new roman;font-size:10pt;" >
</font>
</font>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-align:left;" ><div><table cellspacing="0" cellpadding="0" width="100%" style="font-family:times new roman;font-size:10pt;" ><tr><td valign="bottom" width="4%" style="border-bottom:black 2px solid;text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div>
</td><td valign="bottom" width="28%" colspan="8" style="border-bottom:black 2px solid;" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Options Outstanding
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="34%" colspan="10" style="border-bottom:black 2px solid;" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Options Exercisable
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="4%" colspan="2" style="border-bottom:black 2px solid;text-align:center;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Exercise<br />
</font><font style="display:inline;font-family:times new roman;font-size:10pt;" >Prices
</font>
</td><td valign="bottom" width="1%" style="text-align:right;padding-bottom:2px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Number
</font>
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Outstanding
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;padding-bottom:2px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;padding-bottom:2px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Weighted
</font>
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Average
</font>
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Remaining
</font>
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Contractual
</font>
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Life
</font>
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >(Years)
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;padding-bottom:2px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;padding-bottom:2px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" ><div
 style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Weighted
</font>
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Average
</font>
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Exercise
</font>
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Price
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;padding-bottom:2px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;padding-bottom:2px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Number
</font>
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Exercisable
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;padding-bottom:2px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;padding-bottom:2px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Weighted
</font>
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Average
</font>
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Exercise
</font>
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Price
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;padding-bottom:2px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="4%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="5%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.05
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >29,000,000
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >1.97
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.05
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >29,000,000
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font
 style="display:inline;font-family:times new roman;font-size:10pt;" >0.05
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="4%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="5%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.06
</font>
</div>
</td><td valign="top" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >30,000,000
</font>
</div>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >4.01
</font>
</div>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="top" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.06
</font>
</div>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >7,500,000
</font>
</div>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="top" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.06
</font>
</div>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="4%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="5%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.07
</font>
</div>
</td><td valign="top" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >2,500,000
</font>
</div>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >4.46
</font>
</div>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="top" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.07
</font>
</div>
</td><td valign="top" width="1%"
 style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >500,000
</font>
</div>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="top" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.07
</font>
</div>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="4%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="5%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.08
</font>
</div>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >2,000,000
</font>
</div>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >4.52
</font>
</div>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="top" width="9%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >-
</font>
</div>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="top" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >-
</font>
</div>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="4%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="5%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.09
</font>
</div>
</td><td valign="top" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >1,500,000
</font>
</div>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;"
 >
</font>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.17
</font>
</div>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="top" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.09
</font>
</div>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >1,500,000
</font>
</div>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="top" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.09
</font>
</div>
</td><td valign="top" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="4%" style="border-bottom:black 2px solid;text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="5%" style="border-bottom:black 2px solid;text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.11
</font>
</div>
</td><td valign="top" width="1%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >5,400,000
</font>
</div>
</td><td valign="top" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >1.97
</font>
</div>
</td><td valign="top" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="top" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.11
</font>
</div>
</td><td valign="top" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >4,050,000
</font>
</div>
</td><td valign="top" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="top" width="1%" style="border-bottom:black
 2px solid;text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="top" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.11
</font>
</div>
</td><td valign="top" width="1%" style="text-align:left;padding-bottom:2px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="4%" style="text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="5%" style="text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >70,400,000
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;padding-bottom:4px;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.06
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >42,550,000
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;padding-bottom:4px;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.06
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;padding-bottom:4px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr>
</table><br />
</div>
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Transactions involving stock options issued to employees are summarized as follows:
</font>
</div><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:center;" ><div><table cellspacing="0" cellpadding="0" width="70%" style="font-family:times new roman;font-size:10pt;" ><tr><td valign="bottom" width="46%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Number of
</font>
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Shares
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;"
 >
</font>
</td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Weighted
</font>
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Average
</font>
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Exercise
</font>
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Price Per
</font>
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Share
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Outstanding at October 1, 2009
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >38,920,000
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.11
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Granted
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >59,000,000
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.06
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Exercised
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >-
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Cancelled or expired
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;padding-bottom:2px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new
 roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >(31,020,000
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >)
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;padding-bottom:2px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >(0.11
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >)
</font>
</div>
</td>
</tr><tr><td valign="bottom" width="46%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Outstanding at September 30, 2010
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >66,900,000
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.06
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Granted
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >3,500,000
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.08
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Exercised
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >-
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Canceled or expired
</font>
</div>
</td><td valign="bottom" width="1%"
 style="border-bottom:black 2px solid;text-align:right;padding-bottom:2px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >-
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;padding-bottom:2px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;padding-bottom:2px;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Outstanding at June 30, 2011
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >70,400,000
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0.06
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr>
</table><br />
</div>
</div><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >On January 4, 2011, the Company granted 2,000,000 options to purchase the Company&#8217;s common stock at an exercise price of $0.08 per share for five years to an employee with vesting at 25% each anniversary for the next four years. The fair value of options was determined using the Black-Scholes Option Pricing Model with the following assumptions: dividend yield $-0-, volatility of 170.62% and risk free rate from 2.01%.<br/>
</font>
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The Company recorded $154,499 and $459,968 as stock compensation expense for the three and nine month periods ended June 30, 2011, respectively, and $1,382,248 and $1,969,483 for the three and nine month periods ended June 30, 2010, respectively, for the vesting portion of all employee options outstanding.
</font>
</div>
</div>
</div>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5444-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Statement of Position (SOP)<br> -Number 93-6<br> -Paragraph 53<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 14<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 123R<br> -Paragraph 64, 65, A240<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6418621&amp;loc=d3e17540-113929<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6406099&amp;loc=d3e25284-112666<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E2H">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</a></td>
        <td class="text"><div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" >NOTE C &#8211; ACCOUNTS PAYABLE AND ACCRUED LIABILITIES<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Accounts payable and accrued liabilities at June 30, 2011 and September 30, 2010 are as follows:
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" >
</div><div style="text-align:center;" ><table cellspacing="0" cellpadding="0" width="70%" style="font-family:times new roman;font-size:10pt;" ><tr><td valign="bottom" width="46%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >(Unaudited)
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >June 30,
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >September 30,
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >2011
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >2010
</font>
</div>
</td><td valign="bottom" width="1%" style="padding-bottom:2px;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="text-align:left;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Accounts payable
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >669,874
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >721,340
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="text-align:left;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Accrued consulting fees
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >102,500
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom"
 width="9%" style="text-align:right;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >102,500
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="text-align:left;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Accrued interest payable
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >323,089
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >88,937
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="border-bottom:black 4px double;text-align:left;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Accrued salaries payable
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >220,908
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >54,773
</font>
</div>
</td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="padding-bottom:4px;text-align:left;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Total
</font>
</div>
</td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >1,316,371
</font>
</div>
</td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >967,550
</font>
</div>
</td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr>
</table>
</div>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 19<br> -Subparagraph a<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 20, 24<br> -Article 5<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PayablesAndAccrualsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E2H">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>FAIR VALUE MEASUREMENT<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENT</a></td>
        <td class="text"><div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" >NOTE I - FAIR VALUE MEASUREMENT<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The Company adopted the provisions of ASC 825-10 on October 1, 2008. ASC 825-10 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825-10 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 establishes three levels of inputs that may be used to measure fair value:<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Level 1 - Quoted prices in active markets for identical assets or liabilities.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.<br/>
</font>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Upon adoption of ASC 825-10, there was no cumulative effect adjustment to the beginning retained earnings and no impact on the unaudited condensed consolidated financial statements.
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" ><div><div style="width:100%;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:8pt;" >
</font>
</div>
</div><div style="page-break-after:always;width:100%;" ><div style="text-align:center;width:100%;" >
</div>
</div><div><div style="width:100%;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:8pt;" >
</font>
</div>
</div>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The carrying value of the Company&#8217;s cash and cash equivalents, accounts receivable, accounts payable, short-term borrowings (including convertible notes payable), and other current assets and liabilities approximate fair value because of their short-term maturity. All other significant financial assets, financial liabilities and
 equity instruments of the Company are either recognized or disclosed in the consolidated financial statements together with other information relevant for making a reasonable assessment of future cash flows, interest rate risk and credit risk. Where practicable, the fair values of financial assets and financial liabilities have been determined and disclosed; otherwise, only available information pertinent to fair value has been disclosed.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >At June 30, 2011, there were no identified assets or liabilities measured at fair value on a recurring basis.
</font>
</div>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueDisclosuresAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6925170&amp;loc=d3e19296-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 159<br> -Paragraph 17-22, 27, 28<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=6947722&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 107<br> -Paragraph 15C, 15D<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=6947722&amp;loc=d3e13504-108611<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 107<br> -Paragraph 15A<br> -Subparagraph a-d<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=6947722&amp;loc=d3e13537-108611<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 133<br> -Paragraph 44A, 44B<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6925170&amp;loc=d3e19207-110258<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14172-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 107<br> -Paragraph 3, 10, 14, 15<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 107<br> -Paragraph 15B<br> -Subparagraph a, b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 157<br> -Paragraph 32, 33, 34<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueDisclosuresTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E2H">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>GOING CONCERN<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_GoingConcernAbstract', window );"><strong>Going Concern [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiquidityDisclosureTextBlock', window );">GOING CONCERN</a></td>
        <td class="text"><div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" >NOTE J - GOING CONCERN<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying unaudited condensed consolidated financial statements, at June 30, 2011, the Company has a negative working capital of $4.6 million, incurred a net loss for the nine month period ended June 30, 2011 of $6.1 million and has an accumulated deficit of $157.4 million. These factors, among others, may indicate that the Company will be unable to continue as a going concern for a reasonable period of time.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The Company&#8217;s existence is dependent upon management&#8217;s ability to develop profitable operations. Management is devoting substantially all of its efforts to developing DNA embedded biotechnology security solutions in the United States and Europe and there can be no assurance that the Company&#8217;s efforts will be successful and no assurance can be given that management&#8217;s actions will result in profitable operations or the resolution of its liquidity problems. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might result should the Company be unable to continue as a going concern.
</font>
</div>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_GoingConcernAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>apdn_GoingConcernAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>apdn</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiquidityDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for reporting when there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). Disclose: (a) pertinent conditions and events giving rise to the assessment of substantial doubt about the entity's ability to continue as a going concern for a reasonable period of time, (b) the possible effects of such conditions and events, (c) management's evaluation of the significance of those conditions and events and any mitigating factors, (d) possible discontinuance of operations, (e) management's plans (including relevant prospective financial information), and (f) information about the recoverability or classification of recorded asset amounts or the amounts or classification of liabilities. If management's plans alleviate the substantial doubt about the entity's ability to continue as a going concern, disclosure of the principal conditions and events that initially raised the substantial doubt about the entity's ability to continue as a going concern would be expected to be considered. Disclose whether operations for the current or prior years generated sufficient cash to cover current obligations, whether waivers were obtained from creditors relating to the company's default under the provisions of debt agreements and possible effects of such conditions and events, such as: whether there is a possible need to obtain additional financing (debt or equity) or to liquidate certain holdings to offset future cash flow deficiencies. Disclose appropriate parent company information when parent is dependent upon remittances from subsidiaries to satisfy its obligations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiquidityDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E2H">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
        <td class="text"><div><div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" >NOTE H - COMMITMENTS AND CONTINGENCIES<br />
<br />
</font>
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The Company leases office space under an operating lease in Stony Brook, New York for its corporate use from an entity controlled by a significant former shareholder. Total lease rental expenses for the three and nine month periods ended June 30, 2011 were $36,056 and $108,054, respectively. Total lease rental expenses for the three and nine month periods ended on June 30, 2010 were $21,858 and $62,408, respectively.
</font>
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" ><div><div style="text-align:left;width:100%;" ><font style="display:inline;font-family:times new roman;font-size:8pt;" >
</font>
</div>
</div><div><div style="text-align:right;width:100%;" ><font style="display:inline;font-family:times new roman;font-size:8pt;" >
</font>
</div>
</div>
</div><div>
</div><div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><br />
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >Litigation<br />
<br />
</font>
</font>
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. Except as described below, we are currently not aware of any such legal proceedings that we believe will have, individually or in the aggregate, a material adverse affect on our business, financial condition or operating results.<br />
<br />
</font>
</div><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="font-style:italic;display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >Demodulation, Inc. v. Applied DNA Sciences, Inc., et al. (Civil Action No. - 2:11-cv-00296-WJM-MF):<br />
<br />
</font>
</font>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >On May 18, 2011, the Company was served with a complaint in a lawsuit brought by Demodulation, Inc. against the Company, Corning Incorporated, Alfred University, and Alfred Technology Resources, Inc. On July 8, 2011, the Company filed a motion to dismiss the complaint. In response, on August 3, 2011, Demodulation, Inc. filed an amended complaint. Demodulation, Inc. alleges that it was unable to bring its microwire technology to market due to the wrongful acts of defendants, who allegedly conspired to steal Demodulation, Inc.&#8217;s trade secrets and other intellectual property and to interfere in its business opportunities. Of the 17 claims alleged in the amended complaint, five are asserted against the Company, including alleged misappropriation of trade secrets, antitrust violations, civil RICO, and patent infringement. The Company believes these claims are without merit. The Company intends to file a motion to dismiss the amended complaint for failure to state a claim and on other grounds. The Company intends to vigorously defend the action.
</font>
</div>
</div>
</div>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingenciesDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for commitments and contingencies.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6952336&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6398077&amp;loc=d3e12565-110249<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name FASB Interpretation (FIN)<br> -Number 14<br> -Paragraph 3<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6394976&amp;loc=d3e25287-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 5<br> -Paragraph 9, 10, 11, 12<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-108621<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E2H">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>SUMMARY OF ACCOUNTING POLICIES<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF ACCOUNTING POLICIES</a></td>
        <td class="text"><div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" >NOTE A &#8212; SUMMARY OF ACCOUNTING POLICIES<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >General<br/>
</font>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The accompanying unaudited condensed consolidated financial statements as of June 30, 2011 and for the three and nine months ended June 30, 2011 and 2010 are unaudited. These financial statements have been prepared in accordance with Rule S-X of the Securities and Exchange Commission (the &#8220;SEC&#8221;) and with the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.<br/>
</font>
</div>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the nine month period ended June 30, 2011 are not necessarily indicative of the results that may be expected for the fiscal year ending September 30, 2011. The unaudited condensed consolidated financial statements should be read in conjunction with the consolidated September 30, 2010 financial statements and footnotes thereto included in the Company&#8217;s Annual Report on Form 10-K, as amended, filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;).
</font><br/>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >Business and Basis of Presentation<br/>
</font>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >On September 16, 2002, Applied DNA Sciences, Inc. (the &#8220;Company&#8221;) was incorporated under the laws of the State of Nevada. Effective December 17, 2008, the Company reincorporated from the State of Nevada to the State of Delaware. The Company is principally devoted to developing DNA embedded biotechnology security solutions in the United States and Europe.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Applied DNA Operations Management, Inc., APDN (B.V.I.) Inc. and Applied DNA Sciences Europe Limited. Significant inter-company transactions have been eliminated in consolidation.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >Estimates
</font>
</font><br/>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >Revenue Recognition<br/>
</font>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Revenues are derived from research, development, qualification and production testing for certain commercial products. Revenue from fixed price testing contracts is generally recorded upon completion of the contracts, which are generally short-term, or upon completion of identifiable contractual tasks. At the time the Company enters into a contract that includes multiple tasks, the Company estimates the amount of actual labor and other costs that will be required to complete each task based on historical experience. Revenues are recognized which provide for a profit margin relative to the testing performed. Revenue relative to each task and from contracts which are time and materials based is recorded as effort is expended. Billings in excess of amounts earned are deferred. Any anticipated losses on contracts are charged to income when identified. To the extent management does not accurately forecast the level of
 effort required to complete a contract, or individual tasks within a contract, and the Company is unable to negotiate additional billings with a customer for cost over-runs, the Company may incur losses on individual contracts. All selling, general and administrative costs are treated as period costs and expensed as incurred.
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" ><div><div style="width:100%;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:8pt;" >
</font>
</div>
</div><div><p>
</p>
</div><div><div style="width:100%;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:8pt;" >
</font>
</div>
</div>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >For revenue from product sales, the Company recognizes revenue in accordance with Accounting Standards Codification subtopic 605-10, Revenue Recognition (&#8220;ASC 605-10&#8221;). ASC 605-10 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has
</font><font style="display:inline;font-family:times new roman;font-size:10pt;" >occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management&#8217;s judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for allowances and other adjustments are provided for in the same period the related sales are recorded. The Company defers any revenue for which the product has not been delivered or is subject to refund until such time that the Company and the customer jointly determine that the product has been delivered or no refund will be required. At June 30, 2011 and September 30, 2010, the Company did not record any deferred revenue for the respective periods.
</font><br/>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >Cash Equivalents<br/>
</font>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >For the purpose of the accompanying unaudited condensed consolidated financial statements, all highly liquid investments with a maturity of three months or less are considered to be cash equivalents.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >Accounts Receivable
</font>
</font><br/>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The Company provides an allowance for doubtful accounts equal to the estimated uncollectible amounts. The Company&#8217;s estimate is based on historical collection experience and a review of the current status of trade accounts receivable. It is reasonably possible that the Company&#8217;s estimate of the allowance for doubtful accounts will change. At June 30, 2011 and September 30, 2010, the Company has deemed that no allowance for doubtful accounts was necessary.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >Income Taxes<br/>
</font>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The Company has adopted Accounting Standards Codification subtopic 740-10, Income Taxes (&#8220;ASC 740-10&#8221;) which requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between financial
 statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. <br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >Property and Equipment<br/>
</font>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Property and equipment are stated at cost and depreciated over their estimated useful lives of 3 to 5 years using the straight line method. At June 30, 2011 and September 30, 2010, property and equipment consist of:
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" >
</div><div style="text-align:center;" ><table cellspacing="0" cellpadding="0" width="70%" style="font-family:times new roman;font-size:10pt;" ><tr><td valign="bottom" width="46%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >(Unaudited)
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >June 30,<br />
</font><font style="display:inline;font-family:times new roman;font-size:10pt;" >2011
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >September 30,<br />
</font><font style="display:inline;font-family:times new roman;font-size:10pt;" >2010
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="text-align:left;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Computer equipment
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >27,404
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >27,404
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="text-align:left;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Lab equipment
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >77,473
</font>
</div>
</td><td
 valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >77,473
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="border-bottom:black 2px solid;text-align:left;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Furniture
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >105,985
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >105,985
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >210,862
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >210,862
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="border-bottom:black 2px solid;text-align:left;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Accumulated depreciation
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >210,862
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >207,097
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="padding-bottom:4px;text-align:left;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Net
</font>
</div>
</td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font
 style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >-
</font>
</div>
</td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="padding-bottom:4px;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="border-bottom:black 4px double;text-align:right;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >3,765
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 4px double;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr>
</table>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" >
</div><div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" ><div><div style="width:100%;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:8pt;" >
</font>
</div>
</div><div style="page-break-after:always;width:100%;" ><div style="text-align:center;width:100%;" >
</div><div style="text-align:center;width:100%;" >
</div>
</div><div><div style="width:100%;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:8pt;" >
</font>
</div>
</div>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >Impairment of Long-Lived Assets
</font>
</font><br/>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The Company has adopted Accounting Standards Codification subtopic 360-10, Property, Plant and Equipment (&#8220;ASC 360-10&#8221;). ASC 360-10 requires that long-lived assets and certain identifiable intangibles held and used by the Company be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company evaluates its long lived assets for impairment annually or
</font><font style="display:inline;font-family:times new roman;font-size:10pt;" >more often if events and circumstances warrant. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve break-even operating results over an extended period. The Company evaluates the recoverability of long-lived assets based upon forecasted undiscounted cash flows. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted, based on estimates of future discounted cash flows resulting from the use and ultimate disposition of the asset. ASC 360-10 also requires assets to be disposed of be reported at the lower of the carrying amount or the fair value less costs to sell.<br />
<br />
</font>
</div>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >Net Loss Per Share<br/>
</font>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The Company has adopted Accounting Standards Codification subtopic 260-10, Earnings Per Share (&#8220;ASC 260-10&#8221;) which specifies the computation, presentation and disclosure requirements of earnings per share information. Basic earnings per share have been calculated based upon the weighted average number of common shares outstanding. Dilutive common stock equivalents consist of shares issuable upon conversion of convertible notes and the exercise of the Company&#8217;s stock options and warrants. For the three and nine months ended June 30, 2011 and 2010, common stock equivalent shares are excluded from the computation of the diluted loss per share as their effect would be anti-dilutive.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Fully diluted shares outstanding were 496,504,218 and 495,370,910 for the three month and nine months ended June 30, 2011,  respectively. Fully diluted shares outstanding were 371,785,665 and 362,372,128 for the three and nine months ended June 30, 2010, respectively.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new
 roman;font-size:10pt;" >
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >Stock Based Compensation
</font>
</font><br/>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The Company follows Accounting Standards Codification subtopic 718-10, Compensation (&#8220;ASC 718-10&#8221;) which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the income statement based on their fair values. Stock-based compensation expense recognized under ASC 718-10 for the nine months ended June 30, 2011 and 2010 was $459,967 and $587,235, respectively.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >As of June 30, 2011, 70,400,000 employee stock options were outstanding with 42,550,000 shares vested and exercisable.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >Concentrations<br/>
</font>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and trade receivables. The Company places its cash and temporary cash investments with high credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The Company&#8217;s revenues earned from sale of products and services for the three and nine months ended June 30, 2011 included an aggregate of 65% and 56% from four and three customers of the Company&#8217;s total revenues, respectively. Five and three customers accounted for 90% and 65% of the Company&#8217;s revenues earned from sale of products and services for the three and nine months ended June 30, 2010, respectively.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Four customers accounted for 69% and 90% of the Company&#8217;s total accounts receivable at June 30, 2011 and September 30, 2010, respectively.
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" ><div><div style="width:100%;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:8pt;" >
</font>
</div>
</div><div><p>
</p>
</div><div><div style="width:100%;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:8pt;" >
</font>
</div>
</div>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-indent:0pt;display:block;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" >
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >Research and Development<br/>
</font>
</font>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The Company accounts for research and development costs in accordance with the Accounting Standards Codification subtopic 730-10, Research and Development (&#8220;ASC 730-10&#8221;). Under ASC 730-10, all research and development costs must be charged to expense as incurred. Accordingly, internal research and development costs are expensed as incurred. Third-party research and development costs are expensed when the contracted work has been performed or as milestone results have been achieved. Company-sponsored research and development costs related to both present and future products are expensed in the period incurred. The Company incurred research and development expenses of $47,988 and $18,142 for the three month periods ended June 30, 2011 and 2010, respectively, and $161,645 and $44,944 for the nine month periods ended June 30, 2011 and 2010, respectively.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >Advertising<br/>
</font>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div
 style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The Company follows the policy of charging the costs of advertising to expense as incurred. The Company charged to operations $45,346 and $95,828 for the three and nine month periods ended June 30, 2011, respectively, and $12,225 and $37,680 as advertising costs for the three and nine month periods ended June 30, 2010, respectively.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >Intangible Assets<br/>
</font>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The Company amortizes its intangible assets using the straight-line method over their estimated period of benefit. The estimated useful life for patents is five years while other intellectual property uses a seven year useful life. We periodically evaluate the recoverability of intangible assets and take into account events or circumstances that warrant revised estimates of useful lives or that indicate that impairment exists. All of our intangible assets are subject to amortization.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >Fair Value of Financial Instruments<br/>
</font>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >In the first quarter of fiscal year 2008, the Company adopted Accounting Standards Codification subtopic 820-10, Fair Value Measurements and Disclosures (&#8220;ASC 820-10&#8221;). ASC 820-10 defines fair value, establishes a framework for measuring fair value, and enhances fair value measurement disclosure. ASC 820-10 delayed, until the first quarter of fiscal year 2009, the effective date for ASC 820-10 for all non-financial assets and non-financial liabilities, except those that are recognized or disclosed at fair value in the financial statements on a recurring basis (at least annually). The adoption of ASC 820-10 did not have a material impact on the Company&#8217;s financial position or operations. Refer to Note I for further discussion regarding fair valuation.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Effective October 1, 2008, the Company adopted Accounting Standards Codification subtopic 820-10, Fair Value Measurements and Disclosures (&#8220;ASC 820-10&#8221;) and Accounting Standards Codification subtopic 825-10, Financial Instruments (&#8220;ASC 825-10&#8221;), which permits entities to choose to measure many financial instruments and certain other items at fair value. Neither of these statements had an impact on the Company&#8217;s consolidated financial position, results of operations or cash flows. The carrying value of cash and cash equivalents, accounts payable and short-term borrowings, as reflected in the balance sheets, approximate fair value because of the short-term maturity of these instruments.<br/>
</font>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >Recent Accounting Pronouncements
</font>
</font><br/>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >There were various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to have a material impact on the Company&#8217;s consolidated financial position, results of operations or cash flows.
</font>
</div>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountingPoliciesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for all significant accounting policies of the reporting entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18743-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18854-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Principles Board Opinion (APB)<br> -Number 22<br> -Paragraph 8<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18861-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18726-107790<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SignificantAccountingPoliciesTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E2H">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>CONVERTIBLE NOTES<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAbstract', window );"><strong>Long-Term Debt, Unclassified [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">CONVERTIBLE NOTES</a></td>
        <td class="text"><div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" >NOTE D &#8211; CONVERTIBLE NOTES<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Convertible notes payable as of June 30, 2011 and September 30, 2010 are as follows:<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" >
</div><div style="text-align:left;" ><div><table cellspacing="0" cellpadding="0" width="100%" style="font-family:times new roman;font-size:10pt;" ><tr><td valign="bottom" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" colspan="2" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >(Unaudited)
</font>
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >June 30,
</font>
</div>
</td><td valign="bottom" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" colspan="2" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >September 30,
</font>
</div>
</td><td valign="bottom" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" colspan="2" style="border-bottom:black 2px solid;" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >2011
</font>
</div>
</td><td valign="bottom" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" colspan="2" style="border-bottom:black 2px solid;" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >2010
</font>
</div>
</td><td valign="bottom" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="76%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Secured Convertible Notes Payable dated October 14, 2009, net of unamortized debt discount of $819 (see below)
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >-
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >269,181
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="76%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Secured Convertible Note Payable dated January 7, 2010, net of unamortized debt discount of $673 and $9,521, respectively (see below)
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >-
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;"
 >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >40,479
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="76%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Secured Convertible Note Payable dated June 4, 2010, net of unamortized debt discount of $2,329 and $5,286, respectively (see below)
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >222,671
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >219,714
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="76%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Secured Convertible Notes Payable dated July 15, 2010, net of unamortized debt discount of $50,337 and $535,580, respectively (see below)
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >399,663
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >1,464,420
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="76%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Secured Convertible Notes Payable dated November 19, 2010, net of unamortized debt discount of $29,759 (see below)
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >320,241
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >-
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="76%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Secured Convertible Note Payable dated November 30, 2010, net of unamortized debt discount of $113,211 (see below)
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >636,789
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times
 new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >-
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="76%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Secured Convertible Note Payable dated January 7, 2011, net of unamortized debt discount of $125,711 (see below)
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >624,289
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >-
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="76%" style="border-bottom:black 2px solid;text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Secured Convertible Notes Payable, dated July 15, 2010, modified January 7, 2011, net of unamortized debt discount of $766,970 (see below)
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >748,030
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="76%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Total
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >2,951,683
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >1,993,794
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="76%" style="border-bottom:black 2px solid;text-align:left;" ><div style="text-align:left;text-indent:5pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Less: current portion
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >(2,951,683
</font>
</div>
</td><td valign="bottom"
 width="1%" style="border-bottom:black 2px solid;text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >)
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >(1,774,080
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >)
</font>
</div>
</td>
</tr><tr><td valign="bottom" width="76%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Long-term debt- net
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >-
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >219,714
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr>
</table><br />
</div>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >10% Secured Convertible Promissory Notes dated October 14, 2009<br/>
</font>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >On October 14, 2009, the Company issued an aggregate of $270,000 convertible promissory notes due October 14, 2010 with interest at 10% per annum due upon maturity. The notes are convertible at any time prior to maturity, at the holders&#8217; option, into shares of our common stock at a price equal to the greater of (i) 50% of the average price of our common stock for the ten trading days prior to the date of the notice of conversion or (ii) at $0.092674218 per share, which is equal to a 20% discount to the average volume, weighted average price of our common stock for the ten trading days prior to issuance. At maturity, the notes, including any accrued and unpaid interest, are automatically convertible at $0.092674218 per share. The Company has granted the noteholders a security interest in all the Company&#8217;s assets.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >In accordance with ASC 470-20, the Company recognized an embedded beneficial conversion feature present in the notes. The Company allocated a portion of the proceeds equal to the intrinsic value of that feature to additional paid-in capital. The Company recognized and measured an aggregate of $21,343 of the proceeds, which is equal to the intrinsic value of the embedded beneficial conversion feature, to additional paid-in capital and a discount against the notes. The debt discount attributed to the beneficial conversion feature is amortized over the notes&#8217; maturity period (one year) as interest expense.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The Company recorded the intrinsic value of the embedded beneficial conversion feature ($21,343) to debt discount which will be amortized to interest expense over the term of the notes. The Company recorded the intrinsic value of the embedded beneficial conversion feature ($21,343) to debt discount which will be amortized to interest expense over the term of the notes. Amortization of $819 was recorded for the three and nine months ended June 30, 2011, and $5,321 and $15,145 was recorded for the three and nine month periods ended June 30, 2010, respectively.
</font>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" ><div><div style="width:100%;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:8pt;" >
</font>
</div>
</div><div style="page-break-after:always;width:100%;" ><div style="text-align:center;width:100%;" >
</div>
</div><div><div style="width:100%;text-align:right;" ><font style="display:inline;font-family:times new
 roman;font-size:8pt;" >
</font>
</div>
</div>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-indent:0pt;display:block;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" >
</div><div style="text-indent:0pt;display:block;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</font>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >On October 14, 2010, the Company issued 3,204,776 shares of common stock in settlement of the convertible notes and related interest.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >10% Secured Convertible Promissory Note dated January 7, 2010<br/>
</font>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >On January 7, 2010, the Company issued a $50,000 convertible promissory note due January 7, 2011 with interest at 10% per annum due upon maturity. The note is convertible at any time prior to maturity, at the holder&#8217;s option, into shares of our common stock at a price equal to the greater of (i) 50% of the average price of our common stock for the ten trading days prior to the date of the notice of conversion or (ii) at $0.052877384 per share, which is equal to a 20% discount to the average volume, weighted average price of our common stock for the ten trading days prior to issuance. At maturity, the note, including any accrued and unpaid interest, is automatically convertible at $0.052877384 per share. The Company has granted the noteholder a security interest in all the Company&#8217;s assets.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >In accordance with ASC 470-20, the Company recognized an embedded beneficial conversion feature present in the note. The Company allocated a portion of the proceeds equal to the intrinsic value of that feature to additional paid-in capital.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The Company recognized and measured an aggregate of $35,103 of the proceeds, which is equal to the intrinsic value of the embedded beneficial conversion feature, to additional paid-in capital and a discount against the note. The debt discount attributed to the beneficial conversion feature is amortized over the note&#8217;s maturity period (one year) as interest expense.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The Company recorded the intrinsic value of the embedded beneficial conversion feature ($35,103) to debt discount which will be amortized to interest expense over the term of the note. Amortization of $-0- and $9,521 was recorded for the three and nine months ended June 30, 2011, respectively, and $8,752 and $16,734 was recorded for the three and nine month periods ended June 30, 2010, respectively.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >On January 7, 2011, the Company issued 1,040,142 shares of common stock in settlement of the convertible note and related interest.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >10% Secured Convertible Promissory Note dated June 4, 2010<br/>
</font>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >On June 4, 2010, the Company issued a $675,000 related party convertible promissory note due January 31, 2012 with interest at 10% per annum due upon maturity. The note is convertible at any time prior to maturity, at the holder&#8217;s option, into shares of our common stock at a price equal to the greater of (i) 50% of the average price of our common stock for the ten trading days prior to the date of the notice of conversion or (ii) at $0.038866151 per share, which is equal to a 20% discount to the average volume, weighted average price of our common stock for the ten trading days prior to issuance. At maturity, the note, including any accrued and unpaid interest, is automatically convertible at $0.038866151 per share. The Company has granted the noteholder a security
 interest in all the Company&#8217;s assets.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >In accordance with ASC 470-20, the Company recognized an embedded beneficial conversion feature present in the note. The Company allocated a portion of the proceeds equal to the intrinsic value of that feature to additional paid-in capital. The Company recognized and measured an aggregate of $19,692 of the proceeds, which is equal to the intrinsic value of the embedded beneficial conversion feature, to additional paid-in capital and a discount against the note. The debt discount attributed to the beneficial conversion feature is amortized over the note&#8217;s maturity period as interest expense.
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" ><div><div style="width:100%;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:8pt;" >
</font>
</div>
</div><div style="page-break-after:always;width:100%;" ><div style="text-align:center;width:100%;" >
</div>
</div><div><div style="width:100%;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:8pt;" >
</font>
</div>
</div>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;" ><div style="text-indent:0pt;display:block;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div>
</div>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" >
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The Company recorded the intrinsic value of the embedded beneficial conversion feature ($19,692) to debt discount which will be amortized to interest expense over the term of the note. Amortization of $986 and $2,957 was recorded for the three and nine months ended June 30, 2011, respectively.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >On July 15, 2010, $450,000 of the $675,000 related party convertible promissory note was converted to the same terms and conditions as described in the 10% Secured Convertible Promissory Notes dated July 15, 2010 below.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >10% Senior Secured Convertible Promissory Notes dated July 15, 2010<br/>
</font>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >On July 15, 2010, the Company issued an aggregate of $2,000,000 senior secured convertible promissory notes due July 15, 2011 with interest at 10% per annum due upon maturity to &#8220;accredited investors,&#8221; as defined in regulations promulgated under the Securities Act of 1933, as amended (&#8220;Securities Act&#8221;). The notes are convertible at any time prior to maturity, at the holders&#8217; option, into shares of our common stock (i) prior to the occurrence of Subsequent Financing at a rate of $0.04405, or (ii) after Subsequent Financing in the event the holder elects to receive conversion shares that are not Subsequent Financing securities, at a rate of $0.04405, or as of any conversion date that occurs after the closing of a Subsequent Financing at a rate of 80% of the purchase price paid by investors in the Subsequent Financing. The notes automatically convert at the earlier occurrence of (i) maturity or (ii) Qualified Financing including any accrued and unpaid interest, at a rate as described above. The Company has granted the noteholders a security interest in all the Company&#8217;s assets and the assets of APDN (B.V.I.) Inc., the Company&#8217;s wholly-owned subsidiary.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Subsequent Financing is defined as the issuance and sale by the Company securities that does not qualify as Qualified Financing. Qualified Financing is defined as the issuance and sale by the Company or an affiliate thereof of equity or debt securities in a single transaction that results in gross proceeds of (before transaction fees and expenses) equal to or in excess of $10,000,000.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >In accordance with ASC 470-20, the Company recognized an embedded beneficial conversion feature present in the notes. The Company allocated a portion of the proceeds equal to the intrinsic value of that feature to additional paid-in capital. The Company recognized and measured an aggregate of $678,774 of the proceeds, which is equal to the intrinsic value of the embedded beneficial conversion feature, to additional paid-in capital and a discount against the notes. The debt discount attributed to the beneficial conversion feature is amortized over the notes&#8217; maturity period (one
 year) as interest expense.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The Company recorded the intrinsic value of the embedded beneficial conversion feature ($678,774) to debt discount which will be amortized to interest expense over the term of the notes.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >On January 7, 2011, upon the completion of a Subsequent Financing, the above described conversion rate changed from $0.04405 to $0.37104 with an extended due date from July 15, 2011 to January 7, 2012 on $1,550,000 of the $2,000,000 issued senior convertible promissory notes. All other terms are remaining the same. Although the conversion rate of the remaining $450,000 senior secured convertible promissory notes remained the same, the due date was extended also to January 7, 2012. In conjunction with the conversion rate and term modifications of the $1,550,000 senior secured convertible promissory notes, the Company wrote off the remaining unamortized debt discount of $331,332 to operations. See below discussion of the restructured senior secured convertible promissory notes.
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" ><div><div style="width:100%;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:8pt;" >
</font>
</div>
</div><div style="page-break-after:always;width:100%;" ><div style="text-align:center;width:100%;" >
</div>
</div><div><div style="width:100%;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:8pt;" >
</font>
</div>
</div>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><div style="text-indent:0pt;display:block;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div>
</div>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >10% Senior Secured Convertible Promissory Notes dated November 19, 2010<br/>
</font>
</font>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >On November 19, 2010, the Company issued an aggregate of $350,000 in principal amount of senior secured convertible notes bearing interest at a rate of 10% per annum to &#8220;accredited investors,&#8221; as defined in regulations promulgated under the Securities Act. The notes are convertible, in whole or in part, at any time, at the option of the noteholders, into either (A) such number of shares of the Company&#8217;s common stock, $0.001 par value per share,
</font><font style="display:inline;font-family:times new roman;font-size:10pt;" >determined by dividing (i) the principal amount of each note, together with any and all accrued and unpaid interest and penalties, by (ii) a conversion price of $ 0.032825817, which is equal to a 20% discount to the average volume, weighted average price of our common stock for the ten trading days prior to issuance (the &#8220;Common Conversion Price&#8221;) or (B) securities issued in any Subsequent Financing (&#8220;Subsequent Securities&#8221;) at a conversion price equal to 80% of the price per Subsequent Security paid by investors for Subsequent Securities in a Subsequent Financing (the &#8220;Subsequent Financing Price&#8221;). A &#8220;Subsequent Financing&#8221; is the sale by the Company or an affiliate thereof of securities at any time after November 19, 2010 and prior to the earlier of (i) a Qualified Financing or (ii) November 19, 2011. A noteholder may convert its notes in whole in connection with any one Subsequent Financing or in part in connection with one or more Subsequent Financings. The notes shall be automatically converted upon the earlier of (I) November 19, 2011 and (II) the completion of a Qualified Financing at the election of each noteholder into either (A) shares of common stock at the Common Conversion Price, (B) Subsequent Securities at a conversion price equal to 80% of the Subsequent Financing Price, or (C) securities issued in a Qualified Financing (the &#8220;Qualified Financing Securities&#8221;) at a conversion price equal to 80% of the price per Qualified Financing Security paid by investors for the Qualified Financing Securities in the Qualified Financing.
</font>
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font><br />
</font>
</div>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >A &#8220;Qualified Financing&#8221; is the sale by the Company or an affiliate thereof of securities resulting in gross proceeds (before transaction fees and expenses) in a single transaction equal to or in excess of $10 million. The notes bear interest at the rate of 10% per annum and are due and payable in full on November 19, 2011. <br/>
</font>
</div><div
 style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Until the principal and accrued but unpaid interest under the notes are paid in full, or converted into Conversion Shares pursuant to their terms, the Company&#8217;s obligations under the notes will be secured by a lien on all assets of the Company and the assets of APDN (B.V.I.) Inc., the Company&#8217;s wholly-owned subsidiary.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >In accordance with ASC 470-20, the Company recognized an embedded beneficial conversion feature present in the notes. The Company allocated a portion of the proceeds equal to the intrinsic value of that feature to additional paid-in capital. The Company recognized and measured an aggregate of $76,494 of the proceeds, which is equal to the intrinsic value of the embedded beneficial conversion feature, to additional paid-in capital and a discount against the notes. The debt discount attributed to the beneficial conversion feature is amortized over the notes&#8217; maturity period (one year) as interest expense.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The Company recorded the intrinsic value of the embedded beneficial conversion feature ($76,494) to debt discount which will be amortized to interest expense over the term of the notes. Amortization of $19,071 and $46,734 was recorded for the three and nine month periods ended June 30, 2011, respectively.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</font>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >10% Senior Secured Convertible Promissory Note dated November 30, 2010<br/>
</font>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >On November 30, 2010, the Company issued a $750,000 principal amount senior secured convertible note bearing interest at a rate of 10% per annum to an &#8220;accredited investor,&#8221; as defined in regulations promulgated under the Securities Act. The note is convertible, in whole or in part, at any time, at the option of the noteholder, into either (A) such number of shares of the Company&#8217;s common stock, $0.001 par value per share, determined by dividing (i) the principal amount of each note, together with any and all accrued and unpaid interest and penalties, by (ii) a conversion price of $ 0.03088, which is equal to a 20% discount to the average volume, weighted average price of our common stock for the ten trading days prior to issuance (the &#8220;Common Conversion Price&#8221;) or (B) securities issued in any Subsequent Financing (&#8220;Subsequent Securities&#8221;) at a conversion price equal to 80% of the price per Subsequent Security paid by investors for Subsequent Securities in a Subsequent Financing (the &#8220;Subsequent Financing Price&#8221;). A &#8220;Subsequent Financing&#8221; is the sale by the Company or an affiliate thereof of securities at any time after November 30, 2010 and prior to the earlier of (i) a Qualified Financing or (ii) November 30, 2011. The noteholder may convert its note in whole in connection with any one Subsequent Financing or in part in connection with one or more Subsequent Financings. The note shall be automatically converted upon the earlier of (I) November 30, 2011 and (II) the completion of a Qualified Financing at the election of the noteholder into either (A) shares of common stock at the Common Conversion Price, (B) Subsequent Securities at a conversion price equal to 80% of the Subsequent Financing Price, or (C) securities issued in a Qualified Financing (the &#8220;Qualified Financing Securities&#8221;) at a conversion price equal to 80% of the price per Qualified Financing Security paid by investors for the Qualified Financing Securities in the Qualified Financing.
</font>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" ><div><div style="width:100%;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:8pt;" >
</font>
</div>
</div><div style="page-break-after:always;width:100%;" ><div style="text-align:center;width:100%;" >
</div>
</div><div><div style="width:100%;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:8pt;" >
</font>
</div>
</div>
</div><div style="text-indent:0pt;display:block;" ><div style="text-indent:0pt;display:block;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" ><font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" >
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div>
</div>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" >
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >A &#8220;Qualified Financing&#8221; is the sale by the Company or an affiliate thereof of securities resulting in gross proceeds (before
 transaction fees and expenses) in a single transaction equal to or in excess of $10 million. The note bears interest at the rate of 10% per annum and is due and payable in full on November 30, 2011. <br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Until the principal and accrued but unpaid interest under the note is paid in full, or converted into Conversion Shares pursuant to its terms, the Company&#8217;s obligations under the note will be secured by a lien on all assets of the Company and the assets of APDN (B.V.I.) Inc., the Company&#8217;s wholly-owned subsidiary.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >In accordance with ASC 470-20, the Company recognized an embedded beneficial conversion feature present in the note. The Company allocated a portion of the proceeds equal to the intrinsic value of that feature to additional paid-in capital. The Company recognized and measured an aggregate of $270,078 of the proceeds, which is equal to the intrinsic value of the embedded beneficial conversion feature, to additional paid-in capital and a discount against the note. The debt discount attributed to the beneficial conversion feature is amortized over the note&#8217;s maturity period (one year) as interest expense.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The Company recorded the intrinsic value of the embedded beneficial conversion feature ($270,078) to debt discount which will be amortized to interest expense over the term of the note. Amortization of $67,334 and $156,867 was recorded for the three and nine month periods ended June 30, 2011, respectively.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</font>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >10% Senior Secured Convertible Promissory Note dated January 7, 2011<br/>
</font>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >On January 7, 2011, the Company issued a $750,000 principal amount senior secured convertible note bearing interest at a rate of 10% per annum to an &#8220;accredited investor,&#8221; as defined in regulations promulgated under the Securities Act. The note is convertible, in whole or in part, at any time, at the option of the noteholder, into either (A) such number of shares of the Company&#8217;s common stock, $0.001 par value per share, determined by dividing (i) the principal amount of each note, together with any and all accrued and unpaid interest and penalties, by (ii) a conversion price of $ 0.05529, which is equal to a 20% discount to the average volume, weighted average price of our common stock for the ten trading days prior to issuance (the &#8220;Common Conversion Price&#8221;) or (B) securities issued in any Subsequent Financing (&#8220;Subsequent Securities&#8221;) at a conversion price equal to 80% of the price per Subsequent Security paid by investors for Subsequent Securities in a Subsequent Financing (the &#8220;Subsequent Financing Price&#8221;). A &#8220;Subsequent Financing&#8221; is the sale by the Company or an affiliate thereof of securities at any time after January 7, 2011 and prior to the earlier of (i) a Qualified Financing or (ii) January 7, 2012. The noteholder may convert its note in whole in connection with any one Subsequent Financing or in part in connection with one or more Subsequent Financings. The note shall be automatically converted upon the earlier of (I) January 7, 2012 and (II) the completion of a Qualified Financing at the election of the noteholder into either (A) shares of common stock at the Common Conversion Price, (B) Subsequent Securities at a conversion price equal to 80% of the Subsequent Financing Price, or (C) securities issued in a Qualified Financing (the &#8220;Qualified Financing Securities&#8221;) at a conversion price equal to 80% of the price per Qualified Financing Security paid by investors for the Qualified Financing Securities in the Qualified Financing. <br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >A &#8220;Qualified Financing&#8221; is the sale by the Company or an affiliate thereof of securities resulting in gross proceeds (before transaction fees and expenses) in a single transaction equal to or in excess of $10 million. The note bears interest at the rate of 10% per annum and is due and payable in full on January 7, 2012. <br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Until the principal and accrued but unpaid interest under the note is paid in full, or converted into Conversion Shares pursuant to its terms, the Company&#8217;s obligations under the note will be secured by a lien on all assets of the Company and the assets of APDN (B.V.I.) Inc., the Company&#8217;s wholly-owned subsidiary.
</font>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" ><div><div style="width:100%;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:8pt;"
 >
</font>
</div>
</div><div><p>
</p>
</div><div><div style="width:100%;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:8pt;" >
</font>
</div>
</div>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-indent:0pt;display:block;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" >
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >In accordance with ASC 470-20, the Company recognized an embedded beneficial conversion feature present in the note. The Company allocated a portion of the proceeds equal to the intrinsic value of that feature to additional paid-in capital. The Company recognized and measured an aggregate of $240,233 of the proceeds, which is equal to the intrinsic value of the embedded beneficial conversion feature, to additional paid-in capital and a discount against the note. The debt discount attributed to the beneficial conversion feature is amortized over the note&#8217;s maturity period (one year) as interest expense.<br/>
</font>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The Company recorded the intrinsic value of the embedded beneficial conversion feature ($240,233) to debt discount which will be amortized to interest expense over the term of the note. Amortization of $59,894 and $114,522 was recorded for the three and nine month periods ended June 30, 2011.
</font><br/>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >10% Senior Secured Convertible Promissory Notes issued on July 15, 2010, modified on January 7, 2011<br/>
</font>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >On January 7, 2011, the Company modified previously issued senior secured promissory notes initially dated July 15, 2010 totaling $1,550,000 in principal amount bearing interest at a rate of 10% per annum to &#8220;accredited investors,&#8221; as defined in regulations promulgated under the Securities Act. The notes are convertible, in whole or in part, at any time, at the option of the noteholders, into either (A) such number of shares of the Company&#8217;s common stock, $0.001 par value per share, determined by dividing (i) the principal amount of each note, together with any and all accrued and unpaid interest and penalties, by (ii) a conversion price of $ 0.037104 or (B) securities issued in any Subsequent Financing (&#8220;Subsequent Securities&#8221;) at a conversion price equal to 80% of the price per Subsequent Security paid by investors for Subsequent Securities in a Subsequent Financing (the &#8220;Subsequent Financing Price&#8221;). A &#8220;Subsequent Financing&#8221; is the sale by the Company or an affiliate thereof of securities at any time after January 7, 2011 and prior to the earlier of (i) a Qualified Financing or (ii) January 7, 2012. A noteholder may convert its note in whole in connection with any one Subsequent Financing or in part in connection with one or more Subsequent Financings. The notes shall be automatically converted upon the earlier of (I) January 7, 2012 and (II) the completion of a Qualified Financing at the election of the noteholder into either (A) shares of common stock at the Common Conversion Price, (B) Subsequent Securities at a conversion price equal to 80% of the Subsequent Financing Price, or (C) securities issued in a Qualified Financing (the &#8220;Qualified Financing Securities&#8221;) at a conversion price equal to 80% of the price per Qualified Financing Security paid by investors for the Qualified Financing Securities in the Qualified Financing. The effect of this refinancing was recognized as <font style="display:inline;font-family:times new roman;" >&#8220;debt modification
</font><font style="display:inline;font-family:times new roman;" >&#8221; in the financial statements.
</font>
</font><br/>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >A &#8220;Qualified Financing&#8221; is the sale by the Company or an affiliate thereof of securities resulting in gross proceeds (before transaction fees and expenses) in a single transaction equal to or in excess of $10 million. The notes bear interest at the rate of 10% per annum and is due and payable in full on January 7, 2012. <br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Until the principal and accrued but unpaid interest under the notes are paid in full, or converted into Conversion Shares pursuant to their terms, the Company&#8217;s obligations under the notes will be secured by a lien on all assets of the Company and the assets of APDN (B.V.I.) Inc., the Company&#8217;s wholly-owned subsidiary.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >In accordance with ASC 470-20, the Company recognized an embedded beneficial conversion feature present in the notes. The Company allocated a portion of the proceeds
 equal to the intrinsic value of that feature to additional paid-in capital. The Company recognized and measured an aggregate of $1,499,536 of the proceeds, which is equal to the intrinsic value of the embedded beneficial conversion feature, to additional paid-in capital and a discount against the notes. The debt discount attributed to the beneficial conversion feature is amortized over the notes&#8217; maturity period (one year) as interest expense.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The Company recorded the intrinsic value of the embedded beneficial conversion feature ($1,499,536) to debt discount which will be amortized to interest expense over the term of the note. Amortization of $391,576 and $732,566 was recorded for the three and nine month periods ended June 30, 2011, respectively.
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" ><div><div style="width:100%;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:8pt;" >
</font>
</div>
</div><div style="page-break-after:always;width:100%;" ><div style="text-align:center;width:100%;" >
</div>
</div><div><div style="width:100%;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:8pt;" >
</font>
</div>
</div>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:center;" >
</div>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:left;" >
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >During the quarter ended June 30, 2011, the Company issued an aggregate of 1,023,026 shares of common stock in settlement of the $35,000 of convertible notes and related interest.
</font>
</div>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LongTermDebtAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for long-term debt.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 22<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LongTermDebtTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E2H">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
        <td class="text"><div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" >NOTE E - RELATED PARTY TRANSACTIONS<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The Company&#8217;s current and former officers and stockholders have advanced funds on a non-interest bearing basis to the Company for travel related and working capital purposes. The Company has not entered into any agreement on the repayment terms for these advances. As of June 30, 2011 and September 30, 2010, there were $600,000 and $50,000 advances outstanding, respectively.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The Company has consulting agreements with outside contractors, certain of whom are also company stockholders. The agreements are generally month to month.
</font>
</div>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RelatedPartyTransactionsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for related party transactions, including the nature of the relationship(s), a description of the transactions, the amount of the transactions, the effects of any change in the method of establishing the terms of the transaction from the previous period, stated interest rate, expiration date, terms and manner of settlement per the agreement with the related party, and amounts due to or from related parties. If the entity and one or more other entities are under common ownership or management control and this control affects the operating results or financial position, disclosure includes the nature of the control relationship even if there are no transactions between the entities. Disclosure may also include the aggregate amount of current and deferred tax expense for each statement of earnings presented where the entity is a member of a group that files a consolidated tax return, the amount of any tax related balances due to or from affiliates as of the date of each statement of financial position presented, the principal provisions of the method by which the consolidated amount of current and deferred tax expense is allocated to the members of the group and the nature and effect of any changes in that method. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k))<br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 3A<br> -Section 04<br> -Paragraph b<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 57<br> -Paragraph 1-4<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39678-107864<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 4<br> -Section 08<br> -Paragraph k<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RelatedPartyTransactionsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	word-wrap: break-word;
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E2H">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>CAPITAL STOCK<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_CapitalStockAbstract', window );"><strong>Capital Stock [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_CapitalStockTextBlock', window );">CAPITAL STOCK</a></td>
        <td class="text"><div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" >NOTE F - CAPITAL STOCK<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The Company is authorized to issue 800,000,000 shares of common stock, with a $0.001 par value per share, as the result of a vote of stockholders conducted on June 29, 2010 which effected an increase in the authorized shares of common stock from 410,000,000 to 800,000,000. In addition, the Company is authorized to issue 10,000,000 shares of preferred stock with a $0.001 par value per share. As of June 30, 2011 and September 30, 2010, there were 352,523,001 and 346,366,244 shares of common stock issued and outstanding, respectively.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >During the nine months ended June 30, 2011, the Company issued an aggregate of 888,813 shares valued at $65,000 for future consulting services.<br/>
</font>
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" >
</div><div style="text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;text-align:justify;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >During the nine month periods ended June 30, 2011 and 2010, the Company has expensed $502,083 and $956,438 related to stock based compensation, respectively.
</font>
</div>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_CapitalStockAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>apdn_CapitalStockAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>apdn</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_CapitalStockTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for Capital Stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>apdn_CapitalStockTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>apdn</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0ECJAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2011</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
        <td class="num">$ (6,097,760)<span></span></td>
        <td class="num">$ (5,793,845)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
        <td class="nump">276,608<span></span></td>
        <td class="nump">278,619<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_VestedOptionsIssuedToOfficersDirectorsAndEmployees', window );">Fair value of vested options issued to officers, directors and employees</a></td>
        <td class="nump">459,967<span></span></td>
        <td class="nump">1,969,483<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of capitalized financing costs</a></td>
        <td class="nump">731,595<span></span></td>
        <td class="nump">158,167<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount attributable to convertible debentures</a></td>
        <td class="nump">1,549,230<span></span></td>
        <td class="nump">335,342<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Equity based compensation</a></td>
        <td class="nump">567,083<span></span></td>
        <td class="nump">956,438<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_CommonStockIssuedInSettlementOfInterest', window );">Common stock issued in settlement of interest</a></td>
        <td class="nump">34,960<span></span></td>
        <td class="nump">102,794<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in assets and liabilities:</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Decrease in accounts receivable</a></td>
        <td class="num">(114,804)<span></span></td>
        <td class="num">(9,766)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Decrease (increase) in prepaid expenses and deposits</a></td>
        <td class="nump">43,645<span></span></td>
        <td class="num">(23,221)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Increase in accounts payable and accrued liabilities</a></td>
        <td class="nump">348,822<span></span></td>
        <td class="nump">497,248<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
        <td class="num">(2,200,654)<span></span></td>
        <td class="num">(1,528,741)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Cash flows from investing activities:</a></td>
        <td class="text">&nbsp;<span></span></td>
        <td class="text">&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt', window );">Net proceeds from related party advances</a></td>
        <td class="nump">550,000<span></span></td>
        <td class="text">&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Net proceeds from issuance of convertible notes</a></td>
        <td class="nump">1,645,500<span></span></td>
        <td class="nump">1,337,000<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
        <td class="nump">2,195,500<span></span></td>
        <td class="nump">1,337,000<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net increase in cash and cash equivalents</a></td>
        <td class="num">(5,154)<span></span></td>
        <td class="num">(191,741)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at beginning of period</a></td>
        <td class="nump">17,618<span></span></td>
        <td class="nump">213,307<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of period</a></td>
        <td class="nump">12,464<span></span></td>
        <td class="nump">21,566<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Disclosures of Cash Flow Information:</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Cash paid during the period for interest</a></td>
        <td class="text">&nbsp;<span></span></td>
        <td class="text">&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid during the period for taxes</a></td>
        <td class="text">&nbsp;<span></span></td>
        <td class="text">&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-cash transactions:</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_WarrantsIssuedForFinancingCosts', window );">Fair value of warrants issued for financing costs</a></td>
        <td class="nump">217,971<span></span></td>
        <td class="text">&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Common stock issued in exchange for previously incurred debt</a></td>
        <td class="nump">$ 389,960<span></span></td>
        <td class="nump">$ 1,800,000<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_CommonStockIssuedInSettlementOfInterest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The fair value of common stock issued in settlement of interest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>apdn_CommonStockIssuedInSettlementOfInterest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>apdn</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_VestedOptionsIssuedToOfficersDirectorsAndEmployees">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The fair value of vested options issued to officers, directors and employees.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>apdn_VestedOptionsIssuedToOfficersDirectorsAndEmployees</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>apdn</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_WarrantsIssuedForFinancingCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of warrants issued for financing costs in noncash investing and financing activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>apdn_WarrantsIssuedForFinancingCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>apdn</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The component of interest expense representing the noncash expenses charged against earnings in the period to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate caption: Noncash Interest Expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Principles Board Opinion (APB)<br> -Number 21<br> -Paragraph 16<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 5<br> -Section 03<br> -Paragraph 8<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28541-108399<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AmortizationOfDebtDiscountPremium</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The component of interest expense comprised of the periodic charge against earnings over the life of the financing arrangement to which such costs relate. Alternate captions include Noncash Interest Expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 5<br> -Section 03<br> -Paragraph 8<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Paragraph 8<br> -Article 9<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AmortizationOfFinancingCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents. Includes cash and cash equivalents associated with the entity's continuing operations. Excludes cash and cash equivalents associated with the disposal group (and discontinued operation).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 1<br> -Article 5<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 7<br> -Footnote 1<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3044-108585<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 8, 9<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 7, 26<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in cash and cash equivalents. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 26<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 32<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtConversionConvertedInstrumentAmount1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DepreciationDepletionAndAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3536-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 29<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 27<br> -Subparagraph f<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxesPaid</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 28<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 28<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsReceivable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets,or  income taxes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 28<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of cash paid for interest during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 29<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3536-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestPaid</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash inflow or outflow from financing activity for the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 26<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3574-108585<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInFinancingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash inflow or outflow from investing activity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 26<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3574-108585<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInInvestingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3536-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 28<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 26<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 18<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 19<br> -Subparagraph b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromConvertibleDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash inflow or outflow from the proceeds and repayments made on the long-term borrowing from related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and such forth. Alternate caption: Proceeds from (Payments for) Advances from Affiliates.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 18<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=6922042&amp;loc=SL4591551-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 38<br> -Subparagraph a<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph A1, A4, A5<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 38<br> -Subparagraph c(1)<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 29<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6921930&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=6922042&amp;loc=SL4591552-111686<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 5<br> -Subparagraph b<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=6921628&amp;loc=SL4569616-111683<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProfitLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 28<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SupplementalCashFlowInformationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E2H">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>INTANGIBLE ASSETS<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_IntangibleAssetsDisclosureAbstract', window );"><strong>Intangible Assets Disclosure [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">INTANGIBLE ASSETS</a></td>
        <td class="text"><div><div><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" >NOTE B - INTANGIBLE ASSETS<br />
<br />
</font>
</div><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Intangible assets acquired and their carrying values at June 30, 2011 and September 30, 2010 are as follows:<br />
<br />
</font>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-align:left;" ><table cellspacing="0" cellpadding="0" width="70%" style="font-family:times new roman;font-size:10pt;" ><tr><td valign="bottom" width="46%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >(Unaudited)
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >June 30,
</font>
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >2011
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="10%" colspan="2" style="border-bottom:black 2px solid;" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >September 30,
</font>
</div><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >2010
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Trade secrets and developed technologies (Weighted average life of 7 years)
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >9,430,900
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >9,430,900
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="border-bottom:black 2px solid;text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Patents (Weighted average life of 5 years)
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >34,257
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td
 valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >34,257
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Total Amortized identifiable intangible assets-Gross carrying value:
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >9,465,157
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >9,465,157
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Less:
</font>
</div>
</td><td valign="bottom" width="1%" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Accumulated amortization
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >(3,446,355
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >)
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >(3,173,511
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >)
</font>
</div>
</td>
</tr><tr><td valign="bottom" width="46%" style="border-bottom:black 2px solid;text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Impairment (See below)
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >(5,655,011
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >)
</font>
</div>
</td><td
 valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="9%" style="border-bottom:black 2px solid;text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >(5,655,011
</font>
</div>
</td><td valign="bottom" width="1%" style="border-bottom:black 2px solid;text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >)
</font>
</div>
</td>
</tr><tr><td valign="bottom" width="46%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Net:
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >363,791
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >636,635
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr><tr><td valign="bottom" width="46%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Residual value:
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:right;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td><td valign="bottom" width="1%" style="text-align:left;" ><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >$
</font>
</div>
</td><td valign="bottom" width="9%" style="text-align:right;" ><div style="text-align:right;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >0
</font>
</div>
</td><td valign="bottom" width="1%" style="text-align:left;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >
</font>
</td>
</tr>
</table><br />
</div><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >During the year ended September 30, 2006, the Company&#8217;s management performed an evaluation of its intangible assets (intellectual property) for purposes of determining the implied fair value of the assets at September 30, 2006. The test indicated that the recorded remaining book value of its intellectual property exceeded its fair value for the year ended September 30, 2006, as determined by discounted future cash flows. As a result, upon completion of the assessment, management recorded a non-cash impairment charge of $5,655,011, net of tax, or $0.05 per share during the year ended September 30, 2006 to reduce the carrying value of the patents to $2,091,800. Considerable management judgment is necessary to estimate the fair value. Accordingly, actual results could vary significantly from management&#8217;s estimates.<br/>
</font>
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Total amortization expense charged to operations for the three and nine months ended June 30, 2011 was $90,948 and $272,844, respectively. Total amortization expense charged to operations for the three and nine months ended June 30, 2010 was $90,948 and $272,988, respectively.
</font>
</div>
</div>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_IntangibleAssetsDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>apdn_IntangibleAssetsDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>apdn</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for all or part of the information related to intangible assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6905858&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 142<br> -Paragraph 44, 45, 46<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6905858&amp;loc=d3e16323-109275<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6905858&amp;loc=d3e16265-109275<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IntangibleAssetsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E2H">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
        <td class="text"><div><div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;font-weight:bold;" >NOTE K &#8211; SUBSEQUENT EVENTS<br/>
</font>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >Sale of common stock<br/>
</font>
</font>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >On July 15, 2011, the Company closed a private placement of its common stock.&#160;&#160;The Company issued and sold 105,263,158 shares of Common Stock at a purchase price of $0.0475 per share to accredited investors for gross proceeds of $5,000,000.<br/>
</font>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >A registered broker dealer firm acted as our placement agent with respect to the private placement. In connection with the private placement, the Company paid placement agent commissions and discounts aggregating $265,000.&#160;&#160;In addition, the placement agent or its designees were issued warrants with a seven-year term to purchase an aggregate&#160;of 7,578,948 shares of Common Stock with an exercise price of $0.0475 per share.<br/>
</font>
</div><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >Employment agreements<br/>
</font>
</font>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >On July 11, 2011, the Company&#8217;s Board of Directors approved the terms of employment for each of James A. Hayward, the Company&#8217;s Chief Executive Officer, and Kurt H. Jensen, the Company&#8217;s Chief Financial Officer.&#160;&#160;It is
</font><font style="display:inline;font-family:times new roman;font-size:10pt;" >anticipated that new employment agreements will be entered into as soon as practicable reflecting these terms.&#160;&#160;<br/>
</font>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >In connection with his employment agreement, Dr. Hayward was granted options to purchase 40 million shares of the Company&#8217;s Common Stock at an exercise price per share equal to the average of the bid and asked prices of the Company&#8217;s Common Stock on the Over The Counter (OTC) Bulletin Board on the date of grant..&#160;&#160;The option will vest as follows: 25% on the grant date, and 37.5% on each of the next two anniversaries of the grant date, subject to Dr. Hayward&#8217;s continuous employment.&#160;&#160;If Company revenues for any fiscal quarter increase by more than $1 million over the prior fiscal quarter, then the vesting date for the next 37.5% tranche will be accelerated.&#160;&#160;Exercisability of options for the 40 million shares will be conditioned upon stockholder approval of an amendment of the Company&#8217;s 2005 Incentive Stock Plan made by the Board of Directors increasing the&#160;&#160;aggregate and individual limits on the shares of Company Common Stock issuable under the Plan.&#160;&#160;The Company also granted 15 million shares of the Company&#8217;s Common Stock to Dr. Hayward.
</font>
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" ><div><div style="text-align:left;width:100%;" ><font style="display:inline;font-family:times new roman;font-size:8pt;" >&#160;
</font>
</div>
</div><div style="page-break-after:always;width:100%;" ><div><p>
</p>
</div><div style="text-align:center;width:100%;" >
</div>
</div><div>
</div>
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >In addition, Dr. Hayward agreed to participate in the private placement described above and purchased 10,526,316 shares of the Company&#8217;s Common Stock using $500,000 recently advanced to the Company.&#160;&#160;The Company has
</font><font style="display:inline;font-family:times new roman;font-size:10pt;" >also agreed to issue a one-year senior secured convertible note bearing interest at a rate of 4% per annum in the principal amount of $250,000.<br/>
</font>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >In connection with his employment agreement, Mr. Jensen was granted options to purchase 10 million shares of the Company&#8217;s Common Stock at an exercise price per share equal to the average of the bid and asked prices of the Company&#8217;s Common Stock on the Over The Counter (OTC) Bulletin Board on the date of grant.&#160;&#160;The option will vest as follows: 25% on the grant date, and 37.5% on each of the next two anniversaries of the grant date, subject to Mr. Jensen&#8217;s continuous employment.&#160;&#160;If Company revenues for any fiscal quarter increase by more than $1 million over the prior fiscal quarter, then the vesting date for the next 37.5% tranche will be accelerated.<br/>
</font>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >C.F. Martin &amp; Co. Agreement<br/>
</font>
</font>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >On July 18, 2011, the Company entered into a Joint Development Agreement, dated as of June 30, 2011 with C.F. Martin &amp; Co., Inc., a designer and manufacturer of acoustic guitars, strings for acoustic guitars, and related guitar components and accessories (&#8220;Martin&#8221;). Under the terms of the agreement, Martin and the Company will jointly develop, create and apply new techniques and know-how for labeling and authenticating guitars, guitar strings and related guitar components and accessories using DNA security markers created by the Company.&#160;&#160;Under the agreement, each party shall bear and be responsible for its own expenses and costs of the development and creation of the techniques and know-how.<br/>
</font>
</div><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Subject to certain exceptions for the Company, the agreement provides for a period of exclusivity (&#8220;Period of Exclusivity&#8221;) of six (6) months beginning on June 30, 2011 whereby Martin and the Company agree not to sell, offer for sale, enter into any agreement with any third party for the future sale of, advertise, or market, anywhere in the world, any jointly developed technique for labeling guitars, guitar strings, and related guitar components and accessories with DNA security markers.&#160;&#160;The agreement also provides that Martin shall purchase DNA security markers exclusively from the Company during the longer of the term of the Agreement or the Period of Exclusivity.<br/>
</font>
</div><div style="text-align:left;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The term of the agreement will continue until the parties agree that the development and creation of techniques or know-how for labeling guitars or guitar strings with DNA security markers is complete, unless either party terminates the agreement by giving at least sixty (60) days written notice to the other party.
</font>
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div><div style="text-indent:0pt;margin-left:0pt;margin-right:0pt;" ><div><div style="text-align:left;width:100%;" ><font style="display:inline;font-family:times new roman;font-size:8pt;" >&#160;
</font>
</div>
</div><div style="page-break-after:always;width:100%;" ><div><p>
</p>
</div><div style="text-align:center;width:100%;" >
</div>
</div><div>
</div>
</div><div style="text-indent:0pt;display:block;" ><div><div style="text-indent:0pt;display:block;" ><div style="text-align:center;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" >
</div>
</div>
</div>
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;text-decoration:underline;" >Disc Graphics Agreement<br/>
</font>
</font>
</div><div style="text-indent:0pt;display:block;" >
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >On July 8, 2011, the Company entered into an agreement, dated as of July 7, 2011 with Disc Graphics Inc., a provider of specialty packaging (&#8220;DG&#8221;).<br/>
</font>
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="font-family:times new roman;font-size:10pt;" >
</font>
</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Under the terms of the agreement, DG will purchase DNA security markers from the Company to be incorporated into coatings for DG&#8217;s products.&#160;&#160;Additionally, DG will be the Company&#8217;s exclusive distributor in North America of Markers for the folding carton offset print sector and non-exclusive distributor of DNA security markers for pressure sensitive labels. Under the Agreement, the Company is obligated to provide DNA security markers for up to a fixed amount of coatings. The Company received an initial fee upon entering the agreement, and is entitled to an annual fee for the DNA security markers, as well as fees for any authentication services provided by the Company.&#160;&#160;The initial term of the agreement is three years and will automatically renew for successive one year periods, unless <br/>
</font><font style="display:inline;font-family:times new roman;font-size:10pt;" >either party terminates the agreement by giving written notice to the other party at least ninety (90) days prior to the end of the third year.&#160;&#160;After the initial term, the Company has the right to terminate if DG does not pay the annual fee.
</font>
</div><div>&#160;
</div><div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" ><font style="display:inline;text-decoration:underline;" >3SI Agreement<br/>
</font>
</font>
</div><div style="text-indent:0pt;display:block;" ><br />

</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >On August 9, 2011, the Company entered into a Supplier Agreement, dated as of August 3, 2011 (the &#8220;Supplier Agreement&#8221;), with 3SI Security Systems, Inc., a manufacturer and seller of asset protection security systems based on ink and smoke staining as well as GPS technology (&#8220;3SI&#8221;).&#160;&#160;&#160;On the same date, the parties also entered into a License Agreement, dated as of August 3, 2011 (the &#8220;License Agreement&#8221;).
</font>
</div><div style="text-indent:0pt;display:block;" ><br />

</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >Under the terms of the Supplier Agreement, 3SI will purchase DNA markers and related products (&#8220;Markers&#8221;) from the Company to be incorporated into products subject to certain patents (&#8220;Licensed Patents&#8221;) owned by 3SI (the &#8220;Products&#8221;).&#160;&#160;Pursuant to the License Agreement, 3SI granted a nonexclusive irrevocable license to the Company to make, have made, use, import, offer to sell and sell the Products.&#160;&#160;Under the terms of the Supplier Agreement, 3SI is permitted to purchase the Products from the Company from time to time pursuant to purchase orders.&#160;&#160;The purchase price for the Products will be as set forth in an applicable product schedule for the purchase orders and may be adjusted from time to time pursuant to the terms of the Supplier Agreement.&#160;&#160;Under the terms of the License Agreement, the Company agreed to pay an initial payment and royalties to 3SI based on the number of Products sold, with such royalties being subject to adjustment pursuant to the terms of the License Agreement.
</font>
</div><div style="text-indent:0pt;display:block;" ><br />

</div><div style="text-align:justify;text-indent:0pt;display:block;margin-left:0pt;margin-right:0pt;" ><font style="display:inline;font-family:times new roman;font-size:10pt;" >The terms of the Supplier Agreement and the License Agreement will continue until the expiration of the Licensed Patents, unless earlier terminated under the terms of the respective agreements.&#160;&#160;Under the terms of the Supplier Agreement, 3SI has the right to immediately terminate upon written notice to the Company in the event that the Company fails to continuously maintain a minimum number of Markers to be incorporated into the Products, or upon 30 days written notice to the Company.&#160;&#160;Under the terms of the License Agreement, 3SI has the right to immediately terminate upon written notice to the Company in the event that the Company fails to continuously maintain a minimum number of Markers, or fails to sell Markers to 3SI for incorporation into the Products for a certain time after being ordered.
</font>
</div>
</div>
</div>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SubsequentEventsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SubsequentEventsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
﻿<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=utf-8">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.3.0.11</span><table class="report" border="0" cellspacing="2" id="ID0E3IAG">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Jun. 30, 2011</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash and cash equivalents</a></td>
        <td class="nump">$ 12,464<span></span></td>
        <td class="nump">$ 17,618<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
        <td class="nump">177,833<span></span></td>
        <td class="nump">63,029<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
        <td class="nump">102,675<span></span></td>
        <td class="nump">161,456<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
        <td class="nump">292,972<span></span></td>
        <td class="nump">242,103<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment-net of accumulated depreciation of $210,862 and $207,097 respectively</a></td>
        <td class="text">&nbsp;<span></span></td>
        <td class="nump">3,765<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>Other assets:</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositAssets', window );">Deposits</a></td>
        <td class="nump">23,458<span></span></td>
        <td class="nump">8,322<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNoncurrentNet', window );">Capitalized finance costs-net of accumulated amortization of $1,678,872 and $947,276, respectively</a></td>
        <td class="nump">213,365<span></span></td>
        <td class="nump">522,489<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible assets:</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_apdn_FiniteLivedPatentsIntangibleAssetsNet', window );">Patents, net of accumulated amortization of $34,257 (Note B)</a></td>
        <td class="text">&nbsp;<span></span></td>
        <td class="text">&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intellectual property, net of accumulated amortization and write off of $9,067,109 and $8,794,265, respectively (Note B)</a></td>
        <td class="nump">363,791<span></span></td>
        <td class="nump">636,635<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
        <td class="nump">893,586<span></span></td>
        <td class="nump">1,413,314<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
        <td class="nump">1,316,371<span></span></td>
        <td class="nump">967,550<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToOfficersOrStockholdersCurrent', window );">Advances from officers</a></td>
        <td class="nump">600,000<span></span></td>
        <td class="nump">50,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Convertible notes payable, net of unamortized discount of $1,088,317 and $545,920, (Note D)</a></td>
        <td class="nump">2,951,683<span></span></td>
        <td class="nump">1,774,080<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
        <td class="nump">4,868,054<span></span></td>
        <td class="nump">2,791,630<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long term debt:</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesNoncurrent', window );">Convertible note payable-related party, net of unamortized discount of $5,286</a></td>
        <td class="text">&nbsp;<span></span></td>
        <td class="nump">219,714<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note H)</a></td>
        <td class="text">&nbsp;<span></span></td>
        <td class="text">&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Deficiency in Stockholder' Equity (Note F)</strong></a></td>
        <td class="text"> <span></span></td>
        <td class="text"> <span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- issued and outstanding as of June 30, 2011 and September 30, 2010</a></td>
        <td class="text">&nbsp;<span></span></td>
        <td class="text">&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.001 per share; 800,000,000 shares authorized; 352,523,001 and 346,366,244 issued and outstanding as of June 30, 2011 and September 30, 2010, respectively</a></td>
        <td class="nump">352,523<span></span></td>
        <td class="nump">346,366<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid in capital</a></td>
        <td class="nump">153,112,072<span></span></td>
        <td class="nump">149,396,907<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
        <td class="num">(157,439,063)<span></span></td>
        <td class="num">(151,341,303)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total deficiency in stockholders' equity</a></td>
        <td class="num">(3,974,468)<span></span></td>
        <td class="num">(1,598,030)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Deficiency in Stockholders' Equity</a></td>
        <td class="nump">$ 893,586<span></span></td>
        <td class="nump">$ 1,413,314<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_apdn_FiniteLivedPatentsIntangibleAssetsNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate sum of gross carrying value of a major Finite-Lived Patents Intangible Assets class, less accumulated amortization and any impairment charges. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>apdn_FiniteLivedPatentsIntangibleAssetsNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>apdn</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 20<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 19<br> -Article 5<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 3<br> -Subparagraph a(1)<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 4<br> -Article 5<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3-4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsReceivableNetCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 31<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdditionalPaidInCapitalCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 7<br> -Section 03<br> -Paragraph 12<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Topic 210<br> -SubTopic 10<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br> -Section S99<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -Paragraph 1<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Concepts (CON)<br> -Number 6<br> -Paragraph 25<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 18<br> -Article 5<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.18)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Assets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Section 45<br> -SubTopic 10<br> -Topic 210<br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Paragraph 1<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 9<br> -Article 5<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Unrestricted cash available for day-to-day operating needs, for an entity that has cash equivalents, but does not aggregate cash equivalents with cash on the balance sheet.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 1<br> -Article 5<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 95<br> -Paragraph 7<br> -Footnote 1<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Cash</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 17<br> -Article 9<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 7<br> -Section 03<br> -Paragraph 19<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 25<br> -Article 5<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6952336&amp;loc=d3e14326-108349<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 5<br> -Paragraph 8, 9<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingencies</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 20<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConvertibleNotesPayableCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNoncurrentNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net amount of long-term deferred finance costs capitalized at the end of the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Principles Board Opinion (APB)<br> -Number 21<br> -Paragraph 16<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 17<br> -Article 5<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28555-108399<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredFinanceCostsNoncurrentNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 17<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 8<br> -Article 5<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8,17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DepositAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToOfficersOrStockholdersCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amounts due to recorded owners or owners with a beneficial interest of more than 10 percent of the voting interests or officers of the company. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Paragraph 12<br> -Subparagraph a(1)<br> -Article 6<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 19<br> -Subparagraph a<br> -Article 5<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 4<br> -Section 08<br> -Paragraph k<br> -Subparagraph 1<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 57<br> -Paragraph 2<br> -Subparagraph d<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DueToOfficersOrStockholdersCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate sum of gross carrying value of a major finite-lived intangible asset class, less accumulated amortization and any impairment charges. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 142<br> -Paragraph 45<br> -Subparagraph a(1)<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6905858&amp;loc=d3e16323-109275<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetsNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all Liabilities and Stockholders' Equity items (or Partners' Capital, as applicable), including the portion of equity attributable to noncontrolling interests, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 32<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.32)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 7<br> -Section 03<br> -Paragraph 25<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesAndStockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 21<br> -Article 5<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LongTermDebtNoncurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 4<br> -Section 08<br> -Paragraph k<br> -Subparagraph 1<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.23)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 57<br> -Paragraph 2<br> -Subparagraph d<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 23<br> -Article 5<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NotesPayableRelatedPartiesNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherAssetsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 129<br> -Paragraph 2, 3, 4, 5, 6, 7, 8<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Principles Board Opinion (APB)<br> -Number 12<br> -Paragraph 10<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.28)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Article 3<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 5<br> -Section 02<br> -Paragraph 29<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6386993&amp;loc=d3e5879-108316<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 43<br> -Section A<br> -Paragraph 4<br> -Chapter 3<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Assets<br> -URI http://asc.fasb.org/extlink&amp;oid=6509628<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6787-107765<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PrepaidExpenseCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tangible assets that are held by an entity for use in the production or supply of goods and services, for rental to others, or for administrative purposes and that are expected to provide economic benefit for more than one year; net of accumulated depreciation. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 7<br> -Section 03<br> -Paragraph 8<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 13<br> -Subparagraph a<br> -Article 5<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Statement of Financial Accounting Standard (FAS)<br> -Number 12<br> -Paragraph 5<br> -Subparagraph b, c<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Principles Board Opinion (APB)<br> -Number 12<br> -Paragraph 10<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 31<br> -Article 5<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Article 3<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RetainedEarningsAccumulatedDeficit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of Stockholders' Equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity including portions attributable to both the parent and noncontrolling interests (previously referred to as minority interest), if any. The entity including portions attributable to the parent and noncontrolling interests is sometimes referred to as the economic entity. This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=6921628&amp;loc=SL4568740-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=6922042&amp;loc=SL4590271-111686<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Name Accounting Research Bulletin (ARB)<br> -Publisher AICPA<br> -Number 51<br> -Paragraph 26<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph A3<br> -Appendix A<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher AICPA<br> -Name Accounting Research Bulletin (ARB)<br> -Number 51<br> -Paragraph 25<br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=6921628&amp;loc=SL4568447-111683<br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<FilingSummary xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.3.0.11</Version>
  <ProcessingTime />
  <ReportFormat>Html</ReportFormat>
  <ReportType />
  <ContextCount>9</ContextCount>
  <ElementCount>93</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report>
      <IsDefault>true</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>01 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>02 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/StatementOfFinancialPositionClassified</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>03 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/CondensedConsolidatedBalanceSheetsParentheticals</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>04 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/StatementOfIncome</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>05 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/StatementOfCashFlowsIndirect</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>06 - Disclosure - SUMMARY OF ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/SummaryOfAccountingPolicies</Role>
      <ShortName>SUMMARY OF ACCOUNTING POLICIES</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>07 - Disclosure - INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/IntangibleAssets</Role>
      <ShortName>INTANGIBLE ASSETS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>08 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/AccountsPayableAndAccruedLiabilities</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>09 - Disclosure - CONVERTIBLE NOTES</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.adnas.com/role/PrivatePlacementOfConvertibleNotes</Role>
      <ShortName>CONVERTIBLE NOTES</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>10 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/RelatedPartyTransactions</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>11 - Disclosure - CAPITAL STOCK</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/CapitalStock</Role>
      <ShortName>CAPITAL STOCK</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>12 - Disclosure - STOCK OPTIONS AND WARRANTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/StockOptionsAndWarrants</Role>
      <ShortName>STOCK OPTIONS AND WARRANTS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>13 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>14 - Disclosure - FAIR VALUE MEASUREMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/FairValueMeasurement</Role>
      <ShortName>FAIR VALUE MEASUREMENT</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>15 - Disclosure - GOING CONCERN</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/GoingConcern</Role>
      <ShortName>GOING CONCERN</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>16 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adnas.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Info">Process Flow-Through: 02 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</Log>
    <Log type="Info">Process Flow-Through: 03 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)</Log>
    <Log type="Info">Process Flow-Through: 04 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</Log>
    <Log type="Info">Process Flow-Through: 05 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS</Log>
  </Logs>
  <InputFiles>
    <File>apdn-20110630.xml</File>
    <File>apdn-20110630.xsd</File>
    <File>apdn-20110630_cal.xml</File>
    <File>apdn-20110630_def.xml</File>
    <File>apdn-20110630_lab.xml</File>
    <File>apdn-20110630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles />
  <BaseTaxonomies />
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>34
<FILENAME>Financial_Report.xls
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xls
M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O
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M<B!E9&ET;W(@9&]E<VXG="!S=7!P;W)T(%=E8B!!<F-H:79E(&9I;&5S+B`@
M4&QE87-E(&1O=VYL;V%D(&$@8G)O=W-E<B!T:&%T('-U<'!O<G1S(%=E8B!!
M<F-H:79E+"!S=6-H(&%S($UI8W)O<V]F="!);G1E<FYE="!%>'!L;W)E<BX-
M"@T*+2TM+2TM/5].97AT4&%R=%\T,#@X-V5E9%]D8F)B7S0Y,&-?8F$Y-U]B
M83<V-&,W-#(X,#D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-#`X
M.#=E961?9&)B8E\T.3!C7V)A.3=?8F$W-C1C-S0R.#`Y+U=O<FMB;V]K+FAT
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M;V9T+6-O;3IO9F9I8V4Z97AC96PB('AM;&YS/3-$(FAT='`Z+R]W=W<N=S,N
M;W)G+U12+U)%0RUH=&UL-#`B/@T*/&AE860^#0H\;65T82!N86UE/3-$(D5X
M8V5L(%=O<FMB;V]K($9R86UE<V5T(CX-"@T*/&UE=&$@;F%M93TS1%!R;V=)
M9"!C;VYT96YT/3-$17AC96PN4VAE970^#0H\;&EN:R!R96P],T1&:6QE+4QI
M<W0@:')E9CTS1")7;W)K<VAE971S+V9I;&5L:7-T+GAM;"(^#0H-"CPA+2U;
M:68@9W1E(&US;R`Y73X\>&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX
M.D5X8V5L5V]R:W-H965T<SX-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^1&]C=6UE;G1?86YD7T5N=&ET>5]);F9O<FUA=&EO/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`Q+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0T].1$5.4T5$7T-/
M3E-/3$E$051%1%]"04Q!3D-%/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`R+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^0T].1$5.4T5$7T-/3E-/3$E$051%1%]"04Q!3D-%,3PO
M>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E=',O4VAE970P,RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^
M#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D-/3D1%3E-%
M1%]#3TY33TQ)1$%4141?4U1!5$5-13PO>#I.86UE/@T*("`@(#QX.E=O<FMS
M:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970P-"YH=&UL(B\^
M#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@("`\>#I.86UE/D-/3D1%3E-%1%]#3TY33TQ)1$%4141?4U1!5$5-
M13$\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7
M;W)K<VAE971S+U-H965T,#4N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H
M965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y354U-
M05)97T]&7T%#0T]53E1)3D=?4$],24-)15,\+W@Z3F%M93X-"B`@("`\>#I7
M;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,#8N:'1M
M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K
M<VAE970^#0H@("`@/'@Z3F%M93Y)3E1!3D=)0DQ%7T%34T544SPO>#I.86UE
M/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O
M4VAE970P-RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D%#0T]53E137U!!64%"
M3$5?04Y$7T%#0U)5141?3#PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O
M=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970P."YH=&UL(B\^#0H@("`\
M+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M("`\>#I.86UE/D-/3E9%4E1)0DQ%7TY/5$53/"]X.DYA;64^#0H@("`@/'@Z
M5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`Y+FAT
M;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R
M:W-H965T/@T*("`@(#QX.DYA;64^4D5,051%1%]005)465]44D%.4T%#5$E/
M3E,\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7
M;W)K<VAE971S+U-H965T,3`N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H
M965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y#05!)
M5$%,7U-43T-+/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2
M968],T0B5V]R:W-H965T<R]3:&5E=#$Q+FAT;6PB+SX-"B`@(#PO>#I%>&-E
M;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA
M;64^4U1/0TM?3U!424].4U]!3D1?5T%24D%.5%,\+W@Z3F%M93X-"B`@("`\
M>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,3(N
M:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7
M;W)K<VAE970^#0H@("`@/'@Z3F%M93Y#3TU-251-14Y44U]!3D1?0T].5$E.
M1T5.0TE%4SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F
M/3-$(E=O<FMS:&5E=',O4VAE970Q,RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7
M;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE
M/D9!25)?5D%,545?345!4U5214U%3E0\+W@Z3F%M93X-"B`@("`\>#I7;W)K
M<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,30N:'1M;"(O
M/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE
M970^#0H@("`@/'@Z3F%M93Y'3TE.1U]#3TY#15)./"]X.DYA;64^#0H@("`@
M/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#$U
M+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L
M5V]R:W-H965T/@T*("`@(#QX.DYA;64^4U5"4T51545.5%]%5D5.5%,\+W@Z
M3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE
M971S+U-H965T,38N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*
M("`\+W@Z17AC96Q7;W)K<VAE971S/@T*("`\>#I3='EL97-H965T($A2968]
M,T0B5V]R:W-H965T<R]R97!O<G0N8W-S(B\^#0H@(#QX.D%C=&EV95-H965T
M/C`\+W@Z06-T:79E4VAE970^#0H@(#QX.E!R;W1E8W13=')U8W1U<F4^1F%L
M<V4\+W@Z4')O=&5C=%-T<G5C='5R93X-"B`@/'@Z4')O=&5C=%=I;F1O=W,^
M1F%L<V4\+W@Z4')O=&5C=%=I;F1O=W,^#0H@/"]X.D5X8V5L5V]R:V)O;VL^
M#0H\+WAM;#X\(5ME;F1I9ETM+3X-"CPO:&5A9#X-"B`@/&)O9'D^#0H@("`\
M<#Y4:&ES('!A9V4@<VAO=6QD(&)E(&]P96YE9"!W:71H($UI8W)O<V]F="!%
M>&-E;"!84"!O<B!N97=E<BX\+W`^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*
M+2TM+2TM/5].97AT4&%R=%\T,#@X-V5E9%]D8F)B7S0Y,&-?8F$Y-U]B83<V
M-&,W-#(X,#D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-#`X.#=E
M961?9&)B8E\T.3!C7V)A.3=?8F$W-C1C-S0R.#`Y+U=O<FMS:&5E=',O4VAE
M970P,2YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M
M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB
M=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P
M+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C
M:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@
M<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J
M+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S
M/3-$<F5P;W)T(&ED/3-$240P131+044^#0H@("`@("`\='(^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O
M;F<^1&]C=6UE;G0@86YD($5N=&ET>2!);F9O<FUA=&EO;CQB<CX\+W-T<F]N
M9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XY
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0Q/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$Q/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/D%U9RX@,3`L(#(P,3$\8G(^/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1&]C=6UE;G0@
M86YD($5N=&ET>2!);F9O<FUA=&EO;B!;06)S=')A8W1=/"]S=')O;F<^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N=&ET>2!296=I<W1R
M86YT($YA;64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/D%04$Q)
M140@1$Y!(%-#245.0T53($E.0SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^16YT:71Y($-E;G1R86P@26YD97@@2V5Y
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XP,#`P-S0T-#4R/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4
M<F%D:6YG(%-Y;6)O;#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M87!D;CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^16YT:71Y($-U<G)E;G0@4F5P;W)T:6YG(%-T871U<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^665S/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;G1I='D@5F]L=6YT87)Y
M($9I;&5R<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^3F\\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-U
M<G)E;G0@1FES8V%L(%EE87(@16YD($1A=&4\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/BTM,#DM,S`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N=&ET>2!&:6QE<B!#871E9V]R>3PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^4VUA;&QE<B!297!O<G1I
M;F<@0V]M<&%N>3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^16YT:71Y($-O;6UO;B!3=&]C:RP@4VAA<F5S($]U='-T
M86YD:6YG/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-S(L-S@V
M+#$V,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^1&]C=6UE;G0@5'EP93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^,3`M43QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^1&]C=6UE;G0@4&5R:6]D($5N9"!$871E/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#Y*=6X@,S`L#0H)"3(P,3$\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%M96YD
M;65N="!&;&%G/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#YF86QS
M93QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^1&]C=6UE;G0@1FES8V%L(%EE87(@1F]C=7,\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/C(P,3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1O8W5M96YT($9I<V-A;"!097)I;V0@
M1F]C=7,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/E$S/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO
M8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T,#@X-V5E9%]D
M8F)B7S0Y,&-?8F$Y-U]B83<V-&,W-#(X,#D-"D-O;G1E;G0M3&]C871I;VXZ
M(&9I;&4Z+R\O0SHO-#`X.#=E961?9&)B8E\T.3!C7V)A.3=?8F$W-C1C-S0R
M.#`Y+U=O<FMS:&5E=',O4VAE970P,BYH=&UL#0I#;VYT96YT+51R86YS9F5R
M+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E
M>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A
M9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E
M;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4]
M,T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M
M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^
M#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P13-)04<^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q
M(')O=W-P86X],T0Q/CQS=')O;F<^0T].1$5.4T5$($-/3E-/3$E$051%1"!"
M04Q!3D-%(%-(14544R`H55-$("9N8G-P.R0I/&)R/CPO<W1R;VYG/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,3$\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q,#QB<CX\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#=7)R
M96YT(&%S<V5T<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^0V%S:"!A;F0@8V%S:"!E<75I=F%L96YT<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)FYB<W`[)"`Q,BPT-C0\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD(#$W
M+#8Q.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^06-C;W5N=',@<F5C96EV86)L93PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,3<W+#@S,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C8S+#`R.3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')E<&%I9"!E>'!E;G-E<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`R+#8W-3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$V,2PT-38\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y4;W1A;"!C=7)R96YT(&%S<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,CDR+#DW,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C(T,BPQ,#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;W!E<G1Y+"!P;&%N="!A;F0@
M97%U:7!M96YT+6YE="!O9B!A8V-U;75L871E9"!D97!R96-I871I;VX@;V8@
M)FYB<W`[)#(Q,"PX-C(@86YD("9N8G-P.R0R,#<L,#DW(')E<W!E8W1I=F5L
M>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RPW-C4\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/CQS=')O;F<^3W1H97(@87-S971S.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y$97!O<VET<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,C,L-#4X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^."PS,C(\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-A<&ET86QI>F5D(&9I;F%N
M8V4@8V]S=',M;F5T(&]F(&%C8W5M=6QA=&5D(&%M;W)T:7IA=&EO;B!O9B`F
M;F)S<#LD,2PV-S@L.#<R(&%N9"`F;F)S<#LD.30W+#(W-BP@<F5S<&5C=&EV
M96QY/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,3,L,S8U/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3(R
M+#0X.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^/'-T<F]N9SY);G1A;F=I8FQE(&%S<V5T<SH\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4&%T96YT<RP@;F5T(&]F
M(&%C8W5M=6QA=&5D(&%M;W)T:7IA=&EO;B!O9B`F;F)S<#LD,S0L,C4W("A.
M;W1E($(I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#L\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF
M;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/DEN=&5L;&5C='5A;"!P<F]P97)T>2P@;F5T(&]F(&%C8W5M=6QA
M=&5D(&%M;W)T:7IA=&EO;B!A;F0@=W)I=&4@;V9F(&]F("9N8G-P.R0Y+#`V
M-RPQ,#D@86YD("9N8G-P.R0X+#<Y-"PR-C4L(')E<W!E8W1I=F5L>2`H3F]T
M92!"*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S8S+#<Y,3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8S
M-BPV,S4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y4;W1A;"!!<W-E=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C@Y,RPU.#8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ+#0Q,RPS,30\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0W5R<F5N="!L:6%B
M:6QI=&EE<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^06-C;W5N=',@<&%Y86)L92!A;F0@86-C<G5E9"!L:6%B:6QI=&EE
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PS,38L,S<Q/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.38W
M+#4U,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^061V86YC97,@9G)O;2!O9F9I8V5R<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-C`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C4P+#`P,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]N=F5R=&EB;&4@;F]T
M97,@<&%Y86)L92P@;F5T(&]F('5N86UO<G1I>F5D(&1I<V-O=6YT(&]F("9N
M8G-P.R0Q+#`X."PS,3<@86YD("9N8G-P.R0U-#4L.3(P+"`H3F]T92!$*3PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPY-3$L-C@S/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PW-S0L
M,#@P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^5&]T86P@8W5R<F5N="!L:6%B:6QI=&EE<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-"PX-C@L,#4T/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPW.3$L-C,P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/DQO;F<@=&5R;2!D96)T.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y#;VYV97)T:6)L92!N;W1E('!A>6%B;&4M<F5L871E
M9"!P87)T>2P@;F5T(&]F('5N86UO<G1I>F5D(&1I<V-O=6YT(&]F("9N8G-P
M.R0U+#(X-CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,C$Y+#<Q-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^0V]M;6ET;65N=',@86YD(&-O;G1I;F=E;F-I97,@*$YO=&4@
M2"D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P
M.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY$969I8VEE;F-Y(&EN(%-T;V-K:&]L9&5R)R!%<75I='D@
M*$YO=&4@1BD\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4')E9F5R<F5D('-T;V-K+"!P87(@=F%L=64@)FYB<W`[)#`N,#`Q
M('!E<B!S:&%R93L@,3`L,#`P+#`P,"!S:&%R97,@875T:&]R:7IE9#L@+3`M
M(&ES<W5E9"!A;F0@;W5T<W1A;F1I;F<@87,@;V8@2G5N92`S,"P@,C`Q,2!A
M;F0@4V5P=&5M8F5R(#,P+"`R,#$P/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:RP@<&%R('9A;'5E
M("9N8G-P.R0P+C`P,2!P97(@<VAA<F4[(#@P,"PP,#`L,#`P('-H87)E<R!A
M=71H;W)I>F5D.R`S-3(L-3(S+#`P,2!A;F0@,S0V+#,V-BPR-#0@:7-S=65D
M(&%N9"!O=71S=&%N9&EN9R!A<R!O9B!*=6YE(#,P+"`R,#$Q(&%N9"!397!T
M96UB97(@,S`L(#(P,3`L(')E<W!E8W1I=F5L>3PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,S4R+#4R,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C,T-BPS-C8\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%D9&ET:6]N86P@<&%I
M9"!I;B!C87!I=&%L/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M-3,L,3$R+#`W,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$T.2PS.38L.3`W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-U;75L871E9"!D969I8VET/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q-3<L-#,Y+#`V,RD\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q-3$L
M,S0Q+#,P,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y4;W1A;"!D969I8VEE;F-Y(&EN('-T;V-K:&]L9&5R<R<@
M97%U:71Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S+#DW-"PT
M-C@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH,2PU.3@L,#,P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E1O=&%L($QI86)I;&ET:65S(&%N9"!$969I8VEE
M;F-Y(&EN(%-T;V-K:&]L9&5R<R<@17%U:71Y/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XF;F)S<#LD(#@Y,RPU.#8\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XF;F)S<#LD(#$L-#$S+#,Q
M-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE
M/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-#`X
M.#=E961?9&)B8E\T.3!C7V)A.3=?8F$W-C1C-S0R.#`Y#0I#;VYT96YT+4QO
M8V%T:6]N.B!F:6QE.B\O+T,Z+S0P.#@W965D7V1B8F)?-#DP8U]B83DW7V)A
M-S8T8S<T,C@P.2]7;W)K<VAE971S+U-H965T,#,N:'1M;`T*0V]N=&5N="U4
M<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4
M>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-
M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP
M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP
M="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@
M3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@
M(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5!
M4$%%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS
M<&%N/3-$,2!R;W=S<&%N/3-$,3X\<W1R;VYG/D-/3D1%3E-%1"!#3TY33TQ)
M1$%4140@0D%,04Y#12!32$5%5%,@*%!A<F5N=&AE=&EC86QS*2`H55-$("9N
M8G-P.R0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/DIU;BX@,S`L(#(P,3$\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^4V5P+B`S,"P@,C`Q,#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY3=&%T96UE;G0@3V8@1FEN86YC:6%L(%!O
M<VET:6]N(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^06-C=6UU;&%T960@9&5P<F5C:6%T:6]N(&]N(%!R
M;W!E<G1Y+"!P;&%N="!A;F0@97%U:7!M96YT("AI;B!D;VQL87)S*3PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)FYB<W`[)"`R,3`L.#8R/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)FYB
M<W`[)"`R,#<L,#DW/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y!8V-U;75L871E9"!A;6]R=&EZ871I;VX@;VX@0V%P
M:71A;&EZ960@9FEN86YC92!C;W-T<R`H:6X@9&]L;&%R<RD\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$L-C<X+#@W,CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDT-RPR-S8\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C8W5M
M=6QA=&5D(&%M;W)T:7IA=&EO;B!O;B!0871E;G1S("AI;B!D;VQL87)S*3PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S0L,C4W/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S0L,C4W/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!
M8V-U;75L871E9"!A;6]R=&EZ871I;VX@86YD('=R:71E(&]F9B!O;B!);G1E
M;&QE8W1U86P@<')O<&5R='D@*&EN(&1O;&QA<G,I/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XY+#`V-RPQ,#D\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX+#<Y-"PR-C4\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E5N86UO<G1I
M>F5D(&1I<V-O=6YT(&]N($-O;G9E<G1I8FQE(&YO=&5S('!A>6%B;&4L(&-U
M<G)E;G0@*&EN(&1O;&QA<G,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ+#`X."PS,3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XU-#4L.3(P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y5;F%M;W)T:7IE9"!D:7-C;W5N="!O
M;B!#;VYV97)T:6)L92!N;W1E('!A>6%B;&4M<F5L871E9"!P87)T>2P@;F]N
M+6-U<G)E;G0@*&EN(&1O;&QA<G,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XF;F)S<#LD(#4L,C@V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)FYB<W`[)"`U+#(X-CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')E9F5R<F5D
M('-T;V-K+"!P87(@=F%L=64@*&EN(&1O;&QA<G,@<&5R('-H87)E*3PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)FYB<W`[)"`P+C`P,3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B9N8G-P
M.R0@,"XP,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E!R969E<G)E9"!S=&]C:RP@<VAA<F5S(&%U=&AO<FEZ960\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P+#`P,"PP,#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,"PP
M,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y0<F5F97)R960@<W1O8VLL('-H87)E<R!I<W-U960\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F5F97)R960@<W1O8VLL
M('-H87)E<R!O=71S=&%N9&EN9SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D-O;6UO;B!S=&]C:RP@<&%R('9A;'5E("AI;B!D;VQL87)S
M('!E<B!S:&%R92D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B9N
M8G-P.R0@,"XP,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XF;F)S<#LD(#`N,#`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VLL('-H87)E
M<R!A=71H;W)I>F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX
M,#`L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C@P,"PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VLL('-H87)E<R!I
M<W-U960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,U,BPU,C,L
M,#`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,S0V+#,V-BPR-#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:RP@<VAA<F5S(&]U='-T86YD
M:6YG/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-3(L-3(S+#`P
M,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C,T-BPS-C8L,C0T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].
M97AT4&%R=%\T,#@X-V5E9%]D8F)B7S0Y,&-?8F$Y-U]B83<V-&,W-#(X,#D-
M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-#`X.#=E961?9&)B8E\T
M.3!C7V)A.3=?8F$W-C1C-S0R.#`Y+U=O<FMS:&5E=',O4VAE970P-"YH=&UL
M#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE
M#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB
M#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$
M0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T
M9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO
M=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T
M/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T
M(&ED/3-$240P14)$04<^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^0T].1$5.
M4T5$($-/3E-/3$E$051%1"!35$%414U%3E13($]&($]015)!5$E/3E,@*%53
M1"`F;F)S<#LD*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:"!C;VQS<&%N/3-$,CXS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0R/CD@36]N=&AS($5N9&5D
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/DIU;BX@,S`L(#(P,3$\8G(^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,#QB<CX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,3`\8G(^/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E=F5N=64\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B9N8G-P.R0@,C(Y+#<Q,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B9N8G-P.R0@,3<P+#$Y
M-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B9N8G-P.R0@-C@W+#DW,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B9N8G-P.R0@-#,P+#$X-3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY/<&5R
M871I;F<@97AP96YS97,Z/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E-E;&QI;F<L(&=E;F5R86P@86YD(&%D;6EN:7-T<F%T
M:79E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#4X,"PW.#@\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR
M+#4R.2PW-S<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XT+#4R.2PS-3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XU+#,V,RPR,34\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E<V5A<F-H(&%N9"!D979E
M;&]P;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#<L.3@X
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,3@L,30R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,38Q+#8T-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C0T+#DT-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^1&5P<F5C:6%T:6]N(&%N9"!A;6]R=&EZ
M871I;VX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDQ+#@Y,CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDR
M+#@R,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C(W-BPV,#@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XR-S@L-C$Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@;W!E<F%T:6YG(&5X<&5N<V5S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#<R,"PV-C@\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#8T
M,"PW-#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XT+#DV-RPV,#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XU+#8X-BPW-S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.150@3$]34R!&4D]-($]015)!
M5$E/3E,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L-#DP+#DU
M."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B@R+#0W,"PU-#<I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH-"PR-SDL-C,U*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^*#4L,C4V+#4Y,RD\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]T:&5R(&EN8V]M
M92`H3F]T92!#*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB
M<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y);G1E<F5S="!E>'!E;G-E+"!N970\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#8V-"PP,S<I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,3(V+#,X."D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q+#@Q
M."PQ,C4I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH-3,W+#(U,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y.970@;&]S<R!B969O<F4@<')O=FES:6]N(&9O
M<B!I;F-O;64@=&%X97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#(L,34T+#DY-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@R+#4Y-BPY,S4I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH-BPP.3<L-S8P*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#4L-SDS+#@T-2D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN
M8V]M92!T87AE<R`H8F5N969I="D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DY%5"!,3U-3/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B9N8G-P.R0@*#(L,34T+#DY
M-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B9N8G-P.R0@*#(L-3DV+#DS-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B9N8G-P.R0@*#8L,#DW+#<V,"D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B9N8G-P.R0@
M*#4L-SDS+#@T-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/DYE="!L;W-S('!E<B!S:&%R92UB87-I8R!A;F0@9G5L
M;'D@9&EL=71E9"`H:6X@9&]L;&%R<R!P97(@<VAA<F4I/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B9N8G-P.R0@*#`N,#$I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XF;F)S<#LD("@P+C`Q
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M)FYB<W`[)"`H,"XP,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B9N8G-P.R0@*#`N,#(I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y796EG:'1E9"!A=F5R86=E
M('-H87)E<R!O=71S=&%N9&EN9RU"87-I8R!A;F0@9G5L;'D@9&EL=71E9"`H
M:6X@<VAA<F5S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S4Q
M+#DV,BPR.#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XS,#$L,S8R+#,R.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C,U,"PX,C@L.3<S/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C@W+#0T."PW.3(\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@
M/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S0P.#@W965D
M7V1B8F)?-#DP8U]B83DW7V)A-S8T8S<T,C@P.0T*0V]N=&5N="U,;V-A=&EO
M;CH@9FEL93HO+R]#.B\T,#@X-V5E9%]D8F)B7S0Y,&-?8F$Y-U]B83<V-&,W
M-#(X,#DO5V]R:W-H965T<R]3:&5E=#`U+FAT;6P-"D-O;G1E;G0M5')A;G-F
M97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@
M=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH
M96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N
M=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP
M93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!2
M96UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D
M>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%0TI!1SX-
M"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS
M1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY#3TY$14Y3140@0T].4T],241!5$5$
M(%-4051%345.5"!/1B!#05-(($9,3U=3("A54T0@)FYB<W`[)"D\8G(^/"]S
M=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS
M1#(^.2!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,3QB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$P/&)R
M/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-A
M<V@@9FQO=W,@9G)O;2!O<&5R871I;F<@86-T:79I=&EE<SH\+W-T<F]N9SX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&QO<W,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)FYB<W`[)"`H-BPP.3<L-S8P
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M)FYB<W`[)"`H-2PW.3,L.#0U*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY!9&IU<W1M96YT<R!T;R!R
M96-O;F-I;&4@;F5T(&QO<W,@=&\@;F5T(&-A<V@@=7-E9"!I;B!O<&5R871I
M;F<@86-T:79I=&EE<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^1&5P<F5C:6%T:6]N(&%N9"!A;6]R=&EZ871I;VX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(W-BPV,#@\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-S@L-C$Y/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&
M86ER('9A;'5E(&]F('9E<W1E9"!O<'1I;VYS(&ES<W5E9"!T;R!O9F9I8V5R
M<RP@9&ER96-T;W)S(&%N9"!E;7!L;WEE97,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C0U.2PY-C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ+#DV.2PT.#,\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%M;W)T:7IA=&EO;B!O
M9B!C87!I=&%L:7IE9"!F:6YA;F-I;F<@8V]S=',\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C<S,2PU.34\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-3@L,38W/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!;6]R=&EZ871I;VX@
M;V8@9&5B="!D:7-C;W5N="!A='1R:6)U=&%B;&4@=&\@8V]N=F5R=&EB;&4@
M9&5B96YT=7)E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PU
M-#DL,C,P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,S,U+#,T,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^17%U:71Y(&)A<V5D(&-O;7!E;G-A=&EO;CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-38W+#`X,SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDU-BPT,S@\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O
M;6UO;B!S=&]C:R!I<W-U960@:6X@<V5T=&QE;65N="!O9B!I;G1E<F5S=#PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S0L.38P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`R+#<Y-#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY#:&%N9V4@:6X@87-S971S(&%N9"!L:6%B:6QI=&EE<SH\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5C<F5A
M<V4@:6X@86-C;W5N=',@<F5C96EV86)L93PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH,3$T+#@P-"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B@Y+#<V-BD\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E8W)E87-E("AI;F-R96%S
M92D@:6X@<')E<&%I9"!E>'!E;G-E<R!A;F0@9&5P;W-I=',\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C0S+#8T-3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(S+#(R,2D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN8W)E87-E
M(&EN(&%C8V]U;G1S('!A>6%B;&4@86YD(&%C8W)U960@;&EA8FEL:71I97,\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,T."PX,C(\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT.3<L,C0X
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^3F5T(&-A<V@@=7-E9"!I;B!O<&5R871I;F<@86-T:79I=&EE<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,BPR,#`L-C4T*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L-3(X+#<T
M,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D-A<V@@9FQO=W,@9G)O;2!I;G9E<W1I;F<@86-T:79I=&EE<SH\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T
M<F]N9SY#87-H(&9L;W=S(&9R;VT@9FEN86YC:6YG(&%C=&EV:71I97,Z/"]S
M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!P
M<F]C965D<R!F<F]M(')E;&%T960@<&%R='D@861V86YC97,\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C4U,"PP,#`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#L\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!P<F]C
M965D<R!F<F]M(&ES<W5A;F-E(&]F(&-O;G9E<G1I8FQE(&YO=&5S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#8T-2PU,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#,S-RPP,#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y.970@8V%S:"!P<F]V:61E9"!B>2!F:6YA;F-I;F<@86-T:79I=&EE<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPQ.34L-3`P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PS,S<L
M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^3F5T(&EN8W)E87-E(&EN(&-A<V@@86YD(&-A<V@@97%U:79A;&5N
M=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#4L,34T*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$Y,2PW
M-#$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y#87-H(&%N9"!C87-H(&5Q=6EV86QE;G1S(&%T(&)E9VEN;FEN9R!O
M9B!P97)I;V0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$W+#8Q
M.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C(Q,RPS,#<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D-A<V@@86YD(&-A<V@@97%U:79A;&5N=',@870@96YD(&]F
M('!E<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3(L-#8T
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,C$L-38V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/E-U<'!L96UE;G1A;"!$:7-C;&]S=7)E<R!O9B!#
M87-H($9L;W<@26YF;W)M871I;VXZ/"]S=')O;F<^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D-A<V@@<&%I9"!D=7)I;F<@=&AE('!E<FEO
M9"!F;W(@:6YT97)E<W0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^0V%S:"!P86ED(&1U<FEN9R!T:&4@<&5R:6]D(&9O
M<B!T87AE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/DYO;BUC87-H('1R86YS86-T:6]N<SH\+W-T<F]N
M9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1F%I<B!V86QU
M92!O9B!W87)R86YT<R!I<W-U960@9F]R(&9I;F%N8VEN9R!C;W-T<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C$W+#DW,3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M
M;6]N('-T;V-K(&ES<W5E9"!I;B!E>&-H86YG92!F;W(@<')E=FEO=7-L>2!I
M;F-U<G)E9"!D96)T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XF
M;F)S<#LD(#,X.2PY-C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XF;F)S<#LD(#$L.#`P+#`P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\
M+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-#`X.#=E961?9&)B8E\T.3!C
M7V)A.3=?8F$W-C1C-S0R.#`Y#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O
M+T,Z+S0P.#@W965D7V1B8F)?-#DP8U]B83DW7V)A-S8T8S<T,C@P.2]7;W)K
M<VAE971S+U-H965T,#8N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN
M9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[
M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@
M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E
M>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J
M879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES
M($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT
M86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$4R2#X-"B`@("`@(#QT<CX-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS
M1#(^/'-T<F]N9SY354U-05)9($]&($%#0T]53E1)3D<@4$],24-)15,\8G(^
M/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A
M;CTS1#$^.2!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,3QB
M<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY!
M8V-O=6YT:6YG(%!O;&EC:65S(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4U5-34%262!/1B!!0T-/54Y4
M24Y'(%!/3$E#2453/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
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M=#HP<'0[=&5X="UA;&EG;CIJ=7-T:69Y.R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/E1H92!A8V-O;7!A;GEI;F<@=6YA=61I=&5D(&-O;F1E
M;G-E9"!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',@87,@;V8@
M2G5N92`S,"P@,C`Q,2!A;F0@9F]R('1H92!T:')E92!A;F0@;FEN92!M;VYT
M:',@96YD960@2G5N92`S,"P@,C`Q,2!A;F0@,C`Q,"!A<F4@=6YA=61I=&5D
M+B!4:&5S92!F:6YA;F-I86P@<W1A=&5M96YT<R!H879E(&)E96X@<')E<&%R
M960@:6X@86-C;W)D86YC92!W:71H(%)U;&4@4RU8(&]F('1H92!396-U<FET
M:65S(&%N9"!%>&-H86YG92!#;VUM:7-S:6]N("AT:&4@)B,X,C(P.U-%0R8C
M.#(R,3LI(&%N9"!W:71H('1H92!I;G-T<G5C=&EO;G,@=&\@1F]R;2`Q,"U1
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M,S`L(#(P,3$@87)E(&YO="!N96-E<W-A<FEL>2!I;F1I8V%T:79E(&]F('1H
M92!R97-U;'1S('1H870@;6%Y(&)E(&5X<&5C=&5D(&9O<B!T:&4@9FES8V%L
M('EE87(@96YD:6YG(%-E<'1E;6)E<B`S,"P@,C`Q,2X@5&AE('5N875D:71E
M9"!C;VYD96YS960@8V]N<V]L:61A=&5D(&9I;F%N8VEA;"!S=&%T96UE;G1S
M('-H;W5L9"!B92!R96%D(&EN(&-O;FIU;F-T:6]N('=I=&@@=&AE(&-O;G-O
M;&ED871E9"!397!T96UB97(@,S`L(#(P,3`@9FEN86YC:6%L('-T871E;65N
M=',@86YD(&9O;W1N;W1E<R!T:&5R971O(&EN8VQU9&5D(&EN('1H92!#;VUP
M86YY)B,X,C$W.W,@06YN=6%L(%)E<&]R="!O;B!&;W)M(#$P+4LL(&%S(&%M
M96YD960L(&9I;&5D('=I=&@@=&AE(%-E8W5R:71I97,@86YD($5X8VAA;F=E
M($-O;6UI<W-I;VX@*'1H92`F(S@R,C`[4T5#)B,X,C(Q.RDN#0H\+V9O;G0^
M/&)R+SX-"CPO9&EV/CQD:78@<W1Y;&4],T1T97AT+6EN9&5N=#HP<'0[9&ES
M<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#MT
M97AT+6%L:6=N.FIU<W1I9GD[(#X-"CPO9&EV/CQD:78@<W1Y;&4],T1T97AT
M+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[;6%R
M9VEN+7)I9VAT.C!P=#MT97AT+6%L:6=N.FIU<W1I9GD[(#X\9F]N="!S='EL
M93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M
M86X[9F]N="US:7IE.C$P<'0[)R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II
M;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ
M,'!T.W1E>'0M9&5C;W)A=&EO;CIU;F1E<FQI;F4[)R`^0G5S:6YE<W,@86YD
M($)A<VES(&]F(%!R97-E;G1A=&EO;CQB<B\^#0H\+V9O;G0^#0H\+V9O;G0^
M#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ
M8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA
M;&EG;CIJ=7-T:69Y.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E
M;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR
M:6=H=#HP<'0[=&5X="UA;&EG;CIJ=7-T:69Y.R`^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<@/D]N(%-E<'1E;6)E<B`Q-BP@,C`P,BP@07!P;&EE
M9"!$3D$@4V-I96YC97,L($EN8RX@*'1H92`F(S@R,C`[0V]M<&%N>28C.#(R
M,3LI('=A<R!I;F-O<G!O<F%T960@=6YD97(@=&AE(&QA=W,@;V8@=&AE(%-T
M871E(&]F($YE=F%D82X@169F96-T:79E($1E8V5M8F5R(#$W+"`R,#`X+"!T
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M;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O
M;G0^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L
M87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X
M="UA;&EG;CIJ=7-T:69Y.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
M;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<@/E1H92!U;F%U9&ET960@8V]N9&5N<V5D(&-O;G-O;&ED871E9"!F:6YA
M;F-I86P@<W1A=&5M96YT<R!I;F-L=61E('1H92!A8V-O=6YT<R!O9B!T:&4@
M0V]M<&%N>2!A;F0@:71S('=H;VQL>2UO=VYE9"!S=6)S:61I87)I97,L($%P
M<&QI960@1$Y!($]P97)A=&EO;G,@36%N86=E;65N="P@26YC+BP@05!$3B`H
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M<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O
M;G0M<VEZ93HQ,'!T.W1E>'0M9&5C;W)A=&EO;CIU;F1E<FQI;F4[)R`^4F5V
M96YU92!296-O9VYI=&EO;CQB<B\^#0H\+V9O;G0^#0H\+V9O;G0^#0H\+V1I
M=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[
M;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA;&EG;CIJ
M=7-T:69Y.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T
M.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP
M<'0[=&5X="UA;&EG;CIJ=7-T:69Y.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA
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M:6=H=#HP<'0[=&5X="UA;&EG;CIJ=7-T:69Y.R`^#0H\+V1I=CX\9&EV('-T
M>6QE/3-$=&5X="UI;F1E;G0Z,'!T.VUA<F=I;BUL969T.C!P=#MM87)G:6XM
M<FEG:'0Z,'!T.R`^/&1I=CX\9&EV('-T>6QE/3-$=VED=&@Z,3`P)3MT97AT
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M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^
M#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ
M8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA
M;&EG;CIC96YT97([(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF
M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
M#0H\+V9O;G0^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T
M.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP
M<'0[=&5X="UA;&EG;CIC96YT97([(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y
M.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE
M.C$P<'0[)R`^#0H\+V9O;G0^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI
M;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I
M;BUR:6=H=#HP<'0[=&5X="UA;&EG;CIC96YT97([(#X\9F]N="!S='EL93TS
M1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[
M9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+V1I=CX\9&EV('-T>6QE
M/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z
M,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA;&EG;CIC96YT97([(#X\9F]N
M="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N
M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+V1I=CX\
M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.W1E>'0M:6YD96YT.C!P=#MD
M:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T
M.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
M=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*
M/"]D:78^/&1I=B!S='EL93TS1'1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L
M;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.W1E>'0M86QI
M9VXZ8V5N=&5R.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*
M/"]F;VYT/@T*/"]D:78^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E
M;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR
M:6=H=#HP<'0[=&5X="UA;&EG;CIJ=7-T:69Y.R`^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<@/D9O<B!R979E;G5E(&9R;VT@<')O9'5C="!S86QE
M<RP@=&AE($-O;7!A;GD@<F5C;V=N:7IE<R!R979E;G5E(&EN(&%C8V]R9&%N
M8V4@=VET:"!!8V-O=6YT:6YG(%-T86YD87)D<R!#;V1I9FEC871I;VX@<W5B
M=&]P:6,@-C`U+3$P+"!2979E;G5E(%)E8V]G;FET:6]N("@F(S@R,C`[05-#
M(#8P-2TQ,"8C.#(R,3LI+B!!4T,@-C`U+3$P(')E<75I<F5S('1H870@9F]U
M<B!B87-I8R!C<FET97)I82!M=7-T(&)E(&UE="!B969O<F4@<F5V96YU92!C
M86X@8F4@<F5C;V=N:7IE9#H@*#$I('!E<G-U87-I=F4@979I9&5N8V4@;V8@
M86X@87)R86YG96UE;G0@97AI<W1S.R`H,BD@9&5L:79E<GD@:&%S(`T*/"]F
M;VYT/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY
M.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#YO8V-U<G)E9#L@
M*#,I('1H92!S96QL:6YG('!R:6-E(&ES(&9I>&5D(&%N9"!D971E<FUI;F%B
M;&4[(&%N9"`H-"D@8V]L;&5C=&%B:6QI='D@:7,@<F5A<V]N86)L>2!A<W-U
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M92!R97%U:7)E9"X@070@2G5N92`S,"P@,C`Q,2!A;F0@4V5P=&5M8F5R(#,P
M+"`R,#$P+"!T:&4@0V]M<&%N>2!D:60@;F]T(')E8V]R9"!A;GD@9&5F97)R
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M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
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M.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L
M87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X
M="UA;&EG;CIJ=7-T:69Y.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
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M86-C;W5N=',@=VEL;"!C:&%N9V4N($%T($IU;F4@,S`L(#(P,3$@86YD(%-E
M<'1E;6)E<B`S,"P@,C`Q,"P@=&AE($-O;7!A;GD@:&%S(&1E96UE9"!T:&%T
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M="UA;&EG;CIJ=7-T:69Y.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
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M+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^4')O
M<&5R='D@86YD(&5Q=6EP;65N="!A<F4@<W1A=&5D(&%T(&-O<W0@86YD(&1E
M<')E8VEA=&5D(&]V97(@=&AE:7(@97-T:6UA=&5D('5S969U;"!L:79E<R!O
M9B`S('1O(#4@>65A<G,@=7-I;F<@=&AE('-T<F%I9VAT(&QI;F4@;65T:&]D
M+B!!="!*=6YE(#,P+"`R,#$Q(&%N9"!397!T96UB97(@,S`L(#(P,3`L('!R
M;W!E<G1Y(&%N9"!E<75I<&UE;G0@8V]N<VES="!O9CH-"CPO9F]N=#X-"CPO
M9&EV/CQD:78@<W1Y;&4],T1T97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C
M:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#MT97AT+6%L:6=N
M.FQE9G0[(#X-"CPO9&EV/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.F-E;G1E
M<CL@/CQT86)L92!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I
M9'1H/3-$-S`E('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA
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M969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT
M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P
M86X],T0R(#X\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ
M8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA
M;&EG;CIC96YT97([(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF
M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
M*%5N875D:71E9"D-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[
M(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT
M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\
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M;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*
M/"]F;VYT/@T*/"]T9#X-"CPO='(^/'1R/CQT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0T-B4@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@
M<V]L:60[=&5X="UA;&EG;CIL969T.R<@/CQF;VYT('-T>6QE/3-$)V1I<W!L
M87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ8FQA8VL@,G!X
M('-O;&ED.W1E>'0M86QI9VXZ<FEG:'0[)R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ8FQA8VL@,G!X('-O;&ED.R<@/CQD:78@<W1Y;&4],T1T97AT+6EN
M9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN
M+7)I9VAT.C!P=#MT97AT+6%L:6=N.F-E;G1E<CL@/CQF;VYT('-T>6QE/3-$
M)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG(#Y*=6YE(#,P+#QB<B`O/@T*/"]F;VYT/CQF;VYT
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M;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O
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M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
M4V5P=&5M8F5R(#,P+#QB<B`O/@T*/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1I
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M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/@T*
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M:7IE.C$P<'0[)R`^0V]M<'5T97(@97%U:7!M96YT#0H\+V9O;G0^#0H\+V1I
M=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ
M:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&1I=B!S='EL
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M+7)I9VAT.C!P=#MT97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<@/C(W+#0P-`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D
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M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&1I
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M;6%R9VEN+7)I9VAT.C!P=#MT97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@<W1Y
M;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/C(W+#0P-`T*/"]F;VYT/@T*/"]D:78^
M#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL
M:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG(#X-"CPO9F]N=#X-"CPO=&0^#0H\+W1R/CQT<CX\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$-#8E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^
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M;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
M86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F
M;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y
M;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&1I=B!S='EL93TS1'1E>'0M:6YD
M96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM
M<FEG:'0Z,'!T.W1E>'0M86QI9VXZ<FEG:'0[(#X\9F]N="!S='EL93TS1"=D
M:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N
M="US:7IE.C$P<'0[)R`^-S<L-#<S#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^
M/'1D#0H@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT
M+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF
M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
M#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[(#X\9F]N="!S='EL93TS1"=D
M:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N
M="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B
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M97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
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M=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
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M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.F)L86-K(#)P>"!S;VQI9#MT97AT+6%L:6=N.G)I9VAT.R<@/CQD:78@
M<W1Y;&4],T1T97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM
M;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#MT97AT+6%L:6=N.G)I9VAT.R`^
M/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM
M97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/C$P-2PY.#4-"CPO9F]N
M=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[=&5X
M="UA;&EG;CIL969T.R<@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE
M.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ8FQA8VL@,G!X('-O;&ED.W1E
M>'0M86QI9VXZ<FEG:'0[)R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
M;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[
M=&5X="UA;&EG;CIL969T.R<@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL
M:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#DE('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ8FQA8VL@,G!X('-O;&ED
M.W1E>'0M86QI9VXZ<FEG:'0[)R`^/&1I=B!S='EL93TS1'1E>'0M:6YD96YT
M.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG
M:'0Z,'!T.W1E>'0M86QI9VXZ<FEG:'0[(#X\9F]N="!S='EL93TS1"=D:7-P
M;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US
M:7IE.C$P<'0[)R`^,3`U+#DX-0T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.F)L86-K(#)P>"!S;VQI9#MT97AT+6%L:6=N.FQE9G0[)R`^/&9O
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M.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[(#X\9F]N="!S
M='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@
M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V
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M9VAT.C!P=#MT97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/C(Q,"PX-C(-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L
M:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT
M+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\
M+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[(#X\9F]N="!S='EL93TS1"=D:7-P
M;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US
M:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T
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M+6%L:6=N.G)I9VAT.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[
M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@
M/C(Q,"PX-C(-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\
M9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE
M<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D
M/@T*/"]T<CX\='(^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#0V)2!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.F)L86-K(#)P>"!S;VQI9#MT97AT+6%L
M:6=N.FQE9G0[)R`^/&1I=B!S='EL93TS1'1E>'0M:6YD96YT.C!P=#MD:7-P
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M8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[=&5X="UA;&EG;CIR:6=H
M=#LG(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL
M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^
M#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.F)L86-K(#)P>"!S;VQI9#MT97AT+6%L:6=N.FQE
M9G0[)R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT
M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[=&5X="UA;&EG;CIR
M:6=H=#LG(#X\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ
M8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA
M;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O
M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#XR
M,3`L.#8R#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ8FQA8VL@
M,G!X('-O;&ED.W1E>'0M86QI9VXZ;&5F=#LG(#X\9F]N="!S='EL93TS1"=D
M:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N
M="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B
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M9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"=B;W)D97(M8F]T=&]M.F)L
M86-K(#)P>"!S;VQI9#MT97AT+6%L:6=N.G)I9VAT.R<@/CQD:78@<W1Y;&4]
M,T1T97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP
M<'0[;6%R9VEN+7)I9VAT.C!P=#MT97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@
M<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W
M(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/C(P-RPP.3<-"CPO9F]N=#X-"CPO
M9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[=&5X="UA;&EG
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M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
M3F5T#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$<&%D9&EN9RUB;W1T;VTZ-'!X.W1E>'0M
M86QI9VXZ<FEG:'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF
M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
M#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"=B;W)D97(M8F]T=&]M.F)L86-K(#1P>"!D;W5B;&4[=&5X
M="UA;&EG;CIL969T.R<@/CQD:78@<W1Y;&4],T1T97AT+6EN9&5N=#HP<'0[
M9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P
M=#MT97AT+6%L:6=N.FQE9G0[(#X\9F]N=`T*('-T>6QE/3-$)V1I<W!L87DZ
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M;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#MT97AT+6%L:6=N.G)I9VAT.R`^
M/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM
M97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/BT-"CPO9F]N=#X-"CPO
M9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T1P861D:6YG+6)O='1O;3HT<'@[=&5X="UA;&EG;CIL969T.R`^/&9O
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M8VL@-'!X(&1O=6)L93MT97AT+6%L:6=N.FQE9G0[)R`^/&1I=B!S='EL93TS
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M+6%L:6=N.G)I9VAT.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[
M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@
M/C,L-S8U#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ8FQA8VL@
M-'!X(&1O=6)L93MT97AT+6%L:6=N.FQE9G0[)R`^/&9O;G0@<W1Y;&4],T0G
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M:78^/&1I=B!S='EL93TS1'=I9'1H.C$P,"4[=&5X="UA;&EG;CIL969T.R`^
M/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM
M97,@;F5W(')O;6%N.V9O;G0M<VEZ93HX<'0[)R`^#0H\+V9O;G0^#0H\+V1I
M=CX-"CPO9&EV/CQD:78@<W1Y;&4],T1P86=E+6)R96%K+6%F=&5R.F%L=V%Y
M<SMW:61T:#HQ,#`E.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ8V5N=&5R
M.W=I9'1H.C$P,"4[(#X-"CPO9&EV/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N
M.F-E;G1E<CMW:61T:#HQ,#`E.R`^#0H\+V1I=CX-"CPO9&EV/CQD:78^/&1I
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M=&5R.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I
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M4&QA;G0@86YD($5Q=6EP;65N="`H)B,X,C(P.T%30R`S-C`M,3`F(S@R,C$[
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M8G(@+SX-"CQB<B`O/@T*/"]F;VYT/@T*/"]D:78^#0H\+V1I=CX\9&EV('-T
M>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE
M9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA;&EG;CIJ=7-T:69Y.R`^
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M:')E92!A;F0@;FEN92!M;VYT:',@96YD960@2G5N92`S,"P@,C`Q,2!A;F0@
M,C`Q,"P@8V]M;6]N('-T;V-K(&5Q=6EV86QE;G0@<VAA<F5S(&%R92!E>&-L
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M=&5D('-H87)E<R!O=71S=&%N9&EN9R!W97)E(#0Y-BPU,#0L,C$X(&%N9"`T
M.34L,S<P+#DQ,"!F;W(@=&AE('1H<F5E(&UO;G1H(&%N9"!N:6YE(&UO;G1H
M<R!E;F1E9"!*=6YE(#,P+"`R,#$Q+"`@<F5S<&5C=&EV96QY+B!&=6QL>2!D
M:6QU=&5D('-H87)E<R!O=71S=&%N9&EN9R!W97)E(#,W,2PW.#4L-C8U(&%N
M9"`S-C(L,S<R+#$R."!F;W(@=&AE('1H<F5E(&%N9"!N:6YE(&UO;G1H<R!E
M;F1E9"!*=6YE(#,P+"`R,#$P+"!R97-P96-T:79E;'DN/&)R+SX-"CPO9F]N
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M="US:7IE.C$P<'0[)R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[
M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.W1E
M>'0M9&5C;W)A=&EO;CIU;F1E<FQI;F4[)R`^4W1O8VL@0F%S960@0V]M<&5N
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M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
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M9VYI>F5D('5N9&5R($%30R`W,3@M,3`@9F]R('1H92!N:6YE(&UO;G1H<R!E
M;F1E9"!*=6YE(#,P+"`R,#$Q(&%N9"`R,#$P('=A<R`F;F)S<#LD-#4Y+#DV
M-R!A;F0@)FYB<W`[)#4X-RPR,S4L(')E<W!E8W1I=F5L>2X\8G(O/@T*/"]F
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M;CMF;VYT+7-I>F4Z,3!P=#LG(#Y!<R!O9B!*=6YE(#,P+"`R,#$Q+"`W,"PT
M,#`L,#`P(&5M<&QO>65E('-T;V-K(&]P=&EO;G,@=V5R92!O=71S=&%N9&EN
M9R!W:71H(#0R+#4U,"PP,#`@<VAA<F5S('9E<W1E9"!A;F0@97AE<F-I<V%B
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M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.W1E>'0M9&5C;W)A=&EO;CIU;F1E<FQI;F4[)R`^0V]N8V5N
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M="UA;&EG;CIL969T.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E
M;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR
M:6=H=#HP<'0[=&5X="UA;&EG;CIJ=7-T:69Y.R`^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<@/E1H92!#;VUP86YY)B,X,C$W.W,@<F5V96YU97,@
M96%R;F5D(&9R;VT@<V%L92!O9B!P<F]D=6-T<R!A;F0@<V5R=FEC97,@9F]R
M('1H92!T:')E92!A;F0@;FEN92!M;VYT:',@96YD960@2G5N92`S,"P@,C`Q
M,2!I;F-L=61E9"!A;B!A9V=R96=A=&4@;V8@-C4E(&%N9"`U-B4@9G)O;2!F
M;W5R(&%N9"!T:')E92!C=7-T;VUE<G,@;V8@=&AE($-O;7!A;GDF(S@R,3<[
M<R!T;W1A;"!R979E;G5E<RP@<F5S<&5C=&EV96QY+B!&:79E(&%N9"!T:')E
M92!C=7-T;VUE<G,@86-C;W5N=&5D(&9O<B`Y,"4@86YD(#8U)2!O9B!T:&4@
M0V]M<&%N>28C.#(Q-SMS(')E=F5N=65S(&5A<FYE9"!F<F]M('-A;&4@;V8@
M<')O9'5C=',@86YD('-E<G9I8V5S(&9O<B!T:&4@=&AR964@86YD(&YI;F4@
M;6]N=&AS(&5N9&5D($IU;F4@,S`L(#(P,3`L(')E<W!E8W1I=F5L>2X\8G(O
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M=6YT960@9F]R(#8Y)2!A;F0@.3`E(&]F('1H92!#;VUP86YY)B,X,C$W.W,@
M=&]T86P@86-C;W5N=',@<F5C96EV86)L92!A="!*=6YE(#,P+"`R,#$Q(&%N
M9"!397!T96UB97(@,S`L(#(P,3`L(')E<W!E8W1I=F5L>2X-"CPO9F]N=#X-
M"CPO9&EV/CQD:78@<W1Y;&4],T1T97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB
M;&]C:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#MT97AT+6%L
M:6=N.FIU<W1I9GD[(#X-"CPO9&EV/CQD:78@<W1Y;&4],T1T97AT+6EN9&5N
M=#HP<'0[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9&EV
M/CQD:78@<W1Y;&4],T1W:61T:#HQ,#`E.W1E>'0M86QI9VXZ;&5F=#L@/CQF
M;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S
M(&YE=R!R;VUA;CMF;VYT+7-I>F4Z.'!T.R<@/@T*/"]F;VYT/@T*/"]D:78^
M#0H\+V1I=CX\9&EV/CQP/@T*/"]P/@T*/"]D:78^/&1I=CX\9&EV('-T>6QE
M/3-$=VED=&@Z,3`P)3MT97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@<W1Y;&4]
M,T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N
M.V9O;G0M<VEZ93HX<'0[)R`^#0H\+V9O;G0^#0H\+V1I=CX-"CPO9&EV/@T*
M/"]D:78^/&1I=B!S='EL93TS1'1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L
M;V-K.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I
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M.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L
M87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X
M="UA;&EG;CIC96YT97([(#X-"CPO9&EV/@T*/"]D:78^/&1I=B!S='EL93TS
M1'1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.R`^#0H\+V1I=CX\9&EV
M('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN
M+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA;&EG;CIL969T.R`^
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M.C$P<'0[)R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
M86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.W1E>'0M9&5C
M;W)A=&EO;CIU;F1E<FQI;F4[)R`^4F5S96%R8V@@86YD($1E=F5L;W!M96YT
M/&)R+SX-"CPO9F]N=#X-"CPO9F]N=#X-"CPO9&EV/CQD:78@<W1Y;&4],T1T
M97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SL@/@T*/"]D:78^/&1I=B!S
M='EL93TS1'1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL
M969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.W1E>'0M86QI9VXZ:G5S=&EF>3L@
M/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I
M;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#Y4:&4@0V]M<&%N>2!A
M8V-O=6YT<R!F;W(@<F5S96%R8V@@86YD(&1E=F5L;W!M96YT(&-O<W1S(&EN
M(&%C8V]R9&%N8V4@=VET:"!T:&4@06-C;W5N=&EN9R!3=&%N9&%R9',@0V]D
M:69I8V%T:6]N('-U8G1O<&EC(#<S,"TQ,"P@4F5S96%R8V@@86YD($1E=F5L
M;W!M96YT("@F(S@R,C`[05-#(#<S,"TQ,"8C.#(R,3LI+B!5;F1E<B!!4T,@
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M8W5R<F5D(')E<V5A<F-H(&%N9"!D979E;&]P;65N="!E>'!E;G-E<R!O9B`F
M;F)S<#LD-#<L.3@X(&%N9"`F;F)S<#LD,3@L,30R(&9O<B!T:&4@=&AR964@
M;6]N=&@@<&5R:6]D<R!E;F1E9"!*=6YE(#,P+"`R,#$Q(&%N9"`R,#$P+"!R
M97-P96-T:79E;'DL(&%N9"`F;F)S<#LD,38Q+#8T-2!A;F0@)FYB<W`[)#0T
M+#DT-"!F;W(@=&AE(&YI;F4@;6]N=&@@<&5R:6]D<R!E;F1E9"!*=6YE(#,P
M+"`R,#$Q(&%N9"`R,#$P+"!R97-P96-T:79E;'DN/&)R+SX-"CPO9F]N=#X-
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M="US:7IE.C$P<'0[)R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[
M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.W1E
M>'0M9&5C;W)A=&EO;CIU;F1E<FQI;F4[)R`^061V97)T:7-I;F<\8G(O/@T*
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M.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
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M;V1S(&5N9&5D($IU;F4@,S`L(#(P,3$L(')E<W!E8W1I=F5L>2P@86YD("9N
M8G-P.R0Q,BPR,C4@86YD("9N8G-P.R0S-RPV.#`@87,@861V97)T:7-I;F<@
M8V]S=',@9F]R('1H92!T:')E92!A;F0@;FEN92!M;VYT:"!P97)I;V1S(&5N
M9&5D($IU;F4@,S`L(#(P,3`L(')E<W!E8W1I=F5L>2X\8G(O/@T*/"]F;VYT
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M<'0[)R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.W1E>'0M9&5C;W)A
M=&EO;CIU;F1E<FQI;F4[)R`^26YT86YG:6)L92!!<W-E=',\8G(O/@T*/"]F
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M+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA;&EG;CIL969T.R`^
M#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ
M8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA
M;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
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M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^26X@=&AE(&9I
M<G-T('%U87)T97(@;V8@9FES8V%L('EE87(@,C`P."P@=&AE($-O;7!A;GD@
M861O<'1E9"!!8V-O=6YT:6YG(%-T86YD87)D<R!#;V1I9FEC871I;VX@<W5B
M=&]P:6,@.#(P+3$P+"!&86ER(%9A;'5E($UE87-U<F5M96YT<R!A;F0@1&ES
M8VQO<W5R97,@*"8C.#(R,#M!4T,@.#(P+3$P)B,X,C(Q.RDN($%30R`X,C`M
M,3`@9&5F:6YE<R!F86ER('9A;'5E+"!E<W1A8FQI<VAE<R!A(&9R86UE=V]R
M:R!F;W(@;65A<W5R:6YG(&9A:7(@=F%L=64L(&%N9"!E;FAA;F-E<R!F86ER
M('9A;'5E(&UE87-U<F5M96YT(&1I<V-L;W-U<F4N($%30R`X,C`M,3`@9&5L
M87EE9"P@=6YT:6P@=&AE(&9I<G-T('%U87)T97(@;V8@9FES8V%L('EE87(@
M,C`P.2P@=&AE(&5F9F5C=&EV92!D871E(&9O<B!!4T,@.#(P+3$P(&9O<B!A
M;&P@;F]N+69I;F%N8VEA;"!A<W-E=',@86YD(&YO;BUF:6YA;F-I86P@;&EA
M8FEL:71I97,L(&5X8V5P="!T:&]S92!T:&%T(&%R92!R96-O9VYI>F5D(&]R
M(&1I<V-L;W-E9"!A="!F86ER('9A;'5E(&EN('1H92!F:6YA;F-I86P@<W1A
M=&5M96YT<R!O;B!A(')E8W5R<FEN9R!B87-I<R`H870@;&5A<W0@86YN=6%L
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M;BUR:6=H=#HP<'0[=&5X="UA;&EG;CIL969T.R`^#0H\+V1I=CX\9&EV('-T
M>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE
M9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA;&EG;CIJ=7-T:69Y.R`^
M/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM
M97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/D5F9F5C=&EV92!/8W1O
M8F5R(#$L(#(P,#@L('1H92!#;VUP86YY(&%D;W!T960@06-C;W5N=&EN9R!3
M=&%N9&%R9',@0V]D:69I8V%T:6]N('-U8G1O<&EC(#@R,"TQ,"P@1F%I<B!6
M86QU92!-96%S=7)E;65N=',@86YD($1I<V-L;W-U<F5S("@F(S@R,C`[05-#
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M.C$P<'0[)R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
M86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.W1E>'0M9&5C
M;W)A=&EO;CIU;F1E<FQI;F4[)R`^4F5C96YT($%C8V]U;G1I;F<@4')O;F]U
M;F-E;65N=',-"CPO9F]N=#X-"CPO9F]N=#X\8G(O/@T*/"]D:78^/&1I=B!S
M='EL93TS1'1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL
M969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.W1E>'0M86QI9VXZ;&5F=#L@/@T*
M/"]D:78^/&1I=B!S='EL93TS1'1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L
M;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.W1E>'0M86QI
M9VXZ:G5S=&EF>3L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O
M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#Y4
M:&5R92!W97)E('9A<FEO=7,@=7!D871E<R!R96-E;G1L>2!I<W-U960L(&UO
M<W0@;V8@=VAI8V@@<F5P<F5S96YT960@=&5C:&YI8V%L(&-O<G)E8W1I;VYS
M('1O('1H92!A8V-O=6YT:6YG(&QI=&5R871U<F4@;W(@87!P;&EC871I;VX@
M=&\@<W!E8VEF:6,@:6YD=7-T<FEE<R!A;F0@87)E(&YO="!E>'!E8W1E9"!T
M;R!H879E(&$@;6%T97)I86P@:6UP86-T(&]N('1H92!#;VUP86YY)B,X,C$W
M.W,@8V]N<V]L:61A=&5D(&9I;F%N8VEA;"!P;W-I=&EO;BP@<F5S=6QT<R!O
M9B!O<&5R871I;VYS(&]R(&-A<V@@9FQO=W,N#0H\+V9O;G0^#0H\+V1I=CX-
M"CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\
M+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A
M<G1?-#`X.#=E961?9&)B8E\T.3!C7V)A.3=?8F$W-C1C-S0R.#`Y#0I#;VYT
M96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S0P.#@W965D7V1B8F)?-#DP8U]B
M83DW7V)A-S8T8S<T,C@P.2]7;W)K<VAE971S+U-H965T,#<N:'1M;`T*0V]N
M=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N
M=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\
M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E
M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^
M/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^
M+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE
M860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS
M1$E$,$4R2#X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@
M8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY)3E1!3D=)0DQ%($%3
M4T544SQB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:"!C;VQS<&%N/3-$,3XY($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P
M+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/DEN=&%N9VEB;&4@07-S971S($1I<V-L;W-U<F4@6T%B<W1R86-T
M73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)
M3E1!3D=)0DQ%($%34T544SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
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M4SQB<B`O/@T*/&)R("\^#0H\+V9O;G0^#0H\+V1I=CX\9&EV('-T>6QE/3-$
M=&5X="UA;&EG;CIL969T.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K
M.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^#0H\+V1I=CX\
M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIJ=7-T:69Y.W1E>'0M:6YD96YT.C!P
M=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z
M,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/DEN=&%N9VEB
M;&4@87-S971S(&%C<75I<F5D(&%N9"!T:&5I<B!C87)R>6EN9R!V86QU97,@
M870@2G5N92`S,"P@,C`Q,2!A;F0@4V5P=&5M8F5R(#,P+"`R,#$P(&%R92!A
M<R!F;VQL;W=S.CQB<B`O/@T*/&)R("\^#0H\+V9O;G0^#0H\+V1I=CX\9&EV
M('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[(#X-"CPO
M9&EV/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\=&%B;&4@8V5L
M;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#<P)2!S='EL
M93TS1"=F;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P
M<'0[)R`^/'1R/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0T-B4@<W1Y
M;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y
M.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE
M.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T
M>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!C;VQS<&%N/3-$,B`^/&1I=B!S
M='EL93TS1'1E>'0M86QI9VXZ8V5N=&5R.W1E>'0M:6YD96YT.C!P=#MD:7-P
M;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^
M/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM
M97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/BA5;F%U9&ET960I#0H\
M+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4]
M,T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[
M(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT
M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\
M+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L<W!A;CTS
M1#(@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D
M:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N
M="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B
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M+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\
M+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.F)L86-K(#)P>"!S;VQI9#MT97AT+6%L
M:6=N.FQE9G0[)R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*
M/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E
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M(#Y*=6YE(#,P+`T*/"]F;VYT/@T*/"]D:78^/&1I=B!S='EL93TS1'1E>'0M
M86QI9VXZ8V5N=&5R.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA
M<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4]
M,T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<@/C(P,3$-"CPO9F]N=#X-"CPO9&EV/@T*/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[=&5X="UA;&EG;CIL969T.R<@
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M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\
M+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L<W!A;CTS
M1#(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[)R`^
M/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ8V5N=&5R.W1E>'0M:6YD96YT.C!P
M=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z
M,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/E-E<'1E;6)E
M<B`S,"P-"CPO9F]N=#X-"CPO9&EV/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N
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M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/@T*
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M:7IE.C$P<'0[)R`^5')A9&4@<V5C<F5T<R!A;F0@9&5V96QO<&5D('1E8VAN
M;VQO9VEE<R`H5V5I9VAT960@879E<F%G92!L:69E(&]F(#<@>65A<G,I#0H\
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M.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#MT97AT+6EN9&5N=#HP
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M.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O
M;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@
M;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/CDL-#,P+#DP,`T*/"]F;VYT
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M;&EG;CIL969T.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#MT97AT
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M,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/CDL-#,P+#DP
M,`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@
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M:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
M86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/E!A=&5N
M=',@*%=E:6=H=&5D(&%V97)A9V4@;&EF92!O9B`U('EE87)S*0T*/"]F;VYT
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M)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)2!S='EL93TS1"=B;W)D97(M8F]T=&]M.F)L86-K(#)P>"!S;VQI9#MT
M97AT+6%L:6=N.G)I9VAT.R<@/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.G)I
M9VAT.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T
M.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA
M>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<@/C,T+#(U-PT*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.F)L86-K(#)P>"!S;VQI9#MT97AT+6%L:6=N.FQE9G0[)R`^/&9O;G0@
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M<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D
M/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.F)L86-K(#)P>"!S;VQI9#MT97AT+6%L:6=N.G)I9VAT.R<@
M/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.W1E>'0M:6YD96YT.C!P
M=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z
M,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/C,T+#(U-PT*
M/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1"=B;W)D97(M8F]T=&]M.F)L86-K(#)P>"!S;VQI
M9#MT97AT+6%L:6=N.FQE9G0[)R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II
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M,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
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M/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II
M;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&1I=B!S='EL
M93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ
M8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N
M="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N
M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^.2PT-C4L,34W#0H\+V9O;G0^
M#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&9O
M;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@
M;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L
M:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT
M+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\
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M)R`^#0H\+V9O;G0^#0H\+W1D/@T*/"]T<CX\='(^/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#0V)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQD
M:78@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[=&5X="UI;F1E;G0Z,'!T.V1I
M<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[
M(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT
M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^3&5S<SH-"CPO9F]N
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M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2`^/&9O;G0@<W1Y;&4],T0G9&ES
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M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^
M#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2`^/&9O;G0@
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M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O
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M969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES
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M="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B
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M87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
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M:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
M86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/BD-"CPO
M9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@<W1Y;&4]
M,T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[
M(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT
M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\
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M;CIL969T.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#MT97AT+6EN
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M;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@
M<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W
M(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/DEM<&%I<FUE;G0@*%-E92!B96QO
M=RD-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@
M<V]L:60[=&5X="UA;&EG;CIR:6=H=#LG(#X\9F]N="!S='EL93TS1"=D:7-P
M;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US
M:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=B;W)D97(M8F]T=&]M.F)L86-K(#)P
M>"!S;VQI9#MT97AT+6%L:6=N.FQE9G0[)R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R
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M<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
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M:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)2!S='EL93TS1"=B;W)D97(M8F]T=&]M.F)L86-K(#)P
M>"!S;VQI9#MT97AT+6%L:6=N.G)I9VAT.R<@/CQD:78@<W1Y;&4],T1T97AT
M+6%L:6=N.G)I9VAT.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA
M<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4]
M,T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<@/B@U+#8U-2PP,3$-"CPO9F]N=#X-"CPO9&EV
M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[=&5X="UA;&EG;CIL
M969T.R<@/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[=&5X="UI;F1E
M;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR
M:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT
M+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^*0T*
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M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^3F5T.@T*/"]F
M;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[(#X\9F]N="!S='EL93TS
M1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[
M9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@
M/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[=&5X="UI;F1E;G0Z,'!T
M.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP
M<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL
M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^)FYB<W`[)`T*
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M>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA
M>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@
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M<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/B9N
M8G-P.R0-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&1I
M=B!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I
M<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[
M(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT
M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^-C,V+#8S-0T*/"]F
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M;&EG;CIL969T.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#MT97AT
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M.G)I9VAT.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
M86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F
M;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9&EV('-T>6QE/3-$=&5X="UA;&EG
M;CIL969T.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL
M969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/B9N8G-P.R0-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L
M:6=N.G)I9VAT.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X
M="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA
M<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN
M93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[
M)R`^,`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T
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M>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&1I=B!S='EL93TS1'1E>'0M86QI
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M87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
M;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<@/C`-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N
M="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N
M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/@T*
M/"]T<CX-"CPO=&%B;&4^/&)R("\^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X
M="UA;&EG;CIL969T.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA
M<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^#0H\+V1I=CX\9&EV
M('-T>6QE/3-$=&5X="UA;&EG;CIJ=7-T:69Y.W1E>'0M:6YD96YT.C!P=#MD
M:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T
M.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
M=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/D1U<FEN9R!T:&4@
M>65A<B!E;F1E9"!397!T96UB97(@,S`L(#(P,#8L('1H92!#;VUP86YY)B,X
M,C$W.W,@;6%N86=E;65N="!P97)F;W)M960@86X@979A;'5A=&EO;B!O9B!I
M=',@:6YT86YG:6)L92!A<W-E=',@*&EN=&5L;&5C='5A;"!P<F]P97)T>2D@
M9F]R('!U<G!O<V5S(&]F(&1E=&5R;6EN:6YG('1H92!I;7!L:65D(&9A:7(@
M=F%L=64@;V8@=&AE(&%S<V5T<R!A="!397!T96UB97(@,S`L(#(P,#8N(%1H
M92!T97-T(&EN9&EC871E9"!T:&%T('1H92!R96-O<F1E9"!R96UA:6YI;F<@
M8F]O:R!V86QU92!O9B!I=',@:6YT96QL96-T=6%L('!R;W!E<G1Y(&5X8V5E
M9&5D(&ET<R!F86ER('9A;'5E(&9O<B!T:&4@>65A<B!E;F1E9"!397!T96UB
M97(@,S`L(#(P,#8L(&%S(&1E=&5R;6EN960@8GD@9&ES8V]U;G1E9"!F=71U
M<F4@8V%S:"!F;&]W<RX@07,@82!R97-U;'0L('5P;VX@8V]M<&QE=&EO;B!O
M9B!T:&4@87-S97-S;65N="P@;6%N86=E;65N="!R96-O<F1E9"!A(&YO;BUC
M87-H(&EM<&%I<FUE;G0@8VAA<F=E(&]F("9N8G-P.R0U+#8U-2PP,3$L(&YE
M="!O9B!T87@L(&]R("9N8G-P.R0P+C`U('!E<B!S:&%R92!D=7)I;F<@=&AE
M('EE87(@96YD960@4V5P=&5M8F5R(#,P+"`R,#`V('1O(')E9'5C92!T:&4@
M8V%R<GEI;F<@=F%L=64@;V8@=&AE('!A=&5N=',@=&\@)FYB<W`[)#(L,#DQ
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M;VYT:',@96YD960@2G5N92`S,"P@,C`Q,2!W87,@)FYB<W`[)#DP+#DT."!A
M;F0@)FYB<W`[)#(W,BPX-#0L(')E<W!E8W1I=F5L>2X@5&]T86P@86UO<G1I
M>F%T:6]N(&5X<&5N<V4@8VAA<F=E9"!T;R!O<&5R871I;VYS(&9O<B!T:&4@
M=&AR964@86YD(&YI;F4@;6]N=&AS(&5N9&5D($IU;F4@,S`L(#(P,3`@=V%S
M("9N8G-P.R0Y,"PY-#@@86YD("9N8G-P.R0R-S(L.3@X+"!R97-P96-T:79E
M;'DN#0H\+V9O;G0^#0H\+V1I=CX-"CPO9&EV/@T*/"]D:78^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D
M>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T,#@X-V5E9%]D8F)B
M7S0Y,&-?8F$Y-U]B83<V-&,W-#(X,#D-"D-O;G1E;G0M3&]C871I;VXZ(&9I
M;&4Z+R\O0SHO-#`X.#=E961?9&)B8E\T.3!C7V)A.3=?8F$W-C1C-S0R.#`Y
M+U=O<FMS:&5E=',O4VAE970P."YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N
M8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O
M:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-
M"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0]
M,T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T
M97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E
M(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@
M("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P13)(/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S
M<&%N/3-$,CX\<W1R;VYG/D%#0T]53E13(%!!64%"3$4@04Y$($%#0U)5140@
M3$E!0DE,251)15,\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@@8V]L<W!A;CTS1#$^.2!-;VYT:',@16YD960\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M2G5N+B`S,"P@,C`Q,3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^/'-T<F]N9SY087EA8FQE<R!A;F0@06-C<G5A;',@6T%B<W1R86-T
M73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!
M0T-/54Y44R!005E!0DQ%($%.1"!!0T-2545$($Q)04))3$E42453/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV/CQD:78@<W1Y;&4],T1T
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M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^06-C;W5N=',@<&%Y86)L92!A
M;F0@86-C<G5E9"!L:6%B:6QI=&EE<R!A="!*=6YE(#,P+"`R,#$Q(&%N9"!3
M97!T96UB97(@,S`L(#(P,3`@87)E(&%S(&9O;&QO=W,Z#0H\+V9O;G0^#0H\
M+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO
M8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA;&EG
M;CIL969T.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT
M97([(#X\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W
M:61T:#TS1#<P)2!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M
M86X[9F]N="US:7IE.C$P<'0[)R`^/'1R/CQT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0T-B4@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S
M='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@
M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ
M;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M
M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N
M=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!C;VQS
M<&%N/3-$,B`^/&1I=B!S='EL93TS1'1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y
M.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.W1E>'0M
M86QI9VXZ8V5N=&5R.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[
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M86X[9F]N="US:7IE.C$P<'0[)R`^2G5N92`S,"P-"CPO9F]N=#X-"CPO9&EV
M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN
M;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P
M<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE
M/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$P)2!C;VQS<&%N/3-$,B`^/&1I=B!S='EL
M93TS1'1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T
M.C!P=#MM87)G:6XM<FEG:'0Z,'!T.W1E>'0M86QI9VXZ8V5N=&5R.R`^/&9O
M;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@
M;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/E-E<'1E;6)E<B`S,"P-"CPO
M9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS
M1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[
M9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/@T*/"]T<CX\='(^
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#0V)2!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.F)L86-K(#)P>"!S;VQI9#MT97AT+6%L:6=N.FQE9G0[)R`^
M/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM
M97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[=&5X="UA;&EG;CIL969T.R<@
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M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^,C`Q,0T*/"]F
M;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=B;W)D97(M8F]T=&]M.F)L86-K(#)P>"!S;VQI9#MT
M97AT+6%L:6=N.FQE9G0[)R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
M;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[
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M.C$P<'0[)R`^,C`Q,`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'!A9&1I;F<M8F]T=&]M
M.C)P>#MT97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y
M.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE
M.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/@T*/"]T<CX\='(^/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#0V)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F
M=#L@/CQD:78@<W1Y;&4],T1T97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C
M:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#MT97AT+6%L:6=N
M.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A
M;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^06-C;W5N
M=',@<&%Y86)L90T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[
M(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT
M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\
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M<'0[)R`^)FYB<W`[)`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI
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M;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@
M<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W
M(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N
M.G)I9VAT.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
M86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F
M;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9&EV('-T>6QE/3-$=&5X="UI;F1E
M;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR
M:6=H=#HP<'0[=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/B9N8G-P.R0-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L
M:6=N.G)I9VAT.R`^/&1I=B!S='EL93TS1'1E>'0M:6YD96YT.C!P=#MD:7-P
M;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.W1E
M>'0M86QI9VXZ<FEG:'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN
M93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[
M)R`^-S(Q+#,T,`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@
M/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I
M;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO
M=&0^#0H\+W1R/CQT<CX\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-#8E
M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&1I=B!S='EL93TS1'1E>'0M
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M9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX]
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M=#MT97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II
M;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<@/C$P,BPU,#`-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE
M9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL
M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^
M#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1'1E>'0M86QI9VXZ<FEG:'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN
M;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P
M<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE
M/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG
M;CTS1&)O='1O;0T*('=I9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N.G)I
M9VAT.R`^/&1I=B!S='EL93TS1'1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L
M;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.W1E>'0M86QI
M9VXZ<FEG:'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT
M+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^,3`R
M+#4P,`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT
M('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE
M=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^#0H\
M+W1R/CQT<CX\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-#8E('-T>6QE
M/3-$=&5X="UA;&EG;CIL969T.R`^/&1I=B!S='EL93TS1'1E>'0M:6YD96YT
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M<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N
M="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N
M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT
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M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^
M/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM
M97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT
M+6%L:6=N.G)I9VAT.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[
M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@
M/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D
M:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N
M="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B
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M9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/@T*/"]T<CX\='(^
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M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^06-C<G5E9"!S
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M;W1T;VTZ8FQA8VL@-'!X(&1O=6)L93MT97AT+6%L:6=N.FQE9G0[)R`^/&9O
M;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@
M;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3IB;&%C:R`T<'@@9&]U8FQE.W1E>'0M86QI9VXZ<FEG:'0[)R`^
M/&1I=B!S='EL93TS1'1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA
M<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.W1E>'0M86QI9VXZ<FEG
M:'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL
M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^,C(P+#DP.`T*
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M(&1O=6)L93MT97AT+6%L:6=N.FQE9G0[)R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`T
M<'@@9&]U8FQE.W1E>'0M86QI9VXZ<FEG:'0[)R`^/&1I=B!S='EL93TS1'1E
M>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM
M87)G:6XM<FEG:'0Z,'!T.W1E>'0M86QI9VXZ<FEG:'0[(#X\9F]N="!S='EL
M93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M
M86X[9F]N="US:7IE.C$P<'0[)R`^-30L-S<S#0H\+V9O;G0^#0H\+V1I=CX-
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M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^5&]T86P-"CPO9F]N=#X-"CPO
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M<BUB;W1T;VTZ8FQA8VL@-'!X(&1O=6)L93MT97AT+6%L:6=N.FQE9G0[)R`^
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M9VAT.C!P=#MT97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/C$L,S$V+#,W,0T*/"]F;VYT/@T*/"]D:78^#0H\+W1D
M/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'!A9&1I
M;F<M8F]T=&]M.C1P>#MT97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS
M1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[
M9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'!A9&1I;F<M8F]T=&]M.C1P
M>#MT97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II
M;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`T<'@@9&]U
M8FQE.W1E>'0M86QI9VXZ;&5F=#LG(#X\9&EV('-T>6QE/3-$=&5X="UI;F1E
M;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR
M:6=H=#HP<'0[=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/B9N8G-P.R0-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3IB;&%C:R`T<'@@9&]U8FQE.W1E>'0M86QI9VXZ<FEG:'0[)R`^
M/&1I=B!S='EL93TS1'1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA
M<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.W1E>'0M86QI9VXZ<FEG
M:'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL
M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^.38W+#4U,`T*
M/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1'!A9&1I;F<M8F]T=&]M.C1P>#MT97AT+6%L:6=N
M.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A
M;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O
M;G0^#0H\+W1D/@T*/"]T<CX-"CPO=&%B;&4^#0H\+V1I=CX-"CPO9&EV/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*
M("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-#`X.#=E
M961?9&)B8E\T.3!C7V)A.3=?8F$W-C1C-S0R.#`Y#0I#;VYT96YT+4QO8V%T
M:6]N.B!F:6QE.B\O+T,Z+S0P.#@W965D7V1B8F)?-#DP8U]B83DW7V)A-S8T
M8S<T,C@P.2]7;W)K<VAE971S+U-H965T,#DN:'1M;`T*0V]N=&5N="U4<F%N
M<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E
M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@
M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C
M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T
M>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T
M(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB
M;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$4R2#X-
M"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS
M1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY#3TY615)424),12!.3U1%4SQB<CX\
M+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,3XY($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$Q/&)R
M/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DQO
M;F<M5&5R;2!$96)T+"!5;F-L87-S:69I960@6T%B<W1R86-T73PO<W1R;VYG
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#3TY615)424),
M12!.3U1%4SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I=CX\
M9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R
M9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA;&EG;CIL969T
M.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
M=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.F)O
M;&0[)R`^3D]412!$("8C.#(Q,3L@0T].5D525$E"3$4@3D]415,\8G(O/@T*
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M(&]F($IU;F4@,S`L(#(P,3$@86YD(%-E<'1E;6)E<B`S,"P@,C`Q,"!A<F4@
M87,@9F]L;&]W<SH\8G(O/@T*/"]F;VYT/@T*/"]D:78^/&1I=B!S='EL93TS
M1'1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P
M=#MM87)G:6XM<FEG:'0Z,'!T.W1E>'0M86QI9VXZ;&5F=#L@/@T*/"]D:78^
M/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQD:78^/'1A8FQE(&-E
M;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E('-T
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M/3-$,B`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ8V5N=&5R.W1E>'0M:6YD
M96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM
M<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
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M9F]N="US:7IE.C$P<'0[)R`^2G5N92`S,"P-"CPO9F]N=#X-"CPO9&EV/@T*
M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$=&5X="UA;&EG;CIL
M969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT
M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$=&5X="UA;&EG
M;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
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M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^4V5P=&5M8F5R
M(#,P+`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D
M:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N
M="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/@T*/"]T<CX\='(^/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.F)L86-K
M(#)P>"!S;VQI9#MT97AT+6%L:6=N.FQE9G0[)R`^/&9O;G0@<W1Y;&4],T0G
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M<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@8V]L
M<W!A;CTS1#(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L
M:60[)R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ8V5N=&5R.W1E>'0M:6YD
M96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM
M<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/C(P
M,3$-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ8FQA8VL@,G!X('-O;&ED.W1E>'0M
M86QI9VXZ;&5F=#LG(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF
M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
M#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[=&5X="UA;&EG;CIL969T
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M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^,C`Q,`T*/"]F;VYT/@T*/"]D
M:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[=&5X="UA;&EG;CIL969T.R<@/CQF
M;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S
M(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^
M#0H\+W1R/CQT<CX\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E('-T
M>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&1I=B!S='EL93TS1'1E>'0M86QI
M9VXZ;&5F=#MT97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM
M;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#L@/CQF;VYT('-T>6QE/3-$)V1I
M<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG(#Y396-U<F5D($-O;G9E<G1I8FQE($YO=&5S(%!A>6%B
M;&4@9&%T960@3V-T;V)E<B`Q-"P@,C`P.2P@;F5T(&]F('5N86UO<G1I>F5D
M(&1E8G0@9&ES8V]U;G0@;V8@)FYB<W`[)#@Q.2`H<V5E(&)E;&]W*0T*/"]F
M;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$
M)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^
M/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#MT97AT+6EN9&5N=#HP<'0[
M9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P
M=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY
M.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#XF;F)S<#LD(`T*
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M=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
M;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS
M1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[
M9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@
M/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[=&5X="UI;F1E;G0Z,'!T
M.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP
M<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL
M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^)FYB<W`[)"`-
M"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&1I=B!S='EL
M93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ
M8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N
M="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N
M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^,C8Y+#$X,0T*/"]F;VYT/@T*
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M969T.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#MT97AT+6EN9&5N
M=#HP<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I
M9VAT.C!P=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M
M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#Y396-U
M<F5D($-O;G9E<G1I8FQE($YO=&4@4&%Y86)L92!D871E9"!*86YU87)Y(#<L
M(#(P,3`L(&YE="!O9B!U;F%M;W)T:7IE9"!D96)T(&1I<V-O=6YT(&]F("9N
M8G-P.R0V-S,@86YD("9N8G-P.R0Y+#4R,2P@<F5S<&5C=&EV96QY("AS964@
M8F5L;W<I#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O
M;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@
M;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L
M:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT
M+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\
M+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S
M='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[(#X\9&EV('-T>6QE/3-$=&5X="UA
M;&EG;CIR:6=H=#MT97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SMM87)G
M:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#L@/CQF;VYT('-T>6QE/3-$
M)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG(#XM#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG
M;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
M86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F
M;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y
M.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE
M.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T
M>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG#0H@/@T*/"]F;VYT/@T*/"]T9#X\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N
M.G)I9VAT.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI
M;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I
M;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF
M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
M-#`L-#<Y#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O
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M969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/E-E8W5R960@0V]N=F5R=&EB;&4@3F]T92!087EA8FQE
M(&1A=&5D($IU;F4@-"P@,C`Q,"P@;F5T(&]F('5N86UO<G1I>F5D(&1E8G0@
M9&ES8V]U;G0@;V8@)FYB<W`[)#(L,S(Y(&%N9"`F;F)S<#LD-2PR.#8L(')E
M<W!E8W1I=F5L>2`H<V5E(&)E;&]W*0T*/"]F;VYT/@T*/"]D:78^#0H\+W1D
M/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M
M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O
M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-
M"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&1I
M=B!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I
M<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[
M(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT
M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^,C(R+#8W,0T*/"]F
M;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$
M)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^
M/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM
M97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT
M+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF
M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
M#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y
M)2!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[(#X\9&EV('-T>6QE/3-$=&5X
M="UA;&EG;CIR:6=H=#MT97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SMM
M87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#L@/CQF;VYT('-T>6QE
M/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG(#XR,3DL-S$T#0H\+V9O;G0^#0H\+V1I=CX-
M"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
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M.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
M=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/E-E8W5R960@0V]N
M=F5R=&EB;&4@3F]T97,@4&%Y86)L92!D871E9"!*=6QY(#$U+"`R,#$P+"!N
M970@;V8@=6YA;6]R=&EZ960@9&5B="!D:7-C;W5N="!O9B`F;F)S<#LD-3`L
M,S,W(&%N9"`F;F)S<#LD-3,U+#4X,"P@<F5S<&5C=&EV96QY("AS964@8F5L
M;W<I#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@
M<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W
M(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N
M.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A
M;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O
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M;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*
M/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P
M;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US
M:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT
M('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE
M=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$=&5X="UA;&EG
M;CIR:6=H=#L@/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.W1E>'0M
M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G
M:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[
M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@
M/C$L-#8T+#0R,`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@
M/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I
M;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO
M=&0^#0H\+W1R/CQT<CX\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E
M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&1I=B!S='EL93TS1'1E>'0M
M86QI9VXZ;&5F=#MT97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SMM87)G
M:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#L@/CQF;VYT('-T>6QE/3-$
M)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG(#Y396-U<F5D($-O;G9E<G1I8FQE($YO=&5S(%!A
M>6%B;&4@9&%T960@3F]V96UB97(@,3DL(#(P,3`L(&YE="!O9B!U;F%M;W)T
M:7IE9"!D96)T(&1I<V-O=6YT(&]F("9N8G-P.R0R.2PW-3D@*'-E92!B96QO
M=RD-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S
M='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@
M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V
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M969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/C,R,"PR-#$-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L
M:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT
M+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\
M+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L
M87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@
M<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W
M(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N
M.G)I9VAT.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI
M;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I
M;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF
M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
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M=&5X="UA;&EG;CIL969T.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ;&5F
M=#MT97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP
M<'0[;6%R9VEN+7)I9VAT.C!P=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ
M:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG(#Y396-U<F5D($-O;G9E<G1I8FQE($YO=&4@4&%Y86)L92!D871E
M9"!.;W9E;6)E<B`S,"P@,C`Q,"P@;F5T(&]F('5N86UO<G1I>F5D(&1E8G0@
M9&ES8V]U;G0@;V8@)FYB<W`[)#$Q,RPR,3$@*'-E92!B96QO=RD-"CPO9F]N
M=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D
M:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N
M="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B
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M87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
M;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<@/C8S-BPW.#D-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[
M(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT
M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\
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M9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX]
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M1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G
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M:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[
M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@
M/E-E8W5R960@0V]N=F5R=&EB;&4@3F]T92!087EA8FQE(&1A=&5D($IA;G5A
M<GD@-RP@,C`Q,2P@;F5T(&]F('5N86UO<G1I>F5D(&1E8G0@9&ES8V]U;G0@
M;V8@)FYB<W`[)#$R-2PW,3$@*'-E92!B96QO=RD-"CPO9F]N=#X-"CPO9&EV
M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T1T97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II
M;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL
M93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M
M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI
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M;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@
M<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W
M(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N
M.G)I9VAT.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
M86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F
M;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y
M.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE
M.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@
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M/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II
M;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X-"CPO='(^/'1R/CQT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0W-B4@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB
M;&%C:R`R<'@@<V]L:60[=&5X="UA;&EG;CIL969T.R<@/CQD:78@<W1Y;&4]
M,T1T97AT+6%L:6=N.FQE9G0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO
M8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S
M='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@
M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^4V5C=7)E9"!#;VYV97)T:6)L92!.
M;W1E<R!087EA8FQE+"!D871E9"!*=6QY(#$U+"`R,#$P+"!M;V1I9FEE9"!*
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M+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\
M+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.F)L86-K(#)P>"!S;VQI9#MT97AT+6%L
M:6=N.FQE9G0[)R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*
M/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[=&5X="UA
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M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.F)L86-K(#)P>"!S;VQI9#MT97AT+6%L:6=N.FQE9G0[)R`^/&9O;G0@<W1Y
M;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3IB;&%C:R`R<'@@<V]L:60[=&5X="UA;&EG;CIL969T.R<@/CQF;VYT('-T
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M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.F)L86-K(#)P>"!S;VQI9#MT97AT+6%L:6=N.FQE9G0[)R`^/&9O;G0@
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M.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA
M>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<@/E1O=&%L#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL
M969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT
M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN
M;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P
M<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED
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M:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT
M('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE
M=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG
M;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
M86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F
M;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y
M;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&1I=B!S='EL93TS1'1E>'0M86QI
M9VXZ<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN
M+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D
M:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N
M="US:7IE.C$P<'0[)R`^,2PY.3,L-SDT#0H\+V9O;G0^#0H\+V1I=CX-"CPO
M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X
M="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[
M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@
M/@T*/"]F;VYT/@T*/"]T9#X-"CPO='(^/'1R/CQT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0W-B4@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R
M<'@@<V]L:60[=&5X="UA;&EG;CIL969T.R<@/CQD:78@<W1Y;&4],T1T97AT
M+6%L:6=N.FQE9G0[=&5X="UI;F1E;G0Z-7!T.V1I<W!L87DZ8FQO8VL[;6%R
M9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS
M1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[
M9F]N="US:7IE.C$P<'0[)R`^3&5S<SH@8W5R<F5N="!P;W)T:6]N#0H\+V9O
M;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ8FQA8VL@,G!X('-O;&ED.W1E
M>'0M86QI9VXZ<FEG:'0[)R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
M;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[
M=&5X="UA;&EG;CIL969T.R<@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL
M:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#DE('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ8FQA8VL@,G!X('-O;&ED
M.W1E>'0M86QI9VXZ<FEG:'0[)R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ
M<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE
M9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P
M;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US
M:7IE.C$P<'0[)R`^*#(L.34Q+#8X,PT*/"]F;VYT/@T*/"]D:78^#0H\+W1D
M/CQT9"!V86QI9VX],T1B;W1T;VT-"B!W:61T:#TS1#$E('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ8FQA8VL@,G!X('-O;&ED.W1E>'0M86QI9VXZ;&5F=#LG
M(#X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.W1E>'0M:6YD96YT.C!P
M=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z
M,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/BD-"CPO9F]N
M=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[=&5X
M="UA;&EG;CIR:6=H=#LG(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN
M93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[
M)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=B;W)D97(M8F]T=&]M.F)L86-K(#)P>"!S;VQI9#MT
M97AT+6%L:6=N.FQE9G0[)R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
M;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$.24@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[
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M.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
M=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/BD-"CPO9F]N=#X-
M"CPO9&EV/@T*/"]T9#X-"CPO='(^/'1R/CQT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0W-B4@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9&EV('-T
M>6QE/3-$=&5X="UA;&EG;CIL969T.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y
M.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O
M;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@
M;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/DQO;F<M=&5R;2!D96)T+2!N
M970-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@
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M<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/B9N
M8G-P.R0-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&1I
M=B!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I
M<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[
M(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT
M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^+0T*/"]F;VYT/@T*
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M;CIL969T.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#MT97AT+6EN
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M.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
M=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/C(Q.2PW,30-"CPO
M9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS
M1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[
M9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/@T*/"]T<CX-"CPO
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M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^/&9O;G0@<W1Y;&4]
M,T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N
M.V9O;G0M<VEZ93HQ,'!T.W1E>'0M9&5C;W)A=&EO;CIU;F1E<FQI;F4[)R`^
M,3`E(%-E8W5R960@0V]N=F5R=&EB;&4@4')O;6ES<V]R>2!.;W1E<R!D871E
M9"!/8W1O8F5R(#$T+"`R,#`Y/&)R+SX-"CPO9F]N=#X-"CPO9F]N=#X-"CPO
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M:7IE.C$P<'0[)R`^3VX@3V-T;V)E<B`Q-"P@,C`P.2P@=&AE($-O;7!A;GD@
M:7-S=65D(&%N(&%G9W)E9V%T92!O9B`F;F)S<#LD,C<P+#`P,"!C;VYV97)T
M:6)L92!P<F]M:7-S;W)Y(&YO=&5S(&1U92!/8W1O8F5R(#$T+"`R,#$P('=I
M=&@@:6YT97)E<W0@870@,3`E('!E<B!A;FYU;2!D=64@=7!O;B!M871U<FET
M>2X@5&AE(&YO=&5S(&%R92!C;VYV97)T:6)L92!A="!A;GD@=&EM92!P<FEO
M<B!T;R!M871U<FET>2P@870@=&AE(&AO;&1E<G,F(S@R,3<[(&]P=&EO;BP@
M:6YT;R!S:&%R97,@;V8@;W5R(&-O;6UO;B!S=&]C:R!A="!A('!R:6-E(&5Q
M=6%L('1O('1H92!G<F5A=&5R(&]F("AI*2`U,"4@;V8@=&AE(&%V97)A9V4@
M<')I8V4@;V8@;W5R(&-O;6UO;B!S=&]C:R!F;W(@=&AE('1E;B!T<F%D:6YG
M(&1A>7,@<')I;W(@=&\@=&AE(&1A=&4@;V8@=&AE(&YO=&EC92!O9B!C;VYV
M97)S:6]N(&]R("AI:2D@870@)FYB<W`[)#`N,#DR-C<T,C$X('!E<B!S:&%R
M92P@=VAI8V@@:7,@97%U86P@=&\@82`R,"4@9&ES8V]U;G0@=&\@=&AE(&%V
M97)A9V4@=F]L=6UE+"!W96EG:'1E9"!A=F5R86=E('!R:6-E(&]F(&]U<B!C
M;VUM;VX@<W1O8VL@9F]R('1H92!T96X@=')A9&EN9R!D87ES('!R:6]R('1O
M(&ES<W5A;F-E+B!!="!M871U<FET>2P@=&AE(&YO=&5S+"!I;F-L=61I;F<@
M86YY(&%C8W)U960@86YD('5N<&%I9"!I;G1E<F5S="P@87)E(&%U=&]M871I
M8V%L;'D@8V]N=F5R=&EB;&4@870@)FYB<W`[)#`N,#DR-C<T,C$X('!E<B!S
M:&%R92X@5&AE($-O;7!A;GD@:&%S(&=R86YT960@=&AE(&YO=&5H;VQD97)S
M(&$@<V5C=7)I='D@:6YT97)E<W0@:6X@86QL('1H92!#;VUP86YY)B,X,C$W
M.W,@87-S971S+CQB<B\^#0H\+V9O;G0^#0H\+V1I=CX\9&EV('-T>6QE/3-$
M=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T
M.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA;&EG;CIJ=7-T:69Y.R`^#0H\+V1I
M=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[
M;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA;&EG;CIJ
M=7-T:69Y.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
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M<G-I;VX@9F5A='5R92`H)FYB<W`[)#(Q+#,T,RD@=&\@9&5B="!D:7-C;W5N
M="!W:&EC:"!W:6QL(&)E(&%M;W)T:7IE9"!T;R!I;G1E<F5S="!E>'!E;G-E
M(&]V97(@=&AE('1E<FT@;V8@=&AE(&YO=&5S+B!4:&4@0V]M<&%N>2!R96-O
M<F1E9"!T:&4@:6YT<FEN<VEC('9A;'5E(&]F('1H92!E;6)E9&1E9"!B96YE
M9FEC:6%L(&-O;G9E<G-I;VX@9F5A='5R92`H)FYB<W`[)#(Q+#,T,RD@=&\@
M9&5B="!D:7-C;W5N="!W:&EC:"!W:6QL(&)E(&%M;W)T:7IE9"!T;R!I;G1E
M<F5S="!E>'!E;G-E(&]V97(@=&AE('1E<FT@;V8@=&AE(&YO=&5S+B!!;6]R
M=&EZ871I;VX@;V8@)FYB<W`[)#@Q.2!W87,@<F5C;W)D960@9F]R('1H92!T
M:')E92!A;F0@;FEN92!M;VYT:',@96YD960@2G5N92`S,"P@,C`Q,2P@86YD
M("9N8G-P.R0U+#,R,2!A;F0@)FYB<W`[)#$U+#$T-2!W87,@<F5C;W)D960@
M9F]R('1H92!T:')E92!A;F0@;FEN92!M;VYT:"!P97)I;V1S(&5N9&5D($IU
M;F4@,S`L(#(P,3`L(')E<W!E8W1I=F5L>2X-"CPO9F]N=#X-"CPO9&EV/CQD
M:78@<W1Y;&4],T1T97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SL@/@T*
M/"]D:78^/&1I=B!S='EL93TS1'1E>'0M:6YD96YT.C!P=#MM87)G:6XM;&5F
M=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#L@/CQD:78^/&1I=B!S='EL93TS1'=I
M9'1H.C$P,"4[=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HX<'0[)R`^#0H\+V9O;G0^#0H\+V1I=CX-"CPO9&EV/CQD:78@<W1Y
M;&4],T1P86=E+6)R96%K+6%F=&5R.F%L=V%Y<SMW:61T:#HQ,#`E.R`^/&1I
M=B!S='EL93TS1'1E>'0M86QI9VXZ8V5N=&5R.W=I9'1H.C$P,"4[(#X-"CPO
M9&EV/@T*/"]D:78^/&1I=CX\9&EV('-T>6QE/3-$=VED=&@Z,3`P)3MT97AT
M+6%L:6=N.G)I9VAT.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[
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M>'0M86QI9VXZ8V5N=&5R.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI
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M;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^/&9O;G0@
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M,3!P=#LG(#Y/;B!/8W1O8F5R(#$T+"`R,#$P+"!T:&4@0V]M<&%N>2!I<W-U
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M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+V1I=CX\9&EV('-T
M>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE
M9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA;&EG;CIJ=7-T:69Y.R`^
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M86YU87)Y(#<L(#(P,3`\8G(O/@T*/"]F;VYT/@T*/"]F;VYT/@T*/"]D:78^
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M,3!P=#LG(#Y/;B!*86YU87)Y(#<L(#(P,3`L('1H92!#;VUP86YY(&ES<W5E
M9"!A("9N8G-P.R0U,"PP,#`@8V]N=F5R=&EB;&4@<')O;6ES<V]R>2!N;W1E
M(&1U92!*86YU87)Y(#<L(#(P,3$@=VET:"!I;G1E<F5S="!A="`Q,"4@<&5R
M(&%N;G5M(&1U92!U<&]N(&UA='5R:71Y+B!4:&4@;F]T92!I<R!C;VYV97)T
M:6)L92!A="!A;GD@=&EM92!P<FEO<B!T;R!M871U<FET>2P@870@=&AE(&AO
M;&1E<B8C.#(Q-SMS(&]P=&EO;BP@:6YT;R!S:&%R97,@;V8@;W5R(&-O;6UO
M;B!S=&]C:R!A="!A('!R:6-E(&5Q=6%L('1O('1H92!G<F5A=&5R(&]F("AI
M*2`U,"4@;V8@=&AE(&%V97)A9V4@<')I8V4@;V8@;W5R(&-O;6UO;B!S=&]C
M:R!F;W(@=&AE('1E;B!T<F%D:6YG(&1A>7,@<')I;W(@=&\@=&AE(&1A=&4@
M;V8@=&AE(&YO=&EC92!O9B!C;VYV97)S:6]N(&]R("AI:2D@870@)FYB<W`[
M)#`N,#4R.#<W,S@T('!E<B!S:&%R92P@=VAI8V@@:7,@97%U86P@=&\@82`R
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M.R0P+C`U,C@W-S,X-"!P97(@<VAA<F4N(%1H92!#;VUP86YY(&AA<R!G<F%N
M=&5D('1H92!N;W1E:&]L9&5R(&$@<V5C=7)I='D@:6YT97)E<W0@:6X@86QL
M('1H92!#;VUP86YY)B,X,C$W.W,@87-S971S+CQB<B\^#0H\+V9O;G0^#0H\
M+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO
M8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA;&EG
M;CIJ=7-T:69Y.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
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M;B!A9V=R96=A=&4@;V8@)FYB<W`[)#,U+#$P,R!O9B!T:&4@<')O8V5E9',L
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M960@;W9E<B!T:&4@;F]T928C.#(Q-SMS(&UA='5R:71Y('!E<FEO9"`H;VYE
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M:7IE.C$P<'0[)R`^5&AE($-O;7!A;GD@<F5C;W)D960@=&AE(&EN=')I;G-I
M8R!V86QU92!O9B!T:&4@96UB961D960@8F5N969I8VEA;"!C;VYV97)S:6]N
M(&9E871U<F4@*"9N8G-P.R0S-2PQ,#,I('1O(&1E8G0@9&ES8V]U;G0@=VAI
M8V@@=VEL;"!B92!A;6]R=&EZ960@=&\@:6YT97)E<W0@97AP96YS92!O=F5R
M('1H92!T97)M(&]F('1H92!N;W1E+B!!;6]R=&EZ871I;VX@;V8@)FYB<W`[
M)"TP+2!A;F0@)FYB<W`[)#DL-3(Q('=A<R!R96-O<F1E9"!F;W(@=&AE('1H
M<F5E(&%N9"!N:6YE(&UO;G1H<R!E;F1E9"!*=6YE(#,P+"`R,#$Q+"!R97-P
M96-T:79E;'DL(&%N9"`F;F)S<#LD."PW-3(@86YD("9N8G-P.R0Q-BPW,S0@
M=V%S(')E8V]R9&5D(&9O<B!T:&4@=&AR964@86YD(&YI;F4@;6]N=&@@<&5R
M:6]D<R!E;F1E9"!*=6YE(#,P+"`R,#$P+"!R97-P96-T:79E;'DN/&)R+SX-
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M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^3VX@2F%N=6%R>2`W+"`R,#$Q+"!T
M:&4@0V]M<&%N>2!I<W-U960@,2PP-#`L,30R('-H87)E<R!O9B!C;VUM;VX@
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M:7-S;W)Y($YO=&4@9&%T960@2G5N92`T+"`R,#$P/&)R+SX-"CPO9F]N=#X-
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M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^3VX@2G5N92`T+"`R,#$P+"!T:&4@
M0V]M<&%N>2!I<W-U960@82`F;F)S<#LD-C<U+#`P,"!R96QA=&5D('!A<G1Y
M(&-O;G9E<G1I8FQE('!R;VUI<W-O<GD@;F]T92!D=64@2F%N=6%R>2`S,2P@
M,C`Q,B!W:71H(&EN=&5R97-T(&%T(#$P)2!P97(@86YN=6T@9'5E('5P;VX@
M;6%T=7)I='DN(%1H92!N;W1E(&ES(&-O;G9E<G1I8FQE(&%T(&%N>2!T:6UE
M('!R:6]R('1O(&UA='5R:71Y+"!A="!T:&4@:&]L9&5R)B,X,C$W.W,@;W!T
M:6]N+"!I;G1O('-H87)E<R!O9B!O=7(@8V]M;6]N('-T;V-K(&%T(&$@<')I
M8V4@97%U86P@=&\@=&AE(&=R96%T97(@;V8@*&DI(#4P)2!O9B!T:&4@879E
M<F%G92!P<FEC92!O9B!O=7(@8V]M;6]N('-T;V-K(&9O<B!T:&4@=&5N('1R
M861I;F<@9&%Y<R!P<FEO<B!T;R!T:&4@9&%T92!O9B!T:&4@;F]T:6-E(&]F
M(&-O;G9E<G-I;VX@;W(@*&EI*2!A="`F;F)S<#LD,"XP,S@X-C8Q-3$@<&5R
M('-H87)E+"!W:&EC:"!I<R!E<75A;"!T;R!A(#(P)2!D:7-C;W5N="!T;R!T
M:&4@879E<F%G92!V;VQU;64L('=E:6=H=&5D(&%V97)A9V4@<')I8V4@;V8@
M;W5R(&-O;6UO;B!S=&]C:R!F;W(@=&AE('1E;B!T<F%D:6YG(&1A>7,@<')I
M;W(@=&\@:7-S=6%N8V4N($%T(&UA='5R:71Y+"!T:&4@;F]T92P@:6YC;'5D
M:6YG(&%N>2!A8V-R=65D(&%N9"!U;G!A:60@:6YT97)E<W0L(&ES(&%U=&]M
M871I8V%L;'D@8V]N=F5R=&EB;&4@870@)FYB<W`[)#`N,#,X.#8V,34Q('!E
M<B!S:&%R92X@5&AE($-O;7!A;GD@:&%S(&=R86YT960@=&AE(&YO=&5H;VQD
M97(@82!S96-U<FET>0T*(&EN=&5R97-T(&EN(&%L;"!T:&4@0V]M<&%N>28C
M.#(Q-SMS(&%S<V5T<RX\8G(O/@T*/"]F;VYT/@T*/"]D:78^/&1I=B!S='EL
M93TS1'1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T
M.C!P=#MM87)G:6XM<FEG:'0Z,'!T.W1E>'0M86QI9VXZ:G5S=&EF>3L@/@T*
M/"]D:78^/&1I=B!S='EL93TS1'1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L
M;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.W1E>'0M86QI
M9VXZ:G5S=&EF>3L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O
M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#Y)
M;B!A8V-O<F1A;F-E('=I=&@@05-#(#0W,"TR,"P@=&AE($-O;7!A;GD@<F5C
M;V=N:7IE9"!A;B!E;6)E9&1E9"!B96YE9FEC:6%L(&-O;G9E<G-I;VX@9F5A
M='5R92!P<F5S96YT(&EN('1H92!N;W1E+B!4:&4@0V]M<&%N>2!A;&QO8V%T
M960@82!P;W)T:6]N(&]F('1H92!P<F]C965D<R!E<75A;"!T;R!T:&4@:6YT
M<FEN<VEC('9A;'5E(&]F('1H870@9F5A='5R92!T;R!A9&1I=&EO;F%L('!A
M:60M:6X@8V%P:71A;"X@5&AE($-O;7!A;GD@<F5C;V=N:7IE9"!A;F0@;65A
M<W5R960@86X@86=G<F5G871E(&]F("9N8G-P.R0Q.2PV.3(@;V8@=&AE('!R
M;V-E961S+"!W:&EC:"!I<R!E<75A;"!T;R!T:&4@:6YT<FEN<VEC('9A;'5E
M(&]F('1H92!E;6)E9&1E9"!B96YE9FEC:6%L(&-O;G9E<G-I;VX@9F5A='5R
M92P@=&\@861D:71I;VYA;"!P86ED+6EN(&-A<&ET86P@86YD(&$@9&ES8V]U
M;G0@86=A:6YS="!T:&4@;F]T92X@5&AE(&1E8G0@9&ES8V]U;G0@871T<FEB
M=71E9"!T;R!T:&4@8F5N969I8VEA;"!C;VYV97)S:6]N(&9E871U<F4@:7,@
M86UO<G1I>F5D(&]V97(@=&AE(&YO=&4F(S@R,3<[<R!M871U<FET>2!P97)I
M;V0@87,@:6YT97)E<W0@97AP96YS92X-"CPO9F]N=#X-"CPO9&EV/CQD:78@
M<W1Y;&4],T1T97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM
M;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#MT97AT+6%L:6=N.FIU<W1I9GD[
M(#X-"CPO9&EV/CQD:78@<W1Y;&4],T1T97AT+6EN9&5N=#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9&EV/CQD:78@<W1Y;&4]
M,T1W:61T:#HQ,#`E.W1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$
M)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF
M;VYT+7-I>F4Z.'!T.R<@/@T*/"]F;VYT/@T*/"]D:78^#0H\+V1I=CX\9&EV
M('-T>6QE/3-$<&%G92UB<F5A:RUA9G1E<CIA;'=A>7,[=VED=&@Z,3`P)3L@
M/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.F-E;G1E<CMW:61T:#HQ,#`E.R`^
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M:'0Z,'!T.W1E>'0M86QI9VXZ8V5N=&5R.R`^#0H\+V1I=CX\9&EV('-T>6QE
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M,'!T.W1E>'0M86QI9VXZ8V5N=&5R.R`^#0H\+V1I=CX-"CPO9&EV/@T*/"]D
M:78^/&1I=B!S='EL93TS1'1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K
M.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.W1E>'0M86QI9VXZ
M;&5F=#L@/@T*/"]D:78^/&1I=B!S='EL93TS1'1E>'0M:6YD96YT.C!P=#MD
M:7-P;&%Y.F)L;V-K.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E
M;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR
M:6=H=#HP<'0[=&5X="UA;&EG;CIJ=7-T:69Y.R`^/&9O;G0@<W1Y;&4],T0G
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M92!T:')E92!A;F0@;FEN92!M;VYT:',@96YD960@2G5N92`S,"P@,C`Q,2P@
M<F5S<&5C=&EV96QY+CQB<B\^#0H\+V9O;G0^#0H\+V1I=CX\9&EV('-T>6QE
M/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z
M,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA;&EG;CIJ=7-T:69Y.R`^#0H\
M+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO
M8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA;&EG
M;CIJ=7-T:69Y.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/D]N
M($IU;'D@,34L(#(P,3`L("9N8G-P.R0T-3`L,#`P(&]F('1H92`F;F)S<#LD
M-C<U+#`P,"!R96QA=&5D('!A<G1Y(&-O;G9E<G1I8FQE('!R;VUI<W-O<GD@
M;F]T92!W87,@8V]N=F5R=&5D('1O('1H92!S86UE('1E<FUS(&%N9"!C;VYD
M:71I;VYS(&%S(&1E<V-R:6)E9"!I;B!T:&4@,3`E(%-E8W5R960@0V]N=F5R
M=&EB;&4@4')O;6ES<V]R>2!.;W1E<R!D871E9"!*=6QY(#$U+"`R,#$P(&)E
M;&]W+CQB<B\^#0H\+V9O;G0^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI
M;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I
M;BUR:6=H=#HP<'0[=&5X="UA;&EG;CIJ=7-T:69Y.R`^#0H\+V1I=CX\9&EV
M('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN
M+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA;&EG;CIJ=7-T:69Y
M.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
M=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/CQF;VYT('-T>6QE
M/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MT97AT+61E8V]R871I;VXZ=6YD97)L:6YE.R<@
M/C$P)2!396YI;W(@4V5C=7)E9"!#;VYV97)T:6)L92!0<F]M:7-S;W)Y($YO
M=&5S(&1A=&5D($IU;'D@,34L(#(P,3`\8G(O/@T*/"]F;VYT/@T*/"]F;VYT
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M;VYT+7-I>F4Z,3!P=#LG(#Y/;B!*=6QY(#$U+"`R,#$P+"!T:&4@0V]M<&%N
M>2!I<W-U960@86X@86=G<F5G871E(&]F("9N8G-P.R0R+#`P,"PP,#`@<V5N
M:6]R('-E8W5R960@8V]N=F5R=&EB;&4@<')O;6ES<V]R>2!N;W1E<R!D=64@
M2G5L>2`Q-2P@,C`Q,2!W:71H(&EN=&5R97-T(&%T(#$P)2!P97(@86YN=6T@
M9'5E('5P;VX@;6%T=7)I='D@=&\@)B,X,C(P.V%C8W)E9&ET960@:6YV97-T
M;W)S+"8C.#(R,3L@87,@9&5F:6YE9"!I;B!R96=U;&%T:6]N<R!P<F]M=6QG
M871E9"!U;F1E<B!T:&4@4V5C=7)I=&EE<R!!8W0@;V8@,3DS,RP@87,@86UE
M;F1E9"`H)B,X,C(P.U-E8W5R:71I97,@06-T)B,X,C(Q.RDN(%1H92!N;W1E
M<R!A<F4@8V]N=F5R=&EB;&4@870@86YY('1I;64@<')I;W(@=&\@;6%T=7)I
M='DL(&%T('1H92!H;VQD97)S)B,X,C$W.R!O<'1I;VXL(&EN=&\@<VAA<F5S
M(&]F(&]U<B!C;VUM;VX@<W1O8VL@*&DI('!R:6]R('1O('1H92!O8V-U<G)E
M;F-E(&]F(%-U8G-E<75E;G0@1FEN86YC:6YG(&%T(&$@<F%T92!O9B`F;F)S
M<#LD,"XP-#0P-2P@;W(@*&EI*2!A9G1E<B!3=6)S97%U96YT($9I;F%N8VEN
M9R!I;B!T:&4@979E;G0@=&AE(&AO;&1E<B!E;&5C=',@=&\@<F5C96EV92!C
M;VYV97)S:6]N('-H87)E<R!T:&%T(&%R92!N;W0@4W5B<V5Q=65N="!&:6YA
M;F-I;F<@<V5C=7)I=&EE<RP@870@82!R871E(&]F("9N8G-P.R0P+C`T-#`U
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M97,I(&5Q=6%L('1O(&]R(&EN(&5X8V5S<R!O9B`F;F)S<#LD,3`L,#`P+#`P
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M9W)E9V%T92!O9B`F;F)S<#LD-C<X+#<W-"!O9B!T:&4@<')O8V5E9',L('=H
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M+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\
M+V9O;G0^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I
M<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[
M=&5X="UA;&EG;CIJ=7-T:69Y.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II
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M.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L
M87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X
M="UA;&EG;CIJ=7-T:69Y.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
M;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<@/D]N($IA;G5A<GD@-RP@,C`Q,2P@=7!O;B!T:&4@8V]M<&QE=&EO;B!O
M9B!A(%-U8G-E<75E;G0@1FEN86YC:6YG+"!T:&4@86)O=F4@9&5S8W)I8F5D
M(&-O;G9E<G-I;VX@<F%T92!C:&%N9V5D(&9R;VT@)FYB<W`[)#`N,#0T,#4@
M=&\@)FYB<W`[)#`N,S<Q,#0@=VET:"!A;B!E>'1E;F1E9"!D=64@9&%T92!F
M<F]M($IU;'D@,34L(#(P,3$@=&\@2F%N=6%R>2`W+"`R,#$R(&]N("9N8G-P
M.R0Q+#4U,"PP,#`@;V8@=&AE("9N8G-P.R0R+#`P,"PP,#`@:7-S=65D('-E
M;FEO<B!C;VYV97)T:6)L92!P<F]M:7-S;W)Y(&YO=&5S+B!!;&P@;W1H97(@
M=&5R;7,@87)E(')E;6%I;FEN9R!T:&4@<V%M92X@06QT:&]U9V@@=&AE(&-O
M;G9E<G-I;VX@<F%T92!O9B!T:&4@<F5M86EN:6YG("9N8G-P.R0T-3`L,#`P
M('-E;FEO<B!S96-U<F5D(&-O;G9E<G1I8FQE('!R;VUI<W-O<GD@;F]T97,@
M<F5M86EN960@=&AE('-A;64L('1H92!D=64@9&%T92!W87,@97AT96YD960@
M86QS;R!T;R!*86YU87)Y(#<L(#(P,3(N($EN(&-O;FIU;F-T:6]N('=I=&@@
M=&AE(&-O;G9E<G-I;VX@<F%T92!A;F0@=&5R;2!M;V1I9FEC871I;VYS(&]F
M('1H92`F;F)S<#LD,2PU-3`L,#`P('-E;FEO<B!S96-U<F5D(&-O;G9E<G1I
M8FQE('!R;VUI<W-O<GD@;F]T97,L('1H92!#;VUP86YY('=R;W1E(&]F9B!T
M:&4@<F5M86EN:6YG('5N86UO<G1I>F5D(&1E8G0@9&ES8V]U;G0@;V8@)FYB
M<W`[)#,S,2PS,S(@=&\@;W!E<F%T:6]N<RX@4V5E(&)E;&]W(&1I<V-U<W-I
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M1'=I9'1H.C$P,"4[=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O
M;G0M<VEZ93HX<'0[)R`^#0H\+V9O;G0^#0H\+V1I=CX-"CPO9&EV/CQD:78@
M<W1Y;&4],T1P86=E+6)R96%K+6%F=&5R.F%L=V%Y<SMW:61T:#HQ,#`E.R`^
M/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ8V5N=&5R.W=I9'1H.C$P,"4[(#X-
M"CPO9&EV/@T*/"]D:78^/&1I=CX\9&EV('-T>6QE/3-$=VED=&@Z,3`P)3MT
M97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
M;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HX<'0[
M)R`^#0H\+V9O;G0^#0H\+V1I=CX-"CPO9&EV/@T*/"]D:78^/&1I=B!S='EL
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M:6XM<FEG:'0Z,'!T.W1E>'0M86QI9VXZ8V5N=&5R.R`^#0H\+V1I=CX\9&EV
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M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^/&9O;G0@<W1Y;&4]
M,T0G9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY
M.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#MT97AT+61E8V]R871I
M;VXZ=6YD97)L:6YE.R<@/C$P)2!396YI;W(@4V5C=7)E9"!#;VYV97)T:6)L
M92!0<F]M:7-S;W)Y($YO=&5S(&1A=&5D($YO=F5M8F5R(#$Y+"`R,#$P/&)R
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M=#LG(#Y/;B!.;W9E;6)E<B`Q.2P@,C`Q,"P@=&AE($-O;7!A;GD@:7-S=65D
M(&%N(&%G9W)E9V%T92!O9B`F;F)S<#LD,S4P+#`P,"!I;B!P<FEN8VEP86P@
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M)FYB<W`[)#`N,#`Q('!A<B!V86QU92!P97(@<VAA<F4L(`T*/"]F;VYT/CQF
M;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S
M(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#YD971E<FUI;F5D(&)Y(&1I
M=FED:6YG("AI*2!T:&4@<')I;F-I<&%L(&%M;W5N="!O9B!E86-H(&YO=&4L
M('1O9V5T:&5R('=I=&@@86YY(&%N9"!A;&P@86-C<G5E9"!A;F0@=6YP86ED
M(&EN=&5R97-T(&%N9"!P96YA;'1I97,L(&)Y("AI:2D@82!C;VYV97)S:6]N
M('!R:6-E(&]F("9N8G-P.R0@,"XP,S(X,C4X,3<L('=H:6-H(&ES(&5Q=6%L
M('1O(&$@,C`E(&1I<V-O=6YT('1O('1H92!A=F5R86=E('9O;'5M92P@=V5I
M9VAT960@879E<F%G92!P<FEC92!O9B!O=7(@8V]M;6]N('-T;V-K(&9O<B!T
M:&4@=&5N('1R861I;F<@9&%Y<R!P<FEO<B!T;R!I<W-U86YC92`H=&AE("8C
M.#(R,#M#;VUM;VX@0V]N=F5R<VEO;B!0<FEC928C.#(R,3LI(&]R("A"*2!S
M96-U<FET:65S(&ES<W5E9"!I;B!A;GD@4W5B<V5Q=65N="!&:6YA;F-I;F<@
M*"8C.#(R,#M3=6)S97%U96YT(%-E8W5R:71I97,F(S@R,C$[*2!A="!A(&-O
M;G9E<G-I;VX@<')I8V4@97%U86P@=&\@.#`E(&]F('1H92!P<FEC92!P97(@
M4W5B<V5Q=65N="!396-U<FET>2!P86ED(&)Y(&EN=F5S=&]R<R!F;W(@4W5B
M<V5Q=65N="!396-U<FET:65S(&EN(&$@4W5B<V5Q=65N="!&:6YA;F-I;F<@
M*'1H92`F(S@R,C`[4W5B<V5Q=65N="!&:6YA;F-I;F<@4')I8V4F(S@R,C$[
M*2X@02`F(S@R,C`[4W5B<V5Q=65N="!&:6YA;F-I;F<F(S@R,C$[(&ES('1H
M92!S86QE(&)Y('1H92!#;VUP86YY(&]R(&%N(&%F9FEL:6%T92!T:&5R96]F
M(&]F('-E8W5R:71I97,@870@86YY('1I;64@869T97(@3F]V96UB97(@,3DL
M(#(P,3`@86YD('!R:6]R('1O('1H92!E87)L:65R(&]F("AI*2!A(%%U86QI
M9FEE9"!&:6YA;F-I;F<@;W(@*&EI*2!.;W9E;6)E<B`Q.2P@,C`Q,2X@02!N
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M;6)E<B`Q.2P@,C`Q,2!A;F0@*$E)*2!T:&4@8V]M<&QE=&EO;B!O9B!A(%%U
M86QI9FEE9"!&:6YA;F-I;F<@870@=&AE(&5L96-T:6]N(&]F(&5A8V@@;F]T
M96AO;&1E<B!I;G1O(&5I=&AE<B`H02D@<VAA<F5S(&]F(&-O;6UO;B!S=&]C
M:R!A="!T:&4@0V]M;6]N($-O;G9E<G-I;VX@4')I8V4L("A"*2!3=6)S97%U
M96YT(%-E8W5R:71I97,@870@82!C;VYV97)S:6]N('!R:6-E(&5Q=6%L('1O
M(#@P)2!O9B!T:&4@4W5B<V5Q=65N="!&:6YA;F-I;F<@4')I8V4L(&]R("A#
M*2!S96-U<FET:65S(&ES<W5E9"!I;B!A(%%U86QI9FEE9"!&:6YA;F-I;F<@
M*'1H92`F(S@R,C`[475A;&EF:65D($9I;F%N8VEN9R!396-U<FET:65S)B,X
M,C(Q.RD@870@82!C;VYV97)S:6]N('!R:6-E(&5Q=6%L('1O(#@P)2!O9B!T
M:&4@<')I8V4@<&5R(%%U86QI9FEE9"!&:6YA;F-I;F<@4V5C=7)I='D@<&%I
M9"!B>2!I;G9E<W1O<G,@9F]R('1H92!1=6%L:69I960@1FEN86YC:6YG(%-E
M8W5R:71I97,@:6X@=&AE(%%U86QI9FEE9"!&:6YA;F-I;F<N(`T*/"]F;VYT
M/@T*/"]D:78^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ:G5S=&EF>3MT97AT
M+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[;6%R
M9VEN+7)I9VAT.C!P=#L@/CQF;VYT/CQB<B`O/@T*/"]F;VYT/@T*/"]D:78^
M#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ
M8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA
M;&EG;CIJ=7-T:69Y.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E
M;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR
M:6=H=#HP<'0[=&5X="UA;&EG;CIJ=7-T:69Y.R`^/&9O;G0@<W1Y;&4],T0G
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M8V5S<R!O9B`F;F)S<#LD,3`@;6EL;&EO;BX@5&AE(&YO=&5S(&)E87(@:6YT
M97)E<W0@870@=&AE(')A=&4@;V8@,3`E('!E<B!A;FYU;2!A;F0@87)E(&1U
M92!A;F0@<&%Y86)L92!I;B!F=6QL(&]N($YO=F5M8F5R(#$Y+"`R,#$Q+B`\
M8G(O/@T*/"]F;VYT/@T*/"]D:78^/&1I=@T*('-T>6QE/3-$=&5X="UI;F1E
M;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR
M:6=H=#HP<'0[=&5X="UA;&EG;CIJ=7-T:69Y.R`^#0H\+V1I=CX\9&EV('-T
M>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE
M9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA;&EG;CIJ=7-T:69Y.R`^
M/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM
M97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/E5N=&EL('1H92!P<FEN
M8VEP86P@86YD(&%C8W)U960@8G5T('5N<&%I9"!I;G1E<F5S="!U;F1E<B!T
M:&4@;F]T97,@87)E('!A:60@:6X@9G5L;"P@;W(@8V]N=F5R=&5D(&EN=&\@
M0V]N=F5R<VEO;B!3:&%R97,@<'5R<W5A;G0@=&\@=&AE:7(@=&5R;7,L('1H
M92!#;VUP86YY)B,X,C$W.W,@;V)L:6=A=&EO;G,@=6YD97(@=&AE(&YO=&5S
M('=I;&P@8F4@<V5C=7)E9"!B>2!A(&QI96X@;VX@86QL(&%S<V5T<R!O9B!T
M:&4@0V]M<&%N>2!A;F0@=&AE(&%S<V5T<R!O9B!!4$1.("A"+E8N22XI($EN
M8RXL('1H92!#;VUP86YY)B,X,C$W.W,@=VAO;&QY+6]W;F5D('-U8G-I9&EA
M<GDN/&)R+SX-"CPO9F]N=#X-"CPO9&EV/CQD:78@<W1Y;&4],T1T97AT+6EN
M9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN
M+7)I9VAT.C!P=#MT97AT+6%L:6=N.FIU<W1I9GD[(#X-"CPO9&EV/CQD:78@
M<W1Y;&4],T1T97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM
M;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#MT97AT+6%L:6=N.FIU<W1I9GD[
M(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT
M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^26X@86-C;W)D86YC
M92!W:71H($%30R`T-S`M,C`L('1H92!#;VUP86YY(')E8V]G;FEZ960@86X@
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M9V=R96=A=&4@;V8@)FYB<W`[)#<V+#0Y-"!O9B!T:&4@<')O8V5E9',L('=H
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M=7-T:69Y.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T
M.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP
M<'0[=&5X="UA;&EG;CIJ=7-T:69Y.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA
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M:&4@=&5R;2!O9B!T:&4@;F]T97,N($%M;W)T:7IA=&EO;B!O9B`F;F)S<#LD
M,3DL,#<Q(&%N9"`F;F)S<#LD-#8L-S,T('=A<R!R96-O<F1E9"!F;W(@=&AE
M('1H<F5E(&%N9"!N:6YE(&UO;G1H('!E<FEO9',@96YD960@2G5N92`S,"P@
M,C`Q,2P@<F5S<&5C=&EV96QY+CQB<B\^#0H\+V9O;G0^#0H\+V1I=CX\9&EV
M('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN
M+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA;&EG;CIL969T.R`^
M/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM
M97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/CQF;VYT('-T>6QE/3-$
M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT
M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\
M+V9O;G0^#0H\+V9O;G0^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E
M;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR
M:6=H=#HP<'0[=&5X="UA;&EG;CIJ=7-T:69Y.R`^/&9O;G0@<W1Y;&4],T0G
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M,S`L(#(P,3`\8G(O/@T*/"]F;VYT/@T*/"]F;VYT/@T*/"]D:78^/&1I=B!S
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M(#Y/;B!.;W9E;6)E<B`S,"P@,C`Q,"P@=&AE($-O;7!A;GD@:7-S=65D(&$@
M)FYB<W`[)#<U,"PP,#`@<')I;F-I<&%L(&%M;W5N="!S96YI;W(@<V5C=7)E
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M<B`H02D@<W5C:"!N=6UB97(@;V8@<VAA<F5S(&]F('1H92!#;VUP86YY)B,X
M,C$W.W,@8V]M;6]N('-T;V-K+"`F;F)S<#LD,"XP,#$@<&%R('9A;'5E('!E
M<B!S:&%R92P@9&5T97)M:6YE9"!B>2!D:79I9&EN9R`H:2D@=&AE('!R:6YC
M:7!A;"!A;6]U;G0@;V8@96%C:"!N;W1E+"!T;V=E=&AE<B!W:71H(&%N>2!A
M;F0@86QL(&%C8W)U960@86YD('5N<&%I9"!I;G1E<F5S="!A;F0@<&5N86QT
M:65S+"!B>2`H:6DI(&$@8V]N=F5R<VEO;B!P<FEC92!O9B`F;F)S<#LD(#`N
M,#,P.#@L('=H:6-H(&ES(&5Q=6%L('1O(&$@,C`E(&1I<V-O=6YT('1O('1H
M92!A=F5R86=E('9O;'5M92P@=V5I9VAT960@879E<F%G92!P<FEC92!O9B!O
M=7(@8V]M;6]N('-T;V-K(&9O<B!T:&4@=&5N('1R861I;F<@9&%Y<R!P<FEO
M<B!T;R!I<W-U86YC92`H=&AE("8C.#(R,#M#;VUM;VX@0V]N=F5R<VEO;B!0
M<FEC928C.#(R,3LI(&]R("A"*2!S96-U<FET:65S(&ES<W5E9"!I;B!A;GD@
M4W5B<V5Q=65N="!&:6YA;F-I;F<@*"8C.#(R,#M3=6)S97%U96YT(%-E8W5R
M:71I97,F(S@R,C$[*2!A="!A(&-O;G9E<G-I;VX@<')I8V4@97%U86P@=&\@
M.#`E(&]F('1H92!P<FEC92!P97(@4W5B<V5Q=65N="!396-U<FET>2!P86ED
M(&)Y(&EN=F5S=&]R<R!F;W(@4W5B<V5Q=65N="!396-U<FET:65S(&EN(&$@
M4W5B<V5Q=65N="!&:6YA;F-I;F<@*'1H92`F(S@R,C`[4W5B<V5Q=65N="!&
M:6YA;F-I;F<@4')I8V4F(S@R,C$[*2X@02`F(S@R,C`[4W5B<V5Q=65N="!&
M:6YA;F-I;F<F(S@R,C$[(&ES('1H92!S86QE(&)Y('1H92!#;VUP86YY(&]R
M(&%N(&%F9FEL:6%T92!T:&5R96]F(&]F('-E8W5R:71I97,@870@86YY('1I
M;64@869T97(@3F]V96UB97(@,S`L(#(P,3`@86YD('!R:6]R('1O('1H92!E
M87)L:65R(&]F("AI*2!A(%%U86QI9FEE9"!&:6YA;F-I;F<@;W(@*&EI*2!.
M;W9E;6)E<B`S,"P@,C`Q,2X@5&AE(&YO=&5H;VQD97(@;6%Y(&-O;G9E<G0@
M:71S(&YO=&4@:6X@=VAO;&4@:6X@8V]N;F5C=&EO;B!W:71H(&%N>2!O;F4@
M4W5B<V5Q=65N="!&:6YA;F-I;F<@;W(@:6X@<&%R="!I;B!C;VYN96-T:6]N
M('=I=&@@;VYE(&]R(&UO<F4@4W5B<V5Q=65N="!&:6YA;F-I;F=S+B!4:&4@
M;F]T92!S:&%L;"!B92!A=71O;6%T:6-A;&QY(&-O;G9E<G1E9"!U<&]N('1H
M92!E87)L:65R(&]F("A)*2!.;W9E;6)E<B`S,"P@,C`Q,2!A;F0@*$E)*2!T
M:&4@8V]M<&QE=&EO;B!O9B!A(%%U86QI9FEE9"!&:6YA;F-I;F<@870@=&AE
M(&5L96-T:6]N(&]F('1H92!N;W1E:&]L9&5R(&EN=&\@96ET:&5R("A!*2!S
M:&%R97,@;V8@8V]M;6]N('-T;V-K(&%T('1H92!#;VUM;VX@0V]N=F5R<VEO
M;B!0<FEC92P@*$(I(%-U8G-E<75E;G0@4V5C=7)I=&EE<R!A="!A(&-O;G9E
M<G-I;VX@<')I8V4@97%U86P@=&\@.#`E(&]F('1H92!3=6)S97%U96YT($9I
M;F%N8VEN9R!0<FEC92P@;W(@*$,I('-E8W5R:71I97,@:7-S=65D(&EN(&$@
M475A;&EF:65D($9I;F%N8VEN9R`H=&AE("8C.#(R,#M1=6%L:69I960@1FEN
M86YC:6YG(%-E8W5R:71I97,F(S@R,C$[*2!A="!A(&-O;G9E<G-I;VX@<')I
M8V4@97%U86P@=&\@.#`E(&]F('1H92!P<FEC92!P97(@475A;&EF:65D($9I
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M:6=H=#HP<'0[(#X\9&EV/CQD:78@<W1Y;&4],T1W:61T:#HQ,#`E.W1E>'0M
M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O
M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z.'!T.R<@/@T*
M/"]F;VYT/@T*/"]D:78^#0H\+V1I=CX\9&EV('-T>6QE/3-$<&%G92UB<F5A
M:RUA9G1E<CIA;'=A>7,[=VED=&@Z,3`P)3L@/CQD:78@<W1Y;&4],T1T97AT
M+6%L:6=N.F-E;G1E<CMW:61T:#HQ,#`E.R`^#0H\+V1I=CX-"CPO9&EV/CQD
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M=&5R.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I
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M.R`^#0H\+V1I=CX-"CPO9&EV/@T*/"]D:78^/&1I=B!S='EL93TS1'1E>'0M
M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.R`^#0H\+V1I=CX\9&EV('-T>6QE
M/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z
M,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA;&EG;CIL969T.R`^#0H\+V1I
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M)R`^02`F(S@R,C`[475A;&EF:65D($9I;F%N8VEN9R8C.#(R,3L@:7,@=&AE
M('-A;&4@8GD@=&AE($-O;7!A;GD@;W(@86X@869F:6QI871E('1H97)E;V8@
M;V8@<V5C=7)I=&EE<R!R97-U;'1I;F<@:6X@9W)O<W,@<')O8V5E9',@*&)E
M9F]R90T*('1R86YS86-T:6]N(&9E97,@86YD(&5X<&5N<V5S*2!I;B!A('-I
M;F=L92!T<F%N<V%C=&EO;B!E<75A;"!T;R!O<B!I;B!E>&-E<W,@;V8@)FYB
M<W`[)#$P(&UI;&QI;VXN(%1H92!N;W1E(&)E87)S(&EN=&5R97-T(&%T('1H
M92!R871E(&]F(#$P)2!P97(@86YN=6T@86YD(&ES(&1U92!A;F0@<&%Y86)L
M92!I;B!F=6QL(&]N($YO=F5M8F5R(#,P+"`R,#$Q+B`\8G(O/@T*/"]F;VYT
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M:7IE9"!A;F0@;65A<W5R960@86X@86=G<F5G871E(&]F("9N8G-P.R0R-S`L
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M96YE9FEC:6%L(&-O;G9E<G-I;VX@9F5A='5R92`H)FYB<W`[)#(W,"PP-S@I
M('1O(&1E8G0@9&ES8V]U;G0@=VAI8V@@=VEL;"!B92!A;6]R=&EZ960@=&\@
M:6YT97)E<W0@97AP96YS92!O=F5R('1H92!T97)M(&]F('1H92!N;W1E+B!!
M;6]R=&EZ871I;VX@;V8@)FYB<W`[)#8W+#,S-"!A;F0@)FYB<W`[)#$U-BPX
M-C<@=V%S(')E8V]R9&5D(&9O<B!T:&4@=&AR964@86YD(&YI;F4@;6]N=&@@
M<&5R:6]D<R!E;F1E9"!*=6YE(#,P+"`R,#$Q+"!R97-P96-T:79E;'DN/&)R
M+SX-"CPO9F]N=#X-"CPO9&EV/CQD:78@<W1Y;&4],T1T97AT+6EN9&5N=#HP
M<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT
M.C!P=#MT97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y
M.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE
M.C$P<'0[)R`^/&9O;G0@<W1Y;&4],T0G9F]N="UF86UI;'DZ=&EM97,@;F5W
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M;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^/&9O;G0@
M<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W
M(')O;6%N.V9O;G0M<VEZ93HQ,'!T.W1E>'0M9&5C;W)A=&EO;CIU;F1E<FQI
M;F4[)R`^,3`E(%-E;FEO<B!396-U<F5D($-O;G9E<G1I8FQE(%!R;VUI<W-O
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M92!#;VUP86YY(&ES<W5E9"!A("9N8G-P.R0W-3`L,#`P('!R:6YC:7!A;"!A
M;6]U;G0@<V5N:6]R('-E8W5R960@8V]N=F5R=&EB;&4@;F]T92!B96%R:6YG
M(&EN=&5R97-T(&%T(&$@<F%T92!O9B`Q,"4@<&5R(&%N;G5M('1O(&%N("8C
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M<R!O9B!T:&4@0V]M<&%N>28C.#(Q-SMS(&-O;6UO;B!S=&]C:RP@)FYB<W`[
M)#`N,#`Q('!A<B!V86QU92!P97(@<VAA<F4L(&1E=&5R;6EN960@8GD@9&EV
M:61I;F<@*&DI('1H92!P<FEN8VEP86P@86UO=6YT(&]F(&5A8V@@;F]T92P@
M=&]G971H97(@=VET:"!A;GD@86YD(&%L;"!A8V-R=65D(&%N9"!U;G!A:60@
M:6YT97)E<W0@86YD('!E;F%L=&EE<RP@8GD@*&EI*2!A(&-O;G9E<G-I;VX@
M<')I8V4@;V8@)FYB<W`[)"`P+C`U-3(Y+"!W:&EC:"!I<R!E<75A;"!T;R!A
M(#(P)2!D:7-C;W5N="!T;R!T:&4@879E<F%G92!V;VQU;64L('=E:6=H=&5D
M(&%V97)A9V4@<')I8V4@;V8@;W5R(&-O;6UO;B!S=&]C:R!F;W(@=&AE('1E
M;B!T<F%D:6YG(&1A>7,@<')I;W(@=&\@:7-S=6%N8V4@*'1H92`F(S@R,C`[
M0V]M;6]N($-O;G9E<G-I;VX@4')I8V4F(S@R,C$[*2!O<B`H0BD@<V5C=7)I
M=&EE<R!I<W-U960@:6X@86YY(%-U8G-E<75E;G0@1FEN86YC:6YG("@F(S@R
M,C`[4W5B<V5Q=65N="!396-U<FET:65S)B,X,C(Q.RD@870@82!C;VYV97)S
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M96-U<FET:65S(&%T(&%N>2!T:6UE(&%F=&5R($IA;G5A<GD@-RP@,C`Q,2!A
M;F0@<')I;W(@=&\@=&AE(&5A<FQI97(@;V8@*&DI(&$@475A;&EF:65D($9I
M;F%N8VEN9R!O<B`H:6DI($IA;G5A<GD@-RP@,C`Q,BX@5&AE(&YO=&5H;VQD
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M(&5I=&AE<B`H02D@<VAA<F5S(&]F(&-O;6UO;B!S=&]C:R!A="!T:&4@0V]M
M;6]N($-O;G9E<G-I;VX@4')I8V4L("A"*2!3=6)S97%U96YT(%-E8W5R:71I
M97,@870@82!C;VYV97)S:6]N('!R:6-E(&5Q=6%L('1O(#@P)2!O9B!T:&4@
M4W5B<V5Q=65N="!&:6YA;F-I;F<@4')I8V4L(&]R("A#*2!S96-U<FET:65S
M(&ES<W5E9"!I;B!A(%%U86QI9FEE9"!&:6YA;F-I;F<@*'1H92`F(S@R,C`[
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M=7-T:69Y.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T
M.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP
M<'0[=&5X="UA;&EG;CIJ=7-T:69Y.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA
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M9B`F;F)S<#LD,3`@;6EL;&EO;BX@5&AE(&YO=&4@8F5A<G,@:6YT97)E<W0@
M870@=&AE(')A=&4@;V8@,3`E('!E<B!A;FYU;2!A;F0@:7,@9'5E(&%N9"!P
M87EA8FQE(&EN(&9U;&P@;VX@2F%N=6%R>2`W+"`R,#$R+B`\8G(O/@T*/"]F
M;VYT/@T*/"]D:78^/&1I=B!S='EL93TS1'1E>'0M:6YD96YT.C!P=#MD:7-P
M;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.W1E
M>'0M86QI9VXZ:G5S=&EF>3L@/@T*/"]D:78^/&1I=B!S='EL93TS1'1E>'0M
M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G
M:6XM<FEG:'0Z,'!T.W1E>'0M86QI9VXZ:G5S=&EF>3L@/CQF;VYT('-T>6QE
M/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG(#Y5;G1I;"!T:&4@<')I;F-I<&%L(&%N9"!A
M8V-R=65D(&)U="!U;G!A:60@:6YT97)E<W0@=6YD97(@=&AE(&YO=&4@:7,@
M<&%I9"!I;B!F=6QL+"!O<B!C;VYV97)T960@:6YT;R!#;VYV97)S:6]N(%-H
M87)E<R!P=7)S=6%N="!T;R!I=',@=&5R;7,L('1H92!#;VUP86YY)B,X,C$W
M.W,@;V)L:6=A=&EO;G,@=6YD97(@=&AE(&YO=&4@=VEL;"!B92!S96-U<F5D
M(&)Y(&$@;&EE;B!O;B!A;&P@87-S971S(&]F('1H92!#;VUP86YY(&%N9"!T
M:&4@87-S971S(&]F($%01$X@*$(N5BY)+BD@26YC+BP@=&AE($-O;7!A;GDF
M(S@R,3<[<R!W:&]L;'DM;W=N960@<W5B<VED:6%R>2X-"CPO9F]N=#X-"CPO
M9&EV/CQD:78@<W1Y;&4],T1T97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C
M:SL@/@T*/"]D:78^/&1I=B!S='EL93TS1'1E>'0M:6YD96YT.C!P=#MM87)G
M:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#L@/CQD:78^/&1I=B!S='EL
M93TS1'=I9'1H.C$P,"4[=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4]
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M;V-K.R`^/&1I=B!S='EL93TS1'1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L
M;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.W1E>'0M86QI
M9VXZ8V5N=&5R.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z
M,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H
M=#HP<'0[=&5X="UA;&EG;CIC96YT97([(#X-"CPO9&EV/CQD:78@<W1Y;&4]
M,T1T97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP
M<'0[;6%R9VEN+7)I9VAT.C!P=#MT97AT+6%L:6=N.F-E;G1E<CL@/@T*/"]D
M:78^/&1I=B!S='EL93TS1'1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K
M.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.W1E>'0M86QI9VXZ
M8V5N=&5R.R`^#0H\+V1I=CX-"CPO9&EV/CQD:78@<W1Y;&4],T1T97AT+6EN
M9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SL@/@T*/"]D:78^/&1I=B!S='EL93TS
M1'1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P
M=#MM87)G:6XM<FEG:'0Z,'!T.W1E>'0M86QI9VXZ;&5F=#L@/@T*/"]D:78^
M/&1I=B!S='EL93TS1'1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.R`^
M#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ
M8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA
M;&EG;CIJ=7-T:69Y.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[
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M96%S=7)E9"!A;B!A9V=R96=A=&4@;V8@)FYB<W`[)#(T,"PR,S,@;V8@=&AE
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M="US:7IE.C$P<'0[)R`^5&AE($-O;7!A;GD@<F5C;W)D960@=&AE(&EN=')I
M;G-I8R!V86QU92!O9B!T:&4@96UB961D960@8F5N969I8VEA;"!C;VYV97)S
M:6]N(&9E871U<F4@*"9N8G-P.R0R-#`L,C,S*2!T;R!D96)T(&1I<V-O=6YT
M('=H:6-H('=I;&P@8F4@86UO<G1I>F5D('1O(&EN=&5R97-T(&5X<&5N<V4@
M;W9E<B!T:&4@=&5R;2!O9B!T:&4@;F]T92X@06UO<G1I>F%T:6]N(&]F("9N
M8G-P.R0U.2PX.30@86YD("9N8G-P.R0Q,30L-3(R('=A<R!R96-O<F1E9"!F
M;W(@=&AE('1H<F5E(&%N9"!N:6YE(&UO;G1H('!E<FEO9',@96YD960@2G5N
M92`S,"P@,C`Q,2X-"CPO9F]N=#X\8G(O/@T*/"]D:78^/&1I=B!S='EL93TS
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M>2!.;W1E<R!I<W-U960@;VX@2G5L>2`Q-2P@,C`Q,"P@;6]D:69I960@;VX@
M2F%N=6%R>2`W+"`R,#$Q/&)R+SX-"CPO9F]N=#X-"CPO9F]N=#X-"CPO9&EV
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M.C$P<'0[)R`^3VX@2F%N=6%R>2`W+"`R,#$Q+"!T:&4@0V]M<&%N>2!M;V1I
M9FEE9"!P<F5V:6]U<VQY(&ES<W5E9"!S96YI;W(@<V5C=7)E9"!P<F]M:7-S
M;W)Y(&YO=&5S(&EN:71I86QL>2!D871E9"!*=6QY(#$U+"`R,#$P('1O=&%L
M:6YG("9N8G-P.R0Q+#4U,"PP,#`@:6X@<')I;F-I<&%L(&%M;W5N="!B96%R
M:6YG(&EN=&5R97-T(&%T(&$@<F%T92!O9B`Q,"4@<&5R(&%N;G5M('1O("8C
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M8G-P.R0P+C`P,2!P87(@=F%L=64@<&5R('-H87)E+"!D971E<FUI;F5D(&)Y
M(&1I=FED:6YG("AI*2!T:&4@<')I;F-I<&%L(&%M;W5N="!O9B!E86-H(&YO
M=&4L('1O9V5T:&5R('=I=&@@86YY(&%N9"!A;&P@86-C<G5E9"!A;F0@=6YP
M86ED(&EN=&5R97-T(&%N9"!P96YA;'1I97,L(&)Y("AI:2D@82!C;VYV97)S
M:6]N('!R:6-E(&]F("9N8G-P.R0@,"XP,S<Q,#0@;W(@*$(I('-E8W5R:71I
M97,@:7-S=65D(&EN(&%N>2!3=6)S97%U96YT($9I;F%N8VEN9R`H)B,X,C(P
M.U-U8G-E<75E;G0@4V5C=7)I=&EE<R8C.#(R,3LI(&%T(&$@8V]N=F5R<VEO
M;B!P<FEC92!E<75A;"!T;R`X,"4@;V8@=&AE('!R:6-E('!E<B!3=6)S97%U
M96YT(%-E8W5R:71Y('!A:60@8GD@:6YV97-T;W)S(&9O<B!3=6)S97%U96YT
M(%-E8W5R:71I97,@:6X@82!3=6)S97%U96YT($9I;F%N8VEN9R`H=&AE("8C
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M=&AE<B`H02D@<VAA<F5S(&]F(&-O;6UO;B!S=&]C:R!A="!T:&4@0V]M;6]N
M($-O;G9E<G-I;VX@4')I8V4L("A"*2!3=6)S97%U96YT(%-E8W5R:71I97,@
M870@82!C;VYV97)S:6]N('!R:6-E(&5Q=6%L('1O(#@P)2!O9B!T:&4@4W5B
M<V5Q=65N="!&:6YA;F-I;F<@4')I8V4L(&]R("A#*2!S96-U<FET:65S(&ES
M<W5E9"!I;B!A(%%U86QI9FEE9"!&:6YA;F-I;F<@*'1H92`F(S@R,C`[475A
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M;F%N8VEN9R!W87,@<F5C;V=N:7IE9"!A<R`\9F]N="!S='EL93TS1"=D:7-P
M;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[)R`^)B,X
M,C(P.V1E8G0@;6]D:69I8V%T:6]N#0H\+V9O;G0^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.R<@
M/B8C.#(R,3L@:6X@=&AE(&9I;F%N8VEA;"!S=&%T96UE;G1S+@T*/"]F;VYT
M/B`-"CPO9F]N=#X\8G(O/@T*/"]D:78^/&1I=B!S='EL93TS1'1E>'0M:6YD
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M<W5L=&EN9R!I;B!G<F]S<R!P<F]C965D<R`H8F5F;W)E('1R86YS86-T:6]N
M(&9E97,@86YD(&5X<&5N<V5S*2!I;B!A('-I;F=L92!T<F%N<V%C=&EO;B!E
M<75A;"!T;R!O<B!I;B!E>&-E<W,@;V8@)FYB<W`[)#$P(&UI;&QI;VXN(%1H
M92!N;W1E<R!B96%R(&EN=&5R97-T(&%T('1H92!R871E(&]F(#$P)2!P97(@
M86YN=6T@86YD(&ES(&1U92!A;F0@<&%Y86)L92!I;B!F=6QL(&]N($IA;G5A
M<GD@-RP@,C`Q,BX@/&)R+SX-"CPO9F]N=#X-"CPO9&EV/CQD:78@<W1Y;&4]
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M+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^56YT
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M:6%L(&-O;G9E<G-I;VX@9F5A='5R92`H)FYB<W`[)#$L-#DY+#4S-BD@=&\@
M9&5B="!D:7-C;W5N="!W:&EC:"!W:6QL(&)E(&%M;W)T:7IE9"!T;R!I;G1E
M<F5S="!E>'!E;G-E(&]V97(@=&AE('1E<FT@;V8@=&AE(&YO=&4N($%M;W)T
M:7IA=&EO;B!O9B`F;F)S<#LD,SDQ+#4W-B!A;F0@)FYB<W`[)#<S,BPU-C8@
M=V%S(')E8V]R9&5D(&9O<B!T:&4@=&AR964@86YD(&YI;F4@;6]N=&@@<&5R
M:6]D<R!E;F1E9"!*=6YE(#,P+"`R,#$Q+"!R97-P96-T:79E;'DN#0H\+V9O
M;G0^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L
M87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X
M="UA;&EG;CIJ=7-T:69Y.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI
M;F1E;G0Z,'!T.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^
M/&1I=CX\9&EV('-T>6QE/3-$=VED=&@Z,3`P)3MT97AT+6%L:6=N.FQE9G0[
M(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT
M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.CAP=#LG(#X-"CPO9F]N=#X-"CPO
M9&EV/@T*/"]D:78^/&1I=B!S='EL93TS1'!A9V4M8G)E86LM869T97(Z86QW
M87ES.W=I9'1H.C$P,"4[(#X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT
M97([=VED=&@Z,3`P)3L@/@T*/"]D:78^#0H\+V1I=CX\9&EV/CQD:78@<W1Y
M;&4],T1W:61T:#HQ,#`E.W1E>'0M86QI9VXZ<FEG:'0[(#X\9F]N="!S='EL
M93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M
M86X[9F]N="US:7IE.CAP=#LG(#X-"CPO9F]N=#X-"CPO9&EV/@T*/"]D:78^
M#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ
M8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA
M;&EG;CIJ=7-T:69Y.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E
M;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR
M:6=H=#HP<'0[=&5X="UA;&EG;CIJ=7-T:69Y.R`^/&1I=B!S='EL93TS1'1E
M>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM
M87)G:6XM<FEG:'0Z,'!T.W1E>'0M86QI9VXZ8V5N=&5R.R`^#0H\+V1I=CX\
M9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R
M9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA;&EG;CIC96YT
M97([(#X-"CPO9&EV/CQD:78@<W1Y;&4],T1T97AT+6EN9&5N=#HP<'0[9&ES
M<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#MT
M97AT+6%L:6=N.F-E;G1E<CL@/@T*/"]D:78^/&1I=B!S='EL93TS1'1E>'0M
M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G
M:6XM<FEG:'0Z,'!T.W1E>'0M86QI9VXZ8V5N=&5R.R`^#0H\+V1I=CX-"CPO
M9&EV/CQD:78@<W1Y;&4],T1T97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C
M:SL@/@T*/"]D:78^/&1I=B!S='EL93TS1'1E>'0M:6YD96YT.C!P=#MD:7-P
M;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.W1E
M>'0M86QI9VXZ;&5F=#L@/@T*/"]D:78^/&1I=B!S='EL93TS1'1E>'0M:6YD
M96YT.C!P=#MD:7-P;&%Y.F)L;V-K.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$
M=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T
M.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA;&EG;CIJ=7-T:69Y.R`^/&9O;G0@
M<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W
M(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/D1U<FEN9R!T:&4@<75A<G1E<B!E
M;F1E9"!*=6YE(#,P+"`R,#$Q+"!T:&4@0V]M<&%N>2!I<W-U960@86X@86=G
M<F5G871E(&]F(#$L,#(S+#`R-B!S:&%R97,@;V8@8V]M;6]N('-T;V-K(&EN
M('-E='1L96UE;G0@;V8@=&AE("9N8G-P.R0S-2PP,#`@;V8@8V]N=F5R=&EB
M;&4@;F]T97,@86YD(')E;&%T960@:6YT97)E<W0N#0H\+V9O;G0^#0H\+V1I
M=CX-"CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X
M=%!A<G1?-#`X.#=E961?9&)B8E\T.3!C7V)A.3=?8F$W-C1C-S0R.#`Y#0I#
M;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S0P.#@W965D7V1B8F)?-#DP
M8U]B83DW7V)A-S8T8S<T,C@P.2]7;W)K<VAE971S+U-H965T,3`N:'1M;`T*
M0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*
M0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*
M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O
M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M
M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N
M:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\
M+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I
M9#TS1$E$,$4R2#X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY214Q!5$5$(%!!
M4E19(%1204Y304-424].4SQB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XY($UO;G1H<R!%;F1E9#PO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y*=6XN(#,P+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/E)E;&%T960@4&%R='D@5')A;G-A8W1I;VYS
M(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4D5,051%1"!005)462!44D%.4T%#5$E/3E,\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQD:78^/&1I=B!S='EL93TS1'1E>'0M
M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G
M:6XM<FEG:'0Z,'!T.W1E>'0M86QI9VXZ:G5S=&EF>3L@/CQF;VYT('-T>6QE
M/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.R<@/DY/5$4@12`M
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M:7IE.C$P<'0[)R`^5&AE($-O;7!A;GDF(S@R,3<[<R!C=7)R96YT(&%N9"!F
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M<V4@861V86YC97,N($%S(&]F($IU;F4@,S`L(#(P,3$@86YD(%-E<'1E;6)E
M<B`S,"P@,C`Q,"P@=&AE<F4@=V5R92`F;F)S<#LD-C`P+#`P,"!A;F0@)FYB
M<W`[)#4P+#`P,"!A9'9A;F-E<R!O=71S=&%N9&EN9RP@<F5S<&5C=&EV96QY
M+CQB<B\^#0H\+V9O;G0^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E
M;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR
M:6=H=#HP<'0[=&5X="UA;&EG;CIJ=7-T:69Y.R`^#0H\+V1I=CX\9&EV('-T
M>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE
M9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA;&EG;CIJ=7-T:69Y.R`^
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M+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\
M+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-#`X.#=E961?9&)B8E\T.3!C
M7V)A.3=?8F$W-C1C-S0R.#`Y#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O
M+T,Z+S0P.#@W965D7V1B8F)?-#DP8U]B83DW7V)A-S8T8S<T,C@P.2]7;W)K
M<VAE971S+U-H965T,3$N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN
M9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[
M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@
M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E
M>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J
M879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES
M($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT
M86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$4R2#X-"B`@("`@(#QT<CX-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS
M1#(^/'-T<F]N9SY#05!)5$%,(%-43T-+/&)R/CPO<W1R;VYG/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CD@36]N=&AS($5N
M9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,3$\8G(^/"]T:#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0V%P:71A;"!3=&]C:R!;06)S
M=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D-!4$E404P@4U1/0TL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQD:78^/&1I=B!S='EL93TS1'1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y
M.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.W1E>'0M
M86QI9VXZ:G5S=&EF>3L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE
M.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IB;VQD.R<@/DY/5$4@1B`M($-!4$E404P@4U1/0TL\8G(O
M/@T*/"]F;VYT/@T*/"]D:78^/&1I=B!S='EL93TS1'1E>'0M:6YD96YT.C!P
M=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z
M,'!T.W1E>'0M86QI9VXZ:G5S=&EF>3L@/@T*/"]D:78^/&1I=B!S='EL93TS
M1'1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P
M=#MM87)G:6XM<FEG:'0Z,'!T.W1E>'0M86QI9VXZ:G5S=&EF>3L@/CQF;VYT
M('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE
M=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#Y4:&4@0V]M<&%N>2!I<R!A=71H
M;W)I>F5D('1O(&ES<W5E(#@P,"PP,#`L,#`P('-H87)E<R!O9B!C;VUM;VX@
M<W1O8VLL('=I=&@@82`F;F)S<#LD,"XP,#$@<&%R('9A;'5E('!E<B!S:&%R
M92P@87,@=&AE(')E<W5L="!O9B!A('9O=&4@;V8@<W1O8VMH;VQD97)S(&-O
M;F1U8W1E9"!O;B!*=6YE(#(Y+"`R,#$P('=H:6-H(&5F9F5C=&5D(&%N(&EN
M8W)E87-E(&EN('1H92!A=71H;W)I>F5D('-H87)E<R!O9B!C;VUM;VX@<W1O
M8VL@9G)O;2`T,3`L,#`P+#`P,"!T;R`X,#`L,#`P+#`P,"X@26X@861D:71I
M;VXL('1H92!#;VUP86YY(&ES(&%U=&AO<FEZ960@=&\@:7-S=64@,3`L,#`P
M+#`P,"!S:&%R97,@;V8@<')E9F5R<F5D('-T;V-K('=I=&@@82`F;F)S<#LD
M,"XP,#$@<&%R('9A;'5E('!E<B!S:&%R92X@07,@;V8@2G5N92`S,"P@,C`Q
M,2!A;F0@4V5P=&5M8F5R(#,P+"`R,#$P+"!T:&5R92!W97)E(#,U,BPU,C,L
M,#`Q(&%N9"`S-#8L,S8V+#(T-"!S:&%R97,@;V8@8V]M;6]N('-T;V-K(&ES
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M9&5D($IU;F4@,S`L(#(P,3$L('1H92!#;VUP86YY(&ES<W5E9"!A;B!A9V=R
M96=A=&4@;V8@.#@X+#@Q,R!S:&%R97,@=F%L=65D(&%T("9N8G-P.R0V-2PP
M,#`@9F]R(&9U='5R92!C;VYS=6QT:6YG('-E<G9I8V5S+CQB<B\^#0H\+V9O
M;G0^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L
M87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X
M="UA;&EG;CIJ=7-T:69Y.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI
M;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I
M;BUR:6=H=#HP<'0[=&5X="UA;&EG;CIJ=7-T:69Y.R`^/&9O;G0@<W1Y;&4]
M,T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<@/D1U<FEN9R!T:&4@;FEN92!M;VYT:"!P97)I
M;V1S(&5N9&5D($IU;F4@,S`L(#(P,3$@86YD(#(P,3`L('1H92!#;VUP86YY
M(&AA<R!E>'!E;G-E9"`F;F)S<#LD-3`R+#`X,R!A;F0@)FYB<W`[)#DU-BPT
M,S@@<F5L871E9"!T;R!S=&]C:R!B87-E9"!C;VUP96YS871I;VXL(')E<W!E
M8W1I=F5L>2X-"CPO9F]N=#X-"CPO9&EV/@T*/"]D:78^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-
M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T,#@X-V5E9%]D8F)B7S0Y
M,&-?8F$Y-U]B83<V-&,W-#(X,#D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z
M+R\O0SHO-#`X.#=E961?9&)B8E\T.3!C7V)A.3=?8F$W-C1C-S0R.#`Y+U=O
M<FMS:&5E=',O4VAE970Q,BYH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D
M:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M
M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@
M("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G
M=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT
M+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H
M:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@
M/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P13)(/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N
M/3-$,CX\<W1R;VYG/E-43T-+($]05$E/3E,@04Y$(%=!4E)!3E13/&)R/CPO
M<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0Q/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,3$\8G(^
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1&ES
M8VQO<W5R92!/9B!#;VUP96YS871I;VX@4F5L871E9"!#;W-T<RP@4VAA<F4M
M0F%S960@4&%Y;65N=',@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y35$]#2R!/4%1)3TY3($%.1"!705)2
M04Y44SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I=CX\9&EV
M/CQD:78^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#MT97AT+6EN9&5N
M=#HP<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I
M9VAT.C!P=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M
M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IB;VQD.R<@/DY/5$4@1R`M(%-43T-+($]05$E/3E,@04Y$(%=!4E)!
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M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^/&9O;G0@<W1Y
M;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O
M;6%N.V9O;G0M<VEZ93HQ,'!T.W1E>'0M9&5C;W)A=&EO;CIU;F1E<FQI;F4[
M)R`^5V%R<F%N=',\8G(@+SX-"CQB<B`O/@T*/"]F;VYT/@T*/"]F;VYT/@T*
M/"]D:78^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#MT97AT+6EN9&5N
M=#HP<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I
M9VAT.C!P=#L@/@T*/"]D:78^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ:G5S
M=&EF>3MT97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F
M=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L
M87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG(#Y4:&4@9F]L;&]W:6YG('1A8FQE('-U;6UA<FEZ97,@=&AE
M(&-H86YG97,@:6X@=V%R<F%N=',@;W5T<W1A;F1I;F<@86YD('1H92!R96QA
M=&5D('!R:6-E<R!F;W(@=&AE('-H87)E<R!O9B!T:&4@0V]M<&%N>28C.#(Q
M-SMS(&-O;6UO;B!S=&]C:R!I<W-U960@=&\@;F]N+65M<&QO>65E<R!O9B!T
M:&4@0V]M<&%N>2X@5&AE<V4@=V%R<F%N=',@=V5R92!G<F%N=&5D(&EN(&QI
M974@;V8@8V%S:"!C;VUP96YS871I;VX@9F]R('-E<G9I8V5S('!E<F9O<FUE
M9"!O<B!F:6YA;F-I;F<@97AP96YS97,@:6X@8V]N;F5C=&EO;B!W:71H('1H
M92!S86QE(&]F('1H92!#;VUP86YY)B,X,C$W.W,@8V]M;6]N('-T;V-K+B`\
M8G(@+SX-"CQB<B`O/@T*/"]F;VYT/@T*/"]D:78^/&1I=B!S='EL93TS1'1E
M>'0M86QI9VXZ;&5F=#L@/CQT86)L92!C96QL<W!A8VEN9STS1#`@8V5L;'!A
M9&1I;F<],T0P('=I9'1H/3-$,3`P)2!S='EL93TS1"=F;VYT+69A;6EL>3IT
M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^/'1R/CQT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0T)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F
M=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY
M.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-
M"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#4E('-T>6QE/3-$
M=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
M;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS
M1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[
M9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L<W!A;CTS1#(@<W1Y;&4],T1T97AT
M+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF
M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
M#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I
M<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O
M;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@
M;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(#X\
M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([=&5X="UI;F1E;G0Z,'!T
M.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP
M<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL
M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^5V%R<F%N=',-
M"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL
M93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M
M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI
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M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^
M/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM
M97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT
M+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF
M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
M#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M,"4@8V]L<W!A;CTS1#(@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N
M="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N
M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI
M9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M
M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO
M9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA
M>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R('-T>6QE/3-$=&5X="UA;&EG;CIL
M969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT
M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN
M;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P
M<'0[)R`^#0H\+V9O;G0^#0H\+W1D/@T*/"]T<CX\='(^/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#0E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^
M/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM
M97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-24@<W1Y;&4],T1T97AT
M+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF
M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
M#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I
M<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$P)2!C;VQS<&%N/3-$,B!S='EL93TS1'1E>'0M86QI
M9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M
M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO
M9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA
M>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S
M='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@
M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V
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M.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
M=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*
M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X]
M,T0R(#X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([=&5X="UI;F1E
M;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR
M:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT
M+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^5V5I
M9VAT960-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N
M="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N
M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT
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M969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT
M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN
M;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P
M<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED
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M;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*
M/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P
M;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US
M:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q,"4@8V]L<W!A;CTS1#(@<W1Y;&4],T1T97AT+6%L:6=N
M.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A
M;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O
M;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ
M:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y
M;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(#X\9&EV('-T
M>6QE/3-$=&5X="UA;&EG;CIC96YT97([=&5X="UI;F1E;G0Z,'!T.V1I<W!L
M87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\
M9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE
M<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^4F5M86EN:6YG#0H\+V9O
M;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\
M9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE
M<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D
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M:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y
M;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE
M9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL
M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^
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M96EG:'1E9`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF
M;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S
M(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA
M;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*
M/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E
M(&-O;'-P86X],T0R(#X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([
M=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T
M.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN
M;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P
M<'0[)R`^5V5I9VAT960-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE
M9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL
M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^
M#0H\+W1D/@T*/"]T<CX\='(^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#0E(&-O;'-P86X],T0R('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([(#X\
M9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE
M<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^17AE<F-I<V4-"CPO9F]N
M=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II
M;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,3`E(&-O;'-P86X],T0R(#X\9&EV('-T>6QE/3-$=&5X="UA;&EG
M;CIC96YT97([=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN
M+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D
M:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N
M="US:7IE.C$P<'0[)R`^3G5M8F5R#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA
M;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*
M/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P
M;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US
M:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q,"4@8V]L<W!A;CTS1#(@/CQD:78@<W1Y;&4],T1T97AT
M+6%L:6=N.F-E;G1E<CMT97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SMM
M87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#L@/CQF;VYT('-T>6QE
M/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG(#Y#;VYT<F%C='5A;`T*/"]F;VYT/@T*/"]D
M:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ
M:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y
M;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(#X\9&EV('-T
M>6QE/3-$=&5X="UA;&EG;CIC96YT97([=&5X="UI;F1E;G0Z,'!T.V1I<W!L
M87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\
M9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE
M<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^17AE<F-I<V4-"CPO9F]N
M=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D
M:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N
M="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF
M;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S
M(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!C;VQS<&%N/3-$,B`^
M/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ8V5N=&5R.W1E>'0M:6YD96YT.C!P
M=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z
M,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/D%V97)A9V4-
M"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL
M93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M
M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F
M=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY
M.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-
M"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!C;VQS<&%N
M/3-$,B`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ8V5N=&5R.W1E>'0M:6YD
M96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM
M<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/D%V
M97)A9V4-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N
M="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N
M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/@T*
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M)R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
M=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*
M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X]
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M:7IE.C$P<'0[)R`^3W5T<W1A;F1I;F<-"CPO9F]N=#X-"CPO9&EV/@T*/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[=&5X="UA;&EG;CIL969T.W!A
M9&1I;F<M8F]T=&]M.C1P>#LG(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN
M;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P
M<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED
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M<'0[)R`^3&EF92`H665A<G,I#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ8FQA8VL@,G!X('-O;&ED.W1E>'0M86QI9VXZ;&5F=#MP861D:6YG
M+6)O='1O;3HT<'@[)R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[
M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@
M/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[=&5X
M="UA;&EG;CIL969T.W!A9&1I;F<M8F]T=&]M.C1P>#LG(#X\9F]N="!S='EL
M93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M
M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L<W!A;CTS1#(@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[<&%D9&EN9RUB;W1T;VTZ
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M861D:6YG+6)O='1O;3HT<'@[)R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II
M;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,3`E(&-O;'-P86X],T0R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M8FQA8VL@,G!X('-O;&ED.W!A9&1I;F<M8F]T=&]M.C1P>#LG(#X\9&EV('-T
M>6QE/3-$=&5X="UA;&EG;CIC96YT97([=&5X="UI;F1E;G0Z,'!T.V1I<W!L
M87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\
M9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE
M<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^17AE<F-I<V%B;&4-"CPO
M9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[
M=&5X="UA;&EG;CIL969T.W!A9&1I;F<M8F]T=&]M.C1P>#LG(#X\9F]N="!S
M='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@
M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V
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M>"!S;VQI9#MP861D:6YG+6)O='1O;3HT<'@[)R`^/&1I=B!S='EL93TS1'1E
M>'0M86QI9VXZ8V5N=&5R.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K
M.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y
M;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/D5X97)C:7-E(%!R:6-E#0H\+V9O;G0^
M#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ8FQA8VL@,G!X('-O;&ED.W1E>'0M
M86QI9VXZ;&5F=#MP861D:6YG+6)O='1O;3HT<'@[)R`^/&9O;G0@<W1Y;&4]
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M)R`^)FYB<W`[)`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0U)2!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[
M(#X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MT97AT+6EN9&5N=#HP
M<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT
M.C!P=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M
M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#XP+C`S,#@X
M#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y
M;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE
M9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL
M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^
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M+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\
M+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L
M87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@
M<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W
M(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N
M.G)I9VAT.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI
M;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I
M;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF
M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
M-BXT,@T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT
M('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE
M=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG
M;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
M86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F
M;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9&EV('-T>6QE/3-$=&5X="UA;&EG
M;CIL969T.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL
M969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/B9N8G-P.R0-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L
M:6=N.G)I9VAT.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X
M="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA
M<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN
M93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[
M)R`^,"XS,#@X#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^
M/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM
M97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT
M+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF
M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
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M.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
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M.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
M=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*
M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T
M97AT+6%L:6=N.FQE9G0[(#X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T
M.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P
M=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II
M;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<@/B9N8G-P.R0-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N.G)I
M9VAT.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E
M;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR
M:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT
M+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^,"XS
M,#@X#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@
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M,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N=`T*('-T>6QE/3-$)V1I<W!L
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M:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[
M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@
M/C`N,#,R.#,-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\
M9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE
M<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D
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M<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4]
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M)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$
M)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^
M/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM
M97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T1T97AT
M+6%L:6=N.G)I9VAT.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[
M=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T
M.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN
M;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P
M<'0[)R`^-BXS.0T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@
M/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I
M;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO
M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X
M="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[
M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@
M/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9&EV('-T>6QE/3-$=&5X
M="UA;&EG;CIL969T.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA
M<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4]
M,T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<@/B9N8G-P.R0-"CPO9F]N=#X-"CPO9&EV/@T*
M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T1T
M97AT+6%L:6=N.G)I9VAT.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ<FEG
M:'0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z
M,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y
M.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE
M.C$P<'0[)R`^,"XS,C@S#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL
M969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT
M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN
M;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P
M<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED
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M:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
M86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/C4S,RPQ
M,38-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S
M='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@
M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ
M;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M
M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N
M=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$=&5X="UA;&EG;CIL969T.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ
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M:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[
M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@
M/C`N,S(X,PT*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B
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M969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/B9N8G-P.R0-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-24@<W1Y;&4],T1T97AT+6%L
M:6=N.G)I9VAT.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X
M="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA
M<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN
M93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[
M)R`^,"XP-`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[(#X\
M9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE
M<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D
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M<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4]
M,T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<@/CDL,#`P+#`P,`T*/"]F;VYT/@T*/"]D:78^
M#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL
M:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4]
M,T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[
M(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT
M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\
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M.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
M=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*
M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T
M97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN
M93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[
M)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQD:78@<W1Y;&4],T1T
M97AT+6%L:6=N.FQE9G0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[
M;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL
M93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M
M86X[9F]N="US:7IE.C$P<'0[)R`^)FYB<W`[)`T*/"]F;VYT/@T*/"]D:78^
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M>F4Z,3!P=#LG(#XP+C`T#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL
M969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT
M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN
M;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P
M<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2`-"B!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T
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M<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/C,L
M,#`P+#`P,`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF
M;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S
M(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA
M;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*
M/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9&EV('-T>6QE/3-$=&5X="UA
M;&EG;CIL969T.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I
M;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<@/B9N8G-P.R0-"CPO9F]N=#X-"CPO9&EV/@T*/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T1T97AT
M+6%L:6=N.G)I9VAT.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[
M=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T
M.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN
M;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P
M<'0[)R`^,"XP-`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX]
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M;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<@/B9N8G-P.R0-"CPO9F]N=#X-"CPO9&EV/@T*/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-24@<W1Y;&4],T1T97AT
M+6%L:6=N.G)I9VAT.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[
M=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T
M.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN
M;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P
M<'0[)R`^,"XP-#0P-0T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F
M=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY
M.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-
M"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
M;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&1I=B!S='EL93TS
M1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO
M8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S
M='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@
M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^,RPP,#<L.30V#0H\+V9O;G0^#0H\
M+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA
M>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S
M='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@
M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V
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M969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/C8N,#4-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N
M.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A
M;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O
M;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ
M:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&1I=B!S='EL
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M;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<@/C`N,#0T,#4-"CPO9F]N=#X-"CPO9&EV/@T*/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT
M+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF
M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
M#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I
M<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O
M;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@
M;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L
M:6=N.G)I9VAT.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X
M="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA
M<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN
M93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[
M)R`^,RPP,#<L.30V#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T
M.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
M=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*
M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T
M97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN
M93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[
M)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQD:78@<W1Y;&4],T1T
M97AT+6%L:6=N.FQE9G0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[
M;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL
M93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M
M86X[9F]N="US:7IE.C$P<'0[)R`^)FYB<W`[)`T*/"]F;VYT/@T*/"]D:78^
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M>F4Z,3!P=#LG(#XP+C`T-#`U#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG
M;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
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M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^)FYB<W`[)`T*/"]F;VYT/@T*/"]D
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M+7-I>F4Z,3!P=#LG(#XP+C`U-3(Y#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA
M;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*
M/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P
M;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US
M:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T
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M9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@
M/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I
M;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO
M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(`T*('-T>6QE/3-$
M=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
M;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&1I=B!S='EL93TS
M1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO
M8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S
M='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@
M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^-BXU,PT*/"]F;VYT/@T*/"]D:78^
M#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL
M:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4]
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M,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/B9N8G-P.R0-
M"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&1I=B!S='EL
M93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ
M8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N
M="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N
M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^,"XP-34R.0T*/"]F;VYT/@T*
M/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L
M87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@
M<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W
M(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N
M.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A
M;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O
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M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
M#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I
M<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&1I
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M.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y
M;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/C`N,#4U,CD-"CPO9F]N=#X-"CPO9&EV
M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN
M;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P
M<'0[)R`^#0H\+V9O;G0^#0H\+W1D/@T*/"]T<CX\='(^/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#0E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^
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M;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@
M<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W
M(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/C`N,#8-"CPO9F]N=#X-"CPO9&EV
M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN
M;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P
M<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED
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M:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
M86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/C$R+#`P
M,"PP,#`-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N
M="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N
M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI
M9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M
M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO
M9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA
M>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&1I=B!S
M='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L
M87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\
M9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE
M<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^,RXV,PT*/"]F;VYT/@T*
M/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L
M87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@
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M<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/B9N
M8G-P.R0-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&1I
M=B!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I
M<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[
M(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT
M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^,"XP-@T*/"]F;VYT
M/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I
M<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O
M;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@
M;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L
M:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT
M+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\
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M;VYT+7-I>F4Z,3!P=#LG(#XW+#`P,"PP,#`-"CPO9F]N=#X-"CPO9&EV/@T*
M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T
M97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN
M93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[
M)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$
M)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^
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M;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@
M<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W
M(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/C`N,#8-"CPO9F]N=#X-"CPO9&EV
M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N=`T*('-T>6QE/3-$)V1I<W!L87DZ
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M,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/B9N8G-P.R0-
M"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$-24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&1I=B!S='EL
M93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ
M8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N
M="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N
M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^,"XP-PT*/"]F;VYT/@T*/"]D
M:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ
M:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y
M;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N.G)I
M9VAT.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E
M;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR
M:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT
M+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^,C`P
M+#`P,`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT
M('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE
M=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG
M;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
M86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F
M;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y
M.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE
M.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@
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M>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA
M>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S
M='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@
M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ
M;&5F=#L@/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[=&5X="UI;F1E
M;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR
M:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT
M+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^)FYB
M<W`[)`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)2!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[(#X\9&EV
M('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MT97AT+6EN9&5N=#HP<'0[9&ES
M<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#L@
M/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I
M;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#XP+C`W#0H\+V9O;G0^
M#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N
M="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N
M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT
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M;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<@/C(P,"PP,#`-"CPO9F]N=#X-"CPO9&EV/@T*/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT
M+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF
M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
M#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I
M<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&1I
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M.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y
M;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/C`N,#<-"CPO9F]N=#X-"CPO9&EV/@T*
M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T
M97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN
M93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[
M)R`^#0H\+V9O;G0^#0H\+W1D/@T*/"]T<CX\='(^/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#0E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&1I
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M.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y
M;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/C`N,#D-"CPO9F]N=#X-"CPO9&EV/@T*
M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T
M97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN
M93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[
M)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
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M,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/C$V+#0P,"PP
M,#`-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S
M='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@
M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ
M;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M
M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N
M=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II
M;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&1I=B!S='EL
M93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ
M8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N
M="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N
M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^,"XQ-PT*/"]F;VYT/@T*/"]D
M:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ
M:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y
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M:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
M86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/B9N8G-P
M.R0-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&1I=B!S
M='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L
M87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\
M9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE
M<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^,"XP.0T*/"]F;VYT/@T*
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M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT
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M;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<@/C$V+#0P,"PP,#`-"CPO9F]N=#X-"CPO9&EV/@T*
M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T
M97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN
M93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[
M)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$
M)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^
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M;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@
M<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W
M(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/C`N,#D-"CPO9F]N=#X-"CPO9&EV
M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN
M;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P
M<'0[)R`^#0H\+V9O;G0^#0H\+W1D/@T*/"]T<CX\='(^/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#0E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^
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M;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@
M<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W
M(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/C`N,3`-"CPO9F]N=#X-"CPO9&EV
M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN
M;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P
M<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED
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M:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
M86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/C$L-3`P
M+#`P,`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT
M('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE
M=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG
M;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
M86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F
M;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y
M.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE
M.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@
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M>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA
M>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S
M='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@
M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ
M;&5F=#L@/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[=&5X="UI;F1E
M;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR
M:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT
M+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^)FYB
M<W`[)`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T
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M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N
M="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N
M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT
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M;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<@/C$L-3`P+#`P,`T*/"]F;VYT/@T*/"]D:78^#0H\
M+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E
M>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE
M.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G
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M.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
M=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/B9N8G-P.R0-"CPO
M9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&1I=B!S='EL93TS
M1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO
M8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S
M='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@
M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^,"XQ,`T*/"]F;VYT/@T*/"]D:78^
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M:R`R<'@@<V]L:60[=&5X="UA;&EG;CIL969T.R<@/CQD:78@<W1Y;&4],T1T
M97AT+6%L:6=N.FQE9G0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[
M;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL
M93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M
M86X[9F]N="US:7IE.C$P<'0[)R`^)FYB<W`[)`T*/"]F;VYT/@T*/"]D:78^
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M:6YG+6)O='1O;3HT<'@[)R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
M;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[
M=&5X="UA;&EG;CIL969T.W!A9&1I;F<M8F]T=&]M.C1P>#LG(#X\9F]N="!S
M='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@
M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V
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M,'!T.R<@/C$P+#<P,"PP,#`-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3IB;&%C:R`R<'@@<V]L:60[=&5X="UA;&EG;CIL969T.W!A9&1I;F<M
M8F]T=&]M.C1P>#LG(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF
M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
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M;3HT<'@[)R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
M86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F
M;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[=&5X="UA;&EG
M;CIR:6=H=#MP861D:6YG+6)O='1O;3HT<'@[)R`^/&1I=B!S='EL93TS1'1E
M>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[
M;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL
M93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M
M86X[9F]N="US:7IE.C$P<'0[)R`^,2XT.0T*/"]F;VYT/@T*/"]D:78^#0H\
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M;&ED.W1E>'0M86QI9VXZ;&5F=#MP861D:6YG+6)O='1O;3HT<'@[)R`^/&9O
M;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@
M;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[=&5X="UA;&EG;CIL969T.W!A9&1I
M;F<M8F]T=&]M.C1P>#LG(#X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T
M.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P
M=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II
M;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<@/B9N8G-P.R0-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3IB;&%C:R`R<'@@<V]L:60[=&5X="UA;&EG;CIR:6=H=#MP861D:6YG+6)O
M='1O;3HT<'@[)R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X
M="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA
M<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN
M93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[
M)R`^,"XU,`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B
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M=#MP861D:6YG+6)O='1O;3HT<'@[)R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA
M>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@
M<V]L:60[=&5X="UA;&EG;CIL969T.W!A9&1I;F<M8F]T=&]M.C1P>#LG(#X\
M9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE
M<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D
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M>F4Z,3!P=#LG(#XQ,"PW,#`L,#`P#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ8FQA8VL@,G!X('-O;&ED.W1E>'0M86QI9VXZ;&5F=#MP861D
M:6YG+6)O='1O;3HT<'@[)R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
M;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[
M=&5X="UA;&EG;CIL969T.W!A9&1I;F<M8F]T=&]M.C1P>#LG(#X\9F]N="!S
M='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@
M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V
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M)R`^)FYB<W`[)`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX]
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M('-O;&ED.W1E>'0M86QI9VXZ;&5F=#MP861D:6YG+6)O='1O;3HT<'@[)R`^
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M<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D
M/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0U)2!S='EL93TS1'1E>'0M
M86QI9VXZ;&5F=#MP861D:6YG+6)O='1O;3HT<'@[(#X\9F]N="!S='EL93TS
M1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[
M9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#MP
M861D:6YG+6)O='1O;3HT<'@[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN
M;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P
M<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED
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M;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<@/C4W+#$R-BPS,#(-"CPO9F]N=#X-"CPO9&EV/@T*
M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T
M97AT+6%L:6=N.FQE9G0[<&%D9&EN9RUB;W1T;VTZ-'!X.R`^/&9O;G0@<W1Y
M;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE
M9G0[<&%D9&EN9RUB;W1T;VTZ-'!X.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA
M>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S
M='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@
M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1'1E>'0M86QI9VXZ
M<FEG:'0[<&%D9&EN9RUB;W1T;VTZ-'!X.R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[<&%D9&EN
M9RUB;W1T;VTZ-'!X.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[
M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@
M/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[<&%D9&EN9RUB;W1T;VTZ-'!X
M.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
M=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*
M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T
M97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN
M93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[
M)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)2!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[<&%D9&EN9RUB;W1T;VTZ
M-'!X.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT
M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T1T97AT+6%L:6=N.FQE9G0[<&%D9&EN9RUB;W1T;VTZ-'!X.R`^/&9O;G0@
M<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W
M(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N
M.FQE9G0[<&%D9&EN9RUB;W1T;VTZ-'!X.R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`T
M<'@@9&]U8FQE.W1E>'0M86QI9VXZ;&5F=#LG(#X\9F]N="!S='EL93TS1"=D
M:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N
M="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"=B;W)D97(M8F]T=&]M.F)L86-K
M(#1P>"!D;W5B;&4[=&5X="UA;&EG;CIR:6=H=#LG(#X\9&EV#0H@<W1Y;&4]
M,T1T97AT+6%L:6=N.G)I9VAT.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L
M;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@
M<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W
M(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/C0V+#$R-BPS,#(-"CPO9F]N=#X-
M"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[<&%D9&EN9RUB;W1T;VTZ-'!X.R`^
M/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM
M97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT
M+6%L:6=N.FQE9G0[<&%D9&EN9RUB;W1T;VTZ-'!X.R`^/&9O;G0@<W1Y;&4]
M,T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[
M(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT
M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\
M+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1'1E
M>'0M86QI9VXZ<FEG:'0[<&%D9&EN9RUB;W1T;VTZ-'!X.R`^/&9O;G0@<W1Y
M;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE
M9G0[<&%D9&EN9RUB;W1T;VTZ-'!X.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA
M>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X-"CPO='(^#0H\+W1A8FQE/@T*
M/"]D:78^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#MT97AT+6EN9&5N
M=#HP<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I
M9VAT.C!P=#L@/@T*/"]D:78^/&1I=B!S='EL93TS1'1E>'0M:6YD96YT.C!P
M=#MM87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#L@/CQD:78^/&1I
M=B!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#MW:61T:#HQ,#`E.R`^/&9O;G0@
M<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W
M(')O;6%N.V9O;G0M<VEZ93HX<'0[)R`^#0H\+V9O;G0^#0H\+V1I=CX-"CPO
M9&EV/CQD:78@<W1Y;&4],T1P86=E+6)R96%K+6%F=&5R.F%L=V%Y<SMW:61T
M:#HQ,#`E.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ8V5N=&5R.W=I9'1H
M.C$P,"4[(#X-"CPO9&EV/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.F-E;G1E
M<CMW:61T:#HQ,#`E.R`^#0H\+V1I=CX-"CPO9&EV/CQD:78^/&1I=B!S='EL
M93TS1'1E>'0M86QI9VXZ<FEG:'0[=VED=&@Z,3`P)3L@/CQF;VYT('-T>6QE
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M<FEG:'0Z,'!T.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC
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M96YT.C!P=#MD:7-P;&%Y.F)L;V-K.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$
M=&5X="UA;&EG;CIL969T.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K
M.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y
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M+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\
M+V9O;G0^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([
M(#X\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T
M:#TS1#<P)2!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[
M9F]N="US:7IE.C$P<'0[)R`^/'1R/CQT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0T-B4@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L
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M.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q,"4@8V]L<W!A;CTS1#(@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3IB;&%C:R`R<'@@<V]L:60[)R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ
M8V5N=&5R.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL
M969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.F)O;&0[)R`^3G5M8F5R(&]F#0H\+V9O
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M8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[=&5X="UA;&EG;CIL969T
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M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^
M#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L<W!A
M;CTS1#(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[
M)R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ8V5N=&5R.W1E>'0M:6YD96YT
M.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG
M:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
M86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.F)O;&0[)R`^5V5I9VAT960-"CPO9F]N=#X-"CPO9&EV/CQD:78@<W1Y
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M=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II
M;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.F)O;&0[)R`^4VAA<F4-"CPO9F]N=#X-"CPO9&EV
M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[=&5X="UA;&EG;CIL
M969T.R<@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M
M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N
M=#X-"CPO=&0^#0H\+W1R/CQT<CX\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$-#8E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&1I=B!S='EL93TS
M1'1E>'0M86QI9VXZ;&5F=#MT97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C
M:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#L@/CQF;VYT('-T
M>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#Y"86QA;F-E+"!397!T96UB97(@,S`L
M(#(P,#D-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&9O
M;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@
M;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L
M:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT
M+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\
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M;VYT+7-I>F4Z,3!P=#LG(#XV-"PX,C`L-3`P#0H\+V9O;G0^#0H\+V1I=CX-
M"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
M;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@<W1Y;&4]
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M,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/B9N8G-P.R0-
M"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&1I=@T*('-T
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M>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA
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M:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
M86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/D=R86YT
M960-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@
M<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W
M(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N
M.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A
M;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O
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M="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[
M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@
M/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\
M9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE
M<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D
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M=#LG(#XP+C`U#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^
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M;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<@/D5X97)C:7-E9`T*/"]F;VYT/@T*/"]D:78^#0H\
M+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E
M>'0M86QI9VXZ<FEG:'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN
M93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[
M)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
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M,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/B8C.#(Q,CL-
M"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL
M93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M
M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ<FEG
M:'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL
M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^
M#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL
M:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#DE('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4]
M,T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[
M(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT
M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\
M+W1D/@T*/"]T<CX\='(^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#0V
M)2!S='EL93TS1"=B;W)D97(M8F]T=&]M.F)L86-K(#)P>"!S;VQI9#MT97AT
M+6%L:6=N.FQE9G0[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@/CQD:78@<W1Y;&4]
M,T1T97AT+6%L:6=N.FQE9G0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO
M8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S
M='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@
M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^0V%N8V5L960@;W(@97AP:7)E9`T*
M/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1"=B;W)D97(M8F]T=&]M.F)L86-K(#)P>"!S;VQI
M9#MT97AT+6%L:6=N.G)I9VAT.W!A9&1I;F<M8F]T=&]M.C)P>#LG(#X\9F]N
M="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N
M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.F)L86-K(#)P>"!S;VQI9#MT97AT+6%L:6=N.FQE9G0[)R`^/&9O
M;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@
M;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[=&5X="UA;&EG;CIR:6=H=#LG(#X\
M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MT97AT+6EN9&5N=#HP<'0[
M9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P
M=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY
M.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#XH,3<L-C(P+#4P
M,`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@
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M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^*0T*/"]F;VYT/@T*
M/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.F)L86-K(#)P>"!S;VQI9#MT97AT+6%L
M:6=N.G)I9VAT.W!A9&1I;F<M8F]T=&]M.C)P>#LG(#X\9F]N="!S='EL93TS
M1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[
M9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=B;W)D97(M8F]T=&]M.F)L
M86-K(#)P>"!S;VQI9#MT97AT+6%L:6=N.FQE9G0[)R`^/&9O;G0@<W1Y;&4]
M,T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB
M;&%C:R`R<'@@<V]L:60[=&5X="UA;&EG;CIR:6=H=#LG(#X\9&EV('-T>6QE
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M9F]N="US:7IE.C$P<'0[)R`^*0T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/@T*
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M:7IE.C$P<'0[)R`^0F%L86YC92!A="!397!T96UB97(@,S`L(#(P,3`-"CPO
M9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@<W1Y;&4]
M,T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[
M(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT
M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\
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M;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
M86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F
M;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA
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M<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^)FYB<W`[)`T*/"]F;VYT
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M="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[
M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@
M/@T*/"]F;VYT/@T*/"]T9#X-"CPO='(^/'1R/CQT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0T-B4@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9&EV
M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.W1E>'0M:6YD96YT.C!P=#MD:7-P
M;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^
M/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM
M97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/D=R86YT960-"CPO9F]N
M=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\
M9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE
M<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D
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M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^
M#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1'1E>'0M86QI9VXZ<FEG:'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN
M;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P
M<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE
M/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H
M=#L@/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.W1E>'0M:6YD96YT
M.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG
M:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
M86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/C`N,#0-
M"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL
M93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M
M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/@T*/"]T<CX\
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M<'0[)R`^17AE<F-I<V5D#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIR
M:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M
M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N
M=#X-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II
M;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&1I=B!S='EL
M93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ
M8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N
M="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N
M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^)B,X,C$R.PT*/"]F;VYT/@T*
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M;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
M86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F
M;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y
M;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&1I=B!S='EL93TS1'1E>'0M86QI
M9VXZ<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN
M+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D
M:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N
M="US:7IE.C$P<'0[)R`^)B,X,C$R.PT*/"]F;VYT/@T*/"]D:78^#0H\+W1D
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M('-O;&ED.W1E>'0M86QI9VXZ;&5F=#MP861D:6YG+6)O='1O;3HR<'@[)R`^
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M;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O
M;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.F)L86-K(#)P>"!S;VQI9#MT97AT+6%L:6=N
M.G)I9VAT.R<@/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.W1E>'0M
M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G
M:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[
M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@
M/B@Q-BPT,#`L,#`P#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M8FQA8VL@,G!X('-O;&ED.W1E>'0M86QI9VXZ;&5F=#MP861D:6YG+6)O='1O
M;3HR<'@[)R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#MT97AT+6EN
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M<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D
M/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.F)L86-K(#)P>"!S;VQI9#MT97AT+6%L:6=N.G)I9VAT.R<@
M/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.W1E>'0M:6YD96YT.C!P
M=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z
M,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/B@P+C4P#0H\
M+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ8FQA8VL@,G!X('-O;&ED
M.W1E>'0M86QI9VXZ;&5F=#MP861D:6YG+6)O='1O;3HR<'@[)R`^/&1I=B!S
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M+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^0F%L
M86YC92P@2G5N92`S,"P@,C`Q,0T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI
M9VXZ<FEG:'0[<&%D9&EN9RUB;W1T;VTZ-'!X.R`^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C
M:R`T<'@@9&]U8FQE.W1E>'0M86QI9VXZ;&5F=#LG(#X\9F]N="!S='EL93TS
M1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[
M9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"=B;W)D97(M8F]T=&]M.F)L
M86-K(#1P>`T*(&1O=6)L93MT97AT+6%L:6=N.G)I9VAT.R<@/CQD:78@<W1Y
M;&4],T1T97AT+6%L:6=N.G)I9VAT.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y
M.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O
M;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@
M;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/C4W+#$R-BPS,#(-"CPO9F]N
M=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[<&%D9&EN9RUB;W1T;VTZ-'!X
M.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
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M;VTZ8FQA8VL@-'!X(&1O=6)L93MT97AT+6%L:6=N.FQE9G0[)R`^/&1I=B!S
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M=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II
M;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<@/C`N,34-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[
M<&%D9&EN9RUB;W1T;VTZ-'!X.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II
M;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X-"CPO='(^#0H\+W1A8FQE/CQB<B`O
M/@T*/"]D:78^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ8V5N=&5R.R`^#0H\
M+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.W1E>'0M:6YD96YT
M.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG
M:'0Z,'!T.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIJ=7-T
M:69Y.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T
M.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA
M>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<@/D]N($%P<FEL(#(Y+"`R,#$P+"!W87)R86YT<R!T;W1A;&EN
M9R`Q,"PP,#`L,#`P('=E<F4@:7-S=65D(&EN(&-O;FYE8W1I;VX@=VET:"!S
M97)V:6-E<RX@5&AE('=A<G)A;G1S(&%R92!E>&5R8VES86)L92!F;W(@9FEV
M92!Y96%R<R!F<F]M('1H92!D871E(&]F(&ES<W5A;F-E(&%T(&%N(&5X97)C
M:7-E('!R:6-E(&]F("9N8G-P.R0P+C`V('!E<B!S:&%R92!W:71H(#(U)2!V
M97-T:6YG(&EM;65D:6%T96QY+"`R-24@;VX@3V-T;V)E<B`R.2P@,C`Q,"P@
M,C4E(&]N($%P<FEL(#(Y+"`R,#$Q(&%N9"`R-24@;VX@3V-T;V)E<B`R.2P@
M,C`Q,2X@5&AE(&9A:7(@=F%L=64@;V8@=&AE('=A<G)A;G1S('9E<W1I;F<@
M9'5R:6YG('1H92!N:6YE(&UO;G1H('!E<FEO9"!E;F1E9"!*=6YE(#,P+"`R
M,#$Q('=A<R!D971E<FUI;F5D('5S:6YG('1H92!";&%C:RU38VAO;&5S($]P
M=&EO;B!0<FEC:6YG($UO9&5L('=I=&@@=&AE(&9O;&QO=VEN9R!A<W-U;7!T
M:6]N<SH@9&EV:61E;F0@>6EE;&0@)FYB<W`[)"TP+2P@=F]L871I;&ET>2!O
M9B`Q-S`N-S(E(&%N9"!R:7-K(&9R964@<F%T92!F<F]M(#$N,3<E+CQB<B\^
M#0H\+V9O;G0^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIJ=7-T
M:69Y.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T
M.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$
M=&5X="UA;&EG;CIJ=7-T:69Y.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L
M;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@
M<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W
M(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/E1H92!D971E<FUI;F5D(&9A:7(@
M=F%L=64@;V8@)FYB<W`[)#DS+#4X,"!I<R!C:&%R9V5D(')A=&%B;'D@=&\@
M8W5R<F5N="!P97)I;V0@;W!E<F%T:6]N<RX@1'5R:6YG('1H92!T:')E92!A
M;F0@;FEN92!M;VYT:"!P97)I;V1S(&5N9&5D($IU;F4@,S`L(#(P,3$L("9N
M8G-P.R0Q-"PY,3$@86YD("9N8G-P.R0Y,RPU.#`@=V%S(&-H87)G960@=&\@
M;W!E<F%T:6]N<RP@<F5S<&5C=&EV96QY+CQB<B\^#0H\+V9O;G0^#0H\+V1I
M=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIJ=7-T:69Y.W1E>'0M:6YD96YT
M.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG
M:'0Z,'!T.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIJ=7-T
M:69Y.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T
M.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA
M>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<@/D]N($IU;'D@,34L(#(P,3`L('=A<G)A;G1S('1O=&%L:6YG
M(#,L,#`W+#DT-B!W97)E(&ES<W5E9"!I;B!C;VYN96-T:6]N('=I=&@@<V5R
M=FEC97,@<')O=FED960@:6X@8V]N;F5C=&EO;B!W:71H('1H92!I<W-U86YC
M92!O9B!C;VYV97)T:6)L92!N;W1E<RX@5&AE('=A<G)A;G1S(&%R92!E>&5R
M8VES86)L92!F;W(@<V5V96X@>65A<G,@9G)O;2!T:&4@9&%T92!O9B!I<W-U
M86YC92!A="!A;B!E>&5R8VES92!P<FEC92!O9B`F;F)S<#LD,"XP-#0P-2!P
M97(@<VAA<F4N(%1H92!F86ER('9A;'5E<R!O9B!T:&4@=V%R<F%N=',@=V5R
M92!D971E<FUI;F5D('5S:6YG('1H92!";&%C:RU38VAO;&5S($]P=&EO;B!0
M<FEC:6YG($UO9&5L('=I=&@@=&AE(&9O;&QO=VEN9R!A<W-U;7!T:6]N<SH@
M9&EV:61E;F0@>6EE;&0@)FYB<W`[)"TP+2P@=F]L871I;&ET>2!O9B`Q-S,N
M-34E(&%N9"!R:7-K(&9R964@<F%T92!F<F]M(#(N-#,E+CQB<B\^#0H\+V9O
M;G0^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIJ=7-T:69Y.W1E
M>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM
M87)G:6XM<FEG:'0Z,'!T.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA
M;&EG;CIJ=7-T:69Y.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA
M<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4]
M,T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<@/E1H92!D971E<FUI;F5D(&9A:7(@=F%L=64@
M;V8@)FYB<W`[)#$W-"PT,CD@:7,@8VAA<F=E9"!R871A8FQY('1O(&-U<G)E
M;G0@<&5R:6]D(&]P97)A=&EO;G,@;W9E<B!O;F4@>65A<BX@1'5R:6YG('1H
M92!T:')E92!A;F0@;FEN92!M;VYT:"!P97)I;V1S(&5N9&5D($IU;F4@,S`L
M(#(P,3$L("9N8G-P.R0T,RPV,#<@86YD("9N8G-P.R0Q,S`L.#(Q('=A<R!C
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M;CMF;VYT+7-I>F4Z,3!P=#LG(#Y/;B!!=6=U<W0@,S`L(#(P,3`L('=A<G)A
M;G1S('1O=&%L:6YG(#$P+#`P,"PP,#`@=V5R92!I<W-U960@:6X@8V]N;F5C
M=&EO;B!W:71H('-E<G9I8V5S+B!4:&4@=V%R<F%N=',@87)E(&5X97)C:7-A
M8FQE(&9O<B!F:79E('EE87)S(&9R;VT@=&AE(&1A=&4@;V8@:7-S=6%N8V4@
M870@86X@97AE<F-I<V4@<')I8V4@;V8@)FYB<W`[)#`N,#0@<&5R('-H87)E
M('=I=&@@,S,E('9E<W1I;F<@:6UM961I871E;'D@86YD(#8W)2!U<&]N(&%C
M:&EE=FEN9R!D969I;F5D(&UI;&5S=&]N97,N(%1H92!F86ER('9A;'5E(&]F
M('1H92!V97-T960@=V%R<F%N=',@=V%S(&1E=&5R;6EN960@=7-I;F<@=&AE
M($)L86-K+5-C:&]L97,@3W!T:6]N(%!R:6-I;F<@36]D96P@=VET:"!T:&4@
M9F]L;&]W:6YG(&%S<W5M<'1I;VYS.B!D:79I9&5N9"!Y:65L9"`F;F)S<#LD
M+3`M+"!V;VQA=&EL:71Y(&]F(#$W,RXR-"4@86YD(')I<VL@9G)E92!R871E
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M+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^5&AE
M(&1E=&5R;6EN960@9F%I<B!V86QU92!O9B`F;F)S<#LD,3$S+#@X-2!I<R!C
M:&%R9V5D(')A=&%B;'D@=&\@8W5R<F5N="!P97)I;V0@;W!E<F%T:6]N<RX@
M1'5R:6YG('1H92!T:')E92!A;F0@;FEN92!M;VYT:"!P97)I;V1S(&5N9&5D
M($IU;F4@,S`L(#(P,3$L("9N8G-P.R0R."PS.3,@86YD("9N8G-P.R0X-"PX
M-C<@=V%S(&-H87)G960@=&\@;W!E<F%T:6]N<RP@<F5S<&5C=&EV96QY+CQB
M<B\^#0H\+V9O;G0^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL
M969T.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T
M.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$
M=&5X="UA;&EG;CIJ=7-T:69Y.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L
M;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@
M<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W
M(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/DEN('1H92!M;VYT:"!O9B!.;W9E
M;6)E<B`R,#$P+"!W87)R86YT<R!T;W1A;&EN9R`R+#DV,2PX-S(@=V5R92!I
M<W-U960@:6X@8V]N;F5C=&EO;B!W:71H('-E<G9I8V5S('!R;W9I9&5D(&EN
M(&-O;FYE8W1I;VX@=VET:"!T:&4@:7-S=6%N8V4@;V8@8V]N=F5R=&EB;&4@
M;F]T97,N(%1H92!W87)R86YT<R!A<F4@97AE<F-I<V%B;&4@9F]R('-E=F5N
M('EE87)S(&9R;VT@=&AE(&1A=&4@;V8@:7-S=6%N8V4@870@97AE<F-I<V4@
M<')I8V5S(&9R;VT@)FYB<W`[)#`N,#,P.#@@=&\@)FYB<W`[)#`N,#,R.#,@
M<&5R('-H87)E+B!4:&4@9F%I<B!V86QU92!O9B!T:&4@=V%R<F%N=',@=V5R
M92!D971E<FUI;F5D('5S:6YG('1H92!";&%C:RU38VAO;&5S($]P=&EO;B!0
M<FEC:6YG($UO9&5L('=I=&@@=&AE(&9O;&QO=VEN9R!A<W-U;7!T:6]N<SH@
M9&EV:61E;F0@>6EE;&0@)FYB<W`[)"TP+2P@=F]L871I;&ET>2!O9B`Q-CDN
M,#8E('1O(#$V.2XR,24@86YD(')I<VL@9G)E92!R871E(&9R;VT@,BXQ-B!T
M;R`R+C(P)2X-"CPO9F]N=#X-"CPO9&EV/CQD:78@<W1Y;&4],T1T97AT+6%L
M:6=N.FIU<W1I9GD[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R
M9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X-"CPO9&EV/CQD:78@
M<W1Y;&4],T1T97AT+6EN9&5N=#HP<'0[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I
M;BUR:6=H=#HP<'0[(#X\9&EV/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.FQE
M9G0[=VED=&@Z,3`P)3L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE
M.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z.'!T.R<@
M/@T*/"]F;VYT/@T*/"]D:78^#0H\+V1I=CX\9&EV('-T>6QE/3-$<&%G92UB
M<F5A:RUA9G1E<CIA;'=A>7,[=VED=&@Z,3`P)3L@/CQD:78@<W1Y;&4],T1T
M97AT+6%L:6=N.F-E;G1E<CMW:61T:#HQ,#`E.R`^#0H\+V1I=CX-"CPO9&EV
M/CQD:78^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[=VED=&@Z,3`P
M)3L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY
M.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z.'!T.R<@/@T*/"]F;VYT/@T*
M/"]D:78^#0H\+V1I=CX-"CPO9&EV/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N
M.FIU<W1I9GD[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN
M+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X-"CPO9&EV/CQD:78@<W1Y
M;&4],T1T97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SL@/CQD:78@<W1Y
M;&4],T1T97AT+6%L:6=N.F-E;G1E<CMT97AT+6EN9&5N=#HP<'0[9&ES<&QA
M>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#L@/@T*
M/"]D:78^/&1I=@T*('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([=&5X="UI
M;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I
M;BUR:6=H=#HP<'0[(#X-"CPO9&EV/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N
M.F-E;G1E<CMT97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM
M;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#L@/@T*/"]D:78^/&1I=B!S='EL
M93TS1'1E>'0M86QI9VXZ8V5N=&5R.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y
M.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^#0H\
M+V1I=CX-"CPO9&EV/CQD:78@<W1Y;&4],T1T97AT+6EN9&5N=#HP<'0[9&ES
M<&QA>3IB;&]C:SL@/@T*/"]D:78^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ
M:G5S=&EF>3MT97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM
M;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#L@/@T*/"]D:78^/&1I=B!S='EL
M93TS1'1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.R`^#0H\+V1I=CX\
M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIJ=7-T:69Y.W1E>'0M:6YD96YT.C!P
M=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z
M,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/E1H92!D971E
M<FUI;F5D(&9A:7(@=F%L=64@;V8@)FYB<W`[)#$R,"PX-#`@:7,@8VAA<F=E
M9"!R871A8FQY('1O(&-U<G)E;G0@<&5R:6]D(&]P97)A=&EO;G,@;W9E<B!O
M;F4@>65A<BX@1'5R:6YG('1H92!T:')E92!A;F0@;FEN92!M;VYT:"!P97)I
M;V1S(&5N9&5D($IU;F4@,S`L(#(P,3$L("9N8G-P.R0S,"PR,3`@86YD("9N
M8G-P.R0W,2PW-SD@=V%S(&-H87)G960@=&\@;W!E<F%T:6]N<RP@<F5S<&5C
M=&EV96QY+CQB<B\^#0H\+V9O;G0^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X
M="UA;&EG;CIJ=7-T:69Y.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K
M.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y
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M;V8@2F%N=6%R>2`R,#$Q+"!W87)R86YT<R!T;W1A;&EN9R`Q+#,U-BPT.#0@
M=V5R92!I<W-U960@:6X@8V]N;F5C=&EO;B!W:71H('-E<G9I8V5S('!R;W9I
M9&5D(&EN(&-O;FYE8W1I;VX@=VET:"!T:&4@:7-S=6%N8V4@;V8@8V]N=F5R
M=&EB;&4@;F]T97,N(%1H92!W87)R86YT<R!A<F4@97AE<F-I<V%B;&4@9F]R
M('-E=F5N('EE87)S(&9R;VT@=&AE(&1A=&4@;V8@:7-S=6%N8V4@870@97AE
M<F-I<V4@<')I8V4@;V8@)FYB<W`[)#`N,#4U,CD@<&5R('-H87)E+B!4:&4@
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M)R`^5&AE(&1E=&5R;6EN960@9F%I<B!V86QU92!O9B`F;F)S<#LD.3<L,3,Q
M(&ES(&-H87)G960@<F%T86)L>2!T;R!C=7)R96YT('!E<FEO9"!O<&5R871I
M;VYS(&]V97(@;VYE('EE87(N($1U<FEN9R!T:&4@=&AR964@86YD(&YI;F4@
M;6]N=&@@<&5R:6]D<R!E;F1E9"!*=6YE(#,P+"`R,#$Q+"`F;F)S<#LD,C0L
M,C@S(&%N9"`F;F)S<#LD-#8L,S<P('=A<R!C:&%R9V5D('1O(&]P97)A=&EO
M;G,L(')E<W!E8W1I=F5L>2X\8G(O/@T*/"]F;VYT/@T*/"]D:78^/&1I=B!S
M='EL93TS1'1E>'0M86QI9VXZ;&5F=#MT97AT+6EN9&5N=#HP<'0[9&ES<&QA
M>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#L@/@T*
M/"]D:78^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ:G5S=&EF>3MT97AT+6EN
M9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN
M+7)I9VAT.C!P=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O
M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X\
M9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE
M<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[=&5X="UD96-O<F%T:6]N.G5N
M9&5R;&EN93LG(#Y%;7!L;WEE92!3=&]C:R!/<'1I;VYS/&)R+SX-"CPO9F]N
M=#X-"CPO9F]N=#X-"CPO9&EV/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.FIU
M<W1I9GD[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE
M9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X-"CPO9&EV/CQD:78@<W1Y;&4]
M,T1T97AT+6%L:6=N.FIU<W1I9GD[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ
M8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N
M="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N
M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^3VX@2F%N=6%R>2`R-BP@,C`P
M-2P@=&AE($)O87)D(&]F($1I<F5C=&]R<RP@86YD(&]N($9E8G)U87)Y(#$U
M+"`R,#`U+"!T:&4@:&]L9&5R<R!O9B!A(&UA:F]R:71Y(&]F('1H92!O=71S
M=&%N9&EN9R!S:&%R97,@;V8@8V]M;6]N('-T;V-K(&]F('1H92!#;VUP86YY
M(&%P<')O=F5D('1H92`R,#`U($EN8V5N=&EV92!3=&]C:R!0;&%N(&%N9"!A
M=71H;W)I>F5D('1H92!I<W-U86YC92!O9B`Q-BPP,#`L,#`P('-H87)E<R!O
M9B!C;VUM;VX@<W1O8VL@87,@<W1O8VL@87=A<F1S(&%N9"!S=&]C:R!O<'1I
M;VYS('1H97)E=6YD97(N($]N($UA>2`Q-BP@,C`P-RP@870@=&AE(&%N;G5A
M;"!M965T:6YG(&]F('-T;V-K:&]L9&5R<RP@=&AE(&AO;&1E<G,@;V8@82!M
M86IO<FET>2!O9B!T:&4@;W5T<W1A;F1I;F<@<VAA<F5S(&]F(&-O;6UO;B!S
M=&]C:R!O9B!T:&4@0V]M<&%N>2!A<'!R;W9E9"!A;B!I;F-R96%S92!I;B!T
M:&4@;G5M8F5R(&]F('-H87)E<R!S=6)J96-T('1O('1H92`R,#`U($EN8V5N
M=&EV92!3=&]C:R!0;&%N('1O(#(P+#`P,"PP,#`@<VAA<F5S(&]F(&-O;6UO
M;B!S=&]C:RX@3VX@2G5N92`Q-RP@,C`P."P@=&AE($)O87)D(&]F($1I<F5C
M=&]R<R!U;F%N:6UO=7-L>2!A9&]P=&5D(&%N(&%M96YD;65N="!T;R!T:&4@
M,C`P-2!);F-E;G1I=F4@4W1O8VL@4&QA;B!T:&%T(&EN8W)E87-E9"!T:&4@
M=&]T86P@;G5M8F5R(&]F('-H87)E<R!O9B!C;VUM;VX@<W1O8VL@:7-S=6%B
M;&4@<'5R<W5A;G0@=&\@=&AE(#(P,#4@26YC96YT:79E(%-T;V-K(%!L86X@
M9G)O;2!A('1O=&%L(&]F(#(P+#`P,"PP,#`@<VAA<F5S('1O(&$@=&]T86P@
M;V8@,3`P+#`P,"PP,#`@<VAA<F5S+"!W:&EC:"!W87,@87!P<F]V960@8GD@
M;W5R('-T;V-K:&]L9&5R<R!A="!T:&4@,C`P."!A;FYU86P@;65E=&EN9R!O
M9B!S=&]C:VAO;&1E<G,@:&5L9"!O;B!$96-E;6)E<B`Q-BP@,C`P."X@26X@
M8V]N;F5C=&EO;B!W:71H('1H92!S:&%R92!I;F-R96%S92!A;65N9&UE;G0L
M('1H92!";V%R9"!O9B!$:7)E8W1O<G,@9W)A;G1E9"!A;F0@=V4@:7-S=65D
M(&]P=&EO;G,@=&\@<'5R8VAA<V4@82!T;W1A;"!O9B`S-RPV-S`L,#`P('-H
M87)E<R!A="!A;B!E>&5R8VES92!P<FEC92!O9B`F;F)S<#LD,"XQ,2!T;R!C
M97)T86EN(&ME>2!E;7!L;WEE97,@86YD(&YO;BUE;7!L;WEE92!D:7)E8W1O
M<G,@=6YD97(@=&AE(#(P,#4@26YC96YT:79E(%-T;V-K(%!L86XL(&EN8VQU
M9&EN9R`Q-RPP,#`L,#`P+"`U+#`P,"PP,#`@86YD(#<L,#`P+#`P,"!T;R!*
M86UE<R!!+B!(87EW87)D+"!+=7)T($@N($IE;G-E;B!A;F0@36EN9RU(=V$@
M3&EA;F<L(')E<W!E8W1I=F5L>2X@5&AE(&]P=&EO;G,@9W)A;G1E9"!T;R!O
M=7(@:V5Y(&5M<&QO>65E<R!A;F0@;F]N+65M<&QO>65E(&1I<F5C=&]R<R!V
M97-T960@=VET:"!R97-P96-T('1O(#(U)2!O9B!T:&4@=6YD97)L>6EN9R!S
M:&%R97,@;VX@=&AE(&1A=&4@;V8@9W)A;G0@86YD('1H92!R96UA:6YI;F<@
M=F5S="!R871A8FQY(&5A8V@@86YN:79E<G-A<GD@=&AE<F5A9G1E<B!U;G1I
M;"!F=6QL>2!V97-T960@;VX@=&AE('1H:7)D(&%N;FEV97)S87)Y(&]F('1H
M92!D871E(&]F(&=R86YT+CQB<B\^#0H\+V9O;G0^#0H\+V1I=CX\9&EV('-T
M>6QE/3-$=&5X="UA;&EG;CIJ=7-T:69Y.W1E>'0M:6YD96YT.C!P=#MD:7-P
M;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^
M#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIJ=7-T:69Y.W1E>'0M
M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G
M:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[
M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@
M/D]N($UA>2`R-RP@,C`Q,"P@=&AE(&]U<B!N86UE9"!E>&5C=71I=F4@;V9F
M:6-E<G,@96QE8W1E9"!T;R!F;W)F96ET(&-E<G1A:6X@<W1O8VL@;W!T:6]N
M<R!T;R!P=7)C:&%S92!U<"!T;R`R.2!M:6QL:6]N('-H87)E<R!O9B!O=7(@
M0V]M;6]N(%-T;V-K(&%T(&%N(&5X97)C:7-E('!R:6-E(&]F("9N8G-P.R0P
M+C$Q('1H870@=V5R92!P<F5V:6]U<VQY(&=R86YT960@=&\@=&AE;2!U;F1E
M<B!T:&4@,C`P-2!);F-E;G1I=F4@4W1O8VL@4&QA;BX@26X@;&EE=2!O9B!T
M:&4@9F]R9F5I=&5D(&]P=&EO;G,L(&]U<B!";V%R9"!O9B!$:7)E8W1O<G,@
M9W)A;G1E9"!N97<@<W1O8VL@;W!T:6]N<R!T;R!S=6-H(&YA;65D(&5X96-U
M=&EV92!O9F9I8V5R<R!T;R!P=7)C:&%S92!U<"!T;R`R.2!M:6QL:6]N('-H
M87)E<R!O9B!O=7(@8V]M;6]N('-T;V-K(&%T(&%N(&5X97)C:7-E('!R:6-E
M(&]F("9N8G-P.R0P+C`U('5N9&5R('1H92`R,#`U(%-T;V-K($EN8V5N=&EV
M92!0;&%N('=H:6-H(&%R92!F=6QL>2!V97-T960@86YD(&)E8V%M92!E>&5R
M8VES86)L92!O;B!*=6YE(#(Y+"`R,#$P(&9O;&QO=VEN9R!A<'!R;W9A;"!B
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M;B!*=6QY(#$L(#(P,3`L(&]U<B!";V%R9"!O9B!$:7)E8W1O<G,@9W)A;G1E
M9"!N;VYS=&%T=71O<GD@<W1O8VL@;W!T:6]N<R!U;F1E<B!T:&4@,C`P-2!)
M;F-E;G1I=F4@4W1O8VL@4&QA;B!T;R!O=7(@;F%M960@97AE8W5T:79E(&]F
M9FEC97)S+B!4:&4@;W!T:6]N<R!G<F%N=&5D('1O('1H92!N86UE9"!E>&5C
M=71I=F4@;V9F:6-E<G,@=F5S=&5D('=I=&@@<F5S<&5C="!T;R`R-24@;V8@
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M:7-P;&%Y.F)L;V-K.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG
M;CIJ=7-T:69Y.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I
M;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<@/E1H92`R,#`U($EN8V5N=&EV92!3=&]C:R!0;&%N
M(&ES(&1E<VEG;F5D('1O(')E=&%I;B!D:7)E8W1O<G,L(&5X96-U=&EV97,L
M(&%N9"!S96QE8W1E9"!E;7!L;WEE97,@86YD(&-O;G-U;'1A;G1S(&)Y(')E
M=V%R9&EN9R!T:&5M(&9O<B!M86MI;F<@8V]N=')I8G5T:6]N<R!T;R!O=7(@
M<W5C8V5S<R!W:71H(&%N(&%W87)D(&]F(&]P=&EO;G,@=&\@<'5R8VAA<V4@
M<VAA<F5S(&]F(&]U<B!C;VUM;VX@<W1O8VLN($%S(&]F($IU;F4@,S`L(#(P
M,3$L(&$@=&]T86P@;V8@.2PV-S4L,#`P('-H87)E<R!H879E(&)E96X@:7-S
M=65D(&%N9"!O<'1I;VYS('1O('!U<F-H87-E(#<P+#0P,"PP,#`@<VAA<F5S
M(&AA=F4@8F5E;B!G<F%N=&5D('5N9&5R('1H92`R,#`U($EN8V5N=&EV92!3
M=&]C:R!0;&%N+CQB<B\^#0H\+V9O;G0^#0H\+V1I=CX\9&EV#0H@<W1Y;&4]
M,T1T97AT+6%L:6=N.FIU<W1I9GD[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ
M8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N
M="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N
M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+V1I=CX\
M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIJ=7-T:69Y.W1E>'0M:6YD96YT.C!P
M=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z
M,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/E1H92!F;VQL
M;W=I;F<@=&%B;&4@<W5M;6%R:7IE<R!T:&4@8VAA;F=E<R!I;B!O<'1I;VYS
M(&]U='-T86YD:6YG(&%N9"!T:&4@<F5L871E9"!P<FEC97,@9F]R('1H92!S
M:&%R97,@;V8@=&AE($-O;7!A;GDF(S@R,3<[<R!C;VUM;VX@<W1O8VL@:7-S
M=65D('1O(&5M<&QO>65E<R!O9B!T:&4@0V]M<&%N>2!U;F1E<B!T:&4@,C`P
M-2!);F-E;G1I=F4@4W1O8VL@4&QA;CH-"CPO9F]N=#X-"CPO9&EV/CQD:78@
M<W1Y;&4],T1T97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SL@/@T*/"]D
M:78^/&1I=B!S='EL93TS1'1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K
M.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.VUA<F=I
M;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&1I=CX\9&EV('-T>6QE
M/3-$=&5X="UA;&EG;CIL969T.W=I9'1H.C$P,"4[(#X\9F]N="!S='EL93TS
M1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[
M9F]N="US:7IE.CAP=#LG(#X-"CPO9F]N=#X-"CPO9&EV/@T*/"]D:78^/&1I
M=B!S='EL93TS1'!A9V4M8G)E86LM869T97(Z86QW87ES.W=I9'1H.C$P,"4[
M(#X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([=VED=&@Z,3`P)3L@
M/@T*/"]D:78^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ8V5N=&5R.W=I9'1H
M.C$P,"4[(#X-"CPO9&EV/@T*/"]D:78^/&1I=CX\9&EV('-T>6QE/3-$=&5X
M="UA;&EG;CIR:6=H=#MW:61T:#HQ,#`E.R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HX<'0[)R`^#0H\+V9O;G0^#0H\+V1I=CX-"CPO9&EV/@T*/"]D:78^
M/&1I=B!S='EL93TS1'1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.R`^
M/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ8V5N=&5R.W1E>'0M:6YD96YT.C!P
M=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z
M,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.F)O;&0[)R`^#0H\+V9O;G0^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA
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M:6XM<FEG:'0Z,'!T.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG
M;CIC96YT97([=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN
M+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X-"CPO9&EV/@T*/"]D:78^
M/&1I=B!S='EL93TS1'1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.R`^
M#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIJ=7-T:69Y.W1E>'0M
M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G
M:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[
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M8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q
M,#`E('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG(#X\='(^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#0E('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ8FQA8VL@,G!X('-O;&ED.W1E
M>'0M86QI9VXZ;&5F=#LG(#X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T
M.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P
M=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II
M;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<@/@T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0R."4@8V]L<W!A;CTS1#@@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[)R`^/&1I=B!S='EL93TS1'1E>'0M
M86QI9VXZ8V5N=&5R.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA
M<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4]
M,T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<@/D]P=&EO;G,@3W5T<W1A;F1I;F<-"CPO9F]N
M=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[<&%D9&EN9RUB;W1T;VTZ-'!X
M.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
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M;&EG;CTS1&)O='1O;2!W:61T:#TS1#,T)2!C;VQS<&%N/3-$,3`@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[)R`^/&1I=B!S='EL
M93TS1'1E>'0M86QI9VXZ8V5N=&5R.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y
M.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O
M;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@
M;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/D]P=&EO;G,@17AE<F-I<V%B
M;&4-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@
M<V]L:60[=&5X="UA;&EG;CIL969T.W!A9&1I;F<M8F]T=&]M.C1P>#LG(#X\
M9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE
M<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D
M/@T*/"]T<CX\='(^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#0E(&-O
M;'-P86X],T0R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ8FQA8VL@,G!X('-O
M;&ED.W1E>'0M86QI9VXZ8V5N=&5R.R<@/CQF;VYT('-T>6QE/3-$)V1I<W!L
M87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG(#Y%>&5R8VES93QB<B`O/@T*/"]F;VYT/CQF;VYT('-T>6QE
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M="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q,"4@8V]L<W!A;CTS1#(@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[)R`^/&1I=B!S='EL93TS1'1E>'0M
M86QI9VXZ8V5N=&5R.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA
M<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4]
M,T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<@/DYU;6)E<@T*/"]F;VYT/@T*/"]D:78^/&1I
M=B!S='EL93TS1'1E>'0M86QI9VXZ8V5N=&5R.W1E>'0M:6YD96YT.C!P=#MD
M:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T
M.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
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M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\
M+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([=&5X="UI;F1E
M;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR
M:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT
M+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^5V5I
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M<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^4F5M86EN:6YG#0H\+V9O
M;G0^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([=&5X
M="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA
M<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN
M93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[
M)R`^0V]N=')A8W1U86P-"CPO9F]N=#X-"CPO9&EV/CQD:78@<W1Y;&4],T1T
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M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^*%EE87)S*0T*
M/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#MP861D:6YG+6)O='1O
M;3HR<'@[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A
M;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O
M;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1'1E>'0M86QI9VXZ<FEG:'0[<&%D9&EN9RUB;W1T;VTZ,G!X.R`^/&9O
M;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@
M;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ8FQA8VL@,G!X('-O;&ED.R<@/CQD:78-
M"B!S='EL93TS1'1E>'0M86QI9VXZ8V5N=&5R.W1E>'0M:6YD96YT.C!P=#MD
M:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T
M.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
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M<'0[)R`^079E<F%G90T*/"]F;VYT/@T*/"]D:78^/&1I=B!S='EL93TS1'1E
M>'0M86QI9VXZ8V5N=&5R.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K
M.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y
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M;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^4')I8V4-
M"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[<&%D9&EN9RUB;W1T
M;VTZ,G!X.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
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M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^3G5M8F5R#0H\+V9O
M;G0^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([=&5X
M="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA
M<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN
M93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[
M)R`^17AE<F-I<V%B;&4-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE
M9G0[<&%D9&EN9RUB;W1T;VTZ,G!X.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA
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M)R`^5V5I9VAT960-"CPO9F]N=#X-"CPO9&EV/CQD:78@<W1Y;&4],T1T97AT
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M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^17AE<F-I<V4-
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M.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/@T*/"]T<CX\='(^/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#0E('-T>6QE/3-$=&5X="UA;&EG;CIL969T
M.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#MT97AT+6EN9&5N=#HP
M<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT
M.C!P=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M
M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#XF;F)S<#LD
M#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#4E('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQD:78@<W1Y
M;&4],T1T97AT+6%L:6=N.G)I9VAT.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y
M.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O
M;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@
M;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/C`N,#4-"CPO9F]N=#X-"CPO
M9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA
M>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S
M='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@
M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V
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M.2PP,#`L,#`P#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^
M/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM
M97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT
M+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF
M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
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M.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
M=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/C$N.3<-"CPO9F]N
M=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D
M:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N
M="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[(#X\
M9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE
M<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D
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M)R`^)FYB<W`[)`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[
M(#X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MT97AT+6EN9&5N=#HP
M<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT
M.C!P=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M
M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#XP+C`U#0H\
M+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4]
M,T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT
M.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
M=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*
M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T
M97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN
M93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[
M)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)2!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[(#X\9&EV('-T>6QE/3-$
M=&5X="UA;&EG;CIR:6=H=#MT97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C
M:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#L@/CQF;VYT('-T
M>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#XR.2PP,#`L,#`P#0H\+V9O;G0^#0H\
M+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA
M>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@
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M<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/B9N
M8G-P.R0-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&1I
M=B!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I
M<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[
M(#X\9F]N=`T*('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY
M.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#XP+C`U#0H\+V9O
M;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G
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M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
M)FYB<W`[)`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0U)2!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[(#X\
M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MT97AT+6EN9&5N=#HP<'0[
M9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P
M=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY
M.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#XP+C`V#0H\+V9O
M;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS1#$E
M('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#L@/CQF;VYT('-T>6QE/3-$)V1I
M<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1'1O
M<"!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@
M<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W
M(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@
M=F%L:6=N/3-$=&]P('=I9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N.G)I
M9VAT.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E
M;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR
M:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT
M+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^,S`L
M,#`P+#`P,`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1T
M;W`@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT
M('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE
M=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D
M('9A;&EG;CTS1'1O<"!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL
M969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT
M/@T*/"]T9#X\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,24@<W1Y;&4],T1T
M97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN
M93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[
M)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1T;W`@=VED=&@],T0Y
M)2!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[(#X\9&EV('-T>6QE/3-$=&5X
M="UA;&EG;CIR:6=H=#MT97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SMM
M87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#L@/CQF;VYT('-T>6QE
M/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG(#XT+C`Q#0H\+V9O;G0^#0H\+V1I=CX-"CPO
M=&0^/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA
M;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*
M/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,24@<W1Y
M;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA
M>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$=&]P('=I
M9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9&EV('-T>6QE
M/3-$=&5X="UA;&EG;CIL969T.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L
M;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@
M<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W
M(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/B9N8G-P.R0-"CPO9F]N=#X-"CPO
M9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$.24@<W1Y;&4]
M,T1T97AT+6%L:6=N.G)I9VAT.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ
M<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE
M9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P
M;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US
M:7IE.C$P<'0[)R`^,"XP-@T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V
M86QI9VX],T1T;W`@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F
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M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$=&]P
M('=I9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&1I=B!S
M='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L
M87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\
M9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE
M<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^-RPU,#`L,#`P#0H\+V9O
M;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS1#$E
M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$=&]P
M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@
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M:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
M86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/B9N8G-P
M.R0-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$=&]P('=I
M9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&1I=B!S='EL
M93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ
M8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N
M="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N
M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^,"XP-@T*/"]F;VYT/@T*/"]D
M:78^#0H\+W1D/CQT9"!V86QI9VX],T1T;W`@=VED=&@],T0Q)2!S='EL93TS
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M.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
M=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/B9N8G-P.R0-"CPO
M9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$-24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&1I=B!S='EL93TS
M1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO
M8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S
M='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@
M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^,"XP-PT*/"]F;VYT/@T*/"]D:78^
M#0H\+W1D/CQT9"!V86QI9VX],T1T;W`@=VED=&@],T0Q)2!S='EL93TS1'1E
M>'0M86QI9VXZ<FEG:'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN
M93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[
M)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1T;W`@=VED=&@],T0Q
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M;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^
M/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM
M97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/C(L-3`P+#`P,`T*/"]F
M;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1T;W`@=VED=&@],T0Q
M)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I
M<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1'1O
M<"!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@
M<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W
M(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@
M=F%L:6=N/3-$=&]P('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE
M9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL
M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^
M#0H\+W1D/CQT9"!V86QI9VX],T1T;W`@=VED=&@],T0Y)2!S='EL93TS1'1E
M>'0M86QI9VXZ<FEG:'0[(#X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H
M=#MT97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP
M<'0[;6%R9VEN+7)I9VAT.C!P=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ
M:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG(#XT+C0V#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG
M;CTS1'1O<"!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^
M/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM
M97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T
M9#X\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L
M:6=N.G)I9VAT.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*
M/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,24@<W1Y
M;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9&EV('-T>6QE/3-$=&5X="UA;&EG
M;CIL969T.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL
M969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/B9N8G-P.R0-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\
M=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N
M.G)I9VAT.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI
M;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I
M;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF
M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
M,"XP-PT*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1T;W`@
M=VED=&@],T0Q)2`-"B!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT
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M=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
M;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$
M.24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&1I=B!S='EL93TS1'1E
M>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[
M;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL
M93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M
M86X[9F]N="US:7IE.C$P<'0[)R`^-3`P+#`P,`T*/"]F;VYT/@T*/"]D:78^
M#0H\+W1D/CQT9"!V86QI9VX],T1T;W`@=VED=&@],T0Q)2!S='EL93TS1'1E
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M<"!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&1I=B!S
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M;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<@/C`N,#<-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\
M=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N
M.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A
M;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O
M;G0^#0H\+W1D/@T*/"]T<CX\='(^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#0E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&1I=B!S='EL93TS
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M969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/C`N,#@-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@
M=F%L:6=N/3-$=&]P('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE
M9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL
M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^
M#0H\+W1D/CQT9"!V86QI9VX],T1T;W`@=VED=&@],T0Q)2!S='EL93TS1'1E
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M<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4]
M,T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<@/C(L,#`P+#`P,`T*/"]F;VYT/@T*/"]D:78^
M#0H\+W1D/CQT9"!V86QI9VX],T1T;W`@=VED=&@],T0Q)2!S='EL93TS1'1E
M>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE
M.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS1#$E
M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$=&]P
M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S
M='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@
M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V
M86QI9VX],T1T;W`@=VED=&@],T0Y)2!S='EL93TS1'1E>'0M86QI9VXZ<FEG
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M:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4]
M,T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N
M/3-$=&]P('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\
M9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE
M<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D
M/CQT9"!V86QI9VX],T1T;W`@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI
M9VXZ;&5F=#L@/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[=&5X="UI
M;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I
M;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF
M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
M)FYB<W`[)`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1T
M;W`@=VED=&@],T0Y)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT
M('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE
M=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D
M('9A;&EG;CTS1'1O<"!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL
M969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT
M/@T*/"]T9#X\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,24@<W1Y;&4],T1T
M97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN
M93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[
M)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1T;W`@=VED=&@],T0Q
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M;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^
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M<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1T;W`@=VED=&@]
M,T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T>6QE/3-$
M)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A;&EG;CTS
M1'1O<"!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&1I
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M<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4]
M,T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<@/BT-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\
M=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N
M.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A
M;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O
M;G0^#0H\+W1D/@T*/"]T<CX\='(^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#0E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&1I=B!S='EL93TS
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M969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/C`N,#D-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@
M=F%L:6=N/3-$=&]P('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.G)I
M9VAT.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT
M/@T*/"]T9#X\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,24@<W1Y;&4],T1T
M97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN
M93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[
M)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1T;W`@=VED=&@],T0Y
M)2!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[(#X\9&EV('-T>6QE/3-$=&5X
M="UA;&EG;CIR:6=H=#MT97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SMM
M87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#L@/CQF;VYT('-T>6QE
M/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG(#XQ+#4P,"PP,#`-"CPO9F]N=#X-"CPO9&EV
M/@T*/"]T9#X\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,24@<W1Y;&4],T1T
M97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN
M93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[
M)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1T;W`@=VED=&@],T0Q
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M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT
M9"!V86QI9VX],T1T;W`@=VED=&@],T0Y)2!S='EL93TS1'1E>'0M86QI9VXZ
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M:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y
M;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L
M:6=N/3-$=&]P('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT
M.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
M=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*
M/"]T9#X\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,24@<W1Y;&4],T1T97AT
M+6%L:6=N.FQE9G0[(#X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.W1E
M>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM
M87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
M;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<@/B9N8G-P.R0-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N
M/3-$=&]P('=I9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^
M/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E;G0Z,'!T
M.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP
M<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL
M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^,"XP.0T*/"]F
M;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1T;W`@=VED=&@],T0Q
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M969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT
M/@T*/"]T9#X\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$.24@<W1Y;&4],T1T
M97AT+6%L:6=N.G)I9VAT.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ<FEG
M:'0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z
M,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y
M.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE
M.C$P<'0[)R`^,2PU,#`L,#`P#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D
M('9A;&EG;CTS1'1O<"!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL
M969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT
M/@T*/"]T9#X\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,24@<W1Y;&4],T1T
M97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
M;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$
M,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9&EV('-T>6QE/3-$=&5X
M="UA;&EG;CIL969T.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA
M<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4]
M,T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<@/B9N8G-P.R0-"CPO9F]N=#X-"CPO9&EV/@T*
M/"]T9#X\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$.24@<W1Y;&4],T1T97AT
M+6%L:6=N.G)I9VAT.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[
M=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T
M.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN
M;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P
M<'0[)R`^,"XP.0T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX]
M,T1T;W`@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF
M;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S
M(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^
M#0H\+W1R/CQT<CX\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-"4@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[=&5X="UA;&EG
M;CIL969T.R<@/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[=&5X="UI
M;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I
M;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF
M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
M)FYB<W`[)`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0U)2!S='EL93TS1"=B;W)D97(M8F]T=&]M.F)L86-K
M(#)P>"!S;VQI9#MT97AT+6%L:6=N.G)I9VAT.R<@/CQD:78@<W1Y;&4],T1T
M97AT+6%L:6=N.G)I9VAT.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K
M.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y
M;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/C`N,3$-"CPO9F]N=#X-"CPO9&EV/@T*
M/"]T9#X\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,24@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[=&5X="UA;&EG;CIR:6=H=#LG
M(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT
M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\
M+W1D/CQT9"!V86QI9VX],T1T;W`@=VED=&@],T0Q)2!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.F)L86-K(#)P>"!S;VQI9#MT97AT+6%L:6=N.FQE9G0[)R`^
M/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM
M97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T
M9#X\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$.24@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[=&5X="UA;&EG;CIR:6=H=#LG(#X\
M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MT97AT+6EN9&5N=#HP<'0[
M9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P
M=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY
M.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#XU+#0P,"PP,#`-
M"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$=&]P('=I9'1H
M/3-$,24@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[
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M)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1T;W`@=VED=&@],T0Q
M)2!S='EL93TS1"=B;W)D97(M8F]T=&]M.F)L86-K(#)P>"!S;VQI9#MT97AT
M+6%L:6=N.FQE9G0[)R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[
M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@
M/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$.24@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[=&5X="UA
M;&EG;CIR:6=H=#LG(#X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MT
M97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[
M;6%R9VEN+7)I9VAT.C!P=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL
M:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG(#XQ+CDW#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS
M1'1O<"!W:61T:#TS1#$E('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ8FQA8VL@
M,G!X('-O;&ED.W1E>'0M86QI9VXZ;&5F=#LG(#X\9F]N="!S='EL93TS1"=D
M:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N
M="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1T
M;W`@=VED=&@],T0Q)2!S='EL93TS1"=B;W)D97(M8F]T=&]M.F)L86-K(#)P
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M;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<@/B9N8G-P.R0-"CPO9F]N=#X-"CPO9&EV/@T*/"]T
M9#X\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$.24@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[=&5X="UA;&EG;CIR:6=H=#LG(#X\
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M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
M#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1T;W`@=VED=&@],T0Q)2!S
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M+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\
M+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1T;W`@=VED=&@],T0Y)2!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.F)L86-K(#)P>"!S;VQI9#MT97AT+6%L:6=N
M.G)I9VAT.R<@/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.W1E>'0M
M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G
M:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[
M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@
M/C0L,#4P+#`P,`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX]
M,T1T;W`@=VED=&@],T0Q)2!S='EL93TS1"=B;W)D97(M8F]T=&]M.F)L86-K
M(#)P>"!S;VQI9#MT97AT+6%L:6=N.FQE9G0[)R`^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$
M=&]P('=I9'1H/3-$,24@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R
M<'@@<V]L:60[=&5X="UA;&EG;CIR:6=H=#LG(#X\9F]N="!S='EL93TS1"=D
M:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N
M="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1T
M;W`@=VED=&@],T0Q)2!S='EL93TS1"=B;W)D97(M8F]T=&]M.F)L86-K#0H@
M,G!X('-O;&ED.W1E>'0M86QI9VXZ;&5F=#LG(#X\9&EV('-T>6QE/3-$=&5X
M="UA;&EG;CIL969T.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA
M<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4]
M,T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<@/B9N8G-P.R0-"CPO9F]N=#X-"CPO9&EV/@T*
M/"]T9#X\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$.24@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[=&5X="UA;&EG;CIR:6=H=#LG
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M.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
M=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*
M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-24@<W1Y;&4],T1T
M97AT+6%L:6=N.FQE9G0[<&%D9&EN9RUB;W1T;VTZ-'!X.R`^/&9O;G0@<W1Y
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M(&1O=6)L93MT97AT+6%L:6=N.FQE9G0[)R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`T
M<'@@9&]U8FQE.W1E>'0M86QI9VXZ<FEG:'0[)R`^/&1I=B!S='EL93TS1'1E
M>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[
M;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL
M93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M
M86X[9F]N="US:7IE.C$P<'0[)R`^-S`L-#`P+#`P,`T*/"]F;VYT/@T*/"]D
M:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1'1E>'0M86QI9VXZ;&5F=#MP861D:6YG+6)O='1O;3HT<'@[(#X\9F]N
M="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N
M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI
M9VXZ;&5F=#MP861D:6YG+6)O='1O;3HT<'@[(#X\9F]N="!S='EL93TS1"=D
M:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N
M="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B
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M9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#MP
M861D:6YG+6)O='1O;3HT<'@[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN
M;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P
M<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[<&%D9&EN9RUB;W1T
M;VTZ-'!X.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
M86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F
M;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9&EV('-T>6QE/3-$=&5X="UA;&EG
M;CIL969T.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL
M969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES
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M.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y
M;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/C`N,#8-"CPO9F]N=#X-"CPO9&EV/@T*
M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T
M97AT+6%L:6=N.FQE9G0[<&%D9&EN9RUB;W1T;VTZ-'!X.R`^/&9O;G0@<W1Y
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M(&1O=6)L93MT97AT+6%L:6=N.FQE9G0[)R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`T
M<'@@9&]U8FQE.W1E>'0M86QI9VXZ<FEG:'0[)R`^/&1I=B!S='EL93TS1'1E
M>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[
M;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL
M93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M
M86X[9F]N="US:7IE.C$P<'0[)R`^-#(L-34P+#`P,`T*/"]F;VYT/@T*/"]D
M:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1'1E>'0M86QI9VXZ;&5F=#MP861D:6YG+6)O='1O;3HT<'@[(#X\9F]N
M="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N
M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI
M9VXZ<FEG:'0[<&%D9&EN9RUB;W1T;VTZ-'!X.R`^/&9O;G0@<W1Y;&4],T0G
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M.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
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M<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/C`N
M,#8-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[<&%D9&EN9RUB
M;W1T;VTZ-'!X.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*
M/"]F;VYT/@T*/"]T9#X-"CPO='(^#0H\+W1A8FQE/CQB<B`O/@T*/"]D:78^
M#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([=&5X="UI
M;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I
M;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF
M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
M#0H\+V9O;G0^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T
M.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P
M=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II
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M=#MM87)G:6XM<FEG:'0Z,'!T.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X
M="UA;&EG;CIC96YT97([(#X\9&EV/CQT86)L92!C96QL<W!A8VEN9STS1#`@
M8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$-S`E('-T>6QE/3-$)V9O;G0M9F%M
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M>'0M86QI9VXZ;&5F=#MP861D:6YG+6)O='1O;3HR<'@[)R`^/&9O;G0@<W1Y
M;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R('-T>6QE/3-$
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M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R
M<'@@<V]L:60[=&5X="UA;&EG;CIL969T.W!A9&1I;F<M8F]T=&]M.C)P>#LG
M(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT
M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\
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M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ8FQA8VL@,G!X('-O;&ED.R<@/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N
M.F-E;G1E<CMT97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM
M;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#L@/CQF;VYT('-T>6QE/3-$)V1I
M<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG(#Y796EG:'1E9`T*/"]F;VYT/@T*/"]D:78^/&1I=B!S
M='EL93TS1'1E>'0M86QI9VXZ8V5N=&5R.W1E>'0M:6YD96YT.C!P=#MD:7-P
M;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^
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M<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4]
M,T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<@/E!R:6-E(%!E<@T*/"]F;VYT/@T*/"]D:78^
M/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ8V5N=&5R.W1E>'0M:6YD96YT.C!P
M=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z
M,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/E-H87)E#0H\
M+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ8FQA8VL@,G!X('-O;&ED
M.W1E>'0M86QI9VXZ;&5F=#MP861D:6YG+6)O='1O;3HR<'@[)R`^/&9O;G0@
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M.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA
M>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<@/D]U='-T86YD:6YG(&%T($]C=&]B97(@,2P@,C`P.0T*/"]F
M;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[(#X\9F]N="!S='EL93TS
M1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[
M9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX]
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M=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II
M;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<@/C,X+#DR,"PP,#`-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N
M.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A
M;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O
M;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1'1E>'0M86QI9VXZ<FEG:'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y
M.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE
M.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQD:78@<W1Y
M;&4],T1T97AT+6%L:6=N.FQE9G0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ
M8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N
M="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N
M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^)FYB<W`[)`T*/"]F;VYT/@T*
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M;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*
M/"]F;VYT/@T*/"]T9#X-"CPO='(^/'1R/CQT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0T-B4@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9&EV('-T
M>6QE/3-$=&5X="UA;&EG;CIL969T.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y
M.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O
M;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@
M;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/D=R86YT960-"CPO9F]N=#X-
M"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N
M="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N
M97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT
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M(#XU.2PP,#`L,#`P#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T
M.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
M=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*
M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T
M97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
M;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS
M1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[
M9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[
M(#X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MT97AT+6EN9&5N=#HP
M<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT
M.C!P=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M
M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#XP+C`V#0H\
M+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4]
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M87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
M;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<@/D5X97)C:7-E9`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F
M=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY
M.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-
M"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
M;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^/&1I=B!S='EL93TS
M1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO
M8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S
M='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@
M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^+0T*/"]F;VYT/@T*/"]D:78^#0H\
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M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^
M/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM
M97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T1T97AT
M+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF
M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
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M+6)O='1O;3HR<'@[)R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#MT
M97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[
M;6%R9VEN+7)I9VAT.C!P=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL
M:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG(#Y#86YC96QL960@;W(@97AP:7)E9`T*/"]F;VYT/@T*/"]D:78^#0H\
M+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.F)L86-K(#)P>"!S;VQI9#MT97AT+6%L:6=N.G)I9VAT
M.W!A9&1I;F<M8F]T=&]M.C)P>#LG(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y
M.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE
M.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"=B;W)D97(M8F]T=&]M.F)L86-K(#)P>"!S
M;VQI9#MT97AT+6%L:6=N.FQE9G0[)R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA
M>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W#0H@<F]M86X[9F]N="US
M:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)2!S='EL93TS1"=B;W)D97(M8F]T=&]M.F)L86-K(#)P
M>"!S;VQI9#MT97AT+6%L:6=N.G)I9VAT.R<@/CQD:78@<W1Y;&4],T1T97AT
M+6%L:6=N.G)I9VAT.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA
M<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4]
M,T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<@/B@S,2PP,C`L,#`P#0H\+V9O;G0^#0H\+V1I
M=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ8FQA8VL@,G!X('-O;&ED.W1E>'0M86QI9VXZ
M;&5F=#MP861D:6YG+6)O='1O;3HR<'@[)R`^/&1I=B!S='EL93TS1'1E>'0M
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M)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)2!S='EL93TS1"=B;W)D97(M8F]T=&]M.F)L86-K(#)P>"!S;VQI9#MT
M97AT+6%L:6=N.G)I9VAT.R<@/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.G)I
M9VAT.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T
M.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA
M>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<@/B@P+C$Q#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ8FQA8VL@,G!X('-O;&ED.W1E>'0M86QI9VXZ;&5F=#MP861D:6YG+6)O
M='1O;3HR<'@[)R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#MT97AT
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M969T.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#MT97AT+6EN9&5N
M=#HP<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I
M9VAT.C!P=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M
M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#Y/=71S
M=&%N9&EN9R!A="!397!T96UB97(@,S`L(#(P,3`-"CPO9F]N=#X-"CPO9&EV
M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T1T97AT+6%L:6=N.G)I9VAT.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II
M;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL
M93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M
M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI
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M,#`L,#`P#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O
M;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@
M;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L
M:6=N.G)I9VAT.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*
M/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9&EV('-T>6QE/3-$=&5X="UA
M;&EG;CIL969T.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I
M;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<@/B9N8G-P.R0-"CPO9F]N=#X-"CPO9&EV/@T*/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T1T97AT
M+6%L:6=N.G)I9VAT.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[
M=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T
M.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN
M;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P
M<'0[)R`^,"XP-@T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@
M/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I
M;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO
M=&0^#0H\+W1R/CQT<CX\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-#8E
M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&1I=B!S='EL93TS1'1E>'0M
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M1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T1T97AT+6%L:6=N.G)I9VAT.R`^
M/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[=&5X="UI;F1E;G0Z,'!T
M.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP
M<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL
M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^,RPU,#`L,#`P
M#0H\+V9O;G0^#0H\+V1I=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y
M;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.G)I
M9VAT.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT
M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN
M;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P
M<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Y)2!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[(#X\9&EV('-T>6QE
M/3-$=&5X="UA;&EG;CIR:6=H=#MT97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB
M;&]C:SMM87)G:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#L@/CQF;VYT
M('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE
M=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#XP+C`X#0H\+V9O;G0^#0H\+V1I
M=CX-"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II
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M,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/D5X97)C:7-E
M9`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@/CQF;VYT('-T
M>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO=&0^/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL
M969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT
M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4]
M,T1T97AT+6%L:6=N.G)I9VAT.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ
M<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE
M9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P
M;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US
M:7IE.C$P<'0[)R`^+0T*/"]F;VYT/@T*/"]D:78^#0H\+W1D/CQT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F
M=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY
M.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-
M"CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M=&5X="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
M;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS
M1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[
M9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#L@
M/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I
M;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#LG(#X-"CPO9F]N=#X-"CPO
M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X
M="UA;&EG;CIL969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[
M9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@
M/@T*/"]F;VYT/@T*/"]T9#X-"CPO='(^/'1R/CQT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0T-B4@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R
M<'@@<V]L:60[=&5X="UA;&EG;CIL969T.W!A9&1I;F<M8F]T=&]M.C)P>#LG
M(#X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.W1E>'0M:6YD96YT.C!P
M=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z
M,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/D-A;F-E;&5D
M(&]R(&5X<&ER960-"CPO9F]N=#X-"CPO9&EV/@T*/"]T9#X\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24-"B!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.F)L86-K(#)P>"!S;VQI9#MT97AT+6%L:6=N.G)I9VAT.W!A9&1I;F<M8F]T
M=&]M.C)P>#LG(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT
M+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\
M+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.F)L86-K(#)P>"!S;VQI9#MT97AT+6%L
M:6=N.FQE9G0[)R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*
M/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[=&5X="UA
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M)R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
M=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT/@T*
M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@<V]L:60[=&5X="UA;&EG;CIR:6=H
M=#MP861D:6YG+6)O='1O;3HR<'@[)R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA
M>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<@/@T*/"]F;VYT/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3IB;&%C:R`R<'@@
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M:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+W1D/CQT9"!V86QI9VX],T1B;W1T
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M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&1I=B!S='EL93TS1'1E>'0M
M86QI9VXZ;&5F=#MT97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SMM87)G
M:6XM;&5F=#HP<'0[;6%R9VEN+7)I9VAT.C!P=#L@/CQF;VYT('-T>6QE/3-$
M)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG(#Y/=71S=&%N9&EN9R!A="!*=6YE(#,P+"`R,#$Q
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M969T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
M;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/@T*/"]F;VYT
M/@T*/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4]
M,T1T97AT+6%L:6=N.G)I9VAT.R`^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ
M<FEG:'0[=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE
M9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P
M;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US
M:7IE.C$P<'0[)R`^-S`L-#`P+#`P,`T*/"]F;VYT/@T*/"]D:78^#0H\+W1D
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M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$=&5X="UA;&EG;CIL969T.R`^/&1I
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M.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y
M;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/C`N,#8-"CPO9F]N=#X-"CPO9&EV/@T*
M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T1T
M97AT+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN
M93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[
M)R`^#0H\+V9O;G0^#0H\+W1D/@T*/"]T<CX-"CPO=&%B;&4^/&)R("\^#0H\
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M9F]N="US:7IE.C$P<'0[)R`^3VX@2F%N=6%R>2`T+"`R,#$Q+"!T:&4@0V]M
M<&%N>2!G<F%N=&5D(#(L,#`P+#`P,"!O<'1I;VYS('1O('!U<F-H87-E('1H
M92!#;VUP86YY)B,X,C$W.W,@8V]M;6]N('-T;V-K(&%T(&%N(&5X97)C:7-E
M('!R:6-E(&]F("9N8G-P.R0P+C`X('!E<B!S:&%R92!F;W(@9FEV92!Y96%R
M<R!T;R!A;B!E;7!L;WEE92!W:71H('9E<W1I;F<@870@,C4E(&5A8V@@86YN
M:79E<G-A<GD@9F]R('1H92!N97AT(&9O=7(@>65A<G,N(%1H92!F86ER('9A
M;'5E(&]F(&]P=&EO;G,@=V%S(&1E=&5R;6EN960@=7-I;F<@=&AE($)L86-K
M+5-C:&]L97,@3W!T:6]N(%!R:6-I;F<@36]D96P@=VET:"!T:&4@9F]L;&]W
M:6YG(&%S<W5M<'1I;VYS.B!D:79I9&5N9"!Y:65L9"`F;F)S<#LD+3`M+"!V
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M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^5&AE($-O;7!A
M;GD@<F5C;W)D960@)FYB<W`[)#$U-"PT.3D@86YD("9N8G-P.R0T-3DL.38X
M(&%S('-T;V-K(&-O;7!E;G-A=&EO;B!E>'!E;G-E(&9O<B!T:&4@=&AR964@
M86YD(&YI;F4@;6]N=&@@<&5R:6]D<R!E;F1E9"!*=6YE(#,P+"`R,#$Q+"!R
M97-P96-T:79E;'DL(&%N9"`F;F)S<#LD,2PS.#(L,C0X(&%N9"`F;F)S<#LD
M,2PY-CDL-#@S(&9O<B!T:&4@=&AR964@86YD(&YI;F4@;6]N=&@@<&5R:6]D
M<R!E;F1E9"!*=6YE(#,P+"`R,#$P+"!R97-P96-T:79E;'DL(&9O<B!T:&4@
M=F5S=&EN9R!P;W)T:6]N(&]F(&%L;"!E;7!L;WEE92!O<'1I;VYS(&]U='-T
M86YD:6YG+B`-"CPO9F]N=#X-"CPO9&EV/@T*/"]D:78^#0H\+V1I=CX-"CPO
M9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A
M8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?
M-#`X.#=E961?9&)B8E\T.3!C7V)A.3=?8F$W-C1C-S0R.#`Y#0I#;VYT96YT
M+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S0P.#@W965D7V1B8F)?-#DP8U]B83DW
M7V)A-S8T8S<T,C@P.2]7;W)K<VAE971S+U-H965T,3,N:'1M;`T*0V]N=&5N
M="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N
M="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M
M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M
M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C
M<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@
M1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^
M#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$
M,$4R2#X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L
M<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY#3TU-251-14Y44R!!3D0@
M0T].5$E.1T5.0TE%4SQB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XY($UO;G1H<R!%;F1E9#PO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y*=6XN(#,P+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/D-O;6UI=&UE;G1S(&%N9"!#;VYT:6YG96YC:65S
M($1I<V-L;W-U<F4@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y#3TU-251-14Y44R!!3D0@0T].5$E.1T5.
M0TE%4SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I=CX\9&EV
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M0TE%4SQB<B`O/@T*/&)R("\^#0H\+V9O;G0^#0H\+V1I=CX\9&EV('-T>6QE
M/3-$=&5X="UA;&EG;CIJ=7-T:69Y.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y
M.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^#0H\
M+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIJ=7-T:69Y.W1E>'0M:6YD
M96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM
M<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/E1H
M92!#;VUP86YY(&QE87-E<R!O9F9I8V4@<W!A8V4@=6YD97(@86X@;W!E<F%T
M:6YG(&QE87-E(&EN(%-T;VYY($)R;V]K+"!.97<@66]R:R!F;W(@:71S(&-O
M<G!O<F%T92!U<V4@9G)O;2!A;B!E;G1I='D@8V]N=')O;&QE9"!B>2!A('-I
M9VYI9FEC86YT(&9O<FUE<B!S:&%R96AO;&1E<BX@5&]T86P@;&5A<V4@<F5N
M=&%L(&5X<&5N<V5S(&9O<B!T:&4@=&AR964@86YD(&YI;F4@;6]N=&@@<&5R
M:6]D<R!E;F1E9"!*=6YE(#,P+"`R,#$Q('=E<F4@)FYB<W`[)#,V+#`U-B!A
M;F0@)FYB<W`[)#$P."PP-30L(')E<W!E8W1I=F5L>2X@5&]T86P@;&5A<V4@
M<F5N=&%L(&5X<&5N<V5S(&9O<B!T:&4@=&AR964@86YD(&YI;F4@;6]N=&@@
M<&5R:6]D<R!E;F1E9"!O;B!*=6YE(#,P+"`R,#$P('=E<F4@)FYB<W`[)#(Q
M+#@U."!A;F0@)FYB<W`[)#8R+#0P."P@<F5S<&5C=&EV96QY+B`-"CPO9F]N
M=#X-"CPO9&EV/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.FIU<W1I9GD[=&5X
M="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA
M<F=I;BUR:6=H=#HP<'0[(#X-"CPO9&EV/CQD:78@<W1Y;&4],T1T97AT+6EN
M9&5N=#HP<'0[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[(#X\
M9&EV/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.FQE9G0[=VED=&@Z,3`P)3L@
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M;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^#0H\+V1I
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M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^1G)O;2!T:6UE('1O
M('1I;64L('=E(&UA>2!B96-O;64@:6YV;VQV960@:6X@=F%R:6]U<R!L87=S
M=6ET<R!A;F0@;&5G86P@<')O8V5E9&EN9W,@=VAI8V@@87)I<V4@:6X@=&AE
M(&]R9&EN87)Y(&-O=7)S92!O9B!B=7-I;F5S<RX@2&]W979E<BP@;&ET:6=A
M=&EO;B!I<R!S=6)J96-T('1O(&EN:&5R96YT('5N8V5R=&%I;G1I97,L(&%N
M9"!A;B!A9'9E<G-E(')E<W5L="!I;B!T:&5S92!O<B!O=&AE<B!M871T97)S
M(&UA>2!A<FES92!F<F]M('1I;64@=&\@=&EM92!T:&%T(&UA>2!H87)M(&]U
M<B!B=7-I;F5S<RX@17AC97!T(&%S(&1E<V-R:6)E9"!B96QO=RP@=V4@87)E
M(&-U<G)E;G1L>2!N;W0@87=A<F4@;V8@86YY('-U8V@@;&5G86P@<')O8V5E
M9&EN9W,@=&AA="!W92!B96QI979E('=I;&P@:&%V92P@:6YD:79I9'5A;&QY
M(&]R(&EN('1H92!A9V=R96=A=&4L(&$@;6%T97)I86P@861V97)S92!A9F9E
M8W0@;VX@;W5R(&)U<VEN97-S+"!F:6YA;F-I86P@8V]N9&ET:6]N(&]R(&]P
M97)A=&EN9R!R97-U;'1S+CQB<B`O/@T*/&)R("\^#0H\+V9O;G0^#0H\+V1I
M=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.W1E>'0M:6YD96YT.C!P
M=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z
M,'!T.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.W1E
M>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM
M87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9F]N="US='EL93II
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M<B`O/@T*/&)R("\^#0H\+V9O;G0^#0H\+V9O;G0^#0H\+V1I=CX\9&EV('-T
M>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[(#X-"CPO9&EV
M/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.FIU<W1I9GD[=&5X="UI;F1E;G0Z
M,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H
M=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A
M;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^3VX@36%Y
M(#$X+"`R,#$Q+"!T:&4@0V]M<&%N>2!W87,@<V5R=F5D('=I=&@@82!C;VUP
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M<&]N<V4L(&]N($%U9W5S="`S+"`R,#$Q+"!$96UO9'5L871I;VXL($EN8RX@
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M/@T*/"]D:78^#0H\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM
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M<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U
M:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S
M970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,]
M,T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S
M8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R
M97!O<G0@:60],T1)1#!%,D@^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^1D%)
M4B!604Q512!-14%355)%345.5#QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XY($UO;G1H<R!%;F1E9#PO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y*=6XN(#,P+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#X\<W1R;VYG/D9A:7(@5F%L=64@1&ES8VQO<W5R97,@
M6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y&04E2(%9!3%5%($U%05-54D5-14Y4/"]T9#X-"B`@("`@("`@
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M)R`^5&AE($-O;7!A;GD@861O<'1E9"!T:&4@<')O=FES:6]N<R!O9B!!4T,@
M.#(U+3$P(&]N($]C=&]B97(@,2P@,C`P."X@05-#(#@R-2TQ,"!D969I;F5S
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M86YD(')I<VL@;V8@;F]N<&5R9F]R;6%N8V4N($%30R`X,C4M,3`@97-T86)L
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M=7-T:69Y.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF
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M=#LG(#Y,979E;"`Q("T@475O=&5D('!R:6-E<R!I;B!A8W1I=F4@;6%R:V5T
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M9F]N="US:7IE.C$P<'0[)R`^3&5V96P@,B`M($]B<V5R=F%B;&4@:6YP=71S
M(&]T:&5R('1H86X@3&5V96P@,2!P<FEC97,@<W5C:"!A<R!Q=6]T960@<')I
M8V5S(&9O<B!S:6UI;&%R(&%S<V5T<R!O<B!L:6%B:6QI=&EE<SL@<75O=&5D
M('!R:6-E<R!I;B!M87)K971S('=I=&@@:6YS=69F:6-I96YT('9O;'5M92!O
M<B!I;F9R97%U96YT('1R86YS86-T:6]N<R`H;&5S<R!A8W1I=F4@;6%R:V5T
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M="US:7IE.C$P<'0[)R`^3&5V96P@,R`M(%5N;V)S97)V86)L92!I;G!U=',@
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M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\
M+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO
M8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA;&EG
M;CIJ=7-T:69Y.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
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M=#LG(#Y5<&]N(&%D;W!T:6]N(&]F($%30R`X,C4M,3`L('1H97)E('=A<R!N
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M:6=H=#HP<'0[=&5X="UA;&EG;CIJ=7-T:69Y.R`^#0H\+V1I=CX\9&EV('-T
M>6QE/3-$=&5X="UI;F1E;G0Z,'!T.VUA<F=I;BUL969T.C!P=#MM87)G:6XM
M<FEG:'0Z,'!T.R`^/&1I=CX\9&EV('-T>6QE/3-$=VED=&@Z,3`P)3MT97AT
M+6%L:6=N.FQE9G0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF
M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.CAP=#LG(#X-
M"CPO9F]N=#X-"CPO9&EV/@T*/"]D:78^/&1I=B!S='EL93TS1'!A9V4M8G)E
M86LM869T97(Z86QW87ES.W=I9'1H.C$P,"4[(#X\9&EV('-T>6QE/3-$=&5X
M="UA;&EG;CIC96YT97([=VED=&@Z,3`P)3L@/@T*/"]D:78^#0H\+V1I=CX\
M9&EV/CQD:78@<W1Y;&4],T1W:61T:#HQ,#`E.W1E>'0M86QI9VXZ<FEG:'0[
M(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL>3IT
M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.CAP=#LG(#X-"CPO9F]N=#X-"CPO
M9&EV/@T*/"]D:78^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z
M,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H
M=#HP<'0[=&5X="UA;&EG;CIJ=7-T:69Y.R`^/&9O;G0@<W1Y;&4],T0G9&ES
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M:7-P;&%Y.F)L;V-K.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UI;F1E
M;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR
M:6=H=#HP<'0[=&5X="UA;&EG;CIJ=7-T:69Y.R`^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<@/E1H92!C87)R>6EN9R!V86QU92!O9B!T:&4@0V]M
M<&%N>28C.#(Q-SMS(&-A<V@@86YD(&-A<V@@97%U:79A;&5N=',L(&%C8V]U
M;G1S(')E8V5I=F%B;&4L(&%C8V]U;G1S('!A>6%B;&4L('-H;W)T+71E<FT@
M8F]R<F]W:6YG<R`H:6YC;'5D:6YG(&-O;G9E<G1I8FQE(&YO=&5S('!A>6%B
M;&4I+"!A;F0@;W1H97(@8W5R<F5N="!A<W-E=',@86YD(&QI86)I;&ET:65S
M(&%P<')O>&EM871E(&9A:7(@=F%L=64@8F5C875S92!O9B!T:&5I<B!S:&]R
M="UT97)M(&UA='5R:71Y+B!!;&P@;W1H97(@<VEG;FEF:6-A;G0@9FEN86YC
M:6%L(&%S<V5T<RP@9FEN86YC:6%L(&QI86)I;&ET:65S(&%N9`T*(&5Q=6ET
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M;VYT+7-I>F4Z,3!P=#LG(#Y!="!*=6YE(#,P+"`R,#$Q+"!T:&5R92!W97)E
M(&YO(&ED96YT:69I960@87-S971S(&]R(&QI86)I;&ET:65S(&UE87-U<F5D
M(&%T(&9A:7(@=F%L=64@;VX@82!R96-U<G)I;F<@8F%S:7,N#0H\+V9O;G0^
M#0H\+V1I=CX-"CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM
M+3U?3F5X=%!A<G1?-#`X.#=E961?9&)B8E\T.3!C7V)A.3=?8F$W-C1C-S0R
M.#`Y#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S0P.#@W965D7V1B
M8F)?-#DP8U]B83DW7V)A-S8T8S<T,C@P.2]7;W)K<VAE971S+U-H965T,34N
M:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT
M86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S
M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I
M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E
M=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS
M1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C
M<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E
M<&]R="!I9#TS1$E$,$4R2#X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY'3TE.
M1R!#3TY#15)./&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H(&-O;'-P86X],T0Q/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU
M;BX@,S`L(#(P,3$\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^1V]I;F<@0V]N8V5R;B!;06)S=')A8W1=/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D=/24Y'($-/3D-%
M4DX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQD:78^/&1I=B!S
M='EL93TS1'1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL
M969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.W1E>'0M86QI9VXZ:G5S=&EF>3L@
M/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL:6YE.V9O;G0M9F%M:6QY.G1I
M;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD
M.R<@/DY/5$4@2B`M($=/24Y'($-/3D-%4DX\8G(O/@T*/"]F;VYT/@T*/"]D
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M=&%T96UE;G1S+"!A="!*=6YE(#,P+"`R,#$Q+"!T:&4@0V]M<&%N>2!H87,@
M82!N96=A=&EV92!W;W)K:6YG(&-A<&ET86P@;V8@)FYB<W`[)#0N-B!M:6QL
M:6]N+"!I;F-U<G)E9"!A(&YE="!L;W-S(&9O<B!T:&4@;FEN92!M;VYT:"!P
M97)I;V0@96YD960@2G5N92`S,"P@,C`Q,2!O9B`F;F)S<#LD-BXQ(&UI;&QI
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M9G0Z,'!T.VUA<F=I;BUR:6=H=#HP<'0[=&5X="UA;&EG;CIJ=7-T:69Y.R`^
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M/@T*/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT
M4&%R=%\T,#@X-V5E9%]D8F)B7S0Y,&-?8F$Y-U]B83<V-&,W-#(X,#D-"D-O
M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-#`X.#=E961?9&)B8E\T.3!C
M7V)A.3=?8F$W-C1C-S0R.#`Y+U=O<FMS:&5E=',O4VAE970Q-BYH=&UL#0I#
M;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#
M;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-
M"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N
M=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX
M)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ
M<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO
M:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED
M/3-$240P13)(/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E-50E-%455%3E0@
M159%3E13/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H(&-O;'-P86X],T0Q/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@
M,S`L(#(P,3$\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/CQS=')O;F<^4W5B<V5Q=65N="!%=F5N=',@6T%B<W1R86-T73PO<W1R;VYG
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y354)315%514Y4
M($5614Y44SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I=CX\
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M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA
M>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ
M93HQ,'!T.W1E>'0M9&5C;W)A=&EO;CIU;F1E<FQI;F4[)R`^4V%L92!O9B!C
M;VUM;VX@<W1O8VL\8G(O/@T*/"]F;VYT/@T*/"]F;VYT/@T*/"]D:78^/&1I
M=B!S='EL93TS1'1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.R`^#0H\
M+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIJ=7-T:69Y.W1E>'0M:6YD
M96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM
M<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N
M="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/D]N
M($IU;'D@,34L(#(P,3$L('1H92!#;VUP86YY(&-L;W-E9"!A('!R:79A=&4@
M<&QA8V5M96YT(&]F(&ET<R!C;VUM;VX@<W1O8VLN)B,Q-C`[)B,Q-C`[5&AE
M($-O;7!A;GD@:7-S=65D(&%N9"!S;VQD(#$P-2PR-C,L,34X('-H87)E<R!O
M9B!#;VUM;VX@4W1O8VL@870@82!P=7)C:&%S92!P<FEC92!O9B`F;F)S<#LD
M,"XP-#<U('!E<B!S:&%R92!T;R!A8V-R961I=&5D(&EN=F5S=&]R<R!F;W(@
M9W)O<W,@<')O8V5E9',@;V8@)FYB<W`[)#4L,#`P+#`P,"X\8G(O/@T*/"]F
M;VYT/@T*/"]D:78^/&1I=B!S='EL93TS1'1E>'0M:6YD96YT.C!P=#MD:7-P
M;&%Y.F)L;V-K.R`^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIJ
M=7-T:69Y.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL
M969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES
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M("9N8G-P.R0R-C4L,#`P+B8C,38P.R8C,38P.TEN(&%D9&ET:6]N+"!T:&4@
M<&QA8V5M96YT(&%G96YT(&]R(&ET<R!D97-I9VYE97,@=V5R92!I<W-U960@
M=V%R<F%N=',@=VET:"!A('-E=F5N+7EE87(@=&5R;2!T;R!P=7)C:&%S92!A
M;B!A9V=R96=A=&4F(S$V,#MO9B`W+#4W."PY-#@@<VAA<F5S(&]F($-O;6UO
M;B!3=&]C:R!W:71H(&%N(&5X97)C:7-E('!R:6-E(&]F("9N8G-P.R0P+C`T
M-S4@<&5R('-H87)E+CQB<B\^#0H\+V9O;G0^#0H\+V1I=CX\9&EV('-T>6QE
M/3-$=&5X="UA;&EG;CIL969T.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L
M;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^#0H\+V1I
M=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.W1E>'0M:6YD96YT.C!P
M=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z
M,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI
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M:7IE.C$P<'0[)R`^3VX@2G5L>2`Q,2P@,C`Q,2P@=&AE($-O;7!A;GDF(S@R
M,3<[<R!";V%R9"!O9B!$:7)E8W1O<G,@87!P<F]V960@=&AE('1E<FUS(&]F
M(&5M<&QO>6UE;G0@9F]R(&5A8V@@;V8@2F%M97,@02X@2&%Y=V%R9"P@=&AE
M($-O;7!A;GDF(S@R,3<[<R!#:&EE9B!%>&5C=71I=F4@3V9F:6-E<BP@86YD
M($MU<G0@2"X@2F5N<V5N+"!T:&4@0V]M<&%N>28C.#(Q-SMS($-H:65F($9I
M;F%N8VEA;"!/9F9I8V5R+B8C,38P.R8C,38P.TET(&ES(`T*/"]F;VYT/CQF
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M;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^26X@8V]N
M;F5C=&EO;B!W:71H(&AI<R!E;7!L;WEM96YT(&%G<F5E;65N="P@1'(N($AA
M>7=A<F0@=V%S(&=R86YT960@;W!T:6]N<R!T;R!P=7)C:&%S92`T,"!M:6QL
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M;W=S.B`R-24@;VX@=&AE(&=R86YT(&1A=&4L(&%N9"`S-RXU)2!O;B!E86-H
M(&]F('1H92!N97AT('1W;R!A;FYI=F5R<V%R:65S(&]F('1H92!G<F%N="!D
M871E+"!S=6)J96-T('1O($1R+B!(87EW87)D)B,X,C$W.W,@8V]N=&EN=6]U
M<R!E;7!L;WEM96YT+B8C,38P.R8C,38P.TEF($-O;7!A;GD@<F5V96YU97,@
M9F]R(&%N>2!F:7-C86P@<75A<G1E<B!I;F-R96%S92!B>2!M;W)E('1H86X@
M)FYB<W`[)#$@;6EL;&EO;B!O=F5R('1H92!P<FEO<B!F:7-C86P@<75A<G1E
M<BP@=&AE;B!T:&4@=F5S=&EN9R!D871E(&9O<B!T:&4@;F5X="`S-RXU)2!T
M<F%N8VAE('=I;&P@8F4@86-C96QE<F%T960N)B,Q-C`[)B,Q-C`[17AE<F-I
M<V%B:6QI='D@;V8@;W!T:6]N<R!F;W(@=&AE(#0P(&UI;&QI;VX@<VAA<F5S
M('=I;&P@8F4@8V]N9&ET:6]N960@=7!O;B!S=&]C:VAO;&1E<B!A<'!R;W9A
M;"!O9B!A;B!A;65N9&UE;G0@;V8@=&AE($-O;7!A;GDF(S@R,3<[<R`R,#`U
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M<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^#0H\+V1I=CX\9&EV
M('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.VUA<F=I;BUL969T.C!P=#MM87)G
M:6XM<FEG:'0Z,'!T.R`^/&1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL
M969T.W=I9'1H.C$P,"4[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN
M93MF;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.CAP=#LG
M(#XF(S$V,#L@#0H\+V9O;G0^#0H\+V1I=CX-"CPO9&EV/CQD:78@<W1Y;&4]
M,T1P86=E+6)R96%K+6%F=&5R.F%L=V%Y<SMW:61T:#HQ,#`E.R`^/&1I=CX\
M<#X-"CPO<#X-"CPO9&EV/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.F-E;G1E
M<CMW:61T:#HQ,#`E.R`^#0H\+V1I=CX-"CPO9&EV/CQD:78^#0H\+V1I=CX-
M"CPO9&EV/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.FIU<W1I9GD[=&5X="UI
M;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I
M;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF
M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
M26X@861D:71I;VXL($1R+B!(87EW87)D(&%G<F5E9"!T;R!P87)T:6-I<&%T
M92!I;B!T:&4@<')I=F%T92!P;&%C96UE;G0@9&5S8W)I8F5D(&%B;W9E(&%N
M9"!P=7)C:&%S960@,3`L-3(V+#,Q-B!S:&%R97,@;V8@=&AE($-O;7!A;GDF
M(S@R,3<[<R!#;VUM;VX@4W1O8VL@=7-I;F<@)FYB<W`[)#4P,"PP,#`@<F5C
M96YT;'D@861V86YC960@=&\@=&AE($-O;7!A;GDN)B,Q-C`[)B,Q-C`[5&AE
M($-O;7!A;GD@:&%S(`T*/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ
M:6YL:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG(#YA;'-O(&%G<F5E9"!T;R!I<W-U92!A(&]N92UY96%R('-E;FEO
M<B!S96-U<F5D(&-O;G9E<G1I8FQE(&YO=&4@8F5A<FEN9R!I;G1E<F5S="!A
M="!A(')A=&4@;V8@-"4@<&5R(&%N;G5M(&EN('1H92!P<FEN8VEP86P@86UO
M=6YT(&]F("9N8G-P.R0R-3`L,#`P+CQB<B\^#0H\+V9O;G0^#0H\+V1I=CX\
M9&EV('-T>6QE/3-$=&5X="UI;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[(#X-
M"CPO9&EV/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.FIU<W1I9GD[=&5X="UI
M;F1E;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I
M;BUR:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF
M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
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M;V8@9W)A;G0N)B,Q-C`[)B,Q-C`[5&AE(&]P=&EO;B!W:6QL('9E<W0@87,@
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M86X@)FYB<W`[)#$@;6EL;&EO;B!O=F5R('1H92!P<FEO<B!F:7-C86P@<75A
M<G1E<BP@=&AE;B!T:&4@=F5S=&EN9R!D871E(&9O<B!T:&4@;F5X="`S-RXU
M)2!T<F%N8VAE('=I;&P@8F4@86-C96QE<F%T960N/&)R+SX-"CPO9F]N=#X-
M"CPO9&EV/CQD:78@<W1Y;&4],T1T97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB
M;&]C:SL@/@T*/"]D:78^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#MT
M97AT+6EN9&5N=#HP<'0[9&ES<&QA>3IB;&]C:SMM87)G:6XM;&5F=#HP<'0[
M;6%R9VEN+7)I9VAT.C!P=#L@/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ:6YL
M:6YE.V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT+69A;6EL
M>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[=&5X="UD96-O<F%T
M:6]N.G5N9&5R;&EN93LG(#Y#+D8N($UA<G1I;B`F86UP.R!#;RX@06=R965M
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M+"`R,#$Q+"!T:&4@0V]M<&%N>2!E;G1E<F5D(&EN=&\@82!*;VEN="!$979E
M;&]P;65N="!!9W)E96UE;G0L(&1A=&5D(&%S(&]F($IU;F4@,S`L(#(P,3$@
M=VET:"!#+D8N($UA<G1I;B`F86UP.R!#;RXL($EN8RXL(&$@9&5S:6=N97(@
M86YD(&UA;G5F86-T=7)E<B!O9B!A8V]U<W1I8R!G=6ET87)S+"!S=')I;F=S
M(&9O<B!A8V]U<W1I8R!G=6ET87)S+"!A;F0@<F5L871E9"!G=6ET87(@8V]M
M<&]N96YT<R!A;F0@86-C97-S;W)I97,@*"8C.#(R,#M-87)T:6XF(S@R,C$[
M*2X@56YD97(@=&AE('1E<FUS(&]F('1H92!A9W)E96UE;G0L($UA<G1I;B!A
M;F0@=&AE($-O;7!A;GD@=VEL;"!J;VEN=&QY(&1E=F5L;W`L(&-R96%T92!A
M;F0@87!P;'D@;F5W('1E8VAN:7%U97,@86YD(&MN;W<M:&]W(&9O<B!L86)E
M;&EN9R!A;F0@875T:&5N=&EC871I;F<@9W5I=&%R<RP@9W5I=&%R('-T<FEN
M9W,@86YD(')E;&%T960@9W5I=&%R(&-O;7!O;F5N=',@86YD(&%C8V5S<V]R
M:65S('5S:6YG($1.02!S96-U<FET>2!M87)K97)S(&-R96%T960@8GD@=&AE
M($-O;7!A;GDN)B,Q-C`[)B,Q-C`[56YD97(@=&AE(&%G<F5E;65N="P@96%C
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M;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O
M;G0^#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIJ=7-T:69Y.W1E
M>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM
M87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI
M;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<@/E-U8FIE8W0@=&\@8V5R=&%I;B!E>&-E<'1I;VYS(&9O<B!T:&4@0V]M
M<&%N>2P@=&AE(&%G<F5E;65N="!P<F]V:61E<R!F;W(@82!P97)I;V0@;V8@
M97AC;'5S:79I='D@*"8C.#(R,#M097)I;V0@;V8@17AC;'5S:79I='DF(S@R
M,C$[*2!O9B!S:7@@*#8I(&UO;G1H<R!B96=I;FYI;F<@;VX@2G5N92`S,"P@
M,C`Q,2!W:&5R96)Y($UA<G1I;B!A;F0@=&AE($-O;7!A;GD@86=R964@;F]T
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M:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^5&AE('1E<FT@;V8@
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M86=R965M96YT(&)Y(&=I=FEN9R!A="!L96%S="!S:7AT>2`H-C`I(&1A>7,@
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M/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#MW:61T:#HQ,#`E.R`^/&9O
M;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@
M;F5W(')O;6%N.V9O;G0M<VEZ93HX<'0[)R`^)B,Q-C`[(`T*/"]F;VYT/@T*
M/"]D:78^#0H\+V1I=CX\9&EV('-T>6QE/3-$<&%G92UB<F5A:RUA9G1E<CIA
M;'=A>7,[=VED=&@Z,3`P)3L@/CQD:78^/'`^#0H\+W`^#0H\+V1I=CX\9&EV
M('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([=VED=&@Z,3`P)3L@/@T*/"]D
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M;VYT+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^
M3VX@2G5L>2`X+"`R,#$Q+"!T:&4@0V]M<&%N>2!E;G1E<F5D(&EN=&\@86X@
M86=R965M96YT+"!D871E9"!A<R!O9B!*=6QY(#<L(#(P,3$@=VET:"!$:7-C
M($=R87!H:6-S($EN8RXL(&$@<')O=FED97(@;V8@<W!E8VEA;'1Y('!A8VMA
M9VEN9R`H)B,X,C(P.T1')B,X,C(Q.RDN/&)R+SX-"CPO9F]N=#X-"CPO9&EV
M/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.FIU<W1I9GD[=&5X="UI;F1E;G0Z
M,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR:6=H
M=#HP<'0[(#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UE<R!N97<@
M<F]M86X[9F]N="US:7IE.C$P<'0[)R`^#0H\+V9O;G0^#0H\+V1I=CX\9&EV
M('-T>6QE/3-$=&5X="UA;&EG;CIJ=7-T:69Y.W1E>'0M:6YD96YT.C!P=#MD
M:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T
M.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ
M=&EM97,@;F5W(')O;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/E5N9&5R('1H92!T
M97)M<R!O9B!T:&4@86=R965M96YT+"!$1R!W:6QL('!U<F-H87-E($1.02!S
M96-U<FET>2!M87)K97)S(&9R;VT@=&AE($-O;7!A;GD@=&\@8F4@:6YC;W)P
M;W)A=&5D(&EN=&\@8V]A=&EN9W,@9F]R($1')B,X,C$W.W,@<')O9'5C=',N
M)B,Q-C`[)B,Q-C`[061D:71I;VYA;&QY+"!$1R!W:6QL(&)E('1H92!#;VUP
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M<'0[)R`^96ET:&5R('!A<G1Y('1E<FUI;F%T97,@=&AE(&%G<F5E;65N="!B
M>2!G:79I;F<@=W)I='1E;B!N;W1I8V4@=&\@=&AE(&]T:&5R('!A<G1Y(&%T
M(&QE87-T(&YI;F5T>2`H.3`I(&1A>7,@<')I;W(@=&\@=&AE(&5N9"!O9B!T
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M.VUA<F=I;BUL969T.C!P=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y
M;&4],T0G9&ES<&QA>3II;FQI;F4[9F]N="UF86UI;'DZ=&EM97,@;F5W(')O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<@/CQF;VYT('-T>6QE/3-$9&ES<&QA>3II
M;FQI;F4[=&5X="UD96-O<F%T:6]N.G5N9&5R;&EN93L@/C-322!!9W)E96UE
M;G0\8G(O/@T*/"]F;VYT/@T*/"]F;VYT/@T*/"]D:78^/&1I=B!S='EL93TS
M1'1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.R`^/&)R("\^#0H-"CPO
M9&EV/CQD:78@<W1Y;&4],T1T97AT+6%L:6=N.FIU<W1I9GD[=&5X="UI;F1E
M;G0Z,'!T.V1I<W!L87DZ8FQO8VL[;6%R9VEN+6QE9G0Z,'!T.VUA<F=I;BUR
M:6=H=#HP<'0[(#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.FEN;&EN93MF;VYT
M+69A;6EL>3IT:6UE<R!N97<@<F]M86X[9F]N="US:7IE.C$P<'0[)R`^3VX@
M075G=7-T(#DL(#(P,3$L('1H92!#;VUP86YY(&5N=&5R960@:6YT;R!A(%-U
M<'!L:65R($%G<F5E;65N="P@9&%T960@87,@;V8@075G=7-T(#,L(#(P,3$@
M*'1H92`F(S@R,C`[4W5P<&QI97(@06=R965M96YT)B,X,C(Q.RDL('=I=&@@
M,U-)(%-E8W5R:71Y(%-Y<W1E;7,L($EN8RXL(&$@;6%N=69A8W1U<F5R(&%N
M9"!S96QL97(@;V8@87-S970@<')O=&5C=&EO;B!S96-U<FET>2!S>7-T96US
M(&)A<V5D(&]N(&EN:R!A;F0@<VUO:V4@<W1A:6YI;F<@87,@=V5L;"!A<R!'
M4%,@=&5C:&YO;&]G>2`H)B,X,C(P.S-3228C.#(R,3LI+B8C,38P.R8C,38P
M.R8C,38P.T]N('1H92!S86UE(&1A=&4L('1H92!P87)T:65S(&%L<V\@96YT
M97)E9"!I;G1O(&$@3&EC96YS92!!9W)E96UE;G0L(&1A=&5D(&%S(&]F($%U
M9W5S="`S+"`R,#$Q("AT:&4@)B,X,C(P.TQI8V5N<V4@06=R965M96YT)B,X
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M<R`H)B,X,C(P.TQI8V5N<V5D(%!A=&5N=',F(S@R,C$[*2!O=VYE9"!B>2`S
M4TD@*'1H92`F(S@R,C`[4')O9'5C=',F(S@R,C$[*2XF(S$V,#LF(S$V,#M0
M=7)S=6%N="!T;R!T:&4@3&EC96YS92!!9W)E96UE;G0L(#-322!G<F%N=&5D
M(&$@;F]N97AC;'5S:79E(&ER<F5V;V-A8FQE(&QI8V5N<V4@=&\@=&AE($-O
M;7!A;GD@=&\@;6%K92P@:&%V92!M861E+"!U<V4L(&EM<&]R="P@;V9F97(@
M=&\@<V5L;"!A;F0@<V5L;"!T:&4@4')O9'5C=',N)B,Q-C`[)B,Q-C`[56YD
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M<B`O/@T*#0H\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIJ=7-T:69Y
M.W1E>'0M:6YD96YT.C!P=#MD:7-P;&%Y.F)L;V-K.VUA<F=I;BUL969T.C!P
M=#MM87)G:6XM<FEG:'0Z,'!T.R`^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3II
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M4')O9'5C=',L(&]R('5P;VX@,S`@9&%Y<R!W<FET=&5N(&YO=&EC92!T;R!T
M:&4@0V]M<&%N>2XF(S$V,#LF(S$V,#M5;F1E<B!T:&4@=&5R;7,@;V8@=&AE
M($QI8V5N<V4@06=R965M96YT+"`S4TD@:&%S('1H92!R:6=H="!T;R!I;6UE
M9&EA=&5L>2!T97)M:6YA=&4@=7!O;B!W<FET=&5N(&YO=&EC92!T;R!T:&4@
M0V]M<&%N>2!I;B!T:&4@979E;G0@=&AA="!T:&4@0V]M<&%N>2!F86EL<R!T
M;R!C;VYT:6YU;W5S;'D@;6%I;G1A:6X@82!M:6YI;75M(&YU;6)E<B!O9B!-
M87)K97)S+"!O<B!F86EL<R!T;R!S96QL($UA<FME<G,@=&\@,U-)(&9O<B!I
M;F-O<G!O<F%T:6]N(&EN=&\@=&AE(%!R;V1U8W1S(&9O<B!A(&-E<G1A:6X@
M=&EM92!A9G1E<B!B96EN9R!O<F1E<F5D+@T*/"]F;VYT/@T*/"]D:78^#0H\
M+V1I=CX-"CPO9&EV/@T*/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*
M+2TM+2TM/5].97AT4&%R=%\T,#@X-V5E9%]D8F)B7S0Y,&-?8F$Y-U]B83<V
M-&,W-#(X,#D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-#`X.#=E
M961?9&)B8E\T.3!C7V)A.3=?8F$W-C1C-S0R.#`Y+U=O<FMS:&5E=',O9FEL
M96QI<W0N>&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M
M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB
M=7,M87-C:6DB#0H-"CQX;6P@>&UL;G,Z;STS1")U<FXZ<V-H96UA<RUM:6-R
M;W-O9G0M8V]M.F]F9FEC93IO9F9I8V4B/@T*(#QO.DUA:6Y&:6QE($A2968]
M,T0B+BXO5V]R:V)O;VLN:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E
M=#`Q+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P,BYH=&UL(B\^
M#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,#,N:'1M;"(O/@T*(#QO.D9I;&4@
M2%)E9CTS1")3:&5E=#`T+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE
M970P-2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,#8N:'1M;"(O
M/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`W+FAT;6PB+SX-"B`\;SI&:6QE
M($A2968],T0B4VAE970P."YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H
M965T,#DN:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$P+FAT;6PB
M+SX-"B`\;SI&:6QE($A2968],T0B4VAE970Q,2YH=&UL(B\^#0H@/&\Z1FEL
M92!(4F5F/3-$(E-H965T,3(N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3
M:&5E=#$S+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970Q-"YH=&UL
M(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,34N:'1M;"(O/@T*(#QO.D9I
M;&4@2%)E9CTS1")3:&5E=#$V+FAT;6PB+SX-"CPO>&UL/@T*+2TM+2TM/5].
M97AT4&%R=%\T,#@X-V5E9%]D8F)B7S0Y,&-?8F$Y-U]B83<V-&,W-#(X,#DM
#+0T*
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>35
<FILENAME>0001188112-11-002207-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001188112-11-002207-xbrl.zip
M4$L#!!0````(``>+"C_PU&X1SF\``%QN!@`1`!P`87!D;BTR,#$Q,#8S,"YX
M;6Q55`D``_[V0D[^]D).=7@+``$$)0X```0Y`0``[%UM<]NVLOY^9OH?>'/G
M=I(9R^:;^.*D/>/XY8Q/4]O'3GK:3QV:A"RT%*D"I&WUU]]=@*0HB10IBY3M
M-NU,FXC`[K.+Q6)W`9`?_ODX"95[PCB-H^_>:/OJ&X5$?AS0Z.Z[-U\^GPV<
M-__\_IM_?/B?P4#Y^>/U)R6(_71"HD3Q&?$2$B@/-!DKIW\.Q-.,DF+LJ_O:
MOJDH@T'>^Z/'H34\$PWU?2U_^'C+0GJ(_U4`3,0/O6D`6,9),CT\.'AX>-CW
M@LCC^WX\.=!531NHUL``G+)QR@=WGC<MVH\\?KL?L[N#[$'611L86MZ%D=$"
M>60MNNBJ:AW`T[QA0*:,^"AE;7OWP&,^BT,"C/UD0!ZGH1=Y2<QF9_#WG!#V
M")*"2)G`\$`^S)M&<12EDVI^0<(.DMF4'$"C`;0BC/H%B[`6HW'P\R<:_;ZD
ML8&7)/5:@X>,WJ8)X7DW/TZCA,T6A>#$W[^+[P^RAQ7*]E/&P*+J^F5/*SJ&
M`'F-2/CX%DQJ/E:TF@4\J*!.'OUQ=7M\4M&!1O>$)]5=Y+.*3A%)UEB.,!MH
M4K3VJ,^K.8A'50R:36793);5^F"(#IKKN@?B:=Z44[\:##RH4A"/35VSUPQ9
MUJ)DAXB05QJA>%+!14P66CF3+#F3:($_F;(:`>!)#6VZ#G_$$R_R"Y-[Y+1*
MD]!6._CYQT\W_IA,O$'1"WR=HGQ`#1]R\>B:C!2A\4.4]KLWG$ZF(5(7OXV%
MFT)?.$"HJF6H^X\\R!]G;F?]4!Y,63PE+*&@RV+"'$@@TNWZ<920QT2AX.*.
MY9]_-7X\_=50!_].!6=5`B]Z@.^GR2S[K?B5!OC[B!*F".$6@>6*/S[_X<WW
M*OQCFZ8YU#\<+'?.61U4\,HX@3PT#I;Y@XY9<@*N^GN$/%!-&-J<ROS94B<2
M!:4NN*K,&0>E#OFO)=;Y3YG^FE3JOG*5JNX`5?225'K$?[T<H5)OR/3U*%5Z
M@R33CUO23_ZD*_TLSF+M56AG819KF\]B;9>S^!6J5-U\%O>LTF(6ORJEEF;Q
MDGZZGL52/S!J1^G=:]6/`U;7KWZ*54!U7YE^8`GH=158GE^O<97L:GZE$97*
M^7)SLJ2&"?%XRLCW68IR""UR0OFC,G&D5$?YBK";L<?($H>`WH-BE@7%CA>8
MH6')H'BX*:RR*JHIEMB=D"B>T&@]PVQ]0#EX&XZK1/.G);D;M2?TQFN&I@G2
M*O6LEG%XXX6$7Y-[$J7D@B1*0'PZ\4)(/-4W2F8GUYALU25`"M(4+83E:+:J
MN<,/!S7TMV2^G"HL,3<-57-Z8[X<-"XQUW771E^^"\E7F%N.[=IMF5\33B!%
M'A]!O`)-PGB*1<O3QRF).-G>`AS-U.=(UC+K%%>3<9BN:3X'K@:[,6W7<9Y?
M7RNX-$NSS.&3@!U-8I;0/[V$QM'EZ`Q\7^33Z.XXY@G?>ARUH:-9]AS7.F;]
MP5I1EVUHP[+C:P_K1%32J6@)RBUWW'HRNKJC&W-0:UAUB*EA`'7;L31WUZ`:
M9J&K.:[^O(I:75%LRU*=)X"Z3,:$7<01M$X9`ZL[C_QX0G+/\,CI843#[]XD
M+"5/,:N#KMFMMYB>V2WK?8G=#0E#8/(O$D'<&*+>`XCF*$\@BJ3WI*ME4Q]"
M_&"7_%H[OOU@;9C!0\,R=&WX,K`V3&Q8+E2[O,"^'+VNA@)@`\90WP[KY13S
M&^B5/6VQM#69IF5"&EN"M<)B:P1-!F<YEFT[?2)H,B-;5RVK5P1-QN%:MJ4.
M-T<@W>.GF&]O"0/=M-6A:5>`F'/I`$:#.0R&^M`:ND;?,!IL8J"9KNH.JXRB
M1VVLPC!UV[6,*LNH@W$.A!GAW>5\NF64?>P2_2V9-ZY&MEYVFMTR;[`!"WRC
M8>]&\E6GY,"_^K`U]]P8SE@\018T2L%(,FN)(_Z1C&)&9+O/WB/AIX^PTL0L
M@.R%S<X3,N$0=R%0%HN%*>?7@6,9NI9K+(C2&]H7I)9&1V>[AF/^[=32Y'@A
M^#1=]V^GEJ:%P%(AA;#49U,+$,@\ST>(6$<TZ3S5W(+/1CEF9_(T))>=R=/`
MYXK%0+:C&'#95<^)/YWIQHZP"Z8;NYGN)6TQB>N8GGHL@@G)\TVUCQZG/E9G
M:9CBX>,Y$OT)`SW?JANH^W@LHB7;CC&NM8M%C/IS85QK1B]2CVLQ/E6/QQX?
M-YO_ZM&TE4S;TDJI!%+=BD]M\*R;EMG$!V3%_YW^D=)[+R11PH^28X^Q&6CE
M)R],6\3P3Q&XD6V_2#=0V3,C+4ZV+)>L-,-0[1<%M;:ZI@TM:RND1[ZX8L"O
MB4^@PVV(6[['XO9`BZ"RT3XM0]5+VS7KN/6"J[XD9SN&\11@5XQ,/1ID,5=W
MFM(LS1Q:Y96[@D^W4&J5H^J6/=P(RA'G).'=:4,W=4TMCT^9?C>L:W?.7-VU
M]7:L?3^=I"%>9"KOK\&?0U*QT78E+PW,KD(O2N`9SE&Q$=Z%PE0;8K\%@^X$
MVK,+7#M,FNI8>M\"US9K=?"F<=0,VUK,$&J9;0"K1?[7I-VE#/",PD/RB=Z3
M`%)X+[JCX"#EO"BI?;/]ZT;=.+9KZF7U;(YBAU+4G@U0+5M3W9U(T8U-6H:U
ML"&PGF%/X.K4:5B&[6I/`W="1@2<>"#/TQ!QF@;K4]*S=Z.\H:Z;SL+YE`:>
M_4&L=YR&49Y6&T*4RNTBX#$!B&8N+[1;<JN3VG&-H6,U,,N"P"MOAA$@KAB^
M#SXT^$2]6QI2O.[778CC0HPU5%=#T!;<=P&[-C@T-)B#6@>X@>4]WJ'$8#M.
M2$Z@PY#:MDW5*:EX/<>>T-7'F4/-<HRGH>O%(G5PK991TE?3"/9B8*9C.>K0
M;(_B.)Y,:#(1J2XDOV*CXHY$/K3?*!:J4<M!/]S:UMXS[WR3Q/[OLFS0O4S;
M<FDG"VHNCDHL.HB?38Q6RE-HD45G`&KCD:$^U(VV`(Z"@&)$YX57D$^?1\?>
ME"9>6.K4R;KJ&J[EEBM8S7Q[Q%E_N,[0-$A;]:?CO":)1R,2Y*7FA1QP1'W:
MA5<<:$/-@%BE7(YH9MPCT/HC14/;-"#AV`*H4/(X#@/".":5R>P\\L,47UMS
MA1D)Y-'9"TQP:?H</W4WNHW674<M+T;=0'MF<6O'SG!MTRR?$>Q#W$4_?^6Q
M2W:3H"T(7Y5OU)3$,9XT>O,M(75?+6];M>/?,^:F;:S.,<O;=T=I,HX9_7-A
MP^W\XFQS#>>W^315_E.'=9EO;Q@K--H?QG/.T^YTV`!,,NL%U!JE=03J,DWP
M3B]ZC!VIJ\2Q/WA/5UPMO%*`L7NGV()YGV@W=(?;H.W+$3KJBI=9P[4?>&NL
MLE-XW;H_F3_IY;NM-1R[A[5&8S*KJK.[#6#UX`+;J*R-H^G-";917BW`4JWE
M*`I68]`^ZKY-/'M#V+96O!G`Q<N[)^0V.:%<E$AA39K0=++U@4;#&!KE*U6-
M''L&6)':FZY>SMTV1-AF`[?7J\1U3/N'N=%%WG8P\]-W)``_@$<XNM&?.[1,
MHYRP5K+I`\J*CH:6K98KZ6V@0#;-"#0Y(?+_Y]'J&:#M=627JY-M6/8/<G6V
M:J:CFMW"S(X,Y7N+V=$A,%-Q`;OMKE[3##9T75N'NPV*YY"DXAJ>82W=U.E!
ME#8[==N_*L6U==-I8TWK8#R'**O%?=-Q=+U;4?!8H<?'5RS&US<%'V=?.!Y=
M*&Y='OD)O>]F)`;:4'=LLS1#VC/?%>B*>Q/XQN'R]E_'H,_%.Z4707=]`ZA/
MULV7=7Q"@OS.5KZAC"'7]F_/,0Q[J997RZPW5!7O&C*'PZU178-[G8E=W<O1
M-1$;)%<>2V8"8M?VT9KQUH'1<+GXVHYQ*W,NWDO4H<]:,;'VO'>%N>)`E;MH
M@$_%7'U\_TJ\@W%Y[>E@=7"UA<5A$^Z[P[VZ0`RU8>,]DG6H\<WOA_\E]&Z,
MYRS!.WAWY"*=W!)V.5JICBQ=6KJ,MGK?05&B437#@N@5LL\MT>Q(I'I;RD7"
M2,-T;'P/UNL0J?[BW;R0IKF6KCO::Q&I?N;,15(=W7%MHR.12D6)F-.DL[.A
MCJ$OOE!M3KT;QK6^W#"'3CO.*?D<7XY&U">,XS[(O"K8W8F\I>6[F6>/&&O?
M8J)N![)\UK$4A\#J.#^%W,7A1LVURU7G-FR?`+2[8W-B@OX$"0/,MZEXWX+<
M\I@K]X0RXB<QPZKTZ60:QC/210CF6J[IY!YB<P`[15_Q&C37Q3=\;@^^M&DB
MNYY'-R1)0H(Q\^6HLS=O&*:+-_8WX5E[*6NQSCXWRZHS_ET<83=MW2X?JG\:
MDEV+4Y])VHYC5]\IVUP>,:!?(D]V)$&^XW$9'?=]\'T(LT#/;>H)$'8F0/T-
M5,<Q-'MG$JQZ]5FGB\]0Q_W$;N`\DVBU)8;.19N76Z6WP[/`/;RD9QOB;=_,
M@V;9"_@MZ:\+.?[K,>9!#BT7H+.8+;WLNBMA6C';OC9CNW:1P*UGMIQ9W";2
M=O'#FYD5XX+,06Y<CF%%``/7MH^WG.4`NB7GW>!=C5<<U[6>##<@]/!4?*_D
MISB$GSTV.Z,A]&T%Y?N+^,-!+8EE#ME:<`U)',.R.YY52ULR^@4_AM%$:IGA
M-;D3[]>-D@MO0MHQ.KJZ^G1^>J*<7!PI-\?GIQ?'IS?*^<5QF?LBW14Q`1CS
MPO,H((\_D%D[MN7/R]22FG/*Y#\#M^Z%OQ"/G<KO5;5C-LB_Q;..U+)88DR/
MX<%=S%H*=0-V#9V48I@4W/_WHEE9Q@6Z*[KLY(!6^;-2JT48#)H=2[/4!<TW
M'M'"MD<PGP*<4V>A=]=.)R,`3"2GA=YSHB?9EX=ET72C@=5+W^FJ);7*:3[V
M9_!+RQF)_UWDLD2FCH\$LP&G_QA5?$ID5CE]GDU;J@QLXS^+Y+'OTC$9>A=1
MR%+QY0YRAUG<^@@IWC+\#&0_AG@'JQ6_;\/D?4#OO[U+WF=_5'@RPP^<8OL!
MC?"K4H?J%!_Q:>C-#F^1^/N)Q^YH-`C)2#[-_LZP8"A^$-V]$*`>8J/W;Y2<
MQPBPY$QRHC0*:43$H\'(F]!P=IC0"23\$7E06#SQ(OF,0_1XJ"%]\=<'4:`\
MO(W#(&-P<?GY5#E2OO4FT_?_Z^B:_EZY^?+CCT?7ORB79\K1\?'EEXO/YQ?_
M4JXN/YV#/[U!1+?L`/M^\P_\RP%2+OUUA]K9$<??4I[0T:SS(>F:GH`,7C66
M+Q0]3$%X)HA(3MF[ZQM'<,<#NJC>9QO35V@ZG\=$\<"CB449E]0T\M*`XEL(
MP9D%>*1)_(F#KPLP051&,D3W0H``/XC]:L7C2CQ2P,<1Q5#W%'1T"BR5RBAF
M2@(LDC$C1/P2`4P%%M9DS!58_(#@:B\,RA6\-%&`V5<`*"?5S,?>/5%N"8F4
M*9[)8D"31D(J%F`)2'F@R5BY3D.BW`Q^1J`(Z08_."+WFY'GZ:,_]J([HHCK
MY!PC9^4MMLO]FJZ^OSD]+OZFO7\G^@G:V(Z*\-H7E4TEB17(9B8*KBW[RI&`
M`MH-9WO8=J8$L1+%"?3!"X2@F##,8=$(=#:1IS"E!N,DPG**PL@?*47A;F?*
MG9R'X0S%)%,<%Z]8ET`-0)A.0^B$`X"C&Y*D6GO[;;WQWVLJ=SG'SB,QLO&4
M1CBJ,-#0U+L3^M\38^\%B$!:\UN<;52<2L*F$5I#J!2?Q\%Q9BF$D._$M*3@
MGV'P(^(3SB'O$@/N*2./,IP-'$A*6YI/DLSH8$X5)[:`/$_#A!?S=3Y+%?G%
MR>JY"E,4S3CG#AH!Z@&$2?@]D]RB<]K)V$M`\AF@4,CCE/C"FV0,1R*B4V80
M.B(KQ'2#=HW;GP5#X06>Z*'X.$[#`'DSX@D'`7U^2R,Q8>>S>('0"@*UQOLM
MS%,\_DG``>1Z1EY(.LM\BCC)?L^5HRB"L<S2(P6`Y%[CASWTJ=Y$J'T/V(:D
MY&NV]UW[2W-]U0M\G>@O.`[[F'+X"Y?#CV<!Q/I[59KP7T.TWH?[,BIY",U"
M#Z'J>\K1=!I2F*VB?@3Y(40@?$\YC_S]E4FYY!)$4/$`\QY<1\RF./A`1XR]
MF/:A]\"+\`7=#_[E@MQ[@;>OG(Y&Q!=^]P3<L<1D"TS.7MG_@/];(#\"":LH
M8@RS\/,)`?[@\J47SJF!Y67AA@A'`G(?(U7H',CO2J(K1U4@I`#=X2V%%OXX
MBL/X;J9PZ<K@#W&8RN`I\Y=?(N'D!?_,SZ7XEL76$<LK-:N_HDQ/7[?S$#G)
M$A4\W)_/@=P&T38H_/PPCL$&!_%#!-1X>@O1$86H!*=?>5+.OY>A_%@*Q'"&
M0L.KDPOE[<?]G_;/]]_)68ODJR9U9H_*)SJ1.4JI2@2X$\(&66*E8*F8>UER
M,`_%2$C%MZ1)'I!DRH!F+\W*_Q)FN+L%^A3$F*#C6K_X?@V[.G(N,O.7J4[F
M'6K<"4XS3+%QS1$!=>M<.DO`>2E]PW5NXOT."4T^WL);>)RGDVE6"L"TQQ.+
ML^(3AF]_`DH8[R.CB71HV`G4X(<Q?N6=+Y4,P'&D(@>4B90O,IF``DV6+]\Q
M+V'XZCM>M>_(OO0.6:$?PX+R-9K?R?AF6N>*?%L+PS<8R]G%LF^E[^4AK8P7
M_H`Y*5;[HE8W97$@*X!*(N^5R?I;-NLA&)@0)CQ2UA(F>C[8@M.(/A(D0WU2
M4,`])08>@&.H/?=5#.T'P^ET&D=YB:_D_8IN>Q`647\LQ)IWYV-P0`,(429[
M"D"L($)QQ$`^<:,YIX9N*/'X[^BA$EG9!=TN!&,$`Q]TM.`:O:*C=(-9,`<>
M%!P9.E5);#$_F;M2$?,)#XF`,O:A=XLE+E!WC)46X,#SXM(##4-9X<DJI0"A
M*'X2#Y2`[)1;O(>.Q98QY4D,R@:J6)!B(JPKAD1:`I.3$-\^(_4XE9>(LD+;
M5'S.29%F"XU#6?K*<J=\#($V+CD8(^;C76XZAR8J26@)\U&?CYY0-;9`[3`P
M(YZ)0OG<'"![)*,15I/@5Y0J$J6^CU2\A4XL@.01RW5"I=GR`^:-(;.T?'E\
M$@981-8)Q=0.URI8F_#+M\)0<G#8PQ^#\%+95!R#`LA89LSL1Q3OI3I@*N.:
M65H^@Q@G9IS@BIMB/AJ*"B;Q/2[-*\09!U"_^4<N5N7@S@U-F#,6(6&0"FL5
M"SWN"92:H2*3Q406,A0T=B`<D;LXH9CX>L4;,"%QS70HP@:@!?X(Q&59D1T0
MQ_<0\[,T6K)H+'I2/%)7TF$)8J%.T#D8,)>?B=[+9ZN,*!8^%9T9O3`*1L3H
MP+AGE=KL&70B\DZZ>$CED;Y@N?#W\A>,1C8+&W`5!!]HD(S!U:O_U^<6N=,N
M@:\4/?_CM-1BVMBZ442AHF>7\>5;V(O?`_;%HOJ7JC=]%>FK2%]%*J]%6XKX
M0@1ZY6/TETAESR`>9>6\,DLW%>Z%A"_O!F7Y#2^Z5!R>F1]ZQ/V8*/!8P(%$
M,,]_>7J;Q%/J*Y8Z'&CJGE)1Q5#>EO:^CFZ.L[8+^]+*_/=YP4UD=Z,8`NA;
MO/>L^(R*#`CR2(BZ(>.;$/P?9@Z%%+X7R5PPS]\.E;?:.PR2>0I$((@FF,>A
MB)@)@<QX%R'+2\@CQ-K\O?)6?P<940BMV4P90QA=4;_M<N1B7T;IP-EX)\8I
MRP:RH@`D*;)&(`J&!/-W*I*6]^*7MR:>"@E#XB?R;4<SF1MZ/,96,U&8%,G=
M2=XW3_<+E2+CG!8F&$6V/$_;%HXP_)8&=[*VRLB=)VJ66?D5<0(#8)@7)1:$
M*;9Q\F)(KNE,/%G%6!!&=,!29Y:X[BOBE1Y<%%I%0AZ&\8,G-F?F%8+RZ1J4
M*,O@Y>&3;+.1X_6`+(&2AU;$=2@Y8XI"``NRHVC%]!'I,C*;S6<<4)5)>TDX
M83R8Z(I]G[F@B(#CY/D-Z\.0>3(R2B/<]$THI((I4I$5%B]9V?,2&LJ3T-]B
M&B5B!U:.;*E/&<,J_ZA@NEP_$46>U>-YJ\=B%EU*0`,AJM284J@)^965E!T.
MFF;;UE+[_.O)E%==O!;?<RZ]^.5KY7HGR[V8YBF;HG/,W.KVQWKEX<0Q2`1^
M):0PJ+A/C:],D\XTJX--T,<7[AD/^F;G>P%7^/_M?5MSVT:R\+NK_!^F_#FG
M["J(X?UB)ZF2926KK"/[6,JF]FD+!(8B8A#@XB)9Y]=_W3TSN)`@14HD!8#S
M$$<D@9F>F;YW3S<E*04\FZP(7&Z,\AD0A:>(HH-6E:9[57B1I25)=>C[(*%O
M)7:E6A.2+JOT(!*TM@_*^21VTP0:_E_RC4NWO`RXH-8A%2Z\')XJ69E9<JJ?
M>A%5F**@BAK,]S+Q%>'.1D7`@;6I:)6\_1Z*"Z'X;6#:F8R?(,&J!KN(%K1:
MX'HA0;RH)15#J_CC`WM$VI!(K'VD(H3ZELV!E]H",M"T'IP4U425S*U98J59
MHB@*P*@J@%:##LH+D?),VZ=DGBU\%X-NDWP7V9-;<EJ(A_(YNV3N9=P5B=]!
MF=>)`129WT&52DLBRW0AGKE\D5Z.B,EXQE=0?8+A1=XAC(=FE`I[+U_M4%9M
M80H4S@(C!AP&]X"[_RGSBX&GSCB8U[:Q$;0B6"QM33OE_SBOR$TB;C_FT1V"
MEH#R\L7BU0F<9*QRV-7H\'UV8LQWOV'<,VEC"'Y*$<!PMLBM4KM'5TC@Z]0$
M3Z$14"?[2^8VEDD`!E\R5EL//VY=./D7S/,-(N%U0>.64H`T3]_[$><VGJN-
M)RHF)@+<*!*I%\(A*CMQ(">Z%9<FG""KWX8<M2UT?A&SZ2`+Z!'+4"R&G(&@
M?.):F4O7X(@I;J$"SHN!EO?Z8-YW%;CVOB(0$XET,.ZZX=S$0CVB:`U\GF.F
MC/Q,Z0@_OQHT?WBE!GT4=4=!\I?-;@FDGU^-_2CR9\DDW7XZR;XK(*SCI9']
M,*RM"H&*9P<&'!PS_-BN<H+#FS^5\^OM)K&_NAUDA4!=Q+FJP%VF+58?@L<R
MT3&&N8(3\030LFE]8^WY=T:^XKT7F=GA66R\D)WGR>V5&M8OJ\J,6JE70K%F
M19KUKJ=$16X/0D'34$E6<G0TE#-(#DM(S2,DI"=+V]5+J$YA.!GY]V?S&!`[
M-7GWJVV7E./4\6A?[^HD1QN=Y%ZV9Y_HTAX8W697&Y>:,C5E:LK4JL>AJ>"3
M.=9:1VD0\R@9S0`8S:"S+>Z]?%&#$]6$H@EEWX12B?-\-M=[U>3UKW'@.9C;
M])P>H](SJ++[OC9F7X\^DLHQMU:S9XR&O2-TA&KZK-B1:/H\*OK<H[>@'/BL
MK1!MA6SA%VPUC6&_74LS1-.)IA--)]I<W]DF9KINISGVCN]IZ[W""J&V#@[(
M[*J-#)H^2[>0XZ3/YL!HC@9'2)]/5E7D[2RUPN[\>XWTDTN^CZ#_^BVK)'^#
M-5#-"9>7X/3I(GAIDZ`VW[[*L]63@Q-/*46J)OW*,7Y-^$_:OHXQZ!\J%K(1
M_CV+.J4^X,WVY1TX!%EL->,1M$-(V?`-/QD'W/QV8DXB'KPSW3OS/GR?6<%J
MZA/+DG>MEMYX>,NW>;]PM(VW_JC:-!Q"XN0NV!UH77K.LC/.*LU8E\))%[.Y
MZ014_L:?L$\^Z-2?J+':*97Y*F9/ZB-^*%V%T/7B0@WP1)#V<^P[*)#7Z8L"
M>:HN$_SE8K?;7%VLI8IYXJWE,O_B^X4R_RXBB4M(DJD%IWKHY;K2.1Z`>X.5
M/T,VY:XH&Q]C';KQ?:X0)]4TQWJCJNA[BI;8JPQKP*F*>MC*BVI^BEZA3F#%
MLS`2)>6Q9Y>%%423.J.6&0147SG3ILX3<%/7+U'QG8H!PARB?&GV&#@HT[$H
M9`=SX])9;ND+P)J>%U/[/OBZ@%AVB2PSG\KV1UA5,"DW2">1VY([ZIH0-=CY
MK>P!@&WML(Z6GZY:%.^77="HFW/HI)V28V]BWOJ!*"R5;OU8M;C'@M541S$T
M<,@X"'!\T4F-NKV92<LXJGRHYL/^@];4X5@<D71(7`3S1?-G&$&U4Z5*8:8G
MNM-A\411B'[50:GBCIF5P:DO8ZTHB$B-%3/@`8-T0B(W+,"-);`GKG\7-MC5
ME+JZ9@X;]@`GQ1**">;91A[MQ`/8K3$A!36_*N8ONA_@FTF)QK3#(KPIBTP6
M@B7WB!I9JC;Q<2A*^.+W5$X7,<T/G6SS20(A1^.F&_HIH4L012%P\3Y"-A&T
MHGKCR@Z`_AV<CZH3O$AOHN;C!/9,[H4K4"84PV/#"5E%-UL%845-A&=19W3=
MQ_*J+Y?`QC\!HV%?``6OIF;`EW62%<I+>326JAWO#M24ME13SLW`HXZ=R?DM
MZ2;M)=U$5H[%OB38OC24C6BPN`5-@P4>>0B[F#;^M9/6W8K'R5*[$VJM2B"`
M5&$A@>!0_W%ZN\$^4$.C@J?2JKZ6Z5HR^R8C5!"J.X['@[P2I=$-9UY,I5^P
MGX\_F^&6X%@`2!RAQ$:G=H-]=-Q8=A$5ST2``-E6#)E2E6H`)PQCDM"R4["'
M97-5ZR#Z)&K&@\(CRP2+2L;8[SAM25%4EEW,[LMNZ?BFU"E`**K.%J*K!/[F
M445.G]I+"&F]7)-35.%<L3BU(%$(6)9+3H1;YI@5S#;NEFQ_FSD>,U35147Y
MX3L2WRAO`45/;+G%NH+['AC$KS&JP.I<EC$<R`(.J#OJ&[UFUVBWAH05W5'/
MZ`R:Q@BTD4D.KPB=-L$N@V7Z%;GW@)\;0=(9M(S!L&?T^SV:I=-O`R1MH]4>
M+D#R,`Q-(P]"R?#K,4?]\H568/:EP%P1]_M`4@.9+_?"-9F;I7:\5.V0LVK,
MQ'?)G-JF%4%K2"I,]M266Q'00^M:$6`#)^)+)T)UF)OW0C7!MO.SN>O?<[2B
MA5V.<-V0Z"7-1?Z<E]"&M-K2OHJJV8!L_IX4]\^U!`!!F1II:.[BF!(F*[M$
MV;,\.SXA-4O7FS#-394!ZJKRNML;&:/^@+Y]W1L.C':G5VYN6@LZ."5D6I"C
M((>[S:;1;#97H)F0G#E1BLW&NFVCUQ/O26F+W<ADPTBI;9*7[=E/\EFC%-45
M6&>^AQ$F\6OINN;4+1#T:](?QO'"*(C3GBRJ_ZD#O!QXOI`J<S#N0'J1!SII
M69H1<R`9K-SYB<:RW'8B%CCA-R,Q+.>!`ZMV7/*=HK_16.H'*(Q(Z@*6-O_*
M-R-CL'A+^L[I=7H%&`I@5W`OOEKJ5XCM#!50V`6-FN3"ZITH)IBIT0/MGB'Z
MKV9'0!\VN6/1=D1/HS02?_UX<8:CQ`'U]G*=F1,=(P\ZF$J5<R'(IK(AN5&4
M.8^=>_%XDN["B!PA#VZI]?"V=E<K[:V$`9Z;&VQV+'K)]7L_T`"]_@]B9FI4
M+5P@.+CJT!NN\X)$?@14J!9B+-J9Z*TI&E'VC9-AK5%30((0K9GK`-M5<C.U
M%M3P*Z+9*E3HCP0J($H\B'8%718Q^K)9MYO<.5?N<(\@FT[].<\\,7_PZ?IG
MK3V9%>@LMCK.^9P8=7CEKD;R\'!&ZE<>@NID"7OC(VA3KG^PAH`U.K"L)9>H
M(*B\!-G]M=/]E7D=8'WAXX%-MA89=:C?;.-<[8CX\*J#7':T=I8SV/Y,W9)R
M.'2V/@#[#'84+4AK"MLN6I`JCZ>)*Z-&V-ALD!8(:W'OT3L+S,HS'QQ<-3?U
M0DI#R@QW/74"^V1N8E?";0;![#@9&$6CGKJFWOG!-PK,4W!ZS@.,9J.C-\`Y
MX?C!6O8]GN17I8%LF8X%\,AC/PGG8''[V&GV`:B4/P*=SSX<N`S!T],R@RFU
M7+(KD,YID=.5VY$4^=2WJX&0PY$)][H[,$9#$51\W1H:K6Z[,*`HIGPH3)U5
MGPTY9K]E]+LB5OBZVS5&W6Z!R_L1XVLSK-)BY]2F-`ML4UHVQ^@&YYI>]ZW*
MR19%\(B7^*YC"<_EE("[D2PR%($S,SVGE?P].W9&%LCL5'2=ON[VC$ZW+[C`
MJ&<,'\@66,</BME,VVBW)9?I#(S^L,DHVRH%7JSHD9.6CO<<_*YAA1=T.*9V
MD28NBSLA96-M-7:B8Q8UT/K_R1#*<@[Y<DOLDTQ+[.(>VU+3HF1NCT^<2#"[
M@B;<$TZ\96Y&%%MQ@-6@GUMTX[Z;.NB0AM$#TG]=%SA)##IPTET[1GW,9"&E
M]>-+V9$;["^E]('VCP$KE<&_(H%_>?'D;S>_T3437QDHV6LBN8L0="5$9B[2
M91-4/G.)]OGFXX%X(W^E))/]S[\[(:9`GH)-`2^CK[<`1.R#K@)QOCI.D5E:
M)GZK&>+F#/%73)/YE[K7D49H+]((K6:1^V61%\)FG#A!2#'B(!(YU1,G!%XB
M>$V[V1P:N>CW(_+4AVWA.,B<^1_<Q#SR-!+_,<DM#Y?<$N+]Y8MUXGNP8"=X
MA2J3>64@2S+'KA-.B7E.`G/&R:!'3CRCN>FV3^8-2JWQIH+-96[:S%)(,PGP
M"P#`,>#5(]P/=Z--'8E-%5G5*`YLY(X(769<_(C.%L_W3B8)A63X=OX'UQ&,
MWL'(*@;NYYBWX(>2ZYI!+MT,QI;+$9>0,DMV%&*HD9-DMQ#SW,S,_;2Q&8)`
M>X,7&F&?TJM[;X4X)&216>;9#7-LNC-(/A.3H>P(*#T#4`QXO$S[+XKDI3"E
ME[&"C#W18%_Y!,6USRY]V-$+VL1)')"$Q07'(27T8V";/$_IPH]6H.R7S9PG
M./[9BGR,JK:,LO(5>F4K"'H"@B+Y53!?;V&^).6(!S/433'O**++.#[8RS[1
MKJ]8$-`)FN@KDYG4Y6&I36)*4YZP&^R2._2CB)6'/$O94Y.2/AZF0<QNPH*!
MI.8N$Z217CF=9"U]U"4S-T&O"R]X)OE-BWE21NH[GYOW(G:/J1M3T`5/@'W,
MV-@/`O\.KQ<9:.$'?(*Z=.H;'9LN>=)!)G`:;PXZ]G=QN3/#_,;<,N/T+D]F
M`G@2Q(;0H\7N94Y@/WQ#ZY7;!ZTPZ)FEX2^![\'?ED#SLET)J!NW![(.N$AK
MOC7!+HW!O)[;9!P&=#1@H^(M.U279KZX?*>2^66T`WV$W)IZ:-$"LPD"%!_(
M08`5TK7K]&Q!VT'^@LP1=:7YW%4L&F]%BZN-%EJ?L.;`D5?V4!%"[0,]EI:,
MMFROB>R$"VZ1`O+3CW%X<F.:\W=7:56!%,V_H+<65G@-!_T!<>*7ER\8^TF]
MD_J?A/LI%8O)"Q3\@@^@0/W\ZDS\_9_1'^?_Z31/?H^]$_2POOIE.7]F%;)F
M\+MD=4+HH[A4^F[LN[:Z!OWY^IQ]8"?LXO+Z]/*WBP^?SD%IO3J_OA)L8>NK
M]8?8E4UG+'7)EHMEEX]%-WML=<?6"1:4A7#3U#TFK['*T,:['9[ED\5VH=R-
M1(D0[KHA\"!8\,^OFJ_HLZS729]E.<)!,ZU'^"BI?!S]D<H)*IZ=Y>,QPX_M
M#6O\E9*`W_SIF;$-PMA^NXE(J]M!5@C419RK"MQEVF+UX>`==4IW%A5?R`IB
M6+^J*O-II3`]4FTM\])0!=R#[*DXAM=F(4='JCE+II[TVCQ">GVR[K!Z"=5Q
MP$A7(=UZ#KD5J'BFS$56#D#?]6_0:??FK\4"8)15XT_80*31[-GH*'TGC/K@
MQ#Y:7:PYR>+M$4^5<G]&1A?$P:BY#];Y_,Q1$Z<F3DV<)27.9_-Z5(U,OLA,
MW]5J2V]_:HON7%J.A>RC<VGI&6"G:[1[Q]BX5"SDY0M-H*4[%$V@FD"UVR7K
M=J%B2*?R3I2]JM>,S,0X^2W`BN#YY(MWVM]2%=Y6)^X%]E6_9[3VPL#*?J2:
M4C2E:$K1PGQAFS[Q,-RI-"X7>98/HE'I("K?'FF(JHI'FL67C\6?6E8\DXVQ
MLJ4/M`VF-<MGR/3N&-UNW^CT>@=5+:M&M#HC15/G\U!G:]`Q>GM)A3U*ZM11
M[TWO\*5%G=Y<<;Q'[_IW.L)=Y:#)QBST>`)H;WI&O]<SRG77H&JL8FNNH`/K
MFB]HOJ#Y@O8/%>S:)8]T/+XNAZE3K!](8.IWC,'HL-9MF=%=DZ8FS9+L3[_3
M-_J=P[J%=3CJX,?\E8>.C17*=29@K<Y5L[?U^U//2UV:*#51:J(L&5'FM`WU
M`=/S%2`+%0MUN<GM]OZCJ/Z/E5VI'K_HZK18.K+9-U86?X6AS1O1$R#M#&AZ
MJON*K'A?W&WF36&?E[>B24P<S'W9@,_F6'7:\12HSFSN.EAK-JU5+6M4JYJ9
M4<$:1*'MB(=I$Q9;]`-0#6("FUH"SDPQU=CWOZ7#RR44]*7!!@,<7\5',C"I
M/EH/[*P9)@N$)\;W5)M?=?86G0ZSU<)/0VH[@!5U#1;/87\M.!:7JZU6VQ"&
M>"A&]H"2-9K4+X%&S72@$6W)J.-AXL,U`(.H,G%D?C>P9._K9J/9PZ-FX13K
MB=H;8A"6%@ZX'5NB'\]RO7-JM";O"\.SK]M&<]0RALTF-H_T0-/&[CTNSZ[G
M[]B^H3\<1'0+EFP&]]2!3;;A$<T;,E7?<UTV37&.JCHQ[+F+7!&&")VDKK![
MSR9`0)EI<^B?-/QY4M7S/7"*6K`G<4$KF^J7--<K[J&WKG5=<>/,.R"_UZ.F
M,>K*!I_M0=L8=KL+S>S8WD%I%H,R&@X70-E$T#]0-WN#&MCYHMFRNG;X130<
M./5L^":(N?TI[;12,,AC"VGG\+2\%?WIXXKJV6<LX1.M]^ST[.SSGY?75^S+
MZ;]/J9KVY4?\\NN?YQ_9IXO3#Q>?+JXOSJ^>PD0J6H1_CYKE:5&?#%,@;K9'
MT&,+:%?@B,0KLOI=NLNZLO:19'=N7%E[)ZBYA&<[32S8L+)V-5>W43W:FN)H
MA4"M#SEM7E6UJD?Y;`G+)<'5VBQDQQ6/RT^;NH)WK1=RC/B\C_B$M%74CL%>
ME>#L#Y@@437[6V=(U.1@GSD8NY/MV2>Z]/LC8SCHUE*KUJ2I2;/"I#EHMXQ.
M]PBR)8Y>]2`O/_:FC5WJD#OA?$7/8ZV!E`34FO*<5K-M]&I:"U_3R0%!??E"
M4TIECU1+YR7IC/ET`2;D:0=!.7#T*,5SI]TQFL-1+9F.IA--)[O:D.'0&'5T
M'>6-0\7=^7=F^S'(M2TJ4U1%=(>F:P:8.[<_T;WYGI:>8ST:/<JQD@<*V6QV
M*)7C=^TVMK`;/BMFEQ(=-(V6\%".DT9[76,PZ.P_MZ!;C]R"K595-=6$KN@<
M'!7JR]>J=O[["'T>$2MM&9U6W^@,]I%Y6$INJAF`9@":`:3;-^H/C%[O`(F:
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M-E+MQ&%KQ-Z$^^S[]OS8M`-0JX8UK]D>O,M;N(^S3Y5R@TXTIE<>5$V4-2/*
M=G]DM(;U[!*D59H'59H%C>9WTXNQOO%`..XW5&CZ@XZH1SLR>NU6OAJMUG2J
M`FI-&9S6.C2H$M27+S2)%)U>MVET!_6\WJ95@*U5``RO=;>2_VVCTQX)#:!G
MM(=]K0%4$]2:LK=VNVWT]Y*U6O8#U:!J,MF<3%HC8]"J9TTZK09L'=SX/0;1
MW>IMI0CTFD:G,Y":0*=G](9-K0M4$]2:,KG.:&3T^_NX#UCV`]6@:C+9XJI7
MM]\UNFU=:$MK`Z0-7/JW(DD2E,2M7`.@4_9TND-E0*TI/^NTFT:[JUT`&E1-
M)D<7*]/B?ML80"+MU0V^#:5]J]4QVJV6%O=5`;6F?*S?Z1L#7;!S%Z"^?%$A
M8#6A:(&O!?Z3\_Y:FXK[=L\8'%+<E[Z2SO/C_E&RL7Z[:[2UO-=THNE$B_OM
MQ?UCKV;611E(G/U&<>Q_YMO.Q'FTFC#H]XW1H+EG-:'L]VN/9"$/5,8K7$CE
M^>J@.S2:G7T$2ZN-#'HA95O(8\BSE`NIT(EH=T0RWKXJ<#__(=<&U)J:/FUC
MU&L9_:%._=.@:D)9F_HW&G6,P4A?!'@.7T&O+&CPB8?A.V;%00!@L3E:][[W
MG`9.Z7V:95=#M=V^7"AW9UI!VGAY!QA1-:W^6=UYFB]HOK!SOM`R!H.NT1R6
MR:578ZZ@/22IWN5[-R<1#V842#G!"(O.J:C)V>ZC_5"=V&X]P].:*#515I@H
MCZ8LA/J@.GSAIW'`?ERYW%)U*=K)C'_'8>1,[O=T$KL;CT"VN>4')KJEWL6P
M^(`&D3[,Y@^L*-GE"XSFA*$?W,N\E^(ZWN+DU_2G*J:"`QU++7#ALU=0/3V:
M<CBNV=ST[AD<4PQ'8WK,O+D)^`T<E+A0/&@:S683V]\EQSI/CU6T*+-COC!\
MJPD,*)HR!YL-\#!B9L002^;PA.EY\8S>B>>^QV9F%`=.=-]@UU/5\PP;F&5G
MA+<12%PJS.[X`8O\Y$4#?\:U3'T7\#),NM4-WC-_C@AK(!P^"Z<P+G51\^,`
MQI_-8/HPPNY^.`&.;''&_QN;+HZ/0\)6P$X$^,X;YRWKP1+@3_S%!.#,&RY?
M*AIS@F#"DQ'W6!28V)H,".`^3%>`O]IRIR.Q>#F86'P(L#-X](T#<P.(KYN-
MYJC='W3;K2%M):W(8'=3QX*]#E/833B#']*T,#F7@OG6=^,9OD<-__#8=[`8
MQ"#3LWB#G4:9LXG4H>(A6&Y,;^)AFJ(S(U6OB;VYZ=@)MABB@UT,@@P8CF6Z
M[OTB.A1OA<`AA=-3,X0#-#U<H0)#X@AL4(@,"T!,<=0!Y'?=+%ED4`E>"4,>
MA8T'N95F3UNSIPL/T<$/;$0@P3E.K\Y8=]`\:3?SC"H`,73C4>HC,"N\-FG;
M\/>8>WSB6`Z@?X9V)ASQ$/&:AQA7@1-.\#&/*W#POD72R531%T65P.XLSNTP
MSQD`:P+'"QT+-:]8DC`@IIH2B="V'1P(7D+TAH-@ECEW(M/-SYU;DLUFW`Q)
ME"XSXY;1Z786X2JB_Y40\@VWS%B_``+43!F,>6/"5-'B[N:34\T(`!K'1(X"
MQ/6G!@M*\UQ]^#4=/LOC%:]!-N#X-GOC>YS=<S-XBTTP$^KFW^?<"[FFWSW0
M[R(V![9DN4_"0?9&8OQ;Q)<\+@F4OW.`7X]Y!DU0$"V<>(HZY.=+9>TB#Z@6
MY*?B35.Q*NIS<P<8GRPCD=G3@'.B6`].EX%0CZ;`*SQ;E9]5_60-552VTQ:]
M95^W>D:KV]M\6$F#1:,OE*9K[([X'D%(6QCWQ0.2>?T.V\ON,Z0T?,"LWL1`
MGH-B=S(&/?;;B3D!/'IGNG>@N+W/K.`A=XGL&;;TQ@90;+QU3W7!O7RQF]T[
M+!X6#;`W&2"/\:!R1\_YK!AU>/_787Q9S^@,6\=1RN2WVKL+J=4L="%UC':S
M:PP&_8R_)>=*`"L"#.G(Y3,N;JSA(-92WWM4+`+NDDVF%*.R*>^'P:IJKZET
M;NCBWDO:"7T(#K+4\*K(!TV%K1]P.I/_>.%^[!-<SNAK>*S#.><DK)_#N=<>
M#@:=8;=J#N>M_,WH:GK(W;R\$9NZF^OC;=8"KY3.[&?U99<,16N!0X\*#W1Z
M1JM9B?#`?J,#.3ZJHP.E0^:=^=@%PN_+QU[@8C]IGF0ZKS[9VY[UATO?^]`8
M]-K2]]XW!IWN7GSO&LL/8-VT"JV;EM'L-HU6M_TD]T@EO".U.-;2NB\R?2.U
M[^(@U)WKU%GLN.@/>N2Y4*0Y-X/H?F,_1J=%H[>U(V,?CHS.<-COMWJMHW=D
M+&_$(QP9+U]4W)51"[9T;+Z&Q^7-M49&?]36AO%:P[C(&JX<G>J\GKKE]3Q[
M5L^S2)A'9`+IY"$]YSX2EBJ8?50+U6YO7E.A#1W0:SH:]H5'$\O_#';J-=5&
MQ;Y\';F*Y*^[,B-#'O0C_!QXZO+W5)$-S9G`()'N!;\+Q1EM1D#.T`+%EQR<
M]/26UTQS:Q"%T#6ZU,!#ZJ';Y+%XH%VES\`^-KIHC/R$>$HH3CB4)_S@S>/L
M9-OG@"$K4G9QN_D>G6L<F!!QG5L8P@]"(_F]]5XPI@EL#+$E6$#LFH)E(7"Q
M>T,X1YA+Z[X2_C('@#VU*)[3&G4Z!HX#S(_DVYO,_/G',Q._?=;[T>C"S3E?
M?4O4JA1.SZMX'/+_QN@I^M7Q3,\B7R5ZA@-UOLU&L]MMPBDE7EDT6HO?E/R>
MW^+7*>2,NR#W0P0!]`<."D!6P9'0DS,)]P=VJGCT,-EB8PV,)FT$[FIF#G(Y
MTPRT_E`N@B)TKA_BZ/C2!OLQ3/WA\SBPIF:H?,CDT!W?I^BGMJ-HT!Q2%/E]
MU=ES$Q@INN-SYX;'FA"".IC_C8%+4/^1[(EL?G4[669.AIMC4!D/<#^;@"*7
MO?@(JSS]\O&2O?G0^%?CHO&677A6PU@YR!T`X-Z?^'=(X"'LN&,[9J#US'T(
MBF+:3_FK&0I[1X9'Z&1#$]@=4$=6I*0$+6C3]G%N(/__$B;?XT`%2-THQO3M
MYT=N`:@YF3BN(Q@$X"MRT0DZEB5ID:F5@121F2''@/$B((+0M,A@HA4`NL=N
M1`_=!'X8IKYT)-HQ!ZLI_]:$RQL3TCX+WZ8^;9@<QN'?+1Z&PAW>5+)6HW4]
M8C)5+&;0'PRQZF<5HC+/7<W@Y8OJ9"SNFIKJN*:]N?8D3>VOZD#)D*T6V%"4
M.$@FJDC\F\U=KCAXL64A9`HIV!F%.X,@I(V#C>'=H,<50$E,'3Q_^+LS:#6[
M0E2A'/H>"<,4C64R>>B=O)T-+^:A;C.8Z77+Z"VX"E/#7IK^TKY?9]<WV"D@
MJH^*E'(/`GX'?`9\&94TY3O$YZ*I']],,UF2Z9(E".E[B1]S&Q^#>%U2*,XJ
M]CO9'/1L)EMFNJ%?L#<-,#MPEK]C3RALM-=%,)/Y@G0GND!:TKF@=C/=WRV6
MD%<Z[@*?]F9Q<]9WE>QT6D:GTR:%$D23`*O!KE2/27HZ#L.,KH%,)8BMB.#;
M`ER==J#3#G3:0?6$HDY5..HYCQ7UCV?2?4<.:Q=ZO`25?$854T:/"S^63P5:
M+]K5`$\$:6^&UM*!;!:<[$B=V_$P2`-&UQR=1C.E'*_1;84),>9F(,(H:5PR
MC07E(Y0'C4>N"2IB4)#"(5QZD#''P\B&&I/`HH@B9CT%,HPC`XO<(4ONS>E;
M%L;6E,$RQ^)J2!IR7!60R88A#;);FRT$17I(,G<Y%DAFU]AC<S3+:*/']V#M
MW#H4#\,0FO!?+N,%-W&Q=(4C\F\X;8(TLN^%SQ&LW#7!-/INSCW3%=%*F%>$
M3K-68W+SY#7#NQWM8;LW;`U*=K6%O<'G,GA])L8Y2]?Q!:?)!KPI(/GA;2YH
M(N@38R>P@X7QHUPP/7T@1?O<%$2'2YN9[%@V2BN"L_F0]96*42X';7%O"N<7
MD9]BV!<VJ?"AI7UJL-.'7LHR#">4CHRM`EF90\@F&XCX]Q)7%8B;S1=(XL\B
MZ&P6QMY4!'IQO!8N,7,+:6:F\6TG"B7_2MB50ZX6CV<\+;0ZKSB&GF%O1:_B
M:_#$#$-N1:^'61X*K$AZ6(N"\<B(E6,ONR$7!4NF+7QS<?&VT`U8M'LJTN]*
MZ+,,2&[<$C<NOH(L1UI!HP9193%N;TY/JW%;I(B<K2+\PK4O4D[1,SMD`6N&
M7\4+<(#U4*F`7F&H>FM]<(_ZF/I[H5O+(YQ)VCI:HW"</H#0.V7J(N-`)E\M
MY!QLF'"P*J-A72("@^UPX:$L#T5E.:<IDR^Y4%<F'2H0OG@2.>8]MA/":28Q
M1A"6-7Z0)5L&L5Z^T.BZ`;K^Z46.NZ@*X_E(_78<1TOZ;6J6I":(?((.D$1!
M*CQ)?&7$T9407_,X0"U3:;2.C!FM3O+RQ[`?TDI:!$&%2)4Q!]1D,I#4'B(3
MZ>M)7EF6RG36657P5*?G;)2>,^@;W9'.SM&]1LI&OWM+GA$8?\B.':"2-`>R
MTT9W=]6^2G=';H_M)DL40CC6PO!E#<(LQF!4+;QM8S":1S\ITI*6("R*M("B
M(6,K2P[T!Z(JVP950,-9'U?92UAEH1[7#H(J!XVI5"3HT1P.=<!#!SP.'_!0
MS&U7`0^EP:4,9$W(HP01CQT$/-22=Q+PR+-*'>\XGGB'[@ZHTWE+G,Y;\BS9
MW1D`]%&H5._&P(6?]1I7R3)DCV7.'5.-KD"F`]`8@'[YXC`A:/(LA%N$H)UP
MHPATJMR7R2-;"U1]>O`9#_%IH6<TRQX=>-9QY[K[1'6I[DW"SNU!TV@.AE6(
M.^LF5L=$OGL+.TN,/V`]UO[`Z'2ZLLE4KV\,^UL49=5Q9QUW+@=%ECSNO%#3
M0T>=R]*!3<><=<SYZ3'G7J\]TC%G'7,^6,QYL=G]TR+.2_6)ZAYO7BQ6I:/-
M.MJ<1)N?W5*IH396MNA!)6,'2VQ:8ZH.'I0\>*!3=S9,/WGYXI').^K/>>:)
M^8-/'TN2S6&S="J<IG$L<U8EFT,GH.B0Z6-"IMVFT>YT=,BT="'3&I'B_L*?
M`GL/&/[LC8SA2(4_6UVCUV[O)ORYJ/DNXU0MC;,#1EG+$N)+7&;^4J\[4;9=
M_J1#@"4+`2:G`Z+_UO'CT$W"@@NAOZ4V`(X'0H^<S47M12,?Q!^U&$@K]!=5
M"]650'4$4=U:I:8;.OZFXV_HV'VPP&4)HF]/J&^IPV\Z_+8R_(;XQ2<3+OKC
M1E,'E?%),HI2SI4U'+(GJ`U2[TAWDXR.;+.=W=617I@+^9+8!;DV.(0P`AXT
M`T19ZGI35,_Z"*P)'90L04U-'91\=DS5Y33UM:8JX&DERFF^?/'\;OJ6T1V-
MC%ZG7P5'O:ZI>51$O#?O?H+T!_3O=T8MHS?H"P?_H-,V>OW^7NXW50[]JI0<
MH^O:5"+EIH*,\QA27HYESJH$YW5JSX+&\3$.5"-OT'D#=+`7"MRB^WL+FG7+
M:+8[\%]_E<<7U%ZP(B.7_&Q))^U.3[4I7^[7ARI!P%U36LFDBZP7]_E//_T8
MAR<WICE_]\GW;JY!9_D(JL\U;.X'/(=?P!YA/ZE'OHJ)OL`NW%^G/I[P(RA*
MKH_61/(B@HI'])5/?GYU)O[^S^B/\_]TFB>P<2>X9Z]^62V$RH\=*\J'77Z^
M/F?G[(1]/?]T>GW^D7TY_7K];W;]]?3RZO3L^N+SY96V"_9J%^1#L7$0("TA
MG8`R/:,X#]@!H/_3=T1W,O++IN8M*-GV+3H(X/'8`^4:G3]`:]Y)HNFKP/C8
M#-'QZN<HGQ3V`,9Q$[+$:>[\X!N^HXS:>1S,_7#1/S`U*8#&2(HHMQ<Y#H")
M2)X@G`L!GYOW]`5YO)2=$";@8Q%_XB\Y+D6P7/%Y5%#P&JR@._SG=;\ID@+(
M*I$)`FI4YL=1&,$OL)BRU5"H-U83<@!358[Z!"5"&1R%@W%LRH8`_+,HYX(!
MFD>F0\;FW=2?D9O5=$.?XI@X:!;]!2YFQL6G;\!L#BAR*FQ.0$CZXW$R9@L!
M(B2/.;>]=V>":*X05BU@2,#\"@+F[/3+Q?7I)W9U_?GLGYKZ]DM]Z"&,HZD?
M)(X?5/'84/!*XI'%.ITATQ[6I@&9H>3J2-TBL^#6%SIC3D`!SMNQ%:ET/N#L
M;=7'5/BH1&Q:J)Z.9P7<#+ER2&?@7Z%^3F`S6+>5+HD"[\G'!D,7NO34+BJ\
MA=O3*MJ=><`G/$#Y)F9]<'\>+<HZO;;10XV[*1[O=/M&I]\WVMWN2@U<:>ZV
M%G7/96:E+LX5OLT-3*WA<&@,6QUUS(11-H:37_>%-84:TR0FYV]&JH8\N'50
M>])'?*`C7N?%)C)<[LB"FI!TMY.&VC::PXY05T>]OM'M#!/=&SB1H&M0UJE*
MS@Q?,P4#V]Q%OJC/K%9+\@9SJM=\GIQEYI9ZT)D?1B'%LC\@>%^$2A\^6<=9
M[]]==/8\$7T.J?;\!FH/J3OL\Q<RI=GIY4?VU^E7L*ZOI5V=[?2[4=_?0VS/
MX6?<-?'N;KR'+CC\909@&D3AML=9_M/=2X_K76J[$]]U_3MBTI1*%<8SF!T>
M%/JI-36]&]F_7AY25DM*<F$4]Z5,S33O<KO$>279@86C^X7/YJY_SY?>)ZL5
ME-P$(-+\;O!OD:GJ.CPF-<\,ISD!0'`I@8]BB/Q#-F8>I1F=*L&M*!\YR;G;
M<$4J_6S7'"K%!W%J%G?=<&XB_#^_:KZBSW/4V^5G"O#]_`HC?*^>5!4R"I*_
M;%2Q`**?7XW]*/)GR2S==([#W,0JWLG(?AC47G5`;54(5,0RRT>,A!_;U8&[
M0EM<(5`7L6$]?Y,!U5(*3*6G;&(YU.T4*P2J9C\:5(T-&E2-#?L!57U(;0%M
M%6B\T*2G03U*J^!SZ@_3AD&I0:T/SOTE:_1KA"LUJ%KD:5#KR'[.O_/`<D*,
M/521`ZTM;JQMG)*!6F42KPK<%=KB"H%:'X;_E<],Q],63ME!K0_&G8KF8QK?
M2@UJ??!-6]25`%4C7"5.\='FTWKE.7?;?D]&[0J14[DC.!I"NJ0ZS;4DH_J`
M6A]TPUL9>-TV-EV-<Z4&M3XXMUXT:80K":CU03AM?5<!5(UO53C$7=I"8RP2
M&9R(A^'(3.L;:\^_L]!W'7ME7;)=KY:Z!:S(@M_R>#9>$!V>O-.D'N_.OY>?
M*#=:Z-J%58^<]YL253^<J?/:@!Y>OCAZBOCD3#A[\V]LP/Y6D\21KTV+"*E#
M:$HX\K5I2MAW,EW]<*;.:]/TD#H[F181!TA'K5I5HM>[0HCB#-C%I@?%VR.>
M*N7^8//6YG!82T]:;4`=U1/WVD:W/30&O;[&/@VJ)I35&])O=-N:1BH/ZM'J
M3C4ERV9#JTX:5"V\M)9W+*!J"58OVJRQ!*N^"^SEB]*108V=8.UAIY9T4!M0
M:\J">YV.T6IIY4B#JLEDK0NL,](T4GE0M0%1+[($`T(K3AI4+;RTCG<4H&KY
M52_*K+'\JKX#K'1$4%_W5W>_)+"X117B^.4`M:;L=Z2Z/]>2`VM0-:'L:$.Z
MC=9`TTCE03U:S:FF9+E_S:FZN%X>4--`>MFAK2F9=+2:5QM0M0BK%VW65H1I
M_Y?V?VU.`MUFKY944!M0:\I^434:&*.N#@YJ4#6AK$T`TQRZ!J`>K>Y44[+4
MNI,&54LOK>8=$:A:A-6+-NLLPK033#O!-J:"7J^M[]B4&M2:<N"6T>GUC>ZP
MGH&(6H&J8^G/[@?KU3-?_;A`/5KUJ:9DJ=4G#:J67EK3.R)0M0BK%VW6681I
M/YCV@VU,!3I(4VI0:\I^6VV=):]!U92R03"]T=<NL.J#>K2:4TW)4FM.&E0M
MNM9OR$#K>+4!5<NO>M'FL\BOW15YU^XO[?[:"1'H0C.E!K6FW+>M]2(-JB:3
MA_GSH*5II/*@'JW:5%NRU&J3!E6++JWA'0.H6GK5BS)K*[VTWTO[O38F@7IF
M/M8&U)KRWE;?Z&K%2(.J*>5A%JUKX-<`U*/5G&I+EB76G%Z^T(19+5!K2B5:
MS:L1J%J$U8LX2RW"M/^K5"106_]72TNF4H-:4][;,GI:+]*@:D)YD%`:`UTU
MI?J@'JWB5%.RU(J3!E6++JWC'0NH6G[5BS9K*[^>ZOL:^X'-@Q/Q`)R1:7UC
M[?EW%OJN8[_7!++.,[;QW@G"F)NV[7@WZOGN_'NU*:JW#XK:#A_7;FGIQ$WM
MUC:J."WL[EIZJVD,]J;\U0YO]-JJN;:JT_ONG)3=?412:X<O>FW;KNUHU6K-
M6K1:K==6_[5I.M<&@Z8(K4AH14(K$A5QD9=R41L[J2L(_9H`2[6@+R(6`)G9
M?CQV^9KH2CE6\@`K+5Y)Y4.%O8'1:O>-3K-]@(!AM?"Y7M"7#=1UH?=J[[2&
M7F.YQG(-O=:L=JQ9%?8I+[%NU>UKW>HHH"\;J%KJ',[%HCZ8P+^6:?L0SLF'
M9\S,L`4KW&P)=&:P<\T?=GD2PP<.(L\ZBR&=FS?\9!QP\]N).8EX\,YT[\S[
ML!CBXA5:L&T\6'YCTT/>[/W"T3;Q*)1H[\N(]ON(`JP]YX.N2\_YU#G+B[-_
MQV'D3.Z?03[D9WA.2MNE-+\.3"\TK<CQO9`YWJWOWH(6P>[,`'Z(0F8&G(7Q
M#*"!%VUFAFSBNZY_%[Y;RP*KN!6/7)"DPA0F4GB8Q5TWG)L6[.;/KYJOZ+/4
MT>BSU.@&S52EVQIBFFV3(%;_Z1<]2J<`5WPA>.Z6CR@"/[8W7-4AI>WN]HH^
MWG$:?^R[:AF7\6S,`^9/GD9XU5CLU10X:?CL@?C2D4%M%J+I^2_ZAMO'0,ZG
MMSP`(_H8EOHE<"S.OO#@&!9+;/H(N?3C<J/ZFSA^JV8&?#!=T[.XP:[X/.*D
MHG2:!FLW]UTU<3&N4Q+!5@_G?H43D?I=8]AN8E&1`P3+RG:FM2.5JK'#PU<4
MJ5HPN]GH=FI)F5HI2,;[#;VA#Y@VQ\S5R@%J316`=MMH-@?&J-NO)9O1I*))
M97>RN-FK)9%H69R,=_Z=!Y83:FG\[$AYE"SF?\S9_/W_&[9;[8VR@&IVJ)I6
M#D@KI02U5+OZ9+'XI'O,[4I?M3]#-[?+;>8'C'^?.\%>).K3+M^WRYV$7?:P
MSL9,9\M3JK#X?M,:&/V]N=./F)V\U<Q#,X^Z,X]F8[`/7[]F&YMLI_:!+"8I
M,#-:2E/8=X%[;>MIOTC1AO1'1EM'*4I$*B]?Z$0%W?HD$QIIU[.CGE8+=)I"
MR5#R*!E,U^BTAD:GI^6_IA1-*0]D*6A17'-1K+,4RH*41\EB=):"IA5-*YI6
M=B*5CS@\H9,D=)SS"..<K;[1+6=;FFJS$YTDH9E'[9E'&5O.'`W;V+D+IE;M
MI9+B#K_''E<)$ZU#N&A*49_W2;16J[KJ+U_HGC5UJ#BM"?(!@JP:ASY4`\":
M=JUJ-EJ'N`!;"N+)J3KJ@ZHVCY_&`?MQ>0=6GVNNE.NF+U6\!O*N#^RSQT[G
M@>.R]DADHQII,>'(CV`%W@UKD6L!_V-W/.#,"<.8V\SQF.5['J=RQ("%T92%
M/+AU+!XVV/64Y\L2<Q%AHVJ[$S]@$^>6LWMN!B&;`(`L@A=L,^+,G]`$*F'6
M]-2KG,VIN!T\\+K9:/;9G`<LQ!)P8O)V[P=VRV&S`61G-N.V`\.Y]P;]`!!^
MMB(?$V_3I<H?<CO0@AGM%:^TQ+HFIA,@%<8$2Y1=J9K?C@/\'_[FP<&P&6S^
M%`%V?)MQ0`([K]/"""&S.>#S#!ZW61RJUS\@_SNYLJ:^"\?Y>4Z;C57^\($_
M?)N[8O7XK"CVC#^8L(,S>C9\QP`O'4`[F]T[W+79ZY/FB<%N?=>,'->)[G$1
MK4&S,6C_0&L/G/`;G`GG+,#SH--I-5J#'QJ"2G]<3>EE*PA>`0I$A,H<?!ZW
M7H\Z1F_8!()@%B#Z#3P`9P(T=`_4R:PX"&`M"JU\^+])1]Y@'U/\BZ9XE'BP
M2Y@8%J&BP5ZWNL9($H*"`/%3@0!3IW,9+.#A')G`+1";1I'],.G?8SCR5F\U
MC^ZHHC.;LFA@ICZRA<*'$&\2)@QX"+_?\B!RD'E[?K01@P_Y+?>>Q.&[W68O
M9?*+O#=<8KZT\F=EHIU&K[>:B;8;W8YFHH=GHJU!U^BV1]MR4>;?8L%S3Z@I
M3^6IW8[1;PX$3VW!]\-V2S/59]9\XQN`,+F(51W5M[NH^G8ZA:HO85M_\`.+
MYP"F:4T=3OU";#XA.H'=@I<`P\-5BBT."@^F+/:YU=1.H]U=IZ9V1IK#/@.'
M;76,X;!W:#VU/30ZHX[@J<.N,>P/#LA2M2<AAR`7'IVB.#;`B4N0GG3/=15K
M;1NC?LL8#MK5TUCS7%D^C(RYTQP.$>WH[_:PLUI[+9_RVA\UFOT?$'K\L]U:
MI\>V^OA<N]%N_M"H!HO5K2/WVCJR$(I-W/(EVKOR8VY^A@U/;G]@%I;^KE=K
MQ>>8\\DH44U$KH46](":W`:[O[NU.W>WC@CXL]UJ"J5YT#(&@U%5_1"'B5Y6
M>TV+:OGOIA>;P;U$A@*'!UX)-KK#;M6U<N4KZ?7:HVHYD9L-=.<4*-_P:[O1
MUPZ.YXC##8Q6I_6\C+O=-="D),;=[1N=P2&C<MK;L=3+=S?CT?)L;OGBY-[%
ML-*`!I$WDV=SU[\'7+F*8+V2[80/'JAF"+N(NBIAV:>.<CU#R`'?#&SD"A^=
M`"C,#X#:D"A!&OS*QP&](4*UZ@V0&'"H)&M,-C/_]@/)[/%'/X[""-Y'SD`R
M*A22<@8\`=:"ARZ?//-G<].[9^8<92Z2/'R)L[`+#\T1#"L(+/GBFA[!9,;1
MU!?-P!=E<:N?A#963`O,1?X!TA'8$@XH`1)8B&,&G#"VP6"__C#O<5B$:6"@
M2,8Y30\VT64SSBD\`9/0&')/]KM!L`N.9P7<!*W`$9J0I_H8J['">/PW'"/R
MS_7[B1ZOY@-[1MM`C+LUH'T8KL(9%GNFY\S\.,0XC0T[*N`U9\#]9RA.'@9H
M"ENLUB<.F/2XY34N[A?A`2I8\SA`C-A@,E*]3#D!:B)+6P%#9'YO-1<?`'5S
MZEA3$EK)"8WAF.,@AQ(*<7#W'L`>-D4U"I;UD5O"VRS1;]B`512JHR)JEF!%
MLMTKS^E&5&DB[+]+-.*$`GS<0Y#!.%:Z^L[`Z`]RN[,FGM=JD18!BK$)2/J-
MWS,NF;Z@.<_W3M0WH$*F"`1;L/[4#%RH&Q/I`$+*\S!8+SD:'#_Y`<'XW43>
M>-I@_S#OD>P-]L\XB-@_&NQW[H5<L)4_,)OT'W<F^^28WLV"LD$JMMH?M7NH
MG<`Y;[PX%7C$8Y.C$P%B7IX@=B$H[[-<P<O9!C0US8'?!GP&NXM/X]")^L9-
MP$A`,@`]")%S$TLC9RG,`&HYF\0N/"?AD5-$4R>P<Z])H')S:SU]/V(9Q4Q[
MH(+V0D0$S`/$M9'`K)BHP)],@,0`E;@+R"-0$.S)"7>BA-86I%F&EN,YH=L(
M8^0N,I"4D^)D9X*;"DI[@+212Y-5.0_XK2,8?H8L`/[9)K1,',UU>*QP32XF
M948&@;:&A>'6+BTYC($"5F[>%GN2UQW6I"_T%I<K%IDNF@2.$!;(K',4B/0\
MYA;`F_,4^%+LJN3>K`5.L@;X<I&L0:&%(D"L`'T3L'#E7/!`*Y]+Q1R?3*0&
M/IQ1K5;H`D\A_V-PEB9YC8J4'T)?P-C(C&+X\GX!CS>@'R6"5J'Z2KE%6N,J
M^MB5G#(*!-4=D%E%I-4QH.OU6NQR,#$JA$4(I`DX"1@[-1$3Y)'F8JCD4EX?
M`ITUC-V(?)'`L`*.2ICT&LW((3HSO^%G>#`*G'&<,'+B;;%E\3`4^(C6Q)VD
MIB(9MYI]-]@I?;_@@LHHN"/0;WM9_79JPGZ,.?>4ADPF<<&LH!9W\X9#^JJB
MNDW$X9;H6ABL+#6^E4%EW`<-I9*9KG\!SLY@=GB0_`GHS_1NX&^@'H4^60]`
MRB9=$U%%I>#X06K>)5Y]Z1!(2D8-WH?+AK`@V)0*%YP)&^#BN\/SRUT.H!-B
M=I\0HQ-J*I/;LCL>1Q_O.(T_!@/C:8R\7EDMQS*GUI6+QMN1\G-P@V2Y/(/Z
M4^@N%G?=<&YB"L#/KYJOZ+.\;4^?U=U\8,>O'KT7--TF=8&>7HAKW\'?@^K(
M6Q1/:`]A[RP?SQ)^'&ZXC]644M+Y(G7KSZEN?2R5*!X#?66JT'2Z64QN-8\(
ME<]3?_`>4/E)!>U*4')E&RF2X$][^^7GRK+L>K6J3K]P_K`B[\^NI_Q"#H:#
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M8FDGUL;X__@D@?KR^!+`65.&V]8:D(93$\<J'U:WAMK(T4B-XU&.CH`6=ZH9
M%5XWU^2HY50U:4.K<%6G#2VJ:D2.>S;BM1.KLLA_-$ZL8?WPOP9PUI3?MG4>
MEH93$\<J'U:OK>FBJG`>CVKT,"E6]`@UG+6#LZ:BXD3+B:K"J>6$IL,RX[=V
M'FGGT<;.HY'.@"JC(*HIMVWI#*@]P_GR154@U>11P(];-0QF'8W<.![UZ"AH
M<:^ZD:9%+:2J21A:AZL^=6A)52."K*>D>JH7ZUAZW._#Q[7QWM6`=EH[KYSR
MZ-TKE_1X+`&58!6C8T3EGM'=CUY68430JRC/*HZ2*)]4B+Y^.*"EY/&IF4?/
M`YY5Q]0\H$3+*-]A'"5!=HUF3VO*1TB5+U]HV:Q9P;YE\R+.U+*_Y<*BNB7L
M(%R<M%<5Z+=HWUQR\(NX"8#,;#\>N[Q\8G%U'Y/-5U)YQCAH/MF=^.@.P"7'
MYWI!7S90UP5IJ[W3E86^#IM_C-K]KBBK<L+K296--4&7$GRM15:0$+MMH_=$
M5YLFQ[*#K^6KEJ_U)>B<XTQ],(%1*T#&`?MQY0[(3ZM/V8*#Y4$YCWGM$5>1
MU*\#TPM-*W)\+V2.=^N[MX!?,#K`Q/RY_#X,8VZSR&=\-G?]>P[CF@%G83P#
M,&%$FYDAF_BNZ]^%[YY]C[9$M!S72:@3\9E9W'7#N6G!EOS\JOF*/DL2I,^2
M8`?-E&*W/H&-/<_]QT;52N%M?Y)66^VU(798/B(2_-C><*$/R<(R<\G+>#;F
M`?,GCV0%95[;U10X7[@'45\_O"_SVK:_%'[T5/T7QPFX74.B/KWE@7G#:[BR
M\^\\L)RPCDO[$C@69U]X4,.UD9310F;)VGR,LEP?O\SG.`HCT\,S86;$/EN1
MCWI6RV#MYA,N/&[AD2NQCE$A=W>=_-F=H3%J'\J?7;8SK1VI5(TC'L1376'J
M?%(R9YGI4FL%R7B_!:;WD%EVS#RM'*#6E,'T1D_N?E'=,]6DHDFE="%B+8M+
MX&[;LS0N)=E6"-2:<IC'5VZO[E%J&7Q`"BDEJ*7:U2?+PAUZZ*LF/,],#Q-L
MN,W\@/'O<R?8BQS=\BIO*8(@NU_<$^GCY8MG20JOYY7K-YV6T=R;$_V(.<I;
MS3[*R3XT\]@=\]B3CU^SC4VV4_L^5F4G7/%YQ"D/M-/$!(76GCW$VN333I&B
M#>GWC9&.4-2%5*K&%'6"@@Z*'+MBH!,4RH&21\E@.D_NS5/=(]64HBEE*U$\
MK"61:%&L\Q.J!6I-.8S.3]"@ZO2$2HO"(XX*B/2$?64GO'RA`XPZP%A&O-^'
MU*[@/>3=KTW3;Q7HMY0+J38I:8-\5=#\]]CC*EZ^YXN;V@VHC?2B#3EHFX.R
MG6GM2*5J_%#'RW6\//VPNZ*RAZ\N^G<<1L[DOIQH]-ECOYM>;`;WK"N4#8-%
M4\[._-G<].[9C0C9L[:ZW9W4@HU\-H\#:VJ&//O&_YBS^?O_-VRW!N]#9OFS
MF>\Q4406M!K38UP&'MB<JG;Y$_8:XTULS@,68K$K-O$#-G%N.;OG9D#SX&NR
MWBR@;#1EMQRV5"A*[=X/C)O6%![RX*4@Q*7@$`B3!UL.'^)`C-5@U_#EQ'0"
MI(289E?+N3-#9O.(!S/81YO%(8Z/8WQ`1?KDRIKZ+FSG9WJ<8<DQ?.`/W^:N
M@`F?%95O";(PC&=BZ'<,\,*!8[?9O<-=F[T^:9X8[-9WS<AQG>@>P6@-FHU^
M^P=8A<T")_S&)@$L-C`C&!2.C[4;S=8/#8'^/ZXFH<,B8RTHX#J#[0&WT(B"
M(VKUND9W-*+S>-WMC8Q1?XBUC04J`U[/N1>:A`O\._[-$Z2+IGAT^*('`#$@
M`,`.0&_'MT,&6`##Y[1[`Z8-Y]R*`'W=>T-,V3(ZP[;1[@[5QU%_9'2'G<?.
MTER<18VC2&GN![0:P$73=5-Z4_3AI_9)@VTB>#;X]-./<7AR8YKS=Q^=T'+]
M,`[XY\E99G._<B`2;I_Y8112*;P/P&[L+^;]#'`HO`9\^H"X\\O+%XS]I`:#
M`69.1$^<>O"NAPODGN7P,)TG>1<.TT/$_,HG/[\Z$W__9_3'^7\ZS1/8P1,\
MHE>_2.3.X'DE49X^WE']SG=CWU5U2"\_7Y^S?[`3=O;YCS\NKO\XO[R^8J>7
M'^'SY?7%Y6_GEV<7YU?+PG=!%&MFM$MFY'+`=2"\R00%)58?YRP&>`.4ASZ0
MNDF$2X\QQV-7D0]O?0A\_YO!+F&>?_O!-Z)S)T)1'`")HSR)0RE34*P";8``
M0A((?+IQ.;YG)@MAHQR8%F0_#C!3LAED(,P/8M2/3%?.',`8\$%RP?#1;)#=
M<1#^KSM]H]GK2Z[7',*';IYU[6QV8'8Y#BD!:+>,84^RW7X;3.#AXOS5P/;,
M#%L@\V;Z,]D-@+?-'W9)!\,'[(-UFOXF=ER)H%ZYAD<L;I?E:S?%93WGXV1%
ML>U:&I[QW(PJ/T.-Y/KNQJ/EV6BGD(+\CC0"&D3,],F)G!OZ:5MUK>3RK`*G
M_"MJ5?@D.BWP_P;H%&QFWK,Q'-B,R[XZH'N`NG9K@C(2A\PU[\(8-334.%Q^
M`]K,//`MSM'4"MG=U$'G1N`()0]U&S!1'0_=')8?!R%Y,<;HK^!AV&#_\._X
M+0\,YB:(P!RP6^/QWZ#!(&".-^6H-H$R:?$@,AW0`7DH[$Y0"4T;O2BH686Q
M&\DY<9:`^?!7`.N)@">&M"X!UV1QW?"*&=$#H#7.&#I@4@C/OUM\'C'RMX16
MX(Q1Z^2N?T>[A1X@*PX00/>>>3X\>(??H5T*ZFT8PVXL[Q+-!V_#.`XLG]TY
M8,-.S5LX`4`2=+_$8-7>XR+D)IHW-P$,$\$3)BX)5$,84RW>G$QPM]`>SL`.
M5C-L/!B2\"2HS+8C+.8@HXV+70L;.[>5#N^WW%]L0!`/_OW.`>W=L=Y7A[]^
MY#/?CEWZT6`7GM5@MPUV.I\#XMGLX^4IN[(<#I05BE\-Q@&%W09[<P9HZ+)3
M:K'%+OT&F-OM=ZW6B75[TFRV1_V3OW[_X^2/7]^^VQ_C/@91^]EC?P#C:0V+
MW-GHY0UY@"R8G+8FN?)<Y('(&$S%C=DX\&.`$\WA@A,W;^"-,,H.;<`?@8<L
M`)Y0MK9ML%-W$L!L?PKG-!C;@M'*KZ^Y-?5\U[^Y9U]Y"+PFP1N&GOD86%;A
M.B8.VNK`N'S")F"[L&TS)PSIJ61-#1B*C%<?C&,#V=EI?`.'QSIJT(+%R;%A
M-V;"4,X,5[07+K!C+EDP[!QN<>Q1US0`:QS@EJ!XFSE6X-\YP,JC=-'P!*#%
M-R`1.Q;2`\"_"WSO9A(#-[8B]'^`G)@`)*87P=[<37TYI>V2XR*D!$Q\-XPX
M,.9E$',AB2@P;0XX8`5<REPAU6!Y6'+*BF(A6H"C1_?T.XE,D`\3=`\`DN!B
ME$0`SH^.T]AS4(;"H4UH!:T!LV#'9J$"-9$ZBUMJB%`'2C@S!,S$6$LA=CF>
MY<8B.T0."<=MSA%2D%S*=9M;'6):Y$0!'OBMXXLM@6\M8D1?+\X^"UR<`Z82
M_D_PL#@Z3D6D1&&;E*JAU`34T@(1C?%C$/4@/A=>PCWS;(K?($:M1-:E+1$!
M(--QXX"+8T6OE2FF%2?FR4.[`2J%.59.?.O<^/!(")@B<$C,2"QX#U[L[1S/
M>:?UKZ83_`N#4NF3J7_[L3[JS9C_@XRZ@/4?TC%]`9+RU].+K^Q?IY_^/&=_
MG)]>_?GU')W43XF'[6$[GF72?;J@3=N?(T="J@%.<^N$(A8T8:=79VS8[IVT
MFDB-^08TPT;V9R`\9)79L*L9RA'1L2U4=S]VT0K`"!QW4#R331$"2R:6YQ%W
MC%#7GIL.\>0(&Y9.T!L.IHXY%I%4E.&HD:/.=B\>$=0.8T=WG'M*W,S-('(L
M9XY"!</(",^,FTAV2+_,!I[38']-X0T5%58!X<Q",F\(US-!*4TY"100/ZSJ
MOS%)*80?!XLB(;+$BD7,$:!(A\Z+>Q1SCHU&E]PW#T%W<;B9#]P=S!98B'G#
MT:"4*X2M$+:CH[97;0>!EPZ9"54KNVUYB\0(&#JXPSV9R_@WL5-U,LDQ&,),
M,\/4UL28MI&>&3"W"(:0`BD)>@-B>;X'.X1!![QED<,D>`?4"B><8M?9[#%,
M'3"_`FMZ+^"7NQUF`ARD9WQW9H#K!',LS&9_C,H@Z2J.-X_ER>%9+SX9>\O/
MTDX(%,"]2`%:";6(2K@@2UVB(CE08BV/:3["#(E:F5'?E8S;'28IJ-IK^H1'
MS5H@P/XW]I'FB>>%Q*<HGB2)37`/3!(!DD,_A.`C&:)"]5(C0.76)!"@#0CP
M>8E_"!T6B-]C"D\D>BCV^=\<TB"*A,"97#,H1I#W"R\X7H)>9.V"51%C--E!
MCGSKN_&,"X_8!%DF?AEENX"_<='"R>/IV_="Z-C</0'I0:(:N9.I&H<KAZ7K
MYJ+(BKVB)R_="!@*?D6VI\9*9!N(;U(!\!$_"/RQ,*C1(,\,H(Q',S+%]L1C
MS%*)'!J`I'4,D*``)_-(B:O#D%:-M$*!H!W`XS\+)*$TW!-$`.D%=J$M;7R4
M;M0E/H,/\HVLR@7GDT_-TTRP)FNZ%H<-TQ&/07Q(4<4)V1B3NM".(+X2"IZ4
M:D:(.\2*\IQC0243^$3\0"C/2F]/G",9[$I4Q)D/@_\=VS?"ZW'A,1D3`<84
MHB\.1Y+`K%;-2'F;(,]S/')O3"9"[4U5O07+(5%9:4[B]W)"9&-VX@/`'-NY
MGT!"XZG%%FK`R.@3+KS:7,%ME[.0L\^F+]+\U^1(:%;_#K389'+8#.GM"XMH
MNGC"LM%M+0CKS[GO"2-=HGAJ=Q"^H(<.U`C/9U8\(Y\H2'(N8ENFC;`1+LB#
M&W-8AB>B6$@"@`#<))^VL(M@&`?L41$7(]O(,V/;B<AYAYL5BK_HPB$)ZS1<
M1DX\LI,;E3O])Z=/91*/]GB_XBGI4VKBN7G#3\8!-[^=F!-@!N],]\Z\#XM3
MI]:FS"R]\;@DKN*MV_D]K-TE<56-A92!&@^7?U7]G9,[HI>DEW0L2RJ_AE!;
MLQ^#0989!/>H%2:&^<KK?F8X%<$%_`--+'B%4]C>M"P_QD"""/"@S9;Y<F[>
MBV_"J1]$)^2N&:/7YXZ4SS=I\!O4RULPT!RT^3P_XLF[;XU,,%\FD*T*QU#8
M_+LSH]MUJ;4RYI8IW?TPBA-DH8%GX\")P%P[!2M/S)*[)9%HNF+.;*I8;FK/
M?OF"MH:B56$4Q")ZE-]6LGFY0]-@@`@F^C\1/DJ--FD%/JAP@WI_PVDD<@*J
M=`<*L9#=$'"P[.15#UCH-XJXP;=FZ(L\#EQ2&"9.FCA"PY3.>`*F86B(_`@T
M$>F""85R"`T"#N8!?:98&IJS`?H3+7':>6N1]F!Q'VF<XJW$]#XXLTR$3EJR
MR1:]%XN]<T3RBPO;>FLZKG08I!N`N1[PMK"$LE8UV$YB`C6BMF+WP&1.H\4+
MD=)TQ7_0Z*2PR`3SZPI=@LK-L!!"12L5T1B9`:+TV`R=!ZS/58D=:Y,S\GD<
MGQR@;<#Z^QU>-:S.@:Y+X_B=G;#?/E]<_H:W"L_.OUYJ6MJ/P$:Q2E($L?Y1
M/IH,;YT'?&X&PA=HLAM?"F&+!YZ@*$/Z&@FW,84K$HEB*$!<Y_\2[VN&G^.O
M>+\WG,CD#/@Y2\]2LGG(H-W"+/?3$(7SG9?DU3UYR<92U:5\"@;*`A-V_T8X
MT>[\@.2D9<XQA9GJ&'0;?08GY5+B(:@LJ(38]%+$@!.DEQ.7KB06WH?$(?N-
MEAJ2=HZ@P-BQ].?!2YA?8SDDF5^W>H-&5[U`67&8G0^;[`>X0)CR1HA$^(0N
M:\R-MU!DDSLWERB+"?1CGLGDM"B=363O+"("I;YD-0:Y+%1J`&O+)C7K89`=
M+`TLI^/S[TX887Z["!C,.2V%Q>B)AL%,D3^:>T4E9V%D!$,(_AR3R29.)"(Y
MXNX$T&>#_9$,($:_]>E213ZJBV$6S)T!9L(G@'DB_BA'QL<Q"1\;CME(4V/'
MS^0;AZ@-("S`#.(D9(V(_Z=''.,J(OZ%M'8>8Q:P8EBD\5*H&C023)D*,#]I
MB7#R>R7!4\04QI8%[(M2FX4_/1U(#GX#S,53"4'%NRFC\S1H>DFG<$>99#CP
MF%ROVCE7J2GX(KPTDTFT.Y`=MD_7=H3-QIG((U2Q!I7LA`BMH`=.3NEIN8SC
MS3C/X]2Y=3H::7,YC>X*L$^D1YS?YJI.Z,H14K/[)TLPM/6>7?WYX>K\?_\\
MO[QFY__"2A+/FEM1ZDT]].6E*],E12I;E^G!T]&'M5@P"Z_EM'I%6J**IV,>
MTRTJ5C"7E:2WB#H<Z=;+FRFM?O-]^E?N*@.(!^G4`*9KLU:S9[3[':/5&XJ"
M'.0S.1-#7B55MM+"7+DB6]U!+U-F"^MJ6<)#0\XD+`0$:B+I<C<!JJOR@B7-
M\;JG"H`];ZI4!3#D%.3:#2I)J/V/`_\;;+D-MA#'LF;!#`4X>3+H:FF*'R#K
MX5]RT<ER(RHNOX1+(D_%]SPNS*>D_MC2DWGLI-3YQ1D1(0'/2%U0WC/AE557
M9%'>OF[W>^+T"U#V`I,0Q&U8,>'B'+(&C<W19<IA"\FU(['[S@P"D6,N;N2%
MH,EY)UBP3>3M90O-H>VC+NZF\P-^#HS>8&B,NBOI0@R^JOY<CC1V4&:M3K=U
MJR/>SJEHF<2[@`M]5,NWQ\FW5H%\RQDB'WPS(!/_HQ-P<C&(P,JMO#"$Q$MT
MR--C0>%"U1KAZ]]-!.>TP?YAW@,/L%?/=#9U^(2=?P?CC9POGZDD5B`B/O^,
M@XC]H\%^1_O$>VB07Q.+10Y2S-#(_ES`CUWO-!JTF.HL+EB!W,;G>1$*)P8D
MA6!)6J/T#D$I0+]0F(VJ@/"8X#56>3LGE.=0N$PMR=>?4(&4G0)>%)V1P3X&
M"293TIVJG%I4+[7;3+QZJ;A:B;B+ZMV2$$N5.K!3`;6EWF#>\@#DKQI[[`A-
MT@R_I5<$-IU79OQ]AB'E9=L8<9&]^7Q]]I9]B%V7`\HIGB`>1A\!3D`[T5BI
M[,KL1<)Q5$(1H44AU?`=E7>5P]$P-*@@_,Z@(7Y4#"6I^!K=^9ERL$ZZS.P0
MF8HHF:-;*%]+C@>\5)>>>3'#F&1JB(+Z$LOK&N*N?HA7>N!D@H@BKU9`I>O&
M]R+[F"Z`O$[]O/XM#Y0V1Z5PLZ\3?_-RE3MIFW,5;\7.X%T.:\H3Y@':/G<Y
MW:(H7(-L":B\=9G:N&KP9;158R?54+!T[ES9-Z)<H)0*PDFNR@HHDV@5\K6;
MS1Y>WL?('W!\@81?7!.=C#;M'=7F719!<GLE^RM:9Z)`BK3GI#P,<YT9:JD2
MW7)Z))ULCB!0>25^*THRXAL(WH,FG>F&?L(;6KW'\H$\UFZ?4_O<E;XJ5Y(P
M/<UMZ@8L`+UM>JWZ<YX9>;[-`3\Q&7?;/*QJR/345LW*;!+E=+\CN?@<)?=*
MEMTY:>TJ<^S?"EZBY#LZ:HQ>NV]T6OUM"5L4'G\M>U53NA15PJ(KWI8`,#/0
M@_P&(X;[5F21I:7;1V8]V/$@#(05#VHY"C**O8@(0BZ%"^2'*:K$J"PB\F$%
M4GOH_D#Z#<CS>)8Y#GD#WIRA(D)F?+NG_5,[UVK_")1E]:!2VSI"I;:\.FUZ
M<,>BTCX_V6L?7/3^K/$KQO$QH5)$!?$_P*0&.U5<17OD'N>1*ZP$EW<)L=]]
MK*#U421#$#,_39FY"-J;Q#H6:J^C%%AY=*J2H:D\^(&HDV)Z,287@50/R+:S
M?-Q'B]W$3F1BCA$6><$$;N(;2[]2V1?1X$%^247`?(]\7L35*5_")W;W1O&Q
M=O.]`#+YHO7^;8/]F=AAB>.1Y$5&EHFEJ0RT7*K3W[AO5":,=L[`W&5E(H+]
MBJ5(X90HD\3Y;RPS1+YY_MW)U+^C];DFEDFC8D7P2HP\#5URQ,^2)<MEJGW9
M;@>$:HC9+4D:"]UW!JM70&LKNWB=<ICN4V9K2-R@WGN/,I>8JRD.F2H440%!
M4MA4.P',O4N*[HMZ0F&:Q6YG\$\F@J<EZJ9\U3Z6*O"R2,;[SPJK`"^Z2A4,
M=4^>4SG?G)\H*5J8PS)10<Q6:D0F1Q"&<`&Y;Q&CLV3^)7GB/'TB2_7X4^A\
M9V_Z;T4^99BYQ+S0WZ&%]9H"#A2R@@\0H)2ZA$4'N>L:V'L#H[9HO)AX88&8
MK62UZHU9$K;%KZ*I$]B2DM1VR`L3H4B^,$21X4A<2@B2D@7P-@&H;)P[/W!M
M^GJ1.:&9I0@HSWI6\)EM62VMIHC/K-1WTYT@8S`Y:8IKR/T6C"4Q%PKYF,($
MKLJ_9`_(%G6V1$4"[T8('<7PU=^)N%.Y;X5(I#E-V3G-]<*Y9FG-==.<0+#8
M'%?8%HAF*%&(CI/$S+6R*)5#@"W%XES2%#ZP(+U7D@D&#ZF<*4>C+/:H>(F\
MS258@ZI,(E/ET\4!>[H!#!6][;#%380,#OEBO_D6%+A[F#;`\H$><BJJGRCL
M8C\=77N#M3>X#-[@!XRS!TYSL[?W7#-@\_(/M6"ZAW,38.8U^RTPYU/'"K5K
MX(FN@0T\`U[6W,L[`F"`0=8/D#\;9?I+G8Z4+DQ/=$P7;P^8UC?S!N555G'_
M^%O.-G^ZLK774]#Z%HSWL/ODXV]"]5JOP2]I[:+*L9-IBB`PTO+)-R*LP11A
MR$L-N&;'5E1L;YS*\!U>!DJA&J_N0IP8%9C;"KK;.(Y$'YA+/P!T/\7B]9:)
M*_Y#+4)9;KXKJ@Z`6D4:XP1+'6/T*<*51WX@+_)X)\638&I"X2YA(>B`AU3B
M+>1>Z%":`RF=8=:7E?'>93?5P6)X+O;WD2%+09RK)XOGE/#-)LYWI/PD:J9.
M(5]"/ZG";>(-2P<O7K$)*-64VD%\)2G^G,(GB\BAVRMR!5C(=3POEF^K72T"
MTD!N=`=&-T5*>";6D'6E86B)![<4Y)%+WLCG=4U%_,0ZBHT*1Q5G%DVG<2V$
M5C"[CU4"++IZ%G"D(E%HE.QE/#0PHNDMU5XRT?A7L[U=$^^VML6#)D1J?>!=
M530_1LK\$"$<^0JV5%!&.'D^<".*J18U7%E-,3V(Y3NV=%V-;H?A%&HIS)D@
MI=L^[H6/M<G%H:?8M9'1DU?=-ZU!5A46_L!X#ZEDG:N+YU#$Q$RJOU$M9.GG
MI,_.:(.0S55,S:."59&:?,L>]@:'RNA:RZ]G=2]#J'1XME>*Y5[=AQ&?A6E4
M)Q?(H<M&V`HG2&[M(Z^-9+Y`>H-6C))6"G4\4?4EG/G?.%X(%2T3,GS]MR]7
MV>8_68T1`,RKC$7IRLE?GV6*GCGC,O*=<P"A"W)ADS\!G\,F[8_;XZ6W<[!J
MBGBL=EF$^HBJRWJFTF6RCFRE)2Z&!O'!7)1@8YTT&3%<CG.(+DGYR21>V.R+
M^#$?F[CSA':"*UK$J"]RI@>1_DL<A'&FNFX!(N/X*C''1&4TU46=(."WOK@8
MX,HW\PEDHC7&-R`AJOF!V;4&5CHVL-8KZ,<J"")C(@E[$+[U=7KZEF<.&EBN
M-4IR_-F)EH]RN??D/+-CR2#4$F9U_&+APJ325)-IDX03;!]'UUBHG#XIN+@<
ML<,2?5AH3;D=N^DX"V#(Z#E=<Q=7XU7#FY4+V6`;MSF$`BQ:"H7)7,C[K!$`
M'Q-'>N#?FRXQ7'@.3S!7,]J+9V,A0I)-Q"NL4AY1P>MT@#&791X4T66*$Z_=
MA:5U:&:\>6AE#2XEP=&E#5X9?N'?YTZ0B_(O<L<T%&(&-%VBWMN9+/H<9/(F
M++7(2ZY#[8+;+)D:SFS&;0=@<3,6E#!XBZVEM-V<6#[6AF!+=72PCUV8*6(A
MFM'-L,^=20TGJ=E0/,O0BW)"K!)26<9$$60"LM-<%QW:+"'D(191C8VC/4E>
M)UF5V5)<`R6Q)/M*30@6-U;F*"CA3_R8@C225Q$CYP]<O-C\4UJ;9&6UD5^0
M^S#VDSFWO7>_(D/FG]!'(XGK`O;%N\$<G5,JM'4)8NI[Z+SS'!<X4Q#S5X7E
M2D[#_WR>8,&2*S['@B7-5PR;6=(S?UY]?/7C+_N<-*F24CBIS9UWUX&)'KBK
M^]G8=S<KN(*P_O3CTLM;+>0T+;!U.@-A+^N8G7KV7X#3_/,$FY):S@Q,C9]?
M-1^WM;]TNNW>X*<?=P;2\ZUPQ3GN<X4BD9ORN"^HCL"%=\6CR"56]7ERH>X2
M/+B(//XL'5*KV1Z,NG(-&TX*8/[TX_<Q"+EW^"]\_/]02P,$%`````@`!XL*
M/[=7H`5;!P``MF0``!4`'`!A<&1N+3(P,3$P-C,P7V-A;"YX;6Q55`D``_[V
M0D[^]D).=7@+``$$)0X```0Y`0``[5U?;^(X$'\_Z;X#8I\IL#V==JOV5FWI
MGI!Z6T2[JWM;F60HUB8V9SL4[M/?./QI((GCE';CP#VU#1Y[9GXSXYF)3<\_
MS<.@,0,A*6<7S>Y)I]D`YG&?LL>+YM>'SZT/S4]__/K+>4#9CQ&1T,#Q3)[-
M);UH3I2:GK7;3T]/)T^G)UP\MM]W.MWVWW_=WGL3"$F+,JD(\Z#9P/%G,GYX
MRSVBXL42Y/.1"-83G+8W:^6.T'^UUL-:^E&K^[YUVCV92[^Y9-%B_N9:&/T@
M2YSNQX\?V_&G3=1!HW$N>`!#&#?TSZ_#_A8-\1F1)QX/V_K3]KTB"D)@ZF[\
MF3+4`B7!@$NJ9;\.B)1T3$$SJZ<_4XLI7#0E#:<!K)]-!(POFF3J,Y2PV^W\
M?MK1\KVSG+F]#\M]M($0]N1N-<E>C%P3.?D<\"?99SX5X*D]>4K/MV+/(X$7
M!;%IWN)<6ZO`7`'SG]'23+X"]O'"N'3`O:WE`NTB7&Q+M5HMMN0QD:/80"/9
M>B1DVM;2MB%0<OTDEK_5Z:Y\XMWJ\?=+*4')ZT@(Y&Z]0$!&$,3+?L\>UZZ`
M4PV4@<'XXPU?"?`NQ3:+1'CK:?#7%'+;D6$UHBVC,(QG:U$$<DT_%CPTJ6F]
M+L]@M1%)7)A/]:0D:#:X\$%<--]W=,1]`OHX41A^*]'TI>?QB"DY!`_HC(P"
M^`+*PD1,9/5`QBQY-F*_.8#80,"44/]F/@4FH1BJ[/'UP"A'UFQP?L\$Y[R]
M$]R/+^(7AOIJ(L]^NU&U=IL;5+:%<C?N#P2?@E"+04"8NF3^S3\1G6H;QB!H
M#"8&,L>Q,8OL;L#OP50'DT)?WA[G.!@[0I6)Z#];^V-`;_:7D1VNN53R"V?>
MTL7-WE),ZSQ*A<)G(_=A+^3219Q^\AVY0&%NZ0S\`>ZXF+OUF2+LD6+NMI0C
M&XX2Q([B44;\;$"Z'0=\*2&!'7*6A(ZB9BMV#F+9:<)1Y[.WE(QH@(R`1>*8
M,;C*"GM`%KK(Q,0#GX@(_%+"E)FE<G?(ERRO"+=2CKO9="^"!WXW'E,/A+P3
M]XI[/R8\0/XLH+4@KA&B-JIP-]>^YFR&-8(.T%^X@K5=%H-80%@C`(M4\'_S
MQ=*6DJ:O:TVUZ#,OB/3;M0$7L04H)>@H4EJ_#UPGUIPIE`I9><1,`01(D\V]
MT@(5-3&7E44LPS<21&`0-&MTY1[UNO!F=#[3"G)W`[SF8<B9%9BIH0>.9%HU
M[FY_E[Y/EVP-",5BY9I,J2)!0@13BEI,?.!0VZC/W4[7$!2A#/P;(A@**S$3
MCT(-$O@]P'R.FO8B"^(#!]]&?66:94>=.R725:P)T\#9E?W9I%7XUJLU+ARH
M'XR`['I%O>KX9,$SA-AW!T1HYI^[W@;@K,AK"Z6=<MQ-;O0V3)4.=UIN+',5
MAFG`H`>FMVHFJMI":52%NQE*[2KJNMG%:RG8W3QG=2RU`N.]FX(@VL]6IYE,
M02<]MA)W@QC6/X$A-X'NS?LA950JS=L,5KR9W,EN@LK=)1>:E']8:L3=#&<(
M$E`]$^2]!S,(>'P"IAA*,UU]$"R0W]WLI0=3`5B@Q:I%PPMU//XW_M-\)BB7
MJCZ@&65W]WV$`WO-DH5;+JUVF\3H2O8;$H`<HE>R",SG079'NF/*:86G]I!=
M*=W=+%XI9:D!*!F2VFP%K6,++,^:_(SJ7A:.$:IMI3_.Y!6,N8#EN`<R!WDS
MQ^P(M4<9$8L^BB!+EV5ON6JE?K5_>*[*MWZ"(>3Z:%)K#@=/-0&!$F+F$@FQ
M8;LXU2X@/$KH"W19*E;_[(BY%*T8]]V1QPAT2ELVV?W1[<(#P<=4%6P;B4'5
MV/W!9@I5^6,:]K3[O*'2W=UJ-^*LPL85,!@;CROD4=0&XPQA'2Y8TE^\4,7+
M75":#]3PC*(85XNO4E_(V*25EYZBL_B=B>D5K_TD%5WK?-G.4)6]EP<EXUKG
M1F1W0U2RA8F_!_#R/FXN^0&`::>FM^C2Y]PY_(9;'_AW\5JR+V4$_O/UAEX<
MR[C0+UEOPFG`%Y`9/%XZ4XT!?;'RW#U]D+3!S8$Y]AA?BC4=BS61U1AA.[6\
MQ?7@MX"S!R/5HS*^C380$-(HM,8TB_;@@,U4D,-WC>\G1,`50:&O>:@3Y:(M
M-H?@`(#,4T6I>\=[[J.),_#+C:#/[D&I8--+R2WM2Y'7&*UR:LK!SH63"EB@
M"D!KZ\'R9Y^EOVK+7)H7D]<8YW)JRL$YIP%:-="K[^M:?VW(JD.!"5[<P"_\
M!IL73GB0QF"GRASS^."F>=C<]G]19#!.>)#F8:?*O'Z(`X>C7&X);HJ8?5J"
M69-4U!+T`/SXC<`08\HB/O9_-TY<X5CHY-[<,+2;PE57,P":T4ZT5)>[S<:D
M#(FO<RB!\B[5@0&;4DJ9CN(1QDG-A+XHA#_TM9`9";13#$!0[N_N308+*S5-
M)??_JGI%5)5;O038U+W`$DIS-V;F2-''0"'WA3YKDD.&/E-I[EZMJ"P+/$#H
M,Y6V[Q6-\\U_[<`__@-02P,$%`````@`!XL*/Z#WMIJ/"P``O*0``!4`'`!A
M<&1N+3(P,3$P-C,P7V1E9BYX;6Q55`D``_[V0D[^]D).=7@+``$$)0X```0Y
M`0``[5UM<^(X$OY^5?<?4NQGA@`[LS.I9+>8D&Q1E0M4DMG;;RYA-Z!;6^(D
MF23WZT^RS;M?9+"1LL6G$)#D?OJ16E*WW+K^[2WP+Q;`.*;DIM'^=-FX`.)2
M#Y/I3>/'RWWS:^.W7__YCVL?D[_&B,.%+$_XU1O'-XV9$/.K5NOU]?73:_<3
M9=-6Y_*RW?KS7P_/[@P"U,2$"T1<:%S(\E<\^O*!NDA$#]NH_C9F_K*!;FOU
MK,P2ZK_FLEA3?=5L=YK=]J<W[C5B$37:;RS!R%\]L:JP6?AS*_YQ553534/>
M_O;M6ROZM2'5=7%QS:@/3S"Y4']_/`VVZB"/(/[)I4%+_=IZ%DA``$0,)_>8
M2(5AY(\HQTI-MS[B'$\P*%RJ^2OQ/H>;!L?!W(?E=S,&DYL&FGM$*J/=OOS2
MO52J^$FSY=8Q(@]D=PG@2.F21HX2Y!;QV;U/7_F`>)B!*XZ4:;^]1#S$W*6$
MR<=-(5?=!Q/1\G#02LJTD.\72Y31:9?]4/7USY&@JK7CY)&?@:AQW_1@@D)?
M0U_:TNVW79FL-$"8U"-JW/21DD:--`,(QL"J%'.KW>-DG$EQF!N.H;D"7Z&D
M::T?)R^AHE?IX$D:3*227123R"8^R+:VG@)O`HBW-KY*G`I,>?1<^62?NEN/
M\]7D2%DJJ@C1!/%Q!"ODS2E"\Y8R7BWP!5]^$YFSYF4[F0U_2KYV5I))C#"0
M'_GR*3X:@Q\]V\DN[%PFVC(D]0L:K]G.DS@JZ+37TJ[9[;%MN67W6K:8]+12
M1GS":*"AMN4C:8'`%R&7SZ=S)2F2#Z',`W;3N%1+LKC_7KF4"-DC[_RHHAP#
M,%4?UK_[E(-WTQ`L!+-T/;M`$,.T]X:U^MEF>:=3%WDY=B^'S!5!!43N8,CA
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M2`/KQ9$PN*5<\$=*W-CJYANRPKI.NSX73#UD:0"RS;`-B$!DBN62,L8IQ;Q[
M<_U0'0_ZG5+O%?N^AL4KTXS3-NT=T#6%95%5M\38/[:BOG'NE:[@`2_`&R$A
M>Q5/$3&%)OW*3MNTGZ"TTK>Y*P?5,GNZ(;<>L7H5G;9I3\21I.K#M,V^%JY/
MEG.['2X)7?><DC=#U3^;4O4#1F/L2[T!ESN*R+T^H[Z4B:O=A7C7F,9TFW`Z
MIIT391S<95#9MLS?D%W?`9Y=R>F8=F.4(J.0SQ1XEDUI2]_E"+TKQZ7$++]A
M(7C[*#2\N1JM.!W33I`"?O)]O)H(+6.Y'\(+'4XFV)4=><@VNW4QN<65G8YI
M[\E!G.H!LVW)<DO)`IA02ZM'*F#9(XMYS*_H=$S[7@[BL!B4_5-FJ:G2Z9AV
MNQS$4SH0VYS^#Y1,7X`%?1B+M6](9TF36]'IF':I5+&L*81HFZ7<-`A/X,L5
MN3="3.E@+7\.ISK5G8YI?XP&+>E\ZL*S;"ES2X,`"[6U4CU9FG^!R12(*^7.
MG?LR:SD=T]Z7"@9G`3[;YL!]C`.2N)M&E$7J%X+A<2A4[WRAJD=*3%*I4I3I
M@`A@P'7L<K4/<CJFW4`5=)7J56+;+#YB2:@G@OH'\L.\%Y=22CM=\_ZCRDG*
MBO2GHK?0Z%.B1>=N4:=KVJ5T,B[3H-NV)NMY'HYE&2'L#<@MFF.!_`W1\]Q,
MA96=KFGOTLG8UE.&;3/_$PBI1?#N$",2+^^Y;AB$T>JS+^ER<=YL7ES9Z9KV
M1)V,?SUEV#8W5Z.>VE=\3M>T-^QD_:@ZA7VTB.,1D4:G:Y$7KH)`52;(8DZO
M6]OI&^I,Z9!DJ3EG;SAG;SAG;SAG;S@E->?L#>?L#=:\S?SWS=Z`?.!/L``2
M0OZ1RIV2]65JJ.'$U[[LMKEIAM+2(Q5#2-Z7TWJM)JM.C;D:JN<F#X5MSI1G
MB/9@OP.1,OOJ3)(72.TJ>05>0((@;Q!I-6`\74`N)QE#3!>990;P"3A([<RD
MQ'UI('P:O797S&1N/>/)!0X@L`B0;1:S#W,F)]DHM:[J;H'RG?PO^C?O;%UV
M+>/I"0X@+1^.;>9S#V"9R<UXDH(#Z$D#89N#>"5C[.MYH%R+EG5I\YD)CF%F
M&X=M'M7HC<M'2N0@#QE;B5L\/>57-)^]X!#*"B%EL/?9X,NDD:^^F*Z=DN83
M%Y19P:<(;YN16X_R>PDU/JX5RBZ4=$-*^'>84`9QN1?T!OSN3?9'*3>66_KW
M2`.E0V,U/M5\_H1R/:161=AFM5<PDA'Q76Z*)KF!]HP:YO,SE&<Y%81MEGG$
MJ)2L8*VS+F0^]4(9'K;ESE#]%U.J7QZ?&`%[GB$&WQ''KMIT8C\4ZR!E"A\%
M-<WG42A#D@:8#.9^J2Q]PK\!3V?R8;V%-,-3>`P5O.$DDH</0Z'NLE''$G9D
M&Y*TI<R1+9I/M*##7@4@,UC]:B;`OW_ERSG6?X[UGV/]YUC_QPT@GV/]'X:J
M<ZS_A-RI)+ERNI?;@P66JX7O[S^XRANT<L7U7($7\>G$XN!S^<8^U(F!@^#9
M%B(KN\LUO<D]3.F%FV#K+GSH>?\)>?SRZ`M]`KET<G&4PWKM)WNAU0W5.AYG
M_(A"E7VE)@799@XV@\7RLP^'A\ZSJAL_^%`7E<7A]QR55&9^,OPX?P!7_H6H
M?3[@/`1OG6>G'VWK*5.O'-P%<Y^^0VK@_<"6C)^:.`WCAVO'-BNPV3=7=W:2
M:92>-V\2R:EF_&C&:4=]@2IL.W6S+:Y*6]+'/$JN-F(0X##09CVEKOG#'R:Y
MSU"(;='O98`!O%L:J-!<T52?7L'\J9'3<IVMA>H"SADS^L9+Y?$\,R#/((2_
M>BTO\^Q!F>KFCYF<</(NH1/;HM52&0QD/^Q#_'<#?I*$0"LEO6XCYL^6G':<
ME].,;?'T?>GWK\<JU2WVJYL_AE*2(EV>TZ%:YBW:%SNY6FMYP49RW$;N.S8N
MZ"A%N4Z#YL_`U-0)=,';MI'+[LYY.9,/,@5Y#9H_=E.S<2@";]M^3]\S6DEX
MQ_S!G2I=P>5P?Q#J!V0A5[9'4I_2B/E[5"H(Z67@^B#4KKQ/501O<QHS?R%+
M!507X+/-;2/%=P&\Z,S\DURCO$<;HN%D(WGPN_)`Y0=WM9HP?X'+@91E!G^U
M85NVVM\4?2/7?@F>=VJ9O^*E-FI3D-JV2-?'7HFY-G_92Z5DEP-NVY2M1%?)
MP>4?E=]M@7QEA4;`,/5VMQLY[)=IQOS%,&6FZ;+(;'O/*UW^GNRSC+W+[EF8
M.EFGOOE[8HZG-`62;3[VYW`^CV,!R%^^%#$@$\J".+F"1NI[O1;,WR=3ZE4`
M?5#V.<;CB([*UISK]5H7,W]O3!E]9SFRMO%8MK[=>,6WD)BMDN9O?JF"FSU(
MMBU8E\#4V];RX]H[0KR499<Z_.!3'C+0,)#'-FW^XICC>T`5.JANG9OU7JB<
MK)&Z)#J*D]]35GA*3*>:^<M<*E%^RM$"#>"666&U78YWS^KEF&0?K;96$FBH
M^G<O4+&/=LYHUFW"_-TN-=!^B!**+7W*B[_7+?7<L=P`R7_^#U!+`P04````
M"``'BPH_?4OFS]4M```'F0(`%0`<`&%P9&XM,C`Q,3`V,S!?;&%B+GAM;%54
M"0`#_O9"3O[V0DYU>`L``00E#@``!#D!``#M7>EOX\B5_[[`_@^%W@!Q`_*T
MNWNFC]ED%[(MSVKCMK26>K*#8!'09,EF0I$*27E:^>NW#IXB60>KR"HY^3`8
MV\VJ=_W>J^O5J]_]Y[=M`)YAG/A1^/M7;[^[>`5@Z$:>'S[^_M77]<WYIU?_
M^1__^B^_"_SPKP].`@'Z/DQ^_);XOW_UE*:[']^\^?777[_[]?UW4?SXYMW%
MQ=LW__OE=N4^P:US[H=)ZH0N?`70]S\FY(^WD>NDA%BE^;>'.,@[>/^FH-7Y
M!?[M//_L'/_I_.V[\_=OO_N6>*\HBP+]O\J%P7]H$^?MY\^?WY!_?85T`,#O
MXBB`]W`#\/^_WL^+-J3_??)FGYP_.L[N#?[W-X'S`(,W(7QT4HBYPOW\F!YV
M\/>O$G^["V#^MZ<8;MK9#>*8]I7U@D7]=(ZDI:+^6][Y&S9[QRKX7.OT%O.I
MC[_/V!1O/U3YHQ24F%S"V(^\63@"MT>D-+"]2ITX'8OQ"C$EUM=1Z@3#,UTA
MH\3N'1Q!PP41-<VB<`M'T&Q)IB^[FE2:-CFLZY&$REO47XT2_);"T"MC)^Z-
M$=9IT"V"->XV<FL=!GCLB>(Z[\[."Q%_;]]>?'A_0;C#?_GS=>3NMS!,IR$*
M!:F?'N;A)HJW9.R:/B1I[+AIWA%AGW3_9_&V;PHN<>L:GS%,HGWLPN/^G0>)
M_F64EEEY&R!2>."'X?G7U:O_R.D`)_0`I00JI,"?<F+_]SO:1TVD:5S7OA.[
M.5/H1PY?V1=OW`C-'W;I>5`%XB:.MK+JSEF)9/5HD9W0/.TA*D.'/G.)^$EU
MJI-`][O'Z/F-!_TWV'7P#\2'SB_>YG,3]*<_4R;NX:./"8?IG;-M*`M9L?/3
M?KKG459QB4RM9<<`]VP*_CQ)<[1;J&`.EL7T/"QNKY`OQ4XP1V/0MS_``Q.X
MQ]^J*K:#M@;H9CT#TC5`?9L';X>P3?1:I&4Q_'*5/12"U[&#U_"KP_8A"CJ0
M6_^FORY;::D@->L0T!Y-XK-5M"HNC>N0@T.V*@>.G_LX1OB_A[LH3K%PJ9/N
M$W88;6^B[.=,3G0$54H`%!0`)6%!;&6*WA)B;;6`8,`5-,2PR/\Y"O9AZL2'
M&S]`JW`FY(^_5=5T!VT-("]Z!K1K\^#ND+6):HN4+(9CGJZ'PF_F/S=^XCK!
M+]")9Z%W[:1=J[;.S_LKF,>!"I#SZ$`[![AWM%#V`.[?))IY,E<!;:G*.;"6
MT?RPL9GXTQ4B^QC%[#5=_4O5D-%*5T-4)OV"O&/S,;E5SF9$MD2Y8M&8K>.!
M9]'1=AN%JS1R_[IZ<I`V%OL4'ZOB:3U[+LUJJ#R?$^!*Q[R:D`&$S@102J!"
MRCS<1131,LL^!=L(SK@E3324M^2[WVO4;8=?U#[IK^4V2EJ.67"')A'=)E@5
MNX;U)WK\T:;&H5%7)`TP)LOMWZKKL96V%D#2GJV8(C.%;0.I-5H6A2U'V4,A
M>(J(>YB!F\#IFE#4O^FORU9:*D@M.@2X1Y/X;!6MBDOC.N3@D*W*H>-GN?:\
M07_IVC'K^EK=NSOH:XFBU34OZ=V&.-HA<%LDM4K;HM&4J_1Q$$V#NCBFJ]_K
MTG,+#SIQG8U;EB&[1>AN;%ND=4E\LY0OB_"-DSP0;O(T9@)S&*1%8O,QWK,_
M_QF?L4#,UF)SXX=.Z/I(_BCQ.<ER4LW[V:4/ARK.4=`!BPTH*(&<E`4I<WTT
MDGO."1N,XU>EW2))NQGPLK7S$+0M,CL^U&2(&E4]/O(GTJ<]KE`3L1/T9K4J
M#.0.Y1K`ZZT?PCGZL6T*Q/A8DX8;U#5A%_<+2,?V`+@A:R>([5"S.)@9VAX/
MT=,D@6DB,*,Y^E!-Q>U4E;9-2(\634;:13P&KR5:Y6VDK%:S]<HT2+,#=V&L
M'G^O0[D=/*@C=U+D>=D&X0Z1VY%LF<X%4S@<0N='<P"_<I(G!I[)/ZNILDI!
M*=\(]6,:EU59CF%H0%4\D*'NR/TE%_\`_[;WGYT`H:YU9VEH7G?-V[MM_$[`
M)7STPQ!GFUXZ`;[Q;H[;RA7I=EYGY%2^B]$1ARG7C?;(L/?0A<C(:*ER!],L
MQK!&*U8SQ0`JP)'2V)7U#TH"$X!(%*.9Z5`AHH#&2&:_/7CSM=PL<4%'A_OJ
MXCZMWL/OP?MX'KV,X<[QO=FW'0P3R'?E]N_5,,/D0<5YLXY!UK,U/LL4^-A9
MK=0XQSUSQ4-*0,M$0)EGIE/R.#:T%!1=`NI<A@RPY#/M<*WR,==WIA3*NQJ(
M,0S<VJI.R\#7EU^F4XEP.^90%Z'I=GI8(AY)>0>T4-GAC4HTQC-'/$8SU3#,
MYTAM_*/]3P"A0&M,Y#3(--:T8XIHH#D@6F\0[O"8VV57V`7FI,Y#2`XT'=?=
M;_<!K@H$/+A#DT6?E@1!__:;=V\O)I\^O",M?_/NXN/DXO-'-)],=M!-_6<8
MM-XI,:4-SL"KK(N+SY//;S_6=#&Q5AD"^Q-\MQUH]T*OC(Q=#1$);=GS6*1/
M,!8^1&K[6BTF,>BKC`VD6V#=H1)#VN-QP#I5<Z(^U;CQG?AKN,,),E1,!I+K
MWZDIMI6F4CXC[3##KVG0MHIW#%<K],G+5*3]&IRD7\,-1,L%CZ9SP:LH29,[
M9`6ZAF#/U/EM5;4NR)L:LBF1+*$-`D(&C8D%(2LF[L*Z:+K!"1F)>_"U\]'4
MUO\[,M<F,Y>+";;-6YTM+F[R]W+>^G;RX>.GR:>/V2S^\_<?)^\^?M`_<]6J
M$>9<7A"[$T`V!LP%F7F8(K;]AP#2"(IXFGUS@SV></X41=ZO?A`(S/6DNE%#
M=1^.5:)020_D6WF()#@KB(*<ZFN+)H]]M'0<GUZ`43E1JV);A<EH1PE>Y/E^
M"F]1\/*6*.R%:=(B98M/2316*.XJQ9V*_U!"YX02R$B!=J<R6H972B&U.KRG
M9RO>IAPE,@$B8_?[[R?O?O@(SNZB%(++URK#]##">MF=(\)RV];\$_+^Q\>8
ME!T'R7Z+Q7J,HR0!KA/'!QSBGYU@#XDJP-;Y2Q0#,50#-T!Q90("B#KKU"*>
M\SCA`?C;G>/')%_8?7+B1YA\!Z89/=(1\%&/T18M3%`7B!G_.'R!],E!C9T0
M/$`LPGZ'/DRC1TC6VP_0=?8)1!_!`W!B)*N_]0,GG@#HTP\.^-_\&(1.ND?_
M'E7^A!OZ(?X%X`TKPGE"-8)90OQ_9VX64\&,6(P5;*@VJ(EQI2VVVA53Y91P
M//4X$;OPIQ<P"-`"9N\$8%=L]/*B*HX'O\:(1?35AL38SY.+#Q\G;R\^T_71
MI\G'SRCJ?OBAOD+2$H/U*XE]YJ%QJ!D[,8&;D:#EY%Q?#H+I4,#>%#2D,J$L
M@V[]#<^@0%I!.WOCN<.M[SSX@9_Z,)F&'BFE]10%'HP3?)*5'@0V$(2[4,.'
M+*<J3E>A59SJI0>+]@ADE7'LL2=L,X[7W\ZGE_/;^7H^6X'IW36XGMW,K^:S
MNZM?P/P.K-:+JS_\U^+V>G:_^BV8_<_7^?H7*YQ/_-(4HY$V8PUP?:K2NXUW
MJ/C",US(1CL(7JD*2F(&3W/S9/*E<\")Y"A6H+_$>^@U=<&:N4GTHN=^@`2_
M6JYO9/3(F)11!&V.9=J;>NBGZW;'R1I3].['KF)3)[-IQ2MU7@C1+*'8_1!)
M^48\I-_#=;38;'P7S4<6<75VPH\U`HT53X"%N5,ZI]]#L(Y`3@<L8E"E9$U`
M$==&XZ3^M`S%BQK>,SZ23@!6$=YC(E0-7HB.0L1QBC>8\,Y.'F'X_L-IJ'@S
M6(@KI>O5)05`2.1#LS4>(Z:#QK7LTS`+;W);L4Y(K+/+K9/M5>[#;(<2IV+[
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M)H6$PF]UPM!%:F.N5[M;J:Z*N/RHK52+[LF2ID;`=(`1D+VY0K7<$-PH4K>'
M6Z63+3/_R^`RLWE(.P^S6=X2NW,43M,T]A_V*?;]=81##1(!B8Y8><1I4TC5
M(G-AS814:\D.(;6*WU8YRO(/)J!@"F1<@2I;>">WSAC(.;-H-CZ,JIO5AO^)
M+I&;DAL?Q9W0/>`$X0J;O\U37FA`NC$8D)9Q=A^+L/<SSN9F1)6VKY6K3'71
M5_'OHMO\_4+2,W+Q)-E#S[23,H1NJ>QEE\;Y5;TRQ2=4\6C:FET2^,W%=Q<7
M;\$.QB#!KTG^.WA[,;FX(/_1OZ`Q>Y\^13&>U?X[.+\X!SZQ%QG*H_+I2>"0
M!/O_WH<0O+^8`(QM\LT**1]N'Q"%[,\7FJJ*J6B,5U.,`=2.6Y`&A!`J2<(6
M9:!R)!K$8E8A80ME2P62RMNPO"#>^%1]8M]&67595;X]:U7L[A*W;25EB98%
MUDQ(V0+Q^M,%,V"__^'=Y(=W[R>X%8[&[[__,'G_X</DW???JP=R_7?>553*
MC.D,]&H,Z"KLBQ3`9@DQ3%UL98%8-;)9XM@2Q*>>1UZE<H*EXWOS,*L=45$,
M(ZP+-%;,Y!/F3BD;LZ`",!FTQ@89H4GM27+3XX"X-AJYEZ=E*&[.5&$O4AP7
MK71=2D]+;J56403"WC'\_`[X#10#AY"7$17%I;4E1-[#U/%#Z,V<&.L^F9;7
M(NEV"VM35*"QFN>)<Z<2(G,J("<#SBJ$0$:I];+KF!%27!G'$?+$[,3/1:\4
M)B6]ZP@5>F7@99O;+X%`<!=TG(%B^Q#B,F*[L+"VA'8]^_B#GXE9<5IAWQF8
MZ=%&KUZ'.?`Z.>@();UZM6.NI,+D;TF5[E3+;LWXP@ODS;Y4T07&TE5-6,'P
MD7:&CX'&7%.J8XS+VA5GR_C-*T?`&)FY38<ME*!C-&TO:F%Z5!257+:"A44&
M$1JCCJW3F9I1N*3F>QO*8@J,1NI"CEJ3H%S\E(]UH)\#2,)RZ$TK5:XZ7YU@
M;8CK(J%\`5ZKI$J;Z[4%8,G,!!3LT.H'%88FX.@ECDG]*0[3(4ZW?EM*)?RC
MPDAJ8ZOZXDX(F$_V@#,4CSPTD7'B1$M-/A/*$=XQT^5H&L^.3>A+Y/!E$*T-
M<U!C3(.LXYQ!]&?+^J(B756`Q::\C]/VC('8#$&J1VV1O(\<NL;_*FVPV%0N
MQH'V-QHL&NC[Z(TQKK\LXTN,VO5"LL7A;_.Q$N:(/>A3`!T*0S'TC[@2\&*S
M:7%P?7T/6IQ>7#85IQ=]9Z`S..#Q@#"$*QE9_A2!N$HE7RIX65A1B!$Y@G3-
MX8W(+_3T05T)V07;X]K;^;L'&^IE0<W+CM\AH*\5_//Q`N7'"SK0P)CK]>AL
ML&+Z'.ZU!7N)(&]Z<M=?6Q(O))RBH?M&ZJ.W$D+0^N;"4/.ZKV5Y@NNL.L$B
ME"YGU[LKA9%8@7,5OZV0!3E=L`B!O:7P5+55FW^]+"-S?/9K:^V.NJV/"NOE
M*W.MDZZ!M2`RQVHM8Y)7/$DC7+^A726]IB4*P:I9".;`K*RDJ>.!,2XDU1AA
M+8]JY]5Z30<;JC7IU:5TT'L9\-`4$#MK(D7AN;$(J4U)0\3+=HT97-/5[VLC
M;>&:SI@S<B5O">,5OE?*6,<)=J"S1@*/2ZV%*A`Q6B><F(O0`X@@(!1-K]+D
M],*N97$RINM?\:(2B\IKU-84>R&*2*;%!6YAIVLTU&FQ+JZT.ADE`DHJ=CE6
MEP[8#F6M660=J%%:P"Z/H;?&);TE:Z3?)'5NAO`2.^IN\&47\0Z+S-#3*_Q.
M:Y@10ZZZ40U2'0E-9KU[458GD73Q:DO]`&OA:PAGKY"QT>-;M"#B]E::IF<`
MB-@6,BA0GQIA3=B-4BA,@YPR1</:I+0EK:Y26Z+'<ERDM;;*5T,NQ.OE+JQ>
MA4MHA%&5[#3,U;-VF6TK[XI6));=K%;:K#3$@KON3-:MM@6D9SB.G::0<A2+
M5M@-\;G+ZZX6FLV@;V'=Y@T6EK,465-;J_L^\->WE-8@@$1%R3J"C*^B&\*+
M+:&9S33C2?/BN=T<%BV=113`=6W[[-''R34OEW6)(EV!M05EP]=A'7:9+""@
M+8OD>>A&6TC6,ENQQPB[6JAY$H</E:!&NP9%WQ8]:L*1^CB26:MZ3OR2L,"(
M5=F<`";W\!F&>W@'F>75CKY4+';53E<%X5EO$X#Z,PWI#O$:=<=LT2D'NEFG
M6DHV]6>2.8<F_9KSHP6]7A,^SK[M8)B@93Y_#.ENHX8#+B\J7E9T#O+>+1I)
MN)(?.Z#5)N`X96D)F!$Q^$+M"I*Z93_!$#$5X/((WM8/?2PT?M(A4P-K>!'K
M0#%"2G&IXB89I0G(:-'"##5JN0.9=AHYI32&L-.T&\>W"O,]5LSGU(AJ&0RU
MR\4>(^6E&K/T>P(1<I^0%J[1]""(2'T2?N!@MU,M)"[`D]J<E1+("KH5)&R)
M#4(*:-9W/P&+<&>\%<-X)24]E<(UR<!T=E$)QO/P:LVBHP)*#/]FM5+#D@`_
M*KXM7J+I+@IW<>3M71NN:@MHY=CAK3<1]R772G4[,B9RKLX;$H/I[U)"&%P8
MRRR(=:_"AED`F_;83C&YJUV3^A4J[!LUUK@ZW%&);X%*O7RN#?@?W7Z^C1(A
M#ZQ\K0DC3?IZO##;5C_#/1M_%(DA;:<SVJ)JCD/>S=;@=K%:@9O[Q1>P6,[N
MI^OYXFZEU2'[<<YT25&^1W1)7+<)S?G0<+V/XT)J_E*7TU`1/4)<*?DLJ5=5
M)0'.*)'7MJQWQ930<.73L`MO/YF8Q\_"*2G;<*6E?+,^"9B.+L3_F#D%]`4/
MOEL??ZEZD-U*5RUW@'9IBY=VB-A,%+!$K]S$@$R]V6QQ`D*8:O5`!=Z9+F<G
MYY\IYR%\Q'<3I'@WG8*$9SXW".]748BF0WL4*Q=%W<9+N(EB2+];.]]@,ON6
MQDX4>W[HQ(=Y"K>)])MY0U+5D8\SJ#XTI%/150?`+(*21U`R"2B7^2J%\#D!
M-4X!875BZ\M[(QBB/</KGZCLO51#03A`/(('"KY='#W["=X71+_F,Z04,Z<G
M1%NA$_8BL+=&QAX!D'ZRL>X2AG##?/"ZJX4.C'?RH2%JHK[SJ20XR[HWOG7#
M$;L]1EFH>[$L5()U</;`4+X!WCF331'.QRPO$2$&.!NJE8]4*Q,<4U-Q1!P/
M:U.8$WX:N*F99LT(HT80'*WUE$'HPZ#0_JDY1\M?.,\OF%\ZB>_BY`D_V*?,
MNZ2\EFIH$.1+Q4^+Q]V+Z@030,C0A"%*R+0#"NKAV"M/QCBBL^VB$L'Y0V&B
MS3X(#L"C1`7K%A@6ESN1/@O(HI<KKL8:SG^$_N,3+K./;.$\PKO]]@'&BTWC
M`MN1V(NP;=]5M4>%LKSJ<JA$DYPZR,@#2A\_#]9:J.<XT$P`8L1HI69U_=5*
M-+]D$'"B5H$%)\-"\T+M^24CC-'/U6LPCZ,,H0>!,D6$U"FB3:&2&.Q#/\TK
M"A"%5-1$W^_!3_/L\1,_2#>N$[CXT0[\CV5LS+4W6ZX,5F@NKA\N-E=.\G03
M1+^*W%5B-E-,[A?@2.DJ1G'A$L4Y3`$0$A9=6Q+10./>A?T&X=VQ*.P2"=IE
M/"]!TQS,T1)O$WK0NSQ\3?#S/T6>RM1-_6?Z\CO?=WITIF;`_MRK[BD0,^9T
MP>4!G&'28!Z^!F7&5DG>(A_LK[-CSWQAYN95Y<`6WQ#'Q4JMY#XZ!5F#]Q*G
MWE_V28JC3+*.[B$&@Q_@B\?EJ<4ZTN?J@Y!3?))V0`VHA(L*7WASL>`,-/8F
M\3^?;F`94O^-1X__"3_9!_8J*$PC$!<H#/-='?17_+.+`9A/\"T+<B)/U#."
MEE!S??=X>!R.<>?*=%"0T0?KMM6)F,NF^U<ZY!GW(E;'GNC/,,$;(3N28D&+
M!:ZCQ6;CNS!.KGW$`^HI05+.MKL@.L#6JU=]>U+8_NK/MTIDH%1!1C8KKHAG
M%CEE%"YRVL1J!76C&Y[]E57;Z'Q)%N8$DQO'S\M$1QOP3,T>96;/=O#0F!X5
M9O=J9H<LLUND!9$=S8TF51C<KJQ&Z,7FQ@\=-#T+'Z^B)&6E73";*4YH!3A2
M6A=5GWE>;$!!`1`2IF<N(N(WEB7V6X.W3*@:!?F2Z^Q\-`4@#S5N"@.Y;08R
MY2O7\"'-7[5<QG#K[[?"#M/65J>=&+SI=!U,IGR7]BRC9#S34%@7;#^RW$B2
M'N5A6Q5OGCK5U+.CAT_1EVC<V\<F<W7S'`OH745;G.W(6V-W-%`\J&%RH71F
M1O(Z2->@VK=IUV%+W#@CLU/I',^8_6WOIP=\<(R4[W*4/S[WS+6O,.\*Z]Y*
M`6LZJYZ'*YBF079DR;CU)-5<8?TCR:&*HU:+;.>+VCGZO2"'QT'3F;I]E%);
MOIZFS23JV>>K,9Q84YH.#8L^PW2FY9-?@KHR(AM<=<Y#-X8HAEU#^O_*:<05
MG?F+E8@7[43YTH@DMXIW>`@5<);3>XTC3GD*E]&TZ`A.7D$MMWU.V9:\2/2$
M?H/8$YT$^2+=_0E\Y\$/3!]M-?4Q=<D2(;F'+O2?\0)!R@=;FNNV6#>'`_A=
M3@R4U.QSMVZ-\!W->H-QG.LLI_<:K5PS$V)/R^T6,^UF3#BQ(@K7<A*9C!O+
M&.X<W[O.WF[-+BE.0X_4C9F2P"<5280ZU`U5&2D&B#89^>+V+AXH:-T=2MJ^
MT".C,'XP>A$VYY[&ESZ]R^R=US',B@GOHL1O-[9]TG+.ZE^&K)+1^LPOQB19
MP6V8^BV=`QY=<`*'Z\9H$7E;SE5[30:9'0XUVQ"18L@)8T:?YD91#D"%!?M"
MN8SBQ.>5)VU[?K&'YO1L5[&[D]D]8-O=/L&94;T">%^#!FR\=L((<Q*=C'7O
M0$<XZW&]Q'0(DU=0_[LD5MI2X.8\-Z]:1SP:1CKN17EIV8Q'FGF(L\04(TU;
M)X.@D\'M@)&FH&I_I&$H2##2G(HM)6^I^84-&1<X[)&._7I\']F,1YHB54_'
M55I69X.@58#[`2-0F1)JY8VW_CH3#$JG:F[)(%4FEEKAR$@I+H0>J?)Y#]$:
MBMR:6VSN88`WG99.G!YPSB##?86[4"[3)L6IBJOFM&@-X+.2'%AL7H.,(B`D
M23ZJ:>>4U4U++;U3-:'`:F276Y,X8)Q9;T>LYWC/R!WU+$B&$(\Y25C6!*O"
M-&J%Z020IXSLB#979?:O1(`Y;J4/D!W\Z`LC%0+6!8T.X5EQPDI+2$<#G*^&
M`P!-9"L-%$:IA2OYEBF+EGGU:!,L0_-HTZXFKZ#^DV8K;2FZ9[C+3?IP:)TI
M#[B:5Y10;-]05K[Q(@Y6R33T\/]POO^S$^")Q!+&?N0=G_PP8HY4-VI([<.Q
M4E8^-B`^72(_5$A.`"4*6@YG34>>/DHZCCTOP*8"\:<X5#SS*@>-U&VQU<D/
ML&1*1R@:2EQN,*J>H`I+:#H835'<CN,#BI@_X[L'TE'HN/T04.W@<:"X,\4S
M(4H.$'IVAIL.I8C%&<NM)K+]U^9<P$D!Q#5G-[CF-O+WX>*)@G3\,XIV8#K'
MP.S8>K!"2*K_5>K$:2\S/L!'/\2%VBTW)F5M%G:F$O8'ZXB7M/>[';U6Y@1Y
M(=MYN(GB+;FQ)E+U6+`'Q1O%<GPJW>NND"IK[H(*-8O.D23UTKC]?:K&X]5-
MKMH0%V@(HF1/ZI1OVDUJ]/H6O<NY='S6.RVUS_0\TUJEJ)9%FST3BCLT[1%M
MPG6]>FM0ER(3'9)Q[NUC6D`?9H-%]AQ?^YUG`T_QP82+W/J7FIY_J]-5S`(O
M'AZU!,.M,G:^KV=:L8I@-ORH9#XDX;?;T(]E'E+HM>QBEJ.)P.1(N6OUY9D.
MR937VY@)^GHO_JW,#L2SX]9,G9(7BR9;NM39ME+_!T$);^<P"L\)1%#'88(W
M\J.P7SY/UR-9:+7GH"48K>]Q$\7<<HE"S51>.A+C2,4%<Q)Y\1M$Q):2B3(J
MJ#]+=1(6D:K#^FMNIJSJ"QX:.8433<K&*VTC+1S>/0^S(<*O#1%M9WL&2]_@
M-`J:58&?Q\[R*_"A)XJ'1"73+;Y$]98Q,1#N0K5(N1RG*E&&5)(LB4U`00Z4
M]":`4C0]E,LJIEE@_F3MUZ_D%OSFT@HXV'%W,7SVHWT2'/#1UQ[?RR;%*0W6
M=:7W%E&(6$:![PJ^1-/=2+%(*)<;%4<K>P=Y]Q9-DOFR-TJVVFT&7I%6*6N,
MN+/O/X;^QG?1H-O4PQI^2R\1\;^R-O;%.E#<&I;B4FE;OZ0$6FV&J0%"SK@/
MR6FEL:E_FH;C;>E__?)E>O\+6-R`Z=75XNO=>G[W$U@N;N=7\UFOE]<[EHAS
M-*4-'W':*BTN(K3A(]I285DBSI?B7GY&)2M79-=6C*0F:DO&4S(/MVA%+RN-
M>JC5H0V1H4>DM?*QC2A_PWF312..A#Y:#M-.RU@\W[I;3^]^FE_>SL!TM9JM
M>XTMFB[XT"(L25X*Q@E$EC6L5HK72OC\*%WPR;HORRTA`A8,.A+B-Z[XV&X+
MCC/(FF3T%3^S6I+<J-.W1RV+U+YR:-A(X)8YLW704E1=QS[$R[,_;P>#+J=6
M8#G]94J&O;MKO,:Z_SJ[!K?SZ>7\=K[NN<;2X^NW4?BXAO$6;X<*#("MGZM9
MB<6!B@OB?L]QQ]F-XJ^A&SA)@E;6R`7M&?E8XA^[D87:YS@`,4(J;00S^!<9
MR=J_UV<#K:-0W06L&F"8,K-P;XW2>8<]B[N?9_=KLMBY6ZQ-QOAJ68=U)?M#
M(-YSFZH9090S%2>H5Y>H4K%H%!!5Q+%GG)!]./[2RTSF?4AN'233RS"6&VB]
MP[">I2N<'@H2=;Z3L2;/)6>WTS5:J"RG]^M?P/I^>K>:7JWGBSN=9T+9NT+D
M:3#>*5#KMRJOKC%HJR7FTC>HZ+MXYD<9KK#UY^XLTS(W!5Y,V9HPR@KSC(\U
MZ4]KT#[2G`7!F2]O)U+M4#4/J]/E?#V]!:OUXNH/ZH\JJG(K\H0B^F<?#=U>
M.8KC-+4:=$SFBQ9L+3;5)V6S`9-DWI)'9\F;L,NLZIS`PD>Q8\7<1"U2*66<
MEN9>;&IO,!?5^@@7$U!]JSGGQ((A3Z\J&SFJ_QCHX#W55((D$@')@RA(+(P?
MEU5=BBSU5'L>"2-LN4R&$`NF(YJUV3N*G#I$>/F'>#8$%DNRM"1'9'^<WJ/5
MILG\$)RK[Z<T<H9(&20)$X:N]#55J7X4;QOVX5EI`5$2I.5UJB3MRFY4TE'C
M5NE+,*K`915%VUKFK2*CMF1'(YA6[XI?V*@6C;[]U-3+9^VW+/?4\<N7^?K+
M#.><X('T:D&2^6=W?3/Y]?@GOK!*JH!5"@8)#)[,9FH6$N%(Q=/(%5U"H%8D
MR9Z!4$0!QSYT`O80N18N8Q:S/B(R9+';Z;>*U@&IRQX6#3]".A#Q%.N,PO.5
MZ?P>_#R]_3H#7V;3U=?[&1Y7-!ZK_!21X@C("C&K'&+WMPH[_2S:*H`F_8*L
M8PO"/5?8VH&*;5KF(%14V2.F$_I_V_N>GQ[DEAW,9HIY;@(<*>48YOW7E@_D
MNNH!6!3&1?30R#NTWRP\#UG@J[QH%7`UN[\S60OW(8%_VZ/UT.Q9\`"NLXEJ
MP50V)TKWX(N^`>W<@O@O*G>S?*VUZN<6J!6W@CD/$"H3T=E&KQ'T%H-HJM^B
M48`K.L\/K+(!MZ[#Y6KV/U_1I!W,?IX9/4Y9I4Y*BD:O7!@ZL1]-O_FL%\':
MOU=4.8L')<CG'4]`WC6*.:AS\W!GB=R`.D?G!M!RA2\++38T=5`0,8TVFE#3
MQ8O2?CSN$R=/Y,F+5H&F2^).X#!4/R)X,O1^#9,==,E-L^MHZ_@A"SR=;13!
MP^-%*>QDG>-;=47WX$^4@'D4\41OH$C`!B.>*%:@S(5/R\>*YT>=U'5&&TN0
MTBULXPR/I>=QJYH?/W83>JNG*$[QC4):Y5DTT;1'9^HUJ?MQKY9KGCQ-VMY?
M"CU`:--;PA7J%BV>^ZNLK1YY;VM;]JR=(+C%^QGAP33MY?<%7Q6S#,S2>NKU
M`IY1"-]#%R*^<(4=_(XNKJ0;BE2X8+=3O<8GP)/:-<R"P`0@$BCB4B(6X4](
M"<VKEF)6&;](TAU^?QVYPFWDA$G)IA3FY/O24QA'FG<5;.9$\6,E*<8GH7KT
M3DG)A+7X[:V\KJ)(?:P^/LX5H3T"FL<"\"F!5`67UD%Q&4/\U-7L&[ZK@,MY
M+=(G&-/"E>*(E.E%L8Z@/+\J^,S(@8P>B:R$8E8@U4:<]E!1HPYD+WN:0FU?
MG`Z)S.&Q:#_T>H'-!GA1H.,'QL3'Y*XFBN,PAQ.EL3>+8&7O%B&))WAC@.7K
M?\SP%.U@G!Z6`7YO(/3P<GZ'=Z#0H"\4I02:JP8K<0[58A:E,P&$$AD_"UID
MIF<1YF24T@QB4C8;,07>#_T4WOK/^!VF>F%R,30*=J"8?RW%I5)V/*%T3DB!
M1L%[VR`IIY=&QKRLZ<9\E&X#\4-<Y$JTU$C+:ZGZA)D07TJ7^#,2^55]*\=?
M03TT'YH3-<Z8^>-%96H!>+5]K9J6W$E?+4F\K'AN#VX8PC8SP5F:MJLTO_SF
MG$QOPY=D'W+KCE..W\9UJH+*^I3AMV%-2][FE!ADFU]K>!MTB,'TP<K-8H:X
MK8^S6H"06MEZ?`Y-RM'=0B>!BX?`?R25;"0B8;_^-);>EY5!:32N%>7/4AAH
M/3]"'53(VXA7)<4QWU3H87DSF.^'[.'P.SA*2QQ^<=)];-U4DJ\+%O!L@%?M
M&#J;(8C#3*2U&MPD^%.!'2%#8B+-3\@HV1@')31R##XY<XT,PG[@&PYT0X/-
M=HCU@)9%D*JL;:3V[MCMM&VS#+-O5UO36KEI)Z0"QC:,+1MV0M-';2N049<>
MIM8<-J&TEZ+ZK3&,XIC<J7F*`@_&"3X/3`\B-1JZ&ZE>NN1QHW9?M^S]MX#V
M#Z9I&OL/^Y1L#Z81?LG&KH#)UTGS7J:`>4;<N_8\'P/="9:.[\W#S`U$]JDY
M+17WI,7X4MI_+D@`3`/X81'][`&8H!X:F\K"QAGS\D?J^"'T9DX<^N%C,G7=
M_79/ZEI?PXWO^F(W080[4;T6(LNMVAT12@WDY,!9A2#(*+ZV")CR^FE>'^EA
MRA%7O3"=AVZTA;=1DDR?'3_`H]`ZPF5DH[`:QB^=Q'=%5L0]>U1<+:O)H;22
MABF@M,$9IOX:%/3Q:$XY`%46)H`P81'.%=776(@K8\"4!\CB>PCT#HM-VR>;
M3%VP@68/C"I*7D?W<!?%N`SW+$S%5C<].M,)0!GNM:)S@G\-]AZ^C[?$5%'@
M/`8LWGV)PA1U'.#/YB%:VL/$7@3+*),-;TD<C(?]DL=+N(EB./N&>(EB9$8G
M/LQ3N"6EZ.FTQW^&L\T&NNEB<_6$P`#G898;@F19QG[H^KM`Y(+_@$35?&EX
M;:CX7'TTP.`%BQV,L^VO!\(QJ+$,",\6^=?P"C[VPU&P9L)?;Y!RZ1L1>\1=
M"00I_^-VHLN?1+G5[!\ER8JKO(RA2EZWW:XA`0.;H$X]FGZW=K[!I.G<=3OF
M9M3B(^K4AW8N;?H9PROS`2S[GO`[:1O.)B_".;791MZK=0+7ZG#PQ0^C&,VP
M"_Y#K]X+/=_X`M.GR),KP&:"F]'#A2[]C1D^LH,YRE.U,MSD'S:RZ#*CADBC
MT0?&BSR9/#@.2FPVLEJI>;(`/RH>5W1_M/UHCP\(*.`8JV+6&`]3/\6(@V4<
M;80.%=N^5L,0@[X*=DBW@/9K$6`8TAX#A:WJ,0^CGV&X%[K0V?A4]6"YG;+:
M\3'MTR),=(G9/`7NU.Z(B59.`).,$[&B!ETM%%.LV'QH@(AM]0DX$C>RI[AJ
M-S!O(7?5<<D.6H!(:O;2V5;3'(;'FYZ9#*%":[-D="R"F+`N.B<U`D8:<^1*
M(-(`KO1[C1PAB$B5F+S2FLAP)M)>=8R3X%$MJE%"!'L54D6]/7M@**63YB@I
M9[0QKX7O8NCZ9$&*?@X@_@%?8M_BK?^_D[^C9?\NCKR]2_Z-#]'^?:I>,5>4
M1>TB>DE\`@KRM"I"A0&RBU*R8!'"E=77O-BNCH-1`W,:(S[V,1HR5C!-`_+^
M#MZ#V>X</\:_H)7/LY\(GB/V[%`Y="M(H1C+2\H34-(F+E!2!R5YB\"OIK>6
M>*]F^A&GP;BR*_)"Y*G[."ZV@,0G)((=*$Z(I;A4FA63ZKY54N",$GMMX:Q$
M3B^-&;*LZ49<TD-RQO`3#-$D/L"#AK?U0Q]S1!)1A.$IV9'B!D`OKI7N75&*
M$Y#1I/.-&E4+8=M/3XW=A+ZF'?-8MCC)P1<5Q6'+::AZV"G"E=JY9'8T2!=V
M#S:NZ,2TT#S6$S3,^""31]<PL!H23_;"2!(_=@`G.WK.F+E$D53LR(W74D<R
M!I<O#8D3B$8!J;.,C$UGN8*::,\]$#'/>&#+[PDN8;QZ<F*1,-791`U>/$Y4
M<%5<`$6=`]*[16CB"7X,(P']F\,/O6"'1F$_V*?0ZP&GKA[THHO#IUZPY1<P
MR;2+$K08?QS5\.#(MY_IUST1IS[.U')C7)?D&M+_"T"U5W=#O/4I)H$*B!E/
M?E+B(*<.SG+Z-@W1*GH3>P)4V.RC7@K%3)(]3`]ZEX>O"7YCH#ARG;IH!4YK
M'_>[A*.)@/+E48U2JEXH)?Z1\P(>#N`,LP/\\#4HC_)+EB8=F<#V>(Y>];9<
M,=6+H#&K^OQEGZ7VXI1K)`5)P,9W8[%J??)Z8)FJN8X$!17PN\%)J]85&D<S
M:H6)"AYIRCSVVRR#/HU`P2EHUC#`537DO-PB=Q[+-LUB2:-!UDQ>QM&1N60&
M1E=K?;D6'/[&R*JPR`TD-,-*F.";S<1X=!/%DE#DM]4U(G!X4PKI=D)-6/;N
MD,DWRH@PJS"RV!0/F.?IF]=^0I]:$4&=;%>*(.S)N39,1IO*@^]E.F]!V";0
M]M15`\/]33SBIN5V%T0'F&_`8\;RK2O\2-H6[\Z+1E+YOA0W,OORKK2EF1$%
M.56"8T+W_`$3!E7*%L&ZM[8:NYP*9AXQ/Z<OB@>%[/#X/`$D]H.=A1@[WO&L
MKM+((Z9B!]6"?2@?6<OQJGAXW=@0]\/J_@`A:1$FI=73<J(M;4>32+V'+O2?
M<;VD?BAM:Z\;H0P>!T!GA9K5P&1HA0]*MME,`G(9PYWC>_D#O7GZ4>B1)&"%
M>"K5L6X(]Y%J`&QG;!2I1'C.2A/)3R`2]]$AWQ-ZPL**V87<B]&2'0TVSQCH
MG6GN9,/.AZC[*4IBVF'+\]5-%D6>).Z%:ZF.=>.\CU0#X%[TV6NK7:&/+OFN
MT1,>QK-6:"4MV9/R'IT-DHTBP/V`F2<%=3O/I/OK3#"=1,S<QB%>;(\/E9@E
M2V`05^@IY8#N41[*O(#$K)[J%?2D_@@:S[L0SRZ$'JG%>(_6-P>2=;+8D$<(
M^;XCU%S-,V0X5,%]3H?6'#TK28%H\YK>^+,'SS)*.4:KI,W,8[']8<P5ON(M
M.K51[GH8#,M*-AR^&2^OENR<@`/(:E34.7H`Q8SCS)-DCT8=R&=9K*Z@>M_Z
M7$=)-GV^D[.!<U2$_,:V&H?:=,KR'E6P6.4^6OQD-(<P@?R30K<ZC.NVS$2^
M19VAW]%OZ`><48%^^7]02P,$%`````@`!XL*/QJ=A,(F$@``WAL!`!4`'`!A
M<&1N+3(P,3$P-C,P7W!R92YX;6Q55`D``_[V0D[^]D).=7@+``$$)0X```0Y
M`0``[5W=<]LV$G^_F?L?/.ZS8TOJM74FN8X3VQG/N9;&=MJ[)PY$03*N%*&`
MI&+=7W\+DI(HB@`!BB)`UD]U%0#<WW[@8W>Q^/#KZ]P[66(6$.I_/.V]NS@]
MP;Y+)\2??3S]^GQ[]LOIK__\^]\^>,3_<XP"?`+M_>#]:T`^GKZ$X>+]^?GW
M[]_??1^\HVQVWK^XZ)W_^[?[)_<%S]$9\8,0^2X^/8'V[X/XQWOJHC#^6*;[
MZYAYZP$&YYMO"5OP_SM;-SOC/YWU^F>#WKO78'*:D*@P_ND:#/^A"$[O\O+R
M//[74^#!R<D'1CW\B*<G_+]?'^]V^J")CX)W+IV?\W\]OZ9N-,=^>.5/;OR0
MA*L[?TK9/,8.'^:#O@]7"_SQ-"#SA8?7O[TP//UXBA83'W#U>A<_#2XXJA^D
MXYUKD_<4HA#S\8;36^*#D`CR1C0@?+C/'@H",B5X4H50Q9'U2?Y,_0GV`SR!
M/P+JD0E\9_()>5S#GEXP#H,18O#=%QP2%WE!%>*UOW$0Y^_`TN;X0":G@QQ$
MR&<4O-QZ]'MPYT\(PVYX($W[XU4@+YK/$5L-IU>N2R-0>7\V`HFX!%>2K&PX
M?>+N?)C89F3LX:L@`*VH0M'>&/IDI%A`*5>(C^-/X!<6X<D]06/B@<U58Y;2
MN/KDCAA9@HZ,/.2N%87ZL/B$G`D/-*Q&K,*H^J0^8H^;/EA[N'IFR`^0RR>P
M2@0*QZHP!Z(%"9'W%%+WSTKS6[9_E2D#^@T7,?6@%'\@!G"J:;]HJ"KKPGQ.
M0BYY/A#(GMLV;&(JZKYL.'WB;A%AOR,OPK]A%$0L5M`J5!6.HT_.%PI@`).+
M6:5=R$[_*G/Z.,#?(J#]9HFK*DY^#`4RLON_RX04'\^X4=ZC,?;*R2@:RV-L
M9RB^#[WD^]#>3S&A.U\XB,@19H3"MJ\!:G.?JH%LV!:PL"G",Q\[B/1G"K/D
M\8G.?.8@<A]P`QS>?.0PSL)9$S?`V>UGJI);$TO#?0IW^;A@.(")+#[)W<.P
M.Q_$KR&&(\GF),8'K7SLC+\'7_2HN_,1CY_)*2N;>?DOCNP#5^,@9&A[>O`X
MS'AX1[FO<Y'R197.E!<QZP/LOIO1Y?D$DW-..O\CQG!VT4O=`S_`3T[R]4<\
M(_RC?OB`ML>P#-&BIDYO2V-6>E=LEU[$W/6H\.>>Z':]$FF+\T5\P#QS7XBW
MD?J4T;D^']>TT%(T)U$`I-%X-X9`Y2F;8/;Q].)=<\+X#'@8\N#`B%__A5=2
M:>3:.OUVBV,?CD`>O68$`F<4[O][6LW'U!,(8J>-,VBK`/(P!(SO-VH)$>.(
M'_&",G[VX'Z5*)`;1&$7Y\>VBJ4$E4!*@R:E]#OU(N`G6]T2#_8:4O'DVCK_
M:+=<]N$(!/)C,P))]>26!"[R_H,1@^/+-6P"!3(1-7=^:JM8)(@$DOE'DZ82
MJ\EGH&=&F7QAWVGI_-Q6>12#$8CBIT;7%CJ?4S_VO3V]``N"813R&!U?!.4K
MC*2C\TN[!56"32"WGYN1VQK<,PPKD%"VB7/95EGD4`BX_DNS7-^XPR3K26%;
MIW?1=D'LX1&(Y+(9D5P!31-.UZV'1'/53ANGU]IC^AX.X8&P8=Y?X\!E9)%-
M8A")(-/4Z;7VA"Z"(Q)(0T?T-:#MEN\6?A&=0@2MG5YKS^T21"+)-'2&WZ4L
MF4/599-I[_1:>WR78A+))W-Z_W">]XD?P5.NF*=466&F*!C'?(^"LQE"BT1K
ML!<&ZU_RZI/^[,@HD[C8=;H?Y&6O`=DS3RM1P1`W-.AOUV1JSAB$<"0.]Q-`
M.,5PH$]"L!($,?E>)I1D2)A/+O81V/C5*RF:Y:3M#?KNQ<(I$6*._D[(,H7T
MU0\6V(UGOFLZ1Z1HEU?:QV`XH%16`M%*H'1"O&MVQ`O;<!K[.E3--=_'8%BA
MLLD68)#%V%HCV"RN4H/=;VPP$J$DHF*I%N+HE)G"YA;?P9]*]KEI;#"`4=DP
ML\3+@J^MD6&2RZVP3=]M:##8(9=)L?SVB*_/_):8C>EN[I8)":8Q-65!YMH;
MC(F(9223Y3[]'1(IOX\B6QCAGPT&3DH%(5@&$ZH[)*;UM9-'[&*RY"O(`PY3
M?L@,4-+-9!RFHES+X-2X<34N\1'#"T0F-Z\+?NNN7-2%[4T&>BK*6(BCQCV0
M<>'N\$1U`349*ZIJL'GZ9?EIFD(,\S<$FK9/NL`L7(T\E`0"OD5DP?>(,"5)
MS53<S63427=K5(:C2U/Q,'S!3/GT4M#:9,!*5[`"\KLT^U[C!8]/[-Y/+I#D
M3CNG9]XC)))-L23WR._0?O@ZI3:)..'/-`B#!^J[R4HCGX)+^SH]\^XB75$K
M0.K2E)RO$``0;UY=+^*)B5\HG7PGGJ<P5^L,X_3,.Z)4)W%=7#5NRPY0#<&]
M.E!J$N)[LN2%`D+@4E``KT#(ZIV=GGF?E+;(=B6O![9#*T$&LYI:J'5T>N:]
M7@>JA#K0+JT,I;NZ=#_4M\7[I>J&YA3+;A.UZ_B<*9<#I\<X8/E"/4`3\)-D
MN%)8O%6'</KFG6`Z$20=7%VRW`QN]1"3N)/3-^\NTQ)EJ384`.S00JY264L]
MXJ$PBM,W[VXKD:X\#**(L4,Z<AWA9SJ<3HD+)C1D68,J5XWRSD[?O)^NDD:H
M0>O28I$O9)?:0KD6R#LZ??->ODH:4`ZK2QY<K26A:%8T[^"K).5B*-T)JMU3
M?_:,V?P:C\.M_U)E&RCMZ/3-N^[JV`J6@NS2#)^=QC)U0H%_6^P2C5#I[O3-
M^_T4A%JL#:H`.[3]4ZAG6KCB"WLY??->OAHFAA*$75KY]_ESYZ<NT1&OA02B
M"T-&QE'([>*9<EL`?@#Q0,KLS@\Q2%EE1:GW0\[`O+NQ!D6KGREV1)YJ2]E+
MR(W9%-<DEB?LY5L[`QL\E;6+6)1!5(B_8\M56CVG3!GR39V!>>=E8YI0!+Y+
M.]FKR80D.$:(3.[\M-1\!K;,H5G:V1F8]V,VIBMJ[.C2CN<1AXCX>'*#F`^\
M"JY<-YI'\7[_&D^)2V2[F/+.SL"\S[,Q[5%C1Y?V)/6P]NC[9&=@WN_:F!;6
MQ[*_3C[``7D`SL`J;V\-@6`AS&/J0R.EA[1?&7LK0E1O"'Z['()<@31.%?SM
MX9@\?W(UYS/4_^+?A7=`Y/'Y6C[1^L)'-3*B0T?F#%>RZ(?3K4^[*-==3>%T
M1K2I^M*A^J6)VXZC=^5D<`%P_I(:@Z[#Z;1ZKGCYV#95>-+2FSHYT*7CMR1[
M6L"+:CGG@L%L*BE5:1ZJ!-F.$[A@"OKJHX1:6+E)$*?B#7WM?*2J0]E4F$I_
M@JD&N,9CC1EUV`_3KZ1)#/4,;%/5J^.H2AE\V1L?;5N(=N-E@)7G>7+8<<QD
MA%G\0H-RP%$T@$WEMBHM.,HP9:^.M%LYDK<ZKJ+PA3)N/\I*D>]H0:VN.I6A
M`)[L"9,N*,%=$$3:"I!TLJ#N5_W"WT"3O:+2!<'+GR]2[&E#C;#Z=2`'4/9X
M2]LT(1,'K[!#4.AM0T6QPS1"$:3T79D6JX7&WD#2RX9:9+6I01$XZ2LVK1=_
MZ:Y`T,.&"F4UBWT+3/H\3NM%KK8?D#[X9T$5LYJ%GT,G?8#G<`UH^O&>.Q]^
MQ49#Y-5?LS%![=MS+37%D3US^6YOS[7\)9YKN:_V#H1%*YC^.Q`=>9GE"7DX
M>,1+[$=87J(KU]*FT->.5`02W*.^0XDZPP5FB%\S3`MU*U7&%?6Q*5"E(%@9
M#CN29VHR5!PG''_!/N#U>$+:9$Y\PK&&9(E3]#+[51K`@HB35*("ZU;%UB&C
M?P3A`&-?`.TUS&L>C3,0R_5`VL^"&%,%\9=!ZM(\D,U/S:6E2H0NZ65!9*F"
MR.6`NI3SML<<G47=AIA1!>D6XNA.99T-O,0I=$\#):%N6]L0^#E$K+M(NG-Q
M*BX4_T!]F)HBQC9`RQ=E>4<;`CQ5Q%T*JDLI8>NK@.7"SK6T*HZC<.(J(+^.
M]?8RD:./9SP$;%*.Z[GI%MB4U.^)0'E3`Z!^\`E/*<-)NV?TBH.;5[`$P$Q\
MQ%8Q][1O[A[QJU:%BI3TZZBLZ,XV8L.`U!(_P?%W*JU`(.AAPW,Z^AI2",..
M[/2Z,LDHH"K9'6X;V?!2CHX4=RFO<2M@V"S7]2S6"4R?4$!<[IH@7A1*$SU*
M>MKPZ(V.@!7@V)'V+;A,\@<FLQ=^'PJ&1C/\$,W'F`VG>]D*.5Q#OVCS=^"(
M-KR*HR+[&F!V*0L\6:DVC%-Z!:NPAV/>CR.FK"QJNHFN'B7HW70F#W_0^M:C
MWX,[4&(XVX9O23UO23UO23UO23W=$.];4D_KDWH><,@7*3A@+0FL<9]67P-^
MX7_CPKUR0[),BE>5;TCT!VM9:E`E@!U*)-!U,YCW,E236*D70NB$:*-4KR;_
MC8*D#/TS?<0N]5WB\=2WK7OUF=8W2QSC<Q;D(M6I:4=B45>36T3%UQ2S7$3=
M+<AP.I8BE&?*2)ABQ=0G<,3]C@/N'HII2^^(;5]8NX[/X)3Q0IPW\X5'5[@P
M1Z;B2!:D1S6C+]7YTZ49:+<\7WJMS9^5%C:4=+,A!ZO9*:>,&UU*S]O%RA^.
M6A=(&C$\)]%<66L*^MJ0YV52=00LL:,B74W^EC0RQJLLSWDTNVR34]S!AA2Q
M9C5%S`<[<@`$>YG,M>=D?;WSGW`8>IMKPL)4(9WN-N24-;AMT>!*MU(.78;!
M`JYQ\M\,Z]*G6-0"CHJ#V)!(UNP<H\<;.Y(9CJ5:ZX?.@>F8+$NBCBK=;<@Z
MTQ2PJI84@ZWAB&U1DFP.,FS/%HA,UF7,T\P\."G&6>!)C6$MA5$9T(:4MR.I
MD"K\.@[?]FK5VI#2VK+<;>6Z#!;XS`,LE:8AV8`VY-D=>6(J@]^E$[JZ#[^6
M**@-F7IUABWTD->H.(;3>`6X[_PEG"0.5)N"09R>>4=S#5%S`;(NN8@%R#=N
MSCJR*R2#.7WS[N0:%*4$89<6((#N8CR)KS,]PJYN%1]?A]-LI7SNZ92G7R@-
MP9^L,ZT<%04N3,]0!FY%"+-^E<D\LZ"A);E>3M^\?_AHBE&`]:^YX-2RT#A]
M\[[C6E5%#WIW=K`<-)SP^'_X"X5+Y/&Y<X09H9/\T5"B.3K#.'WS+F*=S8DN
MMNY<'BY&?@66PM@*C"*NP:ZM%;G^3M^\B_=P=2@`56.(<1$K&U#)PLYK@WEO
M[1&TH=:[RXDVW/@&O;!/T6*11$Z1M[[K=N=/*9NC;&5O68J"V@A.W[R?5:N&
MJ#JL;H4"D^CY"!'9Y?5L,Z=OW@>J(RV1^WP748?.EYG:*:5BW6GI]"UP4]8@
MV3U073HPKIG"B^#`GUN?K#\I./3P!#N/!A'#"E/[H4,[`PN\EP?K3QU<L,/#
M*2I]`5L<Q%^<CK.I;BDKS816Z>8,S'LG:Q%=00J:`O0.K1_<S99XW0(`D_K?
MN%,%F!3%U2'F/,[<D\PDJD,X`_.>RR,H314V=&F-*BJHH7*TD'2SH$9*"7FB
M@T67"J5$\SEBJ^$T334!RQA1C[C<.VWB>L8>%2J7686=LBK6I+&0F4^FQ(4%
M9I^V9Q#1)_CXGS*S41K`,;\\2UDO,A]5<$==@!NQ+CB2(G_&`UUI1F4=F[W\
MH$H'`L6>A@Q&3)B*M2CT-F@JZIP7^S44X+7?6)221TT$]Q-Z@C5!R%-9E"2]
M#!F9"G_U#*_BB!:L6W+I"`RQ.MSV&^>(D27L>D<><M<;YFT6QP,-S9CF/?5G
MSYC-^:E,P2:+FALRQBPI*J96V-X"0Q*P5&!!(A3MMX]L@MLS0WX`?.!%&4Q8
MA8@6!0LIZVK(6D1DZ2U7&J-88%D*HA!8F1[.]MM>>L,FOD]<RPDK.V#9F:JH
MK;:5*-`A4W!Q8]/G'@%WBCSR(OK;KY\QI+1(#VP:UZ$'$TO#=@K@&[AM'89T
MRHAC'W&EAC&OU#!*\[<5%H[#!C:TK"@3_2E+M,I2<^#(%BP_!PM4%$`YF#/M
MGQ!X_0N25$7@"6OQDSDS[)MRNDO(T4LVT!G'D,DKT:ABX7H#66#0NM(1Y5+H
MXFZ_N=XBPN+DT=\PXN@X>!-VNJ%CRVB5I5G6S9`5%I&D8G32?A;86`FK!295
MAJK]%O2%QHDUOHN97\L)+3M@V0FMJ*TIKQ_Y%I$)"5=Z:XVLF^D3GH"[(@>@
M'$G[-?TI&@?X6P3CW2RQH4->G@:E*P#%74PE4.3(4<J9$/6Q8%V0L%>4)"%!
MT[R5?#CG1/*3'OS/_P%02P,$%`````@`!XL*/S55.Z,`"```.#<``!$`'`!A
M<&1N+3(P,3$P-C,P+GAS9%54"0`#_O9"3O[V0DYU>`L``00E#@``!#D!``#M
M6UMSXC84?N],_X.'I_:!$#;=M,DDVW&(23TEAF*3=)\ZPA:@J2R[DIR$_OH>
MR3888QP3>LEV>,*6SOT[DHYD<?7C2TB-)\P%B=AUJWMRVC(P\Z.`L/EU:^+U
MVS^T?OST]5=7PE_@$!D2\3F6#@JQB)&/KUL+*>/+3N?Y^?D$!0R)$S\*.Q].
MN]WVZ7G[3$FC.,1,]B,>WN(92JB\;OV1($IF!`<M`]0SL2'F^>PDXG.0<=KM
M_'H_<+7BC/`2Q0%KH#0E3D1[CE"\HI\A,=6RLXZ,I=L^Z^8L',\VQ+],.<W-
M.>]`;T[((L:2L)HVD+PCES'N`%$;J#`G?LX7X)AC'TD<[-1ST4'<YQ'%8+`O
MV_@EIH@A&?%E']YS08HCD"LA10$?.VGGBI3NU'76^75`V.^EB+61E+NC!IV<
M3!.)1<[F1PF3?+EIC,#^R3QZZF2=%<'V$\XAV7;Q9;T5C!1,KG%)=4^1P.N8
MDVH5T%$A';_XBVIZU5/!P+"L`5,C"20Y-6%/6,AJ!6E?E8K7<VTSSQ@BOJA6
MHKLJ=+QLA34;BMV+BXN.[LU)!?&K94-'A63('&6CJ,PIW5,9U?DKPR2+K"9;
M629COL,TZ*GR&FA(33(1)B1B/F[!+&@85XBQ2"()LZ5^5RUQ3-@LREZA007J
M,L_!,9X9.G27RL_KEB!A3%5FZK:%GF_4I-96EIV>GYW^!O/#"9B6DR@G:\S3
M,0`6`7.L-FNP5IR+R*:3>FA!2!1C+@F`L1I`G;_-*Q_1?;T"%C^A[]FI`,_V
M=0I8""/OV">*IOOZ!"R8_J/N*#$>.&"HA\G8WE$":&MN(S]1%8?)`HM)(I<V
MC$X>ZCQJ&00FE%J*E>9<]QJQ3Z==HVWDW,5'Q`(C%6449%UUR@+*LA.!@R'[
MI)_+@SCCSDCJ.#=SJCE?:8!5,V:M.0('`..";[H6',[ZA,&<2A`=14(;WJ-(
MB*PD5!`UI*T%ZP,@M)(#S[VA<VLYKG6KGMSAP+XU/7BY,0>FT[,,]R?+\MPC
M9AN8]2(68`;2X4%$E`1JK;U!5*V([@)C*48(JC2YP)*`:2)%;V^N6AS/WH*C
M\<VFBF^/P.X:C#;L]T*\->ZRYEIHOFL&C>O!S[WE`"S#OC$<66/3LX'@B,DN
M3'I(+/HT>A8V"PAL&.46/-L4M4A]W!,I!53/='\R^H/AXQ&H$E!)&"*^',Y,
M7^]N"9N/8)KS"<XFP#J"6IC.555!A$\CD7"L,)O<WYOCSPH.L]<;3AS/=NZ,
M$0#6LZTC+INXV.`<FY,IQ:80L,JD8&RUUB+P?1D!V_%,Y\Z^&5B&Z;K'$J$<
M]"S%84E?(A5C%D`+3W`P(&A**)&K4=&(LA:<'\K@9&/"-4;F9U-#Y-RJQO$$
M)K.!;=[8`]L[#I0R9B-.GF`M&%'DY\M)Q)[4+@QP<2*9(]:`KA:OBS)>L-@\
M6&-/CR9GZ!V!*0$SQE35RE"[RJ7'$1/(5ZHS.';VUH'0/2V#,+8&>K$?F6/O
ML^&-3<<U>\>"K&+W@V(B$75EY/^>[6R*+;51[VZEOCFR/7,`)=:P]_,QT*7*
M%^(YC'4RP[+PB#AD=[Y^[^JL#?^'K4)*A1WV'CK/]3+Q:(XA]8_K^=:6/PR)
M5+.]BC;,]ZIZQ6Q=W-81U&)RMKT:W-_;7KHQ5(C`ZJ#*6\LYUK9;L/01X0^(
M)O@>(Q4^%?\4C\J>6B"^*P/1-^VQ\6`.)I9Q;YGN9*SW@$<$-A"XBR#/(=U]
MS+.#Y(V6VHA_+$?\;JCV<9#P/6OL'`-=VEY/!?XC`1^M)[Q>!LJMM0&OV$C?
MN-8O$W6T83U8_^]I_ZI3_"@);YL?+:](&$=<&JSR&L>.SY]&>@-D$/E:4`V+
M>FOG?&W5U.Y^:)]U3UY$D'W9V<<"Y6#Z-7\_"W*^?2VHODG14'?.H)1^;*2N
M]E+*#JU:8R5C!U,I\I;V6E1SSVNN(M194\&6/1]D1=7ED29F%/GRE\,,J;J-
MTLB2(N/J[2!;MJZA-+%CQ:2?#M*_?8&DB0%KKO3Q(!/*]TR:&)#SJ(?#E)=O
MDC32GC/IIWWUOW;YI<GT1#G?X%)SU(6:&+OGA]G0<'HLZ)>'ZZZ_(]?4GJ(4
M:RUD7_-J;Y4UR8Z<1ST<E!O;]\&:A*+,=1`\U=<?]S,C8DZM)=FM4FU*_84.
M<RHD1_D'-'77Y;=FY.F%&7T][!+:H-*W)0Y5E07.0"T*C(GBN.-1$N>$!$A:
M!LJ$7+<D3X"<$4K5B7?^GM+&X%\4>%I-D/#T^DFE?WU50.(!>5)G?U(5O^5O
M&@XN.MB0ONAA&,&H1'SY!A]GB(J=3D[3K_[@(9X26>5Z6BG*MWIN^@!FHL]%
MS1"RD_R9XLB"1PZLP]ELK\`T$?>OQLWG.'A#X";PH\W'@=H&J0IHR,J']]F'
MF)XN2HH)]";N+R"=FOB5N54\:W=@B_^F&+TBZPN(V",F\X4:#.`6FF.8E:>8
M#V?N`L&&>)A(Q:K^+'"#H*J"47)+:"+5%A470G6(D(UI6#/\W1%J/@\_P'8&
MS$J/HFTA$AQX$4P)Q,=<W.I;&!%7AZ)6&--HB?,34QV$MS"_CP2I#XHZ#HZ8
M/J1/O;*9BZ6DJVM$$@-HQ9'3F.-+<#__')%ZTH]X=E]1'0P*64R`5RG_#7>;
M.U9>&=>G:14E51/B=U10%3_C57A3W?U.[??PB[RAJR^46PX4^E,/TK\N7<J\
M_;]+L>+Y>04,U=W_'0Q7G703`X]_`5!+`0(>`Q0````(``>+"C_PU&X1SF\`
M`%QN!@`1`!@```````$```"D@0````!A<&1N+3(P,3$P-C,P+GAM;%54!0`#
M_O9"3G5X"P`!!"4.```$.0$``%!+`0(>`Q0````(``>+"C^W5Z`%6P<``+9D
M```5`!@```````$```"D@1EP``!A<&1N+3(P,3$P-C,P7V-A;"YX;6Q55`4`
M`_[V0DYU>`L``00E#@``!#D!``!02P$"'@,4````"``'BPH_H/>VFH\+``"\
MI```%0`8```````!````I('#=P``87!D;BTR,#$Q,#8S,%]D968N>&UL550%
M``/^]D).=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`!XL*/WU+YL_5+0``
M!YD"`!4`&````````0```*2!H8,``&%P9&XM,C`Q,3`V,S!?;&%B+GAM;%54
M!0`#_O9"3G5X"P`!!"4.```$.0$``%!+`0(>`Q0````(``>+"C\:G83")A(`
M`-X;`0`5`!@```````$```"D@<6Q``!A<&1N+3(P,3$P-C,P7W!R92YX;6Q5
M5`4``_[V0DYU>`L``00E#@``!#D!``!02P$"'@,4````"``'BPH_-54[HP`(
M```X-P``$0`8```````!````I($ZQ```87!D;BTR,#$Q,#8S,"YX<V155`4`
J`_[V0DYU>`L``00E#@``!#D!``!02P4&``````8`!@`:`@``A<P`````
`
end

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
